Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.7634631726382044,-2.317653648699601,0.0,0.0,0.0,14/58,5.05%,THEMIS;ITK;NKG7;CCL5;GNLY;CD2;CST7;BIN2;GZMB;HAVCR1;CD96;HPGDS;PRF1;PYHIN1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.8863389204409502,-2.2522233471170896,0.0,0.0,0.0,13/30,5.05%,THEMIS;ITK;NKG7;GRAP2;GNLY;ZNF831;CD2;CST7;BIN2;GZMB;CD96;PRF1;PYHIN1
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.8579298061653209,-2.1385915979740533,0.0,0.004458664199624804,0.01,11/29,5.05%,THEMIS;ITK;GNLY;ZNF831;BCL11B;CD2;GIMAP8;GZMB;CD96;PRF1;PYHIN1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.6992425265821571,-2.1311029974717894,0.0,0.0033439981497186033,0.01,26/83,9.29%,TRGC2;THEMIS;ITK;NKG7;GRAP2;CCL5;GNLY;SAMD3;CD2;CST7;ITGAM;SELPLG;BIN2;GZMB;KLRG1;CD96;PRF1;PYHIN1;HCST;SERPINB9;CD247;AOAH;IL18R1;RASAL3;MYO1F;TGFB1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.9091935572705879,-2.11856921967202,0.0,0.0026751985197748826,0.01,14/24,6.11%,TRGC2;NKG7;GRAP2;CCL5;SKAP1;GNLY;CD2;CST7;KLRC4-KLRK1;GZMB;CD96;PRF1;PYHIN1;HCST
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.7163850911882721,-2.0774631148439417,0.0,0.002229332099812402,0.01,21/75,8.60%,THEMIS;ITK;NKG7;GRAP2;SKAP1;GNLY;CD2;CST7;SELPLG;BIN2;GZMB;CD96;PRF1;CEACAM21;ITGB5;PYHIN1;HCST;RAPGEF6;CD247;ARHGEF1;RASAL3
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.6977845922281604,-2.069221952331962,0.0,0.003821712171106975,0.02,17/58,8.60%,NKG7;GRAP2;GNLY;CD2;CST7;CD37;SELPLG;BIN2;GZMB;CD96;PRF1;CEACAM21;PYHIN1;HCST;CD247;AOAH;RASAL3
prerank,PanglaoDB_Augmented_2021__T Cells,-0.6493706818960054,-1.9613890747968237,0.0,0.026751985197748827,0.14,16/85,5.05%,THEMIS;ITK;NKG7;GRAP2;CCL5;SKAP1;GNLY;CD2;CST7;CYTL1;SELPLG;BIN2;GZMB;CD96;PRF1;PYHIN1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.60986209977253,-1.9413167275338772,0.0,0.029724427997498692,0.16,29/72,15.24%,NKG7;GNLY;CD2;CST7;CD37;GIMAP8;SELPLG;BIN2;GZMB;PRF1;CEACAM21;PYHIN1;HCST;CD247;AOAH;PLEK;RASAL3;MYO1F;NCKAP1L;ITGB2;CD53;LCP2;GIMAP4;GIMAP7;CYTH4;SNX20;IL6R;PIK3R5;PSTPIP1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.8315801857728922,-1.9255486382286022,0.0,0.038790378536735795,0.23,3/17,3.18%,SMDT1;MAIP1;MICU3
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6419946262478183,-1.881717332587514,0.0,0.06931196164871285,0.39,27/64,13.98%,ITK;CCL5;GNLY;CD2;GIMAP8;SELPLG;MAF;BIN2;GZMB;CD96;PRF1;PYHIN1;HCST;CD247;AOAH;HLA-E;PLEK;RASAL3;HAVCR2;ITGB2;CD53;ENTPD1;LCP2;GIMAP4;GIMAP7;CYTH4;SNX20
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.8274227765455595,-1.852510581795553,0.0,0.09028795004240227,0.5,8/16,14.41%,ZDHHC21;IL1A;IL1B;NOS1AP;EGFR;DDAH2;LYPLA1;AKT1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.7627157500940299,-1.8030207049665703,0.0,0.1708011362625502,0.77,5/23,4.52%,ITK;GNLY;CX3CR1;KLRG1;PRF1
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.9586169728426757,-1.7908395419945708,0.0,0.1834421842131348,0.78,2/8,0.21%,CCL5;IKZF3
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.8852411438874563,-1.78457667685485,0.0,0.1881556292241667,0.79,2/9,1.11%,FLNA;LOXL3
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.846702855225837,-1.7784083758527134,0.0,0.19060789453396038,0.81,3/11,2.66%,CCL5;INPP5K;TFAP4
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.8505137030597484,-1.7568966842929525,0.0,0.23683375130948225,0.89,2/10,6.93%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.9256988418375391,-1.7535415460236143,0.0,0.23110742768055234,0.9,3/9,3.18%,SMDT1;MAIP1;MICU3
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.7248168686554827,-1.7460688298360418,0.0,0.24428786483207476,0.92,5/13,10.92%,IKZF3;CD2;IL4I1;NCKAP1L;ABL1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5818246730438658,-1.74555057375225,0.0,0.23608626937013338,0.92,14/70,5.05%,THEMIS;ITK;NKG7;GRAP2;GNLY;ZNF831;CD2;CST7;SELPLG;BIN2;GZMB;CD96;PRF1;PYHIN1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8960891395151521,-1.736952566866166,0.0,0.25032214720750684,0.95,1/8,0.20%,CCL5
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.6337521871506032,-1.7313707762455806,0.0,0.25475185904219905,0.96,8/36,10.10%,TNFAIP8L3;PTAFR;CSF1R;PIK3C2B;IGF1;ADAP2;PI4KB;PLCL2
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.8935229376781372,-1.7236132229056336,0.0,0.26926454666429794,0.97,4/7,9.45%,SKAP1;PLEK;P2RY12;SRC
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.8113808391821841,-1.7108649446178674,0.0,0.304861164649346,0.97,1/10,0.20%,CCL5
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7580374352862208,-1.709068830689021,0.0,0.2974820753989669,0.97,5/15,13.32%,LGALS9;HLA-E;HAVCR2;NLRP3;SYK
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7905140483759474,-1.7079626854864303,0.0,0.28655491836819413,0.97,2/13,3.64%,CCL5;SH2B3
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9572836374459667,-1.7039309177765223,0.0,0.2937764300419454,0.99,2/6,3.49%,COL18A1;CCDC88C
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.8826589704106266,-1.7027206923916767,0.07407407407407407,0.289016982939965,0.99,4/8,6.92%,CX3CR1;TMEM106A;NOS1AP;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.7614139688760815,-1.6761773317532571,0.04,0.3925161966083492,1.0,5/12,13.32%,LGALS9;HLA-E;HAVCR2;NLRP3;SYK
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.7033869866527308,-1.6640632792711323,0.0,0.4342738930434559,1.0,4/19,3.72%,PHLDB2;INPP5K;PFN1;ARAP1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.7344277862367432,-1.6612492538628496,0.0,0.43062066495731177,1.0,6/16,9.94%,TGFBR3;ZNF703;LATS2;BCL9;TGFB1;ENG
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.7451805545753777,-1.6572679204212164,0.0,0.43680975830699253,1.0,5/17,8.50%,SMDT1;MAIP1;MICU3;STOML2;PHB2
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.7538826932877792,-1.6563835333738266,0.0,0.42762643005492434,1.0,3/18,4.12%,IL1B;LGALS9;APPL2
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6898635274759635,-1.6560879650536464,0.0,0.4170162398472611,1.0,4/20,10.58%,NCOA4;NEDD4;M6PR;SORL1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.700478923806497,-1.649642375389589,0.05,0.4391147284601914,1.0,3/21,6.39%,RING1;DDB2;LEO1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.611269032194885,-1.6426650433637173,0.0,0.4648157428108858,1.0,6/27,6.92%,CCL5;FGL1;CD2;DUSP3;IL4I1;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.8932638500186805,-1.6402015749906593,0.0,0.46201401463139186,1.0,2/8,6.93%,RALB;PIP4K2B
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.8800074057074251,-1.631408104566581,0.0,0.49702372498975445,1.0,1/7,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.9167545190279117,-1.6308928964984224,0.0,0.48633737192830556,1.0,2/6,1.11%,FLNA;LOXL3
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.8704136290907369,-1.628533534312104,0.0,0.49156772800863463,1.0,2/5,8.99%,TICAM1;TLR3
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.7969741433114268,-1.623765663839971,0.03571428571428571,0.506330256425685,1.0,3/9,8.50%,TP53;SSBP1;CHTOP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.7223044297770643,-1.6223799650659423,0.037037037037037035,0.5015997224577904,1.0,5/14,9.48%,CX3CR1;FFAR4;LILRB4;IGF1;NLRP3
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8276751708964347,-1.6183140020114766,0.06666666666666667,0.5073545099712597,1.0,4/6,7.01%,CCL5;LGALS9;CD274;TP53
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8688885063755418,-1.615222763020498,0.0,0.514063715561287,1.0,1/8,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.875585758355899,-1.6144367126861539,0.02857142857142857,0.5076932301972776,1.0,1/9,0.13%,STAT4
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.8222436558408548,-1.6135994962477835,0.0625,0.5015997224577905,1.0,3/6,14.15%,TICAM1;TLR3;IRF7
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.7219892244202261,-1.6104877393065296,0.045454545454545456,0.5060109540595469,1.0,5/17,14.30%,CCL5;SH2B3;RIPOR2;CXCL12;LRCH1
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5185124207273296,-1.6092177710535447,0.0,0.5010423894328373,1.0,25/75,13.98%,NKG7;GNLY;CD2;CST7;CD37;SELPLG;BIN2;GZMB;PRF1;CEACAM21;UCP2;HCST;CD247;AOAH;PLEK;RASAL3;MYO1F;NCKAP1L;ITGB2;CD53;LCP2;GIMAP4;GIMAP7;CYTH4;SNX20
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.970831325496217,-1.6085616337087274,0.0,0.49409278783597316,1.0,2/5,0.22%,CCL5;SKAP1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.5365362145438811,-1.6075657851293674,0.0,0.489293809266826,1.0,16/84,12.65%,GRAP2;RALB;CCDC88C;SETDB1;IGF1;USP28;BCR;RAPGEF6;KRAS;TP53;RIN2;CRKL;PLD2;RASGRP2;ABR;RIT2
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.8626651773495415,-1.6072812102865588,0.0,0.4807489104654274,1.0,4/8,12.33%,INPP5K;SETDB1;APOBEC3G;TASOR
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.8824903511920315,-1.6025839644851718,0.02857142857142857,0.4907960361279304,1.0,5/8,9.69%,RUNX3;LILRB4;HLA-E;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.8686205575536501,-1.599016526532681,0.0,0.4986973844410536,1.0,1/6,0.20%,CCL5
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.9530071053790913,1.5938740334374106,0.013888888888888888,1.0,0.69,1/6,1.60%,TGFB2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.868055827603244,-1.5919825507863155,0.04,0.5261223755557268,1.0,4/8,8.95%,RUNX3;LGALS9;CD274;CBFB
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.8848883802687161,-1.5903256883556072,0.08,0.5248253096067451,1.0,1/6,0.13%,STAT4
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7120331145254033,-1.588442065893438,0.0,0.5257242805379032,1.0,3/11,8.99%,TICAM1;MLKL;TLR3
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.857923237468362,-1.5871034932437316,0.06666666666666667,0.5228370440402138,1.0,2/5,9.49%,KHSRP;TREM2
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.9406669249624106,1.5836495016259187,0.0,1.0,0.81,6/12,5.39%,TGFB2;METRN;RELN;CDH2;NFIB;ANXA1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.6499029766895059,-1.582006178491196,0.0,0.5405745974441659,1.0,8/24,16.38%,CPSF1;LSM11;WDR33;SNRPB;CSTF1;CPSF4;CPSF2;TTF2
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.9130945422309582,-1.57986389706903,0.0,0.5438814617745714,1.0,1/5,0.43%,TGFBR3
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.8697204966350989,1.5796335524396314,0.0,0.817772121262701,0.85,5/25,5.12%,PCSK1;FA2H;AANAT;NMRAL1;DMD
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.8486585662246293,-1.5761910980627225,0.0625,0.5493074293937757,1.0,5/9,12.48%,CORO1B;WHAMM;ARFIP1;WASHC5;GSN
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.7026033024926012,-1.5760396962398535,0.05555555555555555,0.5409602252692324,1.0,3/12,8.99%,TICAM1;MLKL;TLR3
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6832803539152899,-1.5741773719694347,0.0,0.5415119584383028,1.0,1/20,0.11%,RNASEL
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.8748095595929438,1.5737336699787388,0.0,0.7200937845563229,0.88,5/26,5.47%,KLF4;LRP2;ACVR1B;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.6676383986587326,-1.571189690112463,0.0,0.5501142352965651,1.0,5/17,11.77%,CCL5;IL1B;IGF1;TGFB1;PLK3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.7778243807540172,-1.570863643957146,0.07142857142857142,0.5427726996762008,1.0,3/9,9.69%,RUNX3;CBFB;NCKAP1L
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.7235309751251404,1.5701057793310789,0.0,0.6269586263014042,0.89,42/100,16.00%,SOCS3;FGF1;AANAT;OPALIN;GFAP;VIM;AMER2;BRINP1;NCAN;GPM6B;AGT;NRXN1;CADM2;MAPK4;PLPPR4;SLC1A2;PHYHIPL;DAAM2;CA10;PTPRZ1;GRIN2A;LUZP2;BAALC;GRIA2;SNAP25;CDH20;FAIM2;TCEAL2;PTN;PLP1;GPRC5B;ADCY8;GRIA3;VSTM2B;SORBS1;NTRK2;SLC25A28;NFASC;STMN2;LY6H;SLC39A12;PLXNB1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.9698957591014553,1.5698760359743358,0.0,0.5254943075521431,0.89,1/9,0.01%,KCNE1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.832594247883069,-1.568922094429562,0.05,0.5426537305112589,1.0,2/7,5.68%,IDE;ERAP2
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.8975945114037502,1.568831428443504,0.0,0.46600030402112647,0.9,1/12,0.44%,PLPP3
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.7758279016575562,-1.5669253174557107,0.09090909090909091,0.5439570323542261,1.0,7/10,19.57%,CX3CR1;TREM2;NMI;TYROBP;SYK;GRN;PLCG2
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.9281276130924203,-1.5667990816912745,0.0,0.5281550018820265,1.0,1/5,0.20%,CCL5
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.9281276130924203,-1.5667990816912745,0.0,0.5281550018820265,1.0,1/5,0.20%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.8769816769668449,-1.565420274590629,0.03571428571428571,0.5282547801729388,1.0,1/10,0.20%,CCL5
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.9530351513572449,1.5632246187158307,0.0,0.49974962966053954,0.92,1/11,0.01%,KCNE1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.6899318221368725,-1.5629975072104179,0.09523809523809523,0.5333199334779783,1.0,4/21,9.69%,ITK;BLNK;BTK;NCKAP1L
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7522570341519049,1.5601700504789344,0.0,0.484605701489008,0.93,49/91,18.44%,PCSK1;FAM13C;PCDH17;LRP4;SULT4A1;GRIA4;PTPRD;KCTD16;BRINP1;NRXN1;MAPK4;PLPPR4;CNTN1;RAB3C;TTLL7;LIFR;ASXL3;PHYHIPL;KIF1B;SYT4;ANK2;ARNT2;CSRNP3;UNC5D;GRIA2;SNAP25;MAP2;UNC13A;AKAP12;CACNA1B;FAIM2;CADPS;FAM171B;ERC2;TAGLN3;MAP1B;CRMP1;KALRN;LSAMP;NFASC;STMN2;ITSN1;NDRG4;ASIC2;SYNPR;CHGB;MAPK10;CPE;ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.822006623142151,-1.559317242836749,0.06666666666666667,0.5455897826245112,1.0,3/7,8.50%,GTF2H2;SSBP1;CHTOP
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.7429761070954911,1.5589164779741966,0.0,0.454317845145945,0.96,36/69,19.35%,PCSK1;DEPP1;FAM13C;PCDH17;KCNT2;PTPRD;AGT;PLPPR4;RAB3C;ASXL3;PHYHIPL;RUNX1T1;SYT4;CSRNP3;CAMK2N1;PTPRT;SNAP25;MAFB;CADPS;FGF14;SH3GL2;GRIA3;SHC2;NFASC;STMN2;LDB2;PEMT;CHGB;MAPK10;ALDH1A1;SORBS2;CPE;EDIL3;ST8SIA3;KCNB2;CNTN3
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.7580027175943806,-1.557709012560073,0.047619047619047616,0.5471152528289603,1.0,2/17,4.02%,CCL5;LGALS9
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.7182231995376158,-1.5522165912790507,0.0,0.5694874657164612,1.0,6/18,10.09%,ITGA5;FLNA;DDR1;ARHGAP35;LCP1;COL5A1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8765847792388758,-1.5519999085465874,0.0,0.5625147157796916,1.0,2/6,8.50%,ITGA5;PHB2
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.7659631444610154,1.5501017676637285,0.0,0.5022277269976992,1.0,28/57,19.09%,KCNE1;GRIA4;JPH1;CACNB2;RELN;NETO1;DMD;ANK3;PRRT1;GRIN2A;NLGN1;DAPK1;ANK2;GRIA2;FGF14;CACNG2;CAMK2B;GRIA3;LRRC7;AHNAK;GRIN2B;SHISA9;NEFL;GRIA1;MAPK8IP2;FGF13;APP;CACNG8
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.7204535030930402,1.5493175458608557,0.0,0.47021896972605315,1.0,53/118,17.24%,FA2H;ST18;OPALIN;GFAP;MOBP;AMER2;NFE2L3;ASPA;ENPP2;OMG;TMEM163;CREB5;ANLN;NCAN;GPM6B;NRXN1;MYRF;MAPK4;SLC1A2;HEPACAM;PHYHIPL;CA10;MOG;KIF1B;GRM3;SRCIN1;PEX5L;OLIG1;GRIA2;PTPRT;TTYH1;MAG;MPPED1;ERMN;NDRG2;FAIM2;PLP1;GPRC5B;ADCY8;VSTM2B;SORBS1;NTRK2;GALC;FASN;TYRO3;ZDHHC9;LY6H;TPPP;BCAS1;SLC39A12;PLLP;SYNPR;NINJ2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.487674748278504,-1.5490038216411077,0.0,0.5721357900958549,1.0,5/52,3.47%,CCL5;PDE12;GTF2F1;ADARB1;CTDP1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.9660448982468963,1.546911479502037,0.013333333333333334,0.46899580629681403,1.0,2/8,0.83%,NAMPT;NUDT12
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.8478983371373611,1.5466728107554755,0.0,0.43614513134010724,1.0,5/23,8.59%,KCNE1;CACNB2;SCN3B;ANK2;PKP2
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.8827881800892073,1.5457848996048578,0.02564102564102564,0.41857817466113073,1.0,1/11,0.04%,GLRA1
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6680985101076028,-1.5457274362073705,0.0,0.5786876798039351,1.0,6/19,9.94%,TGFBR3;ZNF703;LATS2;BCL9;TGFB1;ENG
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.9577280920901463,1.545182199158925,0.0,0.39979970372843165,1.0,1/10,0.01%,KCNE1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5613495409474152,-1.5442875557130118,0.0,0.5795105364914941,1.0,10/38,15.02%,KARS1;TARS2;DARS2;FARSA;CARS2;YARS1;TARS1;WARS1;LARS2;SARS1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.473391423405572,-1.5439046050053888,0.0,0.574310246328595,1.0,21/86,11.90%,NKG7;CCL5;CD300LF;CST7;ITGAM;LY86;SELPLG;BIN2;PIK3R6;HCST;AOAH;PLEK;RASAL3;LTC4S;MYO1F;NCKAP1L;ITGAX;ITGB2;HCK;CD53;TYROBP
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8938167473453893,-1.5438298675191722,0.03125,0.5673791290990906,1.0,1/5,4.36%,RPIA
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.9024159869649694,1.543475520944883,0.025,0.3710262402025218,1.0,3/7,5.13%,FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.9024159869649694,1.543475520944883,0.025,0.3710262402025218,1.0,3/7,5.13%,FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.7302970865828797,-1.5407469264041347,0.0,0.5778428802713746,1.0,4/13,10.58%,CCL5;TRIB1;IGF1;SORL1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.7172669129510737,-1.5399342417045776,0.0,0.5688059291740862,1.0,7/18,16.97%,GZMB;TP53;PPP1R13B;BID;PPP3CC;BCL2;CASP8
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.7172669129510737,-1.5399342417045776,0.0,0.5688059291740862,1.0,7/18,16.97%,GZMB;TP53;PPP1R13B;BID;PPP3CC;BCL2;CASP8
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.7204752082315538,-1.5392450446862211,0.05555555555555555,0.5656594460487854,1.0,5/13,10.61%,FOLR2;SLC46A1;MTHFD2L;MTHFD1L;SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.9077983387846502,-1.5390116962732836,0.0,0.5594031190457834,1.0,2/6,4.05%,TICAM1;SCIMP
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7315424705627313,1.5363569642013057,0.0,0.4160595002915497,1.0,55/79,23.87%,PCDH17;DENND2A;SULT4A1;GRIA4;PTPRD;SCN3B;BRINP1;NCAN;GPM6B;NRXN1;MAPK4;CNTN1;RAB3C;ASXL3;ROBO2;RUNX1T1;ANK2;FMN2;CSRNP3;UNC5D;GRIA2;SNAP25;GABRB3;UNC13A;CACNA1B;CADPS;MAP1B;PLP1;NTRK3;NOVA1;TMEM132B;SH3GL2;CRMP1;LSAMP;MAGI2;GRID2;PNMA2;NFASC;CTNNA2;STMN2;NDRG4;NEFL;ST8SIA3;GRIA1;ATP1B2;GUCY1A2;SNAP91;PAK3;ELAVL3;PTPN5;CNTN2;ATP1A2;B3GAT1;DCLK1;KCNQ2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7343679933152601,1.536117020028999,0.0,0.39661947881241,1.0,26/60,13.01%,LRP4;LRRC4C;SULT4A1;NCAN;CADM2;MAPK4;DPYSL5;CASKIN1;SRRM3;PHYHIPL;CTNND2;PTPRZ1;GALNT13;ANK2;CSRNP3;UNC5D;LINGO1;GRIA2;UNC13A;CACNA1B;ERC2;TAGLN3;MAP1B;CSPG5;ZNF536;PAK5
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.754281497324567,-1.5360081439355808,0.041666666666666664,0.5660405338606032,1.0,5/12,19.11%,KARS1;DARS2;SARS1;TRPT1;RPP30
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.7861735166397117,-1.5358759435020204,0.10526315789473684,0.560236341176112,1.0,3/11,9.41%,TAL1;CEBPA;EP300
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.7933835138165694,1.5331332533272293,0.0,0.4093187442933943,1.0,4/37,5.93%,THBS1;KLF4;BEX3;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7957830610344421,-1.5322608092238277,0.14285714285714285,0.5714777527588067,1.0,4/10,8.11%,LGALS9;SERPINB9;ARRB2;HLA-E
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),-0.8766892732222011,-1.53158719718455,0.029411764705882353,0.567719685872681,1.0,3/5,10.61%,FOLR2;SLC46A1;SLC19A1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7667495490761504,-1.5308998802488545,0.18518518518518517,0.5644969460828347,1.0,3/9,9.45%,SKAP1;PLEK;SRC
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5731774236732082,-1.5307079718830696,0.0,0.5588192463529754,1.0,6/37,6.88%,RNASEL;CCL5;INPP5K;SETDB1;APOBEC3G;BANF1
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.8958937295327656,-1.528745962774984,0.0,0.5639965230975947,1.0,3/7,8.55%,RUBCNL;PIP4K2B;PLEKHM1
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.8682231848613754,-1.528679392006685,0.11764705882352941,0.5521552213664396,1.0,3/5,10.86%,INPP5K;PASK;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.8682231848613754,-1.528679392006685,0.11764705882352941,0.5521552213664396,1.0,3/5,10.86%,INPP5K;PASK;ENPP1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.7737104079100753,1.5277897246886607,0.0,0.4419273584601466,1.0,5/41,3.54%,THBS1;RAB7B;HMGB2;WDR5;FAXDC2
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.7698164254211478,1.526648493091051,0.0,0.43377477736543274,1.0,9/41,8.84%,KCNE1;LRP2;COL11A1;LHFPL3;NDUFB9;PCDH15;CEMIP;SLC26A5;TIMM13
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.9555076130137998,1.5223856359920376,0.0,0.4501532648987739,1.0,3/8,3.54%,RAB7B;HMGB2;FAXDC2
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.7550139395983699,1.5218651096118787,0.0,0.436508585616224,1.0,10/53,5.10%,HS3ST5;OMD;HS3ST2;CHST7;OGN;VCAN;NCAN;B4GAT1;GPC5;CEMIP
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7080652722740082,1.5216089647389155,0.0,0.4218166454547352,1.0,35/86,15.34%,PCSK1;FAM13C;COL11A1;GNRHR;KCNT2;GRIA4;PTPRD;KCTD16;NRXN1;CADM2;PLPPR4;RAB3C;ASXL3;ROBO2;RUNX1T1;SYT4;FMN2;CSRNP3;UNC5D;GRIA2;OLFM3;SCN3A;CADPS;FGF14;TMEM130;NOVA1;ZNF536;GRIA3;LSAMP;MAGI2;SGIP1;NREP;NFASC;STMN2;GAD2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.7622744511528561,1.5182835837658994,0.0,0.43479900439152663,1.0,9/41,8.84%,KCNE1;LRP2;COL11A1;LHFPL3;NDUFB9;PCDH15;CEMIP;SLC26A5;TIMM13
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.9483592090854633,1.5179366081778527,0.014925373134328358,0.4225155959857289,1.0,1/7,0.07%,TOP2A
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.8976969135962272,1.5170650192743975,0.0,0.4154658363196711,1.0,3/11,1.04%,GLRA1;HHIP;NLRP12
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.8245740983192081,1.5168682525201302,0.0,0.4034342464895992,1.0,7/26,8.81%,GLRA1;RACGAP1;ANO4;SLC4A10;SLC11A1;SLC13A4;TTYH1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.4971110637704222,-1.5168454641985385,0.0,0.6049079206150546,1.0,17/71,10.61%,GRAP2;TAL1;ETS1;LYL1;RHOG;P2RX1;SH2B3;HHEX;RPIA;ARHGDIB;FAM78A;EPOR;SIPA1;BTK;ENG;NMI;PTPN7
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.7311939930194103,-1.5165775529015417,0.08,0.6012156673388815,1.0,3/16,10.22%,RING1;DDB2;RNF8
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7931968857710573,-1.5163578857320505,0.0625,0.5962070034435791,1.0,4/7,15.05%,TP53;TGFB1;EGFR;DDX5
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.7005431227580442,-1.5135562239038538,0.05,0.6059186750459192,1.0,5/14,10.61%,FOLR2;SLC46A1;MTHFD2L;MTHFD1L;SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.9456844109352995,1.513388310578368,0.0,0.4188517423958422,1.0,2/9,0.41%,THBS1;KLF4
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.6768140901689529,-1.513355776821993,0.0,0.6006912594657784,1.0,3/11,10.26%,SPIN1;NIFK;RPAP2
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.8393515153287247,-1.5112961230596342,0.10344827586206896,0.6040814435309848,1.0,2/5,10.58%,PLEKHJ1;SORL1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.7562152425138048,-1.5110452404246448,0.05,0.5987094287256186,1.0,1/12,0.20%,CCL5
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.7168975658802843,1.5104664187659766,0.0,0.43330564480794503,1.0,36/80,15.32%,FAM13C;PCDH17;LRP4;LRRC4C;GFAP;PTPRD;BRINP1;NCAN;GPM6B;MAPK4;PLPPR4;FBXL7;ASXL3;PHYHIPL;RUNX1T1;PTPRZ1;NLGN1;SPRY1;ANK2;ARNT2;CSRNP3;GRIA2;MAP2;FAIM2;PTN;MAP1B;PLP1;GPRC5B;NOVA1;PPFIA2;ZNF536;CRMP1;NTRK2;NFASC;STMN2;LY6H
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.7152467850641301,1.50873692948428,0.0,0.4364204754886805,1.0,57/104,19.55%,FAM13C;SULT4A1;AMER2;GRIA4;PTPRD;KCTD16;SCN3B;BRINP1;NCAN;NRXN1;CADM2;MAPK4;PLPPR4;RAB3C;ASXL3;PHYHIPL;CA10;KIF1B;SYT4;ANK2;CSRNP3;GRIA2;SNAP25;OLFM3;MAP2;CACNA1B;FAIM2;TCEAL2;ERC2;TAGLN3;MAP1B;PLP1;NKAIN2;NOVA1;PPFIA2;ADCY8;SH3GL2;ZNF536;CRMP1;LSAMP;PAK5;MAGI2;NFASC;STMN2;LY6H;SCN2A;NDRG4;ASIC2;SYNPR;PIEZO2;KIF5A;MAPK10;LRFN5;ST8SIA3;FGF13;PARM1;CCDC92
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.8269054722886999,1.5083763035875941,0.012195121951219513,0.4273260202284507,1.0,3/17,2.87%,GDPD1;ENPP2;ABHD12B
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",-0.8786982703665943,-1.5069621837807934,0.10526315789473684,0.6133091259939346,1.0,4/5,9.69%,RUNX3;LILRB4;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.8167193287984591,-1.5067920065120286,0.10256410256410256,0.60821425170176,1.0,3/7,17.52%,MAGED2;GSN;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.8520598001975868,-1.5056961636753938,0.03225806451612903,0.6086725952516929,1.0,1/7,4.28%,ZNF675
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.7246501251532445,1.5053638444144901,0.0,0.44081811489017975,1.0,43/71,22.48%,SULT4A1;MAPT;NR4A2;NCAN;NRXN1;MAPK4;DPYSL5;CASKIN1;PHYHIPL;CTNND2;SYT4;SRCIN1;CSRNP3;LINGO1;BSN;GRIA2;SYP;SNAP25;OLFM3;UNC13A;CACNA1B;ERC2;HS6ST3;PAK5;STMN2;LY6H;GAD2;CALY;LONRF2;SCN2A;KIF5A;APLP1;KCNJ6;ST8SIA3;KCNB2;MAPK8IP2;CHD5;GABRG2;SNAP91;TMEM59L;ELAVL3;PTPN5;CNTN2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.9085749671638792,-1.5047472319912865,0.0,0.6061639722932222,1.0,2/7,5.05%,PDE12;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.9275261745890372,1.5044260666201452,0.014492753623188406,0.44043591098870777,1.0,1/5,0.98%,FGF1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7211942924546013,-1.5039496662977514,0.041666666666666664,0.6040853038463092,1.0,2/15,2.07%,BUD23;FBL
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.8286802149165989,-1.5023237722024105,0.0,0.6054529480132023,1.0,3/6,8.53%,TAL1;SH2B3;ZNF385A
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.8803219604282613,1.5020350568405105,0.0,0.41865389430198835,1.0,2/11,4.09%,CENPF;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.8803219604282613,1.5020350568405105,0.0,0.41865389430198835,1.0,2/11,4.09%,CENPF;TEX14
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8803219604282613,1.5020350568405105,0.0,0.41865389430198835,1.0,2/11,4.09%,CENPF;TEX14
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.8803219604282613,1.5020350568405105,0.0,0.41865389430198835,1.0,2/11,4.09%,CENPF;TEX14
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.7806086504080596,1.5019289157743159,0.012195121951219513,0.4086644421703037,1.0,9/37,6.33%,ASPN;SPARC;SVEP1;RBMS3;ADAMTS2;ECM2;DAAM2;RUNX1T1;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.8066575300330131,1.501897554684669,0.0,0.399150678235366,1.0,5/21,8.89%,THBS1;PLPP3;PRKCE;ANXA1;KANK1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.8560280128045237,1.5006040639106135,0.0,0.4025467418618723,1.0,4/19,5.93%,THBS1;KLF4;ANXA1;VEGFA
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8082791674015075,1.500250098648047,0.011764705882352941,0.39649557394555207,1.0,3/21,7.09%,TOP2A;KNSTRN;SMC4
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.7859961789153819,1.4982448396941714,0.0,0.40545343691247004,1.0,3/26,1.13%,KCNE1;FA2H;COBL
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.8644026239566249,-1.49669663603819,0.05555555555555555,0.6282966243172223,1.0,3/7,4.06%,NEDD4;DAB2IP;HHEX
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.914337255584051,1.49635187554055,0.0,0.4104662966144669,1.0,3/9,1.04%,GLRA1;HHIP;NLRP12
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.8386343285050123,1.496347187837466,0.02564102564102564,0.4017329711545846,1.0,3/16,7.01%,KCNE1;KCNT2;SLC11A1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.8012209008562221,1.4959455927585537,0.0,0.39677091809412535,1.0,4/17,6.76%,OMD;OGN;B4GAT1;GNS
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5541442943458894,-1.49441937386481,0.0,0.6338734270466596,1.0,9/27,10.38%,FLNA;MYH9;ACTB;PLEK;ILK;TLN1;P2RY12;UBASH3B;GNAS
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.867032463801602,1.494064450883699,0.011235955056179775,0.4035084208316638,1.0,2/11,0.98%,THBS1;FGF1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.8944428152591903,-1.49165776178718,0.0,0.636697247706422,1.0,1/5,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.8944428152591903,-1.49165776178718,0.0,0.636697247706422,1.0,1/5,0.03%,PHLDB2
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7307456723131365,1.4913513959525748,0.0,0.4194262346387364,1.0,35/69,18.37%,PLPP3;FAM13C;LRP4;TGFB2;COL11A1;KCNT2;PTPRD;BRINP1;VCAN;MAPK4;PLPPR4;FBXL7;LIFR;ASXL3;RUNX1T1;COL23A1;ANK2;CSRNP3;MAP2;PTN;MAP1B;CCDC3;GPRC5B;CRMP1;SHC2;ADGRL2;NFASC;STMN2;LDB2;THY1;MAPK10;CPE;EDIL3;LRFN5;MPDZ
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.8608488820198691,1.4909824957417324,0.02531645569620253,0.41351832101323077,1.0,3/14,5.93%,LRP2;TGFB2;VEGFA
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.8120168269720867,-1.4897405367365943,0.0625,0.6354790769518817,1.0,3/8,7.01%,RPS6KA6;TFAP4;TP53
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.8120168269720867,-1.4897405367365943,0.0625,0.6354790769518817,1.0,3/8,7.01%,RPS6KA6;TFAP4;TP53
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.8292707981912275,1.489003248516208,0.024096385542168676,0.4247871852114586,1.0,1/19,0.01%,KCNE1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.69374283796038,1.488958962477197,0.010101010101010102,0.416772332660299,1.0,66/119,23.87%,SULT4A1;NRG1;TMEM163;BRINP1;INSYN2A;NCAN;RELN;GPM6B;CADM2;MAPK4;DPYSL5;KIF1B;SYT4;NLGN1;GALNT13;ANK2;CSRNP3;CNR1;CHN1;LINGO1;GRIA2;SNAP25;OLFM3;MAP2;MAP9;CACNA1B;KCNH7;FAM171B;ERC2;DNM3;CNTNAP2;TAGLN3;SLITRK5;MAP1B;NOVA1;PPFIA2;SH3GL2;ZNF536;CRMP1;EPHA7;PAK5;SYT1;LINGO2;GRID2;PNMA2;STMN2;NDRG4;NEFL;KIF5A;APLP1;CLSTN2;PREPL;EDIL3;ST8SIA3;SMAD1;SNAP91;TMEM59L;DYNC1I1;ELAVL3;PTPN5;REEP2;CNTN2;RNF138;KIF5C;DCLK1;KCNQ2
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.717716718874642,1.4878476880980716,0.010869565217391304,0.41965507621999515,1.0,39/72,18.79%,PCSK1;SULT4A1;GRIA4;ENPP2;NCAN;NRXN1;RAB3C;ASXL3;PHYHIPL;CTNND2;VEGFA;CA10;SYT4;CSRNP3;UNC5D;GRIA2;PTPRT;SYP;SNAP25;OLFM3;UNC13A;ALCAM;CACNA1B;SCN3A;CADPS;TAGLN3;SH3GL2;PAK5;CCK;NFASC;STMN2;LY6H;GAD2;CALY;ASIC2;CHGB;CPE;ST8SIA3;KCNB2
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.6460896548378653,-1.4864434681222118,0.058823529411764705,0.6466641377668223,1.0,6/12,24.84%,SVIP;DERL2;EDEM2;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.7666353695309995,-1.48639902198808,0.0967741935483871,0.6414609784039159,1.0,1/10,0.20%,CCL5
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.8030467204260303,1.4856402780261062,0.012048192771084338,0.4308585236874999,1.0,8/23,12.01%,CENPF;LRP4;GREB1L;TGFB2;AGT;VEGFA;PAX8;SULF2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.8659910035387925,-1.4841884841621307,0.037037037037037035,0.6464675379525564,1.0,2/6,5.63%,NEXMIF;ACER2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.8178811962423574,1.4826150681138868,0.012345679012345678,0.4496124103212192,1.0,6/24,9.98%,DIAPH3;COBL;SPIRE2;PSTPIP2;WASF1;MICALL2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.9731850439176807,1.4815430796207572,0.014492753623188406,0.4504920106605055,1.0,1/6,0.04%,GLRA1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8733831138247895,-1.4792085704544597,0.1111111111111111,0.6595393273752691,1.0,1/6,0.13%,STAT4
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8733831138247895,-1.4792085704544597,0.1111111111111111,0.6595393273752691,1.0,1/6,0.13%,STAT4
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6240301413870303,-1.4784028357572885,0.0,0.65735068712604,1.0,3/17,5.83%,BUD23;FBL;THUMPD1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.8182506153615097,-1.4783345709041038,0.058823529411764705,0.65205153837034,1.0,3/6,8.08%,GTF2H2;GRK2;ARRB2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.6960556823038572,1.4771648916277718,0.010869565217391304,0.4870600622616356,1.0,27/69,15.32%,SULT4A1;GFAP;NCAN;GPM6B;MAPK4;DPYSL5;SRRM3;PHYHIPL;CTNND2;PTPRZ1;RBM3;ARNT2;CSRNP3;LINGO1;GRIA2;MAP2;RND3;PTN;TAGLN3;CSPG5;PLP1;IGF1R;ZNF536;CRMP1;PAK5;STMN2;LY6H
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.8289178985517768,1.4766402975868407,0.0,0.4851190549863481,1.0,5/20,8.59%,KCNE1;SCN3B;DMD;ANK2;PKP2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.7072374457566188,1.4758441989904911,0.0,0.485968655024446,1.0,44/87,16.89%,LRRC4C;SULT4A1;GFAP;AMER2;GRIA4;PDE10A;SCN3B;SPOCK1;BRINP1;NCAN;NRXN1;CADM2;PLPPR4;RAB3C;GABRB1;PHYHIPL;CA10;SYT4;GRM3;CSRNP3;GRIA2;SNAP25;OLFM3;FAIM2;TCEAL2;TAGLN3;PLP1;NEGR1;PPFIA2;SH3GL2;ZNF536;LSAMP;VSTM2B;PAK5;CCK;CLASP2;FXYD7;NFASC;STMN2;LY6H;GAD2;SCN2A;ASIC2;SYNPR
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7622239665852653,-1.475392820701697,0.08,0.6603281679644335,1.0,3/11,8.11%,IDE;ERAP2;HLA-E
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.8773397497323031,-1.4724854248392543,0.05,0.6673625398297919,1.0,2/7,4.30%,TARS2;DARS2
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.6976743485507355,1.4722935876258878,0.0,0.5098786832572361,1.0,50/114,18.44%,FAM13C;TUB;PCDH17;LRRC4C;SULT4A1;KCTD16;BRINP1;PPP2R5B;NCAN;NRXN1;CADM2;MAPK4;PLPPR4;CNTN1;TTBK2;ASXL3;PHYHIPL;CA10;KIF1B;SYT4;ANK2;AKAP6;CSRNP3;GRIA2;SNAP25;OLFM3;MAP2;CACNA1B;SCN3A;FAIM2;TAGLN3;MAP1B;NOVA1;PPFIA2;ZNF536;CRMP1;KALRN;LSAMP;PAK5;NTRK2;CCK;NFASC;STMN2;LY6H;NDRG4;ASIC2;MAPK10;NMNAT2;CPE;ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.8186743217115006,-1.4720083315947037,0.0,0.663317665763854,1.0,1/8,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.6562579519986916,-1.4712037156872269,0.08,0.6619485117833216,1.0,2/12,10.45%,PKIB;MAP3K4
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.7086972620750325,1.4710178967613357,0.0,0.5148447064508725,1.0,40/81,16.89%,AMER2;GRIA4;KCTD16;SCN3B;NCAN;NRXN1;MEIS2;SLC1A2;PHYHIPL;DIRAS2;CA10;GRM3;GRIN2A;CSRNP3;BSN;GRIA2;FRRS1L;SNAP25;OLFM3;UNC13A;CACNA1B;GABRA2;CADPS;TMEM130;NTRK3;SCN1A;PPFIA2;TMEM132B;LSAMP;PAK5;MAGI2;GRIN2B;CTNNA2;STMN2;GAD2;SLC17A7;SCN2A;NDRG4;ASIC2;SYNPR
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.8211473452010722,-1.4707980622520749,0.06451612903225806,0.6584440227703985,1.0,2/8,12.94%,METAP1D;NAA20
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.9181703808453899,1.4705304157672612,0.0,0.5122974558598085,1.0,1/11,0.01%,KCNE1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.9292328156032313,1.4699428634905622,0.0,0.5089779608900665,1.0,1/9,0.41%,KLF4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.824806376091464,1.46918567068908,0.012658227848101266,0.508556406351061,1.0,5/16,11.94%,PTPRD;RELN;IL1RAPL1;SS18L1;CAMK2B
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.5471642248465449,-1.468949681680681,0.0,0.6637702567265439,1.0,22/138,10.64%,THEMIS;ITK;GRAP2;SKAP1;BTN3A2;PSMB3;PSME3;FYN;CHUK;CD276;BLNK;PSMD12;PSMC4;CD247;SPG21;PSME4;STOML2;BTK;NCKAP1L;IKBKB;HLA-DPA1;INPP5D
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.8489910253327236,1.4683972830429235,0.0,0.5096620190091783,1.0,1/12,0.16%,SOCS3
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6871293831725244,1.4677539381463058,0.010638297872340425,0.5081579002274197,1.0,34/82,17.99%,FAM13C;FGF1;LRP4;GFAP;ASPA;CLIP3;AGT;MAPK4;PLPPR4;PHYHIPL;DAAM2;SEMA3B;NDRG1;ANK2;ARNT2;OLIG1;GRIA2;MAG;FAIM2;PTN;PLP1;GPRC5B;CTHRC1;SHC2;SORBS1;NTRK2;PMP22;NFASC;RGS11;BCAS1;NDRG4;HSPA12A;THY1;CPE
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.7662310193602708,1.4670013498966028,0.012658227848101266,0.5077670033984092,1.0,7/21,8.47%,PRLR;LSR;RARRES1;BAIAP2L1;OVOL2;PPP1R13L;KDM3A
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8321815890282511,-1.4669580880337665,0.09523809523809523,0.6691181059579796,1.0,1/6,0.43%,TGFBR3
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.7595757355215733,-1.4666246710866413,0.13333333333333333,0.6652186555471716,1.0,3/8,18.00%,ZDHHC21;PDE4D;ADRB2
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.8946661463201637,-1.466533512184803,0.16129032258064516,0.6602306346850667,1.0,1/5,8.30%,DDX23
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.840104290093262,-1.4661821876773315,0.0,0.6573937447818896,1.0,4/8,11.90%,TICAM1;ITGAM;ITGB2;TYROBP
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.830403300685817,-1.4653002819470915,0.09090909090909091,0.6565554521032124,1.0,4/8,13.43%,CD300LF;HAVCR1;MILR1;CD226
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.9603441999942409,1.4642361951160479,0.0,0.5270087003692963,1.0,1/7,0.07%,TOP2A
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.7522496608130429,-1.4626504118092827,0.08695652173913043,0.6626732211198086,1.0,4/10,20.11%,FSCN1;OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7793218852552883,1.4625931819506977,0.047619047619047616,0.53505661648331,1.0,4/21,8.42%,SHANK3;RELN;NLGN3;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.7523842530522634,1.4621475859655744,0.0,0.5326396821119502,1.0,11/26,18.90%,CLIP3;TUBB4A;TTBK2;HDGFL3;MAP2;MID1IP1;CLASP2;STMN2;APC2;EML2;FGF13
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.6970165170030884,1.461841458125034,0.0,0.5281444949821611,1.0,38/90,15.34%,PCSK1;PCDH17;LRRC4C;SULT4A1;GRIA4;SCN3B;NRXN1;CADM2;MAPK4;CNTN1;RAB3C;UBE2QL1;ASXL3;PHYHIPL;ROBO2;CTNND2;CA10;SYT4;CSRNP3;UNC5D;GRIA2;PTPRT;SYP;SNAP25;GABRB3;CACNA1B;MAFB;CADPS;TCEAL2;CAMK2B;NOVA1;SH3GL2;LSAMP;PAK5;NFASC;STMN2;LY6H;GAD2
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.8477704363243626,1.4615102778028515,0.0,0.5241458755916643,1.0,1/19,0.01%,KCNE1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8158734357052532,-1.4606524645066494,0.06060606060606061,0.6651516319622093,1.0,5/6,18.12%,KMT2B;SETD1B;SETD1A;KMT2A;KMT2D
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.8519372794037188,1.4604845414034544,0.0,0.5267631231557038,1.0,2/15,0.83%,NAMPT;NUDT12
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.6373391590940595,-1.4602871202859098,0.0,0.6621619193307453,1.0,5/17,17.34%,PKIB;MAP3K4;NBN;TERF2;SMG6
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.9449268205401148,1.4599492938605128,0.0,0.524949126137968,1.0,2/5,2.87%,FAAH;ABHD12B
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7041905719385322,1.458589397603299,0.0,0.5298780762333759,1.0,44/96,17.48%,LRRC4C;SULT4A1;AMER2;GRIA4;SCN3B;NCAN;GPM6B;NRXN1;CADM2;MAPK4;DPYSL5;RAB3C;PHYHIPL;ROBO2;CTNND2;KIF1B;SYT4;GRM3;ANK2;CSRNP3;EPHA3;BSN;GRIA2;SNAP25;OLFM3;UNC13A;CACNA1B;ROBO1;ERC2;NTRK3;NOVA1;PPFIA2;ZNF536;EPHA7;LSAMP;PAK5;CLASP2;CTNNA2;STMN2;GAD2;HIVEP2;NDRG4;SYNPR;KIF5A
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.8140788291479202,-1.4584371640763973,0.038461538461538464,0.6667033922976283,1.0,3/7,11.97%,NEDD4;COMMD1;WNK3
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.7006522028507303,1.4576855137064233,0.0,0.533970973840364,1.0,29/65,17.54%,PCDH17;GFAP;PTPRD;GPM6B;NRXN1;MAPK4;PLPPR4;CNTN1;PHYHIPL;DAAM2;PTPRZ1;ANK2;LINGO1;PTPRT;CHL1;NDRG2;FAIM2;PTN;PLP1;CCDC3;GPRC5B;ZNF536;SHC2;SORBS1;NTRK2;NFASC;STMN2;THY1;ALDH1A1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6797176530147521,-1.457658095239817,0.16,0.665034535730704,1.0,4/11,14.30%,SH2B3;RIPOR2;CXCL12;LRCH1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.792341065471015,1.4574611006961042,0.0,0.5298045024932714,1.0,10/30,9.23%,CENPF;LRP4;GREB1L;TGFB2;ZBTB16;AGT;ROBO2;VEGFA;SOX4;PAX8
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7762014388313867,-1.4562579342863418,0.04,0.6659473962277842,1.0,3/9,7.07%,EHHADH;ACOX1;ACAA1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.7175900908846436,1.455522037300358,0.0,0.541155813015613,1.0,42/81,18.44%,FAM13C;PCDH17;PTPRD;PPP1R9A;AGT;NRXN1;MAPK4;NFIB;PLPPR4;CNTN1;LIFR;ASXL3;PHYHIPL;SYBU;SYT4;ANK2;CSRNP3;GRIA2;PTPRT;SNAP25;MAP2;PXK;FGF14;THSD7A;NOVA1;PPFIA2;UNC5C;KALRN;LMO3;SHC2;PAK5;NTRK2;ADGRL2;NFASC;LIMCH1;STMN2;LONRF2;ESRRG;MAPK10;SORBS2;CPE;ST8SIA3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6637255752994293,1.4551984916572736,0.0,0.5364357956560746,1.0,54/124,21.72%,GLRA1;HTR2B;HTR7;CHRM5;PRKAR2B;GRIA4;CACNB2;NRXN1;GRIK2;SLC1A2;GABRB1;NRXN2;GAD1;GRM3;GRIN2A;NLGN1;NLGN3;BSN;GRIA2;SNAP25;GABRB3;CACNA1B;GRIK1;GABRA2;KCNMB1;CHRM3;PLP1;NOVA1;GRIA3;DLGAP1;SYT1;GABRB2;PMP22;RPS6KA2;GABRA4;HTR1F;GRIN2B;UNC13C;GAD2;GLRB;ASIC2;SDCBP;CPLX1;KIF5A;NRGN;GRM7;GRIA1;GABRD;AMPH;SPG11;GABRG2;DLG4;GRIK4;SYN2
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6922962066458761,1.4550647726939498,0.010638297872340425,0.5305983722321778,1.0,50/96,22.48%,PIANP;CDK14;SULT4A1;GALNTL6;TMEM163;BRINP1;NCAN;MAPK4;SYT16;SRRM3;CA10;SYT4;KCTD8;LINGO1;BSN;GRIA2;SNAP25;OLFM3;CACNA1B;TCEAL2;ERC2;NARF;TAGLN3;SH3GL2;CRMP1;VSTM2B;PAK5;ABLIM3;FXYD7;STMN2;LY6H;CALY;NDRG4;ASIC2;NEFL;KIF5A;APLP1;ST8SIA3;MTUS2;DCTN1;NELL1;SNAP91;TMEM59L;ELAVL3;LHFPL5;POU6F2;PTPN5;REEP2;DNER;CNTN2
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.8896263500703516,-1.4547933381522422,0.03125,0.6680185500839323,1.0,1/5,3.05%,HPS4
prerank,PanglaoDB_Augmented_2021__Pericytes,0.7428357131917106,1.45390853332621,0.021739130434782608,0.5353193926585513,1.0,14/47,7.20%,PLPP3;ASPN;SPARC;SVEP1;ADAMTS2;ECM2;PDE5A;VIM;TNS1;DAAM2;VEGFA;LAMA2;INPP4B;PDZD2
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.8159312109003602,1.4537062251407527,0.012987012987012988,0.5307308224741064,1.0,3/13,4.24%,OMD;OGN;B4GAT1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.8163143959214365,-1.453627484060385,0.13157894736842105,0.6678303551177153,1.0,3/5,16.32%,NR1H3;TIRAP;NINJ1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6878807270607996,-1.453498525638837,0.15384615384615385,0.6631220503513926,1.0,5/13,14.30%,CCL5;CD200R1;RIPOR2;CXCL12;LRCH1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7381414494037211,1.453459201380126,0.011494252873563218,0.5264678457917416,1.0,22/42,19.09%,GRIA4;BEGAIN;RELN;NETO1;PRRT1;GRIN2A;NLGN1;DAPK1;GRIA2;CACNG2;CAMK2B;GRIA3;DLGAP1;LRRC7;GRIN2B;SHISA9;NEFL;DLGAP2;GRIA1;MAPK8IP2;APP;CACNG8
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.718582473520404,-1.4531787011541337,0.1724137931034483,0.6599141491458969,1.0,1/11,1.72%,TAL1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.7778541439708268,-1.453122117925502,0.20833333333333334,0.6554236373448461,1.0,2/6,6.36%,LGALS9;CD274
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.9236284147296359,1.4529616707226989,0.0,0.5249776323557026,1.0,2/8,3.08%,THBS1;PRKCE
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.7632857059816476,1.452293336193948,0.03571428571428571,0.5254238706769266,1.0,4/24,4.59%,HS3ST5;HS3ST2;B4GAT1;GPC5
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.684024599417455,1.4518984837844646,0.0,0.5243976782707563,1.0,42/71,25.96%,SULT4A1;NCAN;MAPK4;DPYSL5;CASKIN1;B4GALNT4;SYT4;CSRNP3;UNC5D;CNR1;LINGO1;UNC13A;CACNA1B;ERC2;ADGRB2;TAGLN3;MAP1B;CSPG5;CRMP1;EPHA7;PAK5;EPHA4;GRID2;PPM1E;STMN2;KIF5A;APLP1;DAB1;NTNG1;EZH2;SNAP91;TMEM59L;NCAM1;ELAVL3;POU6F2;REEP2;KIF5C;KCNQ2;TACC3;GRM5;TSHZ1;BRSK1
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.679629511256625,1.451476397960316,0.01020408163265306,0.5236013165307016,1.0,50/104,17.48%,SULT4A1;PDE5A;AMER2;GRIA4;BRINP1;NCAN;PDE1A;NRXN1;CADM2;RAB3C;NRXN2;CTNND2;SLC24A2;GAD1;CA10;SHANK2;SYT4;GRM3;BSN;GRIA2;SYP;SNAP25;OLFM3;CACNA1B;SLC22A15;FAIM2;CADPS;TCEAL2;CNTNAP2;CACNG2;PLP1;GRIA3;DLGAP1;VSTM2B;PAK5;GRID2;PPM1E;HCN1;CTNNA2;STMN2;LY6H;GAD2;CALY;HIVEP2;ASIC2;SYNPR;SLC24A3;KCNMA1;CPLX1;KIF5A
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.7006760129146674,1.450942850552711,0.0,0.522414474968944,1.0,16/72,14.56%,KCNE1;GLRA1;AANAT;TSHR;EGR1;GABRB1;NSMF;AKAP6;GABRB3;RAPGEF3;PDE2A;IMPACT;GABRB2;RYR3;HCN1;BRCA1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.782180098121595,-1.450843724455209,0.041666666666666664,0.6621116336442834,1.0,1/15,0.20%,CCL5
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.9331275591678839,1.4507052254006128,0.0,0.5178213839452338,1.0,1/6,0.41%,KLF4
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.7650074441315111,1.4486274489480453,0.01282051282051282,0.5290057018864213,1.0,5/20,10.91%,LRP4;TGFB2;ZBTB16;PTN;RBPJ
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7327822810411837,1.4482015794216918,0.03529411764705882,0.5275025241140201,1.0,14/31,13.02%,GRM8;SHANK3;RELN;NRXN1;CDH2;DGKI;TSHZ3;GRM3;NLGN1;NLGN3;UNC13A;GRIK1;CACNG2;SYT1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.7977103483972989,1.4478829291726516,0.0,0.524077617497387,1.0,7/24,9.26%,KCNE1;SCN3B;GNA11;DMD;ANK3;AKAP6;SCN3A
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.7393363162564996,1.4475935498704096,0.024390243902439025,0.5203389277490685,1.0,22/36,22.29%,SULT4A1;GRM8;VGF;NCAN;DPYSL5;CASKIN1;SYT4;LINGO1;KLHL23;UNC13A;CACNA1B;CSPG5;CRMP1;PPM1E;BRCA1;STMN2;KIF5A;APLP1;KCNB2;SNAP91;TMEM59L;REEP2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.8106585639058053,1.4475816868958669,0.03571428571428571,0.5149573217401617,1.0,7/14,12.59%,PRLR;TSHR;CYP3A5;TG;SLC5A9;SLC10A1;FMO5
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.8822890056795736,-1.4465821775674081,0.0,0.6785276245610837,1.0,3/7,9.35%,BIN2;WHAMM;BIN3
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7758411169528711,-1.446367872682637,0.058823529411764705,0.6747445155432202,1.0,3/5,17.79%,APOL2;IL6R;SIGIRR
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.8919161443410761,1.4463649825267668,0.015625,0.5208564795496116,1.0,1/9,0.44%,PLPP3
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.8034688422754208,1.445822661055136,0.012048192771084338,0.5209199045065155,1.0,10/20,15.97%,NAMPT;ZBTB16;SH3PXD2B;ARID5B;CHI3L1;ITGB8;SULF2;SOX6;PKD1;SPTLC2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.8396259745579534,-1.44574826040368,0.02702702702702703,0.6730430482854324,1.0,3/6,13.32%,IL1B;LGALS9;SYK
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.8599112525443157,1.4453302001399153,0.01282051282051282,0.5198694199455742,1.0,8/14,8.25%,METRN;RELN;MYRF;CDH2;NFIB;SOX4;PTPRZ1;ADGRG6
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.8155706895466821,-1.4450155996059642,0.03571428571428571,0.672006203511944,1.0,5/7,18.12%,KMT2B;SETD1B;SETD1A;KMT2A;KMT2D
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.7012954264162394,-1.443974426367162,0.08,0.6725303489678965,1.0,3/10,11.22%,ETS1;ZDHHC21;ITGB2
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.6912537985031324,-1.4437319100982555,0.05555555555555555,0.6685284949586083,1.0,5/15,13.99%,BANF1;CDAN1;TP53;M1AP;RBBP4
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.8105233116308861,-1.4424485395150284,0.03333333333333333,0.6703257499046661,1.0,2/5,5.48%,PMEPA1;SNX25
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.8393842614579233,1.441981003994868,0.0,0.5430704423694054,1.0,6/16,9.49%,GLRA1;ACVR1B;TACR1;RNASE10;VEGFA;POMZP3
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.8976760074553478,1.441932711021248,0.0,0.5376397379457114,1.0,3/7,7.16%,FAAH;ABHD12B;DGAT1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.7794586867495937,1.4412660518276108,0.03488372093023256,0.5378043719371207,1.0,1/19,0.01%,KCNE1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.8334396711445076,1.440655052554479,0.0,0.5388565971152591,1.0,4/17,7.67%,KCNE1;ANK3;FHL1;ANK2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.8435857752354872,1.4402046351674858,0.03614457831325301,0.5371536619599339,1.0,2/15,1.17%,HHIP;FBN2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.823300621993624,-1.4396028071566853,0.1,0.6790545576028576,1.0,2/7,11.40%,LGALS9;CXCL12
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3658491931303131,-1.4391746718643987,0.0,0.6770378240609083,1.0,23/136,9.49%,TNFAIP8L3;CCL5;TGFBR3;CALCR;RPS6KA6;SERPINF2;FFAR4;PDGFD;IL1B;DAB2IP;LGALS9;SCIMP;CSF1R;DUSP3;ICAM1;SIRPA;ROR2;ARRB2;PHB2;P2RY6;CRKL;TGFB1;TREM2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.7898021000989085,1.4386433671033731,0.03488372093023256,0.5466666840534957,1.0,2/22,0.41%,THBS1;KLF4
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.9087591372318177,1.437587438497588,0.0,0.5508928385141116,1.0,1/5,1.60%,TGFB2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.7069354184373722,-1.4367632174659823,0.08695652173913043,0.6834076218609123,1.0,2/12,9.49%,LGALS9;TREM2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.6587199691026969,-1.4362816436411165,0.058823529411764705,0.6813013746603156,1.0,6/15,16.20%,TAPT1;WRAP73;ARHGAP35;KCTD17;MARK4;CROCC
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.775490368222013,1.4362706493804893,0.012658227848101266,0.558639508833231,1.0,3/25,2.35%,KCNE1;AANAT;VGF
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.7411393512632551,-1.436024434791307,0.047619047619047616,0.6781801961818922,1.0,3/13,3.95%,NPC2;ARV1;NPC1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.7036445764063626,1.435802752435137,0.0,0.5577494592371153,1.0,50/100,19.80%,LRRC4C;OPALIN;GFAP;VIM;AMER2;GRIA4;METRN;NCAN;GPM6B;NRXN1;CADM2;PLPPR4;GRIN3A;SLC1A2;HEPACAM;PHYHIPL;RFTN2;CA10;KIF1B;GRM3;PTPRZ1;GRIN2A;NRXN3;BAALC;AKAP6;GRIA2;SEPTIN4;CDH20;CHL1;FAIM2;PLP1;NTRK3;SCN1A;PPFIA2;ADCY8;GRIA3;LSAMP;NTRK2;MAGI2;NFASC;GRIN2B;CTNNA2;SLC39A12;SCN2A;SYNPR;MAPK10;ST8SIA3;GRIA1;LRRTM2;DPP6
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.731812380091419,1.435296109052997,0.03333333333333333,0.556034562698065,1.0,11/33,19.00%,IL1RAPL2;PTPRD;IL1RAPL1;NRXN1;ROBO2;NLGN1;NLGN3;GRID2;CLSTN2;LRFN5;APP
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.7774970423110433,1.4347736140171545,0.011363636363636364,0.5562684368181451,1.0,1/26,0.04%,GLRA1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.7638611152764456,-1.4343752398237288,0.18518518518518517,0.6824345127219281,1.0,2/7,11.70%,DNAJB12;DNAJB14
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.9817795808199578,1.4342900326899997,0.0,0.550256676589377,1.0,1/5,0.41%,KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.9817795808199578,1.4342900326899997,0.0,0.550256676589377,1.0,1/5,0.41%,KLF4
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.8439216247168682,1.4322924473114735,0.029411764705882353,0.5638408971007711,1.0,2/14,3.31%,KCNE1;SCN3B
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8570217545910476,1.4310161299085946,0.02702702702702703,0.5709126903603912,1.0,3/10,12.01%,THBS1;SPRY1;SULF2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.7311972255055564,-1.430453451629674,0.12903225806451613,0.6977809472412818,1.0,4/10,17.54%,GZMB;PLEKHM2;LYST;CEBPG
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.9270093060602131,1.4302514350178703,0.02702702702702703,0.572759304424344,1.0,3/6,6.76%,OMD;OGN;GNS
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.7228842836094673,1.4301326016548288,0.022222222222222223,0.5686479185244117,1.0,5/41,5.47%,THBS1;ACVR1B;TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.89314120970867,1.4296266235141268,0.029411764705882353,0.5689156050508619,1.0,3/8,5.24%,LRP2;CBR1;PIAS4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.9056047904653576,1.429358794288204,0.07042253521126761,0.5669265418060511,1.0,2/7,8.08%,HSPA5;COPS5
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.7839469551483139,-1.4293406061895455,0.04,0.6979371424839439,1.0,2/6,5.70%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.9411988526329916,1.4293023709102932,0.0136986301369863,0.5624300916857597,1.0,2/7,1.92%,CENPF;CENPE
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.7817491484761515,1.4283975934335995,0.011494252873563218,0.5661029418339557,1.0,8/25,10.02%,PLPP3;CYP3A5;DGKI;PLPPR4;ALOX15B;ALOX12;MBOAT2;DGKB
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7649485950156978,1.428382383241301,0.012195121951219513,0.5615368566003881,1.0,3/23,6.52%,GLRA1;VEGFA;NSMF
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.7144175134041509,1.4282373330711529,0.022988505747126436,0.5579473701544416,1.0,9/41,10.95%,DIAPH3;COBL;MAPT;HDGFL3;SPIRE2;PSTPIP2;WASF1;MICALL2;MID1IP1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.7451468405197664,-1.4280660167557016,0.07142857142857142,0.7000384987347628,1.0,4/7,15.05%,PYHIN1;ZNF385A;SPRED2;DDX5
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.95607295859264,1.4269241235178765,0.014705882352941176,0.5658119130448761,1.0,2/6,2.21%,KCNE1;KCNT2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5370250790884035,-1.4267117085770549,0.1,0.7027864287484078,1.0,2/32,0.43%,STAT4;TGFBR3
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.8922533152328334,1.4257526012271249,0.015151515151515152,0.5719972479617971,1.0,2/5,6.28%,TGFB2;SOX4
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.8671201842919711,-1.4256322905147525,0.14285714285714285,0.7043296102844808,1.0,1/5,0.27%,ITGA5
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.8049655614899497,1.4251995724498563,0.02666666666666667,0.5711947746633292,1.0,1/18,0.06%,PCSK1
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.74619199312426,1.4251288409252414,0.023529411764705882,0.5668432890316928,1.0,4/30,5.68%,GLRA1;GRAMD1C;ADCY3;ADAM15
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.9053026783302662,1.4249317383227111,0.0,0.5638589255866896,1.0,1/8,0.53%,NFIL3
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.7043473706351147,1.423733906722099,0.011111111111111112,0.569936370776787,1.0,20/44,14.54%,PCSK1;PLPP3;FAM13C;FGF1;DENND2A;ENPP2;PTPRD;AGT;PHYHIPL;GRIN2A;GABRA2;CADPS;PDE1C;FGF14;SEMA5A;GRIA3;KALRN;LSAMP;SGIP1;NFASC
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.7216723395899287,-1.4234414899818901,0.16666666666666666,0.7096753340346909,1.0,5/7,19.66%,PLEKHM1;SYK;DEF8;PRKCA;ATP6AP1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8367658774557694,-1.4231865473692469,0.10256410256410256,0.7066982756405316,1.0,3/5,14.30%,CD200R1;RIPOR2;LRCH1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7769889124624489,1.422479904286717,0.011764705882352941,0.5756349072325732,1.0,8/21,10.14%,SHANK3;RELN;ANTKMT;ANK3;ANK2;AKAP6;NLGN3;CALM3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.8422450540209196,-1.422175851392741,0.1,0.7085173012189059,1.0,1/6,4.51%,CSF1R
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.6889532395683533,1.4217288754528286,0.02247191011235955,0.5784276192772869,1.0,12/39,13.21%,CLDN18;SHROOM3;THSD4;NTN4;OSMR;DOCK1;VEGFA;SEMA3B;PALLD;RND3;SH3D19;CRLF1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.8473108662739908,1.4213155405146913,0.012987012987012988,0.5769137682822509,1.0,8/16,10.37%,HTR2B;TSHR;HTR7;CHRM5;AGT;ANXA1;CNR1;CHRM3
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.772703717232631,1.4212362131783032,0.023809523809523808,0.5729260154054209,1.0,5/22,13.99%,CLDN18;LSR;CLDN20;MICALL2;PARD3
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7737133108320395,-1.421003036312564,0.17391304347826086,0.7091722905317867,1.0,4/7,21.51%,REST;EIF2AK4;MED1;CNTN4
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.6210508282171932,-1.4204053080770482,0.0,0.7080358749004189,1.0,7/24,17.16%,NCOA4;NEDD4;M6PR;SORL1;CD81;AP4M1;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.7619323846937551,-1.4172642159195603,0.05263157894736842,0.7189998913238337,1.0,5/10,12.48%,MYH9;PLGRKT;KLKB1;HPN;GSN
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.6871700166368296,-1.4168557401329416,0.13043478260869565,0.7162163222702694,1.0,1/15,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.7161665625973117,1.4153625477336438,0.0,0.6210387271070782,1.0,8/43,9.98%,DIAPH3;COBL;ENAH;SVIL;SPIRE2;PSTPIP2;WASF1;MICALL2
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.7026200577041977,1.4148991276419403,0.03296703296703297,0.6209466006814277,1.0,9/34,19.04%,RHOB;RACGAP1;ANLN;CIT;ANK3;SPAST;INCENP;SPTBN1;ROCK1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.6719416564177191,1.4147534519257277,0.0,0.6177366521312775,1.0,55/97,22.48%,AMER2;GRIA4;SCN3B;NRXN1;CADM2;SV2B;PCDH15;RAB3C;SLC1A2;AP3B2;SLC24A2;CA10;KIF1B;SYT4;GRIA2;FRRS1L;SYP;SNAP25;OLFM3;CACNA1B;CDH20;CADPS;CNTNAP2;TMEM130;CACNA2D3;NTRK3;SCN1A;PPFIA2;ZNF536;LSAMP;VSTM2B;PAK5;MAGI2;SGIP1;HCN1;CTNNA2;STMN2;GAD2;SCN2A;FAM135B;SYNPR;HSPA12A;KCNMA1;ST8SIA3;GRIA1;NTNG1;AMPH;ATP1B2;GABRG2;SNAP91;PAK3;NCAM1;ELAVL3;PTPN5;CNTN2
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.4743871453586248,-1.4147329388511751,0.0,0.7203927442536648,1.0,19/75,14.95%,CCL5;PDE12;GBP3;TRIM38;PTAFR;LGALS9;ICAM1;SIRPA;DAPK3;HLA-E;IRF5;OAS2;HLA-DPA1;HCK;FCGR1A;IRF7;CAMK2G;HLA-DRB5;IL12RB1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9616724759247576,1.4137513702925115,0.0,0.6213048931173658,1.0,1/5,0.41%,KLF4
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.49649531612805176,-1.413214413210441,0.0,0.7234116707320244,1.0,12/54,10.92%,PHLDB2;INPP5K;SERPINF2;PFN1;EVL;ARAP1;LPAR1;NF2;SORBS3;ALMS1;PPM1F;ABL1
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.6716161027979909,1.4124923569218217,0.031914893617021274,0.628094420914269,1.0,32/79,18.57%,PLPP3;FAM13C;SPARC;PCDH17;LRP4;COL11A1;PTPRD;BRINP1;AGT;PLPPR4;FBXL7;LIFR;VEGFA;ANK2;CA2;PTN;PLP1;GLUL;SEMA5A;GPRC5B;NTRK2;ADGRL2;NFASC;LDB2;SYNPR;THY1;MAPK10;TIMP3;CPE;EDIL3;MPDZ;CRB1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.9264177294800792,1.4124620620431347,0.0,0.6235761138776899,1.0,1/5,0.98%,FGF1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.7599214645699723,1.4122140684326323,0.024390243902439025,0.6217570161903129,1.0,2/27,0.44%,FA2H;PLPP3
prerank,PanglaoDB_Augmented_2021__Neurons,0.6530201338228033,1.411998794004365,0.0,0.61957187572565,1.0,76/199,17.48%,SCRG1;MAP7D2;SULT4A1;AMER2;VGF;GRIA4;PNMA8A;SCN3B;PPP1R9A;BRINP1;NCAN;PDE1A;NRXN1;CADM2;PQBP1;RAB3C;PHYHIPL;GAD1;CA10;ENO2;SYT4;GRM3;SLC11A1;LUZP2;CSRNP3;CHN1;BSN;GRIA2;CAMK2N1;FRRS1L;RYR2;SYP;SNAP25;OLFM3;UNC13A;CACNA1B;DGKB;BEX2;FAIM2;CADPS;TCEAL2;ERC2;DNM3;CNTNAP2;CACNG2;TAGLN3;TMEM130;SCN1A;PPFIA2;SH3GL2;GRIA3;DLGAP1;VSTM2B;GNAI1;PAK5;SGIP1;CCK;RIMS3;SPOCK3;CTNNA2;STMN2;LY6H;GAD2;SLC17A7;CALY;AIM2;SCN2A;SCN8A;RGS17;NWD2;NDRG4;RASGRF1;SYNPR;KCNMA1;CPLX1;KIF5A
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6607538269967485,1.411947977013725,0.010416666666666666,0.6154708750741424,1.0,45/83,22.48%,LRRC4C;GFAP;CLIP3;BRINP1;VCAN;NCAN;LHFPL3;MAPK4;PLPPR4;PCDH15;PHYHIPL;NRXN2;CTNND2;CA10;ANK2;ARNT2;OLIG1;LINGO1;GRIA2;SNAP25;MAP2;FAIM2;PTN;TAGLN3;CSPG5;PLP1;GPRC5B;ADCY8;ZNF536;CRMP1;VSTM2B;NFASC;STMN2;LY6H;NDRG4;APLP1;NKX6-2;ST8SIA3;ATP1B2;TMEM178A;SNAP91;TMEM59L;ELAVL3;PTPN5;CNTN2
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.875576149759712,1.4116011294418453,0.0641025641025641,0.6145857147740252,1.0,1/9,0.52%,DAPK2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.6749803038309525,-1.4111708340896358,0.10526315789473684,0.7294636904950863,1.0,4/14,4.06%,CEBPA;TFAP4;LATS2;HHEX
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.8302897882097369,-1.4107135521748635,0.07692307692307693,0.7273880419703693,1.0,3/5,11.45%,DNMT3A;KDM1B;MECP2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.8140149592631764,1.4106040019187591,0.0,0.6199198991230868,1.0,7/20,11.96%,KCNE1;SCN3B;ANK2;RYR2;PKP2;CAV3;SCN1A
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.8312168675814555,1.4104370443092653,0.047058823529411764,0.6173639417395806,1.0,2/13,2.46%,GDPD1;ENPP2
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.8900377987462995,1.410311474662146,0.014925373134328358,0.6140231876548876,1.0,2/7,5.28%,ACVR1B;ACVR2A
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.761074899445355,1.410254499846284,0.0379746835443038,0.6102898612243253,1.0,11/20,11.66%,FGF1;VGF;ENAH;SRRM3;RBFOX2;LINGO1;CKB;ADGRB2;CSPG5;TMEM132A;NR2F1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.8983934540789523,1.4097494409614362,0.015384615384615385,0.6100928542418766,1.0,1/7,0.29%,THBS1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.8601489230715583,1.4093277679460683,0.0136986301369863,0.609774903723095,1.0,6/11,10.69%,KCNE1;SCN3B;ANK2;RYR2;PKP2;CAV3
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6860380610233825,1.407870772639264,0.0,0.6193457326800397,1.0,36/77,18.79%,PCSK1;FAM13C;PCDH17;KCNT2;PTPRD;AGT;NRXN1;MAPK4;PLPPR4;CNTN1;RAB3C;ASXL3;PHYHIPL;SYT4;CSRNP3;UNC5D;GRIA2;PTPRT;SNAP25;GABRB3;CADPS;GRIA3;KALRN;SHC2;SORBS1;NFASC;STMN2;LY6H;GAD2;ASIC2;CHGB;MAPK10;SORBS2;CPE;ST8SIA3;KCNB2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.8160340754326975,1.4070864868380635,0.023255813953488372,0.6229947793303321,1.0,6/14,9.10%,SHANK3;RELN;NRXN1;NLGN1;NLGN3;RIMS2
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.699401859353603,-1.4070114497129853,0.06896551724137931,0.7397234976772873,1.0,3/11,3.95%,NPC2;ARV1;NPC1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.8652772727118665,1.4064592544941397,0.043478260869565216,0.6244144463685868,1.0,5/7,12.99%,SLC24A2;SHANK2;PRRT1;SLC24A1;PLK2
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.7638766731643722,-1.4064548900072535,0.11428571428571428,0.7383084007320911,1.0,2/7,10.66%,POMK;IPPK
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7685463806570132,1.4059519015471484,0.024390243902439025,0.6240100733991325,1.0,9/16,19.09%,SHANK3;RELN;PRRT1;NLGN1;NLGN3;CACNG2;SHISA9;MAPK8IP2;CACNG8
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.800468221363559,1.4047942841309726,0.04938271604938271,0.6296486661739789,1.0,2/16,1.15%,SOCS3;ST18
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.7918774883751837,-1.4046467680740544,0.14705882352941177,0.7419063481134307,1.0,5/8,13.31%,CX3CR1;ITGAM;C3;TREM2;C1QC
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.7621719766282284,1.404053202788023,0.056179775280898875,0.6326598698483337,1.0,2/23,2.95%,AANAT;MAPT
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.755074760840162,1.403996851692899,0.022988505747126436,0.6290237074157039,1.0,4/22,6.84%,KCNE1;MTCL1;CEMIP;ANK3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.760367363187069,-1.403335892902994,0.13043478260869565,0.743475885767151,1.0,1/8,4.57%,KRI1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.853862685803439,1.4025106939586003,0.05333333333333334,0.6384484711592886,1.0,1/8,0.16%,SOCS3
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7169873453210437,-1.4022738587011327,0.16129032258064516,0.7437355884805966,1.0,2/5,19.28%,IGF1;LRP6
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.7050027209043066,-1.4021444379673063,0.0,0.7404405394563363,1.0,4/8,12.56%,CX3CR1;CD274;SIRPA;MAPKAPK2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.7044295736471322,1.4021156415977019,0.0,0.6377923595318076,1.0,13/63,5.93%,THBS1;RHOB;SPARC;FGF1;TGFB2;ENPP2;PRKCE;GLIPR2;AGT;DOCK1;DOCK5;ARF6;VEGFA
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.7919278658961282,1.4010193728733051,0.025974025974025976,0.643221468911087,1.0,2/16,2.77%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.7280693492362561,1.4009883409427035,0.022988505747126436,0.6395530070719057,1.0,4/35,5.93%,THBS1;KLF4;BEX3;VEGFA
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.7584342991329528,1.4009573655466063,0.012345679012345678,0.6358735425080415,1.0,7/26,10.37%,FA2H;FAAH;SLC5A9;AATK;OVOL2;ST14;CHRM3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.9689043930440022,1.4007190985379119,0.0,0.6338301837092365,1.0,1/5,0.01%,KCNE1
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.7859447724922144,-1.4004344568090301,0.03333333333333333,0.7431941955217299,1.0,3/6,9.49%,CX3CR1;P2RY12;TREM2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7920192453190893,1.3994072058292675,0.08,0.6410114391512601,1.0,1/12,1.02%,AANAT
prerank,PanglaoDB_Augmented_2021__Myocytes,0.7032856521482026,1.3989076484033494,0.033707865168539325,0.6424951748329383,1.0,8/42,10.69%,CKMT2;LDB3;LAMB1;DOCK1;DOCK5;DMD;LAMA2;CAV3
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.7013451044196825,1.3987059565933084,0.053763440860215055,0.6408390119997281,1.0,13/41,12.83%,SHROOM3;COBL;LRP4;JPH1;ENAH;MFNG;MAPK4;ARFGEF3;LINGO1;CKB;RPL23A;NR2F1;SHC2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.7532204332830916,1.3974822747532898,0.07792207792207792,0.6477907616398035,1.0,3/22,2.64%,HTR2B;TGFB2;GPM6A
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.6968724959510313,1.396214425762927,0.056818181818181816,0.6555944177530273,1.0,14/31,16.47%,MAL;MYRF;ADGRG6;PLP1;B4GALT5;PMP22;PARD3;NFASC;TPPP;BCAS1;SCN2A;SCN8A;EIF2B2;PLLP
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.6488695485930275,-1.3944166996078355,0.05555555555555555,0.7671393297209204,1.0,3/21,6.05%,TNFAIP8L3;NPC2;PRELID3B
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.7221674260522444,1.3942269514019703,0.022988505747126436,0.669325133788508,1.0,3/42,1.19%,FA2H;PLPP3;ALDH3B1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.6472728787567756,1.3936521927326746,0.010101010101010102,0.6705404938417517,1.0,26/112,16.00%,TOP2A;KLF4;TSPAN13;PRLR;ALDH3B1;PRKAR2B;LSR;GLA;MAPT;FKBP5;SEMA3B;ETFB;PAPSS2;CA2;OVOL2;ID2;ST14;BLVRB;CKB;CELSR2;RAPGEFL1;XRCC3;RPS6KA2;SNX10;FDFT1;PLXNB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.9002745265378288,1.3930632401688052,0.04054054054054054,0.6723363253582432,1.0,1/6,1.76%,APOLD1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.9108302010221536,1.3923868553272682,0.025974025974025976,0.6749173858126685,1.0,3/5,5.69%,SHANK3;NRXN1;NRXN2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6640595202463687,1.3923047585157047,0.021505376344086023,0.6715352242839592,1.0,12/49,19.04%,RHOB;RACGAP1;ANLN;CIT;ANK3;SPIRE2;SEPTIN4;SEPTIN8;SPAST;INCENP;SPTBN1;ROCK1
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5512701113491636,-1.392097132121978,0.058823529411764705,0.774321349334841,1.0,4/28,4.08%,LYL1;TCF3;HHEX;BLNK
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.782518129123792,1.3918797191343029,0.04285714285714286,0.6675302664260653,1.0,1/13,0.52%,DAPK2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.782518129123792,1.3918797191343029,0.04285714285714286,0.6675302664260653,1.0,1/13,0.52%,DAPK2
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.4436116993142192,-1.391301018878967,0.0,0.7732949533404522,1.0,24/91,11.90%,NKG7;GNLY;MATK;CD300LF;CST7;ITGAM;P2RX1;SELPLG;MPEG1;BIN2;PIK3R6;HCST;EPOR;AOAH;PLEK;MAFG;MYO1F;TGFB1;ITGAX;ITGB2;HCK;TREML1;PLK3;TYROBP
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.7407569132106719,1.3912459391652494,0.03488372093023256,0.668923939396388,1.0,3/27,1.60%,LRP2;COBL;TGFB2
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8515160170543721,1.390914068329203,0.04477611940298507,0.6640309624653132,1.0,3/10,4.06%,IL1RAPL2;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8515160170543721,1.390914068329203,0.04477611940298507,0.6640309624653132,1.0,3/10,4.06%,IL1RAPL2;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.711188775505328,-1.3904220260193092,0.04,0.7725738142822408,1.0,4/9,14.41%,CD200R1;RIPOR2;LRCH1;AKT1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6863895700363842,1.390345020431697,0.021052631578947368,0.6667114377516744,1.0,31/61,22.48%,PIANP;SULT4A1;CLIP3;BRINP1;NCAN;CASKIN1;SRRM3;B4GALNT4;GAD1;LINGO1;BSN;GRIA2;FAIM2;CKB;ADGRB2;TAGLN3;CSPG5;CELSR2;VSTM2B;STMN2;LY6H;NDRG4;ASIC2;KIF5A;APLP1;NCDN;SNAP91;TMEM59L;ELAVL3;DNER;CNTN2
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.8861899102445882,-1.390163372696082,0.13333333333333333,0.7701794208433862,1.0,4/7,9.69%,APPL2;C3;TREM2;NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.8124005193642928,-1.3896304769848984,0.15151515151515152,0.7688287919874771,1.0,2/5,10.48%,ADARB1;PPM1F
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.7097793387047086,1.3877216457470314,0.03225806451612903,0.684916236151096,1.0,18/49,19.40%,CORO6;HMGB2;CKMT2;LDB3;PDE1A;DMD;LAMA2;RYR2;CKB;CAV3;SORBS1;CPT1A;COL21A1;IL11RA;ATP2A2;SORBS2;SLC25A4;HAMP
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.7485667555369713,-1.3876149456255429,0.18181818181818182,0.773710793516514,1.0,1/7,0.22%,SKAP1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.6060957881485782,-1.3875611097301723,0.09090909090909091,0.7696948859449078,1.0,3/15,13.30%,SPIN1;NIFK;GTF3C2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.8232698636828092,1.386387610123621,0.02702702702702703,0.6919924391908349,1.0,2/11,1.60%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.9331792813373178,1.3861853326935873,0.0,0.6900555069177627,1.0,1/5,0.41%,KLF4
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7224542257698899,1.3859401140857452,0.06097560975609756,0.6883924949172503,1.0,9/30,15.79%,GLRA1;ANO4;GABRB1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.6614200680741944,1.3858482641878296,0.021052631578947368,0.6853924353345401,1.0,20/85,13.75%,FGF1;PRLR;TOM1L1;TGFB2;PRKAR2B;NRG1;ADCY3;VEGFA;CHI3L1;TRAF2;CLSPN;SLC11A1;INSR;TXN;GHR;PRR5;NTRK3;ADCY8;PAK5;PINK1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.7734895040215819,1.3847140087595924,0.024390243902439025,0.6902136493563396,1.0,4/15,10.38%,PRKCE;ANXA1;KANK1;PTN
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5726560109589921,-1.3840124304899806,0.043478260869565216,0.7816014498818219,1.0,5/22,9.29%,TNFAIP8L3;DAB2IP;WDR91;P2RY12;TGFB1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6931515159997059,-1.383520316714604,0.125,0.7803611001300774,1.0,2/12,1.64%,PPP1R16B;INPP5K
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7691153715442572,1.38235685369969,0.07142857142857142,0.7095302740038857,1.0,1/14,0.52%,DAPK2
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8311775469945755,1.382172956307027,0.013513513513513514,0.7065136315764169,1.0,7/11,10.70%,SHANK3;RELN;NRXN1;TSHZ3;NLGN1;NLGN3;CACNG2
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.8247160702448413,-1.3815192486019914,0.125,0.7854326236100965,1.0,4/5,13.39%,CTDP1;RPRD1B;RPAP2;RPRD1A
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.8232021905620829,1.3814668180013299,0.02531645569620253,0.7088831847558297,1.0,1/12,0.16%,SOCS3
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5532598837789814,-1.3800294322411493,0.1111111111111111,0.788057163956843,1.0,9/39,14.37%,ITK;CD2;CD276;LCP1;DDOST;NLRC3;EIF2AK4;JAG2;NCK1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.7842447338136187,1.3791074913954173,0.08641975308641975,0.7269085522335121,1.0,7/14,9.18%,SHROOM3;TOM1L1;SH2D4A;ENAH;BAIAP2L1;OVOL2;RND3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.8790814998021116,1.378944273450043,0.05970149253731343,0.7239931436015595,1.0,3/5,10.91%,VEGFA;HIF1A;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.7271590547758725,1.3784562094579655,0.03529411764705882,0.7245402996364747,1.0,6/23,7.79%,HTR2B;FGF1;PRKCE;RACGAP1;CIT;SVIL
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.6689034685441246,1.3782331214457124,0.0,0.7225817156130744,1.0,51/82,25.71%,ST18;MOBP;AMER2;ASPA;GRIA4;CACNB2;SCN3B;NRXN1;SV2B;SLC4A10;SLC1A2;AP3B2;SLC24A2;MOG;GRIA2;FRRS1L;SYP;KCNT1;UNC80;CADPS;CACNG2;SCN1A;XKR4;CCK;HCN1;CTNNA2;UNC13C;GAD2;FAM135B;RUNDC3A;SYNPR;KCNJ6;DLGAP2;ST8SIA3;FGF13;DPP6;ATP1B2;RPH3A;SEZ6;CYP46A1;CNTN2;SLC24A4;PRKCB;MYT1L;B3GAT1;CNDP1;KCNC2;ATP2B2;CACNA1A;KCNB1;SLC7A14
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.79112641932846,-1.3774083478637342,0.13333333333333333,0.7957665125707327,1.0,2/5,5.70%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.7422477688926958,-1.3763341520091983,0.16,0.7970558923110528,1.0,3/7,8.99%,PDE12;TICAM1;TLR3
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.8699996261542045,1.376310158823898,0.039473684210526314,0.7365687843092469,1.0,5/8,8.31%,ZDHHC15;NRXN1;NRXN2;NLGN1;BSN
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6316971181589841,1.3754876633615243,0.0,0.7402764385671257,1.0,61/166,20.58%,GLRA1;HTR2B;HTR7;CHRM5;PRKAR2B;GRIA4;CACNB2;NAPA;NRXN1;CDH8;GRIK2;SLC1A2;GABRB1;NRXN2;GAD1;KIF1B;GRM3;GRIN2A;NLGN1;NLGN3;BSN;GRIA2;SNAP25;GABRB3;UNC13A;CACNA1B;GRIK1;GABRA2;KCNMB1;ERC2;CHRM3;PLP1;NOVA1;GRIA3;DLGAP1;SYT1;GABRB2;PMP22;RPS6KA2;GRID2;CBLN2;GABRA4;HTR1F;GRIN2B;UNC13C;GAD2;SLC17A7;GLRB;ASIC2;SDCBP;CPLX1;KIF5A;DLGAP2;NRGN;GRM7;GRIA1;GABRD;STXBP2;AMPH;SPG11;GABRG2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.7560671688041254,1.3754378639000746,0.05194805194805195,0.7369887294226878,1.0,2/18,2.46%,FAAH;ENPP2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.8720193394196625,1.3749824876088022,0.014705882352941176,0.7372660575114508,1.0,3/7,12.01%,THBS1;SPRY1;SULF2
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.5377098602622601,-1.3742690518625087,0.0,0.8004110804373087,1.0,11/96,10.00%,ITK;GRAP2;PSMB3;PSME3;CHUK;PSMD12;PSMC4;PSME4;NFATC3;BTK;IKBKB
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.8385369879200494,1.3740770015752817,0.04225352112676056,0.7419431943254552,1.0,4/7,14.46%,THBS1;ANK3;RYR3;FBP1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.7886894262457864,1.3732917805108587,0.013333333333333334,0.7451744594434824,1.0,2/20,1.02%,KCNE1;AANAT
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.6650090221315117,1.3730522796335343,0.031914893617021274,0.7437368560894282,1.0,17/62,18.37%,PLPP3;SHROOM3;COBL;PRLR;AGT;SLC4A10;PHYHIPL;SHANK2;CGNL1;SLC13A4;GPRC5B;SHC2;ADGRL2;PLXNB1;EPB41L4B;CPE;MPDZ
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.7973672213655483,-1.3729189360127234,0.09375,0.7980322968989996,1.0,1/7,0.20%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.7973672213655483,-1.3729189360127234,0.09375,0.7980322968989996,1.0,1/7,0.20%,CCL5
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.7340607980594392,1.3721230173254348,0.011764705882352941,0.74923239355845,1.0,4/25,13.99%,CLDN18;CLDN20;MICALL2;PARD3
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.809271833459106,1.372057200099635,0.03529411764705882,0.745815517102212,1.0,1/12,0.37%,GDPD1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.6687161550009769,1.371944203696212,0.06666666666666667,0.7431178823869603,1.0,11/59,6.33%,TNC;SCRG1;PLPP3;SPARC;ADAMTS2;COL11A1;GADD45B;FBXL7;DAAM2;VEGFA;LAMA2
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.7726891947013669,-1.371235076362446,0.16129032258064516,0.8011264138682996,1.0,1/5,3.24%,FLII
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.6705662464724114,-1.371031322810608,0.2,0.7976708682821148,1.0,8/11,23.40%,CD226;BCL10;CARD11;CD81;RAB29;IKBKG;RELA;PRKD2
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.6775328065749506,1.371026031442608,0.10344827586206896,0.7481251956018277,1.0,6/25,12.38%,SLC51A;SLC16A4;SLCO1A2;ATP8B1;SLCO3A1;SLC10A1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4860673678984232,-1.3707575062519488,0.0,0.7950608934149138,1.0,6/50,6.88%,RNASEL;CCL5;PDE12;ADARB1;APOBEC3G;BANF1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.882422823818009,1.370014170233148,0.1,0.754529268988156,1.0,1/5,4.00%,PIGU
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.8200019924289279,-1.3697591593769103,0.10526315789473684,0.7954346553521598,1.0,3/5,17.79%,TRIB1;LILRA2;SIGIRR
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.8753289711487047,1.3691699766041219,0.05970149253731343,0.7582609817450688,1.0,2/7,3.49%,KNSTRN;RACGAP1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.797712511138799,-1.3691306543169424,0.14705882352941177,0.7948014802251175,1.0,1/6,3.25%,BCL2L1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.7400887689375619,1.3688469562142003,0.08333333333333333,0.7570322871875239,1.0,15/26,21.30%,GRIA4;RELN;GRIN2A;NLGN1;DAPK1;GRIA2;CAMK2B;GRIA3;LRRC7;GRIN2B;NEFL;GRIA1;MAPK8IP2;APP;DLG4
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.8029703916648774,-1.3688410037401437,0.06451612903225806,0.7920450940885735,1.0,1/6,0.22%,SKAP1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.6487090803608992,1.3685419902682354,0.056179775280898875,0.7565282940984193,1.0,16/53,17.47%,NFIL3;IDI1;TM7SF2;SEMA3B;MVD;ABCA2;ALCAM;ERRFI1;GNAI1;FASN;SCD;ANTXR2;FDFT1;HMGCS1;CPEB2;PDK3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.8594825589372636,1.3682983182611073,0.0375,0.7552757152475028,1.0,1/10,0.01%,KCNE1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.7374492750386324,1.3682437200196882,0.033707865168539325,0.7520063050381763,1.0,14/31,18.44%,RAP1GAP;FAAH;COL26A1;PHYHIPL;SYT4;LINGO1;PTOV1;SHC2;SYT1;STMN2;CALY;KLC4;CPLX1;ST8SIA3
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.9415571190676049,1.3670993864833878,0.014285714285714285,0.7594789716632987,1.0,2/6,1.92%,CENPF;CENPE
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.7418399283556278,1.366710875947648,0.011904761904761904,0.7557762124418286,1.0,3/24,1.60%,LRP2;COBL;TGFB2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.7418399283556278,1.366710875947648,0.011904761904761904,0.7557762124418286,1.0,3/24,1.60%,LRP2;COBL;TGFB2
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.8154611814005585,1.366622146478307,0.0410958904109589,0.7526532301251156,1.0,7/12,15.05%,TSHZ3;SLC24A2;SHANK2;GRIN2A;SLC24A1;PLK2;GRIN2B
prerank,PanglaoDB_Augmented_2021__Interneurons,0.6415303323000202,1.366403329859779,0.0,0.7513685082565353,1.0,74/199,17.48%,PIANP;SULT4A1;AMER2;VGF;GRIA4;TACR1;TMEM163;BRINP1;NCAN;RELN;PDE1A;NRXN1;CADM2;MAPK4;SV2B;RORB;RAB3C;PHYHIPL;CTNND2;GAD1;CA10;SYT4;GRM3;CSRNP3;CHN1;LINGO1;BSN;GRIA2;FRRS1L;DNAJC6;SYP;SNAP25;OLFM3;MAP2;UNC13A;RAB15;CACNA1B;SLC22A15;DEPTOR;TCEAL2;ERC2;DNM3;CACNG2;TAGLN3;TRIM9;FAM81A;PPFIA2;ADCY8;SH3GL2;DLGAP1;VSTM2B;LMO3;PAK5;SYT1;ADGRL2;CCK;TMEM132D;GABRA4;SPOCK3;CTNNA2;STMN2;LY6H;GAD2;SLC17A7;SCN8A;HIVEP2;SHISA9;RGS17;NDRG4;SYNPR;HSPA12A;KCNMA1;CPLX1;KIF5A
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.75052842706872,-1.3663482382675456,0.16129032258064516,0.7975270042616012,1.0,4/7,24.77%,TREM2;CDH13;PLCG2;P2RX4
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.695983048782621,1.3656641853968867,0.021739130434782608,0.7539961822459873,1.0,11/46,9.78%,PLPP3;SPARC;SVEP1;ADAMTS2;GFAP;RELN;FBXL7;VEGFA;LAMA2;SYP;FN1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.7607863833629268,1.3650790456048407,0.0684931506849315,0.7562152526668703,1.0,7/16,18.90%,TTBK2;HDGFL3;MID1IP1;CLASP2;STMN2;APC2;FGF13
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.7298312383743628,1.364870399203075,0.024691358024691357,0.7552715728463617,1.0,2/25,6.52%,GLRA1;NSMF
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.7231573497288961,1.3645174071530826,0.03529411764705882,0.7548438169443464,1.0,4/31,6.54%,THBS1;FGF1;MAPT;IER5
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.6800384594347859,1.3644254837975127,0.04597701149425287,0.7518539672493958,1.0,16/43,18.08%,PLPP3;FGF1;SVEP1;FRAS1;NTN4;OSMR;DOCK1;PALLD;RND3;FN1;SH3D19;THBD;UACA;TIMP3;PCSK6;GBP2
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8516319715889342,1.3640499229652723,0.027777777777777776,0.7519902470945647,1.0,2/8,2.77%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6975027763851519,1.3638203422285036,0.022727272727272728,0.7508748605783669,1.0,12/42,17.51%,GLRA1;ANO4;SLC4A10;GABRB1;TTYH1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB;CLIC4
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.7943386803808241,-1.362405023761735,0.1111111111111111,0.8105324382204637,1.0,3/5,15.52%,STIM1;STIM2;CRACR2A
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.9217911946646851,1.3620196956784467,0.028985507246376812,0.7641252743427279,1.0,1/5,7.55%,DAPK1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.7558829918350559,-1.3616898837605669,0.14285714285714285,0.8097065323700987,1.0,4/9,9.69%,RUNX3;LILRB4;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.796789911238436,1.3615369840004827,0.07317073170731707,0.7656494739377755,1.0,1/9,1.60%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.5686804589177298,-1.3611949704530113,0.05263157894736842,0.8077794554832449,1.0,5/21,11.22%,SKAP1;ETS1;SIRPA;HLA-DPA1;ITGB2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.7929564488450799,1.3598551014919777,0.02531645569620253,0.778877579949754,1.0,5/19,10.69%,KCNE1;NETO1;FHL1;ANK2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.6520078441170692,1.35977425625204,0.021505376344086023,0.7759421358807952,1.0,17/89,13.85%,THBS1;KLF4;NAMPT;NLRP12;PRR16;TGFB2;VIM;EIF4A3;SOX4;RBM3;INSR;IRS2;NMD3;DNA2;NOD2;SORBS1;EIF3E
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.8794483478792009,1.359411372963283,0.05970149253731343,0.7757222543397759,1.0,1/5,1.60%,TGFB2
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.7699735374180665,-1.3587564454789707,0.17857142857142858,0.8155459565138962,1.0,1/7,0.89%,MYH9
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.8627536708682084,1.3583281417598017,0.038461538461538464,0.7816295141176085,1.0,3/7,5.71%,NAMPT;SH3PXD2B;ARID5B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.8857054035880987,1.3581182862731358,0.05714285714285714,0.7800940279719307,1.0,2/5,8.42%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.8467700418683821,1.3580770392342194,0.0945945945945946,0.7770041305566845,1.0,3/10,4.31%,HTR2B;NRG1;CDH2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6717685724077995,1.3576106117266775,0.05434782608695652,0.7772237532333759,1.0,21/48,19.09%,SHANK3;RELN;NRXN1;TSHZ3;GRIK2;SLC24A2;SHANK2;GRIN2A;NLGN1;NLGN3;RIMS2;CACNG2;ADCY8;SLC24A1;PLK2;SYT1;RIMS3;GRIN2B;CLSTN2;APP;CACNG8
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.7622043431041391,1.3573299777856884,0.025974025974025976,0.7768436627570093,1.0,1/18,0.16%,SOCS3
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7903646953843672,1.356877929888642,0.10588235294117647,0.7773794953798564,1.0,4/14,10.90%,CHST7;VCAN;NCAN;CSPG5
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.7318310432890083,1.3558347961485573,0.07407407407407407,0.7837970476257,1.0,6/26,8.32%,FBN2;TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.7690325093726558,1.3557084965797583,0.09090909090909091,0.781977381948172,1.0,3/13,6.88%,TOP2A;HMGB2;MTERF1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.8897840827429724,1.3555647107067965,0.08450704225352113,0.7796642537345111,1.0,3/6,5.93%,NR4A2;MANF;VEGFA
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.8947788622298747,1.3544951412387731,0.1038961038961039,0.7834847146589515,1.0,4/5,10.48%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.8947788622298747,1.3544951412387731,0.1038961038961039,0.7834847146589515,1.0,4/5,10.48%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.7536008430173,1.3541646332490869,0.09195402298850575,0.7832826303801325,1.0,3/17,6.70%,THBS1;AGT;TRAF2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.7618606906186155,1.3538922335366805,0.0821917808219178,0.782851249606144,1.0,5/13,15.69%,SLC51A;SLCO1A2;ATP8B1;SLC10A1;STARD5
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.7043128525133833,1.352528733656015,0.05813953488372093,0.7922766472524012,1.0,7/26,13.69%,KLF4;CD55;PPP1R13L;BHLHE40;FOSL2;MLANA;NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.7850204816362026,1.3521419972736106,0.05194805194805195,0.7894485401218033,1.0,1/16,0.29%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.7850204816362026,1.3521419972736106,0.05194805194805195,0.7894485401218033,1.0,1/16,0.29%,THBS1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.7262829257133783,1.3520325691599042,0.10588235294117647,0.7872571059970651,1.0,5/21,9.18%,TNC;NTN4;OSMR;PALLD;RND3
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.7466230290984566,1.3517657946900519,0.03571428571428571,0.7863280479969983,1.0,4/20,13.99%,CLDN18;CLDN20;MICALL2;PARD3
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.7160804971743105,1.3515111385381564,0.05813953488372093,0.785594402808976,1.0,10/31,12.72%,NLRP12;TOM1L1;PPP2R5B;VEGFA;GPNMB;PPP2R5A;CALM3;ERRFI1;IMPACT;EPHA7
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.7163893524651448,-1.3508403825560182,0.125,0.8469523429635116,1.0,2/10,1.00%,CCL5;ZNF703
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.6578110638447933,1.3490313654172241,0.010638297872340425,0.8071526753350098,1.0,22/92,11.58%,KLF4;HHIP;ASPN;SPARC;SVEP1;ADAMTS2;VIM;EGR1;NR4A2;TNS1;LAMB1;NR4A1;VEGFA;CD55;LAMA2;HIF1A;PALLD;CKAP4;FN1;FOSL2;FGR;P4HA1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.8662617214726058,1.3484059920726574,0.039473684210526314,0.8103987660709883,1.0,2/8,2.02%,GFAP;EEF1A2
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7714738817084115,1.3482912219565544,0.06578947368421052,0.8077585850839742,1.0,2/13,10.33%,PRLR;GHR
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.8299193129694196,1.346953985212181,0.08333333333333333,0.81784599408305,1.0,2/8,7.82%,RAB7B;RAB20
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.8928820067989406,1.3467558991142363,0.014705882352941176,0.8165213676809228,1.0,2/5,5.93%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.7743742480354882,1.346401984968693,0.0945945945945946,0.8165630495780384,1.0,3/13,10.91%,LRP4;SRGN;RBPJ
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.6807983642148413,1.3448278221270433,0.031914893617021274,0.8284640994657342,1.0,8/60,8.42%,THBS1;PLPP3;RHOB;SPARC;FGF1;AGT;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.5013940739928536,-1.3445827253140676,0.07142857142857142,0.8750985927186683,1.0,19/49,22.52%,CCND1;CSF1R;TP53;MED24;MED12;CBFB;AGO1;MECP2;MED4;MED1;PAXIP1;MED27;MED30;ZNF45;MED10;MOV10;CDKN1A;MED23;RELA
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.5479505429783545,-1.3443105456701003,0.125,0.8721915174041172,1.0,3/22,4.02%,CCL5;CHUK;LGALS9
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.8836355873698639,1.3441895062366591,0.04225352112676056,0.8302022575058942,1.0,1/6,0.40%,CENPF
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.7580616842437411,-1.343225135173515,0.2222222222222222,0.8724968886637224,1.0,2/7,14.09%,IPPK;ISYNA1
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.7879603939286007,-1.342791329299728,0.05405405405405406,0.8707073855238865,1.0,1/6,2.03%,MYBL1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.7728371418234085,1.3427026379181912,0.07894736842105263,0.8411577250845561,1.0,2/13,5.93%,ASPN;SRGN
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.7754564128614647,1.3417249092817032,0.04938271604938271,0.8464013569012631,1.0,6/16,14.83%,JPH1;CACNB2;DMD;ANK2;CAV3;AHNAK
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6855143652608393,1.3415953069932602,0.054945054945054944,0.8440974161632526,1.0,14/39,18.90%,DDIT4;SEMA3A;GPM6A;SPOCK1;NR4A2;RELN;VEGFA;MAP1B;NTRK2;ASTN2;CCK;CDK5R1;TUBB2A;FGF13
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.6744937310563255,1.3415905929488037,0.08695652173913043,0.8408815171654003,1.0,7/54,6.69%,GLRA1;VIM;MYOT;CKMT2;GNAO1;DMD;LTB4R
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6451548644968482,1.3412853286350503,0.034482758620689655,0.8399357055513896,1.0,29/65,18.37%,FAM13C;LRP4;DENND2A;GULP1;ENAH;DZIP1;FBXL7;LIFR;PTPRG;RUNX1T1;SEMA3B;ANK2;ARNT2;RBFOX2;CSRNP3;TUSC3;PTN;MAP1B;PLP1;GPRC5B;FIGN;ADGRL2;NFASC;ITSN1;HSPA12A;THY1;CPE;EDIL3;MPDZ
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.7109016853999843,-1.341214835610776,0.21875,0.8741084974755006,1.0,3/7,15.42%,CCDC88C;GSN;EMP2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.8200566889947037,-1.3411487106301105,0.20588235294117646,0.8706326825858912,1.0,3/6,13.75%,FBL;PIH1D1;ZNHIT6
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.8041837515692379,1.3411014783273578,0.07894736842105263,0.8386068536924408,1.0,4/10,8.56%,TGFB2;SCN3B;RGS2;RYR2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.7708321922386236,1.3409201894683938,0.0625,0.8369701438241213,1.0,3/16,9.11%,SLC4A10;FHL1;UNC80
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.7220139161622015,1.3408746898769075,0.06976744186046512,0.83414869475052,1.0,12/27,17.67%,SHANK3;RELN;ZDHHC15;NLGN1;SRCIN1;SIPA1L1;NGEF;CAMK2B;PPFIA2;EPHA4;CDK5R1;CFL1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5326937394899113,-1.340760702392195,0.15384615384615385,0.8688769771820243,1.0,6/38,9.29%,FLNA;NEDD4;IL1B;ZPR1;TP53;TGFB1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6605692253105131,1.3395123448866668,0.03260869565217391,0.8454170990213886,1.0,17/50,18.37%,PLPP3;FAM13C;SVEP1;LRP4;LAMB1;FBXL7;LIFR;RUNX1T1;ANK2;PTN;MAP1B;GPRC5B;ADGRL2;THY1;TIMP3;CPE;MPDZ
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.7875561068511312,-1.339147688481777,0.1951219512195122,0.8712437225797083,1.0,2/5,7.11%,LGALS9;MAP2K3
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.7488863464532421,1.3390948044751472,0.058823529411764705,0.8461145652944981,1.0,9/21,17.25%,SHROOM3;ARFGEF3;SHANK2;EYA2;SLC9A7;MROH9;DNAH7;NEBL;KCNMA1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.64022770790733,1.3385594529091334,0.030927835051546393,0.8484429275135499,1.0,31/74,19.64%,LRP4;GFAP;SH3PXD2B;MTCL1;DZIP1;DOCK1;GNA11;SRRM3;LIFR;SEMA3B;SLC13A4;KAZN;ARNT2;RBFOX2;CAMK2N1;NGEF;ALCAM;ADGRB2;MAP1B;TMEM132A;NR2F1;GPRC5B;TYRO3;PLXNB1;NDRG4;HSPA12A;APLP1;CPE;MPDZ;APP;TNFRSF21
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.7042816942935088,1.3383355381951063,0.09411764705882353,0.8477709713429487,1.0,5/28,6.33%,ASPN;SVEP1;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7378096204984389,1.3378536942840402,0.11764705882352941,0.8499025848357603,1.0,6/18,11.83%,HTR2B;SEMA3A;SEMA3B;SEMA6A;FN1;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7506269389213593,1.3377915924108326,0.1791044776119403,0.8471306911043291,1.0,3/10,10.19%,CIT;SHANK2;LIMD1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.8334163010341178,1.3367442887750436,0.09523809523809523,0.8543232777099145,1.0,2/8,7.23%,RACGAP1;SLC13A4
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8488783293868555,1.3365397296811174,0.0958904109589041,0.8530244533071082,1.0,3/9,7.29%,GLRA1;GRIN3A;GRIN2A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7487773321024165,1.3364970702308758,0.037037037037037035,0.8500678242622144,1.0,8/20,15.05%,GLRA1;INSYN2A;GRIN2A;NLGN3;GABRA2;GRID2;GABRA4;GRIN2B
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6507192281911409,1.3360760230949724,0.07865168539325842,0.8506254042437772,1.0,14/38,16.32%,SYCP2L;PREX2;MAPT;CACNB2;CKMT2;LDB3;ZNF483;CADM2;RYR2;SORBS1;HIF3A;L2HGDH;LRP1B;TMEM266
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.8941801610417657,1.3354632824277697,0.07462686567164178,0.8530704222424419,1.0,2/5,8.72%,CLDN18;CLDN20
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.8922486500501244,1.3353564131409927,0.0641025641025641,0.8506849251554963,1.0,2/5,9.23%,FGF1;PAX8
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.8721161582963078,1.3350955005864171,0.07575757575757576,0.8495911349190481,1.0,1/6,0.88%,MDH1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.8645840694354237,1.3349724404019376,0.08108108108108109,0.8477704613318965,1.0,1/5,4.31%,CDH2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8540339449629113,1.3349484995282186,0.09210526315789473,0.8447982084611265,1.0,5/8,11.78%,SHANK3;NRXN1;NRXN2;NLGN1;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.8417028193229749,1.3349149826007671,0.1076923076923077,0.8420466221858274,1.0,1/6,0.22%,HS3ST5
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.6938282823450937,-1.3349135090038042,0.14814814814814814,0.885911806108784,1.0,3/8,15.49%,SH2B3;NCKAP1L;MED1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.6222391970724072,-1.3346806478438744,0.15384615384615385,0.8828771520446002,1.0,3/12,4.84%,FGL1;DUSP3;IL4I1
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.6786562222811398,1.3345702304839833,0.021739130434782608,0.8427183011234419,1.0,13/72,6.77%,PLPP3;ASPN;SVEP1;ADAMTS2;ECM2;ZBTB16;ACSL1;METRN;TNS1;GULP1;AGT;LAMA2;TRIP10
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.6905523758494823,1.3337196906675233,0.1111111111111111,0.8471710948652611,1.0,3/21,8.89%,PRKCE;ANXA1;KANK1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7154457940731735,1.333035425879799,0.11627906976744186,0.8507388674267209,1.0,7/20,17.76%,PTPRD;IL1RAPL1;NRXN1;NLGN1;NLGN3;GRID2;CLSTN2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.7741790602732311,1.3330057073592143,0.09210526315789473,0.847972818306935,1.0,3/15,9.56%,GPR18;GPR65;ROBO1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.7081290956661443,1.3327438429874952,0.09090909090909091,0.8471480851567257,1.0,5/15,20.01%,DGAT1;SCD5;FASN;SCD;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.8844478166826848,1.3324247036435202,0.013888888888888888,0.8473027811971875,1.0,1/8,0.29%,THBS1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.651162833670341,1.3323210297009191,0.020833333333333332,0.845419221447739,1.0,54/89,25.46%,GFAP;AMER2;GRIA4;BRINP1;NR4A2;NCAN;NRXN1;CADM2;RAB3C;CA10;SYT4;GRM3;GRIN2A;GRIA2;SNAP25;OLFM3;MAP2;CACNA1B;CDH20;FAIM2;TCEAL2;TAGLN3;PDE2A;ADCY8;GRIA3;VSTM2B;PAK5;CCK;GRIN2B;CTNNA2;STMN2;LY6H;GAD2;CALY;ASIC2;SYNPR;DAB1;NRGN;ST8SIA3;GRIA1;KCNB2;GABRG2;SNAP91;DLG4;ELAVL3;PTPN5;CNTN2;SORCS3;KCNQ2;RTN4;KCNC2;GRM5;ADGRB3;KCNB1
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),0.9073478541737763,1.3321068780744516,0.0625,0.8445800962386888,1.0,1/5,1.04%,NLRP12
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6730243162640167,1.3318050678859905,0.06315789473684211,0.8443890466072937,1.0,27/56,24.70%,KCNE1;KCNJ13;SLC24A2;KCNH8;KCNH7;KCNMB1;KCNH5;SLC9A7;SLC24A1;SLC9A6;NALCN;HCN1;ATP1B3;SLC24A3;KCNMA1;KCNJ6;KCNB2;KCNJ3;TMEM175;SLC9A1;KCNQ5;SLC24A4;ATP1A2;KCNQ2;CHP1;KCNC2;KCNK10
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7865618063051719,1.3316385129113286,0.05263157894736842,0.8430155564613033,1.0,1/10,1.02%,AANAT
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6729327440769114,1.3315462208130489,0.056179775280898875,0.8407271281753382,1.0,13/37,19.04%,PTPRD;IL1RAPL1;AGT;NRXN1;VEGFA;NLGN1;NLGN3;NPHP1;CNTNAP2;GRID2;THY1;CLSTN2;ROCK1
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.7555874355612712,-1.3313849552054928,0.14705882352941177,0.894596202254995,1.0,2/5,6.57%,IRAK4;SERPINB9
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.7987456954881159,1.3311872120330366,0.015151515151515152,0.8411234230936291,1.0,1/10,0.07%,TOP2A
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.8839351028488479,1.3310832450295538,0.016129032258064516,0.8390474935231942,1.0,1/5,0.74%,LRP2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7505232839049375,1.3309526402291154,0.05128205128205128,0.8372699287835478,1.0,4/15,16.79%,HS3ST5;HS6ST3;HS2ST1;NDST3
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.8530016633672755,1.330820872579684,0.1095890410958904,0.835944835068539,1.0,2/7,7.62%,THBS1;SEMA6A
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.6732535723441933,1.330483114988529,0.056818181818181816,0.8362581577203636,1.0,19/38,23.64%,SCN3B;SLC6A15;SLC24A2;SCN3A;SLC9A7;SCN1A;SLC24A1;SLC9A6;NALCN;HCN1;SCN2A;SCN8A;ASIC2;ATP1B3;SLC24A3;ATP1B2;SLC9A1;SLC24A4;ATP1A2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.6887598147681233,1.3301682666092307,0.08235294117647059,0.8364444285752286,1.0,11/41,10.38%,PLPP3;SPARC;SVEP1;GFAP;TNS1;FBXL7;DAAM2;LAMA2;PALLD;FN1;PTN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.5185992647431003,-1.3301394479467956,0.0,0.8969855128176696,1.0,11/97,10.00%,ITK;GRAP2;PSMB3;PSME3;CHUK;PSMD12;PSMC4;PSME4;NFATC3;BTK;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.9245821707417614,1.3301295101262136,0.028985507246376812,0.8341088930915793,1.0,1/5,0.01%,KCNE1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.7846105655289535,-1.3297782238958524,0.17142857142857143,0.8949755047974153,1.0,1/5,0.44%,FLNA
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.6866205304356044,1.3294971448268433,0.10465116279069768,0.8365650642086697,1.0,4/36,1.60%,THBS1;KLF4;SPARC;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.886248740226129,-1.3293390260840527,0.2,0.89262053777466,1.0,4/6,9.69%,APPL2;C3;TREM2;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.8426473228493404,1.3292783508681827,0.09523809523809523,0.8358212111650979,1.0,3/7,13.66%,TGFB2;PTN;SOX6
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.9072118016073845,1.3292427191310017,0.016666666666666666,0.833511539491147,1.0,2/5,2.85%,TGFB2;NRG1
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.8156851383124706,1.3291257488150192,0.078125,0.8315551423755746,1.0,1/5,8.59%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.6409660779685119,1.3286633854203391,0.0425531914893617,0.8326712990799453,1.0,9/76,8.71%,THBS1;KLF4;PRR16;VIM;EIF4A3;AGT;SOX4;RBM3;VPS11
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.9138048848793057,1.327982119778044,0.030303030303030304,0.8364022020267394,1.0,1/5,0.89%,RAB7B
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7630794688371336,-1.3273642267493577,0.20833333333333334,0.897637557378518,1.0,3/8,8.33%,ETS1;ZPR1;SERBP1
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.6891479434920227,-1.3271209090888063,0.15384615384615385,0.8950518455623497,1.0,2/8,10.81%,SMARCD1;ZMIZ1
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7725825558741719,1.3263709504417416,0.08108108108108109,0.8487994470081198,1.0,7/8,20.58%,GABRB3;GABRA2;GABRB2;PLXNB1;WNT5A;FGF13;GABRG2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.715642211301964,1.3262297623688741,0.08433734939759036,0.8469090390647276,1.0,5/24,10.08%,KCNE1;FHL1;ANK2;AKAP6;KCNMB1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.8171068630477429,1.325223256545562,0.09722222222222222,0.855023165841445,1.0,3/7,8.59%,GFAP;VIM;PKP2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.8323686731447613,1.3250957976559934,0.08,0.8535158033841173,1.0,2/10,5.24%,THBS1;PIAS4
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.8970555923315967,1.3249685557652429,0.0684931506849315,0.8515085949121525,1.0,2/6,4.83%,NRXN1;PCDH15
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.6074124715407734,-1.3247506676959708,0.08,0.9015060726125314,1.0,2/11,10.67%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.6301235370391165,1.3243764884017302,0.05263157894736842,0.8537887662232841,1.0,3/63,5.93%,PCSK1;AANAT;SRGN
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.6396951262950668,-1.3240660852964223,0.13043478260869565,0.9004123729002304,1.0,4/13,9.46%,FLNA;DDR1;ARHGAP35;LCP1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7128497146981823,-1.3236907332643093,0.20833333333333334,0.8980854499792935,1.0,2/9,4.23%,ZNF703;ACTB
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.66257141573012,1.3236542593555727,0.041666666666666664,0.8579308396401919,1.0,27/63,24.70%,KCNE1;KCNT2;KCNJ13;SLC24A2;KCNH8;KCNH7;KCNH5;SLC9A7;SLC24A1;SLC9A6;NALCN;HCN1;SLC12A8;ATP1B3;SLC24A3;KCNJ6;KCNB2;KCNJ3;TMEM175;ATP1B2;SLC9A1;KCNQ5;SLC24A4;ATP1A2;KCNQ2;KCNC2;KCNK10
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.7145659945180156,1.3236207826296773,0.1,0.8554240838538812,1.0,8/23,16.75%,FGF1;NRG1;INSR;TXN;PRR5;NTRK3;PINK1;WNT5A
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.8149915437381945,1.3236125665836562,0.1111111111111111,0.8527560752016268,1.0,1/6,7.97%,INSR
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.745644171713102,1.323271271699786,0.075,0.8536455303339653,1.0,7/24,9.97%,TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2;PAX8;MAFB
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.8144909216588925,-1.3229253893609,0.21212121212121213,0.8980771066054842,1.0,1/6,4.93%,BAP1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7620484408144153,1.32281497254239,0.15942028985507245,0.8549409080759356,1.0,2/8,2.37%,PKIA;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),-0.8149687873556986,-1.3222842051486394,0.16666666666666666,0.8970128370034639,1.0,4/5,11.90%,CX3CR1;ITGAM;TREM2;TYROBP
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.8277802001498599,1.322120266402606,0.11688311688311688,0.8577227808068251,1.0,1/7,5.93%,VEGFA
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",-0.8193873046175943,-1.3219279984345214,0.1111111111111111,0.8949648847159553,1.0,4/6,9.69%,RUNX3;LILRB4;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.8166436546214698,-1.320074445343212,0.1875,0.8985177637069987,1.0,2/5,9.99%,AKNA;TRPV4
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.8818890135096126,1.3200180741342702,0.05,0.8736342254375593,1.0,3/6,9.19%,THBS1;ACSL1;IRS2
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7690317245627674,1.3198364871321497,0.07692307692307693,0.8720572791698833,1.0,9/16,15.54%,NAPA;CDH8;GRIK2;GRIA2;UNC13A;GRIK1;GRID2;UNC13C;SLC17A7
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7416136051113735,-1.3193686639504174,0.25806451612903225,0.8940006087851148,1.0,2/6,9.76%,TMEM119;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.7416136051113735,-1.3193686639504174,0.25806451612903225,0.8940006087851148,1.0,2/6,9.76%,TMEM119;UBASH3B
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6771308311752074,-1.3191260285840534,0.15625,0.891254442478649,1.0,2/6,4.99%,ATP2C1;PKDCC
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.9192043504352865,1.3188240207194077,0.04285714285714286,0.8784155703687636,1.0,3/5,7.33%,NRXN1;NRXN2;NLGN1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6077920473607739,-1.3188000765359567,0.15789473684210525,0.8890462089328792,1.0,5/9,11.24%,IKZF3;MEST;BTK;MESD;HCK
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6293793727333905,1.3187535300712643,0.041237113402061855,0.8762546922843543,1.0,24/80,13.87%,OPALIN;GFAP;ENPP2;CD163;TNS1;NRXN1;PDK4;SLC1A2;RTN1;CA10;CHI3L1;GRIN2A;BAALC;GRIA2;PTPRT;CDH20;CHL1;NDRG2;FAIM2;PLP1;GLUL;GRIA3;NTRK2;KIAA0513
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),-0.8021385387768021,-1.3186899665969105,0.14705882352941177,0.8858322247501382,1.0,3/5,19.57%,IL17RA;MYD88;PLCG2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8270645317681173,1.3183737243188745,0.0684931506849315,0.8771651652725742,1.0,3/7,10.91%,TGFB2;NRG1;RBPJ
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",-0.8343174533204072,-1.3183663026449206,0.08823529411764706,0.883835714351049,1.0,2/5,8.95%,RUNX3;CBFB
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.7717073366302889,1.317474480927901,0.1282051282051282,0.8799434402609065,1.0,2/13,5.12%,VIM;DMD
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.7717073366302889,1.317474480927901,0.1282051282051282,0.8799434402609065,1.0,2/13,5.12%,VIM;DMD
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7085429253564013,1.3173970249729654,0.10714285714285714,0.8775192039167998,1.0,3/21,7.56%,KLF4;GPNMB;FHL1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6283746205764401,1.3172169999883379,0.06315789473684211,0.8763634571539367,1.0,24/83,14.73%,KLF4;SHROOM3;LRP4;FRAS1;SH3PXD2B;GULP1;COL4A5;ENAH;LAMB1;ADGRA3;DOCK1;LIFR;KITLG;PTPRG;RBFOX2;MYO10;PTK7;RND3;POU5F1;SH3D19;PARD3;ADGRL2;UACA;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.7058590517260179,1.3171539783439092,0.1111111111111111,0.8743914827140143,1.0,8/18,21.82%,PRKCE;RACGAP1;CIT;SVIL;CENPV;SPAST;PKP4;CDC25B
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.7543288482013923,1.3170472554745778,0.1111111111111111,0.8724317947192008,1.0,8/16,15.23%,MAPT;WASF1;NTRK3;TMEM108;SH3GL2;NTRK2;MAGI2;STMN2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7040617726955616,1.3167768684335157,0.11627906976744186,0.8726571031762951,1.0,18/28,21.77%,GRM8;GRIA4;GRIK2;GRIN3A;GRM3;GRIN2A;GRIA2;GRIK1;GRIA3;GRID2;GRIN2B;CDK5R1;PLCB1;GRM7;APP;GRIK4;GNAQ;CPEB4
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6801193388922964,1.3167573809286361,0.08641975308641975,0.8702366897578829,1.0,6/21,15.23%,MAPT;STMN3;MAP2;MAP1B;CLASP2;STMN2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7282107264805445,1.3165728992862706,0.07692307692307693,0.8692053884230507,1.0,2/18,3.08%,THBS1;PRKCE
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.45078084707641525,-1.3165637064343392,0.25,0.8893624108568058,1.0,16/55,17.62%,TAL1;TCF3;PSMB3;LMO1;PSME3;PSMD12;PSMC4;PSME4;CBFB;ABL1;SETD1A;PSMA1;KMT2A;PSMA7;PSMD3;PSMB5
prerank,MSigDB_Hallmark_2020__E2F Targets,0.6151005620684635,1.3164677967053462,0.01020408163265306,0.8675373990694569,1.0,39/132,24.51%,TOP2A;DIAPH3;CKS2;CENPE;TBRG4;HMGB2;NAA38;RACGAP1;CIT;TFRC;RPA2;PAICS;SMC4;XPO1;GINS1;ATAD2;DONSON;LMNB1;PRPS1;BRCA1;UBR7;DCK;CDKN1B;ORC6;PRDX4;EZH2;MLH1;RFC1;CDC25B;CTPS1;CBX5;TIMELESS;RPA3;HELLS;PHF5A;BARD1;IPO7;TACC3;NASP
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.8705876305042506,1.3161789570570495,0.09230769230769231,0.867468361624371,1.0,1/6,1.13%,COBL
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.7581272353708033,1.3159749926706021,0.15942028985507245,0.8664549876049454,1.0,2/10,4.01%,TGFB2;LAMB1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.8622294408815854,-1.3155041692526264,0.07407407407407407,0.8904589358679251,1.0,1/5,7.23%,JMJD6
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8106776777895837,1.3155010352684569,0.0958904109589041,0.8679132980745402,1.0,3/9,9.56%,TGFB2;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7094703020215131,1.314722301306227,0.07692307692307693,0.8723731169984783,1.0,5/17,16.79%,HS3ST5;HS6ST3;SULF2;HS2ST1;NDST3
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6814311578551687,1.3145249982564722,0.07777777777777778,0.8718221776276398,1.0,20/39,24.13%,VEGFA;SUV39H2;NDRG1;FMN2;HIF1A;BNIP3L;FAM162A;PINK1;BNIP3;SCN2A;HYOU1;CPEB2;EGLN3;RGCC;CPEB4;PGK1;NOP53;P4HB;EPAS1;RORA
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.7528718482911835,-1.313524886737789,0.23076923076923078,0.8942886432527792,1.0,2/7,10.81%,SMARCD1;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.7134209275113457,1.3135185530231284,0.06172839506172839,0.878000118377517,1.0,11/25,17.67%,SHANK3;ZDHHC15;IL1RAPL1;FCGR2B;SRCIN1;SIPA1L1;PPFIA2;EPHA4;WNT5A;CDK5R1;CFL1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.7628123235118685,1.3134937105347846,0.09210526315789473,0.8756292251565883,1.0,4/12,5.93%,TGFB2;IL15;ANXA1;VEGFA
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.6172947979805802,-1.3134104883178759,0.16666666666666666,0.8912869735049982,1.0,2/12,2.28%,GCLC;TXN2
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8821149382666078,1.3131670327716953,0.07142857142857142,0.8758374890987713,1.0,1/5,1.98%,SHANK3
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7378785727216395,1.312824473314652,0.0875,0.8764797805336563,1.0,10/22,14.19%,MAPT;SPOCK1;NR4A2;MDGA2;SOX4;AGTPBP1;MAP2;FAIM2;NTRK2;GRID2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.84969898371105,1.3124582158045457,0.10606060606060606,0.8742914246171669,1.0,2/7,6.47%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.84969898371105,1.3124582158045457,0.10606060606060606,0.8742914246171669,1.0,2/7,6.47%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7334077064459509,-1.3120894442248656,0.12,0.8941379284973725,1.0,1/9,0.20%,CCL5
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.7931414879294565,-1.3119619897504076,0.16129032258064516,0.8910511433324562,1.0,2/6,11.90%,TICAM1;TYROBP
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.7829483487065233,-1.3118360199365642,0.21428571428571427,0.8877695828586276,1.0,2/6,10.62%,HHEX;BHLHE41
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.7846727222966868,-1.311740633844844,0.17647058823529413,0.8844052811378725,1.0,3/6,8.11%,LGALS9;ARRB2;HLA-E
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.5224942735868594,-1.3113456719246328,0.10526315789473684,0.88205116909149,1.0,3/24,2.19%,PHLDB2;RPS6KA6;RBM19
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.6919993264673737,1.3109573462703197,0.09090909090909091,0.884639080073499,1.0,9/30,20.18%,THBS1;SOX4;IRS2;IGF1R;ADCY8;EIF2B2;PDK3;SLC39A14;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.8482932515790773,1.310667709808957,0.109375,0.8850057858017548,1.0,2/5,9.19%,PRKCE;IRS2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.609393815449041,1.3106422761745393,0.07526881720430108,0.8825559697416244,1.0,19/78,15.73%,LRP4;TGFB2;SHANK3;NRG1;CLIP3;RELN;NRXN1;TFRC;SLF1;FRMPD4;VEGFA;INSR;RAPGEF3;IGF1R;CAMK2B;PPP1R15A;BNIP3;CALY;TPPP
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.8371285867430653,1.310604080041992,0.11267605633802817,0.8803610855763366,1.0,1/7,2.46%,ENPP2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.728799949442389,1.3101220021251012,0.16279069767441862,0.8820427747812946,1.0,4/19,10.90%,CHST7;VCAN;NCAN;CSPG5
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.9056885605560987,1.3099890671957004,0.078125,0.880712412207189,1.0,1/5,3.67%,RELN
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.779386062729581,1.3097334370334512,0.12857142857142856,0.880237513615712,1.0,2/7,17.43%,ENPP2;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6689967865061279,1.3092958390438088,0.1111111111111111,0.8812709642703087,1.0,4/43,1.60%,THBS1;KLF4;SPARC;TGFB2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6777309283003671,1.3091984555611356,0.10975609756097561,0.8795593482025496,1.0,13/30,17.65%,FA2H;LSR;ALOX12;ANXA1;ST14;TXNIP;ERRFI1;COL5A3;PKD1;WNT5A;CASP3;CLIC4;UGCG
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.7764851240032835,1.3085406717369257,0.05,0.8826896769390465,1.0,6/10,19.64%,OPALIN;DAAM2;PTPRZ1;PTN;TNFRSF1B;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.6440792142296458,-1.3080076328300294,0.15789473684210525,0.8926028231834242,1.0,5/14,4.84%,FGL1;SAMSN1;BANK1;DUSP3;IL4I1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.7471909323445217,-1.307800152790648,0.2,0.8899096614465716,1.0,4/9,17.54%,GZMB;PLEKHM2;LYST;CEBPG
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.8721972065253647,1.3076576272572613,0.125,0.8873207204965704,1.0,2/6,8.56%,HTR2B;RYR2
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.8511288706923504,1.307359801943999,0.10256410256410256,0.8864942228962716,1.0,1/5,4.08%,AGT
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.7538985872571723,1.3072092878425023,0.058823529411764705,0.8829342807664908,1.0,7/15,21.90%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.7538985872571723,1.3072092878425023,0.058823529411764705,0.8829342807664908,1.0,7/15,21.90%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.6299917282781264,1.3071262501168412,0.08163265306122448,0.8808329913923605,1.0,20/65,21.16%,ZPBP;TULP2;GRM8;DCC;CLVS1;TALDO1;GAD1;SEPTIN4;NPHP1;MEP1B;MAP7;AGFG1;PEBP1;RFC4;HSPA2;SCG5;EZH2;SNAP91;DBF4;SPATA6
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.669042562125504,1.3070095371868693,0.0875,0.8795954871220499,1.0,5/30,9.25%,PLPP3;FZD6;NR4A2;TCF7;TCF7L1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.6907839025636804,-1.3068637651550894,0.22727272727272727,0.8902046687275087,1.0,2/7,5.70%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6816979215754446,1.3065909064539032,0.034482758620689655,0.8811706964805176,1.0,3/50,1.19%,FA2H;PLPP3;ALDH3B1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.6245630840322752,1.3055557270874845,0.020833333333333332,0.887690867600416,1.0,19/93,7.22%,TNC;THBS1;SPARC;FBN2;ADAMTS2;THSD4;ECM2;COL11A1;VCAN;NCAN;MMP21;ITGA2;COL4A5;LAMB1;TEX14;ADAM15;COL23A1;LAMA2;COL24A1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6211548394854808,1.305208037845389,0.06382978723404255,0.8879034393303004,1.0,26/64,20.69%,RBMS3;DENND2A;PDE10A;ENAH;LAMB1;DZIP1;FBXL7;LIFR;PTPRG;RUNX1T1;ANK2;AKAP12;PPFIBP1;MAP1B;FIGN;ADGRL2;TYRO3;NFASC;LIMCH1;ITSN1;FLRT2;THY1;MPDZ;APBB2;PRKAA2;GUCY1A2
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.7848917074267561,1.3048297088054381,0.09090909090909091,0.8889826149681611,1.0,2/11,7.01%,CADM1;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.7172466466684572,1.3046718518133225,0.07407407407407407,0.8877396146131887,1.0,5/23,10.08%,KCNE1;ANK3;ANK2;AKAP6;KCNMB1
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.8535616003741008,1.30458353116356,0.05555555555555555,0.8858436553789818,1.0,1/7,0.32%,HTR2B
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.7904703465888574,1.3042048410516265,0.11842105263157894,0.887046101327573,1.0,1/13,0.14%,FA2H
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.7947653598601562,1.3041966263404667,0.12345679012345678,0.8846830439005844,1.0,2/9,5.93%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7248367319157952,1.3039794792658836,0.12048192771084337,0.8839942958100131,1.0,6/22,7.62%,HTR2B;SEMA3A;NRG1;CDH2;SEMA3B;SEMA6A
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.7152509060615064,1.3032307091966844,0.10975609756097561,0.8884549418113741,1.0,3/17,8.09%,THBS1;TGFB2;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.5896022092352242,-1.3031451806662078,0.2,0.9022617336975688,1.0,3/14,8.34%,CCL5;GRK2;PLEK
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.790816078641444,1.3030489853579983,0.1232876712328767,0.8875843785691496,1.0,5/9,16.18%,ANK3;SCN3A;SCN1A;SCN2A;SCN8A
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.791151068674963,-1.3029539602465672,0.16666666666666666,0.8997227661706885,1.0,2/5,6.36%,CCL5;CD274
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5961268918465883,1.3028062783786378,0.0707070707070707,0.8870431113879758,1.0,27/105,14.83%,PLPP3;SH2D4A;THSD4;NTN4;MAPT;COL4A5;ENAH;LAMB1;DOCK1;NFIB;DOCK5;LIFR;KITLG;PTPRG;VEGFA;EMC7;RBFOX2;KANK1;PALLD;RND3;MAFB;THSD7A;SH3D19;MAGI2;ADGRL2;UACA;LIMCH1
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.7213379809423048,-1.3026094205204841,0.18181818181818182,0.8976836467252568,1.0,1/5,0.10%,ITK
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.823496318087601,1.3023872130784293,0.12162162162162163,0.8883469755634548,1.0,1/7,0.41%,KLF4
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6818887991821888,1.3023498785020444,0.03571428571428571,0.8862673635991855,1.0,17/44,19.07%,LRP4;LRRC4C;OMG;METRN;CDH2;ROBO2;SIPA1L1;CHN1;LINGO1;MAG;ROBO1;NTRK2;EPHA4;PLXNB1;THY1;PLXNC1;ARHGDIA
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.6432140620699461,1.302119786423311,0.07142857142857142,0.885758868007702,1.0,21/72,16.75%,HHIP;TGFB2;ZBTB16;SH3PXD2B;VCAN;NCAN;BMPR1B;CHI3L1;SOX4;EIF2AK3;PAPSS2;TNFRSF11B;TRPS1;ITGB8;SULF2;DEAF1;ETS2;SOX6;COL10A1;PKD1;WNT5A
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.6943739294870822,1.3020508394029013,0.08139534883720931,0.8839938854301698,1.0,2/28,4.45%,SOCS3;ITPKC
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.42369605959728746,-1.3019135145806875,0.16666666666666666,0.8972000115030723,1.0,32/91,14.83%,CD300LF;ITGAM;LY86;PTAFR;MPEG1;BIN2;PIK3R6;LGALS9;LILRB4;CSF1R;HLA-DRB6;AOAH;PLEK;MYO1F;HAVCR2;ALOX5;WDFY4;NCKAP1L;TLR7;IGSF6;ITGAX;HLA-DPA1;ITGB2;HCK;CD53;TYROBP;FCGR1A;LCP2;CYTH4;SNX20;HLA-DRB5;PIK3R5
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.8203833776415301,1.3017400264778243,0.11428571428571428,0.8842576595767419,1.0,3/8,9.28%,HSPA5;EIF2AK3;HERPUD1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8996463919359441,1.3015614231920283,0.12698412698412698,0.8832921218491541,1.0,1/5,2.95%,MAPT
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.6976914822152654,1.3014236032192201,0.06976744186046512,0.8821113654243398,1.0,5/23,5.39%,TGFB2;MAPT;SPOCK1;CIT;ANXA1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.8028196563955184,-1.300869120032081,0.25806451612903225,0.8987292418508542,1.0,2/5,12.21%,EP300;SPRED2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.47334639259151357,-1.3008271456403526,0.0,0.8952962605254484,1.0,5/56,3.97%,CCL5;GBP3;INPP5K;CHUK;DAB2IP
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.7891033932675007,1.3005269997135909,0.07575757575757576,0.8868968256585626,1.0,3/10,11.28%,ASPA;GAD1;GLUL
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.8104914920817972,1.3004833335799513,0.10256410256410256,0.8849088494783699,1.0,3/8,7.55%,KLF4;RBMS3;DAPK1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7108709250373282,1.3003058356687422,0.09411764705882353,0.8838547169202932,1.0,4/18,10.42%,RORB;NOCT;LIMD1;RANBP3L
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.7295557262245478,-1.299852427364412,0.2413793103448276,0.8962439589975223,1.0,3/7,20.11%,OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7253655836306203,1.2996824188336564,0.136986301369863,0.8869253548651825,1.0,2/11,6.57%,LSR;CGNL1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.8636702641648476,1.2993976209804816,0.11594202898550725,0.8866689391622271,1.0,1/6,6.39%,RXRB
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.7035390353343672,-1.2993179502939751,0.16666666666666666,0.894467255078637,1.0,3/10,11.13%,FLNA;NFKBIE;NFKBIA
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.6389573401836028,1.2992619748339318,0.044444444444444446,0.885570322769096,1.0,17/64,12.11%,SOCS3;TNC;PLPP3;SPARC;SVEP1;LRP4;ADAMTS2;COL11A1;ITGA2;OSMR;LAMA2;INSR;HIF1A;PALLD;FN1;C5AR1;NOD2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.765162658467514,1.298969092645241,0.2222222222222222,0.8858236461096942,1.0,5/11,13.66%,ZBTB16;BMPR1B;MBOAT2;TRPS1;SOX6
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.5925009873402025,-1.2985949221771937,0.13043478260869565,0.8904367166111163,1.0,1/14,1.58%,DNMT3A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.5925009873402025,-1.2985949221771937,0.13043478260869565,0.8904367166111163,1.0,1/14,1.58%,DNMT3A
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.821771736179894,-1.2985606284710067,0.16666666666666666,0.8871020265284393,1.0,2/5,12.00%,IL1B;SEMA4D
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.7537157334830686,1.2977359860797468,0.1111111111111111,0.8938194143921437,1.0,6/12,19.83%,SVIL;SGCZ;IGSF8;ZBTB18;MYL6;SGCD
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.696558326195678,-1.2976805487563683,0.27586206896551724,0.8876000011860778,1.0,2/6,11.02%,NBDY;CNOT6L
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7232838404872327,1.2975885379345504,0.17391304347826086,0.8927106542462481,1.0,2/12,2.37%,PKIA;PRKAR2B
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7174494340867485,1.2975436098996267,0.08139534883720931,0.8907968583669995,1.0,7/20,11.78%,SHANK3;RELN;NRXN1;NLGN1;NLGN3;RIMS2;TMEM108
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.6336528304873235,1.2974849825830757,0.06521739130434782,0.8888692960868492,1.0,19/60,14.83%,PLPP3;NTN4;SH3PXD2B;ENAH;LAMB1;DOCK1;GNA11;DMD;LIFR;KITLG;SPRY1;RBFOX2;BMI1;PALLD;RND3;ERRFI1;SH3D19;UACA;LIMCH1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6864479162979971,1.2969384688373844,0.1,0.8912933224171283,1.0,11/34,20.52%,MAPT;CLIP3;TUBB4A;MAP2;CAV3;STMN2;CDK5R1;TOGARAM1;EML2;DCTN1;FES
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.709579233351772,1.2968171384135183,0.06896551724137931,0.8901790278328361,1.0,10/27,13.20%,FLRT1;SEMA3A;NLGN3;ALCAM;MAP1B;TMEM108;SEMA5A;SH3GL2;IMPACT;SLC9A6
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.6196057985977798,1.2967731334681485,0.07526881720430108,0.8882680902731394,1.0,7/46,8.42%,THBS1;HTR2B;SPARC;HMGB2;NR4A1;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7351774067380141,1.2967575365433988,0.14634146341463414,0.8860374969582058,1.0,2/13,8.09%,GRAMD1C;ABCA2
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.8116532938195861,1.2965844548092431,0.14516129032258066,0.8849454212607656,1.0,3/5,13.96%,H2BC11;IFNLR1;OTUD7B
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.8257189604877676,1.2965775740126455,0.14285714285714285,0.8826646340925677,1.0,1/5,2.53%,EGR1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.8909078676077156,1.296037321727154,0.08450704225352113,0.8849504309099884,1.0,3/6,7.93%,KCNE1;ANK3;AKAP6
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.6426414685987636,1.2951530778694182,0.023255813953488372,0.8902765896777873,1.0,23/73,20.03%,DDIT4;TGFB2;PTPRD;SPOCK1;NR4A2;ERCC2;MANF;IL1RAPL1;RORB;VEGFA;SOX4;OLIG1;ID2;ALK;NTRK2;EPHA5;WNT5A;CASP3;CDK5R1;UGCG;ERCC6;ACSL3;NRBP2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.7372875811897797,1.29512045007489,0.13513513513513514,0.8884179652137841,1.0,2/13,9.19%,THBS1;IRS2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.6802168175614145,1.2950025562124254,0.12643678160919541,0.887101951611248,1.0,2/23,0.55%,SOCS3;SH3BP5
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.5102342501489981,-1.2949837320527249,0.08333333333333333,0.8955765159591201,1.0,12/36,17.44%,RALB;TAPT1;FSCN1;PIP4K2B;ARHGAP35;LCP1;CNOT6L;KCTD17;CAPG;MARK4;CROCC;STX18
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.6348531755670221,1.2947198940296512,0.11494252873563218,0.886856178326115,1.0,12/42,21.61%,TULP2;WDR5;CREB5;SMC1B;POU5F1;GGNBP1;BRCA1;MRPL14;OSBP2;AQP11;SPAG6;SORD
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.7662639567126768,-1.2945540432209863,0.18181818181818182,0.8945067416980098,1.0,2/6,18.37%,TREM2;PRKCA
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6397961553711139,1.2945325916646897,0.041666666666666664,0.8860120453127951,1.0,20/71,15.55%,TNC;PLPP3;SH3PXD2B;LAMB1;OSMR;DOCK1;FILIP1L;GPNMB;SYNC;BMI1;PALLD;RND3;FN1;PPFIBP1;PTN;SASH1;MLANA;PMP22;UACA;ITGAV
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6087928023031963,1.2945204071921408,0.020202020202020204,0.8838609905844378,1.0,34/133,14.80%,SOCS3;TNC;KLF4;PLPP3;NFIL3;NAMPT;RHOB;TGIF1;EGR1;GADD45B;NR4A2;SLC2A3;NR4A1;MAP3K8;VEGFA;IER5;TRIP10;IRS2;ID2;BHLHE40;MXD1;MCL1;FOSL2;IFIT2;PER1;ABCA1;PLK2;NR4A3;PDE4B;ETS2;B4GALT5;RIPK2;PPP1R15A;SOD2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.6316914614529989,1.2943203987042768,0.06666666666666667,0.8831893018945743,1.0,27/70,18.37%,PLPP3;FAM13C;LRP4;VIM;PLPPR4;FBXL7;SRRM3;LIFR;ANK2;ARNT2;RBFOX2;PTN;MAP1B;NR2F1;GPRC5B;FIGN;CRMP1;SHC2;ADGRL2;NFASC;LIMCH1;NDRG4;HSPA12A;THY1;CPE;EDIL3;MPDZ
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.7120874607879965,1.2942920966700582,0.09523809523809523,0.8810790814477732,1.0,11/24,24.51%,CENPF;CENPE;OIP5;CENPP;CENPI;CENPV;CENPK;CENPT;HELLS;ITGB3BP;NASP
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.6656268833096146,1.294050942939235,0.07291666666666667,0.8810569989885583,1.0,6/40,12.98%,RAB3C;ANXA1;TVP23A;RIMS2;RAB15;ABCA1
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7680858000366255,-1.2937131121296852,0.25,0.8950217405132772,1.0,2/5,18.37%,TREM2;PRKCA
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.7500956181269649,-1.2934429557894087,0.24242424242424243,0.8927461726976028,1.0,4/6,20.48%,UQCC2;DDX5;MEF2C;NR1D2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.7847970888023392,1.2925510927278003,0.08823529411764706,0.8914649807560484,1.0,3/10,11.83%,VEGFA;GPNMB;SEMA5A
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.763665462805404,1.2923003781477755,0.14666666666666667,0.8913488962840869,1.0,3/11,11.88%,FAAH;ABHD12B;LIPE
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.667809439537191,-1.2920229211726209,0.16666666666666666,0.8952324706929682,1.0,6/10,18.12%,SETD1B;SETD1A;TET2;ZNF335;KMT2A;KMT2D
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.6958052785581372,1.2917811485041026,0.046511627906976744,0.8937712261315041,1.0,14/39,18.59%,IL1RAPL1;RAB3C;STXBP5L;ANXA1;RIMS2;RAB15;SEPTIN4;CADPS;SYT1;CLASP2;NSF;CPLX1;RAB2B;STXBP6
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.8655217092974162,1.291713399055758,0.11940298507462686,0.8920677808146772,1.0,3/6,9.78%,SEMA3A;SOX4;FN1
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),0.879110230608603,1.2915969511520182,0.09836065573770492,0.8910040994777894,1.0,4/5,12.11%,THBS1;SLC11A1;FCGR2B;NOD2
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6391355040927809,-1.2911775250478297,0.09523809523809523,0.8953869331411947,1.0,3/12,9.29%,ZNF675;IGF1;TGFB1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.815956985685211,1.2906236671872147,0.08860759493670886,0.8973227261281074,1.0,3/8,5.93%,PRLR;NRG1;VEGFA
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.8263612481954056,1.2905981536128104,0.0958904109589041,0.8953090335009424,1.0,1/8,0.32%,HTR2B
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.6745661246550774,1.2903879541364063,0.08433734939759036,0.8946704520962709,1.0,2/28,6.52%,GLRA1;NSMF
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.7252514444072989,1.2902731982500044,0.09523809523809523,0.8932982770429827,1.0,2/13,6.28%,TGFB2;SOX4
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.636119372604664,1.2900778489896159,0.0975609756097561,0.8927568361943872,1.0,3/38,1.04%,KLF4;HHIP;NLRP12
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.7422612624140078,1.2900167780718794,0.07142857142857142,0.8911294574324767,1.0,7/16,21.90%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.7659813153509915,-1.2899889323712541,0.24242424242424243,0.8962416014751433,1.0,2/5,15.10%,UBA7;UBE2E2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.8459348610290253,1.2898546476226487,0.12987012987012986,0.8900419014100633,1.0,2/5,10.33%,PRLR;GHR
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6192468677509914,1.2898394735555583,0.041666666666666664,0.888031104808872,1.0,34/82,22.48%,LRP4;LRRC4C;SHANK3;MYOT;GPM6A;PTPRD;MAPT;CACNB2;NRXN1;CDH2;NRXN2;CTNND2;SHANK2;ANK3;NLGN1;NLGN3;UNC13A;PPFIBP1;DNM3;C5AR1;PPFIA2;CBLN2;UNC13C;LRFN5;NTNG1;APP;DCTN1;PPFIA4;APBB2;PAK3;DNER;NLGN4X;PTPRS;CNTN2
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.46011439941462395,-1.2896069810993038,0.25,0.894644281100089,1.0,27/93,12.19%,CYSLTR1;ITGAM;TRIM38;LY86;PTAFR;MPEG1;IL1B;LGALS9;LILRB4;CSF1R;TMEM106A;HLA-E;PLEK;APOL6;HAVCR2;NLRP3;TREM2;WDFY4;TLR7;IGSF6;MILR1;ITGAX;CSF2RA;ITGB2;HCK;TYROBP;PTPRE
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.6790710069155863,-1.2892013772309314,0.25,0.8928599371947544,1.0,3/7,14.44%,TAL1;TLK2;MAP1S
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7319383292710944,1.2884720832303906,0.1282051282051282,0.8970572015199667,1.0,7/14,25.57%,CGNL1;NLGN1;BSN;KIF3A;DLG4;JAM3;TJP1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.7748328115157256,1.288469637802815,0.1917808219178082,0.8948851501845674,1.0,1/11,0.41%,KLF4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6096146141825654,1.288226016888373,0.07368421052631578,0.8949622594935364,1.0,23/86,11.38%,CLDN18;LRRC4C;TGFB2;MYOT;PTPRD;CADM1;IGSF11;IL1RAPL1;CDH8;CDH2;ROBO2;CDH9;NLGN1;UNC5D;PTPRT;CLDN20;ALCAM;PALLD;MAG;CDH20;ROBO1;CDH12;CELSR2
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.7455260156835906,1.288072578175681,0.11764705882352941,0.8941850985908624,1.0,1/16,0.24%,UAP1L1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.776687124229651,1.2877939302823875,0.1527777777777778,0.8942198355901438,1.0,1/7,1.60%,TGFB2
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.7236644848354413,1.287599786757469,0.10465116279069768,0.8937096603674309,1.0,7/17,10.90%,OMD;OGN;VCAN;NCAN;GNS;ACAT1;CSPG5
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.8386642770104658,1.2875236512653572,0.13846153846153847,0.892223729857192,1.0,1/8,0.41%,KLF4
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.7266088669564476,-1.2871814645266662,0.21739130434782608,0.8972813998178272,1.0,1/8,2.89%,ACTA2
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.8005006171928204,-1.2870807935971074,0.2,0.8941678299675603,1.0,2/6,6.06%,ARHGDIB;IGF1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.6169000238178052,1.2868961874174025,0.041666666666666664,0.8946700247895517,1.0,18/91,7.22%,TNC;THBS1;SPARC;FBN2;ADAMTS2;THSD4;ECM2;COL11A1;VCAN;NCAN;MMP21;ITGA2;COL4A5;LAMB1;ADAM15;COL23A1;LAMA2;COL24A1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8770459833276182,1.2868707520333746,0.08823529411764706,0.8926480289793732,1.0,1/5,5.39%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.691222756292122,1.2867615232664897,0.15476190476190477,0.8916931958292029,1.0,2/23,1.15%,SOCS3;ST18
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.39669671347957325,-1.2864725888295296,0.0,0.8935359761821621,1.0,25/119,11.22%,ITK;STAT4;CCL5;FLNA;CD2;ETS1;LY86;GZMB;IL1B;CD96;PRF1;ICAM1;GALNT1;CD247;HLA-E;TLR3;TGFB1;NLRP3;EIF5A;ST8SIA4;IKBKB;IGSF6;BCL3;EGFR;ITGB2
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.8795235506845351,1.2862271847562268,0.11475409836065574,0.8940802939260768,1.0,1/5,1.04%,NLRP12
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.6893049102686899,1.2860560522594624,0.10126582278481013,0.8934702813711791,1.0,7/30,15.33%,SLF1;RPA2;FIGNL1;FMN2;SPIRE2;KDM1A;ZCWPW1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.8918257050292729,1.286020772793668,0.06060606060606061,0.8917487817081635,1.0,1/5,2.46%,ENPP2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.6964066626301584,1.285723075009809,0.047058823529411764,0.8916388579676064,1.0,3/29,8.16%,TOP2A;SMC4;NCAPH2
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.8554109768159617,1.2856757000727377,0.11940298507462686,0.8898870806260082,1.0,3/5,9.23%,EGR1;HIF1A;PAX8
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7903593485711597,1.2855788502839094,0.1038961038961039,0.8886754964395764,1.0,4/13,11.21%,ROBO2;VEGFA;ROBO1;PDE2A
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7869201312478262,1.2847813485660542,0.09333333333333334,0.8925434974591505,1.0,4/14,8.23%,GLRA1;INSYN2A;GRIN2A;NLGN3
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.6582817150556941,-1.2844630565497435,0.15384615384615385,0.8980043675903671,1.0,3/10,9.28%,SETDB1;BAHD1;POLE3
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.778008210847773,1.284346733048842,0.14666666666666667,0.893809466907174,1.0,3/7,18.19%,PFKM;FBP1;GFPT1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.8158532850020703,1.284213994088197,0.125,0.8929564418687138,1.0,1/8,1.92%,CENPE
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.7662282411618351,1.284007948499069,0.10843373493975904,0.8922760314597207,1.0,1/12,0.01%,KCNE1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7586501225926243,-1.2834337422967057,0.16216216216216217,0.8993646410549756,1.0,3/6,15.42%,RIN2;RAP1A;EMP2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.6118344558212168,1.2833289998679787,0.10638297872340426,0.8958895507475177,1.0,13/72,15.06%,KCNE1;CCPG1;OMG;CD163;ANKUB1;CHL1;FMO5;ABCA1;FAM20A;FGL2;CPM;SOD2;CLMN
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7016438111782786,1.282600325049635,0.12941176470588237,0.8988358550178414,1.0,6/21,13.20%,SEMA3A;NLGN3;ALCAM;MAP1B;SEMA5A;SLC9A6
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5434966013217198,-1.2823902333049797,0.0,0.9004718217562254,1.0,1/29,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.8134504173870174,1.2820220119720604,0.19230769230769232,0.9011195563560654,1.0,3/7,12.25%,RORB;VEGFA;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.7569811266500472,-1.2820165803839425,0.18518518518518517,0.8988570098961005,1.0,2/8,3.55%,SKAP1;IL1B
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.4921854245230454,-1.2818399214458356,0.06666666666666667,0.8965295255982034,1.0,9/36,15.13%,ACSM5;LPL;OSBPL6;MLYCD;CH25H;ALOX5;NDUFAB1;LIPG;ABCD3
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.840474051498517,1.2818349967262357,0.09859154929577464,0.9004684131676572,1.0,2/6,7.82%,RAB7B;RAB20
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6512979431217977,1.2816537789291134,0.10112359550561797,0.8998619374108605,1.0,8/34,11.76%,GPR18;HTR2B;TACR1;AGT;GNA11;LTB4R;GPR65;C5AR1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.6190433429621549,1.2815482669568634,0.08791208791208792,0.8985928747676112,1.0,6/58,7.55%,THBS1;KLF4;NLRP12;BEX3;VEGFA;DAPK1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.6113956769701522,-1.2814115102514292,0.13636363636363635,0.8950848572548946,1.0,3/13,4.84%,SKAP1;SAMSN1;IL4I1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.7937216425797297,1.2813259803128583,0.14285714285714285,0.8984498427135038,1.0,3/7,8.59%,SCN3B;ANK3;PKP2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7392714728864538,1.2806204526071256,0.19444444444444445,0.9023021476670765,1.0,4/13,17.02%,DDIT4;NTRK2;MAGI2;CASP3
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.8494474931212025,1.2806188033458834,0.1506849315068493,0.9002721117789763,1.0,2/7,9.23%,TG;PAX8
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.6277339944055514,-1.2804165979310118,0.16666666666666666,0.8960476762471784,1.0,2/12,4.99%,ARV1;TECR
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6638754673651691,1.2800119995609887,0.16666666666666666,0.9033816743956444,1.0,6/20,20.01%,ACSL1;SCD5;FASN;SCD;HSD17B12;ACSL3
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7780386749867663,1.2798483558140488,0.18055555555555555,0.9029824139382641,1.0,1/7,1.60%,TGFB2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.7114512459399394,-1.2796750755634883,0.18181818181818182,0.8956660187010583,1.0,3/10,8.99%,TICAM1;SCIMP;TLR3
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.7203396880634061,1.279645437548072,0.14814814814814814,0.9025029121565115,1.0,6/16,19.00%,MYRF;SOX4;CSPG5;TPPP;EIF2B2;APP
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.7428436856326524,1.2796431507421733,0.13414634146341464,0.9004702479399428,1.0,6/15,8.23%,LRP4;SHANK3;NRXN1;NRXN2;NLGN1;NLGN3
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8672622341687091,1.2795088968256643,0.1111111111111111,0.8995493333889713,1.0,5/5,13.31%,MAPT;WASF1;TMEM108;SH3GL2;NTRK2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.6078214915489066,1.279461616084266,0.05263157894736842,0.8978991205882167,1.0,27/95,20.03%,DDIT4;TGFB2;SEMA3A;GPM6A;HMGB2;PTPRD;MAPT;SPOCK1;RACGAP1;NR4A2;RELN;CIT;IL1RAPL1;OLIG1;BHLHE40;MAP1B;NTRK2;ASTN2;CCK;WNT5A;CASP3;CDK5R1;TUBB2A;FGF13;ERCC6;ACSL3;NRBP2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.7536136207953313,-1.279037181914044,0.22580645161290322,0.8944302524300719,1.0,3/6,19.49%,DCP1B;EDC3;ZFP36
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.8399531056222884,1.2788394374610148,0.1323529411764706,0.9011348721774,1.0,2/5,10.51%,FBN2;LTBP1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7213840142493625,1.2780288647951672,0.18055555555555555,0.9053702807799036,1.0,5/13,10.96%,CIT;SHANK2;MOB3B;LIMD1;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7299646195228413,1.2776318270768314,0.125,0.9066929502859209,1.0,4/16,9.56%,LRP2;TGFB2;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.5957640712701651,1.2769698136632748,0.02040816326530612,0.9101500831090433,1.0,45/128,25.51%,PCSK1;EEF1A2;RPL23;CARNS1;DMD;RPL37A;RPS6KB2;RPL38;COPS5;RPS6;RPS27A;RPL23A;RPS25;RPS27;DARS1;RPS11;RPS20;RPL9;RPLP2;RPS18;MRPL43;RPL37;RPL14;RPS4X;RPL11;RPS24;MRPL27;MRPL55;RPS9;RPL36;RPS3A;MRPS14;MRPL3;RPL35;RPL4;EEF1A1;RPL32;TNIP1;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.7417620342515637,-1.2762345314838341,0.14285714285714285,0.902215444053866,1.0,4/5,25.75%,ARHGAP12;LRP6;PHACTR4;NOTCH1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7339217692940861,1.2761269125552142,0.14285714285714285,0.9150626256622473,1.0,9/15,23.64%,DMD;ANK2;RYR2;CALM3;ATP2A2;CLIC2;SLC9A1;CACNA1C;ATP1A2
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6174524619297233,1.2756447526672123,0.09782608695652174,0.9170184576116184,1.0,25/70,19.40%,RAP1GAP;COBL;FAAH;PPP1R9A;MAPK4;PHYHIPL;SYBU;ARFGEF3;MYRIP;SHANK2;ANK3;SRCIN1;PTPRT;BMI1;NDRG2;KALRN;SHC2;SORBS1;TPPP;PLXNB1;NEBL;EPB41L4B;SORBS2;MTUS1;HAMP
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.8239108191715951,1.2754765088938154,0.16176470588235295,0.9165987889463245,1.0,1/5,1.60%,TGFB2
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.8478952740213497,1.2754604014693869,0.13333333333333333,0.9147199468964878,1.0,4/5,15.08%,SHANK3;FRMPD4;CAMK2B;CTNNA2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7351362203071182,1.2749860522334306,0.16,0.9162442660721365,1.0,6/12,22.55%,TGFB2;ROBO2;ROBO1;TNFRSF1B;TNFRSF1A;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.6545950431108931,1.2748824461655317,0.1797752808988764,0.9151316384286259,1.0,6/25,5.47%,FBN2;TGFB2;ZBTB16;GPM6B;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.6195012248959513,-1.274768863610447,0.125,0.9012781491973969,1.0,2/10,10.67%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.6195012248959513,-1.274768863610447,0.125,0.9012781491973969,1.0,2/10,10.67%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.7183949520132156,-1.2745296466881808,0.1935483870967742,0.8992421691032763,1.0,1/7,0.20%,CCL5
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.824017645717202,1.2738696696665854,0.1267605633802817,0.9209629140989135,1.0,3/7,11.21%,ROBO2;ROBO1;PDE2A
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.6910418428432481,-1.2737638422875195,0.2413793103448276,0.8987170411887087,1.0,3/6,22.66%,ABL1;CHEK2;MAP2K6
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.5293666452625937,-1.2736963629976596,0.05263157894736842,0.8957720479106838,1.0,9/25,4.52%,TRGC2;NKG7;CCL5;GNLY;CD2;CST7;GZMB;CD96;PRF1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.6449332577786069,1.2735718784006183,0.12048192771084337,0.9211939084568413,1.0,9/43,15.79%,GLRA1;ANO4;GABRB1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6486393568848604,1.2735360715198547,0.14606741573033707,0.9193849098959967,1.0,21/45,22.46%,LRP4;SEMA3A;OMG;DCC;SPOCK1;NLGN1;LINGO1;NGEF;PAQR3;KANK1;MAG;CRMP1;EPHA4;STMN2;THY1;DENND5A;ARHGDIA;PTPN9;BCL11A;RTN4RL1;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.6757786942342708,1.2735083762178865,0.14666666666666667,0.9176825412952312,1.0,2/19,0.85%,THBS1;SPARC
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.6289018676806484,1.2734029273141076,0.08602150537634409,0.9164211804798574,1.0,7/64,5.18%,CENPF;HAUS6;TUBA4A;PRKAR2B;TUBB4A;TUBA1A;CEP152
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6835288130149856,1.2732574993431707,0.2125,0.9157356358372445,1.0,5/12,19.00%,BEGAIN;TMEM108;DLGAP1;DLGAP2;APP
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.7060278392976025,1.27313380486845,0.12162162162162163,0.9147783030577943,1.0,4/16,18.70%,SH3PXD2B;ALOX12;SOD2;SOD1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.861347833094384,1.272889209392844,0.11392405063291139,0.9146867340052564,1.0,2/6,12.44%,FBXL7;RBX1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.6446582231932024,1.2727894875715005,0.06593406593406594,0.9134426662018215,1.0,21/52,24.74%,MACC1;COBL;CYP3A5;TFRC;PDZD2;LARP1B;INSR;ATP5MK;ITGB8;TRHDE;MAP7;CLMN;NEBL;ESRRG;PPARA;ATP10B;TRPM7;CPEB4;PLD1;GDA;FGD4
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.847811317768951,1.2727314389103668,0.15873015873015872,0.9119894529255854,1.0,4/5,15.20%,BAIAP2L1;PPP1R13L;ADGRG6;TRIM16
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.8019717086803158,1.2725534403898708,0.13043478260869565,0.9114374791441819,1.0,1/7,1.60%,TGFB2
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.6781891759290133,1.2725109742538718,0.15476190476190477,0.9098394384286015,1.0,7/31,6.76%,OMD;OGN;VCAN;NCAN;GPC5;CEMIP;GNS
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.8473770083980933,1.2724662052678903,0.1527777777777778,0.90813196901369,1.0,4/6,13.16%,DPYD;DPYSL5;CRMP1;ALDH6A1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.8163915056448927,1.2720981815601655,0.14705882352941177,0.9091383398226899,1.0,1/6,2.50%,ACSL1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7658573260132715,1.271981127110184,0.11842105263157894,0.9079026084186185,1.0,3/11,7.67%,CACNB2;SCN3B;ANK2
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.7688510547769771,1.271861140714285,0.16216216216216217,0.9069416237506679,1.0,2/10,2.58%,ENPP2;GLA
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.7369729454451399,1.2717951908126819,0.17721518987341772,0.9056197113621686,1.0,3/10,5.13%,ACSL1;ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6099830941215346,1.2714235446841597,0.07216494845360824,0.9065462115948054,1.0,18/71,14.64%,CENPE;EEF1A2;MAPT;RELN;SPDYA;INSR;EPHA3;NTRK3;IGF1R;ALK;EPHA6;EPHA7;FLT1;NTRK2;TYRO3;PRKAG2;EPHA4;EPHA5
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.7946585183544332,-1.2713924519287754,0.23529411764705882,0.8973948806213702,1.0,4/5,20.09%,NPR2;PDE1B;ZFP36;CD4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.7946585183544332,-1.2713924519287754,0.23529411764705882,0.8973948806213702,1.0,4/5,20.09%,NPR2;PDE1B;ZFP36;CD4
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.8037021608696913,1.2709983483659406,0.10294117647058823,0.9082531068433463,1.0,2/10,11.06%,XPO1;NMD3
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.7850780027044892,1.2707504641423175,0.18055555555555555,0.9080630207391851,1.0,2/8,4.97%,APOLD1;ALOX15B
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.7888655547505086,1.269532621586278,0.175,0.9154933181431496,1.0,3/7,17.49%,SNAP29;VMP1;ATP2A2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.6793608423534097,1.2691807401388173,0.10112359550561797,0.9162773544654746,1.0,13/26,21.10%,MAPT;AP3B2;SYBU;KIF1B;HIF1A;TMEM108;DYNC1H1;SPAST;NEFL;SOD1;KIF3A;DCTN1;RAB21
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6883307440050436,1.269139356862755,0.17073170731707318,0.9146110606977762,1.0,4/18,11.94%,SHANK3;RELN;NLGN1;CAMK2B
prerank,MSigDB_Hallmark_2020__Apical Surface,0.6855238145078617,1.2684269371829218,0.12941176470588237,0.9184981735136001,1.0,13/24,25.17%,MAL;ATP8B1;SULF2;BRCA1;THY1;HSPB1;NTNG1;APP;RTN4RL1;CRYBG1;FLOT2;GSTM3;CX3CL1
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.7984262601881372,1.2678479335907986,0.23529411764705882,0.9210278943008606,1.0,1/8,0.31%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5606103204094274,-1.2677413828569029,0.2413793103448276,0.9091062555993609,1.0,1/13,2.26%,BTG2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6904228670538661,-1.2670946820705606,0.19047619047619047,0.908556253296741,1.0,3/9,11.22%,ETS1;ALOX5;ITGB2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.6985174205980998,1.266417257427308,0.18840579710144928,0.9300508385112175,1.0,3/13,12.42%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.6694239810122697,1.2663123191979682,0.11764705882352941,0.9289718224079467,1.0,4/30,10.08%,KCNE1;ANK2;AKAP6;KCNMB1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.4927387606165229,-1.266244450708781,0.09090909090909091,0.9088803738159836,1.0,15/36,17.57%,CD2;BTN3A2;IL1B;CD276;LGALS9;IL18R1;TLR3;TLR7;HLA-DPA1;CD226;IL12RB1;BTN3A1;PDE4D;CEBPG;SLAMF6
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.827133248737644,1.2661399075237936,0.15384615384615385,0.9285918832418959,1.0,2/6,11.06%,XPO1;NMD3
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5321774338626153,-1.2659628437681099,0.08333333333333333,0.9036074455994718,1.0,6/25,11.19%,CD300LF;TICAM1;CHUK;TLR3;IKBKB;BIRC2
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5321774338626153,-1.2659628437681099,0.08333333333333333,0.9036074455994718,1.0,6/25,11.19%,CD300LF;TICAM1;CHUK;TLR3;IKBKB;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6529775147638373,-1.2659472582335192,0.30434782608695654,0.9006350542082794,1.0,3/10,20.14%,IPPK;PIH1D1;NOL11
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8205552771366216,1.265453490829795,0.14492753623188406,0.9316607060314516,1.0,1/6,3.01%,GRAMD1C
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.6976519810213397,1.265165180445417,0.1566265060240964,0.9317255067015707,1.0,4/15,13.95%,HTR2B;RYR2;IBTK;RYR3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.6073172097880516,1.2651332297407636,0.042105263157894736,0.930092179898372,1.0,34/84,25.87%,RPL23;RPL37A;FTSJ1;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPS18;DRG2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7;EIF4A2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.48688499671075147,-1.2649761939523843,0.11764705882352941,0.9018853388119443,1.0,1/28,0.03%,PHLDB2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.41579634036574753,-1.264620790983395,0.0,0.9002448352151535,1.0,46/134,13.77%,CD300LF;CX3CR1;MRC2;ITGAM;CEBPA;LY86;GIMAP8;PTAFR;SUSD3;OLFML3;MPEG1;BIN2;LGALS9;HPGDS;LILRB4;P2RY13;CSF1R;ITGB5;UCP2;SLCO2B1;OTULINL;AOAH;PLEK;P2RY6;TMEM119;LTC4S;MYO1F;P2RY12;HAVCR2;CYFIP1;TREM2;WDFY4;IGSF6;ITGAX;ITGB2;HCK;PTGS1;CD53;TYROBP;SKI;ENTPD1;GPR34;LCP2;APBB1IP;GIMAP4;CYTH4
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.7791626411937806,1.2645145132427154,0.14285714285714285,0.9330273450927585,1.0,5/10,16.31%,MYRF;PTPRZ1;SOX6;TPPP;EIF2B2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.5982747048466478,1.264438449386967,0.05102040816326531,0.9317696664557634,1.0,18/101,19.23%,PCSK1;FA2H;PLPP3;ALDH3B1;NMRAL1;DMD;VAPB;ELOVL4;MFSD2A;ARG2;B4GALT5;SLC44A5;PPM1L;SPTLC2;PEMT;GCNT1;GSTP1;PRKD3
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.6610635262338225,1.2642883042917612,0.10843373493975904,0.9310919723519612,1.0,16/39,19.85%,ZNF382;AANAT;PDE10A;SCN3B;SV2B;AP3B2;SLC24A2;TVP23A;MGAT4C;FRRS1L;XKR4;HCN1;UNC13C;KCNJ6;CRB1;SV2C
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.6789615884654262,1.2642570085393308,0.12941176470588237,0.9294362303303438,1.0,5/21,14.57%,HMGB2;ANXA1;MTERF1;DNA2;DDX1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.7385881250191803,1.2641815427355816,0.14864864864864866,0.9281011784538342,1.0,2/11,4.92%,FAAH;FAH
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.47630628388901985,-1.2641076143016226,0.1111111111111111,0.8993335158088851,1.0,9/48,11.91%,RNASEL;CCL5;APPL2;HLA-E;TREM2;NMI;TASL;BIRC2;NLRC3
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.7664583785218084,-1.263291856642728,0.1875,0.8994572146922037,1.0,1/5,0.10%,ITK
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.6167920077659015,-1.2632662175212899,0.25925925925925924,0.8965036106185593,1.0,4/8,12.67%,NPL;IL4I1;GNPDA1;NAGK
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7454415967330003,1.262849501412779,0.19444444444444445,0.9360237762102217,1.0,3/8,17.49%,SCN3B;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.6198593420728279,-1.262739757732698,0.17391304347826086,0.8955249264203227,1.0,1/14,0.20%,CCL5
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8247075328302659,-1.2625312328257448,0.2972972972972973,0.8933568566864135,1.0,2/5,11.34%,BUD23;METTL16
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.8166059204719929,1.2623643965898121,0.1232876712328767,0.9376053504580789,1.0,2/6,6.28%,TGFB2;SOX4
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6987948193099912,1.2622462833733779,0.1411764705882353,0.9366840808932236,1.0,13/22,25.59%,LRP4;OMG;DCC;LINGO1;MAP2;MAG;THY1;FGF13;ARHGDIA;PTPRS;RTN4;GDI1;RUFY3
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.7217691096693853,1.2620547917665466,0.136986301369863,0.9364443390391298,1.0,4/16,18.70%,FGF1;ABCA2;ERLIN1;SOD1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.7632181500505466,-1.261780653383342,0.1891891891891892,0.8931013408179149,1.0,2/5,9.28%,BAHD1;POLE3
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.6689345396174076,-1.2617303118771648,0.20833333333333334,0.8902955073869239,1.0,3/8,10.61%,FOLR2;SLC46A1;SLC19A1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.7579533398807516,1.26146300786498,0.19230769230769232,0.9386188398306969,1.0,4/11,12.52%,HSPA5;EIF2AK3;HERPUD1;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7232800473326024,1.2612451415984636,0.19718309859154928,0.9385768783997012,1.0,4/12,14.98%,CALM3;MAGI2;PPP1R15A;CD300A
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7256040955636218,1.2611595523281969,0.08333333333333333,0.937351491566245,1.0,1/18,1.38%,TOM1L1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.7202569709991238,1.2607858129192508,0.18072289156626506,0.938002795802124,1.0,6/14,8.31%,LRP4;PTPRD;IL1RAPL1;NLGN1;NLGN3;BSN
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7463770297617108,-1.260481619111812,0.25,0.8929461813301046,1.0,4/8,15.49%,CYP19A1;SRD5A1;DHRS9;MED1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.8143222824327563,1.2603326343386796,0.18840579710144928,0.9394857763035968,1.0,2/5,13.75%,HIF1A;PINK1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.6899069858769483,1.2602550621595263,0.18292682926829268,0.9380848988198762,1.0,5/16,15.13%,DGKI;DGAT1;DGKB;LIPE;DGKG
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.7712673211788792,1.2600990865409356,0.17567567567567569,0.9374121645391065,1.0,1/8,2.50%,ACSL1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.7197680941294041,1.2599552621725232,0.21951219512195122,0.9366699858951418,1.0,3/14,10.91%,ACVR2A;BMPR1B;RBPJ
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.8414692512981665,1.2599205957020834,0.11594202898550725,0.9351390639908991,1.0,2/6,10.35%,BSN;ERC2
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.8682513573597099,1.259521941906152,0.11940298507462686,0.9364514350401535,1.0,2/5,11.28%,GAD1;GLUL
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.4716256250352572,-1.259483430706179,0.15384615384615385,0.8938310348424312,1.0,4/47,6.04%,BUD23;ALKBH8;FBL;METTL8
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.7779781093676856,1.259376658089757,0.1791044776119403,0.9359126828091339,1.0,1/7,1.60%,TGFB2
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.693283277466978,1.259244767227703,0.2222222222222222,0.9350362075924971,1.0,3/14,12.42%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.6221258607788986,1.2586689629971053,0.08888888888888889,0.937537088770919,1.0,10/54,12.38%,SLC51A;SLC38A4;SLC16A10;ACSL1;SLCO1A2;SLC6A15;SLC13A3;ATP8B1;MFSD2A;SLC10A1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8259636554192652,1.2577739668861936,0.19444444444444445,0.9418810667249229,1.0,2/5,5.93%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.7026044678501484,-1.257760321618619,0.22580645161290322,0.8976728844124089,1.0,3/6,17.32%,AMPD3;NUDT2;AK9
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.5775106069809461,-1.2572181016105826,0.23076923076923078,0.8967126466933729,1.0,4/21,3.72%,PHLDB2;INPP5K;PFN1;ARAP1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.7794697476771983,1.2571639695832195,0.14285714285714285,0.9449277733424917,1.0,4/8,9.78%,THBS1;ANXA1;F13A1;FN1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.730115979078844,1.2571544721484875,0.13253012048192772,0.9431531984484863,1.0,9/16,23.12%,PFKM;ENO2;PGAM1;GPI;ENO4;PKM;PGK1;ENO1;PGM1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.8234353449051852,1.2570585729065118,0.15942028985507245,0.942111742039486,1.0,1/6,5.93%,VEGFA
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.6956315945196299,1.2562549848511684,0.17721518987341772,0.9464483700882784,1.0,2/16,13.24%,FKBP5;PPID
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6208035052995756,1.2560141705408565,0.06521739130434782,0.9464631644663719,1.0,10/52,14.26%,THBS1;RHOB;SPARC;FGF1;AGT;VEGFA;PTN;GLUL;SASH1;GPI
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7898534862333891,1.2558593266858793,0.17105263157894737,0.9461609355634407,1.0,4/9,13.16%,DPYD;DPYSL5;CRMP1;ALDH6A1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.6186498708165883,1.2556798970790501,0.09574468085106383,0.945543522972992,1.0,19/57,21.95%,TGFB2;NSMF;PTPRZ1;MAG;RETREG1;FAIM2;EPHA7;CRLF1;NTRK2;PINK1;TYRO3;GRID2;SOD2;CDK5R1;SOD1;EGLN3;NRBP2;CPEB4;TNF
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8366771870893999,1.2556452079936653,0.12857142857142856,0.9439111029014846,1.0,2/6,7.67%,TGFB2;ANK2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.6096734912610414,-1.2553456117247093,0.15789473684210525,0.900477016316458,1.0,1/16,0.05%,TNFAIP8L3
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.7864322229439246,1.2553075506271396,0.16417910447761194,0.9443858652355519,1.0,3/9,9.23%,AGT;VEGFA;PAX8
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8271989359292337,1.2551659516712799,0.1044776119402985,0.941859317739223,1.0,2/7,8.93%,SEMA3A;ALCAM
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8271989359292337,1.2551659516712799,0.1044776119402985,0.941859317739223,1.0,2/7,8.93%,SEMA3A;ALCAM
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.6117565384536353,1.2551464859319938,0.0989010989010989,0.9402464644982134,1.0,7/52,11.77%,DEPP1;DAPK2;MAPT;FBXL2;DAPK1;BOK;TYSND1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8506413447890253,1.254343118128503,0.1323529411764706,0.9442514295863141,1.0,2/7,6.28%,SEMA3A;SOX4
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.7840360588086426,1.2543107177301065,0.1388888888888889,0.9426228267989915,1.0,4/8,11.60%,COBL;ZDHHC15;PTN;ALK
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.7320354555363564,1.254308359251258,0.1518987341772152,0.9408792767873909,1.0,2/12,8.42%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.8443574263262088,1.2539944636196374,0.16417910447761194,0.9394293021108903,1.0,2/5,5.93%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.8443574263262088,1.2539944636196374,0.16417910447761194,0.9394293021108903,1.0,2/5,5.93%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7880799972939981,1.2539917206904798,0.15584415584415584,0.9377017069756591,1.0,1/9,4.75%,ARF6
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6943820793538914,1.2537965106939084,0.2463768115942029,0.937268879246835,1.0,3/15,12.42%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.7033367257976684,1.2537948028569403,0.12658227848101267,0.9355004473991995,1.0,4/17,10.14%,TOM1L1;VEGFA;GPNMB;CALM3
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6924062440703408,1.2537679055228117,0.15853658536585366,0.9340124648437332,1.0,12/22,21.30%,SLC4A10;GRIK2;NETO1;NSMF;SYP;CAMK2B;MCTP1;SHISA9;APP;NCDN;SYNGR1;DLG4
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.7044279726947675,-1.2537313560497387,0.23529411764705882,0.9033109840562447,1.0,1/5,8.55%,PLEKHM1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.7901572140672142,1.2530122563929746,0.15789473684210525,0.9377052005339351,1.0,2/8,2.78%,LRRC4C;PTPRD
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.6225349082949097,1.2525501660601455,0.08791208791208792,0.9396793224123691,1.0,19/52,25.55%,CENPF;SUV39H2;PAICS;WDHD1;POU5F1;KDM1A;DNA2;FANCI;GINS1;PFAS;RFC4;ZGRF1;KIF11;SMARCC1;KNTC1;HELLS;HNRNPU;NASP;ATAD5
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.7546548954768832,1.2519489345794212,0.18518518518518517,0.9429052086485917,1.0,4/13,10.14%,JPH1;DMD;AKAP6;CALM3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.7869271343657199,1.2519267255659354,0.19117647058823528,0.9414145105211116,1.0,2/8,11.94%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.5444130343830014,-1.251774648031573,0.16666666666666666,0.9083632272933363,1.0,4/16,4.06%,CEBPA;TFAP4;LATS2;HHEX
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.789707455444085,-1.251312070572568,0.3103448275862069,0.9068237033698447,1.0,3/5,16.16%,ETS1;SERBP1;HABP4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.7575819682410672,-1.251287631335427,0.3333333333333333,0.9039265030395898,1.0,1/7,2.16%,TCF3
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7703196524688687,-1.251012075210248,0.2692307692307692,0.9023257172909483,1.0,1/5,3.27%,ZDHHC3
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7635160852955405,1.2509938419546434,0.18055555555555555,0.9466763337436624,1.0,3/8,5.37%,SLC2A3;SLC5A9;SLC2A9
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.6441733749718654,-1.2508136536625702,0.19230769230769232,0.899885825889989,1.0,3/10,16.22%,SORL1;EDEM2;CD81
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.7035989791061776,1.2505033843965057,0.21052631578947367,0.9482637123899088,1.0,2/13,8.09%,PLPP3;ABCA2
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.80105238969819,1.2501185898403189,0.208955223880597,0.9494229615196765,1.0,2/6,8.80%,CLDN18;ATP8B1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8499609303841026,1.2501173470086124,0.14084507042253522,0.9476783667059164,1.0,3/5,12.61%,DPYD;DPYSL5;CRMP1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.6399525080430981,1.2498958851173727,0.14772727272727273,0.9477070249744415,1.0,10/33,13.02%,PLPP3;THSD4;ACSL1;FAXDC2;AGT;CGNL1;ACSS3;FAM124A;KALRN;SORBS1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8031009216370458,1.249594236878977,0.12857142857142856,0.9481554644001492,1.0,3/6,17.99%,RYR2;RBPJ;CPE
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6433993424617698,1.2495640321219894,0.08139534883720931,0.946590509532127,1.0,8/31,12.25%,COBL;DCC;ZDHHC15;CSMD3;NSMF;PTN;ALK;MFSD2A
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6323664744136963,1.249212470120379,0.04878048780487805,0.9471899560457118,1.0,10/40,10.99%,TGFB2;CADM1;CDH8;CADM2;CDH2;CDH9;CTNND2;PKP2;CDH20;CDH12
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.6521985867073721,1.2487124763838373,0.13793103448275862,0.9487058561192844,1.0,7/27,14.11%,DDIT4;CEMIP;CHI3L1;CALM3;PARD3;PRKAG2;RIPK2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.8460149475213574,1.2486812538247662,0.10344827586206896,0.9473152279336733,1.0,2/5,13.50%,BOK;CYCS
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.5742768070604503,-1.2486384009169986,0.17647058823529413,0.9044456767726252,1.0,1/13,0.43%,TGFBR3
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.6656273156339817,-1.2485859662847536,0.16666666666666666,0.9017613180774292,1.0,5/8,24.84%,SVIP;DERL2;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.8191301417132631,-1.2483716492422174,0.25925925925925924,0.8998930366676704,1.0,2/5,11.40%,CALCR;CXCL12
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6981225994564362,1.2482165226713482,0.17567567567567569,0.94885862918265,1.0,2/15,5.49%,KLF4;LIFR
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.6097969061366398,-1.248087370481038,0.1,0.8983299856999543,1.0,3/17,5.72%,COL18A1;PPP1R16B;ICAM1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6722364162855884,1.2480751199534355,0.13253012048192772,0.9480708114756733,1.0,3/23,7.56%,KLF4;GPNMB;FHL1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.641027281581478,1.247881735982573,0.05952380952380952,0.94803201146221,1.0,13/39,15.77%,TGFB2;ENPP2;PRKCE;GLIPR2;DOCK1;DOCK5;PTPRG;HIF1A;PTN;GLUL;SASH1;CLASP2;DUSP10
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.5848946160861178,-1.2477783813555212,0.2608695652173913,0.8963169040552,1.0,2/15,4.80%,RING1;DDB2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.7005229701989928,1.2476465868499251,0.1518987341772152,0.9478112946438192,1.0,9/23,14.64%,HTR2B;NUDT4;AKAP6;ADGRG6;RIMS2;RAPGEF3;PDE2A;GUCY1B1;EPHA5
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.6781484230617948,1.2475364455093496,0.11842105263157894,0.9467653479863205,1.0,7/15,18.90%,MAPT;HDGFL3;STMN3;CKAP5;STMN2;TPPP;FGF13
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.38990861625937595,-1.2475176615128827,0.0,0.8948164020817108,1.0,17/94,9.49%,TNFAIP8L3;CCL5;CALCR;SERPINF2;FFAR4;PDGFD;LGALS9;SCIMP;CSF1R;ICAM1;ROR2;ARRB2;PHB2;P2RY6;CRKL;TGFB1;TREM2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.6587748496391364,1.2472732126657207,0.16279069767441862,0.9473063017934233,1.0,1/34,0.41%,KLF4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5937580131618329,1.2463929602986639,0.08247422680412371,0.95210864061908,1.0,36/102,25.51%,RPL23;EIF4A3;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;EIF3E;RPLP2;RPS18;UPF3A;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;PYM1;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.8305379649243618,1.24620030784825,0.16666666666666666,0.9520300276890128,1.0,1/6,9.95%,XPO1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6594096368934176,1.2461972554199203,0.12941176470588237,0.9503607660338137,1.0,4/29,4.08%,THBS1;CBR1;MAPT;AGT
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.7630875951080006,1.2461523937846544,0.175,0.9488939815068046,1.0,3/10,4.01%,NTN4;GPM6B;LAMB1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.6326640037118032,1.2461502727189147,0.10989010989010989,0.9472200223922345,1.0,6/37,12.40%,KCNE1;FHL1;AKAP6;KCNMB1;CAV3;KCNIP4
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.6223286639745208,1.2459735158321326,0.2345679012345679,0.9469223683011372,1.0,2/30,3.33%,ECM2;SPOCK1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.4957092211358666,-1.2459493527136665,0.13333333333333333,0.8978531181120234,1.0,5/27,3.47%,CCL5;CX3CR1;INPP5K;TFAP4;CTDP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.6625122194987433,1.2458891665270122,0.17073170731707318,0.9458604427651385,1.0,6/30,8.42%,ACVR1B;RAB7B;HMGB2;FAXDC2;ACVR2A;HIF1A
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.7596966475031683,-1.2454088801558663,0.15625,0.8966056215425073,1.0,2/5,8.95%,RUNX3;CBFB
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.6745433855442513,-1.2449704244779805,0.21875,0.8954483934246482,1.0,1/10,4.39%,LILRB4
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.7021252075877616,1.2447294733073426,0.18292682926829268,0.9520356418675492,1.0,1/15,0.29%,THBS1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.6976463182111956,1.2444257480353866,0.1625,0.9520879470526343,1.0,2/17,3.95%,CENPE;RIOK2
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6412184260589625,1.2443737258455938,0.1625,0.9506661647358732,1.0,6/35,6.33%,SPARC;SVEP1;ADAMTS2;TNS1;DAAM2;LAMA2
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.561412623543483,1.2439856533617104,0.08,0.9518201374230224,1.0,28/124,14.02%,PLPP3;SPARC;COBL;ENPP2;GPM6A;TNS1;ENAH;RIOK2;DGKI;MEIS2;GRIK2;PDK4;CDH9;CD55;LAMA2;ENO2;RGS1;PAPSS2;TCF7L1;PDE1C;DNM3;LSAMP;GNAI1;ABCA1;HS2ST1;NCEH1;SGCE;SHROOM4
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.7532046718921593,-1.2439181746145571,0.3103448275862069,0.8966030731276279,1.0,4/6,20.34%,NBN;TERF2;SMG6;ERCC4
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),0.8761778077462313,1.243654288115193,0.13333333333333333,0.9524374178842914,1.0,3/5,7.02%,CR1;CD22;FCGR2B
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.6720888477713362,1.2435520369624307,0.13095238095238096,0.9513770109717552,1.0,8/24,15.05%,HTR2B;SLC24A2;GRIN2A;RYR2;IBTK;SLC24A1;RYR3;GRIN2B
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7569549731858973,1.243478859105456,0.208955223880597,0.9501917013310801,1.0,9/10,24.36%,SHANK3;NETO1;SYP;CAMK2B;NEURL1;APP;SYNGR1;DLG4;RAB5A
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7463391961264576,1.243377388295243,0.16216216216216217,0.9494119209162963,1.0,2/10,7.44%,SULT4A1;PAPSS2
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.7051346534638732,-1.242976405032463,0.2857142857142857,0.8975455156453305,1.0,1/5,1.11%,LOXL3
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7731613167479157,1.2425230466580652,0.23943661971830985,0.9540033735232187,1.0,2/10,10.33%,PRLR;GHR
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.7984880865647409,1.2422498210851476,0.15942028985507245,0.9542594400931659,1.0,2/7,14.73%,TFRC;BNIP3
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.5501284879219306,-1.2418405684006657,0.24,0.8986458146931865,1.0,5/20,10.53%,NEDD4;IDE;SNX25;TGFB1;SMURF1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6905577080580381,1.241736557392732,0.20512820512820512,0.9563989477552125,1.0,7/13,23.64%,SCN3B;SCN3A;SCN1A;SCN2A;SCN8A;CACNA1C;ATP1A2
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.724851761777349,1.241619013659356,0.16666666666666666,0.9555181037155471,1.0,5/15,15.10%,CR1;CD22;FCGR2B;GPI;DNAJB9
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.6256184305854615,1.2415908405537326,0.12371134020618557,0.9540515617471099,1.0,15/50,18.93%,RIOK2;WDR12;WDR74;PES1;RPL38;XPO1;RPS6;RPS25;GLUL;RRP36;HEATR3;RPL14;RPL11;RPS24;SHQ1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6581987486440135,-1.2403540658309804,0.17857142857142858,0.8992000860465209,1.0,5/13,20.11%,MAP4K4;RAPGEF6;STK26;RAP1A;RAP2A
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6581987486440135,-1.2403540658309804,0.17857142857142858,0.8992000860465209,1.0,5/13,20.11%,MAP4K4;RAPGEF6;STK26;RAP1A;RAP2A
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.7972673039250305,1.240216168316793,0.2028985507246377,0.9622642583063206,1.0,1/7,1.60%,TGFB2
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.7264991533100728,1.2398481719280445,0.18666666666666668,0.9628842539304339,1.0,9/12,25.68%,ADGRG6;ADGRB2;UGT8;PMP22;NFASC;SCN8A;ASIC2;GSTM3;SERPINI1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.5891862518305949,1.239752590654685,0.11458333333333333,0.9619191002835713,1.0,34/87,25.51%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;SRPRA;RPS3A;RPL35;RPL4;SRP19;RPL32;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.5493933991317576,-1.2395833308034248,0.08,0.8987045694007377,1.0,5/18,9.46%,BAIAP2L2;FSCN1;CORO1B;LIMA1;LCP1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.4076340047465682,-1.2390639489938657,0.0,0.8975654731528688,1.0,11/85,7.55%,RALB;MKNK1;PFN1;IRAK4;DUSP3;ITPR2;GRK2;DAPP1;TRIB3;MAP2K3;PLA2G12A
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.7125931245606856,1.2389419314094852,0.15853658536585366,0.9662194895166492,1.0,4/18,8.09%,GLRA1;GRIN3A;GRIN2A;ABCA2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.6755845520237714,1.2389403552350293,0.15384615384615385,0.9645578000503059,1.0,8/20,18.90%,TTBK2;HDGFL3;MAP1B;MID1IP1;CLASP2;STMN2;APC2;FGF13
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.7590096195654147,1.2386721732777968,0.16883116883116883,0.9648545709563969,1.0,3/11,9.21%,SYT4;NLGN1;RAB15
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5888582849862636,1.2383498652419422,0.0707070707070707,0.9656376455340769,1.0,35/113,18.81%,FLRT1;METRN;NRG1;CARNS1;GRAMD1C;SPOCK1;B4GAT1;CASKIN1;SRRM3;SYBU;ARFGEF3;SRCIN1;KCTD1;LINGO1;MAP2;ENDOD1;RETREG1;PDE1C;CKB;ADGRB2;CSPG5;CELSR2;FAM81A;IFT74;OSCP1;TTC5;GNAL;EPB41L4B;NDRG4;HSPA12A;APLP1;CLSTN2;CPE;EML2;MAPK8IP2
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.8186663223939128,1.238075922166881,0.23076923076923078,0.9657589012187032,1.0,2/6,5.93%,NFIB;VEGFA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.6709465240405048,1.237617155016424,0.16455696202531644,0.9670703648572133,1.0,8/18,22.94%,ANK2;RYR2;PKP2;CALM3;CAV3;ATP2A2;FGF13;CACNA1C
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7432613577699841,1.2375533015434117,0.19753086419753085,0.9657968511871887,1.0,7/12,23.64%,DMD;ANK2;RYR2;CALM3;CLIC2;CACNA1C;ATP1A2
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.7998619696068203,1.23687264765361,0.16666666666666666,0.9686493602829902,1.0,2/6,8.23%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.8514274510156367,1.2366602307547674,0.14705882352941177,0.968374980187067,1.0,4/5,14.88%,CR1;CD55;FCGR2B;SUSD4
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.8160978038994702,1.2366139099916462,0.09523809523809523,0.966981303966455,1.0,1/5,1.60%,TGFB2
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.6461305893440474,1.2362357667175543,0.1590909090909091,0.967922227554183,1.0,4/39,4.30%,NUDT12;NUDT16;RIDA;RNASEH2C
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.6119315295165226,-1.236027421896648,0.23809523809523808,0.9026585756213388,1.0,2/10,6.84%,SESN2;SESN3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.6119315295165226,-1.236027421896648,0.23809523809523808,0.9026585756213388,1.0,2/10,6.84%,SESN2;SESN3
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5982247565788884,1.2359727095996829,0.15217391304347827,0.9685653309570462,1.0,9/60,10.90%,OMD;CHST7;OGN;VCAN;NCAN;B4GAT1;PAPSS2;MAT2A;CSPG5
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.6599975173731751,1.2357229113835713,0.2087912087912088,0.9687109051815463,1.0,12/29,21.53%,LRP4;SHANK3;CTNND2;MAP2;PTN;CELSR2;CTNNA2;PHACTR1;MAPK8IP2;KLF7;DLG4;PAK3
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.6137768621175193,1.2355430307389261,0.17333333333333334,0.9682996766901382,1.0,8/28,16.75%,TGFB2;IL15;CDKN2AIP;IER5;FCGR2B;ARG2;NSMCE1;WNT5A
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.5770641164250337,-1.2351320696958803,0.25925925925925924,0.9031598355982507,1.0,1/12,0.62%,SMPD3
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7352940591447419,1.2340198083297058,0.23076923076923078,0.9772538829984831,1.0,5/7,21.77%,GRIN3A;GRIA2;CDK5R1;APP;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.603978038474771,1.2339600879760788,0.13333333333333333,0.9760749392374526,1.0,16/56,18.90%,SHANK3;CLIP3;TUBB4A;VBP1;TTBK2;HDGFL3;MAP2;KANK1;CAV3;MID1IP1;CLASP2;STMN2;APC2;PFDN4;EML2;FGF13
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.7353195629243574,1.2338001843387736,0.13333333333333333,0.9755764651739695,1.0,2/11,3.95%,CENPE;RIOK2
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5180457891387007,-1.2336059739754757,0.21428571428571427,0.9062135164897125,1.0,4/27,5.26%,FLNA;ATRAID;DAB2IP;AZIN2
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.5364873852181791,-1.23358681511404,0.13333333333333333,0.903556261954323,1.0,3/30,4.05%,CCL5;LY86;SCIMP
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.6335478450957843,-1.2332509456013117,0.20833333333333334,0.9020261359110382,1.0,5/15,4.06%,ITGA5;NEDD4;IL1B;DAB2IP;HHEX
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.5268865510819775,-1.2324461470609769,0.2222222222222222,0.9020880215720185,1.0,8/18,18.48%,PSMC4;TP53;MED24;MED12;MED4;MED1;PAXIP1;MED30
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.6414765241046106,1.2322282825867528,0.13793103448275862,0.9862073926353903,1.0,7/35,17.47%,THBS1;CBR1;AGT;SIRT5;PINK1;BRCA1;PDK3
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.8385890047303048,1.232145038210602,0.2028985507246377,0.9851725414387366,1.0,1/5,1.02%,AANAT
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7518133919847042,1.2320479758518863,0.2602739726027397,0.9839882056181165,1.0,5/7,24.46%,DPYD;PAICS;PRPS1;HPRT1;GDA
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5965559180795703,1.2319821009174963,0.1724137931034483,0.9826245965013725,1.0,4/48,4.63%,THBS1;ZBTB16;WDR5;MEIS2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.6384434764431253,1.2319816001532378,0.2,0.9809758975139541,1.0,4/31,6.76%,HS3ST5;HS3ST2;GPC5;GNS
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.811235550452307,1.231710267991689,0.1794871794871795,0.9815091858549985,1.0,1/7,5.39%,ANXA1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.777853966285825,1.231258941728456,0.1794871794871795,0.9832106730335722,1.0,2/8,11.02%,HMGB2;KDM1A
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.8109921121425513,1.2308482041913447,0.17142857142857143,0.984512079654829,1.0,1/5,2.26%,RPL23
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7452138715714147,1.2303071775943766,0.16666666666666666,0.9867480718006495,1.0,3/10,11.27%,COBL;SPIRE2;CARMIL1
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.5896006089941731,1.2299696280685635,0.08421052631578947,0.9873891563606164,1.0,34/103,17.65%,TNC;THBS1;RHOB;SPARC;FBN2;ECM2;COL11A1;VIM;CADM1;GADD45B;SPOCK1;VCAN;ITGA2;IL15;CDH2;VEGFA;LAMA2;ENO2;TNFRSF11B;ID2;FN1;CTHRC1;CRLF1;SNTB1;PMP22;COL5A3;ITGAV;SERPINE2;PLOD1;TGFBI;WNT5A;THY1;TIMP3;APLP1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6907627664618522,1.2299640822257993,0.13414634146341464,0.9857489750377583,1.0,8/19,22.59%,ACSL1;MID1IP1;MFSD2A;PRKAG2;CPT1A;ACSL3;PRKAA2;ACACB
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.7074130892993371,1.229908185013981,0.27058823529411763,0.9844005369052835,1.0,1/22,0.14%,FA2H
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.5433938249995788,-1.2287714527353482,0.2,0.9128424447638924,1.0,4/18,10.93%,SERGEF;IL1B;REST;NR1H3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6575709088790351,1.2287234609705302,0.16666666666666666,0.9909093424476243,1.0,7/19,18.90%,TTBK2;HDGFL3;MID1IP1;CLASP2;STMN2;APC2;FGF13
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6920935265093325,1.2286517377671575,0.18292682926829268,0.9896920013746228,1.0,4/14,21.69%,ANK3;TMTC2;FAM20A;TRPM7
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8759964288616218,1.228444678470035,0.18181818181818182,0.9895582450857073,1.0,1/5,1.95%,SEMA3A
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.6028090078117281,1.228320226590592,0.10989010989010989,0.9888560966226024,1.0,15/71,10.38%,PLPP3;SPARC;FGF1;SVEP1;NR4A2;TNS1;FBXL7;FILIP1L;ARID5B;NOCT;LAMA2;PALLD;AKAP12;FN1;PTN
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.6638306693027005,1.2282112448596711,0.24390243902439024,0.9880217558647605,1.0,3/23,6.95%,ANXA1;SOX4;TCF7
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.8003701364577773,1.2281515379135723,0.22666666666666666,0.9867574714802044,1.0,3/7,10.90%,VCAN;NCAN;CSPG5
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.7073503249048019,1.2280600644161657,0.1875,0.9859739936360785,1.0,1/19,0.29%,THBS1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6164866790813708,-1.2278986058411816,0.3333333333333333,0.9127147890996659,1.0,3/9,9.29%,DDR1;FSCN1;TGFB1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.6287042580683766,1.2277094480366317,0.16666666666666666,0.9866802091568956,1.0,13/31,14.19%,FRAS1;DPYSL5;COL26A1;SEMA6A;UNC5D;LINGO1;GABRB3;CACNA1B;POU5F1;CNTNAP2;CRMP1;EPHA7;GRID2
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.6940484431195223,-1.2276487798386804,0.26666666666666666,0.9110580765438625,1.0,5/7,14.85%,FSCN1;LCP1;HCK;GSN;CAPG
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.7006812145971975,1.2274653371237911,0.21333333333333335,0.9870871770157846,1.0,4/16,14.09%,HS3ST5;TRIM5;TRIM25;TYRO3
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5975072871687226,1.2274164962651215,0.125,0.9860846541055137,1.0,21/93,15.08%,DDIT4;CENPF;SHANK3;RELN;CDH2;NFIB;MEIS2;AATK;ROBO2;CA10;GRIN2A;ARNT2;POU6F1;CNTNAP2;MFSD2A;EPHA7;SOX6;SHROOM4;ADGRL2;GRIN2B;CTNNA2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.6763915219196986,1.2273781762953426,0.2159090909090909,0.9846562365627279,1.0,8/22,21.02%,RGS2;ANK2;RYR2;CALM3;CAV3;PDE4B;ATP2A2;SLC9A1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.6221184914536846,1.2273099025235426,0.13333333333333333,0.983424533613151,1.0,10/48,15.55%,NTN4;RELN;LAMB1;SRCIN1;TMEFF2;FN1;MICALL2;MEGF9;TYRO3;ITGAV
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.7012837855976249,1.226787252174273,0.1518987341772152,0.9859287262842521,1.0,8/18,22.94%,ANK2;RYR2;PKP2;CAV3;PDE4B;ATP2A2;FGF13;CACNA1C
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5767743518050237,1.2266225125722365,0.125,0.9853469270946528,1.0,11/88,13.01%,DIAPH3;RHOBTB3;RHOB;SYNE3;SEMA6A;PALLD;RND3;LIMD1;CSPG5;SH3D19;PAK5
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7923404820530613,1.2262958375855526,0.2878787878787879,0.9858991296524707,1.0,2/7,10.91%,RHOB;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.580859442632436,-1.2258317710542599,0.2608695652173913,0.9160990486650158,1.0,9/14,23.47%,SERGEF;PKDCC;PPM1F;SNX3;CSK;APOE;HMGCR;RHBDF2;WWP2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.7034166484842472,-1.2257867502179962,0.25925925925925924,0.9136231912723899,1.0,1/6,1.84%,CYP19A1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.737299283638581,-1.225648033105601,0.25,0.9115505653936421,1.0,2/5,15.35%,RIN2;RAP1A
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.577139195062601,1.2252829515760357,0.02,0.9914991551012233,1.0,81/254,20.23%,SCRG1;IL1RAPL2;ACVR1B;MOBP;SHANK3;ZBTB16;MAL;GPM6A;NRG1;SPOCK1;VCAN;NCAN;RELN;GPM6B;NRXN1;CDH2;DPYSL5;ROBO2;NRXN2;VEGFA;MOG;SHANK2;SH3GL3;PTPRZ1;NLGN1;SEMA6A;MARCKSL1;ARNT2;RBFOX2;NLGN3;ADGRG6;STMN3;PAX8;GRIK1;SCD5;ROBO1;ADAM23;FN1;CHRM3;PTN;DNM3;ADGRB2;TAGLN3;CSPG5;SEMA5A;RAPGEFL1;BTBD2;SH3GL2;CRMP1;KALRN;LSAMP;UGT8;PMP22;SOX6;TYRO3;IGSF8;PRPS1;NFASC;DPF3;LY6H;GLRB;PKD1;APC2;LDB2;SCN2A;SCN8A;EIF2B2;ASIC2;NINJ2;APLP1;NRGN;NEURL1;NR2C2;GMFB;FGF13;GSTP1;ERCC6;DCTN1;GDF11;NELL1;NPAS2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.8316998486879974,1.225088618459468,0.2112676056338028,0.9913215381084519,1.0,1/6,6.05%,CD55
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.5747891627285364,1.2245267471942336,0.1414141414141414,0.9941586469707322,1.0,39/95,28.13%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;SRPRA;RPS3A;RPL35;RPL4;SRP19;RPL32;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7;SPCS3;MAN1A1;RPL21;RPL10A;SRP54
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.6918667762513697,1.2235919665888122,0.22784810126582278,0.999353176412672,1.0,3/19,5.66%,SH2D4A;TGFB2;MASTL
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6217656002308277,1.223250691916608,0.14772727272727273,1.0,1.0,19/39,22.45%,SHANK3;GPM6A;NRXN1;CDH2;NRXN2;SHANK2;NLGN1;NLGN3;GABRB3;GABRA2;DNM3;GABRB2;GRID2;PLXNB1;WNT5A;FGF13;GABRG2;DNER;NLGN4X
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.7292989796973586,-1.2231454540516407,0.3125,0.9177869472479857,1.0,2/6,11.19%,ZDHHC5;BIRC2
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.6782915969671979,-1.2231130514766098,0.1935483870967742,0.9151730427547802,1.0,4/8,9.88%,CHUK;DAB2IP;TLR3;TLR7
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.6967230458856652,1.222983110181721,0.2112676056338028,1.0,1.0,8/12,28.32%,MYRF;PLP1;B4GALT5;TPPP;EIF2B2;CNTNAP1;B4GALT6;EIF2B5
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5722720503601749,-1.222566310468575,0.30434782608695654,0.9142317477449695,1.0,1/17,0.13%,STAT4
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.8099454502332198,1.2224927967752692,0.20634920634920634,1.0,1.0,5/5,19.04%,LRP2;NLGN1;PTN;PHACTR1;ROCK1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.6181222747223117,1.2222623247434972,0.18604651162790697,1.0,1.0,11/32,21.01%,GFAP;RFX2;TMEM232;PTPRT;CELSR2;CFAP54;PLTP;DNAH7;ENKUR;HSPA2;SPAG6
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.8106874186875872,1.2221908899210079,0.1506849315068493,1.0,1.0,1/7,1.56%,NEK11
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.8182368191567922,1.221936540182535,0.2878787878787879,1.0,1.0,1/6,9.95%,XPO1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.7268721558659208,1.221566509651473,0.1643835616438356,1.0,1.0,3/11,14.56%,WDR5;KDM1A;BRCA1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7932585873633407,1.2211817127326037,0.1791044776119403,1.0,1.0,3/6,18.70%,SOD2;ADPRS;SOD1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8083791115725977,1.2211589403308034,0.21875,1.0,1.0,1/6,10.33%,GHR
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7035116247755157,-1.2210738446481064,0.3103448275862069,0.9167551709073378,1.0,1/6,1.84%,CYP19A1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.7529946241651733,1.220608664491526,0.1506849315068493,1.0,1.0,5/11,18.43%,CLIP3;TUBB4A;MAP2;STMN2;EML2
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6740521619185142,1.2200487013642518,0.22972972972972974,1.0,1.0,1/17,0.52%,DAPK2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.8353254162159168,-1.2200393713145739,0.30303030303030304,0.9181143344012508,1.0,3/5,14.41%,MTLN;STOML2;AKT1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.6477516101516149,-1.2197809120141212,0.22857142857142856,0.9163701443880304,1.0,2/8,4.02%,IL1B;LGALS9
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.648451516040627,1.2191369735598394,0.20253164556962025,1.0,1.0,3/25,2.25%,KMO;ASPA;FOLH1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6594402516087668,1.2190310391686532,0.17073170731707318,1.0,1.0,5/24,14.51%,TULP2;TUB;FSIP2;TULP3;SNX10
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.7511356534885052,-1.2189915662058077,0.28125,0.916236438902386,1.0,2/5,11.74%,RIPOR2;CD53
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.7477685345523004,1.2188838643383204,0.17333333333333334,1.0,1.0,3/10,5.74%,LRP2;TGFB2;KITLG
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.5838424773519568,-1.2185340547128771,0.20689655172413793,0.9153054935485453,1.0,2/13,5.05%,PDE12;PYHIN1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7135693075744601,1.2184708664646489,0.2647058823529412,1.0,1.0,3/12,10.54%,HS3ST5;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.5916708293140853,1.2183078874864228,0.09090909090909091,1.0,1.0,38/106,24.29%,LRP2;LRP4;FLRT1;SHANK3;GPM6A;DCC;PLPPR4;CTNND2;NYAP2;ANK3;NLGN1;MAP2;ALCAM;CNTNAP2;SLITRK5;MAP1B;CELSR2;IMPACT;SLC9A6;PARD3;CCK;CTNNA2;PLXNB1;IQGAP1;MAPK8IP2;NTNG1;APP;ROCK1;KLF7;SPTBN4;UBB;DLG4;PAK3;CNTNAP1;FGFR2;DCLK1;LRRK2;CTTN
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.5168027424266649,-1.2181708320352822,0.07692307692307693,0.9136977607270783,1.0,5/19,9.46%,BAIAP2L2;FSCN1;CORO1B;LIMA1;LCP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.7889039509064263,1.2179134023035398,0.21333333333333335,1.0,1.0,1/6,5.39%,ANXA1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.5760439329807306,1.2177095541595309,0.052083333333333336,1.0,1.0,24/139,7.22%,TNC;THBS1;P4HA3;SPARC;FBN2;ADAMTS2;TGFB2;THSD4;ECM2;COL11A1;SH3PXD2B;VCAN;NCAN;MMP21;ITGA2;GPM6B;COL4A5;LAMB1;COL26A1;ADAM15;COL23A1;LAMA2;COLGALT2;COL24A1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.7583258478456688,-1.2176631340029271,0.2222222222222222,0.9130815286774017,1.0,2/5,9.45%,TP53;SRC
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.7851770762232143,1.217627923934971,0.30434782608695654,1.0,1.0,1/8,0.89%,RAB7B
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.657471557698994,1.2175107783596326,0.24,1.0,1.0,5/18,15.69%,SLC51A;SLCO1A2;ATP8B1;SLC10A1;STARD5
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.7573838222347741,1.217452708160125,0.2328767123287671,1.0,1.0,3/9,20.41%,NFIB;EPHA4;SPTBN4
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.7898076723782335,1.2167593636684086,0.22388059701492538,1.0,1.0,4/7,16.75%,SHANK3;NLGN1;GRID2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7276803292904874,1.2165923394646054,0.19718309859154928,1.0,1.0,6/10,22.74%,INSR;IGF1R;BNIP3;CALCOCO2;TNF;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.45340529181081063,-1.2161401950858863,0.08333333333333333,0.9161612958919193,1.0,12/35,16.16%,BUD23;IL1B;ZPR1;TP53;RIOK1;TGFB1;ZC3H18;EGFR;HSPA1A;GRSF1;DDX5;HABP4
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.7333252340309564,1.21563098171836,0.20270270270270271,1.0,1.0,4/9,16.40%,THBS1;THBD;ENPP4;SERPINE2
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.8252117820666658,1.2155709324781978,0.2463768115942029,1.0,1.0,1/5,2.95%,MAPT
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.7726522743697348,1.215498013467555,0.265625,1.0,1.0,3/8,12.42%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.8254067217291929,1.2153539543186525,0.16417910447761194,1.0,1.0,1/5,2.85%,NRG1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.7086468764345357,1.2152434721762393,0.1891891891891892,1.0,1.0,3/12,7.02%,MANF;EIF2AK3;FCGR2B
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.7622302745376683,1.215071304428494,0.20270270270270271,1.0,1.0,4/6,20.58%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.7622302745376683,1.215071304428494,0.20270270270270271,1.0,1.0,4/6,20.58%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6544100010710923,-1.214949005162577,0.22727272727272727,0.9177584135396246,1.0,4/12,9.69%,IKZF3;IL4I1;BTK;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.813302205608015,1.214863739064153,0.20270270270270271,1.0,1.0,1/5,6.91%,RGS2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.8248297909792198,1.2146134813470417,0.21212121212121213,1.0,1.0,1/5,4.74%,SLF1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.8248297909792198,1.2146134813470417,0.21212121212121213,1.0,1.0,1/5,4.74%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.8248297909792198,1.2146134813470417,0.21212121212121213,1.0,1.0,1/5,4.74%,SLF1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.7427151986503054,1.2145800273911322,0.18292682926829268,1.0,1.0,5/9,8.23%,LRP4;PTPRD;IL1RAPL1;NLGN1;NLGN3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6835771742140861,1.2145788208748454,0.17647058823529413,1.0,1.0,6/19,12.11%,SHANK3;ARF6;GRIN3A;NLGN1;CAMK2B;PPFIA2
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.7880025795905325,1.2145296261497638,0.23684210526315788,1.0,1.0,2/5,21.16%,CCDC39;SPATA6
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.550404430633261,-1.2141414710386762,0.0,0.9181101474588755,1.0,15/123,8.48%,THEMIS;ITK;GRAP2;SKAP1;BTN3A2;PSMB3;PSME3;FYN;CHUK;CD276;PSMD12;PSMC4;CD247;PSME4;STOML2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.730374576853694,1.2140219449834362,0.25675675675675674,1.0,1.0,2/11,5.24%,EGR1;PIAS4
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7619755278903662,1.2140159298527073,0.3013698630136986,1.0,1.0,3/7,18.27%,VEGFA;GAB1;HSPB1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.8118711361634248,1.2138510610266733,0.19402985074626866,1.0,1.0,1/6,2.20%,TBRG4
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6827697861842403,1.2134897728678686,0.19540229885057472,1.0,1.0,4/23,8.42%,KLF4;TGFB2;EGR1;HIF1A
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.633608720404777,1.2134766250885958,0.24675324675324675,1.0,1.0,5/22,14.88%,CR1;CD55;FCGR2B;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7665315233155173,1.2132152144217712,0.22857142857142856,1.0,1.0,2/6,12.11%,NAMPT;NOD2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.6371682205862904,1.2129467683585937,0.21739130434782608,1.0,1.0,4/30,12.98%,RAB3C;TVP23A;RAB15;ABCA1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7287933735210066,1.2127831366025903,0.2972972972972973,1.0,1.0,2/7,14.76%,MAT2A;SPAST
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.7130969728333596,-1.2127582490105167,0.29411764705882354,0.9202533455594324,1.0,3/5,16.22%,LGALS9;HAVCR2;CD81
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),0.7869167547703788,1.2124440289773082,0.25,1.0,1.0,3/5,14.98%,CD22;FCGR2B;CD300A
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.7050415499746627,-1.2123828701528703,0.2564102564102564,0.9190685499622149,1.0,2/5,7.04%,LPL;C3
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.8162635044719864,1.2121702653257282,0.2463768115942029,1.0,1.0,1/5,0.29%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.8162635044719864,1.2121702653257282,0.2463768115942029,1.0,1.0,1/5,0.29%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),-0.7158107058740345,-1.212101682092646,0.2972972972972973,0.9173330035378067,1.0,2/5,4.02%,CX3CR1;LGALS9
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.7791409878748915,1.2118178990215018,0.2361111111111111,1.0,1.0,1/6,1.73%,SULT4A1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6691073687122409,1.2112154112063953,0.23076923076923078,1.0,1.0,2/11,6.23%,IL15;GPNMB
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7275522988533765,1.210882452764627,0.23255813953488372,1.0,1.0,3/10,18.27%,VEGFA;SEMA5A;HSPB1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6382257134328396,1.2104873147416442,0.23595505617977527,1.0,1.0,10/26,19.16%,PRKCE;SCN3B;NETO1;DMD;ANK3;FGF14;CAV3;FXYD7;FGF13;HECW2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.5859463365386427,1.2103623450111245,0.07291666666666667,1.0,1.0,15/98,9.63%,RHOBTB3;RHOB;SHROOM3;COBL;GAS2L3;CORO6;PPP1R9A;ENAH;CGNL1;MARCKSL1;BAIAP2L1;SVIL;SPIRE2;RND3;ERMN
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.6054971146243266,-1.20968245118227,0.20833333333333334,0.9244626463765002,1.0,1/10,0.20%,CCL5
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.7422245128902522,1.2095516798446244,0.2222222222222222,1.0,1.0,3/8,14.15%,OMG;PTN;NREP
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.580925960945435,1.2094232770136921,0.12631578947368421,1.0,1.0,34/84,25.51%,RPL23;RPL37A;SEC61B;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;SRP19;RPL32;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.4136088269322213,-1.209032022236956,0.0,0.9247910021122341,1.0,16/67,14.30%,TICAM1;ITGAM;CHUK;LGALS9;SCIMP;IRAK4;TLR3;BTK;TLR7;IKBKB;NMI;BIRC2;ITGB2;MAPKAPK2;BCL10;TIRAP
prerank,MSigDB_Hallmark_2020__Myogenesis,0.5791605956301432,1.2088067800944684,0.14285714285714285,1.0,1.0,20/97,13.02%,DAPK2;SPARC;PKIA;ACSL1;PFKM;GADD45B;CKMT2;LDB3;GNAO1;DMD;LAMA2;FHL1;SVIL;BHLHE40;CKB;CAV3;SPTAN1;CAMK2B;PDE4DIP;SORBS1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.7328358055336919,1.2087366345577955,0.22535211267605634,1.0,1.0,4/11,12.95%,TOP2A;FANCM;EME2;SHOC1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6766001328166813,1.208465691873395,0.19047619047619047,1.0,1.0,7/21,11.83%,THBS1;SEMA3A;ROBO2;SEMA3B;SEMA6A;ROBO1;SEMA5A
prerank,MSigDB_Hallmark_2020__Hypoxia,0.5688942388384748,1.2081603879363814,0.04081632653061224,1.0,1.0,37/129,20.57%,DDIT4;NFIL3;SAP30;PLIN2;PLAC8;SLC2A3;NCAN;VEGFA;HSPA5;NOCT;ENO2;NDRG1;KDM3A;AKAP12;IRS2;BNIP3L;BHLHE40;FAM162A;FOSL2;RBPJ;ERRFI1;P4HA1;MXI1;GPI;FBP1;PPP1R15A;PHKG1;HDLBP;TGFBI;ZNF292;PDK3;KIF5A;CDKN1B;PPFIA4;KLF7;GYS1;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.6171264713080697,1.208103929660702,0.16129032258064516,1.0,1.0,15/40,20.61%,DCC;MAPT;TFRC;NFIB;GRIN3A;SFMBT1;KANK1;RAPGEF3;PINK1;BNIP3;THY1;ROCK1;KLF7;SUZ12;BCL11A
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.7459211959002092,1.2080853000197378,0.2537313432835821,1.0,1.0,4/6,22.46%,EPHA4;THY1;RTN4RL1;PTPRS
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7503270859546857,1.2080428666781078,0.2923076923076923,1.0,1.0,3/7,23.48%,NR4A3;UGCG;LEPR
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.7214485090248925,1.207890117701051,0.26666666666666666,1.0,1.0,2/10,17.58%,IL15;PLCB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.7214485090248925,1.207890117701051,0.26666666666666666,1.0,1.0,2/10,17.58%,IL15;PLCB1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.7049912031037827,1.2073690956918475,0.19101123595505617,1.0,1.0,5/14,10.69%,DMD;ANK2;RYR2;CALM3;CAV3
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5872811661174788,1.2072476051102554,0.1590909090909091,1.0,1.0,19/66,22.75%,THBS1;PRR16;VIM;EIF4A3;SOX4;RBM3;ABCA2;EIF3E;EPHA4;UPF3A;RPS4X;CASP3;PICALM;PYM1;SIRT3;TNFRSF1A;TNF;SAMD4A;PLD1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.7124815678754323,-1.207191851035019,0.29411764705882354,0.928839243635888,1.0,2/6,9.45%,NEDD4;SRC
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.7447958369821083,1.2070149007521496,0.14473684210526316,1.0,1.0,2/8,5.39%,NLRP12;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.7573250019899848,1.2070018756101633,0.1724137931034483,1.0,1.0,1/7,0.29%,THBS1
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7407413302466453,1.2068060842676376,0.21621621621621623,1.0,1.0,3/9,10.69%,SCN3B;FHL1;CAV3
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5909313523651571,1.2067181808466152,0.19101123595505617,1.0,1.0,14/54,16.75%,THBS1;RHOB;FGF1;VEGFA;CHI3L1;HIF1A;RAPGEF3;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;GAB1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.7294886247939294,1.2066691500128865,0.20270270270270271,1.0,1.0,3/12,7.62%,SEMA3A;NSMF;SEMA6A
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.7606788463074032,1.2065480719449844,0.265625,1.0,1.0,1/5,0.77%,ALG10B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.6853022282396211,1.2064719971596087,0.22666666666666666,1.0,1.0,6/15,19.00%,CEMIP;CHI3L1;CALM3;PRKAG2;RIPK2;APP
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.6058408255672756,1.2062945921122485,0.23333333333333334,1.0,1.0,15/32,27.78%,NRXN1;NRXN2;GAD1;SNAP25;UNC13A;RIMS2;SYT1;GAD2;CPLX1;STXBP2;SYN2;PPFIA3;BRSK1;RIMS1;PTPRN2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.8137147325911483,1.2061140203475695,0.2878787878787879,1.0,1.0,1/5,2.95%,MAPT
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7953217859156216,1.2060315628775407,0.20833333333333334,1.0,1.0,1/6,7.15%,SYCP3
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.6718747367827097,1.2060082508098986,0.1951219512195122,1.0,1.0,6/23,10.14%,JPH1;CEMIP;DMD;ANK2;AKAP6;CALM3
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.602599670221836,1.205985363451309,0.1797752808988764,1.0,1.0,2/51,1.16%,DDIT4;ARAF
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.5950855846160329,1.2059345753249329,0.12222222222222222,0.9996288792483675,1.0,47/80,22.48%,SULT4A1;GFAP;KCTD16;GADD45B;BRINP1;NCAN;CADM2;MAPK4;PLPPR4;UBE2QL1;PHYHIPL;CTNND2;GAD1;CA10;ANK2;GRIA2;PTPRT;SNAP25;OLFM3;MAP2;FAIM2;NKAIN2;HS6ST3;CAMK2B;PPFIA2;SH3GL2;ZNF536;VSTM2B;PAK5;NTRK2;STMN2;LY6H;GAD2;NDRG4;ASIC2;SYNPR;LRFN5;ST8SIA3;PARM1;SPTBN4;GABRG2;SNAP91;TMEM59L;SYN2;ELAVL3;PTPN5;CNTN2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.7594859477796876,1.2058344756061352,0.23529411764705882,0.9990332923004166,1.0,3/9,7.67%,CACNB2;SCN3B;ANK2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6378907715244814,1.2056686512789057,0.1724137931034483,0.9991632062919528,1.0,9/31,15.55%,NTN4;LAMB1;SRCIN1;TMEFF2;FN1;MICALL2;MEGF9;TYRO3;ITGAV
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.6337936446654232,1.2052859030247933,0.2235294117647059,0.9999639025717966,1.0,16/31,23.34%,LRP4;PTPRD;IL1RAPL1;NRXN1;NRXN2;ANK3;NLGN1;NLGN3;SPAST;PICALM;UGCG;SPTBN1;UBXN2B;STX2;NLGN4X;FLOT2
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.810411225708289,1.205103280805844,0.21428571428571427,0.9997956936597558,1.0,1/5,1.98%,SHANK3
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.6560347527589312,1.2049923212058538,0.27380952380952384,0.9990874131158477,1.0,3/20,10.69%,PRR16;DEPTOR;CAV3
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6624533978189509,1.2049780845164935,0.21794871794871795,0.997725684706365,1.0,9/18,21.95%,GRIK2;CDKN2AIP;ANK3;RIMS2;SYT1;RIMS3;CLSTN2;DLG4;TNF
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.8083560162556336,1.2048801509691138,0.19696969696969696,0.9969068241595118,1.0,2/6,10.69%,GLA;CAV3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.5762400139353961,1.2048197690171172,0.05102040816326531,0.9959236689460236,1.0,44/160,17.23%,DDIT4;IL1RAPL2;ZBTB16;MAL;LSR;SPOCK1;VCAN;NR4A2;NCAN;RELN;MYRF;CDH2;NFIB;MEIS2;AATK;ROBO2;CA10;MOG;SOX4;SH3GL3;PTPRZ1;GRIN2A;MARCKSL1;ARNT2;POU6F1;PAX8;GRIK1;ADAM23;CNTNAP2;TAGLN3;MFSD2A;SH3GL2;EPHA7;UGT8;SOX6;SHROOM4;ADGRL2;GRIN2B;TPPP;PKD1;EIF2B2;NDRG4;ASIC2;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5181526394029392,-1.204738418738941,0.10526315789473684,0.9338941645818525,1.0,4/23,10.96%,CCL5;HLA-E;NMI;TASL
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6913874120173609,-1.2045212769752314,0.35714285714285715,0.9320684815336213,1.0,3/5,19.02%,LIMA1;GSN;PLEKHH2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6239408225996846,1.204278630707756,0.14772727272727273,0.9981427046285306,1.0,16/52,19.07%,LRP2;SHANK3;METRN;PTPRD;IL1RAPL1;ROBO2;VEGFA;ROBO1;SS18L1;KDM1A;NTRK2;SMARCD3;PLXNB1;NEURL1;PLXNC1;ARHGDIA
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.6290754910201918,1.2037881613007555,0.20238095238095238,0.9999465483388037,1.0,19/37,23.64%,SCN3B;SLC6A15;SLC5A9;SLC24A2;SLC9B2;SCN3A;SCN1A;SLC24A1;NALCN;HCN1;SCN2A;SCN8A;ASIC2;ATP1B3;SLC24A3;FGF13;SLC24A4;SLC5A6;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7358616510465454,1.2036506193909322,0.22580645161290322,0.9995120210583024,1.0,2/9,5.39%,IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.6305035001144866,-1.2034166253908367,0.3,0.9335784998312755,1.0,1/5,0.20%,CCL5
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7721743145388472,1.2033905162942633,0.21794871794871795,0.996868663686248,1.0,1/10,0.24%,UAP1L1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.7721743145388472,1.2033905162942633,0.21794871794871795,0.996868663686248,1.0,1/10,0.24%,UAP1L1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7721743145388472,1.2033905162942633,0.21794871794871795,0.996868663686248,1.0,1/10,0.24%,UAP1L1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.6686785001476163,1.2031029812609602,0.18072289156626506,0.9974307171769788,1.0,7/20,24.16%,MAPT;INF2;PINK1;BNIP3;DDHD1;STAT2;LRRK2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.6029513940616735,1.2029512903192574,0.16483516483516483,0.9970914381055218,1.0,11/45,19.12%,PCSK1;DMD;GLRX2;BACE2;CPM;TRHDE;CPE;LTA4H;CARNMT1;SOD1;GSTP1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.6166675719734664,1.202926837895003,0.19318181818181818,0.9958545924853679,1.0,12/42,21.46%,PPP2R5B;HSPA5;VAPB;ARFGAP1;DNAJB9;SERP1;SYVN1;HYOU1;GFPT1;CXXC1;DCTN1;SRPRA
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7382111882919609,1.2027421297995642,0.28,0.9954173493354842,1.0,3/10,10.90%,VCAN;NCAN;CSPG5
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6136449404166052,-1.2026391144437614,0.24,0.9338046495252352,1.0,5/11,22.36%,KHSRP;UPF1;ZFP36;MOV10;ZC3H12D
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6443414630043709,1.2023807303331027,0.2857142857142857,0.9963064144649145,1.0,3/17,12.42%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.6831214373055512,1.2019224264452721,0.18292682926829268,0.9979491595997767,1.0,6/19,20.18%,SOX4;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7529704266686991,-1.2019212430720476,0.21428571428571427,0.9334480052491679,1.0,3/6,22.06%,C1QC;CD81;C1QB
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6634250276815264,1.201854773094492,0.18292682926829268,0.9969948479309394,1.0,4/21,14.09%,HTR2B;NYAP2;IGF1R;TYRO3
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.7713594978225748,1.201595587372251,0.2361111111111111,0.9974381769807213,1.0,2/8,10.95%,ANTKMT;MID1IP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.8231575153928584,1.2013367616739183,0.20967741935483872,0.9976543774637185,1.0,2/5,14.73%,TFRC;BNIP3
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5908541709514318,1.200954924362419,0.13829787234042554,0.9989478114538674,1.0,11/66,19.06%,PLPP3;CENPE;RACGAP1;NAPA;KIF15;ARFGAP1;NSF;KIF5A;TMED10;KIF11;KIF3A
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.6397390888496499,-1.2003021038911832,0.2631578947368421,0.9359932381992851,1.0,1/5,3.55%,IL1B
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.7178861304712385,-1.200288181517908,0.3448275862068966,0.9334996780760407,1.0,3/7,16.94%,MMAA;PCCB;MCEE
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),-0.7116038442080375,-1.1999701975648431,0.36363636363636365,0.9320651230892217,1.0,1/5,12.94%,NAA20
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.6425614711265636,1.1997637291114023,0.2391304347826087,1.0,1.0,5/29,12.11%,TGFB2;ROBO2;ROBO1;RBPJ;NOD2
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.7865351261819569,1.1995123681467552,0.20588235294117646,1.0,1.0,3/6,7.78%,FOLH1;AGBL3;AGTPBP1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5667693001397117,1.1992821666227804,0.10101010101010101,1.0,1.0,44/128,22.46%,LRRC4C;SEMA3A;SHANK3;DCC;SPOCK1;RELN;ZDHHC15;IL1RAPL1;CDH2;CSMD3;SRCIN1;SIPA1L1;EPHA3;CHN1;PTK7;PAQR3;ZNF804A;KANK1;MAG;PTN;NTRK3;CAMK2B;PPFIA2;MFSD2A;CRMP1;NTRK2;MAGI2;EPHA4;LRRC7;CTNNA2;STMN2;WNT5A;NDRG4;CDK5R1;CFL1;NTNG1;DENND5A;PTPN9;FES;ATP1B2;FBXO7;PAK3;RTN4RL1;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6075449431493944,1.1989026036598245,0.14285714285714285,1.0,1.0,6/48,7.61%,THBS1;LRP2;AGT;ACVR2A;BMPR1B;SPRY1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4149568320915639,-1.1986346083329467,0.25,0.9339463219439893,1.0,11/57,11.36%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;LEO1;SUPT16H;TCEA1;ADRM1;POLR2C
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.7303741385828847,1.1986076056297754,0.26666666666666666,1.0,1.0,7/12,20.67%,MAPT;SYBU;HIF1A;SPAST;UXT;NEFL;UBB
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.7087008273218425,1.1982368592930053,0.24193548387096775,1.0,1.0,4/9,13.58%,MYRF;ABCA2;PLP1;B4GALT5
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.6662353844026571,1.1982225387857053,0.21951219512195122,1.0,1.0,7/18,23.64%,KCNJ13;SLC12A8;ATP1B3;KCNJ6;KCNJ3;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7372732550443177,1.1980888448641271,0.21333333333333335,1.0,1.0,4/11,10.69%,CDH2;DMD;RYR2;CAV3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.7602621367415578,1.1980588444144435,0.26582278481012656,1.0,1.0,2/7,10.69%,RGS2;CAV3
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.7112588883365373,-1.1977747928465075,0.3888888888888889,0.9340244054431178,1.0,3/6,22.92%,STIM1;CD84;HOMER1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.815096383789605,1.1976970544250998,0.19402985074626866,1.0,1.0,4/7,14.41%,ALOX15B;ALOX12;SCD5;SCD
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7352950618536593,1.1974701576077271,0.3125,1.0,1.0,2/9,14.56%,TGFB2;BRCA1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.6177024328805949,1.1972943046915328,0.2159090909090909,1.0,1.0,13/34,23.12%,PFKM;ENO2;PGAM1;NR4A3;GPI;ENO4;PKM;SLC16A1;SLC16A3;PGK1;ENO1;PDHB;PGM1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.5826478179723091,1.1969855735282566,0.17708333333333334,1.0,1.0,13/66,15.11%,DDIT4;ARAF;TFRC;MTCP1;DMD;VEGFA;PAQR3;RAPGEF3;TXN;NTRK3;PINK1;RIPK2;HCLS1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7613690821176968,1.1969477300405256,0.13333333333333333,1.0,1.0,2/11,5.39%,KLF4;ANXA1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.6962704283056481,-1.1968974134768275,0.35714285714285715,0.934745835733106,1.0,2/7,6.57%,BCL2L1;SERPINB9
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.41068043739730614,-1.1967558830424694,0.25,0.932966566443091,1.0,11/58,11.36%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;LEO1;SUPT16H;TCEA1;ADRM1;POLR2C
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.5771606507047803,-1.196675923537161,0.34782608695652173,0.930769867970612,1.0,7/15,20.78%,PEX13;PEX16;FIS1;ABCD3;PEX2;ACBD5;SLC25A17
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5402946693389554,-1.1966578958995575,0.23529411764705882,0.9284074226385857,1.0,4/21,12.71%,FLNA;ZPR1;TGFB1;EFCAB7
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6081780283199921,-1.1956031768916018,0.3333333333333333,0.9294191682789323,1.0,5/13,11.28%,CYP2S1;HPGDS;DAGLB;ACOX1;PTGS1
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.7685539898568275,1.1955934256760588,0.31343283582089554,1.0,1.0,3/5,17.54%,GAD1;GAD2;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6668839174525935,1.1954661672716098,0.25316455696202533,1.0,1.0,2/16,3.71%,MAPT;CD22
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.7661395442772837,1.1954287541707678,0.25,1.0,1.0,2/5,17.34%,POLG2;RFC4
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.7661395442772837,1.1954287541707678,0.25,1.0,1.0,2/5,17.34%,POLG2;RFC4
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8159830683449054,1.195155808291204,0.13513513513513514,1.0,1.0,1/5,8.33%,SPIRE2
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.586171897618284,1.195066642815291,0.1744186046511628,1.0,1.0,14/39,24.76%,KCNJ13;SYT4;ANK3;CA2;PXK;NKAIN2;PER1;SYT1;KCNJ6;KCNJ3;SPTBN4;HFE;TF;SYT11
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.7422449955133028,1.1948961211680318,0.2564102564102564,1.0,1.0,2/10,13.82%,NUDT16;ZC3H12B
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.643263450508502,1.1948450319961021,0.2619047619047619,1.0,1.0,10/24,25.30%,ABCA2;SIRT5;PINK1;BRCA1;ITGAV;SDCBP;AP1AR;DLG4;BTN2A2;TRAP1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7130906367018932,1.1947939510181824,0.26506024096385544,1.0,1.0,5/15,10.14%,DMD;ANK2;AKAP6;RYR2;CALM3
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.680877491865766,-1.1947834232713326,0.28205128205128205,0.9302844034663076,1.0,4/6,23.44%,WHAMM;GSN;CASS4;MCU
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.6488935580824927,1.1947370045825734,0.2441860465116279,1.0,1.0,6/25,15.09%,THBS1;NR4A1;VEGFA;ROBO1;SEMA5A;E2F7
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.5937896449648252,1.1945258828226093,0.14893617021276595,1.0,1.0,4/52,7.50%,ACVR1B;GALNTL6;CIT;GALNT13
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.704547398635121,1.1944202107387225,0.24050632911392406,1.0,1.0,2/11,9.10%,ANXA1;RIMS2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5314096793365752,-1.194205665748145,0.2727272727272727,0.929666685602295,1.0,6/15,18.48%,MED24;MED12;MED4;MED1;PAXIP1;MED30
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.7918205972870167,1.1941577510398091,0.23529411764705882,1.0,1.0,3/6,8.80%,SHROOM3;MAL;ATP8B1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6226602243876378,1.1940838315559672,0.25333333333333335,1.0,1.0,10/26,21.39%,SH3BP5;RELN;AGT;SRCIN1;GPRC5B;EPHA4;THY1;APP;DLG4;SH3BP5L
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.6698151678107339,1.1939258297261615,0.21428571428571427,1.0,1.0,8/18,19.82%,SCN3B;CACNA1B;SCN3A;CACNG2;SCN1A;SCN2A;SCN8A;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5466310958851535,-1.1936159285980423,0.3076923076923077,0.9291224255359878,1.0,3/15,4.13%,ATRAID;DAB2IP;WDR91
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.7709373713212002,1.1933794677771945,0.2361111111111111,1.0,1.0,1/7,2.58%,GLA
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.7496485513864446,1.1928269944548624,0.21621621621621623,1.0,1.0,3/9,5.74%,LRP2;TGFB2;KITLG
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.6318204564145145,1.1927473541191622,0.2222222222222222,1.0,1.0,9/42,14.70%,PLPP3;ASPN;SVEP1;TNS1;LAMA2;KCNMB1;SH3D19;PMP22;UACA
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.581390130768912,-1.1927208264346318,0.25925925925925924,0.9300516738709509,1.0,4/12,9.49%,CST7;CD200R1;IGF1;TREM2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.5765288685547305,1.1926182578752496,0.21505376344086022,1.0,1.0,15/64,14.71%,TGFB2;ZBTB16;MYOT;DCC;TG;NR4A2;BMPR1B;ARPP21;RYR2;TCF7L1;KCNMB1;CELSR2;GRID2;EPHA5;RGS11
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.8270059209409846,1.1925126595024378,0.2571428571428571,1.0,1.0,2/5,9.75%,EGR1;SIRT5
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.7344053335482308,1.1921638784593476,0.2361111111111111,1.0,1.0,3/10,9.51%,FBN2;RYR2;ID2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7584917925491708,1.192093853404614,0.23529411764705882,1.0,1.0,1/6,1.60%,TGFB2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.5945699623692224,-1.1917037465119853,0.28125,0.9303125087436465,1.0,2/10,2.21%,NEXMIF;SERPINF2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.5622885903841228,1.1915864951531299,0.1,1.0,1.0,55/162,23.18%,RAP1GAP;SEMA3A;SHANK3;NTN4;DCC;RELN;ENAH;NRXN1;PLPPR4;DOK6;ROBO2;GRB10;LAMA2;SEMA3B;ANK3;NRXN3;SEMA6A;UNC5D;EPHA3;NLGN3;PALLD;IRS2;ROBO1;SLITRK5;MAP1B;EPHA6;SEMA5A;SPTAN1;UNC5C;EPHA7;SLC9A6;B4GALT5;PARD3;EPHA4;CCK;EPHA5;CTNNA2;GAB1;WNT5A;SPTBN5;CDK5R1;KIF5A;DAB1;SPTBN1;NTNG1;APP;KLF7;SPTBN4;SPG11;PAK3;NCAM1;CNTN2;NOTCH2;FGFR2;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7176673336087735,1.1914122158421998,0.2911392405063291,1.0,1.0,1/10,0.18%,GPR18
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7721312697132661,1.1912752034361374,0.2571428571428571,1.0,1.0,2/7,4.31%,NRG1;CDH2
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.7886607500375771,1.191142829689889,0.28378378378378377,1.0,1.0,2/7,10.14%,ANK3;CALM3
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.6064196661535396,1.1910370314322987,0.25,1.0,1.0,9/43,13.19%,HTR2B;FGF1;DIRAS2;VEGFA;TRAF2;ROBO1;NOD2;FLT1;SASH1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.742126941757511,1.1909564253975293,0.3283582089552239,1.0,1.0,3/9,12.42%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.7663995732818984,1.1899312137196343,0.27692307692307694,1.0,1.0,3/7,14.95%,MAPT;BNIP3;PRELID1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.6335493602030944,1.1899183872309118,0.23684210526315788,1.0,1.0,5/21,14.88%,CR1;CD55;FCGR2B;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6188775481726739,1.189583945985746,0.25925925925925924,1.0,1.0,9/25,21.95%,GRIK2;CDKN2AIP;RIMS2;SYT1;RIMS3;NSF;CLSTN2;DLG4;TNF
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.8040365386163681,1.1895760028227746,0.29850746268656714,1.0,1.0,3/5,17.77%,SEMA3A;PTN;PHACTR1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.39477972652045,-1.189556865885065,0.125,0.9345429829041707,1.0,14/57,12.39%,PIDD1;RPS6KA6;SESN2;BTG2;TFAP4;ACER2;TP53;ZNF385A;EP300;BCL3;CNOT6L;PLK3;NBN;PLAGL1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.683415567992003,1.1893975418029832,0.21052631578947367,1.0,1.0,3/15,7.10%,WDR12;MAK16;PES1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.7440322573276257,1.1893212830765783,0.19047619047619047,1.0,1.0,2/6,6.82%,IDI1;MVD
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6984860332335276,1.189224322064053,0.26865671641791045,1.0,1.0,2/9,8.59%,RYR2;PKP2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7622765865054036,1.1891836309976236,0.28378378378378377,1.0,1.0,4/8,14.19%,SHANK3;MAPT;ADCY8;GRID2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5987457854497233,1.1889504488866558,0.2619047619047619,1.0,1.0,5/30,15.12%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;NDUFB6
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.7715867572316896,1.1889184167754188,0.2698412698412698,1.0,1.0,4/5,22.31%,P4HA3;P4HA1;EGLN3;P4HB
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6508238117336794,1.1887539808591987,0.21839080459770116,1.0,1.0,7/17,22.55%,NRG1;SGCZ;SMAD1;SGCD;KDM6B;SMAD5;NOTCH2
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7934561487350495,1.1886573471671333,0.23880597014925373,1.0,1.0,5/7,15.32%,UNC13A;RIMS2;SYT1;RIMS3;UNC13C
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.8159626453580053,1.1886163688174252,0.2631578947368421,1.0,1.0,2/5,8.78%,TTBK2;MAP2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.7453615695430927,1.188600458555748,0.225,1.0,1.0,4/10,15.81%,GRIN2A;CIDEB;RIPK2;ASPH
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5162187737224873,-1.1884839525921729,0.125,0.9351382254319576,1.0,2/16,4.65%,BBS10;MKKS
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5598167462802425,-1.1883364330370574,0.23809523809523808,0.9330967686784749,1.0,7/21,15.41%,NEDD4;CLTA;SNX25;TGFB1;SMURF1;BECN1;ZNRF3
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.5827228417386852,1.1882947373426378,0.2,1.0,1.0,22/47,26.70%,NRXN1;SLC6A15;SLC1A2;NRXN2;GAD1;SNAP25;UNC13A;GABRA2;GLUL;PPFIA2;SYT1;GAD2;SLC17A7;CPLX1;STXBP2;PPFIA4;SYN2;ATP1A2;TSPOAP1;PPFIA3;BRSK1;RIMS1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.5623741271263685,1.1879043448180506,0.17894736842105263,1.0,1.0,13/76,15.28%,CENPF;LRP2;SLC38A4;SLC16A10;ARRDC3;SLC6A15;SLC11A1;SLC19A2;FLVCR1;TXNIP;SLC35F3;LRP1B;SCAMP3
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.8216839128484226,1.1877461147958404,0.23076923076923078,1.0,1.0,1/5,5.39%,ANXA1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5850519564663048,1.187608086389111,0.10752688172043011,1.0,1.0,17/78,18.11%,FA2H;PLPP3;ALDH3B1;ENPP2;GLA;VAPB;ABCA2;ARSA;ELOVL4;UGT8;GALC;PPM1L;SPTLC2;SUMF2;UGCG;SUMF1;GBA3
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.6557125687687606,1.187405134354836,0.2976190476190476,1.0,1.0,9/20,24.51%,OIP5;CENPP;CENPI;CENPV;CENPK;CENPT;HELLS;ITGB3BP;NASP
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.6847037258960289,1.1873749203531418,0.24324324324324326,1.0,1.0,4/12,13.02%,SYT4;UNC13A;RIMS2;SYT1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.6847037258960289,1.1873749203531418,0.24324324324324326,1.0,1.0,4/12,13.02%,SYT4;UNC13A;RIMS2;SYT1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.7712065649473123,1.1871149317648306,0.27419354838709675,1.0,1.0,3/7,19.82%,MAPT;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.7250582128664957,1.1870176190553856,0.3287671232876712,1.0,1.0,2/8,6.46%,EEF1A2;PPP2R5A
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.5717064069750073,1.1869830298477866,0.20408163265306123,0.999797925919658,1.0,3/77,1.46%,RHOBTB3;RAB7B;DENND2A
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.5961601313830545,1.186678667637525,0.25842696629213485,1.0,1.0,16/31,30.52%,NRXN1;NRXN2;GAD1;SNAP25;UNC13A;SYT1;GAD2;CPLX1;STXBP2;SYN2;PPFIA3;BRSK1;RIMS1;PTPRN2;HSPA8;NAAA
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7640404061477172,1.186650991792097,0.29333333333333333,0.9991440549528693,1.0,2/8,8.53%,SOCS3;PTPRT
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5762332350056707,1.186640173501289,0.17894736842105263,0.9980115686442786,1.0,26/79,25.03%,GLRA1;SYT4;ANK3;NLGN1;ADCY8;SYT1;RYR3;FBP1;BNIP3;WNT5A;CLIC4;IQGAP1;CDKN1B;PRKAA2;SLC25A24;DLG4;CPNE8;CPNE2;FOS;JUN;HFE;TF;LRRK2;ECT2;SYT11;CPNE3
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7224175534769854,1.1866304127089766,0.2125,0.9968019256995836,1.0,5/10,8.23%,LRP4;PTPRD;IL1RAPL1;NLGN1;NLGN3
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.8256980145537922,1.1864393273144163,0.2571428571428571,0.9969651246069484,1.0,3/5,9.23%,ALOX15B;ANXA1;PAX8
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.5623666394315652,1.1864028868256151,0.2127659574468085,0.9959764434076513,1.0,12/53,13.10%,HTR2B;FGF1;HMGB2;LAMB1;NR4A1;VEGFA;HIF1A;PTN;C5AR1;SEMA5A;NOD2;NR4A3
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6506333845461516,1.1862670203134418,0.27058823529411763,0.9955254014775721,1.0,4/17,12.25%,LSR;DMD;LAMA2;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.5881517167135928,-1.1860893054060824,0.2413793103448276,0.9364229045443959,1.0,1/9,0.62%,SMPD3
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.5881517167135928,-1.1860893054060824,0.2413793103448276,0.9364229045443959,1.0,1/9,0.62%,SMPD3
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.7272043411904086,-1.1858160711658878,0.2972972972972973,0.9348409017624644,1.0,2/6,17.85%,RABEP1;RAB29
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.645581185714988,1.1855647695331069,0.2682926829268293,0.9984416483173602,1.0,4/15,20.01%,ACSL1;DGAT1;HSD17B12;ACSL3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.5582225415914338,-1.1846759057628549,0.2608695652173913,0.9366624560904108,1.0,3/13,17.08%,UBA7;SENP6;DESI2
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.7531527632602184,1.184639139270245,0.2328767123287671,1.0,1.0,3/8,20.43%,CR1;SLC25A4;SLC25A24
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.7839533487314663,1.1842284602130928,0.2857142857142857,1.0,1.0,2/5,18.70%,SOD2;SOD1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5517386932753487,1.18419850097745,0.13131313131313133,1.0,1.0,28/188,14.37%,KCNE1;GLRA1;AANAT;TSHR;VIM;EGR1;HMGB2;MAPT;BRINP1;RORB;PDK4;PTPRK;NSMF;DAPK1;AKAP6;EPHA3;PTK7;RUVBL2;RAPGEF3;PDE2A;NOD2;PDCD1LG2;IMPACT;NR4A3;PDE4B;RYR3;GUCY1B1;HCN1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.6752663583754654,-1.184113767901626,0.34615384615384615,0.9358747558245711,1.0,2/8,6.84%,SESN2;SESN3
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6519420919284428,1.1837605164735032,0.20512820512820512,1.0,1.0,5/15,11.21%,NUDT16;NUDT4;HINT1;ACAT1;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.7160987970862379,1.1837146861262822,0.2463768115942029,1.0,1.0,1/9,0.29%,THBS1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.6276399945836637,1.1836861853725982,0.24705882352941178,1.0,1.0,3/27,4.19%,SLC38A4;SLC16A10;SLC6A15
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.6122382280550872,1.183679120303648,0.20930232558139536,1.0,1.0,5/33,9.18%,RHOBTB3;RHOB;ARF6;NLGN1;RND3
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.7938332390036319,1.1832717499305045,0.1780821917808219,1.0,1.0,3/5,18.11%,GLA;GALC;GBA3
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.4795176857652637,-1.1828708109867632,0.08333333333333333,0.9380938482863656,1.0,8/35,15.02%,KARS1;DARS2;FARSA;YARS1;TARS1;WARS1;LARS2;SARS1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.668155814433442,1.1828357533281202,0.2696629213483146,1.0,1.0,7/21,20.52%,MAPT;CAV3;STMN2;CDK5R1;TOGARAM1;DCTN1;FES
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.7547788315752011,1.1828042425566276,0.3,1.0,1.0,1/6,11.22%,TFIP11
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5570451214049223,-1.182787103524639,0.25806451612903225,0.935979125875436,1.0,2/14,0.94%,RALB;PDE12
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7176590589559884,1.1825567020215848,0.23076923076923078,1.0,1.0,5/11,13.66%,ZBTB16;BMPR1B;MBOAT2;TRPS1;SOX6
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.6117864170876947,1.1822444154982403,0.19318181818181818,1.0,1.0,6/44,6.33%,TNC;SPARC;SVEP1;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6875669612255414,1.1822410386476565,0.2235294117647059,1.0,1.0,3/14,9.93%,B4GAT1;SDF2L1;TMTC2
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.783593078536337,1.1816946768506396,0.3026315789473684,1.0,1.0,3/8,13.37%,ACVR1B;ACVR2A;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.7261262676358841,1.1816213785957352,0.2857142857142857,1.0,1.0,3/7,14.95%,IFNLR1;PINK1;PRELID1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6768566475531435,1.1808533357410749,0.29577464788732394,1.0,1.0,6/14,26.93%,ABCA2;EPHA4;CASP3;PICALM;TNF;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6660187125050546,1.1804749145748121,0.36363636363636365,1.0,1.0,1/10,2.95%,MAPT
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.7918667361339403,1.1804164997108624,0.2608695652173913,1.0,1.0,3/5,14.88%,CR1;CD55;SUSD4
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5781017218049216,1.18039118881101,0.21505376344086022,1.0,1.0,10/49,15.11%,ARAF;TFRC;MTCP1;VEGFA;RAPGEF3;TXN;NTRK3;PINK1;RIPK2;HCLS1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6555089433594652,-1.1803338032309059,0.36666666666666664,0.9410044742527944,1.0,3/7,13.70%,NEK6;RSL1D1;NUAK1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.48698037621775536,-1.1801440994583963,0.06666666666666667,0.9392317233477993,1.0,5/26,6.46%,PHLDB2;NEXMIF;MAP4K4;ACER2;NF2
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6250117294615274,1.1801405850948854,0.23863636363636365,1.0,1.0,6/31,9.71%,KLF4;TGFB2;EGR1;NFIB;HIF1A;POU5F1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.5773517313978122,1.1798432843466695,0.21739130434782608,1.0,1.0,5/55,7.25%,SOCS3;ACVR1B;OSMR;MAP3K8;IL7
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.6532811657606844,1.1797937535266676,0.25609756097560976,1.0,1.0,7/18,21.30%,ARF6;ABCA2;ITGAV;PICALM;SDCBP;APP;DLG4
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.7916085923047401,1.1796219662820946,0.323943661971831,1.0,1.0,2/5,10.69%,CDH2;CAV3
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7351214244380802,1.1796199004859138,0.28378378378378377,1.0,1.0,1/7,3.04%,EIF4A3
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.7291881096239254,1.1796068599946572,0.3389830508474576,1.0,1.0,1/7,5.13%,ALOX12
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.7702748230646568,1.1795722485970772,0.234375,1.0,1.0,1/6,2.58%,GLA
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.7702748230646568,1.1795722485970772,0.234375,1.0,1.0,1/6,2.58%,GLA
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.45040925376272256,-1.1794447120322753,0.16666666666666666,0.9392581469618707,1.0,7/40,6.92%,CCL5;GBP3;IL1B;DAB2IP;LGALS9;MAPK13;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.6918390956876455,1.1790233504921714,0.25333333333333335,1.0,1.0,4/14,13.95%,HTR2B;RYR2;IBTK;RYR3
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.6696246721468117,-1.1789905572004002,0.36,0.9384758132217829,1.0,3/6,11.45%,DNMT3A;KDM1B;MECP2
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.5751034707691153,1.178539598180336,0.15217391304347827,1.0,1.0,9/98,5.66%,CDK14;HAUS6;TUBA4A;PRKAR2B;TUBB4A;TUBA1A;FBXL7;CEP152;MASTL
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6103921166158682,1.178403437268486,0.2891566265060241,1.0,1.0,8/23,17.01%,IDI1;TM7SF2;FAXDC2;MVD;PRKAG2;FDFT1;HMGCS1;INSIG1
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8021937360844443,1.1781215753131775,0.24285714285714285,1.0,1.0,2/5,2.96%,THBS1;PDE10A
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7385866892903685,1.1778993056578224,0.2619047619047619,1.0,1.0,2/10,5.93%,ANXA1;VEGFA
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.5113796915691537,-1.1778502517482803,0.30434782608695654,0.9399827562761771,1.0,5/18,15.39%,ARL2BP;BCL3;CHCHD10;SYNE1;TAF8
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.5745389748471185,-1.1778140702767022,0.2222222222222222,0.9376604335601938,1.0,2/9,4.51%,ZNF703;CSF1R
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.5544120829815211,1.1771470697300597,0.1326530612244898,1.0,1.0,40/133,18.89%,RAP1GAP;SEMA3A;SHANK3;NTN4;DCC;RELN;ENAH;NRXN1;NFIB;DOK6;ROBO2;VEGFA;GRB10;LAMA2;SEMA3B;NRXN3;SEMA6A;UNC5D;EPHA3;CHN1;ALCAM;PALLD;IRS2;ROBO1;EPHA6;SEMA5A;SPTAN1;UNC5C;EPHA7;EPHA4;EPHA5;PLXNB1;GAB1;WNT5A;SPTBN5;CDK5R1;KIF5A;DAB1;SPTBN1;PLXNC1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5848733954793276,1.1770998541889102,0.2268041237113402,1.0,1.0,22/57,25.96%,LRP4;DCC;PLPPR4;ANK3;MAP2;SLITRK5;MAP1B;CELSR2;MFSD2A;PARD3;CCK;CTNNA2;MAPK8IP2;NTNG1;APP;KLF7;SPTBN4;PAK3;FGFR2;MAP1A;TMEM106B;BRSK1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.646757849397952,-1.1766416910184854,0.38095238095238093,0.9385934006630174,1.0,2/8,7.55%,PLA2G4C;PLA2G12A
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.5728232194203438,1.1765174601625765,0.19540229885057472,1.0,1.0,21/51,31.28%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;COX7C;CYCS;NDUFB6;UQCRFS1;UQCRC1;CYC1;COX4I1;COX6C;NDUFS5;NDUFV1;COX6B1;NDUFAF1;NDUFS7;COA6;UQCRC2;NDUFA1;NDUFA10
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.6224572091211036,1.1763969645332266,0.24358974358974358,1.0,1.0,16/28,30.31%,NAPA;DNM3;DNM1;SNAP29;NSF;UBXN2B;NAPG;HACE1;CHP1;MX1;RIMS1;OPA1;VAPA;MX2;GCA;NSFL1C
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.6866436467506497,-1.1763662560311405,0.3157894736842105,0.9347223484765673,1.0,3/6,26.20%,AKAP8L;SUPT6H;NSUN2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.6866436467506497,-1.1763662560311405,0.3157894736842105,0.9347223484765673,1.0,3/6,26.20%,AKAP8L;SUPT6H;NSUN2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5559979454873744,1.176226630207721,0.21875,1.0,1.0,29/81,19.00%,LRRC4C;GRM8;BEGAIN;RELN;CDH2;DGKI;GRIK2;GRM3;NLGN1;IQSEC2;NLGN3;UNC13A;RIMS2;CACNA1B;GRIK1;PXK;NRG3;TMEM108;DLGAP1;SYT1;GRID2;RIMS3;MCTP1;CPLX1;CLSTN2;DLGAP2;GRM7;MAPK8IP2;APP
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.5862774610808391,1.1761680099824094,0.20652173913043478,1.0,1.0,10/38,17.23%,DDIT4;TGFB2;EGR1;MAPT;FCGR2B;EPHA7;GRIN2B;WNT5A;PICALM;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.593571832583828,1.175696063425219,0.2247191011235955,1.0,1.0,6/41,11.83%,HTR2B;HMGB2;NR4A1;VEGFA;HIF1A;SEMA5A
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.6467355856275773,1.1756771555226444,0.24324324324324326,1.0,1.0,3/12,16.75%,TGFB2;GPRC5B;WNT5A
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),0.7876546094301773,1.1754101198529607,0.3114754098360656,1.0,1.0,2/5,11.25%,HMGB2;NEIL1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7776800667443342,1.1752950386577765,0.2361111111111111,1.0,1.0,1/7,1.60%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.7304537018707302,-1.1748505970911896,0.42857142857142855,0.9377798880610364,1.0,1/5,2.21%,SERPINF2
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.5807213692069497,1.174693979763443,0.22826086956521738,1.0,1.0,15/58,18.33%,THBS1;PLPP3;TNS1;DOCK1;ENC1;LAMA2;CGNL1;KCNT1;SASH1;SHROOM4;SMARCD3;LDB2;TIMP3;SORBS2;NRGN
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.7704990144698562,1.1745558942554772,0.28125,1.0,1.0,1/5,0.29%,THBS1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.5444703770125568,1.1743960241440607,0.16666666666666666,1.0,1.0,29/96,20.33%,TGFB2;GPM6A;MAPT;PPP1R9A;GPM6B;LAMB1;MANF;PQBP1;NLGN1;HDGFL3;STMN3;MAP2;MICALL2;CNTNAP2;PLP1;ALK;TMEM108;SH3GL2;NTRK2;B4GALT5;EPHA5;STMN2;RASGRF1;CDK5R1;UGCG;APP;ROCK1;ERCC6;NCDN
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7754982761841646,1.1742050693466832,0.2857142857142857,1.0,1.0,2/6,4.92%,KMO;FAH
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.7911725701491452,1.1740512477701013,0.2459016393442623,1.0,1.0,1/5,3.82%,ERCC2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.527632503378742,-1.1740453411539409,0.18518518518518517,0.9380742532274968,1.0,1/15,0.62%,SMPD3
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.724947614904623,-1.1738995477529461,0.3,0.9359892104990143,1.0,3/6,14.41%,TICAM1;TREM2;AKT1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7434847618811337,1.1737211329348258,0.2972972972972973,1.0,1.0,5/8,8.23%,LRP4;NRXN1;NRXN2;NLGN1;NLGN3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.656200526011695,1.173313415295227,0.24050632911392406,1.0,1.0,6/19,10.91%,LRP2;TGFB2;NRG1;RYR2;PKP2;RBPJ
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6787815240475364,1.1731151310137005,0.2894736842105263,1.0,1.0,7/11,21.42%,CHRM5;GNA11;CHRM3;LY6H;CDK5R1;PLCB1;GNAQ
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.7443429219922405,1.1729755339827481,0.2753623188405797,1.0,1.0,1/5,0.29%,THBS1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5737511863046294,1.1727991500366919,0.1935483870967742,1.0,1.0,14/74,17.35%,TSHR;PRKAR2B;ADCY3;NR4A2;NR4A1;INSR;IRS2;RAB15;ADCY8;SORBS1;NR4A3;PKM;INSIG1;CPEB2
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7275495482316098,-1.1725356842715737,0.3103448275862069,0.9383621211850762,1.0,3/5,26.46%,IDH3B;IDH3G;IDH3A
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.7780419119100742,1.1724381914690776,0.25806451612903225,1.0,1.0,1/6,3.60%,SLC2A3
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.5713217674697374,1.1723544556340753,0.1839080459770115,1.0,1.0,20/50,31.28%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;COX7C;CYCS;NDUFB6;UQCRFS1;UQCRC1;CYC1;COX4I1;COX6C;NDUFS5;NDUFV1;COX6B1;NDUFAF1;NDUFS7;UQCRC2;NDUFA1;NDUFA10
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5733279009173881,-1.1722697031760902,0.3333333333333333,0.9369439140081343,1.0,3/15,3.55%,CCL5;TICAM1;IL1B
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6995308244543534,1.1720409044652609,0.2345679012345679,1.0,1.0,1/9,4.45%,ITPKC
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.80646519096444,1.172017230323269,0.25,1.0,1.0,3/5,15.16%,PTPRZ1;PTN;TNFRSF1B
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6272138024689948,1.1719735868667323,0.22727272727272727,1.0,1.0,8/30,9.23%,COBL;LSR;NRG1;TG;ALOX15B;ANXA1;ARID5B;PAX8
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7842618968583658,1.1715693895846762,0.25757575757575757,1.0,1.0,3/6,20.90%,ITGA2;TBX19;KDM6B
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6696139250160557,1.1711781185870935,0.2602739726027397,1.0,1.0,5/17,10.38%,RACGAP1;ALOX15B;TDG;INSR;PTN
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5788314244813713,-1.1708072955979025,0.2857142857142857,0.9391389313415599,1.0,2/13,3.95%,NPC2;NPC1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5746996143787825,1.1706957091358294,0.22340425531914893,1.0,1.0,11/59,17.42%,GLRA1;SLC1A2;GABRB1;SLC24A2;SLC9A7;SLC24A1;SLC9A6;SLC17A7;GLRB;SLC24A3;PIEZO2
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.5428172303164653,1.1695356776376788,0.15,1.0,1.0,33/118,23.95%,CENPF;PRLR;CENPE;NRG1;MAPT;ANLN;VBP1;DMD;TRAF2;HIGD1C;RPL38;FCHO2;CCDC39;MID1IP1;COX7A2;PDE4DIP;SGIP1;NSG2;CALY;PICALM;TCP1;STXBP6;MAPK8IP2;SHQ1;SMAD1;HSPD1;CENPT;HIP1R;TCF4;SRP19;DNAAF2;NDC1;RTN4
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6629007682666764,-1.1694269223120983,0.3076923076923077,0.9417156647544956,1.0,3/10,11.90%,TICAM1;HLA-E;TYROBP
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6737551382299096,-1.1693157340967446,0.3793103448275862,0.9399734116067551,1.0,2/6,11.40%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.5673113036230946,1.1682080768575736,0.16129032258064516,1.0,1.0,9/99,5.66%,CDK14;HAUS6;TUBA4A;PRKAR2B;TUBB4A;TUBA1A;FBXL7;CEP152;MASTL
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.5580899211243479,1.1681828328167727,0.14285714285714285,1.0,1.0,13/140,9.95%,TOP2A;CENPF;SAP30;CKS2;CENPE;RACGAP1;MEIS2;DMD;RPA2;KIF15;SMC4;HIF1A;XPO1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7063214977804522,1.1678094417032217,0.30666666666666664,1.0,1.0,2/12,5.47%,TGFB2;BMPR1B
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.558555115134123,1.1674037160884865,0.16666666666666666,1.0,1.0,27/116,13.90%,RHOBTB3;KLF4;SH3BP5;ALDH3B1;THSD4;GLA;MAPT;FKBP5;SYBU;SEMA3B;PAPSS2;KAZN;MINDY1;SVIL;OVOL2;SLC19A2;ENDOD1;RETREG1;BHLHE40;DEPTOR;BLVRB;CELSR2;IGF1R;RAPGEFL1;ASB13;FASN;RPS6KA2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7666108696022751,1.167072894249812,0.22857142857142856,1.0,1.0,2/7,4.31%,NRG1;CDH2
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.4969971897409603,-1.1668531682506016,0.22727272727272727,0.9455622602620369,1.0,5/15,15.59%,TFAP4;CTDP1;EP300;HPN;ZNF639
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6344759622827602,1.1666885934569284,0.14634146341463414,1.0,1.0,4/28,17.58%,FZD6;GNAO1;WNT5A;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6896189700941302,1.166517933579439,0.22972972972972974,1.0,1.0,4/12,13.10%,ACSL1;CLIP3;CA2;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.6490194479937011,-1.1663963241473203,0.3333333333333333,0.9447281762976858,1.0,1/6,0.20%,CCL5
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.7344171467250749,-1.1661979345283213,0.36363636363636365,0.9429588971337253,1.0,2/5,19.28%,EDA;LRP6
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.42982763017063846,-1.165842053401816,0.2222222222222222,0.9418120392685728,1.0,2/44,1.70%,TNFAIP8L3;NPC2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5613248275637754,-1.1656236405749874,0.23076923076923078,0.9400260822799329,1.0,2/11,3.34%,ITK;DDR1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.6740347281470048,1.1656175417003314,0.2987012987012987,1.0,1.0,6/11,28.95%,BRCA1;RLIM;LRIF1;PCGF5;HNRNPU;PCGF3
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.48198024805471446,-1.1652376840423304,0.2,0.939116864988762,1.0,3/20,4.33%,ITGA5;CD2;CD200R1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.7427660466499197,1.1650973790164605,0.26865671641791045,1.0,1.0,1/7,7.75%,CA2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6789609736537252,1.165085496384479,0.29411764705882354,1.0,1.0,3/15,8.75%,DDIT4;DMD;PAQR3
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6605994508649744,1.1650442121090645,0.3037974683544304,1.0,1.0,4/17,10.75%,COBL;TGFB2;CLMP;CCDC39
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.6887659809431197,1.164940044136895,0.23684210526315788,1.0,1.0,3/15,6.69%,GLRA1;MCHR2;LTB4R
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.6265255714040106,-1.164500204574686,0.21875,0.9392384635195244,1.0,1/7,2.76%,PLA2G4C
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.7729672777200652,1.1644730792777975,0.3,1.0,1.0,2/5,14.73%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5779268511930535,1.163793897350863,0.2247191011235955,1.0,1.0,16/56,10.99%,SHANK3;GPM6A;NRXN1;CDH8;CDH2;NRXN2;CDH9;CTNND2;SHANK2;NLGN1;NLGN3;PKP2;CDH20;FN1;DNM3;CDH12
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.6328408711701914,-1.1636212181126244,0.3333333333333333,0.9399034799381322,1.0,2/9,11.01%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.6328728481379586,1.162988823357836,0.2840909090909091,1.0,1.0,9/31,19.39%,METRN;MAPT;ROBO2;ROBO1;NTRK2;PLXNB1;PLXNC1;ARHGDIA;MAP3K13
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.7777582509453146,1.1628609926759443,0.23076923076923078,1.0,1.0,2/5,7.93%,ALG10B;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5484886643654078,1.1619623857267036,0.2222222222222222,1.0,1.0,20/116,11.98%,HS3ST5;NLRP12;LRP4;ARRDC3;IL15;NFIB;PTPRG;SRGN;GPNMB;VASN;RGS2;SLC11A1;FCGR2B;SPRY1;SFMBT1;OVOL2;ACOT13;ROBO1;RBPJ;NOVA1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.8157469854480219,-1.1619509325289654,0.3333333333333333,0.942736127535466,1.0,1/5,5.46%,TMEM106A
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.648646569650851,1.1617331870061256,0.32926829268292684,1.0,1.0,2/16,8.56%,RHOB;RYR2
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.6320860991418596,1.1610712247079884,0.2988505747126437,1.0,1.0,10/28,25.59%,SEMA3A;MAPT;MAP2;MAG;MAP3K13;OLFM1;PTPRS;RTN4;CTTN;RUFY3
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.7085992321517387,1.1610311017888912,0.22535211267605634,1.0,1.0,2/12,5.93%,NRG1;VEGFA
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6399401460561829,1.1610180757147022,0.25609756097560976,1.0,1.0,6/20,14.19%,PTPRD;CADM1;IL1RAPL1;NLGN1;ALCAM;GRID2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5339462768774149,1.1609494768373663,0.16666666666666666,1.0,1.0,17/103,13.19%,THBS1;KLF4;RHOB;SPARC;FGF1;TGFB2;VEGFA;CHI3L1;GPNMB;SEMA6A;HIF1A;RAPGEF3;GLUL;ITGB8;SEMA5A;FLT1;SASH1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.6049709814322668,1.1609404029792834,0.27710843373493976,1.0,1.0,6/36,9.78%,TNC;SPARC;ADAMTS2;FBXL7;LAMA2;FN1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.5273852120533771,1.160683722129874,0.13,1.0,1.0,44/236,13.31%,THBS1;HTR2B;NAMPT;FGF1;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;NRG1;TBC1D8;IL15;LAMB1;AGT;OSMR;MEIS2;LIFR;KITLG;VEGFA;SOX4;SPDYA;SHANK2;MVD;IL7;INSR;BMI1;IRS2;ID2;FN1;RPS6;PTN;RBPJ;KDM1A;NTRK3;IGF1R;C5AR1;NOD2;FLT1;SAAL1;NR4A3;CRLF1;NTRK2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.6627382206533761,1.1605592220891692,0.3375,1.0,1.0,2/11,14.56%,WDR5;BRCA1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.39237650683076225,-1.1603324267335393,0.0,0.9458737623489764,1.0,26/111,11.90%,NKG7;CD300LF;ITGAM;CD37;LY86;MPEG1;BIN2;GZMB;PIK3R6;BLNK;CD83;MCTP2;AOAH;IRF5;PLEK;RASAL3;MYO1F;WDFY4;BTK;NCKAP1L;TLR7;ITGAX;ITGB2;HCK;CD53;TYROBP
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6313898379949408,1.1600701084262373,0.17647058823529413,1.0,1.0,10/31,27.28%,SOX4;HIF1A;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2;NR1D1;KCNB1;PPARGC1A
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.6982209029300864,1.1590795924439654,0.2962962962962963,1.0,1.0,1/8,0.55%,CLEC4E
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.6113592390585477,1.1590733231135748,0.20652173913043478,1.0,1.0,12/46,12.83%,SPON1;COBL;PPP1R9A;ASXL3;LRRN1;ANK3;SEMA6A;PTPRT;BMI1;NDRG2;KALRN;SHC2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6789520352309173,1.1590541375752244,0.345679012345679,1.0,1.0,3/12,12.61%,DPYD;DPYSL5;CRMP1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.6156174958895082,1.1588950364364086,0.25301204819277107,1.0,1.0,8/27,16.75%,BRINP1;TMEM161A;RORB;RXRB;EPHA3;PTK7;TRIM16;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.67068497828881,1.158502231588376,0.30666666666666664,1.0,1.0,3/16,11.45%,SH3BP5;SRCIN1;ERRFI1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.7119503853456605,1.1584081846918821,0.26666666666666666,1.0,1.0,6/8,28.68%,DNM3;DNM1;PICALM;SNAP91;MX1;MX2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.7735842031736795,1.1583935944556292,0.26582278481012656,1.0,1.0,2/8,7.78%,NRXN1;AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6140498015729166,1.158349252066731,0.29347826086956524,1.0,1.0,4/36,8.42%,THBS1;ANXA1;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7500700723980692,1.1576679939892431,0.3384615384615385,1.0,1.0,3/7,15.84%,COBL;CLMP;PKD1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.7994096298740232,1.1575926945681987,0.2714285714285714,1.0,1.0,2/5,3.95%,CENPE;RIOK2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.6949571145718662,1.1573893471080434,0.3108108108108108,1.0,1.0,1/8,2.85%,NRG1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.4905808828720415,-1.1573794496412255,0.23076923076923078,0.9540164602527362,1.0,4/26,3.69%,STAT4;CALCR;FYN;NLRP1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7121387333832967,-1.1573231720905401,0.3,0.9519142410649203,1.0,4/7,11.28%,CYP2S1;HPGDS;ACOX1;PTGS1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.7501448829788233,1.1572708085304495,0.36363636363636365,1.0,1.0,2/6,14.95%,MAPT;PRELID1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.6435862122565665,1.1566688030883974,0.3373493975903614,1.0,1.0,3/14,10.19%,WBP11;SRSF12;WBP4
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.5826677666056111,-1.1564863370904432,0.26666666666666666,0.9524781869283597,1.0,3/10,6.16%,CCL5;IGF1;DOCK4
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7559012220765648,1.1564187281592462,0.2638888888888889,1.0,1.0,2/7,5.83%,CACNB2;SESTD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.7911742641945321,1.1563614942286935,0.2647058823529412,1.0,1.0,3/5,18.90%,CAV3;ATP2A2;FGF13
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.5700953881028213,1.1563525388751885,0.2247191011235955,1.0,1.0,18/55,22.13%,PRKCE;NUDT16;RACGAP1;CIT;SVIL;INSR;DYNC1H1;XRCC3;CENPV;SPAST;E2F7;RGCC;PKP4;UBXN2B;GPSM2;DBF4;CDC25B;WIZ
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6949516956573221,1.1562974857480592,0.2463768115942029,1.0,1.0,4/9,13.02%,RYR2;KCNMB1;CALM3;SYT1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6768518950119679,1.1561557849789934,0.3614457831325301,1.0,1.0,2/17,5.47%,LRP4;BMPR1B
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.678657362977877,1.156148310714956,0.2702702702702703,1.0,1.0,5/10,23.64%,RYR2;PKP2;ATP1B2;CACNA1C;ATP1A2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.5767285815043438,1.1559824777148715,0.25274725274725274,1.0,1.0,8/44,20.89%,FGF1;FLRT1;RBFOX2;FLRT2;HNRNPH1;POLR2D;FIBP;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5585560866872477,1.1559309187514257,0.3076923076923077,1.0,1.0,16/62,16.75%,THBS1;KLF4;RHOB;FGF1;VEGFA;CHI3L1;HIF1A;RAPGEF3;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;PKM;GAB1;WNT5A
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.5820686088739507,1.1558618513029264,0.2696629213483146,1.0,1.0,11/45,12.08%,LRP4;COL4A5;ENAH;LAMB1;MTCL1;GNA11;FHL1;RBFOX2;RND3;BOK;FIGN
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6386674404566663,1.1555870935917452,0.23255813953488372,1.0,1.0,6/31,8.23%,LRP2;PTPRD;IL1RAPL1;NRXN1;NLGN1;NLGN3
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.6596677967808157,1.1555683738869662,0.30434782608695654,1.0,1.0,3/14,19.25%,TTLL7;AGTPBP1;TPGS1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.560061454941594,1.1554712944781216,0.21649484536082475,1.0,1.0,22/72,23.48%,PRLR;TSHR;ACSL1;PLAC8;VEGFA;GRB10;INSR;KDM3A;KDM1A;IGF1R;DYNC1H1;FASN;SCD;PEMT;ESRRG;KDM6B;IL18;TNF;ACACB;MFN2;EPAS1;LEPR
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5593172114342977,-1.1554319891210207,0.21739130434782608,0.9541751701546121,1.0,4/10,14.89%,IGF1;TGFB1;EP300;GTF2B
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7101524301754882,1.1552600401428155,0.3787878787878788,1.0,1.0,2/6,5.93%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.6199999343179595,1.1552543926684247,0.3048780487804878,1.0,1.0,9/26,27.52%,VIM;RPS27A;DYNC1H1;UBA52;UBB;DYNC1I1;ATG5;CFTR;DYNLL1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.660157940663312,1.1551156401782152,0.2714285714285714,1.0,1.0,1/10,0.29%,THBS1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.5403326228718841,1.154653539699183,0.1414141414141414,1.0,1.0,43/201,17.01%,RHOBTB3;P4HA3;RHOB;SHROOM3;ADAMTS2;TGFB2;GFAP;COL11A1;VIM;CORO6;MAPT;CLIP3;PPP1R9A;COL4A5;COL26A1;FIGNL1;COL23A1;CGNL1;COLGALT2;COL24A1;MARCKSL1;HDGFL3;STMN3;RND3;ERMN;RPS27A;CARMIL1;P4HA1;FIGN;DYNC1H1;SHROOM4;COL21A1;COL5A3;CKAP5;SPAST;STMN2;KATNAL2;COL10A1;TPPP;HOOK3;PLOD1;TGFBI;NEFL
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.5584136750969142,1.1545262611562759,0.23655913978494625,1.0,1.0,23/76,15.38%,ACVR1B;PTPRD;ACVR2A;LIFR;PTPRG;INSR;EPHA3;PTPRT;GP6;PTN;FGR;NTRK3;IGF1R;ALK;EPHA6;EPHA7;SHC2;FLT1;NTRK2;TYRO3;EPHA4;EPHA5;RASGRP4
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.40097812361622565,-1.1543080116715059,0.16666666666666666,0.9553606007972537,1.0,5/47,4.02%,CCL5;SKAP1;ITGAM;KARS1;LGALS9
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6580847193206392,1.1541930520171324,0.26744186046511625,1.0,1.0,4/18,10.90%,CHST7;VCAN;NCAN;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6822346674822783,1.1532620663231834,0.2564102564102564,1.0,1.0,5/11,16.40%,PTPRZ1;ID2;PTN;TNFRSF1B;SERPINE2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5711254266580904,1.1530125752754532,0.27058823529411763,1.0,1.0,16/45,18.37%,LRP4;ENAH;DZIP1;CDH2;LIFR;PTPRG;RBFOX2;TUSC3;MAP1B;NR2F1;FIGN;KIAA1549;ADGRL2;GLRB;HSPA12A;MPDZ
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5768017512823627,1.1527460865932977,0.27906976744186046,1.0,1.0,7/37,16.87%,TUB;IL15;SLC11A1;FCGR2B;FGR;ITGAV;PYCARD
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.7015291540019801,1.1527041954291468,0.32857142857142857,1.0,1.0,3/7,18.14%,BEGAIN;DLGAP1;DLGAP2
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6881195094326027,-1.152702851714199,0.30303030303030304,0.9575138363912563,1.0,4/5,24.45%,PLCG2;CD36;CYBA;RAB27A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5116472057695068,-1.1526237929171295,0.3181818181818182,0.9555846703247399,1.0,1/16,1.58%,DNMT3A
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6488142939854044,1.1525763809655327,0.25882352941176473,1.0,1.0,6/18,16.11%,OR3A2;PCDH15;NIPSNAP1;RETREG1;C5AR1;GNAL
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7075955782313628,1.1523903826865316,0.3287671232876712,1.0,1.0,5/9,8.23%,LRP4;NRXN1;NRXN2;NLGN1;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7788043121677741,-1.152358922504317,0.34615384615384615,0.954320817755208,1.0,3/6,13.32%,BTK;NCKAP1L;SYK
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.7131995571803861,1.1522559076614767,0.3333333333333333,1.0,1.0,2/8,17.72%,INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.7131995571803861,1.1522559076614767,0.3333333333333333,1.0,1.0,2/8,17.72%,INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.6204258038948656,1.1521426657784593,0.3176470588235294,1.0,1.0,9/30,19.39%,MAPT;SYT4;INSR;UNC13A;RIMS2;GHR;SYT1;PLCB1;MAP3K13
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6319856482711669,1.1520236622641888,0.2625,1.0,1.0,1/19,0.31%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6386293459235803,1.151343278988798,0.2948717948717949,1.0,1.0,6/17,26.93%,ABCA2;EPHA4;CASP3;PICALM;TNF;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.6778821054056556,1.1510579794173668,0.34285714285714286,1.0,1.0,4/13,17.72%,ASXL3;ABCA2;BRCA1;ERLIN1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.5871009208746711,1.1510228896662782,0.19767441860465115,1.0,1.0,7/43,7.16%,SLC51A;ASPN;PLIN2;CBR1;GULP1;CD55;DGAT1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5401532052649816,-1.1507080784546346,0.3333333333333333,0.9573032651823802,1.0,4/22,12.71%,FLNA;ZPR1;TGFB1;EFCAB7
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.7087413347392615,1.1506618826267516,0.3116883116883117,1.0,1.0,2/7,8.09%,AGT;ABCA2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5885416727907999,1.1503490885683325,0.25,1.0,1.0,4/27,9.94%,PTPRD;IL1RAPL1;NSMF;SS18L1
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.8088386501039377,1.149959306755816,0.2698412698412698,1.0,1.0,2/5,10.69%,ANK2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.5330643095189017,-1.1498168113089995,0.25,0.9581565675128597,1.0,1/16,0.20%,CCL5
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5873605070435426,-1.149632308437373,0.2413793103448276,0.9565851969260001,1.0,2/8,14.30%,TREM2;TIRAP
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.7197173279448993,1.1488142548344478,0.3188405797101449,1.0,1.0,1/6,0.55%,CLEC4E
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6782439840553229,1.148269375321026,0.2894736842105263,1.0,1.0,4/11,21.02%,PDK4;SLC9A7;SLC12A8;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.6519444616604002,-1.1480988930190668,0.3103448275862069,0.9570476367337832,1.0,3/8,12.08%,TRIM38;LGALS9;TRIM11
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.6519444616604002,-1.1480988930190668,0.3103448275862069,0.9570476367337832,1.0,3/8,12.08%,TRIM38;LGALS9;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5298729619086586,1.147999484815073,0.14,1.0,1.0,26/166,11.83%,THBS1;ACVR1B;FGF1;TGFB2;SEMA3A;ENPP2;PRKCE;GLIPR2;LAMB1;DOCK1;DOCK5;CEMIP;VEGFA;HSPA5;GPNMB;SEMA3B;NSMF;SEMA6A;INSR;HIF1A;FN1;FGR;CARMIL1;NTRK3;IGF1R;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.6826038913955919,1.147664020318641,0.32894736842105265,1.0,1.0,2/13,9.23%,KLF4;PAX8
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.7793518803754919,1.1475964152531295,0.36363636363636365,1.0,1.0,1/5,1.28%,SLC16A10
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.708564831072641,-1.1475825138426288,0.2413793103448276,0.9565683923761871,1.0,1/5,4.43%,SLC38A1
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.6469947873796404,-1.146786386685841,0.38461538461538464,0.9572290795470355,1.0,1/5,9.49%,TREM2
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.44221593107429186,-1.146766411915349,0.16666666666666666,0.9551869944173276,1.0,18/49,22.52%,CCND1;CSF1R;TP53;MED24;MED12;CBFB;AGO1;MECP2;MED4;MED1;MED27;MED30;ZNF45;MED10;MOV10;CDKN1A;MED23;RELA
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5744847064255368,1.1461842528900694,0.2988505747126437,1.0,1.0,16/51,14.70%,LRP4;ENAH;LAMB1;DOCK1;GNA11;LIFR;KITLG;PTPRG;RBFOX2;RND3;FN1;ERRFI1;FIGN;SH3D19;ADGRL2;UACA
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.7062903379999799,1.1461834274326355,0.3181818181818182,1.0,1.0,2/9,5.93%,IL15;VEGFA
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.6708372277452972,1.1460750076865824,0.3472222222222222,1.0,1.0,2/10,14.73%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.7392636421092049,1.1460611315409575,0.3013698630136986,1.0,1.0,3/5,19.57%,CYREN;TFIP11;ERCC6
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.5815521453829218,-1.1458412841710537,0.3684210526315789,0.9560926883717188,1.0,3/10,13.22%,ITPA;NT5C;GPX1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6093170354352359,1.1455241586643312,0.2926829268292683,1.0,1.0,9/21,17.65%,ERCC2;ANXA1;OVOL2;ST14;TXNIP;WNT5A;CASP3;CLIC4;UGCG
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.653076950019789,1.1454652838478345,0.3048780487804878,1.0,1.0,1/20,0.51%,HHIP
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5600183228327902,1.145221032161573,0.26373626373626374,1.0,1.0,22/71,23.89%,LRP2;KCNJ13;SCN3B;SLC5A9;SLC9B2;SCN3A;KCNMB1;SCN1A;SCN2A;SCN8A;KCNMA1;PIEZO2;KCNJ6;KCNB2;FGF13;KCNJ3;TAF7;TRPM7;SLC3A2;SLC5A6;ATP1A2;CHP1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.695610420876454,1.1447683833787194,0.3142857142857143,1.0,1.0,3/9,9.56%,NR4A1;VEGFA;ROBO1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.6284957426592324,1.1445104789697234,0.25882352941176473,1.0,1.0,3/24,12.52%,RHOB;ANXA1;IMPACT
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7089558797886494,1.1444973162916992,0.35714285714285715,1.0,1.0,1/8,5.93%,VEGFA
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5717271350755029,1.1444759461222525,0.2857142857142857,1.0,1.0,3/57,5.93%,PCSK1;MYRF;SRGN
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.6770902164440908,1.144182142757981,0.2926829268292683,1.0,1.0,3/10,12.42%,SHANK3;RELN;ADCY8
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6618750238485573,-1.1440904038452586,0.38235294117647056,0.9595900443877439,1.0,1/6,0.92%,RAB22A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5827665958466791,-1.14374611766222,0.23333333333333334,0.9581963900897551,1.0,1/10,0.43%,TGFBR3
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.6368268063980806,1.1435824658784488,0.2962962962962963,1.0,1.0,7/19,15.55%,SEMA3A;SEMA3B;SEMA6A;ROBO1;UNC5C;EPHA7;ITGAV
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.5970682142190188,-1.1435715906464101,0.3,0.9565354707354167,1.0,3/8,20.41%,MTHFD1L;AKT1;FPGS
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6231574892038981,-1.1435094528805625,0.35714285714285715,0.9547304286502717,1.0,1/7,9.64%,PJVK
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.5470224227351878,1.1434643545437935,0.2765957446808511,1.0,1.0,9/50,12.25%,LRP2;SLC2A3;TFRC;SLC1A2;SLC13A3;INSR;ABCA2;SLCO3A1;MFSD2A
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.5195747145243106,-1.143462747725939,0.24,0.952630929909429,1.0,10/22,18.26%,ABI3;NEK6;CGAS;ZKSCAN3;RSL1D1;NUAK1;TERF2;HMGA1;SLC30A10;YPEL3
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.5437846866995995,-1.143296577177943,0.3333333333333333,0.9510844037741424,1.0,1/15,0.20%,CCL5
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.7308821070311234,1.143284619025517,0.34285714285714286,1.0,1.0,3/7,18.70%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.6225473778913706,-1.1430482282167798,0.2692307692307692,0.9497557267389971,1.0,1/7,4.95%,PIK3C2B
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.7241990137490953,1.1430257551755973,0.36619718309859156,1.0,1.0,1/8,0.89%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.6220329710458651,-1.1429981028313663,0.34615384615384615,0.9476815610276684,1.0,2/9,0.22%,CCL5;SKAP1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.7197124373398489,1.1427586611705507,0.36231884057971014,1.0,1.0,3/7,12.91%,ADCY3;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.7197124373398489,1.1427586611705507,0.36231884057971014,1.0,1.0,3/7,12.91%,ADCY3;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.719777308853963,1.1424675627000502,0.3055555555555556,1.0,1.0,2/9,6.05%,TGFB2;CD55
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.7241092664342617,1.14241861185473,0.26865671641791045,1.0,1.0,1/8,8.09%,ABCA2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.549514930244787,1.1424013390149454,0.19791666666666666,1.0,1.0,27/88,21.30%,METRN;PTPRD;RELN;IL1RAPL1;ROBO2;EPHA3;PTK7;ZNF804A;ROBO1;SS18L1;PTN;CARMIL1;NTRK3;CAMK2B;NTRK2;MAGI2;LRRC7;STMN2;PLXNB1;WNT5A;NDRG4;PLXNC1;ARHGDIA;MAP3K13;FES;ATP1B2;DLG4
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.5881348819301427,-1.1422312443317788,0.3,0.9479559956619337,1.0,3/12,6.41%,FLNA;UBTF;PHF8
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.5152652356884995,-1.1420057388184093,0.2962962962962963,0.9466432345981926,1.0,4/16,8.99%,RALB;TICAM1;CGAS;TLR3
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5816181757528606,1.1418829653381875,0.2988505747126437,1.0,1.0,16/41,21.73%,LRP2;CTNND2;VEGFA;ANK2;ARNT2;LINGO1;GALNT18;SH3GL2;CRMP1;NTRK2;CPE;APP;STARD13;SPTBN4;SCG5;UCHL1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.7167200558844309,1.141565483924882,0.3472222222222222,1.0,1.0,2/7,10.66%,HIF1A;MCL1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.6708078657506114,1.1415374790380863,0.34285714285714286,1.0,1.0,2/14,2.25%,ASPA;FOLH1
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.6998122647073095,1.1413837089718677,0.3492063492063492,1.0,1.0,2/8,11.76%,EGR1;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.7658683294721595,1.141098608076151,0.296875,1.0,1.0,3/5,21.94%,IL15;ROCK1;IL18
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.6216810966813159,-1.1409500467146436,0.32558139534883723,0.9473069044131414,1.0,1/7,8.11%,HLA-E
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6513575425208354,-1.1408841570921442,0.3548387096774194,0.9454354145164329,1.0,3/5,19.30%,ABCC4;SLC19A1;LRRC8D
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.5561020744065783,1.1408604748481068,0.34444444444444444,1.0,1.0,10/50,15.99%,KMO;ASPA;CARNS1;FAH;GAD1;ACAT1;GLUL;ALDH6A1;BLMH;SLC25A21
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.779647103333458,1.140471367557292,0.35,1.0,1.0,2/5,12.98%,SRGN;ABCA1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.599524347224049,-1.14041868896679,0.2631578947368421,0.9444045263365285,1.0,1/5,2.33%,DHODH
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.7343959918334857,1.1401839968807228,0.32432432432432434,1.0,1.0,2/6,17.49%,VMP1;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.6078043661658972,1.140109216030724,0.2235294117647059,1.0,1.0,1/26,0.41%,KLF4
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7167406518032805,1.139874810614659,0.3287671232876712,1.0,1.0,5/8,22.59%,MID1IP1;PRKAG2;CPT1A;PRKAA2;ACACB
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.748372371916559,-1.139317153161341,0.28125,0.9458991839376977,1.0,2/5,20.06%,TYMS;DCTD
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7414298177607692,1.1390037851155352,0.2894736842105263,1.0,1.0,2/6,21.99%,PAICS;CTPS1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7159234223592889,1.1389773903253082,0.29850746268656714,1.0,1.0,1/6,0.29%,THBS1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5842477346314906,1.1389720687601035,0.24731182795698925,1.0,1.0,15/48,25.89%,NAMPT;PDK4;GRB10;INSR;IRS2;IGF1R;SORBS1;GAB1;SLC39A14;ATP6V0B;APPL1;ATP6V1D;ATP6V0E2;ATP6V1B2;AP3S1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.44756309555072904,-1.138958672475446,0.3,0.9446054950355559,1.0,2/48,0.20%,RNASEL;CCL5
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.7219514564495152,1.1388123719546237,0.3472222222222222,1.0,1.0,2/8,13.03%,CHST7;OGA
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6103158228209992,1.1387096805552162,0.3493975903614458,1.0,1.0,8/25,19.33%,ZBTB16;NFIB;CHI3L1;ITGB8;SULF2;SOX6;PKD1;SLC39A14
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6367190635370423,1.138142184905272,0.2840909090909091,1.0,1.0,4/18,9.93%,B4GAT1;SDF2L1;DPY19L2;TMTC2
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.6019390995029859,1.1380112721924713,0.3068181818181818,1.0,1.0,2/30,3.16%,HMGB2;H2BC11
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.4578404568768706,-1.13785489771833,0.3125,0.9468903546593921,1.0,1/15,1.07%,NDE1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.6623034823690693,1.1377631578914085,0.34523809523809523,1.0,1.0,3/11,23.48%,PRKAG2;GFPT1;LEPR
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.7345664126393974,-1.137605894498277,0.39473684210526316,0.945894807019522,1.0,1/5,1.07%,CX3CR1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7469182251615997,1.1374456960443413,0.38666666666666666,1.0,1.0,3/6,23.04%,ROBO2;PKD1;FGFR2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.6045927206664878,1.1371457885256901,0.27058823529411763,1.0,1.0,9/44,14.64%,HTR2B;PPP1R9A;NUDT4;AGT;EIF2AK3;RYR2;CHRM3;GUCY1B1;MCTP1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6347391748432095,1.1369802798614477,0.2967032967032967,1.0,1.0,8/24,20.52%,MAPT;CAV3;CKAP5;CDK5R1;TOGARAM1;DCTN1;HSPA1B;FES
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7183112123710984,1.1369273366336259,0.2753623188405797,1.0,1.0,4/5,23.00%,ANK3;CNTNAP2;CNTN2;CNTNAP1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.6428675553303018,1.1364388000854344,0.2911392405063291,1.0,1.0,5/18,20.52%,DMD;ANK3;ANK2;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.6399415412579956,1.1362704676825068,0.2625,1.0,1.0,3/16,8.56%,SCN3B;DMD;RYR2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5786069856731741,1.1360541645868314,0.29545454545454547,1.0,1.0,4/30,10.36%,DDIT4;HINT1;ZNF385B;BOK
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5725966162348642,1.1360361763690412,0.25263157894736843,1.0,1.0,11/56,14.56%,ARRDC3;BMI1;SEPTIN4;FANCM;KDM1A;FANCI;PRICKLE1;RBX1;PINK1;RIPK2;BRCA1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.645262068799911,1.1356879346731419,0.32051282051282054,1.0,1.0,5/20,8.32%,TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.747594422983932,1.135504577319163,0.35384615384615387,1.0,1.0,2/5,6.84%,CLIP3;ANK3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.6715906228076595,1.1354808240663006,0.2727272727272727,1.0,1.0,4/10,20.91%,HIF1A;NR4A3;PINK1;FBXO7
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6394596150760374,1.135293026103141,0.3116883116883117,1.0,1.0,6/14,16.87%,NLRP12;BEX3;EPHA7;GRIN2B;AIM2;PYCARD
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.7135278187364148,1.1352102696556543,0.3918918918918919,1.0,1.0,6/7,28.68%,DNM3;DNM1;PICALM;SNAP91;MX1;MX2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6618338315288301,1.1351987291435703,0.2597402597402597,1.0,1.0,2/15,8.42%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7933815352233569,1.1351560957911584,0.2923076923076923,1.0,1.0,2/6,12.19%,SEMA3A;UNC5C
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.5450677735372673,1.1349150442441462,0.27956989247311825,1.0,1.0,9/51,12.25%,LRP2;SLC2A3;TFRC;SLC1A2;SLC13A3;INSR;ABCA2;SLCO3A1;MFSD2A
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7199071557976542,1.1345858549830745,0.375,1.0,1.0,2/8,13.71%,VEGFA;ZSWIM4
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.653708202855932,1.1345661601754087,0.3493975903614458,1.0,1.0,3/13,15.84%,VEGFA;PAX8;PKD1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.626784771923766,1.134563300060646,0.30864197530864196,1.0,1.0,5/26,11.83%,THBS1;VEGFA;PTN;NTRK3;SEMA5A
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5644414980156804,1.1344465258200214,0.25274725274725274,1.0,1.0,2/47,3.97%,ACVR1B;CIT
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.7546474175231577,1.1341331103491283,0.3492063492063492,1.0,1.0,3/5,21.02%,PDK4;SLC9A7;SLC9A1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.4911781148705943,-1.1340639483498183,0.25,0.954546109198796,1.0,7/20,20.78%,PEX13;PEX16;FIS1;ABCD3;PEX2;ACBD5;SLC25A17
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7674739010584288,1.1339780315508967,0.35294117647058826,1.0,1.0,2/5,12.80%,PER1;LMO3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.6162453952292964,1.133777341176008,0.3125,1.0,1.0,5/22,7.62%,THBS1;KLF4;FGF1;VEGFA;SEMA6A
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.6424642397971134,-1.133769756756981,0.36666666666666664,0.9532154725724187,1.0,2/6,4.05%,LY86;SCIMP
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.8023973037582991,1.1337311071093523,0.3225806451612903,1.0,1.0,2/5,14.30%,PAICS;PRPS1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5728466370918693,-1.1337099422873504,0.2608695652173913,0.951276007562401,1.0,4/18,9.39%,NPC1;OSBPL6;ACAA1;CH25H
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.4880090208772423,-1.1332861560739225,0.25,0.9504548103444734,1.0,2/17,2.07%,SETD6;FBL
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.6830801620252754,1.1332818257738113,0.32432432432432434,1.0,1.0,4/10,25.74%,IL7;IRS2;BRWD1;IL7R
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.6830801620252754,1.1332818257738113,0.32432432432432434,1.0,1.0,4/10,25.74%,IL7;IRS2;BRWD1;IL7R
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.748127618412009,1.1326770792904268,0.32432432432432434,1.0,1.0,4/7,22.31%,DGAT1;MFSD2A;ACSL3;P4HB
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.741968267897779,1.1326159770381299,0.3194444444444444,1.0,1.0,1/5,7.02%,FCGR2B
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.7336920253920687,1.1325086134084024,0.41818181818181815,1.0,1.0,3/5,13.58%,MYRF;PLP1;B4GALT5
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6787463630427454,1.1323889483968874,0.375,1.0,1.0,1/10,5.94%,IHO1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6351307681290528,-1.1323758195681168,0.2692307692307692,0.9511816959199582,1.0,2/7,3.97%,ATRAID;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6547287812008764,1.132140171332896,0.3375,1.0,1.0,4/11,11.83%,SEMA3A;SEMA3B;SEMA6A;SEMA5A
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.6991052587735707,1.1320586204682115,0.35714285714285715,1.0,1.0,5/9,21.27%,UCKL1;DCK;HPRT1;UPP2;UCK2
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.6485641495966827,-1.1317514478373847,0.3870967741935484,0.9489991104802287,1.0,2/9,13.50%,MMAA;MMAB
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.6485641495966827,-1.1317514478373847,0.3870967741935484,0.9489991104802287,1.0,2/9,13.50%,MMAA;MMAB
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5986917657859917,1.1316908251800641,0.313953488372093,1.0,1.0,7/23,18.27%,NR4A1;ANXA1;VEGFA;SEMA6A;FLT1;GAB1;HSPB1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.7248021907355375,1.1312793398333532,0.2923076923076923,1.0,1.0,3/6,24.16%,RBX1;SASH1;LRRK2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.6552223431341078,1.131164495323459,0.3291139240506329,1.0,1.0,5/20,9.87%,LRP4;CACNB2;ANK3;UNC13A;PPFIBP1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6402008522067547,1.1306404232599236,0.2898550724637681,1.0,1.0,3/15,9.97%,ZBTB16;MEIS2;MAFB
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6494143184530752,1.1304485307735654,0.3,1.0,1.0,7/19,16.58%,DMD;VEGFA;ANK2;CAV3;KDM1A;SGCZ;NEBL
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6457786720149848,1.129964080796075,0.2988505747126437,1.0,1.0,9/14,17.24%,NRXN1;NCAM2;NRXN2;NLGN1;NRXN3;NLGN3;ASTN2;CDK5R1;NINJ2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7426579897253232,1.129806956755504,0.3116883116883117,1.0,1.0,2/7,7.50%,GALNTL6;GALNT13
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.6148704040737454,1.1294318511430455,0.3176470588235294,1.0,1.0,2/19,13.14%,MAPT;DYNC1H1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5518255229569943,1.129074936409119,0.25263157894736843,1.0,1.0,16/64,16.82%,COBL;RELN;ZDHHC15;EPHA3;PTK7;ZNF804A;PTN;NTRK3;ALK;CAMK2B;NTRK2;MAGI2;LRRC7;STMN2;WNT5A;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.666046749028645,1.1289753379173433,0.3170731707317073,1.0,1.0,5/13,22.80%,CR1;CD55;CD300A;SLAMF8;APPL1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.552369934012861,1.1288570138023588,0.30526315789473685,1.0,1.0,20/83,18.49%,HTR2B;TGFB2;SH3PXD2B;LDB3;MMP21;VEGFA;SOX4;INSR;PKP2;POU6F1;ID2;FN1;NTRK3;SGCZ;PKD1;FLRT2;NDRG4;TBX19;CACYBP;CDKN1B
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.6227530419515181,1.1288035547965038,0.3132530120481928,1.0,1.0,5/23,8.56%,HTR2B;TGFB2;VEGFA;INSR;RYR2
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.5779476630711438,-1.1287034914970724,0.2916666666666667,0.9562966137247226,1.0,2/12,3.57%,CCL5;FOLR2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.524564129295816,1.128493964037337,0.26,1.0,1.0,39/120,24.29%,SHANK3;OMG;GPM6A;MAPT;PPP1R9A;GPM6B;LAMB1;MANF;PQBP1;CTNND2;NYAP2;NLGN1;HDGFL3;STMN3;MAP2;MICALL2;CNTNAP2;PLP1;TMEM108;SH3GL2;SLC9A6;EPHA4;STMN2;PLXNB1;RASGRF1;CDK5R1;GRM7;APP;ROCK1;ERCC6;NCDN;UBB;DLG4;PAK3;UHMK1;CNTNAP1;DCLK1;LRRK2;CTTN
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5749250151533428,1.128462008029421,0.23076923076923078,1.0,1.0,17/39,27.27%,KCNJ13;SLC24A2;SLC9A7;SLC24A1;SLC9A6;SLC12A8;SLC39A12;ATP1B3;KCNJ6;KCNJ3;SLC39A14;ATP1B2;SLC9A1;ATP1A2;SLC6A1;ATP2B4;SLC39A6
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.6139341561445918,1.128321287689982,0.27058823529411763,1.0,1.0,5/21,5.13%,FAAH;CBR1;FAAH2;ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.6545553488163778,1.127822050721828,0.3333333333333333,1.0,1.0,2/14,4.08%,HTR2B;AGT
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.5229497120581764,1.127798797668748,0.24242424242424243,1.0,1.0,24/190,10.04%,THBS1;CENPF;RHOB;CKS2;TGFB2;DTL;SPATA22;TBRG4;RPL23;CCPG1;PPP2R3B;GADD45B;BRINP1;NR4A1;WDR12;ALOX15B;PTPRK;MASTL;FIGNL1;PES1;CAMK2N1;HCFC1;ID2;BEX2
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.4128628132344916,-1.127749994330172,0.23076923076923078,0.9568312632283381,1.0,7/41,7.61%,CARD14;LRP10;DENND1C;ABHD11;SSH3;LLGL2;NBEAL2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5202081486018282,1.1275330571377553,0.21,1.0,1.0,30/127,23.34%,KLF4;RBMS3;TGFB2;MAPT;VEGFA;NOCT;OVOL2;HIF1A;ID2;ROBO1;CCDC3;ITGB8;SH3GL2;HINFP;PINK1;PICALM;SDCBP;SLC24A3;ESR1;APP;FOXP1;AP1AR;OLFM1;PRKAA2;MSR1;DLG4;TNF;NOTCH2;RBL2;FLOT2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.5526579905808364,1.1274328550423336,0.2727272727272727,1.0,1.0,8/55,12.44%,PLPP3;FZD6;NR4A2;TCF7;TCF7L1;RPS27A;CELSR2;RBX1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.5611629614651453,1.1269059754606423,0.30851063829787234,1.0,1.0,13/62,17.20%,PRLR;TSHR;ACSL1;PLAC8;VEGFA;GRB10;KDM3A;KDM1A;IGF1R;DYNC1H1;SCD;PEMT;ESRRG
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5221056616886922,1.1268833434105554,0.16,1.0,1.0,52/256,18.35%,DDIT4;NAMPT;FGF1;PRLR;FLRT1;NRG1;DOCK1;PDK4;PTPRG;VEGFA;GRB10;EIF2AK3;RBFOX2;SIPA1L1;INSR;EPHA3;CHN1;NGEF;PTPRT;IRS2;GHR;FGR;NTRK3;IGF1R;ALK;EPHA6;SULF2;DNM1;KALRN;EPHA7;SHC2;FLT1;SORBS1;NR4A3;NTRK2;ANKS1B;TYRO3;EPHA4;EPHA5;GRIN2B;RASGRP4;ITGAV;ITSN1;FLRT2;GAB1;ANGPT2;CASP3;SDCBP;CDK5R1;PLCB1;HNRNPH1;POLR2D
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.7144679513281542,1.12682661094855,0.3287671232876712,1.0,1.0,1/6,4.50%,ENTPD3
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7624846449987568,1.1265879693807446,0.25806451612903225,1.0,1.0,4/5,20.23%,NLGN1;NR4A3;SGIP1;NPAS2
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.6066593254684621,-1.1259493824407536,0.36,0.9599869171015449,1.0,2/6,8.82%,KRT10;MAFG
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.8010556572244951,1.125667030821466,0.36231884057971014,1.0,1.0,1/5,2.26%,RPL23
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.5376869649692732,1.1233165864164714,0.25,1.0,1.0,15/47,22.45%,LRP4;TGFB2;MYOT;MAPT;CTNND2;NLGN3;PPFIBP1;PPFIA2;CBLN2;VMP1;APP;PPFIA4;APBB2;PAK3;NLGN4X
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.44048087540514247,-1.1228661251540781,0.375,0.9664370394502874,1.0,8/28,11.30%,CCL5;CYP19A1;IL1B;HLCS;TLR3;TGFB1;GGT7;ARL6IP5
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.4193567363389968,-1.122781026589485,0.2857142857142857,0.9647362902321223,1.0,7/33,12.23%,LAMTOR1;CLEC16A;TELO2;TREM2;NCKAP1L;MIOS;PIH1D1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5863184759898123,1.1227380164292426,0.25,1.0,1.0,3/34,3.82%,AANAT;DTL;ERCC2
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.7309045619779833,1.122636276888657,0.3561643835616438,1.0,1.0,3/8,14.11%,VIM;NOD2;RIPK2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.6639041202215096,1.12257091115349,0.379746835443038,1.0,1.0,2/13,1.60%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.7347880108020818,1.122377811146445,0.35384615384615387,1.0,1.0,3/5,22.46%,EPHA4;RTN4RL1;PTPRS
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5619223218931133,1.1222995284911887,0.3411764705882353,1.0,1.0,6/34,11.09%,HSPA5;NDRG2;CALM3;CKB;CASP5;PLP1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7558381394888499,1.1221262096067133,0.4090909090909091,1.0,1.0,3/5,16.40%,ID2;EPHA4;SERPINE2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5514663843774581,-1.121986955600838,0.3333333333333333,0.9650764338896668,1.0,1/10,0.28%,SNAP47
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.6662860049338049,1.1219391066655702,0.43661971830985913,1.0,1.0,4/11,13.58%,MAPT;MAP2;NTRK2;B4GALT5
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6488698521150622,1.1214838728230199,0.30666666666666664,1.0,1.0,4/11,21.80%,INTS12;TRNT1;INTS8;INTS6
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.6829199268278601,-1.121304332941218,0.46153846153846156,0.9651578933149361,1.0,4/5,29.67%,SUPT6H;MTHFR;SUPV3L1;HDAC2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.6786764981066795,1.1210069807804388,0.3918918918918919,1.0,1.0,2/10,12.25%,ACSL1;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.6085940525884641,1.1208568913327321,0.38271604938271603,1.0,1.0,2/15,5.28%,TGFB2;ACVR2A
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.6684693236472414,1.1202641896639591,0.34782608695652173,1.0,1.0,2/7,16.75%,ARIH2;WNT5A
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.6774371982313327,-1.1198812073280693,0.3448275862068966,0.9672639424111422,1.0,1/6,6.43%,PLEKHM2
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.6327062030510618,-1.1197981672509594,0.36363636363636365,0.9653766913753594,1.0,2/7,15.95%,CLEC16A;CARD11
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5182996737966743,1.119757605384547,0.21649484536082475,1.0,1.0,27/127,19.00%,HHIP;NLRP12;RGS20;MFNG;LIFR;CD55;CDKN2AIP;KCTD8;RGS2;OVOL2;FRRS1L;GLRX2;TCF7L1;TRIM5;CAV3;GSKIP;TMEM108;SEMA5A;TULP3;RGS11;RASGRP4;PLCB1;UGCG;ESR1;GRK4;MAPK8IP2;APP
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.638240497172145,-1.1197462656450021,0.41935483870967744,0.96346905500937,1.0,2/9,4.84%,LILRB4;IL4I1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7013268105689097,1.119735728516026,0.33766233766233766,1.0,1.0,4/9,20.52%,DMD;ANK3;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6031017394140459,1.1194610676956105,0.3,1.0,1.0,4/22,10.73%,HS3ST5;TRIM5;TRIM25;IFITM3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7310646935873564,1.1193847333132438,0.35294117647058826,1.0,1.0,3/5,20.67%,TNFRSF1B;RGCC;TNFRSF1A
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6654343347683782,1.1186132255317938,0.3333333333333333,1.0,1.0,3/13,14.18%,WASF1;CSPG5;SLIRP
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.5719879642512472,1.1183408149746465,0.30434782608695654,1.0,1.0,4/38,9.56%,GPR18;IRS2;GPR65;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6609995366955718,1.1183168365610505,0.34177215189873417,1.0,1.0,3/14,13.99%,DDIT4;CALM3;PARD3
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.6492481800045671,1.1181745171167436,0.3614457831325301,1.0,1.0,1/13,0.37%,GDPD1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.546995741308665,1.118141537714933,0.30851063829787234,1.0,1.0,16/55,19.82%,RAP1GAP;TDG;SIPA1L1;EPHA3;CHN1;STMN3;NGEF;TBC1D15;NTRK2;EPHA4;EPHA5;PLXNB1;FGD6;SOD1;PLXNC1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.7372589592298386,1.118124507608044,0.36507936507936506,1.0,1.0,2/6,16.75%,VEGFA;WNT5A
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.4441762567399914,-1.1180619264342182,0.13333333333333333,0.9665004821707877,1.0,6/42,7.56%,CCL5;PDE12;GBP3;LGALS9;SIRPA;DAPK3
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.627827217622513,1.117716376649551,0.3246753246753247,1.0,1.0,4/19,8.66%,BRINP1;RORB;EPHA3;PTK7
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.6609461958823649,1.1176774953173443,0.3411764705882353,1.0,1.0,4/12,11.60%,ASXL3;PPP2R5A;CCDC3;ALK
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5785067991894219,-1.1176398626709871,0.34615384615384615,0.9655317448274187,1.0,3/8,18.60%,TMEM119;BHLHE41;HDAC5
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5616141347765601,1.1175800610121038,0.35106382978723405,1.0,1.0,14/47,17.99%,PLPP3;SVEP1;PRLR;LIFR;LAMA2;MAFB;SH3D19;SASH1;MLANA;COL21A1;ESRRG;ALDH1A1;TIMP3;CPE
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.5482009279183754,1.1172785514135415,0.2916666666666667,1.0,1.0,20/71,19.80%,CENPF;LRP2;ARRDC3;SLCO1A2;SLC19A2;ABCA2;FLVCR1;TXNIP;MFSD2A;SLC35F3;ABCA1;PLTP;LRP1B;SCAMP3;ABCA5;DISP1;PEX3;KIF3A;ARRDC2;NME4
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5441868449522049,1.117198634296906,0.3372093023255814,1.0,1.0,7/37,11.27%,PTPRD;IL1RAPL1;DOCK1;DOCK5;SS18L1;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6304784657626572,1.1170434098219986,0.37349397590361444,1.0,1.0,6/19,11.83%,SEMA3A;SEMA3B;SEMA6A;MAP2;MAG;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.6868602489637199,1.1169055357203777,0.4117647058823529,1.0,1.0,1/10,0.41%,KLF4
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.5938377192631826,1.1166784353099255,0.3582089552238806,1.0,1.0,4/15,19.35%,SELENOI;PNPLA8;NAPEPLD;ETNPPL
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6850787581499536,1.1166284725700648,0.3333333333333333,1.0,1.0,3/11,13.54%,LIPE;AGPS;NCEH1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7452562759822389,1.116519300259138,0.3382352941176471,1.0,1.0,3/5,22.46%,DCC;FGF13;PTPRS
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.7110580667305098,1.1157212879005094,0.31343283582089554,1.0,1.0,1/8,2.58%,GLA
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.5366217807846019,1.115607208217034,0.19387755102040816,1.0,1.0,41/128,25.46%,KCNE1;SCN3B;SLC6A15;SLC24A2;KCNH8;SLC11A1;SCN3A;KCNH7;KCNH5;SLC9A7;TRPC4;SCN1A;SLC24A1;SLC9A6;NALCN;RYR3;HCN1;ITGAV;PKD1;SCN2A;SCN8A;ASIC2;ATP1B3;SLC24A3;ATP2A2;KCNB2;SLC39A14;TMEM175;SLC9A1;TRPM7;KCNQ5;SLC24A4;CACNA1C;ATP1A2;KCNQ2;ATP6V0E2;KCNC2;KCNK10;CACNA1A;TRPC1;KCNB1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5661165998695765,1.1155112421280595,0.3111111111111111,1.0,1.0,14/39,22.46%,SEMA3A;DCC;SPOCK1;PAQR3;KANK1;MAG;CRMP1;EPHA4;GRIN2B;STMN2;DENND5A;PTPN9;RTN4RL1;PTPRS
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.675157621439408,1.11542813287755,0.3380281690140845,1.0,1.0,6/7,29.25%,GABRA2;GABRB2;GABRA4;GABRG2;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5689783078463098,-1.1150915455283683,0.2222222222222222,0.9707189228031243,1.0,1/12,0.62%,SMPD3
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.648099357947175,1.1150450939708314,0.3424657534246575,1.0,1.0,2/14,10.36%,FCGR2B;BOK
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4769299124059548,-1.1147501603801668,0.35294117647058826,0.9699425033171163,1.0,8/23,16.97%,GZMB;TP53;PPP1R13B;BID;PPP3CC;CHCHD10;BCL2;CASP8
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6734741879790148,1.1146243673330298,0.3924050632911392,1.0,1.0,3/13,16.85%,ARF6;STMN3;RASGRF1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.5480111825993471,1.1144785953385772,0.26136363636363635,1.0,1.0,17/48,31.28%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;ACAD9;NDUFB6;TIMMDC1;NDUFAF4;DMAC1;ECSIT;NDUFS5;NDUFV1;NDUFAF1;TMEM126A;NDUFS7;NDUFA1;NDUFA10
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.5480111825993471,1.1144785953385772,0.26136363636363635,1.0,1.0,17/48,31.28%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;ACAD9;NDUFB6;TIMMDC1;NDUFAF4;DMAC1;ECSIT;NDUFS5;NDUFV1;NDUFAF1;TMEM126A;NDUFS7;NDUFA1;NDUFA10
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.6353512989079249,1.1141284697440383,0.358974358974359,1.0,1.0,4/18,16.75%,AGT;BMI1;FN1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.44515429205643764,-1.1140261250895374,0.21428571428571427,0.9700404716662703,1.0,5/26,10.92%,SKAP1;MAP4K4;RIN2;PPM1F;ABL1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.6710049409031634,1.113546594981725,0.33766233766233766,1.0,1.0,3/9,15.13%,DGKI;DGKB;DGKG
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.6394063192104529,1.1135065162854056,0.4177215189873418,1.0,1.0,7/18,24.51%,OIP5;CENPP;CENPI;CENPK;CENPT;ITGB3BP;NASP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.6394063192104529,1.1135065162854056,0.4177215189873418,1.0,1.0,7/18,24.51%,OIP5;CENPP;CENPI;CENPK;CENPT;ITGB3BP;NASP
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.7410897617654358,1.1134237701354714,0.3611111111111111,1.0,1.0,3/7,12.52%,NLRP12;ERRFI1;IMPACT
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.5745066681854717,1.1133614442014879,0.3448275862068966,1.0,1.0,6/33,10.38%,FBN2;GPM6B;ACVR2A;BMPR1B;SRGN;PTN
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.6441591092878733,-1.1133164222840441,0.23529411764705882,0.9700819454202547,1.0,4/6,15.49%,SH2B3;ZNF385A;SRC;MED1
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),0.7902853448285475,1.1128954897462477,0.4189189189189189,1.0,1.0,1/5,0.74%,LRP2
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.6721424486098215,1.112813090206921,0.4,1.0,1.0,6/12,22.40%,SYNE3;DYNC1H1;CLMN;HOOK3;DCTN1;SUN2
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.6843224133481672,1.1126102485680922,0.3116883116883117,1.0,1.0,4/10,16.11%,OR3A2;ADCY3;C5AR1;GNAL
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6236193471313309,1.1124603160820858,0.3670886075949367,1.0,1.0,1/16,0.53%,NFIL3
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.43486823307801714,-1.1124351421533907,0.2857142857142857,0.9707388771024129,1.0,10/45,10.86%,CYB5A;FOLR2;SLC46A1;MMAA;MTHFD2L;HLCS;MTHFD1L;CYB5R3;SLC19A1;ENPP1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6733568356706973,1.111535351950696,0.4125,1.0,1.0,3/9,25.75%,ADCY8;C2CD2L;CFTR
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6250790337909781,1.1115252858736924,0.32051282051282054,1.0,1.0,4/19,14.46%,TGFB2;CGNL1;SPRY1;FBP1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.6546465471054181,1.1115012791845402,0.3253012048192771,1.0,1.0,7/10,29.09%,RPS27A;UBA52;UBB;PGK1;ENO1;MRC1;TLR2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6009853585587974,1.111324515792846,0.37777777777777777,1.0,1.0,3/31,5.47%,LRP2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.5673153297421666,1.1110596203160064,0.29347826086956524,1.0,1.0,4/47,5.52%,RHOB;MAPT;ANXA1;PTPRK
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7348168549939127,1.1109479464680607,0.3,1.0,1.0,2/8,8.53%,PIGU;PTPRT
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.5363365591209439,-1.1106785945613415,0.2727272727272727,0.9744089472758324,1.0,2/11,9.89%,POLD3;TYMS
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.6503673626673627,1.1105051484008936,0.34177215189873417,1.0,1.0,1/14,0.32%,HTR2B
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.6174221630039892,1.1103972626927272,0.3333333333333333,1.0,1.0,6/28,14.71%,HTR2B;SEMA3A;SEMA3B;SEMA6A;SEMA5A;CENPV
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5460686046348868,1.110350423148799,0.25,1.0,1.0,8/63,6.33%,HHIP;SVEP1;OGN;TNS1;FBXL7;DAAM2;VASN;LAMA2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.5361666874906413,1.1101938311008215,0.2653061224489796,1.0,1.0,18/101,13.66%,KLF4;LRP2;ACVR1B;KNSTRN;MAPT;NR4A1;ACVR2A;ANXA1;BMPR1B;VEGFA;SEMA6A;OVOL2;PDE2A;NTRK3;FLT1;NTRK2;MAGI2;SOX6
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.545800144958378,-1.1101269896506176,0.35294117647058826,0.9740787943617815,1.0,6/15,22.88%,HPS4;LYST;RAB29;BLOC1S2;RAB32;PIKFYVE
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.7281413548550393,1.1099323013318132,0.27586206896551724,1.0,1.0,1/6,12.11%,NOD2
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7157342489777974,1.1098812734294157,0.3939393939393939,1.0,1.0,2/5,21.61%,CRYL1;SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7157342489777974,1.1098812734294157,0.3939393939393939,1.0,1.0,2/5,21.61%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7157342489777974,1.1098812734294157,0.3939393939393939,1.0,1.0,2/5,21.61%,CRYL1;SORD
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.7280128403106412,-1.1094532169484765,0.5,0.9740559101055595,1.0,1/5,1.19%,CALCR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.6674884343461384,-1.1092984636293444,0.375,0.9723958105073847,1.0,1/5,9.94%,ENG
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5884772139362067,1.1091455686239908,0.32941176470588235,1.0,1.0,6/25,16.35%,DGKI;DGAT1;DGKB;CAV3;DGKG;GK
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6257939111591629,1.1090429391875358,0.35526315789473684,1.0,1.0,6/19,17.01%,IDI1;TM7SF2;MVD;FDFT1;HMGCS1;INSIG1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.6349106764053875,-1.1087760594842337,0.4166666666666667,0.9720441826511219,1.0,1/5,4.12%,APPL2
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.668262586088527,-1.108307337374755,0.4444444444444444,0.9713070989257026,1.0,4/6,22.22%,NCKAP1L;AKT1;FAS;PPP2R3C
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4633736000200975,-1.1083046252104427,0.2777777777777778,0.9693319832425544,1.0,5/22,13.39%,ZMYND11;SUPT16H;THOC5;HTATSF1;KAT7
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6650511095994898,1.1082339994757393,0.4025974025974026,1.0,1.0,2/11,6.84%,DMD;ANK3
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.612166723390478,-1.1082182970084442,0.37037037037037035,0.9675301313185826,1.0,3/8,8.80%,ATRAID;HPSE;TMEM119
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6293805614058611,1.1081361075138803,0.3880597014925373,1.0,1.0,6/13,30.95%,NUP133;SEH1L;NDC1;RTN4;AHCTF1;NUP153
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.5776994056786381,1.108009996359275,0.38095238095238093,1.0,1.0,8/25,24.51%,OIP5;CENPP;CENPI;ACTR6;CENPK;CENPT;ITGB3BP;NASP
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.689053076361863,1.10781045765952,0.4,1.0,1.0,2/7,5.37%,SLC2A3;SLC2A9
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.475102793669816,-1.1077097264556934,0.3333333333333333,0.9671913827038265,1.0,3/25,12.30%,PKIB;MAP3K4;NBN
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.518981859580514,1.107690094217845,0.32323232323232326,1.0,1.0,25/83,20.52%,GPM6A;MAPT;PPP1R9A;GPM6B;LAMB1;MANF;PQBP1;NLGN1;HDGFL3;STMN3;MAP2;MICALL2;CNTNAP2;PLP1;CARMIL1;TMEM108;SH3GL2;STMN2;RASGRF1;CDK5R1;APP;ROCK1;ERCC6;NCDN;ATP1B2
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7220470669420016,-1.1076100600418124,0.42857142857142855,0.9654287117163004,1.0,3/5,16.94%,MMAA;PCCB;MCEE
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6927507048656759,1.107371910108374,0.37333333333333335,1.0,1.0,1/8,5.82%,DAAM2
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.7515497965343877,1.1073317267282374,0.423728813559322,1.0,1.0,2/5,18.70%,E2F7;SOD1
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),0.6925517619918162,1.1072582022870041,0.35294117647058826,1.0,1.0,1/7,7.02%,FCGR2B
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6628822069905657,1.1071557072571578,0.30952380952380953,1.0,1.0,3/13,7.78%,FBN2;VEGFA;AGTPBP1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.7905876384328938,1.1068447804179504,0.3125,1.0,1.0,3/5,20.18%,MAPT;TPPP;PRKAA2
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.6613137928642632,1.1063093044524637,0.36231884057971014,1.0,1.0,5/8,31.26%,DGKB;DGKG;DGKZ;PIP5K1A;DGKQ
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.5766765715260931,1.1062049277620467,0.36666666666666664,1.0,1.0,12/25,30.03%,ANXA1;ANK2;RYR2;GLRX2;UGCG;GRK4;IGFBP7;SCG5;MTCH1;CDC42SE2;PTPN1;TYMP
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5617075819001682,1.1061029887516856,0.3563218390804598,1.0,1.0,5/32,9.97%,ACVR1B;HMGB2;ACVR2A;HIF1A;MAFB
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6673232069376458,1.106091497253034,0.4,1.0,1.0,5/9,17.01%,MAPT;SYBU;HIF1A;SPAST;NEFL
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6721326711970588,1.1060782503738527,0.3815789473684211,1.0,1.0,2/9,4.97%,AGT;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.5110472560859891,-1.105803645199843,0.2727272727272727,0.9690345885638546,1.0,3/14,14.41%,EGFL7;EGFR;AKT1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7105994712592127,1.1056099008423703,0.3466666666666667,1.0,1.0,3/8,17.13%,ABCA2;BACE2;NECAB1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.4987071597332876,1.1052016789977805,0.15,1.0,1.0,65/336,17.09%,THBS1;HTR2B;NAMPT;TUB;FGF1;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;NRG1;MAPT;TBC1D8;IL15;OSMR;MYRF;FRMD5;MEIS2;BMPR1B;LIFR;KITLG;VEGFA;CDKN2AIP;SOX4;SPDYA;SHANK2;IER5;MVD;SLC11A1;FCGR2B;IL7;AKAP6;INSR;PPP1R13L;HCFC1;RYR2;IRS2;FN1;RPS6;PTN;NTRK3;IGF1R;MFSD2A;FLT1;DYNC1H1;CRLF1;NTRK2;FASN;NSMCE1;PARD3;CIDEB;RIPK2;EPHA4;HCLS1;TNFRSF1B;ITGAV;TPPP;IL11RA;RPS4X;EPB41L4B;WNT5A;PYCARD;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6238342127921677,1.1050594656655848,0.32894736842105265,1.0,1.0,5/16,14.64%,RELN;VEGFA;CRTC3;ADCY8;EPHA5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5870836766651486,-1.1049960934464123,0.38235294117647056,0.9694045901453636,1.0,4/10,8.11%,CX3CR1;LGALS9;ARRB2;HLA-E
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6577208543724613,1.1048706015199392,0.36,1.0,1.0,5/10,30.54%,RNF139;SERPINE2;LRRK2;SNX12;PRNP
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6625952173291775,1.1046696373400062,0.352112676056338,1.0,1.0,3/9,24.16%,TXN;NR4A3;LRRK2
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.6628130821477249,1.1044103360235624,0.37333333333333335,1.0,1.0,5/11,27.92%,COX7C;CYCS;COX4I1;COX6C;COX6B1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.6077202351622557,1.1043481128092452,0.3972602739726027,1.0,1.0,4/14,14.41%,ACAT1;SCD5;FASN;SCD
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6712317572252733,1.1043250991055487,0.32894736842105265,1.0,1.0,3/9,23.18%,KIF5A;SPG11;KIF5C
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5464340045336449,1.1042675693248316,0.37777777777777777,1.0,1.0,6/37,17.88%,ARAF;RPL23;XPO1;CAV3;RNF139;RPL11
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6561148216152224,1.1039719665943029,0.35802469135802467,1.0,1.0,1/19,1.60%,TGFB2
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.600460161177372,1.103933757858437,0.3068181818181818,1.0,1.0,9/22,17.26%,LRP4;NRXN1;NRXN2;NLGN1;SAV1;PTN;MAGI2;LRRC7;THY1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.5731121343965133,1.103726577808451,0.32954545454545453,1.0,1.0,6/30,9.40%,FAAH;ACSL1;FAAH2;ALOX15B;ALOX12;SCD5
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6634413668478495,-1.103617906231423,0.37037037037037035,0.971380383091782,1.0,3/7,9.89%,MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.717419111467732,1.1031482108557886,0.2698412698412698,1.0,1.0,2/7,8.09%,ALG10B;ABCA2
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.6098345330580915,1.1025610888823267,0.38271604938271603,1.0,1.0,9/16,24.41%,DNAH11;ADCY10;CCDC39;CFAP54;DNAH17;DNAH7;DNHD1;DNAAF2;DNAAF5
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5855044347059418,1.1021735222260245,0.375,1.0,1.0,5/38,4.83%,TULP2;GRM8;COL11A1;SLC4A10;PCDH15
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6526518123389585,1.102172921023636,0.4024390243902439,1.0,1.0,4/14,15.05%,JPH1;GRIN2A;RYR2;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6634984105214589,1.1015953696603686,0.3875,1.0,1.0,1/11,2.26%,RPL23
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.7509452239481055,1.1014733612547645,0.3076923076923077,1.0,1.0,2/5,5.13%,ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5994723472955258,1.1014078448591487,0.3048780487804878,1.0,1.0,6/19,24.73%,ABHD12B;MBOAT2;OSBPL10;OSBPL5;SERINC5;LPCAT4
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.5308186701785617,1.1010915384878728,0.30303030303030304,1.0,1.0,4/77,3.06%,TOP2A;IDI1;ACSL1;CADM1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.5955356883756453,-1.1010388387593395,0.3333333333333333,0.9770727601848526,1.0,2/7,9.69%,LGALS9;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.731932296425406,1.100909821825918,0.43243243243243246,1.0,1.0,3/6,13.66%,ZBTB16;BMPR1B;SOX6
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.6886856740783346,1.1009070918611832,0.4117647058823529,1.0,1.0,4/7,30.58%,MYRF;SOD1;PTEN;EPB41L3
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.550792313427498,1.1007522763850077,0.2717391304347826,1.0,1.0,18/72,17.51%,RHOB;FRMD5;ALOX15B;PTPRK;ADAM15;PTPRT;KANK1;TMEFF2;ROBO1;MAGI2;EPHA4;MCTP1;LIMCH1;SPOCK3;SPINT2;DUSP10;THY1;CLIC4
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.7351237432483152,1.1006614400758779,0.38235294117647056,1.0,1.0,3/6,21.87%,PRPS1;GUK1;MACROD1
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.6621382845440951,-1.100633349680608,0.4473684210526316,0.9762304050711972,1.0,3/5,9.24%,CX3CR1;CRKL;P2RY12
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6811014595757436,-1.1005876714288763,0.5151515151515151,0.9743625377945256,1.0,3/7,9.24%,CX3CR1;CD200R1;P2RY12
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.6553064660801785,1.1002400638350442,0.4117647058823529,1.0,1.0,7/12,29.11%,SVIL;IGSF8;DISP1;ZBTB18;MYL6;BASP1;LARGE1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.6825865168218633,1.1001513367417481,0.4305555555555556,1.0,1.0,4/8,21.27%,UCKL1;DCK;UPP2;UCK2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.6825865168218633,1.1001513367417481,0.4305555555555556,1.0,1.0,4/8,21.27%,UCKL1;DCK;UPP2;UCK2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.40964449361507566,-1.099964254641376,0.5,0.9740965276853027,1.0,6/45,11.55%,PDE12;NT5C3B;DCP1B;EDC3;CNOT6L;LSM6
prerank,MSigDB_Hallmark_2020__UV Response Up,0.5087023338923164,1.0999024523369447,0.29473684210526313,1.0,1.0,32/105,23.99%,RHOB;HTR7;TUBA4A;PTPRD;NR4A1;TFRC;RXRB;ENO2;GRINA;DGAT1;CA2;MGAT1;NTRK3;TYRO3;CCK;POLG2;SOD2;GRPEL1;NXF1;CASP3;RFC4;CCND3;SLC25A4;MAPK8IP2;OLFM1;HSPA2;DLG4;SELENOW;WIZ;FOS;ATF3;HNRNPU
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.6064111197742074,1.0998287012155497,0.379746835443038,1.0,1.0,3/18,10.85%,MAPT;MAP2;MAP1B
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.6755561034515591,1.099464755246536,0.37333333333333335,1.0,1.0,5/10,23.34%,ABCA2;PICALM;TMED10;ROCK1;FLOT2
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6898682980139486,1.099215959896429,0.4383561643835616,1.0,1.0,1/7,14.10%,PRKAG2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5797937686443969,1.0988927015976322,0.3493975903614458,1.0,1.0,4/20,17.88%,RPL23;EPHA4;ALAD;RPL11
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5817941550935755,1.098892504704858,0.32926829268292684,1.0,1.0,9/37,16.87%,DAPK2;EIF2AK3;HERPUD1;SEPTIN4;BOK;MCL1;PINK1;BCL2L2;PYCARD
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.690633265978529,1.0988656240307564,0.34375,1.0,1.0,2/7,19.25%,TTLL7;TPGS1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5385019282358826,1.0988053768061596,0.3411764705882353,1.0,1.0,11/30,16.11%,GRM8;CHRM5;ADCY3;RGS1;AKAP12;CHRM3;PDE2A;ADCY8;GNAI1;HTR1F;GNAL
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6460356878983624,1.0987392244674627,0.38666666666666666,1.0,1.0,4/9,14.04%,CCDC39;CFAP54;DNAH17;DNAH7
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.5467301657780608,1.0986984645041526,0.38202247191011235,1.0,1.0,5/47,9.18%,RHOBTB3;RHOB;GPM6B;EPHA3;RND3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.5320641326836814,1.0983964583269616,0.3978494623655914,1.0,1.0,22/57,29.46%,VEGFA;HSPA5;EPHA3;TMEFF2;RAPGEF3;TFIP11;CARMIL1;IMPACT;DNAJB2;MCTP1;AIDA;HSPA1B;HSPA2;TNF;NOP53;RDX;SYT11;IRAK3;SCAMP5;DDX3X;RIOK3;HSPA8
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5345205755579248,-1.0979435740426593,0.3076923076923077,0.9777149428874835,1.0,2/12,2.38%,CX3CR1;SELPLG
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6383609850126537,1.0973829119784586,0.3815789473684211,1.0,1.0,6/12,21.42%,CHRM5;GNA11;CHRM3;CDK5R1;PLCB1;GNAQ
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.55347143631496,1.0973137483546478,0.4,1.0,1.0,18/45,27.81%,WDR12;WDR74;MAK16;PES1;RPL23A;HEATR3;NHP2;MRPL20;RPL14;RPL11;NOP53;RPL3;RPL24;MRTO4;RPL7;PAK1IP1;TRAF7;RPL10A
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.646311384734351,1.0972458825370408,0.34146341463414637,1.0,1.0,2/17,7.97%,KLF4;INSR
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.5147333005347225,-1.0971361377568654,0.3888888888888889,0.9779277003474862,1.0,4/16,4.84%,IKZF3;SAMSN1;BANK1;IL4I1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5638996706989743,1.0967635194228473,0.28888888888888886,1.0,1.0,9/36,11.38%,MYOT;CADM1;IGSF11;CDH2;ROBO2;PTPRT;PALLD;ROBO1;CELSR2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.49427276390727826,1.096726738758765,0.31958762886597936,1.0,1.0,18/107,14.16%,TOM1L1;TGFB2;CENPE;EGR1;RELN;AGT;MTCP1;VEGFA;SPDYA;CLSPN;SLC11A1;SRCIN1;INSR;CALM3;GPRC5B;PAK5;PRKAG2;EPHA4
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.5600887073189129,1.096702365914545,0.3333333333333333,1.0,1.0,11/29,23.95%,RTN1;ABCA2;NTRK2;EPHA4;CASP3;PICALM;TMED10;ROCK1;RTN3;TNF;RTN4
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6750603703150482,-1.0966828670724134,0.4117647058823529,0.9773606800960684,1.0,3/5,18.40%,ENPP1;LRMDA;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.5430002688066705,1.0965761215948338,0.30526315789473685,1.0,1.0,12/64,14.96%,THBS1;KLF4;CBR1;AGT;VEGFA;INSR;IFNLR1;PAX8;MAGI2;FASN;PRELID1;NSF
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.643949217640224,1.0962504631031416,0.4025974025974026,1.0,1.0,2/11,3.76%,MMP21;DNAH11
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.7219192134008404,1.0961996196919963,0.3230769230769231,1.0,1.0,4/6,20.56%,MAPT;APP;DCTN1;SPG11
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.6937636711695598,1.09594861445036,0.417910447761194,1.0,1.0,2/6,25.09%,LMO3;GPS2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.5040626381160107,1.095889979267204,0.23232323232323232,1.0,1.0,46/236,21.06%,KLF4;NUDT12;NLRP12;RBMS3;TGFB2;MAPT;EIF4A3;NUDT16;RIDA;ENC1;SRGN;VEGFA;GPNMB;NOCT;EIF2AK3;SLC11A1;FCGR2B;DAPK1;OVOL2;PUS7;HIF1A;BMI1;ZNF540;ID2;ROBO1;CCDC3;ITGB8;SH3GL2;SMYD5;HINFP;PINK1;CENPV;RNF139;PICALM;SLC24A3;ESR1;SHQ1;APP;RGCC;FOXP1;HSPA1B;OLFM1;PRKAA2;SUZ12;EZH2;MSR1
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.7339383320759052,1.095841324633061,0.375,1.0,1.0,1/6,6.18%,SUV39H2
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.5308058705008608,-1.0957685193603297,0.32,0.9779217675193114,1.0,3/8,17.31%,ALOX5;MOCS1;MOCS2
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.5085816172016032,1.0955941859624825,0.2653061224489796,1.0,1.0,34/149,24.05%,OMD;ARAF;PLIN2;ENPP2;TALDO1;FAH;LIFR;DGAT1;ETFB;LIPE;ABCA1;SORBS1;CMPK1;DNAJB9;ITSN1;NKIRAS1;GRPEL1;ATP1B3;PEMT;BCL6;UQCRC1;SOD1;RMDN3;SLC66A3;RTN3;CYC1;GPAT4;CD151;IMMT;SLC5A6;PGM1;GPD2;SPARCL1;PDCD4
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.6128091865273149,1.0952993894788574,0.35443037974683544,1.0,1.0,10/18,29.78%,RPA2;RPS27A;POLE2;RFC4;UBA52;UBB;RFC1;RPA3;REV3L;POLH
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.5464679725415995,1.095210585692797,0.3118279569892473,1.0,1.0,11/62,12.01%,CDK14;AMER2;TLE1;DAAM2;CTNND2;GRB10;PTK7;KANK1;TCF7L1;GSKIP;SULF2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.7260857122215665,1.0947318016048313,0.40625,1.0,1.0,2/5,26.33%,RTN4;RSAD2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.6016114336886225,1.0945907654347935,0.3488372093023256,1.0,1.0,4/23,18.86%,ANK3;NSF;PREPL;SPTBN1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.6551344824390551,-1.0945307556908592,0.3888888888888889,0.9796309459563641,1.0,5/6,14.41%,INPP5K;RUBCNL;PPP1R3F;PPP1R3E;AKT1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6803073867286651,-1.0939828492322898,0.44,0.9788236340517639,1.0,1/6,3.69%,NLRP1
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7725615441266802,1.093888667237853,0.391304347826087,1.0,1.0,1/5,14.62%,ACP3
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7420627023929359,1.0938818534777466,0.35714285714285715,1.0,1.0,1/6,2.98%,CARNS1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6149792367520649,1.0938644385155232,0.37333333333333335,1.0,1.0,6/14,15.94%,CDH8;CDH9;NLGN1;CDH20;CDH12;CDH10
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.600618133484027,1.0935990366872899,0.3218390804597701,1.0,1.0,3/28,7.52%,PLPP3;PLPPR4;MTMR7
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.6570185083953047,1.0930468317652948,0.43243243243243246,1.0,1.0,3/11,5.93%,KLF4;FGF1;VEGFA
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6146465028714058,1.0929482181776835,0.3974358974358974,1.0,1.0,5/18,13.66%,NFIB;BMPR1B;EIF2AK3;SULF2;SOX6
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.6748941403494728,1.0926734270099048,0.4444444444444444,1.0,1.0,2/7,4.01%,NTN4;LAMB1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.46253856976381413,-1.092601323024934,0.3333333333333333,0.9813502139771805,1.0,2/18,7.03%,NDE1;LLGL2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.35689503663059624,-1.0925443304628366,0.3333333333333333,0.9795321816690635,1.0,21/151,13.10%,RNASEL;SCNM1;NUFIP1;ELAVL4;ADARB1;RP9;SNRNP35;KHSRP;SF3A1;MTPAP;DDX23;SMU1;AKAP8L;HNRNPUL1;AURKAIP1;IVNS1ABP;LSM6;M1AP;FASTKD2;SON;PPP1R9B
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7252993855082492,1.0925172314924876,0.30985915492957744,1.0,1.0,5/10,21.19%,SLC4A10;GRIK2;SYP;SHISA9;SYNGR1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.6664716506322983,1.0924320905004796,0.352112676056338,1.0,1.0,2/7,11.76%,CR1;C5AR1
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.7396267327891605,1.0918498849614795,0.36764705882352944,1.0,1.0,1/5,5.93%,VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.7396267327891605,1.0918498849614795,0.36764705882352944,1.0,1.0,1/5,5.93%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.5225731128679374,1.0917097606632495,0.35802469135802467,1.0,1.0,5/42,5.52%,THBS1;SPARC;TGFB2;NFIB;PTPRK
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.5181580123885793,1.0916658188982546,0.2916666666666667,1.0,1.0,22/85,22.40%,CENPF;CENPE;NUP133;RCC1;SBDS;CENPP;XPO1;RPS27;PLK2;DYNC1H1;CENPI;CLASP2;CKAP5;INCENP;SEH1L;KIF11;CENPK;GPSM2;DYNC1I1;CENPT;KNTC1;SUN2
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.6771932092284081,1.0914838794091006,0.37333333333333335,1.0,1.0,3/9,13.13%,CACNB2;CALM3;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6914357309479219,1.09117224266689,0.3582089552238806,1.0,1.0,1/7,6.89%,GRM3
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.6992886480070186,1.0905028363958027,0.42857142857142855,1.0,1.0,2/7,7.04%,HSPA5;SEC61B
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.5438743762188659,1.0904310073834482,0.3263157894736842,1.0,1.0,18/79,20.08%,ACVR1B;TGFB2;DCC;TP53TG5;ADAM15;CDKN2AIP;FHL1;MAP2;MAG;TCHP;DNAJB2;ING1;FBP1;BCL6;CDKN1B;FGF13;HSPA1B;APBB2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.49719133848637653,-1.0902342154879552,0.23529411764705882,0.9836397097065126,1.0,6/13,9.40%,INPP5K;CORO1B;CSF1R;LIMA1;PLEK;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.6839144063508077,1.090066087366572,0.38571428571428573,1.0,1.0,3/8,17.04%,GPM6B;CAV3;PICALM
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6534788012547597,1.090063831990189,0.34177215189873417,1.0,1.0,6/15,29.58%,RUVBL2;NHP2;TCP1;SHQ1;CCT8;DKC1
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6806167143095464,1.090054098060097,0.38235294117647056,1.0,1.0,2/9,6.89%,GRM8;GRM3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5379673989362268,1.0895905171314277,0.3473684210526316,1.0,1.0,24/58,25.96%,DCC;MAPT;PLPPR4;ANK3;SLITRK5;MAP1B;PLP1;SEMA5A;PARD3;NREP;CCK;CTNNA2;CDK5R1;GRM7;NTNG1;APP;KLF7;SPTBN4;PAK3;RTN4RL1;FGFR2;RTN4;MAP1A;BRSK1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6883534654777412,1.0894097208374525,0.35135135135135137,1.0,1.0,1/6,6.67%,PDIA2
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.6311701453365508,-1.0892435279095476,0.42424242424242425,0.9842876454787565,1.0,1/7,14.41%,AKT1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.5659426490845685,1.0890019298133613,0.3522727272727273,1.0,1.0,7/26,13.66%,DMD;LAMA2;FHL1;POU6F1;CAV3;SGCE;SOX6
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.5132385225250853,1.0889313028955192,0.30303030303030304,1.0,1.0,18/106,17.54%,MDH1;CBR1;IDI1;ACSL1;BMPR1B;PTPRG;XIST;ENO2;CA2;NCAPH2;GLUL;RDH11;FASN;CPT1A;GAD2;ALAD;HMGCS1;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.6310517561007876,1.0887906247582002,0.38571428571428573,1.0,1.0,3/9,20.52%,CD300A;STXBP2;FES
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.5437013385156142,1.0887874152252812,0.375,1.0,1.0,9/81,7.93%,KLF4;LRP2;ACVR1B;NLRP12;IL1RAPL1;ACVR2A;BMPR1B;ROBO2;AKAP6
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6427837825728198,1.088376526740455,0.38961038961038963,1.0,1.0,3/9,24.13%,GRAMD1C;INSIG1;RORA
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6923198813996593,1.088298304614125,0.38235294117647056,1.0,1.0,3/7,20.73%,BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.5815396150552096,-1.0879609123545655,0.3333333333333333,0.9862547586391412,1.0,3/11,11.47%,NEDD4;TGFB1;NUP214
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.6781561495626902,1.0876032297672888,0.3246753246753247,1.0,1.0,2/10,5.93%,FBN2;VEGFA
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.5977755882355125,1.0874429527691474,0.38202247191011235,1.0,1.0,10/25,23.12%,PFKM;ENO2;PGAM1;GPI;ENO4;PKM;ENOSF1;PGK1;ENO1;PGM1
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.5862671535223493,-1.0874140003619646,0.3142857142857143,0.9860507364554854,1.0,2/6,11.95%,FFAR4;CTBP2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.5440981954812882,-1.087393795161877,0.32,0.9842413451691449,1.0,3/10,11.90%,RIC3;GPD1L;TYROBP
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.4970325872047824,-1.0873430890547087,0.2857142857142857,0.9824916214029816,1.0,11/19,20.55%,TRIM38;LGALS9;VPS37B;CHMP2B;TRIM11;KPNA6;FMR1;CHMP2A;CD4;CD74;TSG101
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5189163948075148,-1.0872378015803323,0.28,0.9809323513539253,1.0,2/13,2.38%,CX3CR1;SELPLG
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7094052316208653,1.0872013416178692,0.40540540540540543,1.0,1.0,1/9,1.15%,ST18
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.721521570133975,1.0871977026439426,0.4,1.0,1.0,2/5,16.56%,PRPS1;DCK
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5645298886819146,1.0871509377993225,0.4024390243902439,1.0,1.0,7/32,10.99%,CADM1;CDH8;CADM2;CDH2;CDH9;CDH20;CDH12
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.7116307624666783,1.087126824950513,0.417910447761194,1.0,1.0,5/7,28.68%,DNM3;DNM1;MX1;OPA1;MX2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.7116307624666783,1.087126824950513,0.417910447761194,1.0,1.0,5/7,28.68%,DNM3;DNM1;MX1;OPA1;MX2
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6820355398351164,1.0870691005681896,0.3283582089552239,1.0,1.0,1/7,5.93%,SRGN
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.6932055040295297,1.0862445366390037,0.36764705882352944,1.0,1.0,4/7,22.55%,MFNG;FCGR2B;GPR183;NOTCH2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.562899342136717,1.0861339521143936,0.3116883116883117,1.0,1.0,6/31,13.75%,GFAP;AGT;TRAF2;HCFC1;VPS11;PINK1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.6318485382046357,1.085622094390561,0.42857142857142855,1.0,1.0,2/9,8.89%,ENPP2;KANK1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7043778649461891,1.0854157635130504,0.42857142857142855,1.0,1.0,1/5,3.99%,MFNG
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.5709094432312369,1.0850211006366852,0.35714285714285715,1.0,1.0,7/22,23.19%,ERCC2;TFRC;FANCB;ZCWPW1;ERCC6;KMT5C;TIMELESS
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.3380276062421141,-1.0849982922942703,0.25,0.9856090984841844,1.0,12/99,5.05%,NKG7;IKZF3;MEP1A;CD2;CD37;LY86;MPEG1;BIN2;BANK1;HHEX;CEACAM21;PYHIN1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.5318764700906686,-1.084680181362113,0.4166666666666667,0.9846507051788607,1.0,3/12,9.94%,TGFBR3;TGFB1;ENG
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.7061783584422657,1.0843477050474866,0.40540540540540543,1.0,1.0,3/8,16.72%,STEAP2;ATOX1;SLC31A2
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6775297081495142,-1.0842026278615289,0.5,0.984165381373323,1.0,1/5,4.35%,WRAP73
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.6830076496112752,1.0840530031526672,0.4852941176470588,1.0,1.0,4/6,24.74%,WNT5A;STAT1;FGFR2;CTNNBIP1
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6992958417435582,1.083873860208904,0.42424242424242425,1.0,1.0,1/7,2.95%,MAPT
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.6996164958730822,1.0838139360205927,0.42424242424242425,1.0,1.0,3/6,28.74%,CCDC39;SRP54;PROX1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.6654335694814936,1.0835317699129494,0.38028169014084506,1.0,1.0,3/10,14.31%,CHST7;OGA;AMDHD2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.5035290870356335,-1.0835168361820717,0.375,0.984462645944395,1.0,5/22,7.04%,CCL5;CX3CR1;NOS1AP;SIRPA;C3
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.6385162797451044,1.083501874980458,0.4,1.0,1.0,7/10,32.12%,ABCA2;PMP22;TPPP;CNTNAP1;EPB41L3;NCMAP;DICER1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5390446611384633,1.0831893334058147,0.3516483516483517,1.0,1.0,11/55,18.26%,GALNTL6;GALNT8;B4GAT1;GALNT13;SDF2L1;TMTC2;GALNT18;OGA;B4GALT5;PLOD1;GCNT1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.5842037794403038,1.0826523130535646,0.3918918918918919,1.0,1.0,2/16,7.02%,THBS1;FCGR2B
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5274644720696445,-1.0823714203552897,0.4,0.9864469881655342,1.0,6/25,13.83%,MYH9;PLEKHM2;LAMTOR1;PLEKHM1;MILR1;DEF8
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7009361458819988,1.0821651470640752,0.391304347826087,1.0,1.0,4/6,25.08%,ANXA1;AKIRIN1;ROCK1;MEGF10
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7195503579373094,1.0821456218983074,0.42028985507246375,1.0,1.0,1/7,1.15%,ST18
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.6611083596551851,1.0818621625735696,0.42857142857142855,1.0,1.0,5/8,32.33%,KDM1A;BRCA1;JARID2;ZNF274;RIF1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.6755153360426862,-1.0818220748715555,0.4117647058823529,0.98596100484145,1.0,3/6,21.93%,CHMP2B;LYST;VPS4B
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.7039202610990121,1.0817504369265383,0.3561643835616438,1.0,1.0,3/8,19.00%,ATOX1;SLC31A2;APP
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.6678045563562242,1.0815843446695743,0.42105263157894735,1.0,1.0,3/9,12.50%,VEGFA;PDE2A;SH3GL2
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6532949493168941,1.0811719904859851,0.4230769230769231,1.0,1.0,2/9,9.51%,TGFB2;ID2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.6720520486723227,-1.0811265019094973,0.45454545454545453,0.9859167310740953,1.0,1/5,4.51%,CSF1R
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.7495379279256543,1.0810127953543007,0.4264705882352941,1.0,1.0,2/5,17.58%,RNASE10;PLCB1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5222576492212437,1.080785457679487,0.3655913978494624,1.0,1.0,25/65,24.66%,MAPT;INSR;EPHA3;IRS2;FGR;NTRK3;IGF1R;ALK;EPHA6;EPHA7;FLT1;NTRK2;TYRO3;EPHA4;EPHA5;LDB2;NPRL2;CDKN1B;SOD1;SLAMF8;EEF1A1;RBL2;FGFR2;HNRNPU;ECT2
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.6167987430499758,1.0807470163987734,0.3974358974358974,1.0,1.0,3/15,14.56%,WDR5;KDM1A;BRCA1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5572855926535675,1.0806583391637183,0.35555555555555557,1.0,1.0,10/48,16.21%,MAPT;CLIP3;FIGNL1;STMN3;FIGN;DYNC1H1;SPAST;KATNAL2;TPPP;HOOK3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.5778331557641015,-1.0803756031843075,0.3076923076923077,0.9867505891521002,1.0,3/10,16.09%,CPSF1;CPSF4;CPSF2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.5711875164329547,1.0799370966460875,0.35714285714285715,1.0,1.0,5/23,16.94%,SOX4;MYRIP;IRS2;ADCY8;C2CD2L
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.684854537284165,1.079899677240511,0.44594594594594594,1.0,1.0,1/9,2.24%,DPYD
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.586761585524123,1.0797858162381166,0.38961038961038963,1.0,1.0,11/28,14.19%,LRRC4C;RELN;GRIK2;NLGN1;IQSEC2;NLGN3;CACNA1B;GRIK1;PXK;NRG3;GRID2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7044438232000906,1.0792439848290518,0.4266666666666667,1.0,1.0,2/6,20.45%,CALM3;CLIC2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7044438232000906,1.0792439848290518,0.4266666666666667,1.0,1.0,2/6,20.45%,CALM3;CLIC2
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.6914588550178903,1.0791098913033517,0.39436619718309857,1.0,1.0,3/8,14.60%,HSPA5;BOK;PPP1R15A
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.5129809312808803,1.078408662433583,0.3645833333333333,1.0,1.0,14/115,13.14%,CENPF;HAUS6;TUBA4A;DTL;PRKAR2B;TUBB4A;TUBA1A;FBXL7;CEP152;FHL1;KCNH5;RBX1;PSMB4;DYNC1H1
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.5477080038634847,-1.0783796799021115,0.43333333333333335,0.990441995327059,1.0,1/10,0.20%,CCL5
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),0.7154679139457334,1.0779966685044284,0.38333333333333336,1.0,1.0,2/5,19.82%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.7306009360807608,1.0778526547979537,0.390625,1.0,1.0,2/5,16.75%,NR4A2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.6383575845400017,1.0774151428863163,0.41975308641975306,1.0,1.0,5/17,17.04%,ARF6;EPHA3;MCTP1;CD300A;PICALM
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.610053377441419,1.0773512379106012,0.40963855421686746,1.0,1.0,5/15,11.83%,SEMA3A;VEGFA;SEMA3B;SEMA6A;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5129922910013184,1.0770842386351813,0.3711340206185567,1.0,1.0,20/119,16.75%,THBS1;KLF4;PRR16;VIM;EGR1;EIF4A3;SOX4;RBM3;INSR;HIF1A;IRS2;MID1IP1;NMD3;DNA2;MFSD2A;SORBS1;EIF3E;UPF3A;RPS4X;CNEP1R1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.5575389096488761,1.0766922698601895,0.36904761904761907,1.0,1.0,12/27,25.59%,LRP4;OMG;LINGO1;MAG;PTN;HOOK3;THY1;ARHGDIA;TNF;RTN4;GDI1;RUFY3
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.5429875033581555,1.076667229077512,0.3563218390804598,1.0,1.0,13/29,23.98%,NLGN1;NLGN3;DNAJC6;FCHO2;DNM3;DNM1;SYT1;ITSN1;PICALM;AMPH;SNAP91;NLGN4X;MX1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.5043361968523558,1.0765776036930739,0.3368421052631579,1.0,1.0,8/75,12.44%,TOP2A;HMGB2;NUP133;COPS5;TCF7L1;RPS27A;FAM50A;RBX1
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.6678061239857722,1.076430597901529,0.44155844155844154,1.0,1.0,4/8,28.02%,AP3B2;AP3S1;AP3B1;AP3M2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.6678061239857722,1.076430597901529,0.44155844155844154,1.0,1.0,4/8,28.02%,AP3B2;AP3S1;AP3B1;AP3M2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5428715661062369,1.0763199810954387,0.4329896907216495,1.0,1.0,7/54,10.37%,HTR2B;PPP1R9A;NUDT4;EIF2AK3;ANK2;RYR2;CHRM3
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.3584815493442945,-1.076273014162602,0.3333333333333333,0.9939134192844392,1.0,20/86,15.72%,INPP5K;PLA2G4C;PIK3R6;CSF1R;PIK3C2B;MTMR14;INPP5E;PIP4K2B;PLA2G12A;PLEK;PI4KB;INPP5D;OCRL;VAC14;MTMR10;PI4KA;PIK3R5;RAB4A;PLCB2;MTMR1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.6524472893303143,-1.0759226516308145,0.5,0.993084010973246,1.0,1/5,4.12%,APPL2
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.49920280278188306,1.0759199763882152,0.32989690721649484,1.0,1.0,25/111,18.49%,PLPP3;COL11A1;PRKAR2B;PRKCE;NFIB;ACVR2A;INPP4B;SFMBT1;SIPA1L1;RND3;BHLHE40;LTBP1;MAP1B;IGF1R;CELF2;KALRN;MAGI2;PMP22;ADGRL2;SCN8A;INSIG1;KCNMA1;TOGARAM1;GCNT1;CDKN1B
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7202269059026001,1.0758261146813737,0.36764705882352944,1.0,1.0,2/5,19.16%,TENT4B;SND1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.6406601685812141,1.0755799325858006,0.3950617283950617,1.0,1.0,3/8,28.24%,TPPP;LIMK2;RAB11A
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.4722712049566578,-1.0753565165732863,0.3333333333333333,0.9931290137060835,1.0,4/27,12.71%,FLNA;ZPR1;TGFB1;EFCAB7
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.3606947600916346,-1.075147063845493,0.2222222222222222,0.9918183422262901,1.0,4/44,6.93%,RALB;SESN2;SESN3;PIP4K2B
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.5375889340445229,1.0747329466226416,0.39325842696629215,1.0,1.0,7/45,13.24%,TGFB2;ARF6;SOX4;MYRIP;APBB3;IRS2;PPID
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6129172392253737,1.074659399532953,0.4430379746835443,1.0,1.0,2/15,14.71%,MAPT;CENPV
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6588112945332676,1.074633611621238,0.39705882352941174,1.0,1.0,1/10,3.06%,CADM1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6588112945332676,1.074633611621238,0.39705882352941174,1.0,1.0,1/10,3.06%,CADM1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.49998988100983516,1.0745336160554217,0.37373737373737376,1.0,1.0,17/97,14.65%,KLF4;ARRDC3;INSR;EPHA3;BMI1;NTRK3;IGF1R;ALK;EPHA6;EPHA7;FLT1;NTRK2;PINK1;TYRO3;EPHA4;EPHA5;POLG2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.5803013192842671,1.0744578107203229,0.3333333333333333,1.0,1.0,9/18,24.76%,SLC24A2;SHANK2;PRRT1;SLC24A1;PLK2;PNKD;NLGN4X;LRRK2;SYT11
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6445510364172342,1.0744155262265223,0.4268292682926829,1.0,1.0,1/8,7.93%,AKAP6
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.6730644627992799,1.0744141000015108,0.4342105263157895,1.0,1.0,4/10,14.47%,KMO;FAH;ACAT1;BLMH
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6443515976256867,1.0742127433438753,0.3972602739726027,1.0,1.0,6/13,15.55%,TGFB2;HIF1A;FN1;LTBP1;ITGB8;ITGAV
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.4377136734421089,-1.0738171711616087,0.4,0.9938566714591152,1.0,7/45,5.34%,PHLDB2;IL17RD;ZNF703;BCL9L;IL1B;DAB2IP;WWTR1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.5331064651459282,1.0737764825081726,0.3977272727272727,1.0,1.0,16/52,23.00%,ACVR1B;TGFB2;DCC;TRAF2;BOK;MCL1;SIVA1;BCL2L2;TNFRSF1B;ITGAV;CASP3;TNFRSF1A;TNF;BAG3;APPL1;DEDD
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.6600097634197296,1.0735405610408573,0.37662337662337664,1.0,1.0,5/10,31.79%,VEGFA;SORBS2;FHOD3;MYH11;TTN
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.5562503590009632,1.0734026203514864,0.39080459770114945,1.0,1.0,4/31,5.24%,LRP2;PRLR;CYP3A5;PIAS4
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.5601934415223105,-1.0731283393094835,0.2903225806451613,0.9937215987312357,1.0,6/9,18.77%,GGTA1;LTC4S;ALOX5;GGT7;ALOX5AP;MGST2
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5792953683739498,1.072820393055648,0.40789473684210525,1.0,1.0,4/18,12.79%,RACGAP1;SLC13A4;SLC19A2;SLC35F3
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6680505999340982,1.072790580667838,0.4358974358974359,1.0,1.0,4/11,20.18%,PDK4;PRKAG2;PPARA;PRKAA2
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.4293746019138706,-1.0727538260995193,0.2777777777777778,0.9927732909887016,1.0,6/25,10.15%,GAL3ST4;IDUA;ST6GALNAC3;MAN2B2;ST8SIA4;MAN2B1
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.7298303831022744,1.072394400078253,0.4305555555555556,1.0,1.0,2/5,8.83%,KMO;AFMID
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.4709649217770012,-1.0720651208533885,0.3,0.992919981912651,1.0,5/17,16.16%,TFAP4;ZNF675;NFKBIA;ILRUN;HABP4
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6473252780239707,-1.0716268007022036,0.3611111111111111,0.9923567842483114,1.0,1/7,4.23%,ACTB
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.6947553084507362,1.0713026682783542,0.4657534246575342,1.0,1.0,1/8,2.24%,DPYD
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.6056325252372771,1.0706534038609623,0.3888888888888889,1.0,1.0,4/18,15.09%,CDK14;ID2;HINFP;E2F7
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.41444197608667177,-1.0706286201858777,0.25,0.9931864145391077,1.0,6/27,13.61%,MYH9;APH1A;TGFB1;RBMX;HM13;CTSH
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.6942516236997628,1.070490235530356,0.4696969696969697,1.0,1.0,1/6,7.47%,MPG
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.48485342346951193,1.0703972329913303,0.33,1.0,1.0,41/217,20.67%,TOP2A;DAPK2;RHOB;TGFB2;CLIP3;GADD45B;PNMA1;SOX4;DAPK1;CSRNP3;ARHGEF4;NGEF;SEPTIN4;BNIP3L;RPS6;BOK;RRP1B;FAM162A;RPS27A;IFIT2;C3ORF38;KALRN;EPHA7;PPID;RPS6KA2;PNMA2;BNIP3;RBM5;ITSN1;PYCARD;CASP3;CDK5R1;KCNMA1;BCL6;NEURL1;SOD1;SHQ1;OLFM1;UBA52;HSPD1;UBB
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.5581268261863069,1.070359429813205,0.38271604938271603,1.0,1.0,5/23,13.44%,WDR12;MAK16;PES1;RPL7L1;NHP2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6440884745690629,1.0703429179076778,0.39759036144578314,1.0,1.0,1/15,1.04%,NLRP12
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.33752641752362966,-1.070339358106544,0.2857142857142857,0.992145322730096,1.0,15/67,15.13%,RANBP6;PEX13;APPL2;NUP155;RPAIN;PHB2;IPO13;NUP214;NUP188;PTTG1IP;PEX16;SYK;AKT1;FIS1;ABCD3
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.5197076247572605,1.0703039808038202,0.40217391304347827,1.0,1.0,5/69,5.13%,FA2H;FAAH;ACSL1;ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.5418392852993978,1.0702778875658423,0.40217391304347827,1.0,1.0,9/44,7.22%,P4HA3;ADAMTS2;TGFB2;COL11A1;COL4A5;COL26A1;COL23A1;COLGALT2;COL24A1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.7148376736592277,1.0702438008187294,0.40298507462686567,1.0,1.0,3/5,19.58%,IRS2;BCL6;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6762853841736645,1.0702400207398821,0.4533333333333333,1.0,1.0,2/9,9.19%,PRKCE;IRS2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.553196983098091,1.070163770197268,0.3977272727272727,1.0,1.0,9/36,20.23%,TMEM161A;SLF1;EYA2;FMN2;SPIRE2;BRCA1;ZCWPW1;ERCC6;NPAS2
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.6463577156602924,-1.070149006033857,0.3333333333333333,0.9907806796589989,1.0,3/5,14.85%,FSCN1;LCP1;CAPG
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6602470741887029,1.0696078224386465,0.3380281690140845,1.0,1.0,6/14,25.33%,CEMIP;AKAP6;CALM3;THY1;CX3CL1;TRPC1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5882920397622207,1.0695928934787948,0.4,1.0,1.0,8/19,28.11%,EGR1;HIF1A;DNAJB2;PINK1;HSPA1B;EPAS1;WASHC1;HSP90AB1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.623278838153941,1.0693557668326747,0.3815789473684211,1.0,1.0,3/14,5.74%,LRP2;TGFB2;KITLG
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.5694357746424834,1.0693457294300461,0.3977272727272727,1.0,1.0,13/36,28.33%,TFRC;SLC11A1;TTYH1;FTH1;SLC39A14;ATP6V0B;ATP6V1D;HFE;TF;ATP6V0E2;ATP6V1B2;SLC11A2;ATP6V1E2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.5797361924453942,1.0691072610403747,0.4090909090909091,1.0,1.0,8/18,21.94%,AGT;ALOX15B;ABCA1;ITGAV;ABCA5;PPARA;MSR1;IL18
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.5887440771976269,1.0690729753866706,0.4074074074074074,1.0,1.0,5/21,13.10%,CLIP3;INSR;IRS2;SORBS1;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.6289437456122297,-1.0690679037226776,0.5384615384615384,0.9918851654616457,1.0,1/7,0.88%,CST7
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.68044317655031,1.0688776680209262,0.42857142857142855,1.0,1.0,2/6,17.24%,TG;DIO1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.677559668650494,1.068457216692595,0.4146341463414634,1.0,1.0,3/8,7.78%,RORB;VEGFA;AGTPBP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.49416230101386355,1.0684274555538893,0.3711340206185567,1.0,1.0,26/142,15.52%,THBS1;DDIT4;NLRP12;PDE10A;TLE1;PPP2R5B;CD22;CIT;PHLPP1;SHANK2;CGNL1;HERPUD1;DEPTOR;LIMD1;MCL1;CAV3;PDE2A;PER1;PIK3IP1;MAGI2;PINK1;OTUD7B;UACA;DGKG;BCL2L2;PEBP1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.6765173073080297,-1.0682054608934624,0.35714285714285715,0.9926843588012687,1.0,3/6,9.49%,CRKL;P2RY12;TREM2
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7513804690819792,1.067847105830327,0.38461538461538464,1.0,1.0,3/6,8.52%,GRIN3A;NLGN1;NGEF
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4968313315351918,1.0678265851235365,0.3473684210526316,1.0,1.0,20/67,16.11%,TSHR;GRM8;ADCY3;ADGRE1;GNA11;GNAO1;RGS1;CNR1;ADGRG6;AKAP12;GPR65;ADGRB2;PDE2A;RXFP1;ADCY8;GNAI1;ABCA1;ADGRL2;HTR1F;GNAL
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.51946653503864,1.0677958136482626,0.358695652173913,1.0,1.0,10/59,10.64%,NLRP12;MAPT;BEX3;KHDC1;TRAF2;EIF2AK3;ROBO1;BOK;FAM162A;CASP5
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.5315660498445073,1.0676306107332423,0.4065934065934066,1.0,1.0,7/76,5.22%,HAUS6;TUBA4A;PRKAR2B;TUBB4A;TUBA1A;CEP152;TTBK2
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.7133320316713911,1.0675936684646479,0.453125,1.0,1.0,1/5,6.89%,GRM3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.7133320316713911,1.0675936684646479,0.453125,1.0,1.0,1/5,6.89%,GRM3
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.6385187608486815,1.0675425037077386,0.39759036144578314,1.0,1.0,5/16,23.89%,SH2D4A;MTMR9;ZCCHC9;HSP90B1;CHP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.5038831822975217,1.0672184431722385,0.3979591836734694,1.0,1.0,12/144,5.18%,CENPF;NEK11;HAUS6;TUBA4A;CENPE;PRKAR2B;ANLN;ERCC2;RIOK2;TUBB4A;TUBA1A;CEP152
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.546105156348499,1.0672112160406853,0.4146341463414634,1.0,1.0,10/31,28.28%,DTL;TRIM25;RBX1;RNF126;FANCL;NEURL1;UHRF1;ATXN7L3;RAD18;UBE2O
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.7284152510350085,1.0671463208998002,0.4461538461538462,1.0,1.0,2/5,5.37%,SLC5A9;SLC2A9
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.677203028622512,1.0670465283928021,0.45714285714285713,1.0,1.0,4/7,24.02%,CNTNAP2;SPTBN4;CNTN2;MTCH1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.6953331247580652,1.0670029021999214,0.4307692307692308,1.0,1.0,4/7,23.64%,ATP1B3;ATP1B2;SLC9A1;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.6950183440224846,1.066972297341811,0.4666666666666667,1.0,1.0,3/6,19.31%,TXNIP;E2F7;ORC6
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5906670056618015,1.0669189407790103,0.43209876543209874,1.0,1.0,3/18,9.19%,TFRC;IL7;IRS2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.6087889605143022,1.066898558908108,0.42857142857142855,1.0,1.0,5/12,22.60%,CLIP3;APP;SPG11;DYNC1I1;BAG3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.6145827679013203,1.0668297496614012,0.4523809523809524,1.0,1.0,1/15,1.82%,CR1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.6879175742681458,-1.0664486788491363,0.4594594594594595,0.9957098910072225,1.0,3/5,21.64%,APH1A;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6516793485141624,1.066280978586687,0.4266666666666667,1.0,1.0,4/11,23.18%,NLGN1;KIF5A;SPG11;KIF5C
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5721690738258227,1.0661695625041276,0.38372093023255816,1.0,1.0,5/22,10.38%,FBN2;GPM6B;ACVR2A;BMPR1B;PTN
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.5971832338066846,1.066112434289474,0.43478260869565216,1.0,1.0,6/17,25.09%,CD22;FCGR2B;CD300A;FOXP1;PRKCB;GPS2
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.6505768517413129,1.0658371839556269,0.463768115942029,1.0,1.0,3/10,20.73%,BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.6110823069711475,1.0655307674193744,0.41025641025641024,1.0,1.0,5/15,20.67%,ROBO2;ROBO1;TNFRSF1B;ROCK1;TNFRSF1A
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6095841431093031,1.0654715675822446,0.38461538461538464,1.0,1.0,2/15,8.50%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6095841431093031,1.0654715675822446,0.38461538461538464,1.0,1.0,2/15,8.50%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.5834992289096878,1.065353057494985,0.3953488372093023,1.0,1.0,8/25,27.78%,SOX4;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2;KCNB1;PTPRN2
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.6704783357377594,1.064659002294139,0.4461538461538462,1.0,1.0,1/8,13.75%,PINK1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.6916785181167386,1.0644443055033983,0.4647887323943662,1.0,1.0,4/7,28.51%,FGR;LILRB2;MICB;BAG6
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4892359897879651,1.0643315714536594,0.3,1.0,1.0,38/291,11.71%,THBS1;HTR2B;KLF4;FGF1;RBMS3;PRR16;VIM;RPL23;EGR1;TLE1;EIF4A3;CADM1;IL15;AGT;TFRC;VEGFA;SOX4;EIF2AK3;ANK3;SLC11A1;RBM3;ANK2;OVOL2;HIF1A;CAMK2N1;HCFC1;ZNF804A;RIMS2;ID2;ROBO1;FN1;RBPJ;FGR;POLR1C;PDE2A;TENT4B;NTRK3;ITGB8
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.6765498317833956,1.0642473650414963,0.4647887323943662,1.0,1.0,1/9,0.29%,THBS1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.5490046448569718,1.0642243641243325,0.35294117647058826,1.0,1.0,12/36,23.50%,DTL;RPA2;TRIM25;RPS27A;NSMCE1;BRCA1;RFC4;USP43;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.6748149375867154,1.0642101586407233,0.4794520547945205,1.0,1.0,1/6,13.97%,ACAD9
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.5676348301372418,1.0640650922212462,0.4175824175824176,1.0,1.0,13/41,21.10%,RAB3C;STXBP5L;ANXA1;RIMS2;RAB15;SEPTIN4;SYT1;MCTP1;NSF;DISP1;CPLX1;SCG5;RAB21
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.6888214399133109,1.0640340716011267,0.4852941176470588,1.0,1.0,3/8,19.64%,FCGR2B;CD300A;TNFRSF21
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.5061064399502277,-1.0640222180304224,0.4,1.0,1.0,4/18,9.49%,MYH9;CSF1R;THOC5;TREM2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.7189148844911818,1.0639668118274455,0.40789473684210525,1.0,1.0,1/5,7.61%,SPRY1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.5626774312530152,1.0637696051662588,0.4772727272727273,1.0,1.0,3/35,6.65%,NUDT4;ITPKC;INPP4B
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.6859288280074489,1.063573927207964,0.3770491803278688,1.0,1.0,4/6,24.94%,TRAF2;TNFRSF1A;TNF;TRADD
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6898989335801622,1.0635620163951847,0.40540540540540543,1.0,1.0,2/6,7.77%,NUDT16;ADARB2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.5379294247934594,-1.0635557681583752,0.36,1.0,1.0,4/13,9.94%,TGFBR3;EGFL7;TGFB1;ENG
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6621818874613136,1.062609805825436,0.4714285714285714,1.0,1.0,2/7,16.87%,CARMIL1;PYCARD
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.6538982330926646,1.0625343051077332,0.44594594594594594,1.0,1.0,4/8,28.66%,ST14;ALDH1A1;LEPR;DUOX1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.6760689342416437,1.062310438859389,0.38571428571428573,1.0,1.0,2/5,16.87%,CARMIL1;PYCARD
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.6614723056465006,1.0621932217363266,0.47297297297297297,1.0,1.0,4/8,23.64%,ATP1B3;KCNMA1;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.49568098611994005,1.0621114613578286,0.336734693877551,1.0,1.0,11/117,10.54%,THBS1;KLF4;NLRP12;CR1;ANXA1;SRGN;GPNMB;SLC11A1;FCGR2B;FN1;TRIM25
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.4122756661214904,-1.0620675079000779,0.3076923076923077,1.0,1.0,5/28,14.41%,MRPL57;MRPS11;SLC25A33;FASTKD2;LARS2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4278389086904388,-1.0614209848706426,0.3333333333333333,1.0,1.0,7/22,15.38%,CYB5A;MAIP1;TRAM2;EGFR;TRAM1;SGTA;STX5
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.7173976017289956,1.0612321455763982,0.4745762711864407,1.0,1.0,1/5,11.17%,DNA2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.6177197920249621,1.0610994941141,0.44871794871794873,1.0,1.0,4/17,10.88%,HMGB2;H2BC11;SLC11A1;GSDMD
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.3856131473682818,-1.0610021417329725,0.2,1.0,1.0,3/38,3.49%,PPP1R16B;SESN2;CCDC88C
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.6539061598900533,1.0609697571570058,0.4520547945205479,1.0,1.0,2/8,16.05%,VEGFA;GAB1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5889119468775977,1.0607503707544113,0.43902439024390244,1.0,1.0,1/23,0.29%,THBS1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.6673150982782667,1.0606550607546492,0.44155844155844154,1.0,1.0,1/8,0.58%,P4HA3
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.7250712714631167,1.0606174874244958,0.4507042253521127,1.0,1.0,4/5,27.50%,DEPTOR;CAV3;RDX;PTEN
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5290137636275511,1.0605334843363576,0.4065934065934066,1.0,1.0,11/47,19.12%,TGFB2;CCPG1;NUDT16;MEIS2;SPDYA;HCFC1;PKD1;CCND3;CDKN1B;APP;RGCC
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.6019221154612369,-1.060520264843075,0.39285714285714285,1.0,1.0,5/9,25.75%,LEO1;RNF8;RNF20;CDC73;RNF40
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.571918923707097,-1.06040051561826,0.4444444444444444,0.9993176873591608,1.0,2/10,9.49%,CST7;TREM2
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6563863342594572,1.0602661213416735,0.4027777777777778,1.0,1.0,4/9,29.11%,DGAT1;GK;GPAT4;LPGAT1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.38011651739943075,-1.0601594862909807,0.375,0.9983376911480933,1.0,11/62,14.41%,RALB;TFAP4;GTF2F1;ACTB;SORL1;NFKBIA;ILRUN;DISC1;DAB2;CTSZ;AKT1
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.5303997886408233,1.060002277284528,0.46511627906976744,1.0,1.0,7/32,18.39%,KLF4;ANKRD22;RAB20;ST14;FBP1;CEBPD;LTA4H
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5785258152484568,-1.0598105963809408,0.37037037037037035,0.9976569065458816,1.0,3/9,16.09%,CPSF1;CPSF4;CPSF2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.5134399053947768,1.0597634223505346,0.3763440860215054,1.0,1.0,10/81,9.78%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;VEGFA;F13A1;ENDOD1;FN1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5605250355754751,1.0594571035990834,0.48863636363636365,1.0,1.0,3/36,6.65%,NUDT4;ITPKC;INPP4B
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.7063562708570809,1.0594257204401447,0.44,1.0,1.0,2/7,13.13%,ANK2;PDE4B
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.3372948994727759,-1.059221147933212,0.0,0.9973474481535735,1.0,15/100,4.51%,CCL5;ADORA1;LOXL3;PLA2G4C;TMIGD3;OLR1;KLRG1;CHUK;IL1A;IL1B;FOLR2;CD96;LGALS9;BLNK;CSF1R
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3864646087207428,-1.0591534855756337,0.2222222222222222,0.9958365132097785,1.0,13/36,15.13%,ACSM5;TECR;GPX4;LPL;HACD4;GSTM4;LTC4S;MLYCD;ALOX5;NDUFAB1;LIPG;FADS1;ABCD3
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5937610497102135,1.0590443873191069,0.4342105263157895,1.0,1.0,7/22,20.18%,PDK4;ASXL3;MID1IP1;SORBS1;PRKAG2;PPARA;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.556007486341819,-1.058841488347643,0.3939393939393939,0.9948455740800201,1.0,1/8,6.39%,LEO1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.570041829428142,1.0588156780067857,0.43529411764705883,1.0,1.0,8/22,20.67%,IL1RAPL1;ANXA1;SYT4;TNFRSF1B;GRM7;STXBP6;PNKD;TNFRSF1A
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5832282105681118,1.0586927265165336,0.43037974683544306,1.0,1.0,3/20,14.07%,TOM1L1;VPS37C;RNF126
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.671602663809546,1.0585358087672279,0.515625,1.0,1.0,2/7,11.28%,GLYATL1;GLUL
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6572446341815943,1.0584029830632797,0.4819277108433735,1.0,1.0,2/9,10.69%,RGS2;CAV3
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5829332408594456,1.057861602763603,0.4074074074074074,1.0,1.0,6/18,19.83%,SCN3B;DMD;RYR2;SGCZ;SOD1;SGCD
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.5621170706900667,1.0576185028623168,0.43333333333333335,1.0,1.0,10/32,23.50%,DTL;RPA2;TRIM25;RPS27A;RFC4;USP43;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.4894940709889245,-1.057302170648038,0.35,0.9971350095142631,1.0,1/12,0.88%,CST7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.7083677370219374,1.0572329603202126,0.3918918918918919,1.0,1.0,4/6,28.32%,SYT4;SYT1;KCNB1;SCAMP5
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.5450570596455604,1.0569448506947097,0.45054945054945056,1.0,1.0,4/35,13.75%,MAPT;INF2;PDE2A;PINK1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5376094287668333,1.0569056287851442,0.4090909090909091,1.0,1.0,8/26,17.26%,TLE1;RTN1;VEGFA;UNC5C;CRMP1;ETS2;CDK5R1;THY1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5987081638015779,1.05669017844445,0.4383561643835616,1.0,1.0,6/14,23.94%,VEGFA;ARNT2;HINFP;PKD1;FGFR2;PTPRR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6249921574855287,1.056639548632307,0.45,1.0,1.0,3/11,18.89%,SEMA3A;PLXNB1;PLXNC1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.6378856036250352,-1.0564999605226002,0.4166666666666667,0.997805112133918,1.0,2/5,8.11%,LGALS9;HLA-E
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.606028248068577,1.0561274878786762,0.42105263157894735,1.0,1.0,3/12,22.07%,DGAT1;GK;GPAT4
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.5757096190748305,1.0560147576993273,0.43209876543209874,1.0,1.0,7/25,24.51%,OIP5;CENPP;CENPI;CENPK;CENPT;ITGB3BP;NASP
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.6873753002702893,1.055715395236508,0.4675324675324675,1.0,1.0,5/8,26.68%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.6873753002702893,1.055715395236508,0.4675324675324675,1.0,1.0,5/8,26.68%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.6873753002702893,1.055715395236508,0.4675324675324675,1.0,1.0,5/8,26.68%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.577057569411701,1.0553583471293995,0.46511627906976744,1.0,1.0,7/22,23.86%,SEC61B;HERPUD1;SYVN1;AUP1;SURF4;TECPR2;HSP90B1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.39001975962490965,-1.055223402366099,0.42857142857142855,0.9994717092732716,1.0,17/59,17.62%,TAL1;TCF3;PSMB3;LMO1;PSME3;PSMD12;PSMC4;PSME4;CBFB;ABL1;SETD1A;PSMA1;KMT2A;PSMA7;PSMD3;PDCD2;PSMB5
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.6178533850700445,1.0550466456326606,0.4588235294117647,1.0,1.0,1/13,2.26%,RPL23
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5840080114625897,1.054986126222917,0.4482758620689655,1.0,1.0,5/20,14.16%,SHANK3;RELN;PTN;ADCY8;EPHA4
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6653541101274117,1.0549583134775238,0.47297297297297297,1.0,1.0,1/6,11.45%,ERRFI1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.6874854147039018,1.0547525408773892,0.5064935064935064,1.0,1.0,4/6,29.48%,UHRF2;HELLS;UHRF1;ZNF445
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5725466396462724,1.0545283875516418,0.3953488372093023,1.0,1.0,5/21,10.38%,FBN2;GPM6B;ACVR2A;BMPR1B;PTN
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.7003833989480025,1.0540505775776472,0.4805194805194805,1.0,1.0,1/5,7.61%,SPRY1
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.654369353105745,1.0538710804784766,0.46774193548387094,1.0,1.0,1/8,3.16%,H2BC11
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.520074943793581,1.053216872745684,0.42857142857142855,1.0,1.0,2/48,1.04%,KLF4;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7024110702140676,1.052930842077948,0.4520547945205479,1.0,1.0,2/5,27.28%,DDB1;PPARGC1A
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.5172281982654765,1.0527962240065551,0.3723404255319149,1.0,1.0,5/78,6.91%,NUDT12;TBRG4;NUDT16;RIDA;GEMIN2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6228339046054369,1.0525155385740304,0.3918918918918919,1.0,1.0,2/8,8.09%,ALG10B;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.6407399650821926,1.0523942634466266,0.4578313253012048,1.0,1.0,4/9,21.95%,AGT;NOD2;SIRT3;TNF
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.5392093551517876,-1.0522595141713194,0.37037037037037035,1.0,1.0,4/10,13.86%,RPUSD3;UQCC2;FASTKD2;RPUSD4
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.574484242483001,1.05192052494675,0.3902439024390244,1.0,1.0,7/20,27.08%,RYR2;NR4A3;PDE4B;APLP1;SLC9A1;LRRK2;ATP2B4
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6357391864341116,1.0518575884289882,0.5,1.0,1.0,2/10,7.04%,HSPA5;SEC61B
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.6687783139468415,1.0515544965248655,0.4861111111111111,1.0,1.0,1/7,0.74%,LRP2
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.718336719408751,1.0513813164753474,0.35714285714285715,1.0,1.0,1/5,1.60%,TGFB2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6117527383773673,1.0513703620619699,0.4605263157894737,1.0,1.0,3/13,9.68%,WDR12;PES1;RPL7L1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.4666245247314155,-1.0513539345665055,0.42105263157894735,1.0,1.0,3/17,5.72%,CCL5;OLR1;ICAM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.39277428042832185,-1.0511571771830401,0.2857142857142857,1.0,1.0,9/65,10.00%,PSMB3;PSME3;CHUK;ITGB5;PSMD12;PSMC4;HLA-E;PSME4;IKBKB
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5198142574838213,-1.0509166201072728,0.36363636363636365,1.0,1.0,1/12,1.17%,PGM2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7122134789042305,1.0507526538929395,0.4782608695652174,1.0,1.0,1/5,9.56%,ROBO1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.37970365399955813,-1.0504866126734642,0.4444444444444444,1.0,1.0,16/62,15.78%,CARD14;PSMB3;PSME3;CHUK;PSMD12;PSMC4;MAP3K14;COPS8;PSME4;TLR3;BIRC2;PSMA1;TIRAP;AKT1;NFKB2;PSMA7
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6722547366776987,1.0502814066833672,0.4533333333333333,1.0,1.0,5/7,29.09%,RPS27A;UBA52;UBB;MRC1;TLR2
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6722547366776987,1.0502814066833672,0.4533333333333333,1.0,1.0,5/7,29.09%,RPS27A;UBA52;UBB;MRC1;TLR2
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.576369325444471,1.0502190922212353,0.4430379746835443,1.0,1.0,4/16,14.40%,SYT4;RIMS2;SYT1;RIMS3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.5435986998379886,1.0500604332375705,0.4069767441860465,1.0,1.0,9/29,25.83%,PDZD2;PTPRT;NPHP1;ITGB8;DNAH7;ESRRG;MAP3K13;CX3CL1;TCTN1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.4868032311849826,-1.0498963361762288,0.3684210526315789,1.0,1.0,1/14,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.4868032311849826,-1.0498963361762288,0.3684210526315789,1.0,1.0,1/14,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.6423921047796486,1.0496636819175764,0.4625,1.0,1.0,2/10,15.93%,TUSC3;MAGT1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.5762716552463915,1.0495063640097686,0.4155844155844156,1.0,1.0,10/28,33.64%,RPA2;FIGNL1;KDM1A;ZCWPW1;IL7R;H1-0;SPIDR;BLM;SMARCAD1;ZRANB3
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.4984099718443329,-1.0494276800411164,0.38095238095238093,1.0,1.0,1/11,3.46%,ABCG2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6459002822633327,1.0493936010846046,0.43478260869565216,1.0,1.0,2/8,9.19%,THBS1;IRS2
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.6036473525450508,1.0491338067148845,0.4146341463414634,1.0,1.0,6/18,29.58%,RUVBL2;NHP2;TCP1;SHQ1;CCT8;DKC1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.5482083504003428,1.0489876707177463,0.38461538461538464,1.0,1.0,4/36,7.01%,FGF1;TGFB2;NRG1;SLC11A1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3959426610572578,-1.0489266284931926,0.3,1.0,1.0,9/62,10.00%,PSMB3;PSME3;CHUK;ITGB5;PSMD12;PSMC4;HLA-E;PSME4;IKBKB
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.4664444104168383,-1.0484336886398662,0.5238095238095238,1.0,1.0,5/11,27.19%,CDK11B;SAFB;SUPT6H;SRPK1;SAFB2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.6489536958393223,1.0483966002482672,0.3717948717948718,1.0,1.0,2/9,7.78%,FOLH1;AGTPBP1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.5925521400598079,-1.0481787110266518,0.4482758620689655,0.999783789662654,1.0,1/6,1.79%,PUS1
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),-0.6177352777426905,-1.0481422242864598,0.3793103448275862,0.9982400751106506,1.0,2/6,10.27%,CD300LF;MILR1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.698295003461259,1.047890992849868,0.4696969696969697,1.0,1.0,2/5,24.13%,NLGN1;RORA
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.4911692832478678,1.0478089333922482,0.4888888888888889,1.0,1.0,18/51,23.99%,MAPT;PPP2R5A;CAMK2N1;IRS2;DEPTOR;CAV3;GSKIP;PRKAG2;PPM1E;THY1;NPRL2;HSPB1;CDKN1B;GSTP1;TAF7;GNAQ;CHP1;HNRNPU
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.5111772231300993,1.047664357255309,0.3854166666666667,1.0,1.0,14/69,13.55%,PLPP3;PRLR;NTN4;TNS1;AGT;KITLG;CD55;VASN;RXRB;SEMA3B;MAFB;BOK;SHC2;ABLIM3
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5860186192034736,1.0475410988465494,0.4268292682926829,1.0,1.0,5/23,20.67%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.5710300954699999,1.047501126516063,0.41025641025641024,1.0,1.0,5/20,15.55%,THBS1;ANXA1;XKR4;TYRO3;ITGAV
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.5081603575883475,1.0473602222337803,0.44680851063829785,1.0,1.0,5/43,10.14%,THBS1;MAPT;NDRG1;HIF1A;CALM3
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.6268112844012422,1.0472034460513744,0.44285714285714284,1.0,1.0,3/12,13.37%,VEGFA;INSR;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.5711347642127836,-1.04666954752528,0.4074074074074074,1.0,1.0,3/10,13.45%,LEO1;SUPT16H;BRD4
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.5397405506712631,1.0466610714627422,0.4642857142857143,1.0,1.0,5/25,18.92%,SPARC;MFSD2A;SH3D19;CFL1;NTNG1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.5191019307972093,1.0466094363871845,0.4895833333333333,1.0,1.0,16/62,22.29%,NUDT12;IDI1;ACSL1;PFKM;SLCO1A2;ABCA2;LIPE;ABCA1;ABCA5;DIO1;PNPLA8;ALDH1A1;SOD1;HACL1;CYP46A1;PIPOX
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.6328551086817176,-1.0462639443306323,0.5217391304347826,1.0,1.0,3/8,9.89%,MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.6024909532479096,1.0461706172592367,0.44,1.0,1.0,4/17,13.20%,SLC4A10;CA2;SLC9A7;SLC9A6
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.6746972473044561,1.04606237252061,0.5068493150684932,1.0,1.0,3/6,30.54%,CHP1;ATP2B4;PRNP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6746972473044561,1.04606237252061,0.5068493150684932,1.0,1.0,3/6,30.54%,CHP1;ATP2B4;PRNP
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.7156706547942054,1.0459567178309044,0.5,1.0,1.0,1/5,2.95%,MAPT
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.601024068793947,-1.0459475359526524,0.4,0.9992625392925079,1.0,1/6,0.62%,SMPD3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.6101397745324197,1.0455850536524445,0.4868421052631579,1.0,1.0,6/14,22.66%,RPL23;RPS20;RPL37;CHD5;UBB;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5750245295587687,1.0455693857458799,0.45,1.0,1.0,4/23,8.42%,ACVR1B;HMGB2;ACVR2A;HIF1A
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.4754815361522864,1.0455097492051648,0.36363636363636365,1.0,1.0,22/171,12.76%,LRP4;RBMS3;CDK14;FZD6;AMER2;DKK2;TLE1;GPC5;DAAM2;CTNND2;LZTS2;SOX4;PTK7;KANK1;RUVBL2;LIMD1;PRICKLE1;GSKIP;SEMA5A;GPRC5B;RBX1;PSMB4
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.5740064953557181,1.0454937495262562,0.38823529411764707,1.0,1.0,3/26,17.66%,ZDHHC15;PAQR3;TMED10
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6127145504454256,1.0454307797726747,0.49295774647887325,1.0,1.0,1/9,14.23%,CLASP2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.5169417427034835,1.0450164763840022,0.4166666666666667,1.0,1.0,15/77,20.08%,ACVR1B;TGFB2;ALOX15B;TP53TG5;ADAM15;CDKN2AIP;FHL1;TCHP;DNAJB2;ING1;FBP1;BCL6;CDKN1B;HSPA1B;APBB2
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.5421789503969936,1.0448640004055363,0.40625,1.0,1.0,8/32,26.32%,HHIP;PDCL;TULP3;TXNDC15;FGFR2;IFT122;RORA;IFT81
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.47235850238955657,1.0447840193102023,0.44329896907216493,1.0,1.0,16/85,15.98%,GFAP;NRG1;NAPA;TFRC;SLF1;VEGFA;HSPA5;TRAF2;HCFC1;SEPTIN8;TFIP11;IMPACT;ABCA1;PINK1;TPPP;AIDA
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.4872069844900321,1.0447691191104667,0.38,1.0,1.0,40/134,28.68%,ATAD3A;MTERF1;HIGD1C;AGTPBP1;HCFC1;TIMM13;BNIP3L;WASF1;SIRT5;DNM3;COX7A2;IFIT2;DNM1;GABPB1;CYCS;PINK1;SLIRP;TOMM20;POLG2;BNIP3;ATP5F1D;TFAM;SLC25A4;HSPD1;CHCHD3;SIRT3;FBXO7;MFN2;MX1;POLRMT;LRRK2;CLUH;MTM1;TIMM22;TOMM40;SIRT4;PPARGC1A;OPA1;PPRC1;MX2
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6190692728808138,1.044722099204066,0.45454545454545453,1.0,1.0,3/11,20.01%,ACSL1;HSD17B12;ACSL3
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3573192135769127,-1.0447077896466697,0.3333333333333333,1.0,1.0,21/114,11.19%,CCL5;CARD14;GBP3;INPP5K;PSMB3;PSME3;EDA2R;CHUK;DAB2IP;CDIP1;PSMD12;PSMC4;MAP3K14;TP53;ILK;PSME4;EIF5A;IKBKB;EDA;NFKBIA;BIRC2
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6087121786713029,1.0446125499791288,0.48863636363636365,1.0,1.0,7/14,33.30%,ADCY10;GUCY1B1;TIMELESS;KCNC2;SPIDR;BLM;FOXO1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6310147507921965,1.0441450318681635,0.4266666666666667,1.0,1.0,4/9,21.49%,CYCS;UQCRFS1;UQCRC1;CYC1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5299320895314535,-1.043676202361955,0.2857142857142857,1.0,1.0,2/11,4.10%,CORO1B;TRIB1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5888670421022245,1.0435048140277865,0.4025974025974026,1.0,1.0,8/16,23.34%,SVEP1;OVOL2;PLOD1;ATP2A2;UGCG;STS;FGFR2;FLOT2
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.6781808742140517,1.0432103738965033,0.47058823529411764,1.0,1.0,3/6,22.46%,DCC;FGF13;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.3829671123294716,-1.0431132181013767,0.36363636363636365,1.0,1.0,8/26,9.69%,FGL1;LILRB4;DUSP3;IL4I1;CD274;RIPOR2;HAVCR2;NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.49016575483115987,1.0430413267998297,0.4421052631578947,1.0,1.0,12/104,12.76%,LRP4;RBMS3;FZD6;AMER2;DKK2;TLE1;LZTS2;RUVBL2;LIMD1;PRICKLE1;RBX1;PSMB4
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5470089382689172,1.0428091634047472,0.4772727272727273,1.0,1.0,4/29,18.86%,ANK3;NSF;PREPL;SPTBN1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5513778904518146,1.0427940342271185,0.45348837209302323,1.0,1.0,6/22,18.41%,LRP2;GPC5;AKR1B1;RDH11;ALDH1A1;NAPEPLD
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.5787238285299172,1.042793497730389,0.4533333333333333,1.0,1.0,6/20,17.01%,IDI1;TM7SF2;MVD;FDFT1;HMGCS1;INSIG1
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.6844940736938997,1.0426083881854724,0.5352112676056338,1.0,1.0,2/5,5.93%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5623271482448828,1.0425010101601702,0.4117647058823529,1.0,1.0,5/26,13.70%,BRIP1;CLSPN;DNA2;DONSON;HINFP
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.6875959737184429,1.0424589634759323,0.43478260869565216,1.0,1.0,4/5,30.54%,SERPINE2;LRRK2;SNX12;PRNP
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5901344007691426,1.042443539278128,0.40789473684210525,1.0,1.0,3/21,19.16%,NUDT16;TENT4B;SND1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.49373291644921524,1.0423189437136775,0.3673469387755102,1.0,1.0,25/142,20.08%,ACVR1B;TGFB2;PAPPA2;SPOCK1;AGT;TFRC;ATAD3A;TP53TG5;ADAM15;CDKN2AIP;FHL1;AKAP6;TCHP;NRG3;MFSD2A;DNAJB2;PAK5;ING1;FBP1;SDCBP;BCL6;CDKN1B;HSPA1B;TAF9B;APBB2
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.6788537871688758,-1.041999360385774,0.4230769230769231,0.9973899069742134,1.0,4/5,24.91%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.6788537871688758,-1.041999360385774,0.4230769230769231,0.9973899069742134,1.0,4/5,24.91%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.6788537871688758,-1.041999360385774,0.4230769230769231,0.9973899069742134,1.0,4/5,24.91%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.6788537871688758,-1.041999360385774,0.4230769230769231,0.9973899069742134,1.0,4/5,24.91%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.508359154128184,-1.0419682063686977,0.38461538461538464,0.9957631413378849,1.0,6/13,11.91%,APPL2;LILRB4;SIRPA;TREM2;CHID1;NLRC3
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5357030577208068,1.0415012284344605,0.3448275862068966,1.0,1.0,12/42,22.71%,IDI1;TM7SF2;MVD;ABCA1;FDFT1;ABCA5;HMGCS1;INSIG1;SNX17;OSBPL5;CYP46A1;MSMO1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.48891492553727933,1.040930898306449,0.40404040404040403,1.0,1.0,22/80,23.87%,RHOB;FGF1;ENPP2;NRG1;FRMD5;TTBK2;SRCIN1;SPOCK3;SPINT2;LDB2;PLXNB1;SERPINE2;NRG4;PLXNC1;ROCK1;FES;NRG2;TBCCD1;TMSB10;SST;HACE1;CCDC125
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6905170739142242,1.0407723333597494,0.43037974683544306,1.0,1.0,2/8,5.13%,ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6478571127920913,1.040629218638009,0.4931506849315068,1.0,1.0,6/13,28.06%,REEP3;RTN3;REEP2;RTN4;REEP1;TMEM33
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.5899614091426937,-1.0405421883032238,0.42857142857142855,0.9976903100930078,1.0,1/8,1.02%,SIDT1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5374411424102461,1.0404271097481723,0.5056179775280899,1.0,1.0,1/25,0.07%,TOP2A
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.4951375625002713,1.0401596070427461,0.42857142857142855,1.0,1.0,31/128,19.64%,NFIL3;RHOB;PLIN2;GADD45B;GLIPR2;SLC2A3;FAH;MAP3K8;NDRG1;CA2;ALCAM;GPR65;CKAP4;BHLHE40;ITGAE;MXD1;IFITM3;IGF1R;P4HA1;NFKBIZ;FGL2;GUCY1B1;AHNAK;TNFRSF1B;ITGAV;CASP3;APLP1;CCND3;PLEC;DENND5A;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.45720390171617364,-1.0401466575121363,0.2631578947368421,0.9970707235680131,1.0,1/18,0.05%,TNFAIP8L3
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.6269749033233705,1.040075083498279,0.44871794871794873,1.0,1.0,4/9,25.77%,VAPB;VCPIP1;RTN4;BNIP1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.5077175690493756,1.039603391380242,0.4157303370786517,1.0,1.0,10/50,15.09%,PRKCE;RACGAP1;CIT;SVIL;MAP9;CALM3;PLK2;CENPV;SPAST;E2F7
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.5449532994928317,1.0395777565974649,0.42168674698795183,1.0,1.0,1/24,0.31%,DDIT4
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.5359550596650824,1.0395570734591788,0.43333333333333335,1.0,1.0,11/33,23.50%,DTL;RPA2;TRIM25;RPS27A;POLE2;RFC4;USP43;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6115070483354308,1.0395560239125912,0.5061728395061729,1.0,1.0,5/14,18.57%,MTCL1;PARD3;LRRC7;CLIC4;CRB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.5463930782771848,1.039265433082316,0.4230769230769231,1.0,1.0,6/20,21.02%,AGT;RGS2;CAV3;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.6386112156139577,1.0391210995291398,0.5352112676056338,1.0,1.0,1/9,0.29%,THBS1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6874169914086562,1.03910010558939,0.5540540540540541,1.0,1.0,3/8,14.21%,HTR2B;PDE2A;GUCY1B1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5068411728965848,1.0390082884261103,0.39325842696629215,1.0,1.0,22/67,26.03%,THBS1;SYT4;NLGN1;RYR2;KCNMB1;CALM3;ADCY8;SYT1;RYR3;WNT5A;KCNMA1;CLIC4;IQGAP1;PRKAA2;SLC25A24;CPNE8;CPNE2;ECT2;SYT11;CPNE3;TRPC1;ADCY1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.5428684894576675,1.0389463183378518,0.4235294117647059,1.0,1.0,1/33,0.41%,KLF4
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.691631880092939,1.038907401896518,0.5131578947368421,1.0,1.0,1/6,5.57%,ROBO2
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.6424780958466014,1.0385709878486282,0.46774193548387094,1.0,1.0,1/5,10.38%,PTN
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.6049973243961917,1.0385197694890493,0.4533333333333333,1.0,1.0,3/14,8.49%,RFX2;SYCP3;DPY19L2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.5955328423115744,-1.0385179141981107,0.4666666666666667,1.0,1.0,2/5,17.31%,MOCS1;MOCS2
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5385120601084723,1.0377145161803218,0.45161290322580644,1.0,1.0,8/40,21.66%,LRP2;ACVR2A;BMPR1B;RBPJ;VWC2;PCSK6;SMAD1;SMAD5
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.4810642539091631,1.0376691555284934,0.41414141414141414,1.0,1.0,27/163,19.07%,TOP2A;CENPF;TUBA4A;CENPE;RACGAP1;ANLN;ARF6;KIF1B;KIF15;SMC4;PALLD;WASF1;MID1IP1;SPTAN1;DYNC1H1;LMNB1;CKAP5;ITSN1;HOOK3;INCENP;UXT;SORBS2;FGD6;KIF11;SPTBN1;ROCK1;ARHGDIA
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),0.7134145521194881,1.0374837714878031,0.4426229508196721,1.0,1.0,4/5,28.68%,DNM3;DNM1;MX1;MX2
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),0.7134145521194881,1.0374837714878031,0.4426229508196721,1.0,1.0,4/5,28.68%,DNM3;DNM1;MX1;MX2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.7065017966117533,1.037460212283931,0.4666666666666667,1.0,1.0,2/6,19.82%,PINK1;ATP5IF1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6088269930943734,1.037375520049665,0.4794520547945205,1.0,1.0,1/13,7.38%,RBM3
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.5264718409063861,1.0369339515762275,0.42045454545454547,1.0,1.0,4/37,12.52%,RHOB;ANXA1;GLRX2;IMPACT
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6268687639051627,1.0368048195412425,0.4246575342465753,1.0,1.0,1/9,6.19%,HSPA5
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.5219126548575299,1.0367816454280783,0.375,1.0,1.0,18/65,19.33%,PRLR;FKBP5;GNA11;PGAM1;RBFOX2;RND3;BOK;GALNT18;ERRFI1;SH3D19;ADGRL2;ZDHHC9;PEBP1;PLXNB1;EPB41L4B;CPE;MPDZ;SLC39A14
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5977415332928049,1.0367124212117926,0.4868421052631579,1.0,1.0,5/14,22.59%,MID1IP1;PRKAG2;CPT1A;PRKAA2;ACACB
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.5966046164402221,1.0366000692677428,0.48717948717948717,1.0,1.0,4/15,21.95%,NUDT16;ESR1;SHQ1;TNF
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.5199213797069404,1.0365674462503718,0.44086021505376344,1.0,1.0,3/39,3.90%,NUDT12;NUDT16;RIDA
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.605374457564185,1.0364464460090113,0.4875,1.0,1.0,6/14,28.24%,KIF5A;SPG11;KIF5C;SYT11;LIMK2;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.7037113160123363,1.0363071651928097,0.4782608695652174,1.0,1.0,2/5,14.56%,KDM1A;BRCA1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.579124455820395,1.0358346598229502,0.4691358024691358,1.0,1.0,3/17,12.57%,WDR12;PES1;ERI2
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.6185291749708843,1.0356001094570035,0.4383561643835616,1.0,1.0,2/10,15.96%,VBP1;PFDN4
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.5286688028654773,1.0355921869673148,0.4943820224719101,1.0,1.0,7/47,13.15%,HTR2B;FGF1;POU5F1;CALM3;TXNIP;PLK2;SMYD5
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.4799259716753057,-1.0354371438653684,0.47058823529411764,1.0,1.0,6/17,17.54%,RHOG;CYFIP1;NCKAP1L;GSN;CAPG;CDC42
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6082121573341914,1.0353307661868363,0.4342105263157895,1.0,1.0,2/10,17.09%,ITGA2;SDCBP
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6519182247393455,1.0352784544446445,0.5070422535211268,1.0,1.0,3/7,31.71%,DNA2;TOP3A;LIG3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5056183574065076,1.0349909617888433,0.45652173913043476,1.0,1.0,9/67,11.40%,TGFB2;SH3PXD2B;LDB3;SOX4;PKP2;POU6F1;ID2;FN1;NTRK3
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.4759011027099312,-1.0349486215752952,0.42857142857142855,1.0,1.0,11/25,23.08%,CCDC88C;PYHIN1;EP300;GSN;CTSH;FBXL3;PEX2;CUL3;BTRC;PRKN;CDC73
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4272055306101814,-1.034906202021885,0.4,1.0,1.0,7/24,12.96%,LGALS9;IGF1;CD274;SIRPA;HAVCR2;NLRC3;ILRUN
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5040710026902987,1.0348712424571884,0.46236559139784944,1.0,1.0,5/64,8.16%,KNSTRN;CENPE;TEX14;SMC4;NCAPH2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.4771230521241182,1.034809995508251,0.37373737373737376,1.0,1.0,74/275,25.72%,TNC;ARAF;EEF1A2;PAPPA2;RPL23;VGF;VCAN;LAMB1;CDH2;RPL37A;FBXL2;RPS6KB2;GOLM1;RPL38;COPS5;CKAP4;FN1;RPS6;CHRM3;LTBP1;RPS27A;RPL23A;TMEM132A;RPS25;RPS27;DARS1;SLC35A1;RPS11;RPS20;L2HGDH;RPL9;RPLP2;RPS18;MRPL43;SERP1;RPL37;UBE2M;RPL14;RPS4X;CHGB;RPL11;RPS24;CPE;MRPL27;MRPL55;LTA4H;RPS9;APP;RPL36;UBA52;IGFBP7;ERO1A;RPS3A;MRPS14;MRPL3;P4HB;RPL35;RPL4;EEF1A1;RPL32;TNIP1;DUSP12;SPARCL1;HSP90B1;RPL3;TF;RPL27A;RPL24;UBE2D2;RPL12;RPL30;RPS16;RPL7;SPCS3
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.5025522453751525,1.0347411654485157,0.41237113402061853,1.0,1.0,19/106,19.00%,TULP2;TUB;ARF6;RPA2;SEC61B;FSIP2;ANK2;PAQR3;TULP3;SNX10;DDX1;PPP1R15A;SERP1;AUP1;CNEP1R1;RPL11;GBP2;UBE2J2;APP
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5700886148929005,1.0345216513009416,0.49411764705882355,1.0,1.0,10/27,32.76%,TFRC;ATP6V0B;ATP6V1D;HFE;TF;ATP6V0E2;ATP6V1B2;ATP6V1E2;MCOLN1;ATP6V0A1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.6041374363078292,1.0344804058393715,0.4383561643835616,1.0,1.0,6/10,32.01%,BRCA1;CTBP1;TAF7;JARID2;SET;MACROH2A1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.6995154521359557,1.0344061058303669,0.463768115942029,1.0,1.0,4/6,29.28%,BMI1;PCGF5;PCGF3;PCGF6
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.49168051569833165,1.0343165763571647,0.44565217391304346,1.0,1.0,12/83,10.64%,NLRP12;ST18;MAPT;BEX3;KHDC1;TRAF2;EIF2AK3;DAPK1;ROBO1;BOK;FAM162A;CASP5
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5300179497933126,1.0341648688468745,0.47368421052631576,1.0,1.0,4/28,8.89%,THBS1;SPOCK1;ADAM15;KANK1
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6912881857583197,1.033672814711564,0.5254237288135594,1.0,1.0,3/5,13.20%,TMEM108;SH3GL2;SLC9A6
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.48386610305986194,1.0336083371162947,0.44329896907216493,1.0,1.0,13/118,12.76%,LRP4;RBMS3;FZD6;AMER2;DKK2;TLE1;LZTS2;GRB10;RUVBL2;LIMD1;PRICKLE1;RBX1;PSMB4
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.5605114527129594,-1.033546937887857,0.42424242424242425,1.0,1.0,1/6,4.12%,APPL2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.5605114527129594,-1.033546937887857,0.42424242424242425,1.0,1.0,1/6,4.12%,APPL2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6182031696212422,1.0333746454627168,0.5063291139240507,1.0,1.0,5/12,23.64%,ATP1B3;KCNMA1;ATP1B2;SLC9A1;ATP1A2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6016092084370555,1.033339927457671,0.45569620253164556,1.0,1.0,9/14,36.42%,SLC12A8;ATP1B3;KCNMA1;ATP1B2;ATP1A2;SLC12A5;SLC12A2;SLC12A9;ATP1B1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.6577055685666597,1.0331951399876484,0.4444444444444444,1.0,1.0,5/9,22.40%,SYNE3;DYNC1H1;CLMN;DCTN1;SUN2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.48447250619379123,1.0329692771443886,0.4897959183673469,1.0,1.0,19/152,15.64%,ACVR1B;CDK14;HAUS6;TUBA4A;PRKAR2B;TUBB4A;TUBA1A;FBXL7;CEP152;MASTL;SPDYA;RCC1;PLK2;DYNC1H1;HINFP;CLASP2;CKAP5;SPAST;CCNB3
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.5993464302759757,1.0327681223923129,0.4794520547945205,1.0,1.0,3/12,19.00%,VBP1;PFDN4;APP
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.49078411192354976,1.0327600174940503,0.4489795918367347,1.0,1.0,18/112,14.34%,DDIT4;PLPP3;NLRP12;DMD;CAMK2N1;PAQR3;DEPTOR;CALM3;CAV3;NTRK3;ERRFI1;IBTK;GSKIP;SH3GL2;IMPACT;PARD3;PRKAG2;PPM1E
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5496565199811464,1.032715392438268,0.4606741573033708,1.0,1.0,15/27,28.02%,AP3B2;KIF1B;SPAST;NEFL;KIF5A;HSPB1;SOD1;KIF3A;RAB21;KIF5C;MAP1A;AP3S1;RAB27B;AP3B1;AP3M2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.7087358136678686,1.0326625966275096,0.5666666666666667,1.0,1.0,2/5,17.04%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5414379979262341,1.0325676554686645,0.4625,1.0,1.0,4/24,14.56%,DTL;CLSPN;DONSON;BRCA1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.49444502243413957,1.0322637170863027,0.40816326530612246,1.0,1.0,20/151,16.31%,THBS1;PRR16;VIM;EIF4A3;RIDA;ENC1;SOX4;EIF2AK3;RBM3;DAPK1;PUS7;ZNF540;IMPACT;EIF3E;DDX1;RBM4B;UPF3A;RNF139;RPS4X;EIF2B2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.5690631926292139,1.0322166609467385,0.49382716049382713,1.0,1.0,8/21,17.91%,ANXA1;OVOL2;HIF1A;ST14;WNT5A;UXT;CEBPD;ESR1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5297305466878052,1.032038629106322,0.4523809523809524,1.0,1.0,5/31,11.98%,ARRDC3;IL15;ACOT13;RBPJ;NOVA1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.6085595171523369,1.0312802168634012,0.5185185185185185,1.0,1.0,6/14,22.14%,CDH2;CAV3;PKD1;PIEZO2;PKD2L2;LHFPL5
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.47799498789815903,1.0310041446026157,0.43,1.0,1.0,41/215,20.14%,KLF4;FGF1;RBMS3;RPL23;EGR1;TLE1;TFRC;VEGFA;EIF2AK3;ANK3;SLC11A1;ANK2;OVOL2;INSR;HIF1A;CAMK2N1;HCFC1;ZNF804A;RIMS2;ID2;ROBO1;FN1;RBPJ;PDE2A;NTRK3;ITGB8;NTRK2;MAGI2;HINFP;BRCA1;NSF;EPB41L4B;WNT5A;SLC24A3;RPL11;APP;ROCK1;RGCC;SMAD1;HSPA1B;OLFM1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.5948674239956724,1.0309885726060495,0.4634146341463415,1.0,1.0,4/15,16.10%,SEC61B;HERPUD1;SYVN1;AUP1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5289868062053211,1.030938655538568,0.4823529411764706,1.0,1.0,10/41,13.47%,VGF;PDK4;SOX4;INSR;RPS6;CAV3;TENT4B;IGF1R;ADCY8;BACE2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.49186723827289824,1.0305699170718834,0.45263157894736844,1.0,1.0,14/59,22.36%,TUB;CLIP3;IL15;ANXA1;SLC11A1;FCGR2B;BOK;DYNC1H1;CALY;PYCARD;ACSL3;TNF;CD151;HIP1R
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5612894241937171,1.0303287042105866,0.449438202247191,1.0,1.0,4/27,10.69%,HTR2B;GLA;HIF1A;CAV3
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.6233103711577009,-1.0302949596282949,0.4883720930232558,1.0,1.0,1/6,1.17%,PGM2
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.6459539508979235,-1.030278792423068,0.5185185185185185,1.0,1.0,4/7,9.69%,APPL2;C3;TREM2;NCKAP1L
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.5423529455293943,1.0301731713114692,0.4878048780487805,1.0,1.0,6/25,14.41%,ALOX12;ACSS3;ACAT1;SCD5;FASN;SCD
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.5811166942793318,1.0300698618074624,0.47126436781609193,1.0,1.0,7/25,19.04%,PGAM1;RBM3;RBM4B;PICALM;TMED10;APP;ROCK1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.6298098962416192,-1.029897495060819,0.45454545454545453,1.0,1.0,1/5,8.11%,HLA-E
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.6298098962416192,-1.029897495060819,0.45454545454545453,1.0,1.0,1/5,8.11%,HLA-E
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5701704818253531,1.0298621743861158,0.45977011494252873,1.0,1.0,9/21,24.03%,TUBA1A;KIF1B;MYO10;HOOK3;KIF5A;TUBA1C;DYNC1I1;KIF5C;TUBA1B
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.5728815082245627,1.0297979622593303,0.4875,1.0,1.0,4/15,10.75%,FGF1;VEGFA;CHI3L1;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5713756408840132,-1.0294926437416092,0.4230769230769231,1.0,1.0,2/11,14.95%,HLA-E;IL12RB1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.7029167067736743,1.0293313990774222,0.5254237288135594,1.0,1.0,2/5,18.70%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.7029167067736743,1.0293313990774222,0.5254237288135594,1.0,1.0,2/5,18.70%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.7029167067736743,1.0293313990774222,0.5254237288135594,1.0,1.0,2/5,18.70%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6491305213430891,1.0291733009288526,0.49230769230769234,1.0,1.0,4/6,33.18%,RGCC;PTEN;MACROH2A1;ATF5
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.36180775851758307,-1.0288426114050402,0.3333333333333333,1.0,1.0,12/51,14.75%,TRIM38;PTAFR;ICAM1;HLA-E;IRF5;OAS2;HLA-DPA1;HCK;FCGR1A;IRF7;CAMK2G;HLA-DRB5
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6880217931799008,1.028758710301985,0.5277777777777778,1.0,1.0,4/5,30.61%,GRIP1;GRIPAP1;RAB11A;ARHGAP44
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6741199402568776,1.0286267221421799,0.5616438356164384,1.0,1.0,3/6,24.64%,TXN;GUCY1B1;KCNC2
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.39481678746932586,-1.0285732447499552,0.3,1.0,1.0,13/53,11.90%,CD300LF;ITGAM;P2RX1;PTAFR;MPEG1;LGALS9;P2RY13;AOAH;IRAG2;ALOX5;HCK;PTGS1;TYROBP
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6152636254568241,1.0281230433141435,0.5277777777777778,1.0,1.0,3/7,23.00%,ADGRG6;PARD3;CNTNAP1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6152636254568241,1.0281230433141435,0.5277777777777778,1.0,1.0,3/7,23.00%,ADGRG6;PARD3;CNTNAP1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6034686758327981,1.0280480450039364,0.4358974358974359,1.0,1.0,4/11,29.58%,TCP1;GNL3;CCT8;DKC1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.4880085938826031,1.0280347529053981,0.4583333333333333,1.0,1.0,19/78,23.98%,TMEM140;IL15;IL7;TRIM5;TRIM25;TXNIP;IFITM3;IFIT2;TENT5A;SLC25A28;RIPK2;TRIM26;GBP2;PSMA3;STAT2;TRIM14;SELL;CASP1;MX1
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.6010537624128498,1.0278402934159412,0.4788732394366197,1.0,1.0,4/9,23.83%,ATP5F1D;ATP5F1A;ATP5MC1;ATP5PB
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.532688467002226,1.0278211847052807,0.4819277108433735,1.0,1.0,3/31,3.54%,PRLR;TM7SF2;FAXDC2
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.6770879536664883,1.027769835390085,0.5441176470588235,1.0,1.0,3/7,20.18%,MAPT;TPPP;PRKAA2
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.5914666699123962,-1.0277593841876091,0.42105263157894735,1.0,1.0,1/5,7.01%,TP53
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.43993741715855883,-1.0276771255571853,0.3333333333333333,1.0,1.0,9/12,28.77%,LTO1;MMS19;CIAO2B;CISD3;ISCA1;NFU1;YAE1;GLRX5;CIAO1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.6044074625658675,1.0273467571833454,0.4567901234567901,1.0,1.0,2/18,7.97%,KLF4;INSR
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.5642615751083238,1.027226746826128,0.43373493975903615,1.0,1.0,4/23,13.70%,BRIP1;CLSPN;DONSON;HINFP
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5208813718225922,1.0270973928168217,0.45555555555555555,1.0,1.0,7/41,14.81%,KLF4;CLIP3;NR4A2;NR4A1;MAFB;NR4A3;TMEM120B
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.4362744416219302,-1.0270683812024421,0.4,1.0,1.0,3/15,10.19%,ETS1;CSF1R;SPOCK2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5120578994520729,1.0269744326520522,0.42857142857142855,1.0,1.0,8/41,16.87%,DDIT4;BOK;MCL1;CIDEB;BRCA1;BCL2L2;TNFRSF1B;PYCARD
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5630627271012213,1.0268089210427391,0.45977011494252873,1.0,1.0,5/23,17.29%,MTCL1;LRGUK;SPAST;TPPP;TOGARAM1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.5869153105839847,1.026693987916276,0.47368421052631576,1.0,1.0,6/17,14.64%,AKAP6;ADGRG6;RIMS2;RAPGEF3;PDE2A;EPHA5
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6489282624349457,1.0266164364644086,0.4027777777777778,1.0,1.0,3/9,15.84%,ROBO2;PAX8;PKD1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.5486763347340423,1.0262917754993695,0.4875,1.0,1.0,3/27,7.91%,SLC16A4;SLC6A15;SLC13A3
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.5950619889438068,1.0256706961241253,0.46835443037974683,1.0,1.0,6/10,30.55%,ABCA2;PLTP;ABCB4;PLEKHA3;PLEKHA8;CERT1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.6010673020340489,1.0255673865542405,0.5211267605633803,1.0,1.0,6/16,17.02%,DCC;BOK;MCL1;BCL2L2;ITGAV;CASP3
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5323701970759807,-1.0254632691000785,0.35,1.0,1.0,3/12,8.34%,INPP5K;TP53;PLEK
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.6744620084123961,1.0252877966886078,0.4262295081967213,1.0,1.0,3/5,18.70%,SOD2;KCNMA1;SOD1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.5282142816758315,1.0251102846171418,0.4482758620689655,1.0,1.0,12/36,20.84%,FAAH;ACSL1;FAAH2;ALOX15B;ALOX12;ACAD9;CPT1A;PNPLA8;LTA4H;GSTP1;ACSL3;HACL1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5699990468625754,1.0250881914282914,0.49382716049382713,1.0,1.0,4/20,15.72%,ANK3;TMTC2;FAM20A;SLC12A8
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5688156971002527,1.025002787902445,0.5119047619047619,1.0,1.0,5/24,20.67%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5280720159362194,1.0248634534346792,0.4691358024691358,1.0,1.0,4/27,5.13%,FAAH;FAAH2;ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.6324722012246147,1.0247965762075306,0.4864864864864865,1.0,1.0,2/8,16.36%,TRIM5;TRIM26
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.48675997932903947,1.0245676545951372,0.43010752688172044,1.0,1.0,22/93,24.16%,ALDH3B1;MAPT;TMEM161A;PTPRK;ERMP1;DAPK1;HIF1A;CYCS;PINK1;SOD2;CPEB2;SOD1;GSTP1;HSPA1B;PRKAA2;SLC25A24;ERO1A;VRK2;STX2;FOS;JUN;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.6532278449716599,1.0245278916549947,0.5492957746478874,1.0,1.0,3/7,14.88%,CR1;CD55;SUSD4
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.6786581503721465,1.0245037455009218,0.4857142857142857,1.0,1.0,4/6,30.61%,GRIP1;GRIPAP1;RAB11A;ARHGAP44
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6361097021480084,1.0243936165747265,0.4838709677419355,1.0,1.0,4/7,26.43%,WNT5A;MAP3K13;DLG4;GRIP1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.7127902162211811,1.0243317637796465,0.4444444444444444,1.0,1.0,4/5,26.66%,ADCY3;MAP1A;BRSK1;SLC6A1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6359440733414697,1.024204159752649,0.47297297297297297,1.0,1.0,1/8,7.22%,ETFB
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.7061783044147916,1.0240094049455148,0.5068493150684932,1.0,1.0,3/5,24.05%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5763274526809897,1.0232980383330297,0.4222222222222222,1.0,1.0,5/17,20.67%,RPS27A;SYVN1;RNF139;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5545870338926149,1.0232351361816596,0.5238095238095238,1.0,1.0,5/23,11.86%,SCN3B;ANK3;PKP2;NKAIN2;PER1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5292999235188581,1.0231847680014536,0.48863636363636365,1.0,1.0,11/31,30.08%,MAPT;RPA2;MCL1;NSMCE1;NPAS2;CDK9;BCLAF1;ETAA1;FEM1B;POLH;WDR76
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5663562361425553,1.0228315464218762,0.5180722891566265,1.0,1.0,5/23,11.21%,TGFB2;ROBO2;SOX4;ROBO1;PDE2A
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.5365001339504313,1.0226131441413528,0.4880952380952381,1.0,1.0,11/28,23.94%,VEGFA;ARNT2;SULF2;DEAF1;HINFP;BRCA1;PKD1;WNT5A;ALDH1A2;FGFR2;PTPRR
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.6622816643417434,1.0225752051904042,0.484375,1.0,1.0,2/6,24.16%,TXN;LRRK2
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.5509911592350729,1.0225057144999627,0.4567901234567901,1.0,1.0,5/18,21.25%,PIGU;PIGQ;PIGF;PIGL;PIGG
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.6307900782220276,1.0222671600483741,0.48484848484848486,1.0,1.0,1/8,7.95%,OVOL2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.46162625254768863,-1.0222459584987897,0.5625,1.0,1.0,6/18,12.69%,TTC39B;ARV1;OSBPL6;LAMTOR1;NR1H3;LIPG
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5467369800934369,1.021931429721661,0.47126436781609193,1.0,1.0,4/24,18.57%,MTCL1;PARD3;LRRC7;CRB1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5583947167813851,1.0219128378181261,0.5185185185185185,1.0,1.0,5/19,18.90%,KCNJ13;AKAP6;CHRM3;KCNJ6;KCNJ3
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.5079523036654112,1.0218570569332834,0.425531914893617,1.0,1.0,2/45,1.68%,THBS1;TGIF1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.4855493228132949,1.021746028392356,0.5,1.0,1.0,14/144,8.89%,THBS1;DDIT4;HHIP;NLRP12;DCC;TLE1;NR4A2;AGT;GRB10;RGS2;SPRY1;SEMA6A;PTPRT;KANK1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.6324441695798274,-1.0216524163747138,0.5121951219512195,1.0,1.0,2/5,8.58%,ACAA1;GSTM4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.5345603825970568,1.0212268450093662,0.5,1.0,1.0,6/26,14.37%,SCN3B;FHL1;ANK2;CHRM3;CAV3;FXYD7
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.49971142486479647,1.0210296122740732,0.45555555555555555,1.0,1.0,13/53,17.26%,ECM2;ITGA2;PTPRK;ADAM15;OTOA;FN1;ITGB8;PPFIA2;SORBS1;SGCE;ITGAV;PKD1;THY1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.5417360762522848,1.0207057089028788,0.4888888888888889,1.0,1.0,9/36,18.86%,FA2H;CR1;ANK3;ANK2;CAV3;NSF;SERP1;UGCG;SPTBN1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5278222503560595,1.0205964639153793,0.5238095238095238,1.0,1.0,4/31,14.56%,THBS1;TRAF2;FAIM2;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.6743111655691743,1.0200263728744141,0.5588235294117647,1.0,1.0,1/5,19.12%,GSTP1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.5856955673796959,1.0198250742169956,0.5064935064935064,1.0,1.0,1/13,5.39%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.46729471260042643,-1.0197338779723333,0.3888888888888889,1.0,1.0,3/10,12.12%,SESN2;SESN3;EIF2AK4
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5579977492213724,1.0196085829616213,0.4875,1.0,1.0,10/28,28.33%,SLC11A1;RAB20;DMXL2;ATP6V0B;SLAMF8;ATP6V1D;ATP6V0E2;ATP6V1B2;GPR89B;ATP6V1E2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5733288843976183,1.0192134314489922,0.4936708860759494,1.0,1.0,1/14,3.90%,RIDA
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.644826641368871,1.0189651447427002,0.48484848484848486,1.0,1.0,2/5,29.05%,RNF169;UBR5
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.5050913667494062,1.0188707625097042,0.3956043956043956,1.0,1.0,8/35,20.59%,ETFB;NDUFS8;NR4A3;CYCS;ATP5F1D;UQCRFS1;UQCRC1;SIRT3
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.6170237644813633,1.0186463579228613,0.49333333333333335,1.0,1.0,1/8,6.91%,RGS2
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.6068933677124376,1.0185264675751773,0.5522388059701493,1.0,1.0,2/11,8.56%,VGF;RYR2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5246447205664073,-1.0184239722274309,0.42105263157894735,1.0,1.0,1/15,0.94%,PDE12
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.49657280937544857,1.018364284061523,0.4574468085106383,1.0,1.0,19/68,29.29%,NDUFA2;NDUFB9;SCO2;NDUFA3;NDUFS8;ACAD9;NDUFB6;UQCRFS1;TIMMDC1;SCO1;NDUFAF4;DMAC1;ECSIT;NDUFS5;COX20;NDUFV1;NDUFAF1;TMEM126A;NDUFS7
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.5138223962526245,1.018255299727584,0.4777777777777778,1.0,1.0,12/61,12.92%,HTR2B;FGF1;AGT;DIRAS2;VEGFA;RGS2;SPRY1;PAQR3;ROBO1;CAV3;NOD2;FLT1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.6396782056790565,1.018148613647725,0.5428571428571428,1.0,1.0,5/10,28.80%,HERPUD1;AQP11;RNFT1;BAG6;USP25
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.430377271263453,-1.017326485117721,0.37037037037037035,1.0,1.0,2/16,4.39%,LATS2;LILRB4
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.45947578697348124,-1.0172312508131107,0.2857142857142857,1.0,1.0,1/17,1.07%,NDE1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.6539229239312385,-1.0170772489076771,0.5357142857142857,1.0,1.0,2/5,20.49%,AP4M1;LIN7B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.5181109363095606,1.0169410643462808,0.4,1.0,1.0,10/33,28.51%,RPL23;CAMLG;SDCBP;RPL11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6064170972085723,1.0168974961006239,0.4268292682926829,1.0,1.0,7/13,26.11%,MAP9;GNAI1;DYNC1H1;DCTN1;GPSM2;TACC3;BORA
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.4605187773937084,-1.0168065609089376,0.30434782608695654,1.0,1.0,4/14,9.69%,SH2B3;ZNF385A;SRC;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.6672903613412771,-1.0166808628826558,0.53125,1.0,1.0,2/5,4.39%,LGALS9;LILRB4
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.548307409275335,1.0165216023989974,0.5238095238095238,1.0,1.0,9/22,25.14%,CLIP3;TUBB4A;MAP2;KANK1;STMN2;EML2;HIP1R;SSH2;TWF1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.48961568860044413,-1.0159227324318525,0.39285714285714285,1.0,1.0,1/11,0.28%,GNLY
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.6689867373010518,1.015873593178208,0.4722222222222222,1.0,1.0,3/5,17.49%,ANK2;RYR2;ATP2A2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.49869905530397557,1.015809136789462,0.4659090909090909,1.0,1.0,13/39,16.22%,FZD6;EMILIN2;ANLN;ITGA2;KIF15;BAIAP2L1;OVOL2;BMI1;ST14;BOK;FMO5;BRCA1;INCENP
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.6507648565971206,1.0158038726708143,0.4852941176470588,1.0,1.0,1/8,0.29%,THBS1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5511689147184352,1.015681427715057,0.4625,1.0,1.0,8/21,28.90%,MFSD2A;SLC44A5;PEMT;CHPT1;SLC44A1;GPAT4;PCTP;LPCAT1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4910702950050797,1.0152962770079799,0.5053763440860215,1.0,1.0,28/75,29.07%,CD22;RAB3C;STXBP5L;RIMS2;RAB15;SEPTIN4;ARFGAP1;FGR;SYT1;NSF;ITGAV;RNF139;PICALM;CPLX1;SNX17;FES;RAB21;HIP1R;PLD1;LRRK2;RAB5A;SCARB1;AP2S1;RAB11A;ATP9A;PTPN1;BET1L;SNX12
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.4690793634602366,1.0146453824664419,0.41,1.0,1.0,51/226,24.36%,SOCS3;TNC;DTL;ZBTB16;ASB14;VGF;WDR5;VCAN;LAMB1;CDH2;FBXL7;ASB16;GOLM1;COPS5;HIF1A;CKAP4;FN1;LTBP1;TMEM132A;GAN;STT3B;RBX1;PSMB4;DCAF6;HIF3A;ASB13;FBXO27;UBE2M;SUMF2;CHGB;SUMF1;KLHL2;APP;FBXL5;FBXL13;PSMC2;IGFBP7;FBXO7;PSMA3;PSMB2;P4HB;SPSB3;DDB1;EPAS1;PSMD5;ATG5;SPARCL1;HSP90B1;TF;PSMD7;RAB5A
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.3539804811347106,-1.0146350076413793,0.4166666666666667,1.0,1.0,12/39,17.01%,CCL5;INPP5K;STIM1;CACNA1D;WNK3;STIM2;CAMK2G;LILRA2;BCL2;CRACR2A;IL16;EPB41
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.4986362709649604,1.014443116023201,0.5168539325842697,1.0,1.0,11/42,16.60%,FGF1;TGFB2;LAMB1;NR4A1;VEGFA;C5AR1;NOD2;NR4A3;DEAF1;DUSP10;EPB41L4B
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.5388426305306485,1.014406792782603,0.5232558139534884,1.0,1.0,5/23,14.98%,CR1;GPNMB;FCGR2B;PDCD1LG2;CD300A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.571941180368082,1.0142193652176665,0.49333333333333335,1.0,1.0,4/14,23.30%,ABCA2;VPS11;ATP5IF1;RDX
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.5608757556807819,1.014147335667286,0.4588235294117647,1.0,1.0,4/17,16.10%,SEC61B;HERPUD1;SYVN1;AUP1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.5543701041695525,1.0141067324327058,0.5,1.0,1.0,4/21,11.07%,HMGB2;H2BC11;GSDMD;FGR
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.5029908211458463,1.0137513997696797,0.48314606741573035,1.0,1.0,10/37,23.36%,ITGA2;RARRES1;PPP1R13L;BACE2;BNIP3;TMEM14A;HSPB1;SLC16A3;CD151;EPAS1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.4620204745568187,1.0137358809499497,0.47,1.0,1.0,38/204,20.67%,TOP2A;DAPK2;RHOB;CLIP3;GADD45B;PNMA1;SOX4;DAPK1;CSRNP3;ARHGEF4;NGEF;SEPTIN4;BNIP3L;RPS6;BOK;RRP1B;FAM162A;RPS27A;IFIT2;C3ORF38;KALRN;PPID;RPS6KA2;PNMA2;BNIP3;RBM5;ITSN1;PYCARD;CASP3;KCNMA1;BCL6;NEURL1;SOD1;SHQ1;OLFM1;UBA52;HSPD1;UBB
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6286450946595724,1.013672627156882,0.5,1.0,1.0,3/10,24.80%,PAICS;PFAS;IMPDH1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.48337330391411715,1.013500862663964,0.4835164835164835,1.0,1.0,14/61,26.38%,MAPT;STMN3;VPS11;PDE2A;PDE4DIP;PINK1;CENPV;PLXNB1;CLIC4;SURF4;RDX;SYT11;TJP1;MTM1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.4868113409325028,1.0134593852849352,0.4583333333333333,1.0,1.0,18/99,14.56%,KCNE1;AANAT;EGR1;ADCY3;GABRB1;AKAP6;GABRB3;RUVBL2;RAPGEF3;PDE2A;ADCY8;IMPACT;GNAI1;NR4A3;GABRB2;RYR3;HCN1;BRCA1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6675405497158955,1.0134154750098914,0.5416666666666666,1.0,1.0,4/7,18.44%,RELN;NRXN1;CAMK2B;NEURL1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.381646292186137,-1.0132988635663716,0.35714285714285715,1.0,1.0,7/35,12.30%,HUS1;POLD3;TPRKB;CTC1;TEP1;LTO1;NBN
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.662826231433432,1.013232837080866,0.5588235294117647,1.0,1.0,1/5,6.28%,SOX4
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.4651018852247406,1.0131761271387503,0.47,1.0,1.0,58/294,20.67%,THBS1;HTR2B;KLF4;LRP2;PRLR;ARAF;TLE1;NAA38;NR4A2;TFRC;ATAD3A;PDK4;BEX3;ALOX12;RNF144B;ANXA1;VEGFA;HSPA5;FIGNL1;PTPRZ1;IL7;FMN2;COPS5;MAG;BNIP3L;RETREG1;FAIM2;MCL1;RPS27A;IGF1R;PLK2;CRLF1;NTRK2;PINK1;TYRO3;RIPK2;BNIP3;SOD2;PRELID1;HCLS1;BCL2L2;NUAK2;WNT5A;CASP3;TMEM14A;CFL1;HSPB1;SOD1;MAPK8IP2;ARHGDIA;GSTP1;HSPA1B;TAF9B;NRBP2;PRKAA2;UBA52;HSPD1;UBB
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5825515402797227,1.0130882230203537,0.5,1.0,1.0,8/22,23.95%,DCC;MAP2;MAG;DUSP10;CDKN1B;FGF13;PTPRS;RTN4
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6415950501514793,1.0127344886033727,0.5540540540540541,1.0,1.0,1/8,11.45%,ERRFI1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.6221367418646568,1.0126948943948233,0.5068493150684932,1.0,1.0,4/8,23.89%,GPR65;IMPACT;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6030806329235124,1.0124524508141381,0.4936708860759494,1.0,1.0,3/10,17.91%,NTRK3;FLT1;ESR1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.6106465706218691,1.012136149774932,0.527027027027027,1.0,1.0,1/10,2.50%,ACSL1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.6317382634831435,1.0115520647778895,0.5147058823529411,1.0,1.0,4/11,7.93%,CACNB2;CEMIP;ANK2;AKAP6
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.5314260721867791,1.0113575301520208,0.4666666666666667,1.0,1.0,11/35,20.67%,RPA2;FANCB;FANCM;RPS27A;FANCI;XRCC3;FANCL;FAN1;FANCA;UBA52;UBB
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4033342726997122,-1.011143832379672,0.38461538461538464,1.0,1.0,3/30,3.07%,NCOA4;NEDD4;PMEPA1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5424227707648601,-1.011088793336816,0.37037037037037035,1.0,1.0,2/8,3.55%,ITGA5;IL1B
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.49315055333789876,1.0107826432698752,0.494949494949495,1.0,1.0,18/116,15.16%,KLF4;SPON1;TSPAN13;ITGA2;RELN;F13A1;GPNMB;SEMA3B;CA2;SNAP25;AKAP12;ID2;MAFB;GPRC5B;PDCD1LG2;PPP1R15A;MAP7;TNFRSF1B
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5677541656290868,1.0100494823973722,0.4567901234567901,1.0,1.0,5/15,28.68%,DNM3;DNM1;MX1;OPA1;MX2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6471766425650187,1.0099871724774934,0.5263157894736842,1.0,1.0,1/7,6.28%,SOX4
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6308064428249998,1.0098770198149507,0.5416666666666666,1.0,1.0,4/8,27.08%,RYR2;PDE4B;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6308064428249998,1.0098770198149507,0.5416666666666666,1.0,1.0,4/8,27.08%,RYR2;PDE4B;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5171754805387526,-1.0096206847137978,0.5217391304347826,1.0,1.0,4/10,4.16%,ABCG2;FOLR2;SLC46A1;SLC2A8
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.45161521131619603,-1.0095715176545819,0.42105263157894735,1.0,1.0,1/20,0.13%,STAT4
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5571996840520634,1.0095597419259286,0.4605263157894737,1.0,1.0,10/23,27.47%,SLC4A10;CA2;SLC9A7;SLC9A6;SLC9A1;CHP1;LRRK2;CFTR;SLC26A3;GPR89B
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.5725037938013104,1.0094679927024524,0.4931506849315068,1.0,1.0,2/10,14.56%,RAPGEF3;BRCA1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.591368509826416,-1.0093920087690078,0.4864864864864865,1.0,1.0,2/7,5.28%,MYBL1;APOBEC3G
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),0.686355770082274,1.0093568465997191,0.5692307692307692,1.0,1.0,1/5,22.97%,SLC5A6
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6159063541048353,1.0091967280227732,0.5063291139240507,1.0,1.0,2/12,5.84%,SHANK3;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.6692952437235613,1.009178325804171,0.53125,1.0,1.0,1/6,7.02%,FCGR2B
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.6683815415736346,1.0091747999140406,0.5362318840579711,1.0,1.0,1/6,2.31%,CBR1
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.4583179072645425,1.0088220200821563,0.48484848484848486,1.0,1.0,33/226,15.11%,FGF1;ARAF;TOM1L1;TGFB2;CENPE;ENPP2;CLIP3;FAXDC2;RELN;IL15;AGT;TFRC;MTCP1;CEMIP;ACVR2A;VEGFA;CHI3L1;GPNMB;SPDYA;INSR;SLCO3A1;RAPGEF3;CALM3;TXN;GHR;NTRK3;NTRK2;FAM20A;PINK1;PRKAG2;RIPK2;LIMCH1;HCLS1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.47609911784934433,-1.0086759769940805,0.38095238095238093,1.0,1.0,3/13,16.58%,METTL8;METTL16;TRMT6
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.6388045778807853,1.0085912004552804,0.4605263157894737,1.0,1.0,5/9,32.01%,BRCA1;LRIF1;HNRNPU;MACROH2A2;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.3773766894651843,-1.0085890486092262,0.25,1.0,1.0,10/35,15.15%,CD2;IL1B;LGALS9;TLR3;TLR7;SYK;HSPA1A;BCL10;TIRAP;LILRA2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.47846484195825323,1.008582945912036,0.4725274725274725,1.0,1.0,20/75,23.55%,THBS1;PRR16;VIM;EIF4A3;SOX4;RPS6KB2;RBM3;EIF3E;PKM;UPF3A;RPS4X;RCC1L;POLR2D;RPS9;PYM1;POLR2G;SAMD4A;PLD1;UHMK1;TRMT10C
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.48777540701067834,-1.00807341187941,0.4642857142857143,1.0,1.0,1/7,1.56%,SESN2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5238504000737918,1.0079407026115226,0.5333333333333333,1.0,1.0,4/34,15.20%,WDR5;YEATS2;PER1;TRIM16
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.39180458314489064,-1.007904990938148,0.3684210526315789,1.0,1.0,6/36,11.88%,NUP42;PHAX;NUP155;RAE1;NUP214;NUP188
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5278646280757482,1.007776243632258,0.49411764705882355,1.0,1.0,4/31,5.13%,TM7SF2;FAXDC2;ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.5424716658224886,1.0077176104531924,0.4782608695652174,1.0,1.0,11/30,23.12%,MDH1;ENO2;PGAM1;AKR1B1;GPI;FBP1;SLC39A14;SORD;PGK1;ENO1;PGM1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.5986953130926003,-1.007325581808286,0.5588235294117647,1.0,1.0,3/5,32.05%,CSNK2A2;NUMA1;TPR
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.46531330835861223,1.0072454349241602,0.4742268041237113,1.0,1.0,28/160,17.02%,DDIT4;DAPK2;RHOB;ZBTB16;MAL;DCC;PRKCE;ERCC2;CIT;ALOX15B;ADAM15;DAPK1;SEMA6A;GLRX2;SEPTIN4;BOK;FAM162A;CASP5;TCHP;IFIT2;PAK5;CIDEB;PPP1R15A;BNIP3;SCN2A;PYCARD;IFI27L2;CASP3
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.5554688055798123,1.007146513952863,0.5060240963855421,1.0,1.0,6/20,20.18%,PDK4;MID1IP1;PRKAG2;BRCA1;ERLIN1;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6021138704574281,1.0070546798344575,0.4666666666666667,1.0,1.0,3/10,13.02%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5257415158688563,1.0070138901926486,0.4625,1.0,1.0,4/32,7.02%,TUB;IL15;SLC11A1;FCGR2B
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.4639559149890374,-1.0069972797364255,0.3,1.0,1.0,5/13,11.22%,ITGAM;LGALS9;SCIMP;NMI;ITGB2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.5573848756236262,1.0068823741387614,0.4578313253012048,1.0,1.0,2/18,5.78%,THBS1;PTPRG
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5685230886501923,1.0066129276477267,0.5609756097560976,1.0,1.0,4/19,9.56%,TGFB2;ROBO2;SOX4;ROBO1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.6797252632099168,1.006494649818264,0.47761194029850745,1.0,1.0,1/5,5.93%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.6790092843441771,1.0062678686278372,0.5342465753424658,1.0,1.0,3/6,24.05%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.6561194332998336,1.0061446366981763,0.4782608695652174,1.0,1.0,2/5,19.12%,AGT;RGCC
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.6731113223945391,1.0059416321313825,0.5147058823529411,1.0,1.0,3/5,23.27%,PDK4;PDK3;PDPR
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.6731113223945391,1.0059416321313825,0.5147058823529411,1.0,1.0,3/5,23.27%,PDK4;PDK3;PDPR
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.5613426003954584,1.005814041729663,0.48148148148148145,1.0,1.0,3/19,8.56%,SCN3B;DMD;RYR2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.46983107126318985,1.0054925247315438,0.4489795918367347,1.0,1.0,14/119,9.78%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;VEGFA;F13A1;SYT4;STEAP2;SNAP25;RIMS2;ENDOD1;FN1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.4950006375227097,1.0054603383754277,0.5268817204301075,1.0,1.0,15/59,21.77%,GPNMB;TRAF2;PTPRZ1;MAG;RETREG1;CRLF1;NTRK2;PINK1;TYRO3;SOD2;TNFRSF1B;SOD1;NRBP2;FBXO7;CPEB4
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.5614936322320726,1.005184135331146,0.5301204819277109,1.0,1.0,5/16,11.45%,FGF1;VEGFA;CHI3L1;CCDC39;ERRFI1
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.6547977295439028,-1.0051171619745785,0.6071428571428571,1.0,1.0,2/5,11.40%,TREM2;CXCL12
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.5495088609134635,1.005083125798469,0.4880952380952381,1.0,1.0,3/35,7.38%,KLF4;AGT;RBM3
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.6546997613836589,-1.0049499262427732,0.5172413793103449,1.0,1.0,1/5,1.67%,PEX13
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.5132475963421163,1.0047949857238694,0.47368421052631576,1.0,1.0,13/31,32.33%,SLF1;FMN2;FANCB;SPIRE2;ZCWPW1;ERCC6;KMT5C;TIMELESS;SPIDR;PARP9;ARID2;PRKDC;RIF1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.6708861285336416,1.0046892037113397,0.5285714285714286,1.0,1.0,2/5,31.01%,TAPBPL;HLA-DMB
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.641531336110178,1.00463951543655,0.5151515151515151,1.0,1.0,1/7,12.11%,NOD2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.5763874974607969,1.00447312313746,0.5316455696202531,1.0,1.0,4/13,14.75%,LRP2;VEGFA;KDM1A;SMARCD3
prerank,MSigDB_Hallmark_2020__Glycolysis,0.479422422371616,1.0044667874442235,0.5670103092783505,1.0,1.0,31/127,20.57%,DDIT4;MDH1;SAP30;VCAN;TALDO1;VEGFA;HSPA5;ENO2;PGAM1;PKP2;IRS2;TXN;FAM162A;P4HA1;MXI1;HS2ST1;PRPS1;PKM;HDLBP;PLOD1;TGFBI;NDST3;ZNF292;PDK3;GFPT1;SOD1;EGLN3;PPFIA4;GYS1;SLC16A3;ERO1A
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5490542803837954,1.0044329255468796,0.5375,1.0,1.0,2/23,6.24%,RHOB;FIGNL1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.38765606127089347,-1.0043342098541888,0.45454545454545453,1.0,1.0,8/32,16.86%,RBM23;JMJD6;CDK11B;KHDRBS3;METTL16;SON;CPSF4;SAFB
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5628357967714919,1.0041526350282555,0.4625,1.0,1.0,1/16,0.89%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.5951559908092666,1.0040601011559114,0.5,1.0,1.0,5/12,20.39%,CALM3;MAGI2;PPP1R15A;CD300A;MTMR9
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.390961136665726,-1.0039613483521181,0.35714285714285715,1.0,1.0,5/23,11.22%,CCL5;IRAK4;BSG;NCKAP1L;ITGB2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.4782481901164315,1.0037996668010234,0.5212765957446809,1.0,1.0,9/67,13.02%,TGFB2;MAPT;CDKN2AIP;SYT4;AKAP6;UNC13A;RIMS2;MFSD2A;SYT1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.6269854644889372,-1.0037472302466104,0.4838709677419355,1.0,1.0,4/7,21.64%,APH1A;GALNT11;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6576595294289002,1.003720897628479,0.4782608695652174,1.0,1.0,1/7,3.04%,EIF4A3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5734316545661966,1.0035933114782927,0.4588235294117647,1.0,1.0,5/13,25.30%,SIRT5;PINK1;BRCA1;PPARA;TRAP1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6037058329364473,1.003288459800055,0.5,1.0,1.0,4/13,24.54%,CALM3;CLIC2;ATP1A2;GNB5
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.5790773076229657,-1.0032048756508594,0.42857142857142855,1.0,1.0,2/7,6.92%,CX3CR1;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.40669078530439967,-1.0029907258692028,0.5,1.0,1.0,1/22,0.20%,CCL5
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.5204011455703628,1.0027979503144084,0.5172413793103449,1.0,1.0,9/31,26.82%,TIMM13;PINK1;TOMM20;GRPEL1;HSPD1;FBXO7;MFN2;TIMM22;TOMM40
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.6363568795243172,1.0027017938232277,0.4931506849315068,1.0,1.0,4/7,32.80%,CSRP1;FHOD3;TTN;ACTN2
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.5969969179604429,1.0026908368667817,0.5416666666666666,1.0,1.0,2/12,7.75%,SLC4A10;CA2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6472654469402174,1.0025573293327985,0.5194805194805194,1.0,1.0,4/7,30.61%,GRIP1;GRIPAP1;RAB11A;ARHGAP44
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4644558330561414,-1.0025257415657494,0.38461538461538464,1.0,1.0,2/11,8.99%,ZDHHC5;TLR3
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.622295250752256,1.002412310033408,0.5522388059701493,1.0,1.0,4/6,34.21%,EZH2;DOT1L;RIF1;EZH1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.4749737902856682,1.0023515870308728,0.5,1.0,1.0,24/91,28.51%,THBS1;HSPA5;PDIA2;TRAF2;EIF2AK3;HERPUD1;PPP1R15A;DNAJB9;SYVN1;RNF139;HYOU1;RASGRF1;ATP2A2;ERO1A;P4HB;ATF3;JUN;HSP90B1;CFTR;DDRGK1;TMEM33;SCAMP5;EIF2B5;BAG6
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5146995220740994,1.0022762209633118,0.5280898876404494,1.0,1.0,16/38,30.00%,HSPA5;HERPUD1;STT3B;DNAJB2;HSPB1;HSPA1B;HSPD1;HSPA2;HSPA14;BAG3;HSP90AB1;HSPA9;HSPA13;PTPN1;HSPA8;HSPA4L
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.47602240535109325,1.002208801950653,0.48,1.0,1.0,15/145,10.60%,DDIT4;KLF4;ACVR1B;PVT1;ZBTB16;ALOX15B;CDKN2AIP;IER5;NDRG1;HINT1;SLC19A2;ST14;MXD1;FAM162A;TXNIP
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5162983741012953,1.0017855873013128,0.5108695652173914,1.0,1.0,8/48,18.19%,ALG10B;MGAT4C;TUSC3;MGAT1;STT3B;MCFD2;MAGT1;GFPT1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.6547846585031376,1.0013554463384673,0.5492957746478874,1.0,1.0,3/6,26.34%,FOXP1;GPR183;PTGER4
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5700765110668555,1.0005950607197391,0.5301204819277109,1.0,1.0,2/13,17.78%,ETFB;UQCRFS1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.5738377100314278,1.000486091973304,0.4666666666666667,1.0,1.0,3/9,23.04%,PRPS1;HPRT1;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.5849925144503455,1.0004788293450568,0.5277777777777778,1.0,1.0,1/11,1.60%,TGFB2
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.38396870920119003,-1.0002016343005595,0.3,1.0,1.0,16/66,9.66%,NKG7;GRAP2;CD300LF;NCOA4;TAL1;LYL1;P2RX1;GYPC;BIN2;UCP2;RBM38;EDRF1;EPOR;MYO1F;HTATSF1;BTK
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4806680856312223,-1.0001732309018023,0.35294117647058826,1.0,1.0,9/20,23.25%,LEO1;SUPT16H;THOC5;KAT7;BRD4;SUPT5H;THOC1;CDC73;SUPT6H
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.4505675443475127,1.000171575446623,0.53,1.0,1.0,77/400,19.12%,THBS1;HTR2B;KLF4;NAMPT;FGF1;PRLR;ST18;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;HMGB2;NRG1;TBC1D8;IL15;AGT;OSMR;TFRC;MEIS2;ALOX15B;LIFR;PTPRK;KITLG;VEGFA;GPNMB;SOX4;SPDYA;SHANK2;IER5;MVD;IL7;RBFOX2;INSR;CAMK2N1;IFNLR1;IRS2;ID2;FN1;RPS6;BOK;PTN;NTRK3;IGF1R;ALK;FLT1;DNAJB2;NR4A3;CRLF1;NTRK2;MAGI2;RPS6KA2;RNF126;SOD2;CLMN;E2F7;HCLS1;RBM5;ITGAV;IL11RA;RNF139;RPS4X;SDCBP;BCL6;THAP12;COPS9;CTBP1;NEURL1;CDKN1B;RPS9;PRKRA;CHD5;EGLN3;APP;FTH1;RGCC
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5822917886066548,1.0001390376770585,0.525,1.0,1.0,7/16,26.70%,NLGN1;SNAP25;SLC17A7;CPLX1;RAB5A;BRSK1;RIMS1
prerank,MSigDB_Hallmark_2020__Complement,-0.31444490285246657,-1.0,1.0,1.0,1.0,18/137,10.19%,CCL5;CASP7;ITGAM;RHOG;PFN1;GZMB;OLR1;FYN;SH2B3;APOBEC3G;ERAP2;DOCK4;CASP10;C3;PLEK;KLKB1;SRC;SPOCK2
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.5096490357128145,0.9998585685406891,0.5053763440860215,1.0,1.0,6/55,13.70%,ACVR1B;CDK14;SPDYA;RCC1;PLK2;HINFP
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.4384830825041308,-0.9997801684828185,0.5,1.0,1.0,5/26,12.23%,SESN2;SESN3;CLEC16A;TELO2;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.5634475922841565,0.9997454805214057,0.5584415584415584,1.0,1.0,5/19,20.18%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6758760654457772,0.999668568029217,0.53125,1.0,1.0,1/5,13.39%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6758760654457772,0.999668568029217,0.53125,1.0,1.0,1/5,13.39%,XRCC3
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6104817843080523,0.9993494303045914,0.5263157894736842,1.0,1.0,5/9,27.64%,HIF1A;HAMP;HFE;TF;SLC11A2
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.5016192072571592,-0.9992782072281224,0.391304347826087,1.0,1.0,2/12,12.33%,SETDB1;TASOR
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.6005342617126713,0.9990590492117,0.5324675324675324,1.0,1.0,3/10,16.36%,TRIM5;IFITM3;TRIM26
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.5391491691271214,-0.9990349762657911,0.43333333333333335,1.0,1.0,3/9,17.35%,DFFB;REXO4;FBH1
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.5180702439602625,-0.9989707603281136,0.46153846153846156,1.0,1.0,1/8,0.86%,HUS1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6112887581060948,0.9988433599119676,0.5675675675675675,1.0,1.0,3/8,27.28%,IRS2;DDB1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5376133707674106,0.9987888644787685,0.4883720930232558,1.0,1.0,3/22,13.75%,ARRDC3;BMI1;PINK1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6314698434112853,0.9986057835193904,0.5641025641025641,1.0,1.0,2/7,5.93%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.5277916305952081,0.9984334897794063,0.47297297297297297,1.0,1.0,4/20,14.88%,CR1;CD55;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6566571856736132,0.9983289392023678,0.5882352941176471,1.0,1.0,2/5,20.44%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.6566571856736132,0.9983289392023678,0.5882352941176471,1.0,1.0,2/5,20.44%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.6382501324641958,0.9982963725213904,0.5362318840579711,1.0,1.0,3/6,20.24%,MAP9;KIF11;UBXN2B
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.5302172268687814,-0.998295443363486,0.4827586206896552,1.0,1.0,3/9,6.36%,LGALS9;LILRB4;CD274
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6353217250173999,0.9980462011587383,0.45454545454545453,1.0,1.0,2/7,22.68%,PINK1;MFN2
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5621605502961979,0.9980127950496568,0.524390243902439,1.0,1.0,3/16,11.83%,MAPT;VEGFA;SEMA5A
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.31437631759384677,-0.9977894803589117,0.3333333333333333,1.0,1.0,17/80,15.54%,RANBP6;ARL2BP;HHEX;APPL2;NUP155;RPAIN;PHB2;BCL3;IPO13;NUP214;NUP188;CHCHD10;PTTG1IP;SYK;AKT1;TAF8;XPA
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.5982151331886234,0.9977744134496694,0.5,1.0,1.0,3/9,24.13%,ABCA2;INSIG1;RORA
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.6304964110315641,0.9975819253624871,0.569620253164557,1.0,1.0,3/7,17.48%,SYT4;PPFIA2;KIF5A
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.523540253487687,0.9975535682307115,0.5168539325842697,1.0,1.0,8/47,25.11%,HTR2B;MCL1;PINK1;NRBP2;MTMR9;LEPR;LRRK2;TBC1D14
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4677125671724889,0.9971975285503725,0.5757575757575758,1.0,1.0,35/178,25.22%,DEPP1;HTR2B;DAPK2;GFAP;EEF1A2;MAPT;FBXL2;DAPK1;TRIM5;BOK;MCL1;PLK2;PINK1;PRKAG2;BNIP3;CASP3;CDK5R1;NPRL2;HSPB1;ROCK1;PRKAA2;MTMR9;TRIM65;UCHL1;ATP6V0B;TRIM14;EEF1A1;ATP6V1D;LEPR;LRRK2;ATP6V0E2;ATP6V1B2;TBC1D14;ATG13;DRAM1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.5661734502633801,0.9969615296259959,0.5308641975308642,1.0,1.0,9/27,28.11%,MASTL;CALM3;MAGI2;PPP1R15A;CD300A;PPP4R4;HSP90B1;PPP1R11;HSP90AB1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3611764897675758,-0.9968159322483304,0.42105263157894735,1.0,1.0,3/30,5.50%,HUS1;POLD3;CTC1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4799296384107785,0.9967813642632897,0.532608695652174,1.0,1.0,13/48,23.30%,KLF4;ANXA1;GPNMB;FHL1;ID2;E2F7;PKD1;PLCB1;CCND3;RGCC;APPL1;RBL2;RDX
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.49878046090525785,0.9967113638103124,0.4868421052631579,1.0,1.0,7/24,24.69%,CYREN;FANCB;TFIP11;POLQ;ERCC6;RNF169;MAGEF1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.4527760796960365,0.9966642953491411,0.4742268041237113,1.0,1.0,25/120,23.78%,BRIP1;RPL23;RPA2;PPP1R13L;DNA2;PRR5;TTC5;RPS20;PRKAG2;BRCA1;RPL37;CDK5R1;RFC4;RPL11;CHD5;TAF9B;PRKAA2;TAF7;MEAF6;NOP53;HEXIM1;RBBP8;RPA3;BARD1;SETD9
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5068281061627065,0.9965556556646668,0.4891304347826087,1.0,1.0,12/41,19.00%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;AIM2;WNT5A;PYCARD;TMED10;HSPB1;APP
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.5214381678842341,0.9963844960137967,0.5,1.0,1.0,8/20,28.86%,NUDT13;CMPK1;NME4;GUK1;CTPS1;AK5;TXNRD1;AK6
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5472462147047302,0.9963521372633907,0.527027027027027,1.0,1.0,5/14,21.02%,AGT;AKAP6;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.618907076096099,0.9961809885322523,0.5147058823529411,1.0,1.0,3/8,15.23%,STMN3;CKAP5;STMN2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.4229503546080933,-0.996082971095628,0.4444444444444444,1.0,1.0,6/22,18.16%,PEX13;PEX16;FIS1;ABCD3;PEX2;ACBD5
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6052994359506045,0.9960253795679227,0.4805194805194805,1.0,1.0,1/10,1.54%,PLIN2
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.6584845226420847,0.9958475053375111,0.4714285714285714,1.0,1.0,3/6,19.58%,IRS2;BCL6;FOXP1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.43439574733348374,-0.9958055625623241,0.5294117647058824,1.0,1.0,2/18,1.98%,CYB5A;CYP2S1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5907744926044921,0.9956430830245807,0.5522388059701493,1.0,1.0,1/9,2.77%,HMGB2
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.6404773187084435,0.9956349667694738,0.5074626865671642,1.0,1.0,1/5,14.47%,BLMH
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.501466150132961,0.9955705653804346,0.5376344086021505,1.0,1.0,6/45,19.50%,KLF4;POLG2;RFC4;TCP1;RGCC;PARM1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5558678800788814,-0.9953511449159312,0.5185185185185185,1.0,1.0,1/7,0.21%,IKZF3
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.40193204561815665,-0.9949024619875251,0.5625,1.0,1.0,2/22,3.55%,PHLDB2;IL1B
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4773187622147945,0.9947375118331739,0.5274725274725275,1.0,1.0,14/73,21.76%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;SH3GL2;DYNC1H1;KIF5A;KIF11;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5229452888682466,0.9947329757881105,0.5402298850574713,1.0,1.0,7/41,19.12%,THBS1;VEGFA;HIF1A;ANGPT2;HSPB1;ATP5F1A;RGCC
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6347305785317402,0.9946043393257143,0.5324675324675324,1.0,1.0,3/8,10.90%,VCAN;NCAN;CSPG5
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.5118787452250234,0.9945341599565828,0.5113636363636364,1.0,1.0,8/39,22.77%,ANK3;STEAP2;NSF;PREPL;STXBP6;SPTBN1;OSBPL5;EXOC5
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.59076210593761,0.99449808326524,0.5263157894736842,1.0,1.0,2/11,14.18%,WASF1;SLIRP
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.5223540245508742,-0.9944858882595017,0.5,1.0,1.0,4/14,20.41%,GCLC;GCLM;MGST2;FPGS
prerank,MSigDB_Hallmark_2020__Apical Junction,0.46086901826855986,0.9943286033660136,0.52,1.0,1.0,22/123,17.26%,CLDN18;CERCAM;VCAN;ITGA2;CDH8;CADM2;CNTN1;ALOX15B;ADAM15;NRXN2;MVD;NLGN3;TNFRSF11B;ADAM23;NEGR1;GNAI1;SGCE;NFASC;PKD1;TGFBI;INSIG1;THY1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.5758717916392438,0.9941866133806933,0.5657894736842105,1.0,1.0,5/17,20.18%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.5758717916392438,0.9941866133806933,0.5657894736842105,1.0,1.0,5/17,20.18%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.6676436704922,0.9941274364493907,0.5774647887323944,1.0,1.0,4/6,18.44%,RELN;NRXN1;CAMK2B;NEURL1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.6068274260326211,0.9940923633114647,0.5205479452054794,1.0,1.0,3/9,13.02%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6251778283742234,0.9938473422098555,0.5142857142857142,1.0,1.0,4/9,23.64%,ATP1B3;ATP1B2;SLC9A1;ATP1A2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6251778283742234,0.9938473422098555,0.5142857142857142,1.0,1.0,4/9,23.64%,ATP1B3;ATP1B2;SLC9A1;ATP1A2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.5396186236977326,0.9934051183407132,0.5308641975308642,1.0,1.0,9/31,17.58%,SVEP1;ENAH;LAMB1;RND3;TCF7L1;SH3D19;UACA;NRG4;TIMP3
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.4101026890232649,-0.9931863748959802,0.5,1.0,1.0,5/36,6.91%,CCL5;IL1B;UQCC2;ITPR2;PASK
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.43997049439674857,-0.992974161711574,0.3125,1.0,1.0,6/18,21.38%,FSCN1;CYFIP1;ARPC2;CDC42;ACTR2;WASF2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6050441698083671,0.9929360818061865,0.527027027027027,1.0,1.0,4/9,10.91%,TGFB2;NRG1;ADGRG6;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.6049117079094566,0.9924933033279617,0.546875,1.0,1.0,3/8,20.73%,TMEFF2;GSTP1;TAF7
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.5366703058539513,-0.9924669626882762,0.41379310344827586,1.0,1.0,3/6,12.67%,NPL;GNPDA1;NAGK
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.6314756501486124,0.9922314123654773,0.5138888888888888,1.0,1.0,4/9,24.95%,AGT;GUCY1B1;KCNC2;FPR1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.5071496607784436,0.9918190047006759,0.5465116279069767,1.0,1.0,15/55,27.52%,VIM;RETREG1;RPS27A;DYNC1H1;CALCOCO2;AUP1;UBA52;UBB;DYNC1I1;ATG5;LGALS8;ATG13;CFTR;DDRGK1;DYNLL1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.6495193435360184,0.9916950714355776,0.5373134328358209,1.0,1.0,1/5,2.57%,CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.6495193435360184,0.9916950714355776,0.5373134328358209,1.0,1.0,1/5,2.57%,CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.6495193435360184,0.9916950714355776,0.5373134328358209,1.0,1.0,1/5,2.57%,CYP3A5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5603385790242705,0.991578814917352,0.5294117647058824,1.0,1.0,7/16,28.70%,SCN3B;CAV3;FXYD7;UTRN;ATP2B4;FGF12;SNTA1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5569200610078051,0.9912067969560181,0.5647058823529412,1.0,1.0,7/21,17.04%,CR1;EPHA4;PRELID1;GRIN2B;AIM2;PYCARD;PICALM
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.6033323997738382,0.9911787636879387,0.5897435897435898,1.0,1.0,3/8,16.36%,TRIM5;IFITM3;TRIM26
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.6594016763963715,0.991163312352706,0.5373134328358209,1.0,1.0,3/6,19.78%,ERC2;CBLN2;DCTN1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6278122615351039,0.9910687298523599,0.5230769230769231,1.0,1.0,4/10,17.58%,EIF2AK3;GHR;IGF1R;PLCB1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.5112364834520765,-0.9910685517292455,0.47058823529411764,1.0,1.0,5/11,12.59%,POLD3;ADK;DGUOK;TYMS;AMPD3
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.47293089579193376,0.9909723828412195,0.5604395604395604,1.0,1.0,14/75,21.76%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;SH3GL2;DYNC1H1;KIF5A;KIF11;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5520735351727615,0.9909515782811754,0.5176470588235295,1.0,1.0,3/17,9.39%,SUV39H2;ANTKMT;CSKMT
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.5336205137716212,0.9904995181254972,0.5232558139534884,1.0,1.0,4/18,17.08%,MMP21;DNAH11;CCDC39;ENKUR
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.5351321772258846,-0.9903468138718055,0.4827586206896552,1.0,1.0,2/10,9.42%,SRRT;PUS10
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5385328143648827,0.9903439521985097,0.5,1.0,1.0,7/16,17.65%,ANXA1;ST14;TXNIP;WNT5A;CASP3;CLIC4;UGCG
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5038047286247215,0.9903199106464015,0.4782608695652174,1.0,1.0,11/38,19.00%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;AIM2;WNT5A;PYCARD;HSPB1;APP
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.47241992322704296,0.9901397223249393,0.5161290322580645,1.0,1.0,9/64,13.14%,KNSTRN;NUDT16;RACGAP1;IHO1;RCC1;MAP9;CALM3;PLK2;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6688644951959659,0.9900525503099001,0.5217391304347826,1.0,1.0,1/5,10.14%,CALM3
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5166429668976711,0.9898951934586692,0.55,1.0,1.0,7/17,23.95%,RTN1;NTRK2;PICALM;ROCK1;RTN3;FLOT2;RTN4
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.5074256722171465,0.9896864077089019,0.4772727272727273,1.0,1.0,13/34,23.50%,RPA2;TDG;MPG;DNA2;NEIL1;POLQ;ADPRS;RFC4;POLL;ERCC6;NEIL2;RFC1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.4122537146084868,-0.9896074349619458,0.4375,1.0,1.0,7/21,17.79%,TRIB1;NMI;NLRC3;ILRUN;TRAFD1;LILRA2;SIGIRR
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.5111989589961512,-0.9895876443150589,0.5454545454545454,1.0,1.0,1/8,2.89%,ACTA2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.5866205614558077,0.9892553925237435,0.5571428571428572,1.0,1.0,4/9,26.66%,SLC9A7;SLC9A6;SLC9A1;SLC6A1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5625379989088204,0.9892476260777163,0.573170731707317,1.0,1.0,5/19,10.75%,COBL;LSR;ANXA1;ARID5B;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.6300106610022166,0.9892336149889533,0.5714285714285714,1.0,1.0,1/6,2.46%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.585915088607772,0.9892123785845259,0.5443037974683544,1.0,1.0,1/10,1.54%,PLIN2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.45166985904401824,-0.9889673603415028,0.391304347826087,1.0,1.0,1/14,2.09%,SLC30A5
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5021918413611064,-0.9888522069949993,0.4642857142857143,1.0,1.0,6/11,23.80%,WHAMM;ARPC2;ARPC3;ACTR2;ARPC5L;ACTR3
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5240722465361869,-0.9885664936028479,0.5,1.0,1.0,1/7,1.07%,CX3CR1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.5432426164390274,0.9880418615322717,0.5131578947368421,1.0,1.0,10/24,21.61%,LRP2;FAH;SLC13A3;GHR;CRYL1;FBP1;TGFBI;GBA3;NME4;SORD
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.5037869843631941,0.9879738214901953,0.46153846153846156,1.0,1.0,11/36,29.30%,TIMM13;TOMM20;PMPCA;GRPEL1;HSPD1;FBXO7;MFN2;TIMM22;TOMM40;AGK;PMPCB
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.4458751620078304,-0.9878622774934925,0.6,1.0,1.0,5/16,10.76%,IL1B;APPL2;IGF1;SORL1;REST
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5410211060366533,0.9877406881776907,0.5058823529411764,1.0,1.0,1/21,0.29%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5930531740604804,0.9874073210302051,0.5394736842105263,1.0,1.0,5/13,15.43%,ANK2;AKAP6;RYR2;CALM3;VMP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5158486613534514,0.9870137445678918,0.5294117647058824,1.0,1.0,5/20,24.74%,ID2;HCLS1;FES;TNF;CTNNBIP1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.4621384187265899,0.9869865222835794,0.52,1.0,1.0,65/233,25.51%,BRIP1;EEF1A2;RPL23;NR4A2;RPL37A;RPA2;CLSPN;RPS6KB2;RPL38;COPS5;PAX8;RPS6;RPS27A;RPL23A;DNA2;RPS25;RPS27;DARS1;DONSON;B4GALT5;RPS11;RPS20;RPL9;RPLP2;BRCA1;EEF1B2;RPS18;MRPL43;RPL37;RPL14;RPS4X;POLE2;RFC4;RPL11;RPS24;MRPL27;MRPL55;GCNT1;POLR2D;RPS9;RPL36;ORC6;POLL;POLR2G;DBF4;RPS3A;MRPS14;MRPL3;RPL35;RPL4;RBBP8;EEF1A1;RPL32;TIMELESS;TNIP1;ORC3;RPA3;BARD1;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5175833889002063,0.9869402951936362,0.5517241379310345,1.0,1.0,3/29,10.07%,DAPK2;NR4A2;DEPTOR
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.6735848714886651,-0.9868643858044861,0.5675675675675675,1.0,1.0,1/5,9.29%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.6865869447434725,0.9868265412783288,0.5507246376811594,1.0,1.0,3/5,23.96%,ADAM15;ATP2A2;HFE
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.6865869447434725,0.9868265412783288,0.5507246376811594,1.0,1.0,3/5,23.96%,ADAM15;ATP2A2;HFE
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.6568528295675129,0.9865201241205925,0.581081081081081,1.0,1.0,3/6,23.24%,SART3;NOP53;TNIP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3698080416891848,-0.9863510055389342,0.5,1.0,1.0,1/36,0.13%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.4175700299054535,-0.9863402853286808,0.391304347826087,1.0,1.0,6/16,15.23%,BCL2L1;PKDCC;ABI3;TGFB1;DAB2;PPFIA1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.6153492191474834,0.9863380661299506,0.52,1.0,1.0,3/7,17.67%,DYNC1H1;CLASP2;CFL1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5730205203265542,0.9861845582634787,0.5571428571428572,1.0,1.0,1/13,4.45%,ITPKC
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.6377278580309531,0.9861027917557563,0.5223880597014925,1.0,1.0,3/6,26.02%,MAGI2;IQGAP1;BASP1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.614589068666662,0.9856688663253209,0.581081081081081,1.0,1.0,8/11,33.88%,B4GAT1;HS2ST1;NDST3;CSGALNACT2;EXT1;CSGALNACT1;B3GNT2;FUT9
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.5508145249632956,0.9856517010472157,0.5714285714285714,1.0,1.0,7/19,23.50%,RPA2;RPS27A;RFC4;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.5625290258187584,0.9853899476547079,0.5945945945945946,1.0,1.0,3/12,9.08%,PRKAR2B;AKAP6;AKAP12
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.4953600924871951,-0.985146587223994,0.5,1.0,1.0,5/11,24.91%,EXOSC10;EXOSC9;EXOSC8;XRN1;EXOSC2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.5743730927912475,0.9843290224063524,0.5324675324675324,1.0,1.0,3/14,24.49%,SLC11A1;DMXL2;ATP6V0E2
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.67543198839649,0.9841169051253643,0.578125,1.0,1.0,2/5,8.53%,SHANK3;FRRS1L
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6623831728576859,0.9840817042058042,0.5753424657534246,1.0,1.0,3/7,10.90%,VCAN;NCAN;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.47065567471799274,0.9836537795317255,0.4891304347826087,1.0,1.0,16/74,19.12%,HTR2B;FGF1;MTCP1;CEMIP;DIRAS2;VEGFA;SPDYA;ROBO1;CALM3;NOD2;FLT1;PKD1;INCENP;WNT5A;CCND3;RGCC
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5460539934702846,0.9835926285279255,0.5625,1.0,1.0,2/19,8.50%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.466978103201184,0.9835571631230652,0.4891304347826087,1.0,1.0,8/70,8.95%,EIF4A3;RIDA;ENC1;RTN1;EIF2AK3;DAPK1;PUS7;ZNF540
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5817206009367105,0.9835261914567239,0.5875,1.0,1.0,5/12,27.28%,ANTKMT;PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.4508547993647244,0.9833475536084102,0.5612244897959183,1.0,1.0,14/103,13.75%,GFAP;PAPPA2;SPOCK1;CD22;AGT;TFRC;ATAD3A;TRAF2;HCFC1;ERMN;ARFGAP1;NRG3;PAK5;PINK1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.5652677339544523,-0.9830503356836667,0.5161290322580645,1.0,1.0,2/6,17.72%,WARS1;PUM3
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.4644106947632124,0.9830400867401405,0.5714285714285714,1.0,1.0,40/162,23.12%,DDIT4;NFIL3;NAMPT;TUBA4A;IDI1;TM7SF2;GLA;SLC2A3;TFRC;HSPA5;COPS5;SDF2L1;BHLHE40;P4HA1;RDH11;FGL2;GPI;SCD;PPP1R15A;SERP1;PPA1;HMGCS1;INSIG1;ATP2A2;CACYBP;LTA4H;EGLN3;HPRT1;ACSL3;PSMC2;HSPD1;ERO1A;ATP5MC1;PSMA3;SORD;PGK1;ENO1;IMMT;ATP6V1D;PGM1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.41622801420870387,-0.9827737008413648,0.35,1.0,1.0,6/28,10.27%,RAB22A;PLEKHJ1;LAPTM4B;LAMTOR1;WASHC5;CHMP2B
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.4993912479733622,-0.9827330981996203,0.5172413793103449,1.0,1.0,4/11,15.54%,POLD3;DDB2;XPC;XPA
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.5258368391232142,0.9827157944211391,0.5662650602409639,1.0,1.0,6/32,8.59%,CACNB2;SCN3B;ANK3;FHL1;ANK2;PKP2
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6158994519617607,0.9826082372404202,0.5857142857142857,1.0,1.0,3/8,23.30%,VPS11;RAB21;RDX
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.6031874302533681,0.9818184634518985,0.5915492957746479,1.0,1.0,1/10,8.09%,ABCA2
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.6176570006654005,-0.9817892282240388,0.5789473684210527,1.0,1.0,4/5,14.41%,INPP5K;PPP1R3F;PPP1R3E;AKT1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.548098775048516,0.9817322710771137,0.5555555555555556,1.0,1.0,8/24,26.48%,ATP5ME;ATP5F1D;ATP5F1A;CHCHD3;ATP5MC1;IMMT;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.6274094052951615,0.981637840537575,0.6029411764705882,1.0,1.0,2/7,11.40%,VEGFA;NTRK3
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.5492145999783965,-0.9814858531726066,0.5,1.0,1.0,3/8,19.49%,AGO1;RBM4;ZFP36
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5492145999783965,-0.9814858531726066,0.5,1.0,1.0,3/8,19.49%,AGO1;RBM4;ZFP36
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.6675054834252643,0.9812869110030344,0.5245901639344263,1.0,1.0,1/5,1.28%,SLC16A10
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.4950120829679163,0.9809935274470615,0.5730337078651685,1.0,1.0,6/35,20.67%,MAPT;RPS27A;TGFBI;APP;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.3889097459413799,-0.9809120011607492,0.5,1.0,1.0,13/52,10.43%,CD2;BTN3A2;IL1B;CD276;LGALS9;LILRB4;CD274;SIRPA;IL18R1;TLR3;HAVCR2;TLR7;HLA-DPA1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5767792923752704,0.9805589540568873,0.5333333333333333,1.0,1.0,4/15,18.27%,HIF1A;PINK1;SOD2;HSPB1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.47453611016274805,0.9804409949709281,0.5157894736842106,1.0,1.0,20/80,23.73%,FA2H;CYP3A5;CKMT2;ALOX12;CKB;FASN;CPT1A;PNPLA8;SLC16A1;ACSL3;PPARA;SLC16A3;HACL1;SCPEP1;PDHB;MSMO1;ALDH1A2;SLC5A6;ECHDC3;BTD
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.6533521349120831,0.9804317664684573,0.59375,1.0,1.0,1/5,16.21%,HOOK3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.5456387088931969,0.9803453078703906,0.5925925925925926,1.0,1.0,6/20,17.03%,MAPT;TFRC;PINK1;BNIP3;PRELID1;TMEM14A
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.6589439301296649,0.9803422933547428,0.5967741935483871,1.0,1.0,3/5,23.04%,PTPRK;KLF9;FGFR2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5341887864606676,0.9803211473866056,0.5925925925925926,1.0,1.0,4/17,12.42%,TSHR;ADCY3;RXFP1;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.6481060921965978,0.980235963495303,0.5223880597014925,1.0,1.0,1/6,5.24%,PIAS4
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6440111981453144,0.9799448781169013,0.5689655172413793,1.0,1.0,1/5,4.66%,RORB
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6440111981453144,0.9799448781169013,0.5689655172413793,1.0,1.0,1/5,4.66%,RORB
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.6502504605099036,0.9798474229981013,0.6842105263157895,1.0,1.0,4/5,29.84%,CACNG2;CACNG8;DLG4;CACNG3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.6502504605099036,0.9798474229981013,0.6842105263157895,1.0,1.0,4/5,29.84%,CACNG2;CACNG8;DLG4;CACNG3
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.6224479639517211,0.9795778125465529,0.5,1.0,1.0,2/8,5.13%,ALOX15B;ALOX12
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6039712648564446,0.9795553393844159,0.5616438356164384,1.0,1.0,3/9,14.16%,SEMA3A;CHN1;EPHA4
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.523104656227942,0.97943324480338,0.5061728395061729,1.0,1.0,8/29,24.04%,ARF6;SGIP1;PICALM;SNAP91;RAB21;HIP1R;HFE;TF
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6287472251059549,0.9793851310788303,0.5135135135135135,1.0,1.0,1/6,5.47%,BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5393446971905853,0.979085857371254,0.5529411764705883,1.0,1.0,4/20,10.91%,VEGFA;HSPA5;HIF1A;RBPJ
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.48227808683319495,0.9786324609844488,0.48936170212765956,1.0,1.0,7/45,14.56%,NEK11;DTL;RPA2;CLSPN;EME2;DONSON;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.5225855328276744,-0.9785549114384176,0.36363636363636365,1.0,1.0,3/7,15.66%,NR1H3;WNK3;KMT2A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.44780224890764947,0.9783330000264003,0.5567010309278351,1.0,1.0,42/153,25.51%,RPL23;EIF4A3;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;TENT4B;RPS27;RPS11;RPS20;RPL9;EIF3E;RPLP2;RPS18;UPF3A;RPL37;RPL14;RPS4X;RPL11;RPS24;POLR2D;RPS9;RPL36;PYM1;UBA52;POLR2G;RPS3A;RPL35;SAMD4A;RPL4;RPL32;RPL3;RPL27A;RPL24;MRTO4;CNOT6;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.532748637469632,0.9782981589043002,0.47560975609756095,1.0,1.0,2/19,13.24%,FKBP5;PPID
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5297392627889723,0.9780725088438428,0.5185185185185185,1.0,1.0,3/22,13.75%,ARRDC3;BMI1;PINK1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.5171132025589258,-0.9780512358402838,0.36666666666666664,1.0,1.0,1/8,1.43%,GTF2H5
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3853102203960702,-0.9780229173351088,0.4444444444444444,1.0,1.0,1/34,0.13%,STAT4
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.580321661084529,0.9777052406705704,0.5595238095238095,1.0,1.0,6/14,36.59%,PER1;SFPQ;SMARCAD1;HDAC9;HDAC4;HDAC3
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5019716561041876,-0.9774100659056904,0.5,1.0,1.0,1/14,0.36%,SCNM1
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.38583626911607083,-0.9773634857169997,0.35294117647058826,1.0,1.0,2/30,3.97%,RING1;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.38583626911607083,-0.9773634857169997,0.35294117647058826,1.0,1.0,2/30,3.97%,RING1;DAB2IP
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.5778540809802282,0.9773488268403255,0.5714285714285714,1.0,1.0,3/13,26.21%,SCO2;SCO1;COX20
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.5551276388220031,0.977245647852379,0.5625,1.0,1.0,4/14,14.60%,HSPA5;ANK2;RYR2;PPP1R15A
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4447141411305889,0.9772334076315545,0.59,1.0,1.0,83/482,20.36%,TOP2A;THBS1;HTR2B;DAPK2;RHOB;LRP2;PRLR;ARAF;CLIP3;GADD45B;NAA38;AGT;TFRC;PNMA1;ATAD3A;RNF144B;ANXA1;PHLPP1;VEGFA;HSPA5;FIGNL1;SOX4;NSMF;TRAF2;NDRG1;IL7;DAPK1;FMN2;CSRNP3;COPS5;ARHGEF4;NGEF;PAX8;SEPTIN4;BNIP3L;BEX2;FAIM2;RPS6;BOK;RRP1B;FAM162A;MCL1;RPS27A;IFIT2;IGF1R;SRA1;ALK;C3ORF38;KALRN;PLK2;PPID;PINK1;RPS6KA2;CIDEB;RIPK2;GRID2;PNMA2;BNIP3;PRELID1;BCL2L2;RBM5;NUAK2;ITSN1;WNT5A;PYCARD;CASP3;TMEM14A;KCNMA1;BCL6;CFL1;HSPB1;NEURL1;SOD1;SHQ1;EGLN3;ARHGDIA;GSTP1;HSPA1B;TAF9B;OLFM1;PRKAA2;UBA52;HSPD1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5743188462613766,0.9770319190827408,0.5538461538461539,1.0,1.0,2/9,19.35%,SELENOI;ETNPPL
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.44729956111046,0.9769758761199313,0.59,1.0,1.0,47/332,18.27%,BRIP1;DDIT4;DAPK2;RHOB;FGF1;NLRP12;ARAF;PRKAR2B;MAPT;RACGAP1;PPP2R5B;RPA2;PHLPP1;VEGFA;FBXL2;TRAF2;TRIP10;NLGN1;AKAP6;ARHGAP23;PEX5L;ARHGEF4;PPP1R13L;CHN1;NGEF;AKAP12;MOB3B;DNA2;PDE2A;PRR5;NTRK3;KALRN;GNAI1;PAK5;NTRK2;TTC5;PRKAG2;BRCA1;ITGAV;ITSN1;WNT5A;PYCARD;CDK5R1;RFC4;RPL11;ARAP2;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.6390867800113849,0.976950514226326,0.4857142857142857,1.0,1.0,1/6,8.09%,ABCA2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5818092370760073,0.9768021372964252,0.5588235294117647,1.0,1.0,2/9,12.99%,RAPGEF3;PLK2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.31733832998048783,-0.9766182989074329,0.5,1.0,1.0,10/69,10.92%,RALB;CCND1;DAB2IP;TRIB1;ACTB;CSF1R;TRIB3;TELO2;SRC;ABL1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.6685171668563354,0.9763153187513336,0.5970149253731343,1.0,1.0,2/5,28.61%,PPIB;VAPA
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.616438764513811,0.9762681814352935,0.5483870967741935,1.0,1.0,2/6,27.69%,CDS2;PGS1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.4963610001390763,-0.9761115247102071,0.4827586206896552,1.0,1.0,5/14,15.15%,KARS1;NMI;TYROBP;SYK;LILRA2
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.5748923747096198,0.9761094702939946,0.547945205479452,1.0,1.0,1/8,18.59%,STXBP6
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.4989677467568814,-0.9760112847487415,0.4642857142857143,1.0,1.0,2/9,13.73%,TGFB1;DAB2
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.47942501405481164,0.9753236343109853,0.550561797752809,1.0,1.0,11/45,18.49%,DDIT4;EGR1;MAPT;FCGR2B;CIDEB;RIPK2;BNIP3;GRIN2B;WNT5A;PICALM;CDKN1B
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.6145945480300511,0.97496123284193,0.527027027027027,1.0,1.0,2/7,22.13%,DBF4;WIZ
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.5946826109013237,0.9749586393498255,0.4782608695652174,1.0,1.0,2/10,15.20%,VGF;TRIM16
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.5171930127831346,0.9746842922622106,0.5774647887323944,1.0,1.0,6/19,19.64%,VCAN;VEGFA;THBD;ITGAV;APP;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.5758031494158241,-0.9745310253741346,0.5277777777777778,1.0,1.0,1/6,1.07%,CX3CR1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.5528419925660504,0.9744365161998424,0.5616438356164384,1.0,1.0,2/13,10.15%,OVOL2;ST14
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.5629179494985657,0.9743353117344682,0.5555555555555556,1.0,1.0,2/8,16.75%,GPRC5B;WNT5A
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.3236961670543364,-0.9741492044728872,0.4166666666666667,1.0,1.0,18/61,16.45%,RPRD1B;DHX38;LEO1;CPSF1;LSM11;MTPAP;CHTOP;THOC5;WDR33;DDX39A;RPRD1A;SLU7;GRSF1;CSTF1;CPSF4;CPSF2;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.5010696225760767,-0.9737004286336252,0.48148148148148145,1.0,1.0,4/10,9.49%,IL1B;CD200R1;IGF1;TREM2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.63528480764111,0.9736402973403557,0.5797101449275363,1.0,1.0,4/9,24.11%,HOOK3;KIF3A;DCTN1;NIN
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4888131299089219,0.9735852250863928,0.5978260869565217,1.0,1.0,2/49,1.04%,KLF4;NLRP12
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4819376088050878,0.9735672062873618,0.5684210526315789,1.0,1.0,15/68,21.66%,ASPN;LRP2;ACVR2A;BMPR1B;VASN;SPRY1;RPS27A;MAGI2;VWC2;PEG10;SMAD1;PPARA;UBA52;UBB;SMAD5
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5892910380598789,0.9734034178391531,0.5308641975308642,1.0,1.0,2/10,10.37%,AGT;CHRM3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.45227465519704346,0.9731255160039982,0.5851063829787234,1.0,1.0,7/94,3.33%,KLF4;NLRP12;TSHR;HTR7;PRKAR2B;CD163;ADCY3
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.5155687786090074,-0.9726745762208746,0.45,1.0,1.0,4/15,13.86%,RPUSD3;UQCC2;FASTKD2;RPUSD4
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6538255173727587,0.972192358052306,0.6307692307692307,1.0,1.0,2/5,16.75%,PKD1;WNT5A
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5623524004024292,0.9721753019333322,0.5675675675675675,1.0,1.0,4/10,23.00%,ADGRG6;PARD3;SOD1;CNTNAP1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.5979476870257363,0.9720517449400683,0.5416666666666666,1.0,1.0,3/11,16.75%,VEGFA;DGKG;WNT5A
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.6279730788768421,0.9718557372982707,0.5492957746478874,1.0,1.0,3/5,23.04%,ROBO2;WNT5A;FGFR2
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.4748299320558716,0.9716115156308182,0.6185567010309279,1.0,1.0,31/90,24.32%,VEGFA;SUV39H2;NDRG1;FMN2;HIF1A;BNIP3L;LIMD1;FAM162A;RPS27A;RBX1;PSMB4;HIF3A;PINK1;BNIP3;SCN2A;HYOU1;CPEB2;EGLN3;RGCC;UBA52;PSMC2;UBB;PSMA3;PSMB2;PGK1;NOP53;P4HB;EPAS1;PSMD5;RORA;PSMD7
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3362211284205843,-0.971444747550589,0.6,1.0,1.0,12/60,9.29%,TGFBR3;TAL1;CEBPA;LYL1;SELPLG;SH2B3;RUNX3;CSF1R;TP53;MEIS1;PLEK;TGFB1
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6153558953532884,0.9713900921013746,0.53125,1.0,1.0,2/9,5.93%,RORB;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.5192683821305502,-0.9713663950412784,0.46153846153846156,1.0,1.0,1/9,1.78%,CEBPA
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.637428521063272,0.9712932414612383,0.5692307692307692,1.0,1.0,2/6,22.13%,DBF4;WIZ
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5642720261848988,0.9711758129342858,0.6103896103896104,1.0,1.0,3/14,21.80%,INTS12;INTS8;INTS6
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5029534164374696,0.9711396880515364,0.5487804878048781,1.0,1.0,5/32,10.91%,HTR2B;TGFB2;HIF1A;RANBP3L;RBPJ
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.6014278797953073,0.971134072923537,0.5909090909090909,1.0,1.0,5/9,35.90%,NDC1;RTN4;AHCTF1;NUP153;NUP205
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5750668022724407,0.9711058572179776,0.5769230769230769,1.0,1.0,4/12,14.83%,CACNB2;DMD;PDE4B;AHNAK
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.6127476307648592,-0.9710369587337843,0.5,1.0,1.0,1/5,3.97%,DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.5156240427259428,0.9708953227399815,0.5316455696202531,1.0,1.0,6/24,14.16%,RELN;AGT;SRCIN1;GPRC5B;NTRK2;EPHA4
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.5063680563475175,0.9706463539030061,0.5543478260869565,1.0,1.0,12/40,24.08%,MDH1;ENO2;PGAM1;IRS2;GPI;FBP1;SLC39A14;SORD;PGK1;ENO1;PGM1;GALM
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.48966567442027636,0.9705731977523891,0.5425531914893617,1.0,1.0,6/46,10.82%,ASPN;FBN2;VASN;SPRY1;LTBP1;RPS27A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5192327648992071,0.9705007322076378,0.56,1.0,1.0,4/21,21.32%,CYREN;TFIP11;ERCC6;KMT5C
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.6143577356442004,0.9700973824887166,0.5217391304347826,1.0,1.0,3/8,22.33%,ENTPD3;CMPK1;AK5
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.29360943417497387,-0.9698966922931214,0.5,1.0,1.0,20/83,17.43%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;WDR33;DDX39A;RAE1;NUP214;NUP188;SLU7;CPSF4;MCM3AP;CPSF2;THOC7;POLDIP3;SMG6;UPF1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.5460401741844859,0.9698229123792012,0.5280898876404494,1.0,1.0,5/22,15.93%,TUSC3;MGAT1;STT3B;MCFD2;MAGT1
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.5822314453404838,0.969810496715352,0.5285714285714286,1.0,1.0,3/12,21.43%,SRSF12;SART3;PRPF6
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6335296615758522,0.9696252784488243,0.6176470588235294,1.0,1.0,3/7,14.19%,AGTPBP1;FAIM2;GRID2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.45689482140964727,0.9689126300472494,0.5806451612903226,1.0,1.0,14/77,21.76%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;SH3GL2;DYNC1H1;KIF5A;KIF11;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.5588138225450792,0.9687816218369791,0.5277777777777778,1.0,1.0,1/13,2.23%,ASPA
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.6824613418813881,0.9687703852353612,0.6323529411764706,1.0,1.0,2/5,13.10%,DOCK5;NR4A3
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.5423868108982361,0.9687407288855392,0.5444444444444444,1.0,1.0,3/26,7.97%,KLF4;GLA;INSR
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5284603424602602,0.9686573135781489,0.5402298850574713,1.0,1.0,2/21,4.00%,SOCS3;PIGU
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.6057313089866888,0.9685971012594239,0.5555555555555556,1.0,1.0,4/9,22.46%,PTN;EPHA4;RTN4RL1;PTPRS
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6389086401040963,0.9685225291919309,0.5833333333333334,1.0,1.0,2/6,23.04%,PAX8;FGFR2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4758818670718012,0.968297987343278,0.5698924731182796,1.0,1.0,7/50,10.42%,FBN2;RORB;ACVR2A;BMPR1B;NOCT;LIMD1;RANBP3L
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4845443467709331,0.9678133762780969,0.5617977528089888,1.0,1.0,11/41,24.29%,GPM6A;NYAP2;WASF1;CNTNAP2;SLC9A6;PLXNB1;UBB;CNTNAP1;DCLK1;LRRK2;CTTN
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.4138497396031891,-0.9675434805601545,0.5555555555555556,1.0,1.0,3/22,3.18%,SMDT1;MAIP1;MICU3
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.5055012678102335,-0.9674272498192535,0.47058823529411764,1.0,1.0,3/8,8.88%,TAL1;SH2B3;THOC5
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.5304589977365123,0.9671075827573059,0.5443037974683544,1.0,1.0,5/23,21.30%,VEGFA;INSR;MAGI2;SDCBP;DLG4
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.5549405166535563,-0.9670498841068997,0.5357142857142857,1.0,1.0,1/6,3.55%,IL1B
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.5389858286694399,0.9669330039824128,0.6024096385542169,1.0,1.0,8/25,21.90%,INSR;HIF1A;PFKFB4;PINK1;APP;PPARA;PRKAA2;ENO1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.506385636305692,-0.9668613993820137,0.45,1.0,1.0,2/12,4.60%,LILRB4;DUSP3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.4742926408540776,0.9664111906324706,0.5057471264367817,1.0,1.0,11/50,17.54%,KLF4;CLDN18;ALOX15B;DDX3Y;ST14;THBD;CRLF1;SCD;FBP1;CEBPD;ALDH1A1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.5049358694854613,0.9663009502486103,0.5454545454545454,1.0,1.0,7/26,18.41%,LRP2;CYP3A5;GPC5;AKR1B1;RDH11;ALDH1A1;NAPEPLD
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.6370055669038505,0.9652891715597129,0.5538461538461539,1.0,1.0,1/6,5.83%,SESTD1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.4596844633594478,-0.9651726087897343,0.5,1.0,1.0,3/9,6.06%,IL1A;IL1B;IGF1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5527941813632103,0.9650337499552919,0.5945945945945946,1.0,1.0,7/15,26.70%,NLGN1;RIMS2;RIMS3;PREPL;LRRK2;RAB5A;RIMS1
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5718147810440661,0.9649568628784208,0.5714285714285714,1.0,1.0,3/10,11.02%,PTPRZ1;ID2;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5067639905996768,0.9649240188092635,0.5357142857142857,1.0,1.0,4/24,10.96%,SHANK3;KANK1;CAV3;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.5218471542503452,0.9648814198270602,0.5454545454545454,1.0,1.0,5/30,12.25%,COBL;TGFB2;KITLG;RBPJ;MFSD2A
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.5721916793863294,-0.9648426988270281,0.48148148148148145,1.0,1.0,1/7,7.38%,DCP1B
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.45158506643214397,0.9647625807387471,0.5757575757575758,1.0,1.0,17/124,12.92%,THBS1;FGF1;SEMA3A;LAMB1;CEMIP;VEGFA;HSPA5;GPNMB;SEMA3B;SEMA6A;INSR;FGR;CARMIL1;NTRK3;IGF1R;SEMA5A;FLT1
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6321786279791758,0.9645533458091208,0.625,1.0,1.0,4/6,35.63%,FBP1;PPARA;GIT1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6321786279791758,0.9645533458091208,0.625,1.0,1.0,4/6,35.63%,FBP1;PPARA;GIT1;HDAC4
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.5228065090336546,0.9644729562160416,0.5543478260869565,1.0,1.0,9/27,23.12%,MDH1;ENO2;PGAM1;GPI;FBP1;SLC39A14;PGK1;ENO1;PGM1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6003322293483081,0.9643993320019145,0.5833333333333334,1.0,1.0,2/8,9.56%,SEMA6A;ROBO1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.5418318833396139,-0.9641977363631008,0.45714285714285713,1.0,1.0,2/6,4.74%,PLA2G4C;ZFYVE1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5983012010341369,0.9634640959645797,0.5942028985507246,1.0,1.0,2/8,19.91%,KANK1;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5983012010341369,0.9634640959645797,0.5942028985507246,1.0,1.0,2/8,19.91%,KANK1;AP1AR
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.4537830584880482,0.9633115267537165,0.5757575757575758,1.0,1.0,55/190,23.48%,HTR2B;ACVR1B;PRLR;TSHR;TGFB2;ZBTB16;ACSL1;PLAC8;CADM1;GLIPR2;IL15;AGT;TFRC;BMPR1B;VEGFA;GRB10;SLC11A1;NLGN1;KDM3A;PAX8;GHR;PTN;KDM1A;FGR;IGF1R;ABCA1;DYNC1H1;B4GALT5;SOX6;SCD;TRIM16;TXK;WNT5A;PEMT;SDCBP;ESRRG;PLCB1;CFL1;NR2C2;SOD1;ROCK1;RGCC;MAP3K13;OLFM1;EZH2;KDM6B;KMT5C;ENO1;IL18;TNF;BMP1;MFN2;EPAS1;PPIB;LEPR
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.3961330677307607,-0.9632015134622542,0.4166666666666667,1.0,1.0,9/32,10.92%,SERPINF2;PFN1;EVL;LPAR1;NF2;PLEK;SORBS3;PPM1F;ABL1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.6410834869768918,0.9631008791751614,0.5074626865671642,1.0,1.0,3/7,20.52%,ANK2;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.542396878743781,0.9629764171356281,0.5833333333333334,1.0,1.0,10/20,29.46%,HSPA5;SDF2L1;DNAJC7;HSPA1B;ERO1A;HSPA2;HSPA14;HSPA9;HSPA13;HSPA8
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.49425790097024824,-0.9629559017659693,0.5555555555555556,1.0,1.0,2/9,4.69%,PDE12;UQCC2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.6648024266175228,0.9628120247598811,0.640625,1.0,1.0,5/6,30.54%,INSR;APP;DCTN1;MAP1A;PRNP
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.618163370609236,0.9627590326850821,0.5616438356164384,1.0,1.0,1/7,11.17%,DNA2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.37066016113533956,-0.9627435256775714,0.5,1.0,1.0,10/44,11.22%,RAMP1;NEDD4;PLEKHJ1;LILRB4;SNX25;GRK2;ARRB2;TGFB1;SMURF1;ITGB2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.633993522093179,0.9627397676639687,0.6212121212121212,1.0,1.0,1/5,5.93%,VEGFA
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.4322961235162872,-0.9626628402221195,0.4,1.0,1.0,4/16,6.06%,GAL3ST4;HPSE;B4GALT7;IGF1
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.6422995691884867,0.9626566465321158,0.5862068965517241,1.0,1.0,1/5,13.16%,ALDH6A1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5666858240090312,0.9624714673185635,0.5342465753424658,1.0,1.0,1/12,1.90%,DTL
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.5436183373853023,0.9617943914752457,0.5955056179775281,1.0,1.0,5/23,15.93%,TUSC3;MGAT1;STT3B;MCFD2;MAGT1
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.6530990173231157,0.9617891599876787,0.5737704918032787,1.0,1.0,2/5,8.33%,FMN2;SPIRE2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4847336710575941,0.9617373296846691,0.6153846153846154,1.0,1.0,9/56,12.42%,GPR18;JPH1;TACR1;CD55;RYR2;GPR65;CAV3;C5AR1;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3075145141830243,-0.9615854404503896,0.75,1.0,1.0,18/126,7.03%,LURAP1;FLNA;TICAM1;TRIM38;EDA2R;CHUK;LGALS9;IRAK4;ATP2C1;TMEM9B;LPAR1;TMEM106A;TMED4;MAP3K14;ZDHHC13;CASP10;NEK6;TIFA
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.3443779566153265,-0.9615048896738136,0.4375,1.0,1.0,7/44,9.49%,MYH9;CEBPA;LGALS9;CSF1R;THOC5;EP300;TREM2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5823045895428534,0.9611101913841749,0.5866666666666667,1.0,1.0,3/12,19.04%,ROBO2;ROBO1;ROCK1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5092265213717996,0.9610004305871384,0.5529411764705883,1.0,1.0,8/35,19.94%,WDR5;TFRC;PES1;BAIAP2L1;RCC1;FASN;PRDX4;TUBA1C
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5181578125056324,0.9609334653777832,0.5822784810126582,1.0,1.0,5/29,14.46%,TGFB2;SPRY1;STMN3;KANK1;FBP1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.615772104527579,0.9607240197150352,0.625,1.0,1.0,3/9,14.86%,STT3B;OGA;FBXO27
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5812317925504342,0.9603836948940614,0.5584415584415584,1.0,1.0,1/8,4.08%,AGT
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),0.6391781812061188,0.9602322873383614,0.5774647887323944,1.0,1.0,2/5,21.87%,ADPRS;MACROD1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.5087963870424946,-0.9601795643434557,0.5,1.0,1.0,4/9,12.67%,NPL;GNPDA1;ST6GAL1;NAGK
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.5011266389249079,0.9598783142285459,0.6091954022988506,1.0,1.0,8/43,14.16%,VIM;RPL23;FCGR2B;GRIN2A;IGF1R;NOD2;RIPK2;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.3522744756519443,-0.9593313840203052,0.38461538461538464,1.0,1.0,5/47,5.34%,FLNA;SESN2;ZPR1;PYHIN1;WWTR1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.44825457109974154,0.9591342877957749,0.5760869565217391,1.0,1.0,5/60,7.25%,SOCS3;CLIP3;LIFR;TRAF2;IL7
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.3650178683018096,-0.9586093047722979,0.2,1.0,1.0,7/45,9.66%,LYL1;TCF3;BANK1;HHEX;BLNK;PHB2;BTK
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.623754120330295,0.9584541587558775,0.5555555555555556,1.0,1.0,1/5,14.79%,POLR3H
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5739365840439287,0.9583098965129427,0.5694444444444444,1.0,1.0,3/13,15.16%,CD55;TRAF2;TNFRSF1B
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.5604893035158911,-0.9581066412086744,0.6296296296296297,1.0,1.0,1/6,0.21%,FGL1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.29492018562941086,-0.9580834545163709,0.6,1.0,1.0,20/81,17.43%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;WDR33;DDX39A;RAE1;NUP214;NUP188;SLU7;CPSF4;MCM3AP;CPSF2;THOC7;POLDIP3;SMG6;UPF1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.5179238984674349,0.9574332361296239,0.5,1.0,1.0,4/21,12.01%,SH3PXD2B;SBDS;RANBP3L;SULF2
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.4797854897324282,0.9572656416634514,0.5795454545454546,1.0,1.0,5/47,12.98%,GPR18;KANK1;GPR65;ROBO1;ABCA1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4717318983560797,0.9571909569727877,0.5806451612903226,1.0,1.0,6/62,9.92%,RHOBTB3;RHOB;GPM6B;EPHA3;RND3;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.41056660569951847,-0.9570782924387299,0.3125,1.0,1.0,4/26,3.55%,CCL5;SKAP1;SERPINF2;IL1B
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.4898721127754903,0.9568036378081632,0.5862068965517241,1.0,1.0,16/44,26.03%,SYT4;NLGN1;ADCY8;SYT1;RYR3;WNT5A;CLIC4;IQGAP1;PRKAA2;SLC25A24;CPNE8;CPNE2;ECT2;SYT11;CPNE3;ADCY1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5668252303509002,0.9567652765415804,0.5733333333333334,1.0,1.0,4/10,27.45%,ADCY10;CCDC39;DNAAF2;AQP4
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.5830862726550013,0.9565360642415018,0.5974025974025974,1.0,1.0,4/10,23.89%,CEMIP;SLC9A1;CEMIP2;CHP1
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.6242548341460856,0.9564596115407692,0.5967741935483871,1.0,1.0,1/5,9.97%,MAFB
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3751947684292828,-0.9564320857096296,0.47058823529411764,1.0,1.0,3/28,8.11%,IDE;ERAP2;HLA-E
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.6193122452854258,0.9561555779012061,0.6388888888888888,1.0,1.0,2/7,7.77%,NUDT16;ADARB2
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),0.6156662275058818,0.9560163582841297,0.5915492957746479,1.0,1.0,3/5,37.58%,RIOK3;C1QBP;DHX58
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4542585678284025,0.9556266928951193,0.5517241379310345,1.0,1.0,12/42,16.11%,TSHR;ADCY3;ADGRE1;CNR1;ADGRG6;GPR65;ADGRB2;RXFP1;ADCY8;ABCA1;ADGRL2;GNAL
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4493553074367244,0.955568842661312,0.5789473684210527,1.0,1.0,15/76,22.02%,ALDH3B1;TMEM161A;ERMP1;CYCS;PINK1;SOD2;CPEB2;SOD1;GSTP1;HSPA1B;PRKAA2;SLC25A24;ERO1A;VRK2;STX2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5031504623066975,0.955548020916195,0.6091954022988506,1.0,1.0,7/28,20.24%,MAPT;GPM6B;TTBK2;CAV3;OTUD7B;PICALM;UBXN2B
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.5204244736653643,0.9553220951496058,0.575,1.0,1.0,3/19,16.75%,SAP30;RBX1;WNT5A
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.35577293355444223,-0.9552871304737852,0.625,1.0,1.0,6/50,4.23%,CEBPA;TFAP4;CCND1;LATS2;HHEX;ACTB
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5514681340312668,0.9551955622049195,0.5714285714285714,1.0,1.0,5/14,35.80%,SEC24C;SEC31A;MIA3;SEC23B;RAB1A
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6626723212147471,0.9550473132854458,0.6521739130434783,1.0,1.0,4/7,24.11%,HOOK3;KIF3A;DCTN1;NIN
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5518596490591546,0.9550177486284332,0.5697674418604651,1.0,1.0,8/18,27.58%,OGN;SOD2;NDRG4;CDKN1B;MFN2;PDCD4;PTEN;PRKG1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.5786617814034375,0.9549142664486696,0.6666666666666666,1.0,1.0,3/14,5.71%,COBL;LSR;ARID5B
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4689860989470069,0.9546473287354817,0.5813953488372093,1.0,1.0,10/52,12.99%,TSHR;HTR7;PRKAR2B;CD163;ADCY3;FCGR2B;FGR;RXFP1;ADCY8;PLK2
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.4339504023034706,-0.954578477891333,0.55,1.0,1.0,2/17,4.39%,CALCR;LILRB4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4834891864742698,0.9544707405918417,0.6477272727272727,1.0,1.0,4/48,10.07%,THBS1;AGT;TRAF2;DEPTOR
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5005372147255589,0.9544581697683666,0.6179775280898876,1.0,1.0,10/44,17.58%,ZBTB16;LAMB1;FBXL7;SYNC;PALLD;RND3;FN1;UACA;ANGPT2;TIMP3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.3460200011513639,-0.9542189629843825,0.5,1.0,1.0,9/27,11.40%,CX3CR1;RHOG;BIN2;CORO1B;LPAR1;DOCK4;ARRB2;PLEKHG5;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.48544204569614524,0.9541195631643984,0.5333333333333333,1.0,1.0,5/42,5.93%,TGFB2;ECM2;RNASE10;FRMD5;VEGFA
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5706945904310546,0.953532501853294,0.5753424657534246,1.0,1.0,4/9,27.39%,ABCA1;ABCA5;ABCG1;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4519942748478457,-0.9527945949383346,0.43333333333333335,1.0,1.0,2/12,6.06%,TGFBR3;IGF1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.5734775968308818,0.9527051361614999,0.5454545454545454,1.0,1.0,2/7,23.32%,STAT1;DDB1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5217718822326161,0.9525572316823765,0.5476190476190477,1.0,1.0,10/22,26.70%,SYT4;RIMS2;RAB15;SYT1;RIMS3;PREPL;LRRK2;RAB5A;SYT11;RIMS1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5902642170574444,0.9523615780466386,0.6301369863013698,1.0,1.0,4/8,22.14%,COL11A1;SCN1A;PIEZO2;LHFPL5
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.5053863271684784,0.9522583206651861,0.6236559139784946,1.0,1.0,13/47,20.52%,MAPT;PRKCE;ARF6;BAIAP2L1;CAV3;CARMIL1;PINK1;TPPP;PYCARD;CDK5R1;TOGARAM1;DCTN1;FES
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.5285526888139994,0.9521594511476068,0.5833333333333334,1.0,1.0,10/24,29.46%,HSPA5;SDF2L1;DNAJC7;HSPA1B;ERO1A;HSPA2;HSPA14;HSPA9;HSPA13;HSPA8
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.5996515506680362,0.951517314266031,0.5714285714285714,1.0,1.0,3/7,21.17%,POLQ;POLL;MLH1
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4952264304686118,0.95147444074907,0.5609756097560976,1.0,1.0,12/37,29.09%,NRG1;FCGR2B;EPHA3;PXK;MCTP1;ITGAV;HAMP;SYT11;PTEN;SCAMP5;SNX12;TLR2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.6245146968291644,0.9513760648276863,0.620253164556962,1.0,1.0,4/6,29.79%,HS2ST1;NDST3;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.585596571777097,0.9511603434662718,0.6329113924050633,1.0,1.0,3/10,19.12%,H2BC11;CCDC3;GSTP1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5664514144966878,0.9509849489353553,0.6075949367088608,1.0,1.0,1/12,1.73%,SULT4A1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.4432453473482373,0.9508739523618585,0.6043956043956044,1.0,1.0,19/84,21.95%,CENPE;RELN;SPDYA;CAMK2N1;DEPTOR;CAV3;FGR;GSKIP;C5AR1;PRKAG2;PPM1E;THY1;HSPB1;IQGAP1;SOD1;GSTP1;TAF7;GNAQ;TNF
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.5542250404154121,0.9507407851841628,0.5375,1.0,1.0,4/15,29.76%,SCO2;SCO1;COX20;COA6
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.4698009386872337,0.9503916812318471,0.6630434782608695,1.0,1.0,13/61,20.06%,PLPP3;MAPT;PAQR3;IRS2;NTRK3;IBTK;SH3GL2;IMPACT;FBP1;NPRL2;CDKN1B;ROCK1;PPARA
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.5689950256190184,-0.9503315368332377,0.42857142857142855,1.0,1.0,3/5,14.41%,IL18R1;ALOX5;AKT1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.5689950256190184,-0.9503315368332377,0.42857142857142855,1.0,1.0,3/5,14.41%,IL18R1;ALOX5;AKT1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.416996577437432,-0.9502863169096765,0.5,1.0,1.0,4/23,8.72%,ZDHHC3;DAB2IP;DELE1;BID
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5782759596554756,0.9500433107304079,0.5769230769230769,1.0,1.0,5/10,27.58%,SOD2;CDKN1B;PDCD4;PTEN;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.6054412547135108,0.9499144555628999,0.5822784810126582,1.0,1.0,3/8,21.94%,ANXA1;NFKBIZ;IL18
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5374073526074514,0.9497484510550569,0.5822784810126582,1.0,1.0,4/16,24.80%,PAICS;PFAS;HPRT1;IMPDH1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5476013631576266,0.9497189834285518,0.6027397260273972,1.0,1.0,2/12,13.70%,NRG1;HINFP
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.5912560315209381,0.94952458360528,0.581081081081081,1.0,1.0,4/8,30.03%,UPP2;NME4;MACROD1;TYMP
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.5273426806747255,0.9491628949758018,0.5411764705882353,1.0,1.0,3/26,4.08%,CR1;SPOCK1;AGT
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.49821233467749926,-0.9491151228475945,0.6666666666666666,1.0,1.0,5/14,12.66%,GSDMB;GZMB;NLRP1;TREM2;NAIP
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.6065921674208044,0.9490861341312858,0.631578947368421,1.0,1.0,2/8,18.08%,SLC11A1;GBP2
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5376160890263252,0.9489991893260923,0.573170731707317,1.0,1.0,5/16,22.87%,INSR;IRS2;SORBS1;APPL1;CLTCL1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.500660235000211,0.9489947970820628,0.5974025974025974,1.0,1.0,14/27,33.83%,PIGU;PIGQ;ST6GALNAC5;PIGF;ST8SIA3;PIGL;PIGG;B4GALT6;LARGE1;PIGA;MPPE1;SCCPDH;ST8SIA5;PIGH
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.523023151436754,-0.9488197890383969,0.42857142857142855,1.0,1.0,3/8,8.88%,MYH9;CSF1R;THOC5
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.36940355350252263,-0.948625732490858,0.5789473684210527,1.0,1.0,1/21,0.20%,CCL5
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.45420094190928206,0.9484344068401164,0.6326530612244898,1.0,1.0,17/107,15.77%,PLPP3;PTPRD;PPP2R3B;PPP2R5B;PLPPR4;PTPRK;PTPRG;PPP2R5A;PTPRZ1;MTMR7;PTPRT;PP2D1;PPM1E;FBP1;ACP3;PPM1L;DUSP10
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.4756808208802343,0.9482653114868459,0.5869565217391305,1.0,1.0,12/44,17.49%,TGFB2;AGT;ANK2;RYR2;CALM3;CAV3;CELF2;RYR3;FXYD7;ASPH;ATP1B3;ATP2A2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.47569419413220143,0.9482045494877877,0.55,1.0,1.0,11/33,29.49%,RPA2;FIGNL1;FANCB;KDM1A;POLQ;ERCC6;TIMELESS;MAGEF1;SPIDR;UBQLN4;ARID2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5606219072020967,-0.9477301797337448,0.5294117647058824,1.0,1.0,1/7,7.91%,APH1A
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5155347360643867,0.9475774027612305,0.6,1.0,1.0,6/23,21.04%,CR1;SOX4;IL7;DUSP10;BCL6;RHOH
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.5828735836273432,0.947465204554148,0.547945205479452,1.0,1.0,1/9,5.39%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3618064280384615,-0.947287198354234,0.46153846153846156,1.0,1.0,4/42,7.84%,RALB;IDE;TRIB3;NVL
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.3494734978953552,-0.9472575290553096,0.6428571428571429,1.0,1.0,3/39,4.04%,FRRS1;ABCG2;SLC46A1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4705394458743746,0.9470856689007776,0.5806451612903226,1.0,1.0,13/46,25.09%,H2BC11;CLIP3;TRAF2;CCDC3;SPPL2B;PYCARD;GSTP1;HSPA1B;TNFRSF1A;TNF;CASP1;TRADD;GPS2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.5098068472247682,0.9465914058424447,0.6266666666666667,1.0,1.0,9/21,19.64%,MYRF;EIF2AK3;PTPRZ1;PTN;PARD3;TNFRSF1B;TPPP;NKX6-2;TNFRSF21
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.5804009295893102,0.9464832182460083,0.620253164556962,1.0,1.0,3/8,23.05%,ADCY10;DYNC1I1;DNAAF2
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.6074066803420787,0.9464146680035871,0.6027397260273972,1.0,1.0,5/9,29.85%,MTERF1;TFAM;TEFM;POLRMT;FOXO3
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.5155850747839159,-0.9463319060601303,0.5909090909090909,1.0,1.0,2/10,12.33%,SETDB1;TASOR
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.3167214406156382,-0.9463240953374668,0.5454545454545454,1.0,1.0,15/51,17.13%,GTF2H5;GTF2H2;UBTF;CPSF1;LSM11;TTF1;WDR33;SNRPB;CSTF1;CPSF4;POLR1F;CPSF2;TTF2;TBP;MNAT1
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),-0.5906537088377328,-0.9462718269936321,0.6451612903225806,1.0,1.0,2/5,9.49%,P2RY12;TREM2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.47556492879676837,-0.9460691434214983,0.5652173913043478,1.0,1.0,2/12,3.95%,NPC2;NPC1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.4392576747637956,0.9460213042318899,0.6060606060606061,1.0,1.0,27/101,24.29%,LRP2;SPARC;CD163;TFRC;FCGR2B;INSR;NLGN3;DNAJC6;FCHO2;WASF1;DNM3;TMEM108;DNM1;SGIP1;LRP1B;HYOU1;PICALM;GRK4;COLEC12;SNAP91;AP2A2;MSR1;HIP1R;CLTCL1;HSP90B1;MX1;CTTN
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5422738312665674,0.9459317422074657,0.5466666666666666,1.0,1.0,7/14,29.33%,CR1;C5AR1;FPR3;FPR1;MICB;BAG6;C5AR2
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.6173013836580498,0.9458809918272383,0.6056338028169014,1.0,1.0,4/8,28.04%,DONSON;MCMDC2;ORC3;MCM3
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.6247912509756586,0.945616618825001,0.5657894736842105,1.0,1.0,4/7,31.79%,NEBL;FHOD3;PROX1;TTN
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.6606056719323691,0.9455606712612965,0.6197183098591549,1.0,1.0,1/5,14.56%,BRCA1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.6208630575028872,0.9454800961069857,0.6229508196721312,1.0,1.0,2/6,24.34%,AKR1B1;TSPOAP1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4652962037476034,0.944751979123414,0.6391752577319587,1.0,1.0,19/90,25.89%,NAMPT;PDK4;GRB10;INSR;IRS2;RAB15;IGF1R;SORBS1;PKM;GAB1;INSIG1;CPEB2;SLC39A14;ATP6V0B;APPL1;ATP6V1D;ATP6V0E2;ATP6V1B2;AP3S1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.4452911610012103,0.944378038188268,0.6288659793814433,1.0,1.0,25/107,22.40%,CENPF;CENPE;NUP133;RCC1;MAP9;SBDS;CENPP;XPO1;RPS27;PLK2;DYNC1H1;CENPI;CLASP2;CKAP5;SPAST;INCENP;SEH1L;TOGARAM1;KIF11;CENPK;GPSM2;DYNC1I1;CENPT;KNTC1;SUN2
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.5864854547606689,0.944367697232083,0.6266666666666667,1.0,1.0,5/12,29.85%,MTERF1;TFAM;TEFM;POLRMT;FOXO3
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5000413283957333,0.9440594334080767,0.6046511627906976,1.0,1.0,7/40,10.38%,TNC;ENAH;FBXL7;MYO10;RND3;TCF7L1;PTN
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5598075773742126,-0.9440244601431452,0.5428571428571428,1.0,1.0,2/5,18.69%,COPRS;PRDM4
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.6273414599418833,0.9439045157369125,0.6451612903225806,1.0,1.0,2/6,17.04%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.4611628233055668,0.9438892423883655,0.6263736263736264,1.0,1.0,14/66,17.04%,DDIT4;EGR1;DCC;MAPT;GPNMB;NSMF;TRAF2;FCGR2B;FAIM2;GRID2;GRIN2B;TNFRSF1B;WNT5A;PICALM
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5790031848583588,0.9437545622821348,0.5753424657534246,1.0,1.0,1/9,11.02%,KDM1A
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.4111017591500358,-0.943667843630813,0.52,1.0,1.0,5/14,9.24%,PFN1;EVL;ABI3;PLEKHM1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5310164327205491,0.943291472968361,0.5789473684210527,1.0,1.0,2/18,4.31%,NRG1;CDH2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.648138374543973,0.943271434821316,0.6086956521739131,1.0,1.0,1/5,15.11%,HCLS1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.44659992090051237,-0.9432172204657181,0.47368421052631576,1.0,1.0,6/15,13.05%,CSF1R;MLF1;TP53;PLEK;TGFB1;PLD4
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.575581152204979,-0.9431699578096715,0.5333333333333333,1.0,1.0,1/5,7.63%,SVIP
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.5426246106304152,0.9429954264363699,0.6125,1.0,1.0,2/24,6.82%,IDI1;MVD
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.47429230122683186,-0.9428740198230452,0.6666666666666666,1.0,1.0,1/9,1.17%,PGM2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.47429230122683186,-0.9428740198230452,0.6666666666666666,1.0,1.0,1/9,1.17%,PGM2
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.6380743307034815,0.9428203736677077,0.6451612903225806,1.0,1.0,1/5,7.75%,CA2
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6190751970678053,0.9427309907816278,0.5857142857142857,1.0,1.0,1/5,13.13%,PDE4B
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4428973610150112,0.9427055202014716,0.7040816326530612,1.0,1.0,36/148,22.03%,SHANK3;SH3PXD2B;CACNB2;SCN3B;SYNE3;ZDHHC15;NRXN1;RAB3C;NRXN2;ANK3;NLGN1;ANK2;PKP2;FCHO2;RAB15;SAV1;PTN;CAV3;KCNIP4;MAGI2;CLASP2;LRRC7;MAP7;ATP1B3;THY1;CPE;KCNB2;SPTBN1;FGF13;ROCK1;DPP6;SPTBN4;TNFRSF1A;DLG4;TNF;CYP46A1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.5423158871941688,-0.9426314049969116,0.5,1.0,1.0,3/6,13.75%,NUFIP1;PIH1D1;ZNHIT6
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.6200718425987968,0.9421446985806925,0.6056338028169014,1.0,1.0,4/6,32.59%,GK;COQ2;GK5;GOT1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.5465816585065137,0.9420640683237844,0.6,1.0,1.0,3/15,12.53%,AGT;CAV3;CELF2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.6339798404422905,0.9420240175791089,0.6060606060606061,1.0,1.0,2/5,11.28%,NMD3;GLUL
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.47656564412250046,-0.9417234918621737,0.4666666666666667,1.0,1.0,1/9,15.01%,EIF2S2
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5719178250698214,0.9417069132704905,0.6375,1.0,1.0,1/10,2.95%,MAPT
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.4930980687604935,-0.9415975925170819,0.55,1.0,1.0,4/12,11.13%,LPL;C3;MEST;NFKBIA
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.5477260177757931,0.9415767614309377,0.56,1.0,1.0,1/9,1.65%,TRMT9B
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.48001232695739543,0.9413914494554771,0.6304347826086957,1.0,1.0,5/46,14.09%,HTR2B;NYAP2;IRS2;IGF1R;TYRO3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.33547195464819646,-0.9413452423952468,0.5454545454545454,1.0,1.0,10/56,11.83%,CCL5;IL1B;STXBP4;NNAT;UQCC2;ITPR2;AACS;ALOX5;REST;CACNA1D
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6505124777097807,0.9411100506756965,0.6623376623376623,1.0,1.0,2/5,29.23%,CPNE3;AGK
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.46799806724349596,-0.9410185894713006,0.47619047619047616,1.0,1.0,2/15,2.05%,TTC39B;ARV1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4389720529580348,0.9408630548653573,0.625,1.0,1.0,12/92,8.23%,SPARC;LRRC4C;SHANK3;MAPT;INF2;ZDHHC15;CDH2;GPNMB;NSMF;SRCIN1;SIPA1L1;CHN1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.5119294279282673,0.940838540110384,0.5465116279069767,1.0,1.0,4/18,10.75%,FGF1;VEGFA;CHI3L1;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5286184258939686,0.9407684448052961,0.6265060240963856,1.0,1.0,2/16,12.11%,TGFB2;NOD2
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.6376655069264024,0.9398459646090334,0.6451612903225806,1.0,1.0,2/7,8.02%,ACSS3;ACAT1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5266613447076111,-0.9398332704732199,0.6,1.0,1.0,3/9,4.12%,INPP5K;IL1B;APPL2
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.45007864238518974,-0.9398329240257485,0.5263157894736842,1.0,1.0,1/11,0.47%,RALB
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.3613846981448357,-0.9397466716184544,0.6363636363636364,1.0,1.0,7/29,18.33%,NEDD4;PRR5L;SORL1;PLK3;STX18;RAB29;CEP290
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6315734301070186,0.9396170015394582,0.6266666666666667,1.0,1.0,3/5,33.30%,GUCY1B1;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6315734301070186,0.9396170015394582,0.6266666666666667,1.0,1.0,3/5,33.30%,GUCY1B1;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.5878997057155281,0.9395775172079948,0.6153846153846154,1.0,1.0,2/7,32.12%,PRKRA;DICER1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.5049286796955897,0.9392817863531432,0.6022727272727273,1.0,1.0,6/22,26.51%,RPS27A;SYVN1;RNF139;UBA52;UBB;MAN1A1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4637892362811499,0.9391306218833376,0.5393258426966292,1.0,1.0,6/38,11.98%,ARRDC3;IL15;ACOT13;RBPJ;CCDC3;NOVA1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.49846527781109984,0.9389577778115049,0.5697674418604651,1.0,1.0,1/34,1.38%,TOM1L1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.44439553967981915,0.9384028065939384,0.6632653061224489,1.0,1.0,23/106,23.11%,NLRP12;IL1RAPL1;OSMR;ANXA1;LIFR;CHI3L1;SLC11A1;AKAP6;IFNLR1;MCL1;IFITM3;HCLS1;CALCOCO2;CASP3;TIMP3;APP;PTPN9;CDK9;PTPN20;PTPN5;STAT1;ALDH1A2;CASP1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.4376707143052164,0.9383171876961831,0.6494845360824743,1.0,1.0,15/125,16.61%,BRIP1;CYREN;HMGB2;PIAS4;RPA2;EME2;DNA2;XRCC3;NSMCE1;BRCA1;DDX1;POLQ;KDM4B;FAN1;ACTR5
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5391987518773407,0.9382830813550104,0.6621621621621622,1.0,1.0,4/13,14.21%,ADCY3;ADCY10;ADCY8;GUCY1B1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.42631953223214963,0.9382607099612259,0.83,1.0,1.0,125/716,21.87%,SOCS3;HS3ST5;TNC;THBS1;DAPK2;ALG10B;ACVR1B;ARAF;CDK14;NEK11;TGFB2;DTL;ZBTB16;ASB14;VGF;PTPRD;WDR5;PPP2R3B;PRKCE;PPP2R5B;VCAN;PIGU;LAMB1;CDH2;PDK4;FBXL7;ACVR2A;ANXA1;BMPR1B;AATK;PTPRK;ASB16;PTPRG;F13A1;GAD1;PPP2R5A;FBXL2;EIF2AK3;PTPRZ1;PRRT1;GOLM1;MTMR7;DAPK1;NIM1K;INSR;COPS5;HIF1A;PTPRT;PP2D1;CKAP4;SIRT5;FN1;CHRM3;PXK;LTBP1;FGR;TMEM132A;MGAT1;CLK2;LIPE;CAMK2B;GAN;STT3B;RBX1;PSMB4;PLK2;PAK5;OGA;DCAF6;SLC35A1;HIF3A;B4GALT5;FAM20A;ASB13;PINK1;PRKAG2;PPM1E;FBXO27;SERP1;PPM1L;NUAK2;UBE2M;DUSP10;TXK;SUMF2;CHGB;PDK3;MAPK10;UGCG;SUMF1;CPE;CTBP1;ST8SIA3;GRK4;GMFB;KLHL2;EGLN3;APP;ROCK1;TEC;MAP3K13;PPP2R3A;PIK3R4;PTPN9;FBXL5;FBXL13;NRBP2;PRKAA2;UBA52;PSMC2;IGFBP7;ERO1A;SIRT3;CDK9;ZC3HAV1;FBXO7;DUSP16;PSMA3;DUSP6;PAK3;PSMB2;VRK2;CTDSP1;CDC25B;MACROD1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.4868282815529063,0.9382469337875627,0.5795454545454546,1.0,1.0,6/25,18.90%,MAPT;HDGFL3;CLASP2;CKAP5;TPPP;FGF13
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.28608701577804935,-0.9381694456856757,0.7142857142857143,1.0,1.0,21/85,17.43%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;WDR33;DDX39A;RAE1;NUP214;NUP188;ENY2;SLU7;CPSF4;MCM3AP;CPSF2;THOC7;POLDIP3;SMG6;UPF1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4320679355241861,0.9381039250048033,0.71,1.0,1.0,49/252,19.04%,THBS1;RHOB;FGF1;SEMA3A;ENPP2;LAMB1;FRMD5;ALOX15B;CEMIP;TTBK2;ANXA1;PTPRK;ADAM15;VEGFA;HSPA5;GPNMB;SEMA3B;SRCIN1;SEMA6A;INSR;PTPRT;KANK1;TMEFF2;ROBO1;FGR;CARMIL1;NTRK3;IGF1R;SEMA5A;CAMK2B;FLT1;SASH1;MAGI2;EPHA4;MCTP1;SOD2;LIMCH1;CTNNA2;DUSP10;LDB2;PLXNB1;SERPINE2;SDCBP;THY1;CLIC4;PHACTR1;PLXNC1;NTNG1;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.6196094556441767,0.9380329863882384,0.6268656716417911,1.0,1.0,3/5,18.70%,DOCK5;KCNMA1;SOD1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.3712794860264974,-0.9378207172986466,0.5,1.0,1.0,3/27,3.60%,GTF2H5;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.3712794860264974,-0.9378207172986466,0.5,1.0,1.0,3/27,3.60%,GTF2H5;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.3526723481034708,-0.9377052275469077,0.6,1.0,1.0,17/107,10.78%,GRAP2;RALB;RHOG;SETDB1;ARHGDIB;IGF1;USP28;RAPGEF6;KRAS;TP53;ARHGEF1;CRKL;CYFIP1;GNA12;PLEKHG5;ADGRG1;RASGRP2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.6105657751296663,0.9375806413693943,0.6623376623376623,1.0,1.0,1/6,2.57%,CYP3A5
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.5514684641212114,0.9374100924729599,0.6307692307692307,1.0,1.0,4/9,38.73%,PNPLA8;PGS1;PLA2G4A;HADHA
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.4296783276596325,-0.9370350609594443,0.5909090909090909,1.0,1.0,4/11,12.48%,WHAMM;CYFIP1;WASF3;GSN
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.38970993058100784,-0.9364767404994945,0.4,1.0,1.0,4/24,11.55%,NT5C3B;DCP1B;EDC3;LSM6
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.560041551303351,0.9361077451487273,0.6049382716049383,1.0,1.0,3/11,24.13%,PDK4;PDK3;RORA
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.5316625820222942,-0.9358824314661769,0.4722222222222222,1.0,1.0,5/5,46.86%,RACK1;LTN1;ZNF598;MTRES1;NEMF
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.3795182250298075,-0.9357435318609525,0.5,1.0,1.0,1/18,1.07%,NDE1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6175242189639369,0.9355823301117323,0.618421052631579,1.0,1.0,5/8,33.47%,ADCY8;CORO2B;MACROH2A1;EIF4G1;CRHBP
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.4377454151376008,-0.9353030997988818,0.5909090909090909,1.0,1.0,1/15,0.99%,MAIP1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.43796228457759473,0.9351975686513897,0.6464646464646465,1.0,1.0,47/175,25.51%,EEF1A2;RPL23;RPL37A;FTSJ1;RPS6KB2;RPL38;COPS5;RPS6;RPS27A;RPL23A;RPS25;RPS27;DARS1;RPS11;RPS20;RPL9;RPLP2;EEF1B2;RPS18;MRPL43;DRG2;RPL37;PPA1;RPL14;RPS4X;RPL11;RPS24;MRPL27;MRPL55;RPS9;RPL36;UBA52;RPS3A;MRPS14;MRPL3;RPL35;RPL4;EEF1A1;RPL32;TNIP1;RPL3;RPL27A;RPL24;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.4422473017156697,-0.9350642468113884,0.4444444444444444,1.0,1.0,9/25,21.38%,FSCN1;ABI3;CYFIP1;ARPC2;CDC42;CAPZB;FER;ACTR2;WASF2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.5750588695861849,0.9350338344175474,0.6025641025641025,1.0,1.0,3/9,29.58%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.5417996671972418,0.934921034202832,0.620253164556962,1.0,1.0,10/17,33.40%,RPL23A;MRPL20;RPL11;NOP53;RPL3;RPL24;TRAF7;RPL6;RPLP0;MDN1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.529497193876493,0.9347810390542564,0.6071428571428571,1.0,1.0,3/17,7.91%,SLCO1A2;SLC13A4;SLC13A3
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.5885691610202001,0.934218914783103,0.6231884057971014,1.0,1.0,1/10,2.58%,GLA
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.5124647881601445,0.9340720794501479,0.5853658536585366,1.0,1.0,9/22,29.11%,MID1IP1;MFSD2A;SORBS1;CNEP1R1;PPARA;CHP1;SIRT4;SCARB1;LPGAT1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.5037509108979319,0.9340068767699844,0.5783132530120482,1.0,1.0,4/21,13.75%,RPS6KB2;RPS6;PRR5;PINK1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.5866353130699133,-0.9340050816146026,0.5833333333333334,1.0,1.0,2/5,27.04%,ATP6AP1;ATP6V1G1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.3801883184312829,-0.9336648026785375,0.4666666666666667,1.0,1.0,3/29,5.26%,FLNA;IL1B;AZIN2
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5185662340363404,0.9336320554432614,0.5975609756097561,1.0,1.0,5/20,21.02%,GPM6B;EPHA3;LIMCH1;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.48777150119256807,-0.9331246610917864,0.5333333333333333,1.0,1.0,2/8,7.01%,BCL2L1;TP53
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.5750486630366038,0.9329338871494165,0.6103896103896104,1.0,1.0,5/11,24.16%,GRIN2A;GRID2;GRIN2B;MAPK8IP2;LRRK2
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.5934954691269455,0.9326354576641165,0.5822784810126582,1.0,1.0,1/7,14.76%,SPAST
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.46707297447590823,0.9324737645838355,0.5578947368421052,1.0,1.0,5/44,13.70%,ACVR1B;SPDYA;RCC1;PLK2;HINFP
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.41659980373737,-0.9323510477693145,0.5416666666666666,1.0,1.0,4/17,6.36%,LGALS9;LILRB4;IGF1;CD274
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.478390822451884,0.9316026432400323,0.5783132530120482,1.0,1.0,3/18,9.19%,SOX4;MYRIP;IRS2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.48763896777679605,0.9314835052445632,0.5833333333333334,1.0,1.0,12/31,28.80%,CAMLG;ALAD;SDCBP;RPL11;AQP11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6;USP25
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.31392708144526443,-0.9314691152903913,0.75,1.0,1.0,18/89,10.78%,NKG7;IKZF3;CD37;LY86;MPEG1;BIN2;BANK1;HHEX;CEACAM21;PYHIN1;PLEK;RASAL3;ALOX5;WDFY4;BTK;NCKAP1L;HVCN1;RASGRP2
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5325030308861018,0.9314437115051906,0.625,1.0,1.0,5/18,21.89%,GRIN2A;CIDEB;RIPK2;ASPH;PGK1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.6413389977384985,0.9311124538486998,0.671875,1.0,1.0,3/5,23.48%,NR4A3;SGIP1;LEPR
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5622707730001483,-0.9310521741152475,0.5185185185185185,1.0,1.0,1/6,4.12%,APPL2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.4604796997780872,-0.9309765978671204,0.5238095238095238,1.0,1.0,2/12,7.10%,CYP19A1;SRD5A1
prerank,MSigDB_Hallmark_2020__Androgen Response,0.436058365232063,0.9308904763844961,0.6907216494845361,1.0,1.0,16/84,18.04%,IDI1;FKBP5;BMPR1B;LIFR;ARID5B;INPP4B;NDRG1;AKAP12;TMEM50A;SCD;MAP7;DNAJB9;ITGAV;HMGCS1;INSIG1;CCND3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.523739995384952,0.9308177980187698,0.6111111111111112,1.0,1.0,4/21,11.42%,SHANK3;CTNND2;INSR;IGF1R
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5160466612815494,0.9307917633028963,0.6309523809523809,1.0,1.0,5/19,7.67%,PIGU;ARF6;PTPRK;PRRT1;ANK2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.42344764962730447,0.9305272507267361,0.6868686868686869,1.0,1.0,63/187,28.68%,LRP2;CR1;NAPA;TFRC;TRIP10;ANK3;ANK2;VAPB;DNAJC6;SYP;FCHO2;DNM3;CAV3;RPS27A;SGCZ;DNM1;SH3GL2;SYT1;SGIP1;SPAST;SNAP29;SERP1;AGFG1;ITSN1;REEP3;WNT5A;PICALM;SPTBN1;UBA52;UBXN2B;AMPH;UBB;ATP10B;AP2A2;SYNGR1;HIP1R;SUN2;CNTN2;MFN2;CLTCL1;NAPG;PLEKHA3;HACE1;CHP1;MX1;CHMP5;MTCH1;TF;CTTN;RAB5A;PDCD6IP;CHMP7;IL7R;CFTR;REPS2;RIMS1;REEP1;AP2S1;IGF2R;TMEM33;OPA1;VAPA;MX2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5058262561828119,0.9304447350300805,0.6463414634146342,1.0,1.0,1/30,0.29%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.5022686267067491,-0.9304162010928463,0.5384615384615384,1.0,1.0,3/9,17.30%,ZKSCAN3;TERF2;SLC30A10
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.44396547692525223,0.9301367916846801,0.6382978723404256,1.0,1.0,13/77,14.98%,TSHR;HTR7;CR1;PRKAR2B;CD163;ADCY3;FCGR2B;FGR;RXFP1;ADCY8;PLK2;TYRO3;CD300A
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5350042985104958,0.9300525433982487,0.5797101449275363,1.0,1.0,4/11,22.59%,MVD;ACAT1;HMGCS1;ACACB
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.5001037520164652,-0.929782001065068,0.5,1.0,1.0,2/8,6.91%,TECR;HACD4
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.5001037520164652,-0.929782001065068,0.5,1.0,1.0,2/8,6.91%,TECR;HACD4
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.4648051588323811,0.929292037766719,0.5824175824175825,1.0,1.0,4/52,7.81%,FGF1;FLRT1;NR4A1;RBFOX2
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.43413146027787763,0.9292282009277548,0.6391752577319587,1.0,1.0,2/101,1.46%,RHOBTB3;DENND2A
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.5588014801868462,0.9291587988378737,0.6081081081081081,1.0,1.0,4/11,19.34%,SVIL;IGSF8;ZBTB18;MYL6
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.4861702775674498,0.9291161564011624,0.6705882352941176,1.0,1.0,3/36,11.02%,RHOB;FIGNL1;KDM1A
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5326973910555667,0.928991015070828,0.6582278481012658,1.0,1.0,1/14,1.14%,PRLR
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.43521824740867754,0.9289206404366378,0.673469387755102,1.0,1.0,30/114,19.52%,ACVR1B;COBL;SHANK3;ZBTB16;ENPP2;RELN;ZDHHC15;NRXN1;TFRC;BMPR1B;VEGFA;NLGN1;INSR;PPP1R13L;RAPGEF3;PTN;ALK;CAMK2B;B4GALT5;SOX6;PINK1;CLASP2;BNIP3;WNT5A;PLCB1;CFL1;NEURL1;NR2C2;MAP3K13;DDHD1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.5048442732740942,0.9288148699658458,0.6144578313253012,1.0,1.0,7/22,25.61%,MAPT;MAP2;HCLS1;TPPP;PAK3;CTTN;ARHGAP18
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.5863168358742236,0.9287470348334474,0.6575342465753424,1.0,1.0,2/8,11.83%,CARMIL1;SEMA5A
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6127519704251931,0.9285593579848302,0.6461538461538462,1.0,1.0,2/8,8.02%,ACSS3;ACAT1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4289128254932691,0.9272830728206327,0.6938775510204082,1.0,1.0,26/161,14.83%,THBS1;FGF1;CLIP3;FAXDC2;TFRC;ACVR2A;VEGFA;GPNMB;INSR;EPHA3;HIF1A;SLCO3A1;NTRK3;IGF1R;ALK;EPHA6;PFKFB4;EPHA7;FLT1;NTRK2;FAM20A;PINK1;TYRO3;EPHA4;EPHA5;LIMCH1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.6199707985990552,0.9271914368540581,0.6571428571428571,1.0,1.0,3/5,35.25%,GRM5;PRNP;GOPC
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5941995689132031,0.9270538140581065,0.6153846153846154,1.0,1.0,4/5,32.62%,EIF3E;CDK9;EIF3D;EIF4G1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.3625777389191061,-0.9270233169444473,0.4,1.0,1.0,5/40,8.46%,PSMB3;PSME3;PSMD12;PSMC4;PSME4
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.5583475056456092,-0.9268925530367147,0.6206896551724138,1.0,1.0,2/5,9.24%,HPS4;P2RY12
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.6071747656127495,0.9266471719405508,0.6521739130434783,1.0,1.0,2/6,13.75%,PRR5;PINK1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.6410375570344128,0.9266388821136887,0.6666666666666666,1.0,1.0,1/5,3.07%,CACNB2
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5493520939675207,0.9265995000213015,0.5866666666666667,1.0,1.0,5/9,27.75%,TCHP;ODF2L;CDK10;LIMK2;CCP110
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.5156811219095203,0.9265753630148474,0.5974025974025974,1.0,1.0,5/12,23.38%,GHR;MFSD2A;SOD1;APP;PPIB
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.44606378034825733,0.9265414172191255,0.6938775510204082,1.0,1.0,40/137,25.51%,RPL23;MAPT;WDR12;WDR74;RPL37A;IMP3;PES1;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;RPL9;RPLP2;RPL37;RPL14;RPL11;RPS24;MPHOSPH6;RPS9;RPL36;NOB1;UBA52;NOP53;RPL35;RPL4;RPL32;WDR3;MPHOSPH10;RPL3;RPL27A;RPL24;MRTO4;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.5393571266826384,0.9260497769032633,0.5975609756097561,1.0,1.0,1/9,5.39%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.41582326256545904,-0.9259788613337923,0.4375,1.0,1.0,8/19,17.16%,LGALS9;SCIMP;IRF5;TLR3;SYK;TIRAP;IL16;LAPTM5
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4433124162158854,0.9259700942738688,0.6043956043956044,1.0,1.0,18/63,21.53%,SIPA1L1;EPHA3;CHN1;NGEF;EPHA6;DNM1;KALRN;EPHA7;ANKS1B;EPHA4;EPHA5;GRIN2B;ITSN1;SDCBP;CDK5R1;ROCK1;AP2A2;PAK3
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.5899591796427327,0.9259529151267574,0.6428571428571429,1.0,1.0,4/9,28.61%,CFL1;PPIB;IGF2R;VAPA
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.5640981631686471,0.9257011898950719,0.5822784810126582,1.0,1.0,2/12,12.11%,IL15;NOD2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.656230292048118,0.9256175845705592,0.625,1.0,1.0,3/5,17.54%,GAD1;GAD2;ALDH1A1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.559318389845945,-0.9253554795927936,0.6,1.0,1.0,3/7,14.26%,MAN2B2;MAN2B1;MANBA
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.5749623494095424,0.9252795984946912,0.6119402985074627,1.0,1.0,1/8,1.94%,VIM
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.6273987421882594,0.9250076037804784,0.6567164179104478,1.0,1.0,2/5,21.77%,CPEB2;CPEB4
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3396474057755404,-0.9249285026133442,0.6,1.0,1.0,6/27,18.33%,PRR5L;TGFB1;LCP1;PLK3;RAB29;CEP290
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3875771358312462,-0.9248403900667357,0.5,1.0,1.0,3/34,3.64%,TGFBR3;TAL1;SH2B3
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.4237848055069752,0.9247277559568949,0.79,1.0,1.0,60/304,27.28%,DIAPH3;SYNE3;ATAD3A;EIF2AK3;MTERF1;SEMA6A;AGTPBP1;VAPB;HCFC1;VPS11;ATP8B1;PALLD;SIRT5;LIMD1;CSPG5;SH3D19;GABPB1;PAK5;PPID;CYCS;PINK1;CLASP2;POLG2;VMP1;AUP1;GOLGA8B;SPTBN5;THY1;PEX3;TMED10;CFL1;FGD6;FAM174B;TFAM;KIF3A;UBXN2B;SIRT3;VPS51;SURF4;CENPT;RAB30;CNTNAP1;KIF5C;BRWD1;HACE1;RHOU;CHMP5;POLRMT;MAST4;LRRK2;DYNC2H1;FGD4;PDCD6IP;CHMP7;BNIP1;CLUH;SORT1;PEX10;SIRT4;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.5394828868594629,0.9244423207151647,0.6,1.0,1.0,7/11,27.28%,PDK4;TYSND1;NR4A3;PRKAG2;PPARA;SIRT4;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.49904639033349185,-0.9243830203588029,0.6206896551724138,1.0,1.0,3/9,6.07%,IL1B;DAGLB;MTLN
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6352068443448402,0.9242444759885428,0.6666666666666666,1.0,1.0,2/5,33.30%,GSTP1;FOXO1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.5744538203648799,0.924214933676925,0.6338028169014085,1.0,1.0,1/8,1.94%,VIM
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.462480302565738,0.9238220845805639,0.6774193548387096,1.0,1.0,6/48,13.50%,KLF4;NAPSB;FCGR2B;FGR;CD93;CYCS
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.6249727380069635,0.9236648678738348,0.6027397260273972,1.0,1.0,1/5,7.01%,SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.38186795849033206,-0.923597681141084,0.5238095238095238,1.0,1.0,6/23,12.96%,LGALS9;IGF1;SIRPA;HAVCR2;NLRC3;ILRUN
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5756535889592607,-0.9235181307806002,0.6333333333333333,1.0,1.0,1/5,0.32%,NEXMIF
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.4592919422510635,0.9233708784369196,0.6309523809523809,1.0,1.0,6/34,14.21%,ADCY3;PAPSS2;ACAT1;ADCY10;ADCY8;GUCY1B1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.6049740635762157,0.9232438659508041,0.6,1.0,1.0,2/5,22.74%,CALCOCO2;FYCO1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.4974501160919697,0.9232196901954601,0.6024096385542169,1.0,1.0,4/22,17.47%,PDK4;IRS2;FBP1;PDK3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.4771675596554328,0.9230076749982423,0.6404494382022472,1.0,1.0,3/44,8.10%,TRMT9B;FTSJ1;PUS7
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.611606345380111,0.9229947082545968,0.68,1.0,1.0,5/11,30.54%,INSR;APP;DCTN1;MAP1A;PRNP
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6037853282533671,0.922981177538719,0.7142857142857143,1.0,1.0,4/8,20.06%,IRS2;TYSND1;MFSD2A;PPARA
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5862400361419383,0.9229755384622427,0.6111111111111112,1.0,1.0,2/7,22.25%,NREP;RTN4RL1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.5827301302385073,0.922641148036759,0.5915492957746479,1.0,1.0,5/7,40.87%,MCMDC2;MCM3;MCM6;MCM5;MCM7
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.6153727247289583,0.9225707440891595,0.6461538461538462,1.0,1.0,1/6,13.69%,NFKBIZ
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.61441669962333,0.9223414312261339,0.6470588235294118,1.0,1.0,3/7,25.49%,ABCA1;BMP1;PRKACB
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5598816178756967,0.922064630973147,0.6857142857142857,1.0,1.0,1/9,10.19%,LIMD1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5373224577207335,0.9218143719430086,0.618421052631579,1.0,1.0,1/14,1.90%,DTL
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.6314990750618494,0.9217319138163553,0.6794871794871795,1.0,1.0,6/7,36.57%,GINS1;MCMDC2;MCM3;POLA1;GINS3;MCM6
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5907978269324086,0.9217167157401244,0.6268656716417911,1.0,1.0,3/6,22.74%,MAPT;KIF3A;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.42898222037546957,0.9212888954100938,0.6597938144329897,1.0,1.0,35/144,22.39%,FBN2;TGFB2;ZBTB16;GLIPR2;BRINP1;AGT;CDH2;ALOX15B;ACVR2A;BMPR1B;KITLG;NOCT;PPP1R13L;PAX8;ID2;PTN;RANBP3L;GPRC5B;IMPACT;LMO3;SOX6;CTNNA2;VWC2;SDCBP;PLCB1;AKIRIN1;RGCC;OLFM1;NELL1;FES;EZH2;MSR1;IL18;AAMDC;TCF4
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4372002559355352,0.9210586701721055,0.6526315789473685,1.0,1.0,15/86,19.79%,ALG10B;B4GAT1;MGAT4C;TUSC3;GALNT18;MGAT1;STT3B;OGA;B4GALT5;SERP1;MAGT1;PLOD1;GFPT1;ST8SIA3;AQP11
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5528923948668217,0.9209899224585993,0.625,1.0,1.0,2/13,9.02%,SRSF12;PCBP4
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.4912712622456426,0.9207681274779007,0.6629213483146067,1.0,1.0,4/39,4.68%,TULP2;GRM8;COL11A1;SLC4A10
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.45697866665944864,0.9206752267772937,0.6136363636363636,1.0,1.0,6/49,8.44%,RHOB;BRINP1;NR4A1;ALOX15B;PTPRK;CAMK2N1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.4681862859038841,-0.9206184587496323,0.5,1.0,1.0,3/15,4.36%,G6PC3;PGM2;RPIA
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.5058826763144116,0.920060617645417,0.5802469135802469,1.0,1.0,2/18,14.56%,WDR5;BRCA1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.43945798304028266,0.9199996488236852,0.7078651685393258,1.0,1.0,13/73,22.77%,CLVS1;NAPA;STEAP2;DNAJC6;RP2;SH3D19;SH3GL2;SCAMP3;STXBP6;APP;FTH1;OSBPL5;EXOC5
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.4452793732599375,-0.9199891785601277,0.6956521739130435,1.0,1.0,2/12,9.88%,IRAK4;TLR7
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.42715808230710495,0.9197433757651591,0.7676767676767676,1.0,1.0,40/238,20.67%,THBS1;HTR2B;LRP2;PRLR;ARAF;NAA38;TFRC;ATAD3A;RNF144B;ANXA1;VEGFA;HSPA5;FIGNL1;IL7;FMN2;COPS5;BNIP3L;FAIM2;MCL1;RPS27A;IGF1R;PLK2;RIPK2;BNIP3;PRELID1;BCL2L2;NUAK2;WNT5A;CASP3;TMEM14A;CFL1;HSPB1;ARHGDIA;GSTP1;HSPA1B;TAF9B;PRKAA2;UBA52;HSPD1;UBB
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.5028988032045499,0.9197391029251197,0.6153846153846154,1.0,1.0,4/16,12.91%,PRKAR2B;PEX5L;PDE2A;GNAI1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.5535065102285512,0.919641033810166,0.6301369863013698,1.0,1.0,2/10,16.56%,SLC19A2;DCK
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5659394895766966,0.9191705477585296,0.6164383561643836,1.0,1.0,1/8,13.39%,XRCC3
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.45551215706589715,0.9188969801172018,0.6770833333333334,1.0,1.0,15/62,20.06%,HMGB2;TMEM161A;ANXA1;NOCT;RXRB;SLC11A1;ABCA2;PAQR7;HNRNPA0;SCD;TRIM16;ESR1;PELI1;FOXP1;PPARA
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.3344730097133931,-0.9183848384453713,0.631578947368421,1.0,1.0,6/25,9.02%,INPP5K;BANK1;SH2B3;TRIB3;ARRB2;OTUD3
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.45508394611907815,-0.9183135009971308,0.5652173913043478,1.0,1.0,2/7,11.40%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.4254187196401897,0.9182680854500227,0.6907216494845361,1.0,1.0,30/144,24.55%,CR1;SRGN;EIF2AK3;ANK3;VAPB;SYP;VPS11;ATP8B1;CAV3;DNM1;CLASP2;SNX10;SERP1;VMP1;HOOK3;GOLGA8B;REEP3;SPTBN5;TMED10;FAM174B;SPTBN1;UBXN2B;VPS51;SYNGR1;SURF4;SUN2;RAB30;HACE1;LRRK2;DYNC2H1
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.5517403390303562,0.9179931827696262,0.6455696202531646,1.0,1.0,3/10,17.39%,CR1;DUSP10;BCL6
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.5380856221572663,-0.9178066296209227,0.5517241379310345,1.0,1.0,1/6,1.00%,ZNF703
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.44011625209933375,0.9175415027996646,0.6804123711340206,1.0,1.0,43/162,25.51%,RPL23;RIOK2;WDR12;WDR74;RPL37A;IMP3;PES1;RPL38;SBDS;XPO1;RPS6;RRP1B;RPL23A;RPS25;GLUL;RPS27;RRP36;HEATR3;RPL9;RPLP2;RPL37;RPL14;RPL11;RPS24;MPHOSPH6;RPS9;RPL36;NOB1;UBA52;NOP53;RPL35;RPL4;RPL32;WDR3;MPHOSPH10;RPL3;RPL27A;RPL24;MRTO4;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4813301234534702,0.9173058934241,0.6235294117647059,1.0,1.0,6/24,15.11%,SOCS3;IL15;VEGFA;GHR;CRLF1;HCLS1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.497526738313391,0.9172785152753538,0.6233766233766234,1.0,1.0,4/17,17.67%,STMN3;CKAP5;STMN2;CFL1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.554174421091585,0.9171548810044206,0.6666666666666666,1.0,1.0,1/11,6.91%,RGS2
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5854419174669024,0.9169474613001354,0.676056338028169,1.0,1.0,4/6,38.57%,DDX1;DDX3X;DHX9;SSB
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.48898853570973166,0.9168175742839836,0.6027397260273972,1.0,1.0,9/23,22.90%,HTR7;TBC1D8;SGCZ;GUCY1B1;SOD1;ROCK1;SGCD;SCPEP1;STAT1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.42966564317576855,-0.9168118123964598,0.5652173913043478,1.0,1.0,4/11,15.05%,TP53;TGFB1;EGFR;DDX5
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5384345504784906,0.9167336616254317,0.6578947368421053,1.0,1.0,6/16,19.64%,CIT;FAM162A;BNIP3;SCN2A;APP;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5501856320595606,0.9166023243136221,0.6164383561643836,1.0,1.0,2/9,20.02%,GSTP1;RNF13
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5460144690459604,0.9164186598327762,0.631578947368421,1.0,1.0,3/10,17.01%,HSPA5;PDIA2;INSIG1
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.6609613789265067,0.916402132784303,0.6984126984126984,1.0,1.0,2/5,26.96%,STPG4;TOX
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.6609613789265067,0.916402132784303,0.6984126984126984,1.0,1.0,2/5,26.96%,STPG4;TOX
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.48073644323737624,0.9163940017850771,0.6136363636363636,1.0,1.0,8/31,25.64%,ZBTB16;NOCT;ID2;LMO3;NAPEPLD;AAMDC;HNRNPU;PIM1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.46257308183305007,0.9161319847310964,0.6595744680851063,1.0,1.0,19/76,23.71%,BRIP1;RPA2;CLSPN;WDHD1;DNA2;DONSON;BRCA1;POLG2;POLE2;RFC4;ORC6;POLL;DBF4;RFC1;RBBP8;TIMELESS;ORC3;RPA3;BARD1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.5260135490755771,0.916074587875036,0.6212121212121212,1.0,1.0,1/11,4.20%,TFRC
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.4369923309673266,-0.9158153948894704,0.5625,1.0,1.0,4/20,7.82%,NDE1;KIF3B;KIF1C;TRAK2
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5915251498650504,0.9157351716554214,0.6571428571428571,1.0,1.0,2/5,20.74%,KDM1A;CDK9
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.47564326397501266,-0.9154961677355661,0.5,1.0,1.0,1/8,0.74%,NUFIP1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.42776280387442,-0.9152410973394035,0.5454545454545454,1.0,1.0,3/22,6.56%,PPP1R16B;ICAM1;RAPGEF6
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5500028997070606,0.9151232735537033,0.6285714285714286,1.0,1.0,1/9,1.65%,TRMT9B
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.29604894466247084,-0.9149553747129512,0.875,1.0,1.0,20/66,18.26%,LRP10;DENND1C;TC2N;ARAP1;MAPK13;MAP2K3;NBEAL2;HLA-E;BCL3;ARHGAP27;PSD4;IRF7;OSTF1;R3HDM4;NFKB2;DEF6;RPS6KA1;SIGIRR;CDC42SE1;YPEL3
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.579063207187037,0.91455453554064,0.6301369863013698,1.0,1.0,1/7,5.47%,BMPR1B
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5483795228361004,0.9144410687823145,0.6410256410256411,1.0,1.0,4/9,38.15%,GRK4;PDE6B;FNTA;CAMKMT
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.4802681499060277,0.9143257332041496,0.631578947368421,1.0,1.0,7/23,30.23%,IRS2;FBP1;SORD;PGM1;GALM;GAA;CHST1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.3750423630889218,-0.9143159973483639,0.5882352941176471,1.0,1.0,7/22,17.94%,LSM11;MTPAP;SNRPB;EXOSC10;CPSF2;UPF1;TUT7
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5525353063785563,0.9140204907653353,0.625,1.0,1.0,1/10,9.92%,RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.5753110036562719,0.9139872110355942,0.6363636363636364,1.0,1.0,1/6,6.73%,SYT4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.49970481452647675,0.9134880060464501,0.6388888888888888,1.0,1.0,1/19,1.04%,NLRP12
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.4698811858801451,-0.9131477811504203,0.5384615384615384,1.0,1.0,3/12,16.82%,MYO1F;MYO1D;MYO7A
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5905086819895164,0.912815148397104,0.6031746031746031,1.0,1.0,4/6,38.62%,GPS2;UBR5;PLAA;PARP10
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.47330017422375337,-0.9126323164994721,0.5217391304347826,1.0,1.0,2/10,6.57%,NCOA4;SERPINB9
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.39124049972646724,-0.9123556047834971,0.47058823529411764,1.0,1.0,1/14,3.24%,FLII
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.5735697555760351,-0.9121801346949618,0.6176470588235294,1.0,1.0,1/6,2.10%,GCLC
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.5735697555760351,-0.9121801346949618,0.6176470588235294,1.0,1.0,1/6,2.10%,GCLC
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.6038967797477043,0.9120798892450801,0.6621621621621622,1.0,1.0,2/6,29.04%,VCPIP1;WAPL
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5980835490625176,0.9115291023648812,0.6486486486486487,1.0,1.0,2/8,13.10%,DOCK5;NR4A3
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.40883607201611377,-0.9112259616679945,0.5,1.0,1.0,4/17,13.28%,MYH9;APH1A;RBMX;HM13
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.37463860799649534,-0.9111582053948704,0.5454545454545454,1.0,1.0,12/46,19.43%,GZMB;DAB2IP;IDE;CLTA;RSPRY1;CAPN2;CTSH;CTSZ;CASP8;PISD;CTSC;RAB7A
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.5530741061954075,0.910951160996776,0.6493506493506493,1.0,1.0,3/11,23.99%,ANXA1;KLF9;HNRNPU
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.6079867859992322,0.9108496591838346,0.6666666666666666,1.0,1.0,1/5,5.39%,ANXA1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.5039147600302838,0.9108155421045866,0.6666666666666666,1.0,1.0,4/22,13.15%,SUV39H2;ANTKMT;CSKMT;SMYD5
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5824319989269815,0.9107776649960203,0.618421052631579,1.0,1.0,3/9,13.66%,ZBTB16;BMPR1B;SOX6
prerank,MSigDB_Hallmark_2020__Coagulation,0.4414330652935652,0.9101906732008935,0.6881720430107527,1.0,1.0,8/66,12.87%,THBS1;SPARC;ITGA2;ANXA1;FN1;RAPGEF3;CRIP2;THBD
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5251757965702593,-0.9099169879791746,0.5,1.0,1.0,1/11,0.99%,MAIP1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.4362591276385202,0.9096101815473088,0.6979166666666666,1.0,1.0,15/65,17.65%,SLC51A;ACSL1;SLCO1A2;ABCA2;ATP8B1;SLCO3A1;MFSD2A;SLC10A1;ABCA1;PLTP;PRELID1;STARD5;ABCA5;PEX3;UGCG
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.48798593144824004,0.9095489614381383,0.6477272727272727,1.0,1.0,6/23,20.91%,IL1RAPL1;FCGR2B;ZNF804A;CTNNA2;NTNG1;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.5302026440688732,-0.9094886311375688,0.5,1.0,1.0,1/5,15.13%,MARK4
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5645962323333653,0.9091819005084946,0.6296296296296297,1.0,1.0,2/12,11.08%,NEK11;EME2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.4091139073571829,-0.9091346956811394,0.5294117647058824,1.0,1.0,4/18,9.69%,NEXMIF;ACER2;P2RY12;NCKAP1L
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.44611609668872804,-0.9085324548161844,0.6296296296296297,1.0,1.0,1/10,0.43%,TGFBR3
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.5807599047475822,-0.9084661636891577,0.5897435897435898,1.0,1.0,1/5,4.02%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5230279080894001,0.9083755985353952,0.7228915662650602,1.0,1.0,3/18,10.98%,RAP1GAP;KANK1;TCHP
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.48828389375208825,-0.9081637273945188,0.4827586206896552,1.0,1.0,2/6,30.75%,CD4;NECTIN2
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.48828389375208825,-0.9081637273945188,0.4827586206896552,1.0,1.0,2/6,30.75%,CD4;NECTIN2
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.644654490562748,0.9077913560717723,0.6986301369863014,1.0,1.0,1/5,8.78%,MAP2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.39637021742986395,-0.9076394498856724,0.6875,1.0,1.0,5/20,11.90%,TICAM1;SIRPA;NCKAP1L;HLA-DPA1;TYROBP
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.43827716276206896,0.9076154644326829,0.648936170212766,1.0,1.0,14/68,24.32%,KLF4;FBXL7;GPNMB;FHL1;RBX1;PSMB4;E2F7;RGCC;PSMC2;PSMA3;PSMB2;RBL2;PSMD5;PSMD7
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.4168335062215451,0.9075476666966659,0.7142857142857143,1.0,1.0,20/141,14.83%,ALG10B;FGF1;CLIP3;FAXDC2;TFRC;ACVR2A;VEGFA;GPNMB;PPP2R5A;NSMF;INSR;SLCO3A1;RAPGEF3;CALM3;TXN;NTRK3;NTRK2;FAM20A;PINK1;LIMCH1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.43790397806222686,0.9071468825559439,0.6631578947368421,1.0,1.0,20/85,25.97%,ARAF;RNF144B;HERPUD1;XPO1;PRICKLE1;RNF144A;ARIH2;RBX1;DNAJB2;CAMLG;SDCBP;RPL11;HSPA1B;NOP53;HFE;LRRK2;BBS7;MAP1A;USP5;DDRGK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.443559068052122,0.9068852234954478,0.6804123711340206,1.0,1.0,14/70,15.54%,PLPP3;SVEP1;TAMALIN;NTN4;DOCK1;PALLD;FN1;TMTC2;SH3D19;THBD;BACE2;PMP22;UACA;ENPP4
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5104589076049825,-0.9066894031712663,0.5625,1.0,1.0,2/6,17.54%,NR1H3;CDC42
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.5750377905844873,0.906668859936979,0.696969696969697,1.0,1.0,1/7,1.94%,VIM
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.6276649073815626,0.906223517106489,0.6865671641791045,1.0,1.0,2/5,26.93%,ABCA1;ABCG1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.5804728393369162,0.9061721549836722,0.6714285714285714,1.0,1.0,2/8,8.53%,CHI3L1;PTPRT
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.321281882836979,-0.9060446821715318,0.5,1.0,1.0,9/91,5.29%,PHLDB2;NEXMIF;TMIGD3;EVL;ADARB1;DAB2IP;TRIB1;DUSP3;ARHGDIB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.47037793041332304,-0.9055449664999926,0.5161290322580645,1.0,1.0,3/10,13.32%,ITGAM;ITGB2;SYK
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.4564074634094915,-0.9054707195394661,0.5333333333333333,1.0,1.0,5/15,18.60%,TMEM119;MAML1;BHLHE41;FBXO22;HDAC5
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.4484080673422623,0.9054195001125922,0.6477272727272727,1.0,1.0,4/40,8.38%,SULT4A1;HINT1;ACAT1;ACOT13
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5283087717920857,0.9053696180902112,0.6133333333333333,1.0,1.0,1/13,11.02%,KDM1A
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.5971074756083983,0.9051819392441092,0.6285714285714286,1.0,1.0,4/5,32.19%,SLC39A12;SLC39A14;SLC39A6;SLC39A8
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.48067206226870174,-0.9050319097383172,0.47619047619047616,1.0,1.0,2/11,12.33%,SETDB1;TASOR
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.47152850513383565,-0.9049274621183591,0.5789473684210527,1.0,1.0,3/13,9.25%,SERPINF2;A2M;KLKB1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5107845922202968,0.9048000086375709,0.5875,1.0,1.0,2/12,13.14%,LIMD1;DYNC1H1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5514547423623337,-0.9045409569304808,0.6923076923076923,1.0,1.0,1/6,7.01%,TP53
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.480200716136176,0.9045318663554256,0.6741573033707865,1.0,1.0,2/22,5.28%,TGFB2;ACVR2A
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.45999790817272573,0.9045246571841701,0.6818181818181818,1.0,1.0,2/40,3.16%,HMGB2;H2BC11
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.35731462765394295,-0.9044743298893967,0.5833333333333334,1.0,1.0,2/28,10.45%,PKIB;MAP3K4
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.43133390957385803,0.9043853280044744,0.71,1.0,1.0,10/72,16.85%,RAP1GAP;TBC1D8;TBC1D13;SIPA1L1;NGEF;GPR65;NTRK3;TBC1D15;APC2;RASGRF1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5130576722272313,0.9043565559691457,0.6790123456790124,1.0,1.0,2/18,9.02%,SRSF12;PCBP4
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5679001988622507,0.9040370258854539,0.6575342465753424,1.0,1.0,1/10,6.05%,CD55
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.37737005674310375,-0.9040151575107147,0.5555555555555556,1.0,1.0,3/18,11.40%,PFN1;ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.6351989301119292,0.903985814996505,0.7183098591549296,1.0,1.0,1/5,3.33%,ADCY3
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.5785148880857214,0.9035169055576925,0.6376811594202898,1.0,1.0,4/9,25.30%,ASXL3;GSTP1;PPARA;TRAP1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.49334322340553216,0.9033362531009883,0.7,1.0,1.0,2/25,5.67%,SLF1;RPA2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4984841170650784,0.9032877081631471,0.6029411764705882,1.0,1.0,1/11,4.20%,TFRC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.49866603417200916,0.9032603516111981,0.6097560975609756,1.0,1.0,7/19,23.50%,RPA2;RPS27A;RFC4;UBA52;UBB;RFC1;RPA3
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.4386129902724259,0.9031727979057665,0.6875,1.0,1.0,23/93,25.87%,DDIT4;EIF4A3;VEGFA;HSPA5;IMP3;EIF2AK3;HERPUD1;ARFGAP1;NHP2;DNAJB9;SERP1;HYOU1;TUBB2A;CXXC1;DCTN1;ERO1A;SRPRA;BAG3;ATF3;HSP90B1;CNOT6;SPCS3;EIF4A2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.46558279998537305,0.9030766072389649,0.6976744186046512,1.0,1.0,11/34,18.44%,GLA;ABCA2;ARSA;UGT8;GALC;SUMF2;ST6GALNAC5;UGCG;SUMF1;GBA3;ST8SIA3
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.35715924401783494,-0.9029964542450585,0.42857142857142855,1.0,1.0,5/41,8.46%,PSMB3;PSME3;PSMD12;PSMC4;PSME4
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5114855635318095,0.9029497227633719,0.6901408450704225,1.0,1.0,5/16,30.95%,GSDMD;NDC1;RTN4;AHCTF1;NUP153
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.540404018683058,0.9028314265816058,0.6582278481012658,1.0,1.0,1/12,6.91%,RGS2
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4588456179049017,-0.9026946411191414,0.5769230769230769,1.0,1.0,4/11,14.41%,BCL2L1;IGF1;GPX1;AKT1
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.31965361538939735,-0.9024632103746849,0.45454545454545453,1.0,1.0,15/53,16.45%,RPRD1B;DHX38;CPSF1;MTPAP;CHTOP;THOC5;WDR33;DDX39A;RPRD1A;SLU7;CSTF1;CPSF4;CPSF2;THOC7;POLDIP3
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.46325934108441186,0.9022945772621562,0.6511627906976745,1.0,1.0,9/26,23.50%,RPA2;TDG;MPG;NEIL1;ADPRS;RFC4;POLL;RFC1;RPA3
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.47809694411429055,0.9019324645135093,0.6071428571428571,1.0,1.0,7/24,34.83%,SIRT5;SIRT3;ZC3HAV1;SIRT4;PARP9;TIPARP;PARP11
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.48047491185491054,-0.9016569391064579,0.5925925925925926,1.0,1.0,3/9,18.64%,EP300;KAT7;KAT5
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.43345072676383134,0.9005107192557918,0.6630434782608695,1.0,1.0,11/73,19.04%,EIF4A3;RIDA;ENC1;EIF2AK3;DAPK1;PUS7;ZNF540;EIF3E;RNF139;CPEB2;ROCK1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.4678787872672265,-0.9001728142037422,0.4857142857142857,1.0,1.0,2/7,12.15%,UQCC2;SLC25A33
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.4678787872672265,-0.9001728142037422,0.4857142857142857,1.0,1.0,2/7,12.15%,UQCC2;SLC25A33
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.4877879908263777,0.9001415713155317,0.6588235294117647,1.0,1.0,5/24,14.10%,GRB10;INSR;IRS2;SORBS1;PRKAG2
prerank,MSigDB_Hallmark_2020__Apoptosis,0.43709076254621265,0.8999860490121309,0.7978723404255319,1.0,1.0,25/114,19.04%,TOP2A;RHOB;TGFB2;DPYD;HMGB2;GADD45B;PPP2R5B;PLPPR4;ANXA1;ENO2;BNIP3L;TXNIP;MCL1;IFITM3;SPTAN1;BRCA1;SOD2;BCL2L2;CASP3;TIMP3;HSPB1;CDKN1B;SOD1;APP;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6111038571325831,0.8998329025744146,0.6842105263157895,1.0,1.0,1/5,2.58%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6111038571325831,0.8998329025744146,0.6842105263157895,1.0,1.0,1/5,2.58%,GLA
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.3532187396284675,-0.8998235380044474,0.6153846153846154,1.0,1.0,2/30,10.45%,PKIB;MAP3K4
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.48788484384793857,0.899819303208685,0.6627906976744186,1.0,1.0,6/24,22.81%,ATP8B1;MFSD2A;ABCA1;ATP10B;ATP8A2;ABCB4
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.4253920800754335,-0.8996499594436815,0.625,1.0,1.0,3/18,10.57%,SLC46A1;UCP2;HVCN1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.35445715051852106,-0.8996222918881797,0.6428571428571429,1.0,1.0,6/33,7.47%,TAL1;LYL1;RHOG;HHEX;FAM78A;EPOR
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.2999806082707396,-0.8995685009334926,1.0,1.0,1.0,19/115,12.71%,FLNA;ITGAM;HPS4;GZMB;FYN;IL1B;ZPR1;BAP1;TP53;ZDHHC2;PRR5L;PPP1R13B;BID;TGFB1;SORL1;ITGB2;PLK3;PPP3CC;EFCAB7
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4474985422449156,-0.8993943138950604,0.5,1.0,1.0,5/10,11.89%,CCND1;TP53;RFWD3;PLK3;SDE2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.42623916114383487,0.899209624053213,0.7111111111111111,1.0,1.0,18/67,21.42%,SH3BP5;SRCIN1;CAMK2N1;PTPRT;DEPTOR;CAV3;GSKIP;PRKAG2;PPM1E;DUSP10;PYCARD;THY1;HSPB1;CDKN1B;GSTP1;TAF7;SH3BP5L;GNAQ
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.36516089059772827,-0.89897075389329,0.6666666666666666,1.0,1.0,10/29,14.41%,SESN2;LATS2;LILRB4;PYHIN1;WWTR1;NVL;TGFB1;ILRUN;KAT7;AKT1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.4363166857950653,0.8986636245987066,0.648936170212766,1.0,1.0,6/55,14.56%,RHOB;ANXA1;FIGNL1;CLK2;INTS3;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.4820655267068147,-0.8983573224652492,0.6363636363636364,1.0,1.0,1/12,0.94%,PDE12
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5188049373439831,0.8982381174470825,0.6666666666666666,1.0,1.0,2/11,13.02%,SYT4;SYT1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.43374291607873233,0.8982258720900094,0.6451612903225806,1.0,1.0,15/64,23.57%,TGFB2;ARF6;SPRY1;KANK1;IRS2;ARFGAP1;FBP1;RASGRP4;RASGRF1;ARHGDIA;STARD13;NOTCH2;MFN2;RDX;STARD8
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),0.6010792571796443,0.8978972844702203,0.7236842105263158,1.0,1.0,4/7,33.24%,PRELID1;ABCB4;DBI;ABCA3
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.49185815380090997,0.8976121757920387,0.6707317073170732,1.0,1.0,7/21,28.33%,RAB20;ATP6V0B;SLAMF8;ATP6V1D;ATP6V0E2;ATP6V1B2;ATP6V1E2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.5341610165507111,0.8974226044843436,0.625,1.0,1.0,3/10,15.33%,MEI1;SYCP3;ZCWPW1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.5936160786086986,0.896715223393291,0.696969696969697,1.0,1.0,2/5,23.55%,TRNT1;TRMT10C
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.42417082086692237,0.8967013107738419,0.6804123711340206,1.0,1.0,5/74,5.52%,ACVR1B;TGFB2;ACVR2A;BMPR1B;PTPRK
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.4358577121918997,-0.8964648347209476,0.5652173913043478,1.0,1.0,1/15,0.28%,SNAP47
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.49432354444465665,0.8964259196311353,0.6511627906976745,1.0,1.0,3/18,6.84%,MTCL1;CEMIP;ANK3
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.6090119255674236,0.896413816344166,0.6379310344827587,1.0,1.0,3/5,34.23%,PMPCA;PMPCB;IMMP2L
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.5633758997292655,0.8964033090127647,0.6578947368421053,1.0,1.0,3/11,14.11%,VIM;NOD2;RIPK2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5053379149465451,0.8962439136069533,0.6097560975609756,1.0,1.0,4/17,15.51%,EIF2AK3;HERPUD1;BOK;SYVN1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.5322718066234384,-0.8960534164405182,0.5666666666666667,1.0,1.0,1/5,4.84%,IL4I1
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.5538839646875456,0.8960263666472714,0.6486486486486487,1.0,1.0,4/9,30.01%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.5538839646875456,0.8960263666472714,0.6486486486486487,1.0,1.0,4/9,30.01%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.5538839646875456,0.8960263666472714,0.6486486486486487,1.0,1.0,4/9,30.01%,DNA2;XRCC3;SLX4;BLM
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.41626193638283965,0.895928947726972,0.7142857142857143,1.0,1.0,24/115,20.84%,RAP1GAP;TGFB2;CBR1;PDK4;FAH;GAD1;PAPSS2;CA2;ID2;NDRG2;BLVRB;ARG2;ETS2;PINK1;FBP1;SPINT2;PEMT;ATP2A2;ESR1;HPRT1;ADH5;SSR3;TNFRSF1A;HACL1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.5091271950586618,-0.8957522387542117,0.5294117647058824,1.0,1.0,2/5,21.08%,AGO1;MOV10
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.3677912920279833,-0.8955794332481306,0.6190476190476191,1.0,1.0,8/25,17.85%,LILRB4;DUSP3;CD226;BCL10;CARD11;CD81;LAPTM5;RAB29
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.5721744255657166,-0.8955643278820267,0.6206896551724138,1.0,1.0,1/5,9.57%,CAP1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.2944050922166033,-0.8954680588784862,0.875,1.0,1.0,14/58,14.79%,RANBP6;SNUPN;APPL2;NUP155;RPAIN;PHB2;IPO13;NUP214;NUP188;PTTG1IP;SYK;SNRPB;AKT1;BACH2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.42933756480864155,0.8954111671084336,0.7551020408163265,1.0,1.0,42/148,25.51%,RPL23;RIOK2;WDR12;WDR74;RPL37A;MAK16;IMP3;PES1;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;NHP2;RPL9;RPLP2;RPL37;RPL14;RPL11;RPS24;MPHOSPH6;RPS9;RPL36;NOB1;UBA52;NOP53;RPL35;RPL4;RPL32;WDR3;MPHOSPH10;RPL3;RPL27A;RPL24;MRTO4;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.4961405009428598,-0.8952135308976698,0.5161290322580645,1.0,1.0,2/6,12.94%,B4GALT7;XYLT1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.5199733644213116,-0.8947541264159667,0.5555555555555556,1.0,1.0,1/5,7.01%,TP53
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4246303074557939,0.8947297220923177,0.7021276595744681,1.0,1.0,13/70,15.11%,SOCS3;ENPP2;RELN;IL15;AGT;VEGFA;SRCIN1;GHR;GPRC5B;CRLF1;RIPK2;EPHA4;HCLS1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.4694068003666679,0.894380693521506,0.7160493827160493,1.0,1.0,10/33,21.77%,HSPA5;EIF2AK3;NIM1K;IMPACT;PRKAG2;NUAK2;PIK3R4;SESN1;PRKAA2;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.37515171201994046,-0.894100211560767,0.6190476190476191,1.0,1.0,4/16,13.31%,ZNF675;LILRB4;TLR3;C1QC
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.5056119879323292,0.8940197549121967,0.6493506493506493,1.0,1.0,1/12,0.29%,THBS1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.37707228381506674,-0.8939567057502118,0.5555555555555556,1.0,1.0,1/26,0.92%,RAB22A
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5364713017776119,-0.8937110878597119,0.56,1.0,1.0,1/6,0.42%,EYS
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.4946013309561041,-0.8932683065289465,0.5185185185185185,1.0,1.0,1/7,2.10%,GCLC
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.4946013309561041,-0.8932683065289465,0.5185185185185185,1.0,1.0,1/7,2.10%,GCLC
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.3072025633515101,-0.8931113405291607,0.8181818181818182,1.0,1.0,4/58,4.04%,FRRS1;SLC30A5;ABCG2;SLC46A1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.4746195203993417,0.8930956147876362,0.6794871794871795,1.0,1.0,5/15,23.95%,RTN1;NTRK2;ROCK1;RTN3;RTN4
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.30396169767350245,-0.8929322459251507,0.6666666666666666,1.0,1.0,15/86,9.46%,SKAP1;GTF2H5;TAL1;GTF2H2;FSCN1;DAB2IP;DDB2;PSMC4;MTLN;TP53;PLEK;BID;TGFB1;SRC;LCP1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.5458594284287016,0.8927279797473606,0.6811594202898551,1.0,1.0,6/12,34.31%,DONSON;TIMELESS;BLM;LIG3;ZRANB3;GMNN
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.514210464916305,0.8926935823148747,0.6363636363636364,1.0,1.0,6/16,25.08%,DMD;KDM1A;SGCZ;NEBL;RORA;MEGF10
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4380539739191337,0.8920323108348303,0.6923076923076923,1.0,1.0,11/49,17.26%,PLPP3;ITGA2;DOCK1;ADAM15;FN1;PTN;FGR;ITGB8;ITGAV;TXK;THY1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5213783144804458,0.8919168440653947,0.6212121212121212,1.0,1.0,5/11,33.78%,FANCB;ERCC6;TIMELESS;ARID2;WDR48
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.31997279423870034,-0.8918643902677924,0.625,1.0,1.0,2/58,0.93%,CCL5;PAIP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5303836498137344,0.8917357543255072,0.6891891891891891,1.0,1.0,3/14,19.52%,PINK1;BNIP3;DDHD1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3258412360440305,-0.8914152379307763,0.42857142857142855,1.0,1.0,15/77,9.97%,RNASEL;FLNA;PDE12;ZMYND11;BCL2L1;NLRP1;PRF1;APOBEC3G;MAP3K14;MLKL;CGAS;NCBP3;TLR3;TLR7;OAS2
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5295007223410874,-0.8909302638864642,0.5517241379310345,1.0,1.0,3/6,18.54%,SENP6;SENP1;SENP5
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.3407361071941043,-0.8905558974872281,0.6666666666666666,1.0,1.0,3/41,4.04%,FRRS1;ABCG2;SLC46A1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5578028202749534,0.890407967161179,0.6973684210526315,1.0,1.0,3/9,17.47%,PDK4;SCD;PDK3
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.4137558418980323,0.8903846162420272,0.7755102040816326,1.0,1.0,15/144,17.99%,PCSK1;PAPPA2;FOLH1;SRGN;ERMP1;FBXL2;ST14;SPPL2B;TYSND1;BACE2;CPM;TRHDE;CASP3;PCSK6;CPE
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.5578218227471474,0.8903298494089765,0.6571428571428571,1.0,1.0,4/9,27.39%,PLTP;ABCA5;ABCG1;SCARB1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.47702727121263855,-0.8902875756845529,0.6190476190476191,1.0,1.0,2/11,5.14%,KRT10;FARSA
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.4426753306566774,0.8900129275530932,0.6923076923076923,1.0,1.0,9/52,13.47%,PDK4;SOX4;INSR;HIF1A;RPS6;CAV3;IGF1R;ADCY8;BACE2
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6292174059496376,0.8899656843425753,0.7222222222222222,1.0,1.0,2/5,10.31%,DMD;TXN
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.5516121183816164,0.889788190652416,0.6756756756756757,1.0,1.0,1/8,0.29%,THBS1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5645045450502646,0.8897490706313814,0.7352941176470589,1.0,1.0,1/8,5.00%,SLC1A2
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.5488455856213781,0.8894216318206558,0.6301369863013698,1.0,1.0,4/9,23.36%,HIF1A;COPS9;RPL11;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5406714445993455,0.8893450896688028,0.6666666666666666,1.0,1.0,3/9,15.50%,FRMD5;SPOCK3;SPINT2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.6076174427788965,0.8892953037360494,0.6984126984126984,1.0,1.0,3/5,14.30%,SLC2A9;CARMIL1;PRPS1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.4978749740469032,-0.8892873019927996,0.6363636363636364,1.0,1.0,2/8,11.83%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.32907932774514953,-0.8892710420559484,0.8571428571428571,1.0,1.0,7/39,9.55%,PEX13;EHHADH;MTLN;ACOX1;ACAA1;ECI1;CYP4V2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2882844578580874,-0.8892242484653772,1.0,1.0,1.0,24/168,7.03%,LURAP1;FLNA;TICAM1;PIDD1;TRIM38;PPM1N;ZMYND11;EDA2R;CHUK;IL1B;DAB2IP;LGALS9;IRAK4;ATP2C1;LILRB4;TMEM9B;LPAR1;TMEM106A;TMED4;MAP3K14;ZDHHC13;CASP10;NEK6;TIFA
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4997121400940282,0.8889794774538764,0.6172839506172839,1.0,1.0,5/18,16.87%,FAM162A;PINK1;CIDEB;BNIP3;PYCARD
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.5225699086709131,-0.8882897206937977,0.64,1.0,1.0,2/6,11.99%,COL5A1;SKI
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.4517004529678839,-0.8881554639153619,0.6,1.0,1.0,4/14,16.82%,SYNE2;MYO1F;MYO1D;MYO7A
prerank,PanglaoDB_Augmented_2021__B Cells,-0.2854722358269031,-0.8879309345876271,1.0,1.0,1.0,33/106,18.56%,NKG7;CD2;CD37;LY86;BIN2;BANK1;BLNK;CEACAM21;PLEK;RASAL3;IRAG2;WDFY4;NCKAP1L;HVCN1;CD53;LCP2;CYTH4;SNX20;BACH2;EDEM2;IL12RB1;PSTPIP1;HMGA1;GPR174;CD72;IL16;LAPTM5;ALOX5AP;SLAMF6;TBC1D10C;TLR10;RNASE6;ITGAL
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.48217272011285534,0.8878797856013659,0.6506024096385542,1.0,1.0,7/20,26.38%,ENO2;ENO4;NPRL2;ENO1;RAB5A;TBC1D14;MTM1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.45224880344742396,0.8878307531048927,0.6914893617021277,1.0,1.0,14/60,20.52%,MAPT;PRKCE;ARF6;BAIAP2L1;CAV3;CARMIL1;SEMA5A;STMN2;PYCARD;CDK5R1;TOGARAM1;APP;DCTN1;FES
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.43737003523168416,0.8875934240251321,0.7386363636363636,1.0,1.0,8/45,15.50%,PRLR;ACSL1;MVD;SCD5;ELOVL4;AGPS;SCD;FDFT1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5103902677630555,0.8875921037888271,0.6588235294117647,1.0,1.0,5/15,27.14%,INSR;IGF1R;BNIP3;TNF;IRAK3
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.5194756806038991,-0.8872708197490531,0.5925925925925926,1.0,1.0,3/9,10.00%,ZDHHC21;IL1B;IKBKB
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5847435129265498,0.8871094422895286,0.5833333333333334,1.0,1.0,3/6,31.25%,BRCA1;BARD1;RNF6
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.5081834177454366,-0.886841840021337,0.7037037037037037,1.0,1.0,3/6,14.60%,LYPLA1;ABHD17A;ABHD10
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.5081834177454366,-0.886841840021337,0.7037037037037037,1.0,1.0,3/6,14.60%,LYPLA1;ABHD17A;ABHD10
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.44492010961298106,-0.886836943811104,0.65625,1.0,1.0,3/10,20.11%,OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.48917988605804913,0.8867866088647863,0.6197183098591549,1.0,1.0,4/13,21.02%,AGT;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.5915559772296015,0.8867569204005256,0.6865671641791045,1.0,1.0,6/6,40.87%,MCMDC2;ORC3;MCM3;MCM6;MCM5;MCM7
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.32562305385411167,-0.8866589796883348,0.7333333333333333,1.0,1.0,4/29,9.72%,FLNA;WRAP73;KIF3B;ABRAXAS2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.42320059468775745,0.8864913673679475,0.6451612903225806,1.0,1.0,18/78,24.89%,KLF4;DTL;AGT;ABCA2;PLK2;NSF;APC2;WNT5A;CDKN1B;APP;HECW2;IL18;TNF;DDB1;BARD1;HACE1;FZR1;UHRF1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.5458523007916452,-0.8862642861837483,0.6153846153846154,1.0,1.0,1/6,0.86%,HUS1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.4305155046728939,0.8859877245443513,0.7021276595744681,1.0,1.0,11/56,19.12%,THBS1;NR4A2;HERPUD1;MCL1;PINK1;PRELID1;BCL2L2;ITGAV;TMEM14A;MAPK8IP2;GSTP1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.47360159008277597,0.8856794753260748,0.6626506024096386,1.0,1.0,3/24,8.94%,TOM1L1;INSR;RCC1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.4261178093977085,0.8856081123595234,0.7010309278350515,1.0,1.0,11/86,7.02%,HTR2B;NLRP12;CADM1;IL15;AGT;ANXA1;SRGN;MOG;GPNMB;SLC11A1;FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4392986320351201,0.8852625661382283,0.5977011494252874,1.0,1.0,12/31,24.13%,NLRP12;TLE1;PER1;OTUD7B;PYCARD;ESR1;GSTP1;RHOH;NR1D1;STAT1;TNIP1;RORA
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.45697374846635624,0.8849641461527101,0.6774193548387096,1.0,1.0,10/38,21.95%,PRKCE;CLIP3;ARF6;EPHA3;GNAI1;SORBS1;SPTBN1;PTPN9;GPSM2;TNF
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.5700156273789809,0.8848064447059104,0.7230769230769231,1.0,1.0,5/7,33.61%,VMP1;PRKCB;MIA3;LRP1;ZDHHC17
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.5802116466274876,0.8847240387323329,0.676923076923077,1.0,1.0,4/6,39.92%,TMED10;TMED2;ARFGAP2;ARFGAP3
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.5802116466274876,0.8847240387323329,0.676923076923077,1.0,1.0,4/6,39.92%,TMED10;TMED2;ARFGAP2;ARFGAP3
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.5802116466274876,0.8847240387323329,0.676923076923077,1.0,1.0,4/6,39.92%,TMED10;TMED2;ARFGAP2;ARFGAP3
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.4765369383185081,-0.8845863790376183,0.5517241379310345,1.0,1.0,2/8,8.11%,CD274;HLA-E
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.28301852043597797,-0.8844441585078385,0.75,1.0,1.0,21/85,17.80%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;WDR33;DDX39A;RAE1;NUP214;NUP188;SLU7;CPSF4;MCM3AP;CPSF2;THOC7;POLDIP3;SMG6;UPF1;FMR1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.6066864346991683,0.8844059988261005,0.7142857142857143,1.0,1.0,1/5,5.13%,ALOX12
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.41995624183395486,0.8842334795494233,0.7708333333333334,1.0,1.0,6/98,9.01%,SOCS3;PIGU;ITPKC;INPP4B;MTMR7;PIGQ
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.506786898172908,-0.8841431271881945,0.5428571428571428,1.0,1.0,1/5,22.45%,PRKN
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.5533622076304129,0.8838988604869515,0.6615384615384615,1.0,1.0,1/5,8.95%,SLCO3A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6432098882856956,0.8837074887584822,0.6986301369863014,1.0,1.0,4/5,32.19%,SLC11A1;SLC39A14;SLC11A2;SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6432098882856956,0.8837074887584822,0.6986301369863014,1.0,1.0,4/5,32.19%,SLC11A1;SLC39A14;SLC11A2;SLC39A8
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.5328194426321906,-0.8835593466268383,0.6666666666666666,1.0,1.0,1/6,0.42%,EYS
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.4364577226743639,0.8833938396399738,0.75,1.0,1.0,12/60,20.23%,HTR2B;GPNMB;SOX4;TRAF2;BNIP3L;IMPACT;PINK1;BNIP3;TNFRSF1B;DUS2;HSPA1B;NPAS2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.5944975054819828,0.8833410092884186,0.7575757575757576,1.0,1.0,3/5,35.28%,PKM;YBX3;DHX9
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5070283897596396,0.883283900812949,0.6493506493506493,1.0,1.0,6/14,26.48%,ATP5ME;ATP5F1D;ATP5F1A;ATP5MC1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4930899033223672,0.8830371965120132,0.7317073170731707,1.0,1.0,2/17,3.78%,CLIP3;ZDHHC15
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4930899033223672,0.8830371965120132,0.7317073170731707,1.0,1.0,2/17,3.78%,CLIP3;ZDHHC15
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5247724764056345,0.8829477074973087,0.6805555555555556,1.0,1.0,5/13,26.27%,INTS12;INTS3;INTS8;INTS6;INTS10
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.3187607643016429,-0.8824942900765478,0.5,1.0,1.0,22/73,15.24%,CD300LF;ITGAM;LY86;PTAFR;MPEG1;BIN2;ICAM1;AOAH;PLEK;MYO1F;IGSF6;ITGAX;ITGB2;HCK;CD53;TYROBP;LCP2;CYTH4;SNX20;PIK3R5;LILRA2;PSTPIP1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.5845315911003819,0.8824050617399873,0.7164179104477612,1.0,1.0,2/8,10.38%,MAFB;PTN
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.570344268470668,0.8822702104796959,0.6515151515151515,1.0,1.0,1/5,5.13%,ALOX12
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.42480092538555314,0.8822575479129444,0.7473684210526316,1.0,1.0,18/96,17.28%,ZBTB16;MEIS2;RORB;NOCT;RUNX1T1;VASN;SPRY1;OVOL2;PKP2;ID2;LIMD1;RANBP3L;SRA1;ABCA1;ITGAV;ABCA5;WNT5A;NELFB
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.5017999435404484,0.8822421737981836,0.64,1.0,1.0,4/19,16.75%,CD55;TRAF2;NOD2;WNT5A
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.40214864907809034,0.8817991016945346,0.6808510638297872,1.0,1.0,9/80,11.24%,KLF4;ANKRD22;NFIB;MARCKSL1;RAB20;BHLHE40;ST14;FOSL2;MGAT1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.611573335093487,0.881625305327022,0.8166666666666667,1.0,1.0,4/5,36.83%,HNRNPU;UHRF1;DHX9;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.611573335093487,0.881625305327022,0.8166666666666667,1.0,1.0,4/5,36.83%,HNRNPU;UHRF1;DHX9;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.4836651360736053,0.8815471624982777,0.7162162162162162,1.0,1.0,4/19,17.23%,TGFB2;MCL1;EPHA7;CDK5R1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.4697043823126609,-0.8813869882098977,0.65625,1.0,1.0,4/7,21.16%,LYPLA1;ABHD17A;ABHD10;APOE
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.6018803519406283,0.8808522764373051,0.6901408450704225,1.0,1.0,2/5,21.01%,SRSF12;PRPF39
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.5689721326113578,0.8806147630566736,0.7428571428571429,1.0,1.0,4/9,24.74%,ARHGEF4;DNM3;FGD6;FGD4
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.5594580812884805,-0.8805736068771919,0.625,1.0,1.0,2/5,11.83%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.28440227305010696,-0.880564194778669,1.0,1.0,1.0,13/73,10.13%,CCL5;SERGEF;IL1A;IL1B;UQCC2;ITPR2;IGF1;LLGL2;ARFIP1;TGFB1;TREM2;ALOX5;P3H1
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.5365011266508571,-0.8800802217675768,0.5172413793103449,1.0,1.0,2/5,9.49%,IL1B;TREM2
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.44573832976444333,0.8799310071059274,0.6896551724137931,1.0,1.0,11/36,26.93%,PDK4;ABCA2;PINK1;FASN;PDK3;PPARA;ACACB;CNDP1;BTN2A2;MBOAT7;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.40654134129558506,0.879597117774061,0.86,1.0,1.0,44/305,18.49%,CENPF;KLF4;NFIL3;ZBTB16;HMGB2;NRG1;TLE1;TSHZ3;RORB;PIAS4;PTPRK;ARID5B;SUV39H2;RUNX1T1;ZNF93;SFMBT1;RBFOX2;KCTD1;YEATS2;ATP8B1;ZNF540;ID2;BHLHE40;LIMD1;RBPJ;KDM1A;PRICKLE1;PER1;DEAF1;HINFP;BRCA1;DPF3;RLIM;LANCL2;YAF2;WNT5A;HIC2;CDK5R1;BCL6;PLCB1;CTBP1;MTA3;NKX6-2;CDKN1B
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.46579862100033514,0.8795191198502157,0.6483516483516484,1.0,1.0,6/26,22.18%,ANLN;RPS27A;RGCC;UBA52;UBB;KNTC1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.48862555650275075,0.8794178801827658,0.68,1.0,1.0,4/17,17.26%,CD22;FCGR2B;CD300A;THY1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.5808271708348256,0.8793961748506076,0.7647058823529411,1.0,1.0,3/8,20.67%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.4671778773240132,-0.8791956792154457,0.7916666666666666,1.0,1.0,2/11,10.76%,ALG1;ALG2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.581792053804242,0.8789763062576865,0.7123287671232876,1.0,1.0,5/7,39.94%,GFPT1;CSGALNACT1;EXTL2;FUT8;GMDS
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.5769309973826926,0.8789658806111874,0.7297297297297297,1.0,1.0,3/5,35.20%,STARD5;SCARB1;STARD4
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.5769309973826926,0.8789658806111874,0.7297297297297297,1.0,1.0,3/5,35.20%,STARD5;SCARB1;STARD4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.3194821866934718,-0.8789308513036254,0.6,1.0,1.0,11/49,12.00%,NEXMIF;DSCAM;ARHGDIB;ACER2;NF2;RIPOR2;SIPA1;TGFB1;PLXNA4;PLXNA2;SEMA4D
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.5537793716651659,0.8787082361664947,0.75,1.0,1.0,1/9,5.00%,SLC1A2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.4652125474060933,0.8786512050497082,0.6829268292682927,1.0,1.0,4/29,7.02%,THBS1;GULP1;DOCK1;FCGR2B
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2851713319927265,-0.8786338413205674,0.7142857142857143,1.0,1.0,13/57,12.98%,TGFBR3;APPL2;ITGB5;ZFYVE9;ARRB2;TGFB1;SRC;ACVR1;ENG;SMURF1;ZMIZ1;SKI;USP9Y
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5423472946811736,0.8785504974929718,0.6883116883116883,1.0,1.0,3/10,29.58%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.5073581863230724,0.8784938771955728,0.6944444444444444,1.0,1.0,1/11,0.29%,THBS1
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.5216816871538889,0.8782119903187635,0.65,1.0,1.0,4/9,34.53%,GPR183;MYO1G;CD99;SLC12A2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5299249014982966,0.8780992532113129,0.6716417910447762,1.0,1.0,1/14,0.29%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.44869610317636865,-0.8777496495700484,0.6,1.0,1.0,1/8,1.15%,STPG1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.5174361312365771,0.8776523470881012,0.6619718309859155,1.0,1.0,3/13,23.52%,HSPD1;CTPS1;HELLS
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5084452525755597,-0.8775961074623811,0.6086956521739131,1.0,1.0,2/9,8.91%,IL1B;AKAP8L
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.48590721640120094,0.8772676011196141,0.6785714285714286,1.0,1.0,7/20,21.04%,CR1;TCF7;IL7;PRELID1;FANCA;SOD1;RHOH
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.4221930342827491,-0.8772386485970403,0.6190476190476191,1.0,1.0,7/19,14.15%,CHUK;IRF5;TLR3;HAVCR2;TLR7;NLRC3;IRF7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.424828641232587,0.8770016448238984,0.6770833333333334,1.0,1.0,8/69,8.95%,EIF4A3;RIDA;ENC1;EIF2AK3;DAPK1;PUS7;CAMK2N1;ZNF540
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.5382276516626453,0.8762462129419416,0.7023809523809523,1.0,1.0,3/12,22.26%,PLK2;BRCA1;C10ORF90
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.3906774135573883,-0.8762167749041101,0.5333333333333333,1.0,1.0,5/18,13.88%,IL1A;IL1B;IGF1;TGFA;ANAPC4
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.45387528609094246,0.8761914354245365,0.7191011235955056,1.0,1.0,12/40,21.77%,PTPRZ1;HIF1A;MAG;RETREG1;CRLF1;NTRK2;PINK1;TYRO3;SOD2;SOD1;NRBP2;CPEB4
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5353363433739966,-0.8761807161137872,0.6774193548387096,1.0,1.0,3/5,15.64%,SRC;BCL2;MLLT11
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.5672552029827582,0.8756641204580394,0.7142857142857143,1.0,1.0,2/5,22.55%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.3622972624454541,-0.875360017680496,0.6296296296296297,1.0,1.0,3/32,9.74%,RALB;PIP4K2B;UBQLN2
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.48674143552093796,0.8753159163384463,0.631578947368421,1.0,1.0,3/14,11.25%,TDG;MPG;NEIL1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.5316816026986708,0.8752494262599207,0.6410256410256411,1.0,1.0,2/11,6.05%,CADM1;CD55
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.5593982022768268,0.8751050190667354,0.6625,1.0,1.0,2/7,9.90%,NIPSNAP1;RETREG1
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.5492416197981711,-0.8750267152729294,0.6451612903225806,1.0,1.0,4/5,23.24%,TRPV4;CAB39;SLC12A6;STK39
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.5083993853906055,0.8749537824745217,0.6455696202531646,1.0,1.0,2/12,9.10%,ANXA1;RIMS2
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.5770102037480698,0.8747359491427805,0.7702702702702703,1.0,1.0,2/7,21.95%,MFSD2A;TNF
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4014185439235605,0.8746963303024775,0.8469387755102041,1.0,1.0,24/180,13.75%,PLPP3;FGF1;CLIP3;PPP2R5B;FAXDC2;TFRC;ACVR2A;VEGFA;GPNMB;PPP2R5A;EIF2AK3;INSR;PAQR3;SLCO3A1;FN1;FGR;NTRK3;IBTK;SH3GL2;IMPACT;EPHA7;NTRK2;FAM20A;PINK1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.45153509892455496,0.8744733717105877,0.6506024096385542,1.0,1.0,7/21,31.91%,DGAT1;CAV3;GK;GPAT4;GK5;LPGAT1;SLC27A5
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.40218876163990913,0.8742091632646289,0.9,1.0,1.0,51/369,18.49%,CENPF;KLF4;NFIL3;ZBTB16;HMGB2;NRG1;TLE1;EIF4A3;RIDA;TSHZ3;RORB;ENC1;PIAS4;PTPRK;ARID5B;SUV39H2;RUNX1T1;ZNF93;EIF2AK3;DAPK1;SFMBT1;RBFOX2;PUS7;KCTD1;YEATS2;ATP8B1;ZNF540;ID2;BHLHE40;LIMD1;RBPJ;KDM1A;PRICKLE1;PER1;DEAF1;HINFP;BRCA1;DPF3;RLIM;LANCL2;RNF139;YAF2;WNT5A;HIC2;CDK5R1;BCL6;PLCB1;CTBP1;MTA3;NKX6-2;CDKN1B
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4863087251201006,0.8742011056531397,0.6705882352941176,1.0,1.0,7/16,30.67%,AKAP6;SLC9A1;TNF;CHP1;ATP2B4;PRNP;CAMTA1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.5625957915232762,0.8740346588668404,0.676923076923077,1.0,1.0,1/6,5.00%,SLC1A2
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.4855637778118471,-0.8738728939725775,0.5882352941176471,1.0,1.0,1/7,5.00%,ITGB5
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.3899446819707479,-0.873867779923575,0.625,1.0,1.0,4/18,6.49%,NEDD4;FFAR4;ACTB;TRIB3
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.5942546920141695,0.873843854469273,0.704225352112676,1.0,1.0,3/5,27.90%,CFL1;PPIB;IGF2R
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4874477802532088,0.8737860743688778,0.65,1.0,1.0,5/20,16.85%,RELN;IRS2;RASGRP4;ITGAV;RASGRF1
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.44878088671093447,-0.8736610152078896,0.4827586206896552,1.0,1.0,3/9,15.28%,CHTOP;PIH1D1;ZNF335
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.4642160253879784,0.8735468110756499,0.6987951807228916,1.0,1.0,7/23,20.14%,INSR;GHR;MFSD2A;PLCB1;SOD1;APP;OLFM1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.35748156663216957,-0.8733853909720403,0.6923076923076923,1.0,1.0,5/26,9.49%,ZMYND11;ZNF675;DUSP3;SIRPA;TREM2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.5142224367557924,-0.8731184535526815,0.6,1.0,1.0,3/6,14.41%,CCND1;EGFR;AKT1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.42890401835007563,-0.8728410902964198,0.5333333333333333,1.0,1.0,10/15,24.45%,ABCB7;ALOX5;SLC25A33;SLC30A10;PLCG2;SPHK2;CD36;PIKFYVE;CYBA;RAB27A
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.55009746333608,-0.8727565865875097,0.6785714285714286,1.0,1.0,1/5,14.81%,FIS1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.44230030517075164,-0.8726007072098352,0.6538461538461539,1.0,1.0,6/12,19.49%,ELAVL4;ELAVL1;MAPKAPK2;TIRAP;MYD88;ZFP36
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.4750607937609094,-0.8722582432499048,0.55,1.0,1.0,1/9,1.95%,SETD6
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.5293281157595238,0.8722542700101277,0.7125,1.0,1.0,3/11,16.40%,ALOX12;THBD;SERPINE2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.43243852027274143,0.871892517296681,0.6976744186046512,1.0,1.0,9/52,12.99%,TSHR;HTR7;PRKAR2B;CD163;ADCY3;FGR;RXFP1;ADCY8;PLK2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.34472460662557486,-0.8717982968635163,0.5,1.0,1.0,11/57,10.00%,CHUK;LGALS9;TRIB1;MAP4K2;MAP3K5;MAPK13;MAP2K3;SH2D3C;MAP3K10;CRKL;IKBKB
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5302336376464547,0.8717215248993988,0.6301369863013698,1.0,1.0,5/8,29.79%,B3GAT1;CSGALNACT2;B3GAT2;DSE;CSGALNACT1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4526553874342949,0.8715978014736645,0.6823529411764706,1.0,1.0,3/30,5.47%,TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.4526553874342949,0.8715978014736645,0.6823529411764706,1.0,1.0,3/30,5.47%,TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.4864970155889075,0.8714906904125331,0.675,1.0,1.0,10/22,26.70%,RIMS2;RIMS3;MCTP1;CPLX1;PREPL;PNKD;LRRK2;RAB5A;SYT11;RIMS1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.3124358453216629,-0.8713369042035146,1.0,1.0,1.0,44/152,13.98%,CCL5;CD300LF;CX3CR1;ITGAM;LY86;PTAFR;SAMSN1;MAF;MPEG1;BIN2;IL1B;RUNX3;LGALS9;SCIMP;HPGDS;CD200R1;LILRB4;CSF1R;CD83;UCP2;ARL11;SLCO2B1;AOAH;IRF5;PLEK;P2RY6;MYO1F;HAVCR2;TREM2;WDFY4;IGSF6;ITGAX;ITGB2;HCK;SLC15A3;CD53;TYROBP;GPR34;FCGR1A;LCP2;SYK;DAB2;CYTH4;SNX20
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.31839848790198,-0.8709465235430035,0.6,1.0,1.0,13/65,11.88%,NUP42;CCHCR1;PHAX;DHX38;NUP155;CHTOP;THOC5;TGFB1;SMURF1;DDX39A;RAE1;NUP214;NUP188
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.44098882379782345,0.8708704085033765,0.7530864197530864,1.0,1.0,7/39,10.99%,CDH8;CDH2;CDH9;CTNND2;PKP2;CDH20;CDH12
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.4264988163015296,0.8708260067604561,0.6951219512195121,1.0,1.0,8/40,20.52%,ERCC2;ATOX1;GLRX2;TXN;SOD2;SOD1;PRDX4;FES
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.4365268191514502,0.8706402474248237,0.75,1.0,1.0,14/42,28.90%,ENPP2;MBOAT2;MFSD2A;SLC44A5;PEMT;PNPLA8;CHPT1;SLC44A1;GPAT4;LPCAT4;MBOAT7;DBI;PCTP;LPCAT1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.3795623343926784,-0.8704730709131078,0.8421052631578947,1.0,1.0,2/15,2.05%,NPC2;ARV1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.49282662240238356,0.8704092094820096,0.6097560975609756,1.0,1.0,4/14,18.56%,CR1;DUSP10;BCL6;FANCA
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.5117597820523838,0.8703740708791666,0.7083333333333334,1.0,1.0,3/11,11.25%,TDG;MPG;NEIL1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.519242837145982,0.8702438308040681,0.625,1.0,1.0,2/9,10.35%,KIF1B;ERC2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5270957325133863,0.8700499712173114,0.6666666666666666,1.0,1.0,3/9,16.75%,SULF2;DEAF1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.42984543625614996,0.870008433737369,0.7391304347826086,1.0,1.0,10/65,15.73%,PLPP3;MAPT;DMD;PAQR3;NTRK3;IBTK;SH3GL2;IMPACT;PPP1R15A;TPPP
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.4701465804296906,0.8699669260797271,0.6818181818181818,1.0,1.0,6/30,19.12%,TOM1L1;BRINP1;PLK2;BCL6;CDKN1B;RGCC
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.4394926820123293,0.8696075541231619,0.7415730337078652,1.0,1.0,7/52,19.57%,CYREN;HMGB2;PIAS4;BRCA1;POLQ;POLL;ERCC6
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4840206463890296,0.8693388623755407,0.6578947368421053,1.0,1.0,5/17,21.66%,VEGFA;HIF1A;RBPJ;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5101131012316383,-0.8693028153429896,0.5357142857142857,1.0,1.0,2/6,9.06%,FYN;ABCB7
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.5497771788422751,0.8689874141449608,0.7012987012987013,1.0,1.0,2/9,15.11%,NOD2;HCLS1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.394490402635157,-0.8688919748154134,0.5333333333333333,1.0,1.0,6/17,15.39%,ARL2BP;TAPT1;BCL3;CHCHD10;AKT1;TAF8
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.4895382759099813,0.8685762588820797,0.6666666666666666,1.0,1.0,6/15,26.48%,ATP5ME;ATP5F1D;ATP5F1A;ATP5MC1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3438298321507197,-0.8685148985323436,0.5833333333333334,1.0,1.0,10/29,13.05%,TICAM1;APPL2;LILRB4;SIRPA;TREM2;ALOX5;CHID1;NLRC3;IL17RA;PLD4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5435870981515979,0.8685077727441749,0.7108433734939759,1.0,1.0,4/8,27.28%,PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.5435870981515979,0.8685077727441749,0.7108433734939759,1.0,1.0,4/8,27.28%,PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.5922771501912425,0.8684915028097941,0.7323943661971831,1.0,1.0,2/6,25.90%,MX1;TRIM56
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.5651081852852888,0.868422591226771,0.6857142857142857,1.0,1.0,3/5,24.41%,CCDC39;DNAH7;DNAAF5
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4792682734858975,0.86817261143716,0.6265060240963856,1.0,1.0,5/17,31.26%,CLK2;FBP1;DDB1;PPARGC1A;DGKQ
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.503114625187826,-0.8680520559963144,0.7037037037037037,1.0,1.0,4/7,24.37%,RNF8;RNF168;MSH6;MSH2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5254380801336642,0.8677789546317417,0.6338028169014085,1.0,1.0,1/9,6.19%,HSPA5
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5474333324336039,0.8675510062213369,0.6621621621621622,1.0,1.0,1/6,9.28%,HERPUD1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.5265370648622814,0.8674876993479113,0.7323943661971831,1.0,1.0,1/9,7.47%,MPG
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.5265370648622814,0.8674876993479113,0.7323943661971831,1.0,1.0,1/9,7.47%,MPG
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.49032566919963294,0.8673819252263423,0.7176470588235294,1.0,1.0,4/21,19.58%,VPS11;PER1;BRCA1;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.5134031491582617,0.8671231750262401,0.7164179104477612,1.0,1.0,1/11,0.29%,THBS1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.39784864036151274,0.8670252427064863,0.7525773195876289,1.0,1.0,20/109,17.91%,GRM8;CD163;ITGA2;TNS1;F13A1;CHI3L1;LTB4R;CA2;TNFRSF11B;HIF1A;MAFB;CD93;THBD;ABCA1;SNX10;ITGAV;TGFBI;CEBPD;KCNMA1;ESR1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.4622341667220396,0.8659559186719163,0.6829268292682927,1.0,1.0,3/25,5.47%,FBN2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.4322835293063977,0.8658029921300976,0.7241379310344828,1.0,1.0,8/43,21.97%,WDR5;HCFC1;RUVBL2;PER1;TRIM16;CHD5;MORF4L2;MEAF6
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.4355457497720394,0.8655049045156038,0.7191011235955056,1.0,1.0,9/35,18.11%,GLA;ABCA2;ARSA;UGT8;GALC;SUMF2;UGCG;SUMF1;GBA3
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.3983997884135744,0.8653881957843946,0.797979797979798,1.0,1.0,22/140,15.16%,RAB7B;CLEC12A;KMO;PLAC8;CD163;CADM1;VCAN;CD22;ADGRE1;ANXA1;SLC11A1;FCGR2B;GPR65;ITGAE;FGR;FCGR2C;PDCD1LG2;NR4A3;FGL2;CD300A;HCLS1;TNFRSF1B
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.4741255393363379,0.8649073328122148,0.7058823529411765,1.0,1.0,9/21,34.64%,ATP8B1;ABCA1;ATP10B;ATP8A2;ABCB4;ATP9A;ATP11A;ATP10A;ATP8A1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.45135111422892044,0.8646253896805478,0.7209302325581395,1.0,1.0,10/35,26.50%,TBRG4;WDR74;PES1;NDUFAF4;HSPD1;SORD;MPHOSPH10;GNL3;MRTO4;SRM
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.39728124375483503,0.8641868344550053,0.85,1.0,1.0,52/306,21.89%,HTR2B;DAPK2;ACVR1B;CDK14;NEK11;TGFB2;PRKCE;DGKI;PDK4;ACVR2A;BMPR1B;AATK;EIF2AK3;PRRT1;DAPK1;NIM1K;INSR;DGKB;LIMD1;PXK;FGR;ALK;CLK2;LIPE;CAMK2B;EPHA7;PLK2;PAK5;FAM20A;PINK1;PRKAG2;DGKG;NUAK2;TXK;GK;PDK3;MAPK10;CTBP1;GRK4;GMFB;APP;ROCK1;TEC;MAP3K13;PIK3R4;NRBP2;PRKAA2;CDK9;PAK3;VRK2;CDC25B;PGK1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.500526624639314,0.8640349857181555,0.6951219512195121,1.0,1.0,2/14,9.02%,SRSF12;PCBP4
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4684768492047333,-0.863909658478233,0.6153846153846154,1.0,1.0,1/7,11.60%,HPN
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.483289903409119,0.8639033239996733,0.7317073170731707,1.0,1.0,7/23,19.11%,TFRC;SLC11A1;ATOX1;TTYH1;TRPC4;SLC31A2;FTH1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4345740168786246,-0.8638995281122573,0.59375,1.0,1.0,4/11,23.39%,TRAPPC10;STX5;LMAN1;SNX1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.46360636650916076,0.8638554688014605,0.6447368421052632,1.0,1.0,9/24,31.77%,RPA2;POLE2;ORC6;DBF4;ORC3;RPA3;MCM3;NOC3L;POLA1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.4493203854300392,0.8636614477068281,0.7640449438202247,1.0,1.0,8/45,20.23%,TMEM161A;EYA2;STPG4;BRCA1;ZCWPW1;RGCC;ERCC6;NPAS2
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.5234159076207273,0.8635970141192185,0.6666666666666666,1.0,1.0,1/6,7.72%,NUP133
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.37340908675578743,-0.8635675452310033,0.7,1.0,1.0,2/22,3.47%,GTF2F1;CTDP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.4476686243319379,0.8635399640946585,0.6627906976744186,1.0,1.0,2/29,1.52%,THBS1;OGN
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.5090775476798837,0.8635349738965273,0.7236842105263158,1.0,1.0,4/11,19.12%,ALOX15B;ALOX12;LTA4H;GSTP1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.46431662628619524,0.8633519825084154,0.7215189873417721,1.0,1.0,1/31,1.92%,CENPE
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5695217766083296,0.8633407365444304,0.746268656716418,1.0,1.0,2/7,8.56%,ANK2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.5327468542920086,0.8632537216884131,0.7164179104477612,1.0,1.0,2/11,16.75%,IL7;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.42084963319385726,0.8631326883332011,0.7708333333333334,1.0,1.0,11/89,11.83%,THBS1;LRP2;FGF1;NRG1;KITLG;CHI3L1;INSR;IRS2;TXN;IGF1R;SEMA5A
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.4207216971528878,0.8628126713125313,0.8105263157894737,1.0,1.0,14/76,18.66%,HSPA5;SEC61B;HERPUD1;TRIM25;RNF175;STT3B;DNAJB2;FBXO27;DNAJB9;SYVN1;RNF139;AUP1;ERLIN1;UBE2J2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5258117594028863,0.8627293569862845,0.75,1.0,1.0,6/11,34.08%,PINK1;TMEM39A;LRRK2;MTM1;CHMP4B;FEZ1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.5187984271213966,0.8626121035760995,0.72,1.0,1.0,3/11,24.54%,CALM3;CLIC2;GNB5
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.4043883821608067,0.8623208123845855,0.84,1.0,1.0,16/150,14.80%,SOCS3;GPR18;NAMPT;IL15;ARID5B;IL7;HIF1A;TRIM25;TXNIP;IFITM3;IFIT2;PDE4B;SLC25A28;RIPK2;FGL2;SOD2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.33803035851462493,-0.8621560294489445,0.7333333333333333,1.0,1.0,4/22,6.92%,ZMYND11;ZNF675;DUSP3;SIRPA
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.538016364969898,0.8621543397289484,0.7468354430379747,1.0,1.0,2/9,12.89%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.538016364969898,0.8621543397289484,0.7468354430379747,1.0,1.0,2/9,12.89%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4391301526371843,0.8621522191842994,0.7045454545454546,1.0,1.0,6/30,15.11%,SOCS3;IL15;VEGFA;GHR;CRLF1;HCLS1
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.5739573024697827,0.8619140221028763,0.6911764705882353,1.0,1.0,3/5,23.89%,IMPACT;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.49174341041066744,0.861862175932363,0.7261904761904762,1.0,1.0,6/18,30.33%,NDUFS8;ATP5F1D;UQCRC1;SIRT3;NDUFS7;UQCRC2
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.5377284177505157,0.8617876227531026,0.6857142857142857,1.0,1.0,2/8,15.98%,BMPR1B;AIDA
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.5714306097731258,0.8617658202968045,0.7205882352941176,1.0,1.0,1/6,5.67%,RPA2
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4560600574541416,0.8615348595902516,0.7529411764705882,1.0,1.0,9/30,24.93%,TUSC3;C5AR1;GPR155;MFSD2A;SHROOM4;MAGT1;APP;TNF;GRM5
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.5001432900496728,-0.8612134440363507,0.7027027027027027,1.0,1.0,1/6,3.55%,IL1B
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.5392777381918273,0.8610924609470897,0.6842105263157895,1.0,1.0,2/9,18.18%,PDCL;TXNDC15
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.3444190429137653,-0.8609197706235638,0.6521739130434783,1.0,1.0,6/32,14.71%,NUP42;NUP155;RAE1;NUP214;NUP188;XPOT
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3444190429137653,-0.8609197706235638,0.6521739130434783,1.0,1.0,6/32,14.71%,NUP42;NUP155;RAE1;NUP214;NUP188;XPOT
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.4883907568799225,0.8609179616405903,0.717948717948718,1.0,1.0,6/16,29.58%,TCP1;TNF;CHP1;CORO2B;CCT8;DKC1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.40269853573906705,0.8607221446447653,0.7684210526315789,1.0,1.0,14/77,16.87%,TRAF2;HINT1;ZNF385B;BOK;MCL1;GSKIP;CIDEB;BRCA1;PPP1R15A;BNIP3;BCL2L2;TNFRSF1B;SCN2A;PYCARD
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.4543698462504624,-0.8607027539090704,0.5588235294117647,1.0,1.0,2/10,7.91%,IDE;APH1A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.45101999262287285,0.8606968090027927,0.6666666666666666,1.0,1.0,3/26,10.38%,THBS1;VEGFA;PTN
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.490603491959198,0.8600612349268726,0.7105263157894737,1.0,1.0,6/17,31.86%,RYR2;SRPRA;SPCS3;MAN1A1;SRP54;SRP14
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5467476825631494,0.8600607063890955,0.6714285714285714,1.0,1.0,3/6,23.61%,RYR2;NDRG4;IFT122
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.44143941415033694,0.8598727011140488,0.7849462365591398,1.0,1.0,4/50,12.11%,TGFB2;MFNG;RBPJ;NOD2
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.4395298911550652,0.8597122890703929,0.7741935483870968,1.0,1.0,3/42,12.11%,CLEC4E;RPS27A;NOD2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.5804847642133413,0.859707364090385,0.6805555555555556,1.0,1.0,2/5,34.72%,TMEM33;LNPK
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.2967370172871825,-0.859568894057345,0.7272727272727273,1.0,1.0,11/48,12.39%,PIDD1;BTG2;CCND1;TP53;ZNF385A;RFWD3;EP300;CNOT6L;PLK3;SDE2;PLAGL1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.5090255178753814,0.8595508436039802,0.6666666666666666,1.0,1.0,3/12,14.86%,STT3B;OGA;FBXO27
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.5530871748990439,0.8594665259035804,0.7083333333333334,1.0,1.0,4/7,35.48%,SLC12A8;SLC12A5;SLC12A2;SLC12A9
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.5530871748990439,0.8594665259035804,0.7083333333333334,1.0,1.0,4/7,35.48%,SLC12A8;SLC12A5;SLC12A2;SLC12A9
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.4195458023652792,0.8592830034611326,0.7333333333333333,1.0,1.0,8/48,19.90%,TGFB2;CDKN2AIP;AKAP6;INSR;MFSD2A;SDCBP;PLCB1;TAF9B
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.5338532927076476,0.859152516545781,0.6986301369863014,1.0,1.0,3/8,30.01%,TIMELESS;SPIDR;BLM
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5232250002292004,0.8590729667208922,0.75,1.0,1.0,1/17,0.74%,LRP2
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.5611063927447056,0.8588609513622021,0.6623376623376623,1.0,1.0,2/6,20.67%,UXT;UBB
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.32747756480502954,-0.858848056710784,0.9285714285714286,1.0,1.0,7/46,7.92%,KRT10;APPL2;FARSA;KCNC3;ALDH9A1;RYR1;SSBP1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.4358917042055189,0.8584598370302411,0.7386363636363636,1.0,1.0,15/48,19.40%,RHOB;TM7SF2;RND3;GHR;GLUL;SAMD5;SLC10A1;ALDH6A1;SCD;BNIP3;OCIAD1;EPB41L4B;HMGCS1;SPTBN1;HAMP
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.5061241720654228,0.8583258654314322,0.7088607594936709,1.0,1.0,2/11,5.93%,ANXA1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.44079627247496905,0.8582834545869946,0.7222222222222222,1.0,1.0,9/45,18.27%,TMEM161A;HERPUD1;MCL1;PINK1;SOD2;BCL2L2;SYVN1;HYOU1;HSPB1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4770354505201338,0.8580328217921965,0.6419753086419753,1.0,1.0,4/18,10.91%,TGFB2;SOX4;PKP2;RBPJ
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.40892575094705164,0.8580082179011567,0.8020833333333334,1.0,1.0,26/109,23.94%,PTPRD;PPP2R3B;PPP2R5B;PTPRK;PTPRG;PPP2R5A;PTPRZ1;MTMR7;EYA2;PTPRT;PP2D1;PPP2R2B;PPM1E;PPP1R15A;PPM1L;DUSP10;PPP2R3A;PTPN9;DUSP16;DUSP6;CTDSP1;PTPN5;PTPRS;DUSP12;SSH2;PTPRR
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.4526942902014387,-0.8578730714522791,0.5666666666666667,1.0,1.0,2/7,19.01%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.438751115932615,0.8574531355526739,0.6966292134831461,1.0,1.0,5/31,14.56%,DTL;CLSPN;DONSON;INTS3;BRCA1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.3943320959935902,-0.8571902774423973,0.7619047619047619,1.0,1.0,4/22,4.11%,TGFBR3;SERPINF2;EGFL7;EFNB2
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.5115610632494044,0.8570914583949547,0.726027397260274,1.0,1.0,2/9,18.93%,PTN;MTUS1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.4259566906072666,0.8568094120784768,0.717391304347826,1.0,1.0,17/49,29.07%,CLIP3;CD22;EPHA3;ARFGAP1;MCTP1;CALY;PICALM;SNX17;ROCK1;CD151;HIP1R;RAB5A;SYT11;AP2S1;SCAMP5;PTPN1;SNX12
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.5735935705182464,0.8568020842767947,0.746268656716418,1.0,1.0,3/5,19.00%,ROBO2;ROBO1;APP
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.5349963362254347,0.8566687871925174,0.7333333333333333,1.0,1.0,3/11,19.00%,ATOX1;SLC31A2;APP
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4238790957308528,0.8566375180345495,0.6736842105263158,1.0,1.0,9/52,19.12%,TGFB2;ARF6;APBB3;CADPS;PPID;CLASP2;TMED10;RAB2B;RGCC
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.4771701964875194,0.8563497319764914,0.7108433734939759,1.0,1.0,6/24,23.22%,GEMIN2;DBR1;BCAS2;WDR83;PRPF6;MPHOSPH10
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.40584211673303755,0.8562585999280854,0.8041237113402062,1.0,1.0,26/156,15.84%,FGF1;TGFB2;SHANK3;RELN;NRXN1;GRB10;CDKN2AIP;IL7;NLGN1;NLGN3;HIF1A;KANK1;RIMS2;PDCL;ROBO1;RBPJ;NTRK3;TMEM108;SULF2;NOD2;LMO3;SORBS1;SASH1;TRIM16;ITGAV;LANCL2
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.36135192579394193,-0.8562169211300946,0.6666666666666666,1.0,1.0,5/25,13.45%,ZMYND11;LEO1;SUPT16H;RNF8;BRD4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.5152918076038357,-0.8559618896599034,0.6666666666666666,1.0,1.0,2/7,20.52%,ST6GAL1;ST3GAL1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.49871502175629623,0.8559215679824533,0.725,1.0,1.0,2/13,10.69%,PRKCE;CAV3
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.43758327394332375,0.8558172589609675,0.7415730337078652,1.0,1.0,4/38,7.02%,HMGB2;NOCT;SLC11A1;FCGR2B
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.3931603005039668,-0.8557129604080279,0.64,1.0,1.0,3/19,3.18%,SMDT1;MAIP1;MICU3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.48156427454937856,0.855685122690989,0.7051282051282052,1.0,1.0,5/15,23.34%,RANBP3L;SRA1;PLCB1;AKIRIN1;FLOT2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.40094495267983177,-0.8556070366889208,0.56,1.0,1.0,1/7,2.33%,DHODH
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.5490578062882727,0.8553724378985519,0.7205882352941176,1.0,1.0,2/7,28.47%,APPL1;CTNS
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.4149085589218931,0.8553362097495767,0.7708333333333334,1.0,1.0,18/77,19.12%,SPARC;APOLD1;GPM6A;PLAC8;TNS1;LIFR;SRGN;CD55;CD93;MFSD2A;THBD;FLT1;SHROOM4;LDB2;CLIC4;TIMP3;PLEC;RGCC
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.5085808336657863,0.8551354834152657,0.7945205479452054,1.0,1.0,1/13,0.29%,THBS1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.42586075906213405,0.8551008920602625,0.7608695652173914,1.0,1.0,12/49,25.09%,ZBTB16;NOCT;RUNX1T1;ID2;LMO3;WNT5A;TNF;AAMDC;NR1D1;RORA;ANKRD26;GPS2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.4362217743576108,-0.854964893544247,0.65,1.0,1.0,1/14,1.74%,RRP7A
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.544222431040312,0.8547567781300551,0.7638888888888888,1.0,1.0,4/9,19.81%,CKAP5;EML2;DCTN1;HSPA1B
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.5246291107338564,-0.85469893492729,0.5428571428571428,1.0,1.0,2/5,9.20%,PHF8;KDM7A
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.517906749010078,0.854641101736013,0.7108433734939759,1.0,1.0,4/11,17.23%,EPHA3;SEMA5A;EPHA4;CDK5R1
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5400143572727073,0.8545443554613487,0.6986301369863014,1.0,1.0,1/8,14.46%,FBP1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.5026833997308995,0.8543283303748833,0.6708860759493671,1.0,1.0,1/8,3.08%,PRKCE
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.5093655775350592,-0.854248169156625,0.6764705882352942,1.0,1.0,1/5,14.84%,PRCP
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.5495411514225824,0.8538350657862256,0.7536231884057971,1.0,1.0,1/6,8.82%,FCHO2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.4604105073658706,0.8537362628046937,0.7088607594936709,1.0,1.0,4/23,13.55%,ARHGEF4;WASF1;CARMIL1;ABLIM3
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5386778744709001,0.8536936150305485,0.7160493827160493,1.0,1.0,3/9,34.15%,SEMA5A;HMOX1;LOXL2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.46729844836632084,0.8536133651967476,0.6941176470588235,1.0,1.0,3/23,18.80%,MAPT;TENT4B;PRKRA
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4176066340557942,-0.8536132435120704,0.75,1.0,1.0,5/13,16.22%,LPL;ITGB2;SYK;CDH13;CD81
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.4094151896360295,0.8536065549765521,0.7872340425531915,1.0,1.0,18/67,27.50%,KLF4;NLRP12;TYRO3;EPHA4;GRID2;CTNNA2;LRFN5;MACIR;PPARA;TNFRSF1A;RTN4RL1;PTPRS;NR1D1;RORA;GPS2;PTGER4;IRAK3;PTEN
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5026349531447029,0.8535468614052252,0.6794871794871795,1.0,1.0,1/8,3.08%,PRKCE
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.5824537780245913,0.8535385630235057,0.7619047619047619,1.0,1.0,4/5,40.98%,DLG4;CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.5824537780245913,0.8535385630235057,0.7619047619047619,1.0,1.0,4/5,40.98%,DLG4;CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5561277911434699,0.8533567666841053,0.7123287671232876,1.0,1.0,3/5,24.19%,ID2;FGFR2;BBS7
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5090727125022255,0.8532039169600769,0.65,1.0,1.0,5/10,41.05%,PRKAA2;KCNB1;EIF4G1;MTOR;ULK1
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.5094128582716886,0.8529195140815563,0.6712328767123288,1.0,1.0,3/10,26.82%,TOMM20;GRPEL1;TOMM40
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4427986919629767,0.8528903323059329,0.7444444444444445,1.0,1.0,6/39,15.09%,BRIP1;CLSPN;NDRG1;DONSON;HINFP;E2F7
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.43409742203488827,0.8528030888976856,0.6630434782608695,1.0,1.0,13/42,24.66%,BRINP1;NLGN1;ID2;ALK;GPRC5B;IMPACT;NREP;VWC2;CDK5R1;ROCK1;TCF4;LRRK2;ECT2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.40837555804675696,0.8527915340908394,0.78125,1.0,1.0,34/137,23.95%,PLPP3;RPL23;SOX4;ANK2;HCFC1;PINK1;EPHA4;CDC37L1;SYVN1;CDC37;CAMLG;ATP1B3;RPL11;GBA3;TCP1;PRKRA;HSPA1B;GTPBP4;TAF9B;HSPD1;MTMR9;ATP1B2;RAB21;GNAQ;NOP53;WIZ;C10ORF90;HIP1R;BAG3;NAPG;FLOT2;PPIB;CHP1;RTN4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.4240381318513334,0.8527544161252872,0.7777777777777778,1.0,1.0,14/66,21.12%,TGFB2;SEMA3A;GADD45B;VEGFA;TRAF2;FCGR2B;NOD2;SASH1;PYCARD;SDCBP;PLCB1;APP;ANKRD6;EMC10
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.33928793120732265,-0.85267404131003,0.7692307692307693,1.0,1.0,5/27,10.00%,CHUK;CCDC88C;MAP3K5;MAPK13;IKBKB
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.4068579137236622,0.8526515099788461,0.7959183673469388,1.0,1.0,19/136,16.35%,HTR2B;PLPP3;PFKM;PTPRD;NUDT4;ITPKC;PLPPR4;ALOX15B;INPP4B;LIMD1;ALK;PFKFB4;EPHA7;GPI;FBP1;ACP3;PPA1;DUSP10;GK
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.41873294603223227,0.8522219863832029,0.7303370786516854,1.0,1.0,15/50,29.14%,PQBP1;PCBP4;RRP1B;CLK2;NOVA1;FAM50A;AHNAK;TNFRSF1B;HNRNPH1;METTL4;MBNL2;HNRNPH3;CLK1;AKAP17A;PTBP3
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.525182393058796,0.8520967184057178,0.7083333333333334,1.0,1.0,3/10,20.90%,NRG1;PLD3;KDM6B
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.5061203746560805,-0.8520712848465006,0.6153846153846154,1.0,1.0,3/6,31.44%,MAPRE1;DIAPH1;KIF20B
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5284419296102644,-0.8520170664543837,0.6666666666666666,1.0,1.0,1/5,3.55%,IL1B
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.43271215533868923,0.8519597925856851,0.7,1.0,1.0,6/34,20.74%,TMEM161A;EYA2;BRCA1;ERCC6;NPAS2;CDK9
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.4103107251720466,0.851825998415786,0.8061224489795918,1.0,1.0,17/114,13.75%,THBS1;LRP2;FGF1;NRG1;PPP2R5B;KITLG;PHLPP1;CHI3L1;INSR;IRS2;TXN;NTRK3;IGF1R;SEMA5A;NTRK2;MAGI2;PINK1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.32350736689418136,-0.8517763742638369,0.8666666666666667,1.0,1.0,6/31,9.41%,ZDHHC21;ZDHHC3;ZDHHC5;ZDHHC13;ZDHHC2;EP300
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.5684343320875658,0.8517405645751068,0.76,1.0,1.0,2/6,9.56%,HIF1A;ROBO1
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.39346210000134946,-0.8517198157914665,0.6153846153846154,1.0,1.0,1/10,1.67%,PEX13
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3952910193977383,0.8515639285701038,0.8541666666666666,1.0,1.0,22/137,20.41%,NAPA;CNIH4;CD55;ANK3;ANK2;VAPB;ARFGAP1;SPTAN1;SEC24C;DYNC1H1;MCFD2;SPAST;NSF;HYOU1;SPTBN5;TMED10;GRIA1;SPTBN1;TRAPPC6B;DCTN1;NRBP2;SPTBN4
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.4935388760785639,0.8512945369779129,0.6486486486486487,1.0,1.0,5/11,23.04%,PTPRK;EPB41L4B;KLF9;NOTCH2;FGFR2
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.3454042583144733,-0.850610301906275,0.8,1.0,1.0,1/38,0.44%,FLNA
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5195805246594078,0.8503116622585601,0.7297297297297297,1.0,1.0,5/14,26.27%,INTS12;INTS3;INTS8;INTS6;INTS10
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.4796492158007367,-0.8498205229068306,0.6756756756756757,1.0,1.0,2/5,22.46%,NR1H3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.4796492158007367,-0.8498205229068306,0.6756756756756757,1.0,1.0,2/5,22.46%,NR1H3;PPARG
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.4286004385088569,0.849699810630722,0.7582417582417582,1.0,1.0,7/36,18.39%,ENPP2;CYP3A5;RIDA;AMDHD2;TRHDE;PNPLA8;LTA4H
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.45618572600207913,0.8493242226638198,0.7558139534883721,1.0,1.0,5/25,20.67%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.4636957057349328,-0.8491840207922535,0.65625,1.0,1.0,3/7,27.36%,MTIF3;MRRF;GFM2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.4997495245138648,-0.8491765369565056,0.6,1.0,1.0,1/6,16.41%,VEZF1
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5442110077556641,0.848805032425215,0.6811594202898551,1.0,1.0,3/7,19.00%,PTN;EPHA4;APP
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.4965363449903001,0.848789853138752,0.7012987012987013,1.0,1.0,5/14,18.70%,TMEM108;DYNC1H1;NEFL;KIF5A;SOD1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.420440824000271,0.8485638873479829,0.8279569892473119,1.0,1.0,22/86,36.11%,NEK11;EYA2;RUVBL2;INCENP;MTA3;MORF4L2;TBL1XR1;EZH2;UHRF1;SUDS3;ATXN7L3;TAF6L;PRMT1;MSL3;SUPT3H;HDAC9;MAP3K12;TRERF1;EYA3;NTMT1;HDAC4;BRD8
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.5761402725424721,0.8484332192361285,0.7692307692307693,1.0,1.0,2/5,19.54%,PFAS;HPRT1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.4765041757679036,-0.8483336742035935,0.6774193548387096,1.0,1.0,3/9,15.58%,PRF1;SYK;DVL2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.46884900333508084,0.8479720388543237,0.675,1.0,1.0,3/17,6.76%,GPC5;CHI3L1;GNS
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.5363282204855245,0.8477291485375973,0.7941176470588235,1.0,1.0,1/6,22.52%,METTL4
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.45018616643792997,0.8475988117742279,0.6941176470588235,1.0,1.0,3/27,11.28%,LRP2;SNAP25;GLUL
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.38668310638815834,-0.8475770530695481,0.7142857142857143,1.0,1.0,3/17,5.51%,LATS2;WWTR1;MOB1A
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.456632634766491,0.8474378145972361,0.7176470588235294,1.0,1.0,5/26,17.36%,ADCY3;ADAM15;ADCY8;GNAI1;KLF9
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5229914021349216,0.8473882512328493,0.7384615384615385,1.0,1.0,2/8,24.16%,TXN;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.5638930378715541,0.8473628229238969,0.7464788732394366,1.0,1.0,2/5,11.83%,VEGFA;SEMA5A
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.4105849257335398,0.8473590044647848,0.851063829787234,1.0,1.0,13/64,18.66%,HSPA5;SEC61B;HERPUD1;TRIM25;RNF175;STT3B;DNAJB2;FBXO27;DNAJB9;SYVN1;AUP1;ERLIN1;UBE2J2
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.41405409494183115,0.8472008117164341,0.6947368421052632,1.0,1.0,12/65,19.50%,RAP1GAP;COBL;DOCK1;GNA11;ST14;ITGAV;PLXNB1;HDLBP;EPB41L4B;CPE;MTUS1;PARM1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.4282363041144196,0.8470508585306248,0.7,1.0,1.0,3/20,14.85%,MINDY1;OTUD7B;VCPIP1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5165854296755765,-0.8469773971487029,0.6923076923076923,1.0,1.0,2/8,10.76%,FFAR4;REST
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.44078317715650234,0.8468942060580897,0.6966292134831461,1.0,1.0,6/29,15.77%,GADD45B;PHLPP1;VEGFA;PER1;SASH1;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.5324779236722259,0.8468522743079911,0.6666666666666666,1.0,1.0,3/7,28.11%,ABCA2;LILRB2;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.5284430548665597,0.846699802020907,0.7419354838709677,1.0,1.0,1/7,9.51%,ID2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.4361990042572198,0.8466381738567337,0.7634408602150538,1.0,1.0,11/45,19.19%,HTR2B;SLC24A2;ANK2;VAPB;RYR2;TMTC2;SLC24A1;FAM20A;SLC24A3;ATP2A2;RMDN3
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.43507787783421725,0.8462911815457734,0.7272727272727273,1.0,1.0,6/42,15.29%,RBFOX2;SRSF12;KHDRBS2;NOVA1;CELF2;RBM5
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4477180920693912,0.8460030548141357,0.725,1.0,1.0,11/32,28.11%,MAP2;KDM1A;DYNC1H1;PINK1;EPHA5;STXBP2;FES;NR1D1;LRRK2;BRSK1;HSP90AB1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5380978184495292,-0.8456226961197857,0.6129032258064516,1.0,1.0,2/5,9.41%,TGFB1;EP300
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5380978184495292,-0.8456226961197857,0.6129032258064516,1.0,1.0,2/5,9.41%,TGFB1;EP300
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.49053869338298306,0.845553183345376,0.6823529411764706,1.0,1.0,3/16,13.19%,GADD45B;VEGFA;SASH1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.4270161359691624,0.845550801132405,0.7613636363636364,1.0,1.0,6/37,14.85%,MAPT;GPC5;ABCA2;MAP2;KDM1A;VCPIP1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2952044422924592,-0.845298040752613,0.7,1.0,1.0,17/82,11.19%,CARD14;PSMB3;PSME3;EDA2R;CHUK;CDIP1;PSMD12;PSMC4;MAP3K14;TP53;ILK;PSME4;EIF5A;IKBKB;EDA;NFKBIA;BIRC2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.4298862447884982,0.8451419680348187,0.717948717948718,1.0,1.0,7/25,22.46%,PTPRZ1;PTPRT;DUSP10;PTPN9;DUSP16;DUSP6;PTPRS
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.5032054764657937,0.8450320005727615,0.6933333333333334,1.0,1.0,1/10,2.31%,CBR1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.5211646450518089,0.844939461221384,0.7236842105263158,1.0,1.0,1/10,6.56%,FBXL2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.4169576526332456,-0.8444840369561079,0.6666666666666666,1.0,1.0,1/11,0.43%,TGFBR3
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.5218287053141052,0.8439636062981959,0.7361111111111112,1.0,1.0,1/8,8.71%,VPS11
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5245490588534396,0.8438884520725067,0.7428571428571429,1.0,1.0,4/8,32.51%,MFSD2A;CNEP1R1;SCARB1;NR1H2
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.50863012271419,-0.8438701314908342,0.6,1.0,1.0,3/7,25.06%,UPF1;SHFL;GSPT1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.386597487451133,0.8438263826739445,0.9,1.0,1.0,78/426,23.74%,KLF4;NFIL3;SAP30;TGIF1;ZBTB16;RPL23;NFIX;NR4A2;NFIB;MEIS2;ARID5B;VEGFA;SUV39H2;KCTD1;YEATS2;HCFC1;BMI1;POU6F1;TRPS1;ID2;POU5F1;BHLHE40;MXD1;RPS27A;RBPJ;KDM1A;PDE2A;NR2F1;MXI1;PER1;IMPACT;ZNF536;ZNF550;NR4A3;DEAF1;ETS2;PPID;DRAP1;OTUD7B;FBP1;E2F7;LDB2;ZNF248;UXT;SDCBP;BCL6;ESR1;CTBP1;MTA3;NR2C2;TBL1XR1;ZBTB18;HAMP;ZNF684;FOXP1;TAF9B;KLF7;PPARA;UBA52;BCL11A;UBB;ZNF778;TAF7;EZH2;ENO1;TNF;NOP53;BAG3;CBX5;HEXIM1;NR1D1;STAT1;FGFR2;ATF3;JUN;MYT1L;CGGBP1;SFPQ
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5250773711323462,0.8437306990541357,0.7027027027027027,1.0,1.0,5/10,29.67%,MBOAT2;OSBPL10;OSBPL5;LPCAT4;OSBPL8
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.43050939412577016,-0.8434411084587908,0.6785714285714286,1.0,1.0,1/10,1.64%,INPP5K
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.41699103489231487,-0.843052134441357,0.5862068965517241,1.0,1.0,2/14,14.95%,HLA-E;IL12RB1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.4451539044100841,0.8430129874340471,0.7727272727272727,1.0,1.0,4/26,11.07%,CD55;FCGR2B;TRIM5;FGR
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.33666824304449544,-0.8430041154112445,0.8,1.0,1.0,3/23,6.06%,GAL3ST4;B4GALT7;IGF1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.49106249603353624,0.8428422584102763,0.7160493827160493,1.0,1.0,2/16,12.11%,IL15;NOD2
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.42239822012598427,-0.8423685649353643,0.8,1.0,1.0,5/13,17.07%,IDE;ERAP2;GGT7;CTSH;CPQ
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.48048117809568824,0.842293367237863,0.7261904761904762,1.0,1.0,5/15,15.73%,MYRF;RIMS2;PARD3;TNFRSF1B;TPPP
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.43183442251041965,0.8422206316164275,0.7529411764705882,1.0,1.0,4/35,11.30%,VGF;SLC4A10;IRS2;TENT4B
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.5242524651020033,0.842145462627284,0.7435897435897436,1.0,1.0,4/10,27.23%,NOD2;SLAMF8;ECSIT;SIRT4
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.38948623509276686,0.8421348966477555,0.8383838383838383,1.0,1.0,32/167,22.92%,MDH1;NDUFA2;PDK4;ETFB;ACAT1;TIMM13;COX7A2;NDUFA3;NDUFS8;ALDH6A1;COX7C;CYCS;GPI;CPT1A;ATP5ME;PMPCA;NDUFB6;GRPEL1;ATP5F1D;UQCRFS1;UQCRC1;ATP5F1A;SLC25A4;ATP5MC1;CYC1;COX4I1;ATP6V0B;IMMT;PDHB;MFN2;COX6C;ATP6V1D
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.4430357878090886,0.8421152160040039,0.7625,1.0,1.0,11/31,27.40%,VPS11;MICALL2;ARIH2;ABLIM3;PINK1;UBE2J2;ATP5IF1;RHOU;LRRK2;ATG13;SAE1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.46764847218331673,0.8420896749970909,0.76,1.0,1.0,5/16,27.28%,NR4A3;CYCS;GFPT1;LEPR;PPARGC1A
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.4619603286987057,-0.8419691994984168,0.6666666666666666,1.0,1.0,1/7,3.34%,DDR1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.4572194803117947,0.8416965935278545,0.7209302325581395,1.0,1.0,4/28,16.40%,CAMK2N1;ASPH;RNF139;SERPINE2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.44080377832044587,-0.8414824610282026,0.6153846153846154,1.0,1.0,3/10,14.49%,SUPT16H;RBBP4;UBN1
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.35235882861692913,-0.8408669289316179,0.8235294117647058,1.0,1.0,3/30,5.84%,NPC2;NPC1;LIMA1
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.514918884243599,0.8405126495959356,0.7066666666666667,1.0,1.0,3/7,28.66%,CLCA4;CFTR;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4289629323687168,0.8401296579918465,0.7582417582417582,1.0,1.0,11/54,24.16%,PIAS4;SEPTIN4;FANCI;PRICKLE1;PINK1;RIPK2;BRCA1;UBB;TNIP1;GNL3;LRRK2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.39480698148788784,-0.8397711437939568,0.6521739130434783,1.0,1.0,1/11,0.67%,MEI4
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.5272555169772178,0.839511219723032,0.7532467532467533,1.0,1.0,3/7,30.01%,XRCC3;SLX4;BLM
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.25848213449139035,-0.8393259770443052,1.0,1.0,1.0,17/113,11.36%,GTF2H5;NPR2;ITPA;POLD3;ELOA;GTF2F1;DDB2;TAF13;GPX4;TP53;DGUOK;TYMS;VPS37B;NT5C;ADRM1;RAE1;POLR2C
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.5218633700275259,0.8387794845224031,0.6857142857142857,1.0,1.0,3/8,36.88%,ST6GALNAC5;FUT9;FUT8
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.5218633700275259,0.8387794845224031,0.6857142857142857,1.0,1.0,3/8,36.88%,ST6GALNAC5;FUT9;FUT8
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5305204888618402,0.838745670959241,0.7808219178082192,1.0,1.0,1/10,1.98%,SHANK3
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.41415347428383975,-0.8380989415044321,0.6538461538461539,1.0,1.0,5/14,7.04%,INPP5K;FFAR4;IL1B;TRIB3;C3
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.36973135170332694,-0.8379188164999506,0.7058823529411765,1.0,1.0,4/19,9.76%,ZNF675;LILRB4;TLR3;UBASH3B
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.338562012540315,-0.8378097942705816,0.75,1.0,1.0,9/66,8.95%,TAL1;TCF3;PSMB3;LMO1;PSME3;PSMD12;PSMC4;PSME4;CBFB
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.372718371904294,-0.8376332256604833,0.625,1.0,1.0,5/20,10.91%,ZNF703;CYP19A1;TGFB1;GGT7;EGFR
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.40925955021464255,0.8374900565008233,0.7901234567901234,1.0,1.0,5/35,11.27%,DOCK1;DOCK5;KANK1;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.4450587855861911,0.8369937456848827,0.7108433734939759,1.0,1.0,7/30,24.04%,VEGFA;INSR;MAGI2;SGIP1;RAB21;HFE;TF
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.3740613963455032,-0.8369030261906281,0.6190476190476191,1.0,1.0,3/18,11.34%,PUS1;METTL8;METTL16
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.35165590097245225,-0.8368600739830081,0.7142857142857143,1.0,1.0,2/26,3.25%,MAIP1;BCL2L1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.3175644286905936,-0.8368218406215788,0.75,1.0,1.0,6/36,9.05%,EHHADH;MTLN;ACOX1;ACAA1;ECI1;IVD
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.493053760424944,0.8367297517400738,0.6447368421052632,1.0,1.0,3/11,9.56%,NR4A1;VEGFA;ROBO1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.25769069092485064,-0.8365881103431861,1.0,1.0,1.0,23/144,15.13%,FLNA;KIF27;EHD4;RTTN;WDR35;MKKS;KIF3B;INPP5E;EXOC7;BBS9;TMEM67;TCTN3;ABCC4;OCRL;IFT43;GSN;DISC1;GALNT11;NUDCD3;CCDC66;RAB3IP;CDC14B;MARK4
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.2957276834974734,-0.8363896637539985,1.0,1.0,1.0,8/105,5.97%,TNFAIP8L3;PSMB3;PSME3;NFYC;SC5D;PSMD12;PSMC4;RUBCNL
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.43790191228129866,0.8363346605941255,0.7386363636363636,1.0,1.0,8/32,28.13%,HSPA5;SEC61B;TOMM20;GRPEL1;HSPD1;TOMM40;PEX10;SRP54
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.5653847766175654,0.8362955679082656,0.71875,1.0,1.0,1/5,14.30%,PRPS1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4068476827334761,0.8361248999185449,0.8526315789473684,1.0,1.0,17/125,14.16%,DAPK2;ACVR1B;RIOK2;AATK;EIF2AK3;DAPK1;INSR;FGR;IGF1R;ALK;CLK2;CAMK2B;FLT1;NTRK2;PINK1;TYRO3;EPHA4
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.5302356194738069,0.8359902433735815,0.6376811594202898,1.0,1.0,3/6,29.76%,NDUFB6;NDUFV1;COA6
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.4010310295865783,-0.8359016163095994,0.6451612903225806,1.0,1.0,4/10,10.93%,CD300LF;HAVCR2;MILR1;NR1H3
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.3929539411882958,-0.8358409189219851,0.7,1.0,1.0,3/17,4.04%,ABCG2;FOLR2;SLC46A1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.4801129172513586,0.835606881070084,0.7564102564102564,1.0,1.0,2/16,9.39%,SUV39H2;CSKMT
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.42117544082685526,0.8353536162691121,0.75,1.0,1.0,13/41,23.88%,GRIN2A;DAPK1;CYCS;CIDEB;RIPK2;UACA;GRIN2B;ASPH;AIM2;PYCARD;TNF;CASP1;GRAMD4
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.5499791613189523,0.8352307904312765,0.7123287671232876,1.0,1.0,3/6,35.85%,CHP1;CABP1;MDFIC
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.5499791613189523,0.8352307904312765,0.7123287671232876,1.0,1.0,3/6,35.85%,CHP1;CABP1;MDFIC
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.47404088067974104,0.8351963031970796,0.7435897435897436,1.0,1.0,4/17,28.20%,VPS11;CHCHD3;MFN2;OPA1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.4406278112561811,0.8350711907114867,0.7976190476190477,1.0,1.0,9/27,28.77%,ANTKMT;MAP2;DYNC1H1;RNF139;LRRK2;GRIPAP1;ATP9A;MX2;PTPN1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.5468318064361934,0.8350635023818743,0.7323943661971831,1.0,1.0,4/8,33.64%,DONSON;TIMELESS;BLM;ZRANB3
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.428620569985007,0.8349115499259326,0.7640449438202247,1.0,1.0,17/37,33.40%,SBDS;RPL23A;RPS27;MRPL20;RPL11;NOP53;MTERF3;RPL3;RPL24;TRAF7;DHX37;DDX3X;RPL6;RPLP0;C1QBP;MRPS7;MDN1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.38290167588420265,0.8348961516298542,0.85,1.0,1.0,40/201,25.17%,SH3PXD2B;TLE1;NAPA;FBXL7;DMD;TRAF2;TCF7;TCF7L1;WASF1;FN1;BOK;GSDMD;DARS1;SEC24C;ADCY8;RBX1;PDE4DIP;PPID;MCFD2;PARD3;NSF;AIM2;PICALM;TMED10;FANCA;GRIA1;TRAPPC6B;TNFRSF1A;SLC9A1;DLG4;TNF;KNTC1;COL16A1;NAPG;HFE;LRRK2;F8;CNIH1;TRADD;CX3CL1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5668044318745628,0.8346926065602085,0.7638888888888888,1.0,1.0,1/5,6.76%,EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5465687748432118,0.8346482897982225,0.7230769230769231,1.0,1.0,1/5,10.36%,BOK
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.4307801029961258,0.83463000762895,0.7380952380952381,1.0,1.0,4/34,12.11%,TFRC;IL7;IRS2;NOD2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.5179665233719787,0.8346274532113928,0.7105263157894737,1.0,1.0,2/10,18.02%,VEGFA;CTBP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.4024065143426892,-0.8345814168366891,0.6896551724137931,1.0,1.0,2/12,8.52%,KHSRP;PRR5L
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.5188520532179128,0.8345587145734118,0.72,1.0,1.0,4/12,23.46%,RPL23;SMARCD3;SMARCC1;SMARCD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.5053515216184219,0.8345407839201091,0.7125,1.0,1.0,2/9,26.31%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.5053515216184219,0.8345407839201091,0.7125,1.0,1.0,2/9,26.31%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.5053515216184219,0.8345407839201091,0.7125,1.0,1.0,2/9,26.31%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.5271512935793599,0.8340759455307301,0.7671232876712328,1.0,1.0,2/8,14.85%,OTUD7B;VCPIP1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.5472574190178106,0.8340328263845662,0.7794117647058824,1.0,1.0,2/6,30.43%,TACC3;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.5472574190178106,0.8340328263845662,0.7794117647058824,1.0,1.0,2/6,30.43%,TACC3;ANAPC7
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.43757058595587106,0.8335465964632681,0.75,1.0,1.0,1/24,6.30%,ZNF93
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4408004793749748,0.8334390960487095,0.7407407407407407,1.0,1.0,10/27,21.95%,EGR1;ALOX15B;IL7;HIF1A;WNT5A;PYCARD;APP;FOXP1;IL18;TNF
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.577734365849146,0.8333707089897475,0.828125,1.0,1.0,1/5,14.56%,BRCA1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.5297196685435483,0.8331988531198572,0.6721311475409836,1.0,1.0,4/6,44.59%,STAT1;JAK3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.5297196685435483,0.8331988531198572,0.6721311475409836,1.0,1.0,4/6,44.59%,STAT1;JAK3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.5520899137126027,0.8331380573157819,0.7258064516129032,1.0,1.0,1/5,11.81%,CLK2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.350325202540254,-0.8330819109867504,0.6666666666666666,1.0,1.0,6/21,16.09%,LEO1;CPSF1;MTPAP;WDR33;GRSF1;CPSF2
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.350325202540254,-0.8330819109867504,0.6666666666666666,1.0,1.0,6/21,16.09%,LEO1;CPSF1;MTPAP;WDR33;GRSF1;CPSF2
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.4992071362863757,0.8329372597907465,0.6818181818181818,1.0,1.0,1/9,8.94%,RCC1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.49230513189541425,0.832628865380846,0.7972972972972973,1.0,1.0,3/13,24.80%,PAICS;PFAS;IMPDH1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4809778085092288,0.8321431447211151,0.7215189873417721,1.0,1.0,7/17,26.00%,ADCY8;EPHA5;C2CD2L;KLF7;NR1D1;CFTR;PIM3
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.5101791400464912,0.8320645023812379,0.6764705882352942,1.0,1.0,3/8,24.34%,AKR1B1;CYP46A1;TSPOAP1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.43342506081284643,-0.8318698801390184,0.6666666666666666,1.0,1.0,2/9,5.72%,KRT10;ICAM1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.3999894827764268,0.8318102448425555,0.8469387755102041,1.0,1.0,45/170,25.51%,RPL23;WDR12;WDR74;RPL37A;IMP3;INTS12;PES1;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;RPL9;INTS3;RPLP2;RPL37;RPL14;RPL11;RPS24;MPHOSPH6;RPS9;PRKRA;RPL36;SMAD1;NOB1;UBA52;INTS8;INTS6;NOP53;RPL35;RPL4;RPL32;WDR3;MPHOSPH10;RPL3;RPL27A;RPL24;MRTO4;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.46685129322776414,0.8316039491699603,0.7297297297297297,1.0,1.0,2/11,21.11%,FCGR2B;GPR183
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5297883155834221,0.8315486617741864,0.7971014492753623,1.0,1.0,3/9,17.94%,RANBP3L;PLCB1;AKIRIN1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5121117491325221,-0.8314645063715195,0.717948717948718,1.0,1.0,2/5,18.20%,IVD;MCCC1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.4314197264523997,0.8310587194182473,0.6753246753246753,1.0,1.0,7/22,24.29%,PTPRK;FN1;SORBS1;THY1;PLEC;CD151;CTTN
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.5702620512307375,0.8309774169370415,0.7704918032786885,1.0,1.0,1/5,13.96%,OTUD7B
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.44731913546633917,0.8305527503525054,0.7682926829268293,1.0,1.0,11/28,24.16%,SH2D4A;MAP2;RRP1B;NEIL1;CPEB2;SLC39A14;ATP5IF1;ZCCHC9;RDX;CHP1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.44076809447483023,0.8304415771908586,0.7439024390243902,1.0,1.0,9/25,27.40%,VPS11;MICALL2;ARIH2;ABLIM3;PINK1;UBE2J2;RHOU;ATG13;SAE1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3643365026755196,-0.8304218345189438,0.7058823529411765,1.0,1.0,3/16,3.55%,BCL2L1;IL1A;IL1B
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.37955618282484355,0.8303214445823098,0.95,1.0,1.0,63/332,20.40%,HTR2B;KLF4;RHOB;ACVR1B;ST18;TGFB2;CR1;BRINP1;NR4A1;ALOX15B;TP53TG5;PTPRK;ADAM15;CDKN2AIP;GPNMB;SOX4;EIF2AK3;FCGR2B;FHL1;CAMK2N1;IFNLR1;BNIP3L;TXNIP;TCHP;SEMA5A;IMPACT;DNAJB2;SMYD5;MAGI2;RPS6KA2;ING1;FBP1;BNIP3;SOD2;CLMN;E2F7;TNFRSF1B;RBM5;RNF139;PLXNB1;TGFBI;BCL6;THAP12;CTBP1;DUS2;NEURL1;CDKN1B;PRKRA;PLXNC1;CHD5;APP;ARHGDIA;FTH1;RGCC;ORC6;TNFRSF21;AQP11;HSPA1B;GTPBP4;APBB2;SUZ12;NPAS2;IGFBP7
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.4760346527470437,0.8301992806241176,0.7142857142857143,1.0,1.0,4/15,19.82%,PPOX;FLVCR1;ALAD;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5064174635896757,0.8300844013654866,0.7236842105263158,1.0,1.0,2/12,7.93%,NRG1;AKAP6
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.4668358764931204,-0.8296392233885324,0.5882352941176471,1.0,1.0,2/7,13.22%,PXDNL;GPX1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.5447924331036592,0.8292707311292213,0.6865671641791045,1.0,1.0,1/6,12.11%,NOD2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.4661715028018496,0.8285898081548299,0.7195121951219512,1.0,1.0,3/23,9.25%,TLE1;TCF7;TCF7L1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.4764572139194134,0.8285847165156587,0.7222222222222222,1.0,1.0,6/14,26.43%,MFSD2A;WNT5A;NTNG1;MAP3K13;DLG4;GRIP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.4570064673826269,0.8284326332336553,0.7283950617283951,1.0,1.0,11/26,26.11%,MAP9;GNAI1;DYNC1H1;DCTN1;HSPA1B;GPSM2;HNRNPU;CHMP5;TACC3;PDCD6IP;BORA
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.5505340148745104,0.8282589498130953,0.7910447761194029,1.0,1.0,1/5,15.37%,ANTXR2
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.39081319600758746,0.8281885684060118,0.8163265306122449,1.0,1.0,20/120,14.11%,NAMPT;ACVR1B;TACR1;IL15;OSMR;ADGRE1;SLC1A2;ACVR2A;RNF144B;CD55;KIF1B;RGS1;HIF1A;MXD1;ITGB8;C5AR1;NOD2;ABCA1;PDE4B;RIPK2
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.42119572103768577,-0.827915532332637,0.6296296296296297,1.0,1.0,3/12,7.04%,HHEX;ANXA4;C3
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.4634450361638087,0.8277295580006558,0.7435897435897436,1.0,1.0,1/18,0.29%,THBS1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.5441152488202441,0.8277183858448829,0.76,1.0,1.0,3/6,29.23%,TIMM13;TIMM22;AGK
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.4610019260856012,0.8272869504892273,0.7283950617283951,1.0,1.0,5/19,28.68%,DNM3;DNM1;MX1;OPA1;MX2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.38476561205666276,0.8268021406529107,0.86,1.0,1.0,37/179,22.19%,PLPP3;RAB7B;RELN;AGT;TFRC;ARID5B;VEGFA;TRAF2;COPS5;SLCO3A1;TRIM5;TRIM25;RPS27A;KDM1A;ALK;CRTC3;NOD2;ADCY8;RIPK2;EPHA5;HCLS1;AIM2;TRIM26;WNT5A;PYCARD;DHX33;ESR1;APP;RGCC;MAP3K13;HSPA1B;UBA52;UBB;BEX1;IL18;TNF;TRIM14
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3959058439680209,0.8266852381164749,0.7931034482758621,1.0,1.0,8/57,19.10%,NAPA;VAPB;SEC24C;MCFD2;NSF;TMED10;GRIA1;TRAPPC6B
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.4464769012527079,0.8262940644015113,0.7682926829268293,1.0,1.0,3/28,4.50%,NUDT16;RNASEH2C;ENTPD3
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.4903422345968123,-0.8258639166831135,0.78125,1.0,1.0,2/6,8.11%,LGALS9;HLA-E
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4038350407193905,0.8252199361494461,0.7872340425531915,1.0,1.0,14/63,25.16%,TBC1D8;TBC1D13;VPS11;DYNC2LI1;TBC1D15;PLK2;NPRL2;C10ORF90;TBC1D2;RDX;ATG5;RAB5A;TBC1D14;PDCD6IP
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5399934569476664,0.8250901811661829,0.8,1.0,1.0,2/7,16.67%,SLC1A2;DISP1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5399934569476664,0.8250901811661829,0.8,1.0,1.0,2/7,16.67%,SLC1A2;DISP1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.27056269416349826,-0.824788139440336,1.0,1.0,1.0,16/113,12.08%,ATRAID;ZNF711;TRIM38;PRDM10;RNF187;KHSRP;IGF2BP3;IGF1;PCBP3;SIRPA;HMG20A;LAMTOR1;TREM2;REST;ADNP2;TRIM11
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.5218688697352183,-0.8244427412586494,0.7096774193548387,1.0,1.0,1/5,10.58%,SORL1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.5580862033858747,0.8244195917550604,0.7575757575757576,1.0,1.0,1/6,19.57%,ERCC6
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5070950378187691,0.824381871327732,0.7162162162162162,1.0,1.0,3/10,20.62%,DNAJB2;HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4839981581150029,0.8243038436815991,0.6962025316455697,1.0,1.0,5/17,21.95%,MASTL;PPP1R15A;PPP4R4;ROCK1;TNF
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5228913447034169,0.8238904810814859,0.6716417910447762,1.0,1.0,2/7,24.74%,FES;CTNNBIP1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.5317339152435474,0.8237117737495476,0.7377049180327869,1.0,1.0,3/7,10.38%,IHO1;FMN2;PTN
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.37689572752775147,-0.8235730748776969,0.7777777777777778,1.0,1.0,2/12,10.92%,PDGFD;ABL1
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.3699883522321096,0.8234775680407576,0.8260869565217391,1.0,1.0,10/83,15.38%,CLEC4E;CLEC12A;CR1;SLC11A1;SIRPB2;FGR;C5AR1;ARG2;CD300A;RASGRP4
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.4054834877070432,0.8234545571572405,0.8089887640449438,1.0,1.0,21/67,28.05%,RPA2;FANCB;FANCM;XRCC3;NSMCE1;BRCA1;POLQ;MCMDC2;FAN1;POLL;SWI5;RNF138;RBBP8;RPA3;SFPQ;SLX4;PSMD14;RAD54B;SPIDR;MCM3;REV3L
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.31121321394299245,-0.8232995284261829,0.7857142857142857,1.0,1.0,6/34,12.96%,UBA7;SIRPA;HAVCR2;NLRC3;UFD1;ILRUN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.36264872888179334,-0.8230673706674699,0.7619047619047619,1.0,1.0,5/14,15.23%,BCL2L1;ABI3;TGFB1;DAB2;PPFIA1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.4865456082163225,0.8230094508704523,0.8181818181818182,1.0,1.0,2/20,6.70%,CD55;TRAF2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.5620336727865397,0.8229898503595562,0.7164179104477612,1.0,1.0,2/5,17.13%,ABCA2;NECAB1
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.5740706449685948,0.8227411815766851,0.8,1.0,1.0,1/5,5.39%,ANXA1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.5434967333345347,0.8224792066726615,0.8076923076923077,1.0,1.0,1/6,5.39%,ANXA1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.46478453482766796,0.8223801034637045,0.7027027027027027,1.0,1.0,5/14,23.74%,SOD2;HSPB1;SOD1;P4HB;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.5836070739926358,0.8217772374876967,0.8095238095238095,1.0,1.0,3/5,40.31%,FGFR2;FGFR1;FGFR3
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4074718351239168,0.8217731318204882,0.7578947368421053,1.0,1.0,3/48,6.11%,KLF4;ANXA1;CHI3L1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.48148120567984304,0.8215809831881333,0.6865671641791045,1.0,1.0,1/11,4.20%,TFRC
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.3732974955289089,0.8215428867509094,0.98,1.0,1.0,102/645,20.19%,KLF4;NFIL3;ACVR1B;FGF1;SAP30;RBMS3;TGFB2;RPL23;EGR1;MAPT;TLE1;TFRC;RORB;PQBP1;VEGFA;TDG;MOG;NOCT;SOX4;EIF2AK3;ANK3;TCF7;SLC11A1;APBB3;HINT1;ANK2;ARNT2;OVOL2;INSR;HIF1A;CAMK2N1;HCFC1;GLRX2;BMI1;FOXN2;ZNF804A;ZKSCAN5;PCBP4;RIMS2;TCF7L1;TRIM5;ID2;ROBO1;POU5F1;FN1;MAFB;BHLHE40;LIMD1;RRP1B;RBPJ;PDE2A;CELSR2;NTRK3;CCDC3;ITGB8;CLK2;PER1;NOVA1;FAM50A;SH3GL2;ZNF536;TULP3;NTRK2;SOX6;NFKBIZ;HINFP;ZNF143;PINK1;DRAP1;CIAO3;BRCA1;AHNAK;HCLS1;RLIM;TXK;YAF2;TRIM26;EPB41L4B;ACTR5;WNT5A;PICALM;MLF2;ESRRG;SLC24A3;BCL6;RPL11;ESR1;HNRNPH1;NKX6-2;NR2C2;CXXC1;APP;ROCK1;RGCC;SART3;FOXP1;SMAD1;HSPA1B;APBB2;OLFM1;PRKAA2;NELL1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.37465015584100675,-0.8214374799439954,0.7,1.0,1.0,2/12,10.86%,TGFB1;ENPP1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.48629452350406294,0.8213927562519863,0.7631578947368421,1.0,1.0,3/9,10.91%,TGFB2;SPRY1;RBPJ
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.510471103820111,-0.8211223664843336,0.6153846153846154,1.0,1.0,2/5,4.84%,THAP4;IL4I1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5291665140291844,0.820805194930243,0.8133333333333334,1.0,1.0,4/10,28.74%,SOX4;PKD1;ALDH1A2;PROX1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.4969002955965164,0.8204432642331241,0.7972972972972973,1.0,1.0,2/11,26.31%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.41725798324236735,-0.8204106312796644,0.64,1.0,1.0,2/14,7.01%,IL1B;TP53
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5057006348864015,0.820323008405953,0.7301587301587301,1.0,1.0,2/8,15.47%,RBX1;UBE2M
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.559112499150172,0.819900671365908,0.7746478873239436,1.0,1.0,3/5,31.82%,SYCE2;BAG6;RAD21
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.559112499150172,0.819900671365908,0.7746478873239436,1.0,1.0,3/5,31.82%,SYCE2;BAG6;RAD21
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.4409377789541594,0.8198840084546726,0.7586206896551724,1.0,1.0,6/18,25.72%,ARF6;VEGFA;THY1;ROCK1;COL16A1;IQSEC1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.4563356407836008,0.8193654871713679,0.7469879518072289,1.0,1.0,5/27,20.74%,FANCM;EME2;DNA2;ZGRF1;CDK9
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.42839027545026476,-0.8192382763462568,0.6923076923076923,1.0,1.0,1/8,2.07%,FBL
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.49773477743402095,0.8191073788948091,0.6578947368421053,1.0,1.0,4/7,46.93%,EIF4G1;EIF4E2;EIF4ENIF1;DDX6
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.49773477743402095,0.8191073788948091,0.6578947368421053,1.0,1.0,4/7,46.93%,EIF4G1;EIF4E2;EIF4ENIF1;DDX6
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.5171754781971194,0.8190965204451502,0.726027397260274,1.0,1.0,1/7,16.87%,PYCARD
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.42764363857527093,0.8190651678277321,0.7386363636363636,1.0,1.0,3/22,12.45%,CR1;GPNMB;PDCD1LG2
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.5075370646168893,0.8189365667700229,0.76,1.0,1.0,1/8,6.76%,EIF2AK3
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.5064921374546925,0.8188296574220628,0.7333333333333333,1.0,1.0,2/13,3.95%,NUDT16;RIOK2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.45066215961019945,0.8187636443846159,0.7647058823529411,1.0,1.0,7/25,21.04%,DNAJC6;FCHO2;SGIP1;ITSN1;PICALM;SNAP91;AP2A2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.40319589737811823,0.8185675104802485,0.8043478260869565,1.0,1.0,7/59,18.99%,WDR5;YEATS2;RUVBL2;PER1;TRIM16;CHD5;MORF4L2
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.4673627912192053,-0.8185178620592449,0.7142857142857143,1.0,1.0,6/8,21.97%,LTC4S;ALOX5;FADS1;ALOX5AP;MGST2;MGST3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.3353741660399274,-0.8184252866472352,0.6666666666666666,1.0,1.0,7/29,10.92%,SERPINF2;EVL;LPAR1;NF2;SORBS3;PPM1F;ABL1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.2942925767932186,-0.818107469191263,0.6666666666666666,1.0,1.0,5/50,6.51%,FLNA;NDE1;CTDP1;WRAP73;KIF3B
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.42139325698353763,0.818027689893535,0.7738095238095238,1.0,1.0,3/36,19.26%,RPL23;SNAP29;PYM1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.40781775250044544,0.8174088852618234,0.7078651685393258,1.0,1.0,5/39,6.23%,CR1;IL15;TFRC;ANXA1;GPNMB
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5172892418666559,0.8173846701830355,0.7272727272727273,1.0,1.0,3/8,15.70%,KDM3A;KDM1A;KDM4B
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.5321287471122848,0.8173838143898584,0.7702702702702703,1.0,1.0,1/7,2.24%,DPYD
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3865749581631169,0.8173040039980597,0.78125,1.0,1.0,18/77,22.36%,RHOBTB3;RHOB;MAPT;GPM6B;EPHA3;STMN3;RND3;IQCJ-SCHIP1;EPHA5;TPPP;PLXNB1;CLIC4;IQGAP1;ROCK1;PRKAA2;RHOH;PAK3;HIP1R
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.5193617472912015,0.8172006613332439,0.7777777777777778,1.0,1.0,1/7,9.02%,RUVBL2
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.49332818673784107,-0.8168610203131142,0.6944444444444444,1.0,1.0,4/6,24.41%,EXOSC10;EXOSC9;EXOSC8;XRN1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.5076216261778068,0.8168498729161138,0.7567567567567568,1.0,1.0,5/12,35.85%,BARD1;CHP1;CABP1;NUP153;MDFIC
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.494174854717968,0.8165908655808087,0.8142857142857143,1.0,1.0,1/14,0.41%,KLF4
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.3234788582666855,-0.8163717368627517,0.75,1.0,1.0,4/28,10.68%,NDE1;TRAK2;MYO1F;MYO1D
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.4428710568100627,0.8163256689321714,0.7804878048780488,1.0,1.0,2/31,2.77%,LRP2;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4174258333992472,-0.8162691054904427,0.7142857142857143,1.0,1.0,7/21,14.37%,INPP5K;IL1B;APPL2;PIP4K2B;ENPP1;PTPRE;NCK1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.4204830911789324,0.8161319970718517,0.8210526315789474,1.0,1.0,16/52,23.64%,HTR2B;SLC24A2;ANK2;VAPB;RYR2;SLC24A1;ATP1B3;SLC24A3;KCNMA1;ATP2A2;RMDN3;ATP1B2;SLC9A1;ATP13A4;SLC24A4;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.4800983754299044,0.8154223725299915,0.76,1.0,1.0,3/10,22.66%,IFITM3;TRIM14;HEXIM1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3842418105895088,0.8153929890061652,0.95,1.0,1.0,45/272,25.11%,CENPF;LRP2;ARRDC3;TBC1D8;NAPA;TFRC;ARF6;RAB3C;TVP23A;TBC1D13;ANK3;RAB20;RAB15;TXNIP;TBC1D15;ABCA1;LRP1B;NSF;SCAMP3;VMP1;TMED10;PREPL;SNX17;SPTBN1;KIF3A;ARRDC2;STXBP2;SCG5;RAB21;STX2;ATP6V0B;STX19;PRKCB;ATP6V1D;TBC1D2;NAPG;NDC1;HSP90B1;HFE;TF;CTTN;RAB5A;ATP6V0E2;ATP6V1B2;TBC1D14
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.4569551447223278,0.8153208068126592,0.7916666666666666,1.0,1.0,1/15,12.46%,PDE4DIP
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.5643664368172774,0.8148723406293038,0.803030303030303,1.0,1.0,1/5,10.54%,TRIM25
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),-0.45325163271117985,-0.8147891111303488,0.7428571428571429,1.0,1.0,1/7,3.55%,IL1B
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.42761777883717583,0.8147027241155226,0.75,1.0,1.0,5/28,9.19%,CD22;TFRC;FCGR2B;IL7;IRS2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3881681106872406,0.8145731456985517,0.7634408602150538,1.0,1.0,17/53,25.17%,NLRP12;IL15;AGT;OSMR;PDE2A;GPRC5B;NFKBIZ;WNT5A;NAPEPLD;APP;TNFRSF1A;IL18;TNF;TNIP1;PDCD4;TRADD;CX3CL1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.5536554646333773,0.8144773365501822,0.7941176470588235,1.0,1.0,1/5,2.57%,CYP3A5
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.4439763319025231,0.8141620946424594,0.7283950617283951,1.0,1.0,10/23,29.46%,HSPA5;HSPA1B;HSPD1;HSPA2;HSPA14;BAG3;HSPA9;HSPA13;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.5088274997071703,-0.8141518608376251,0.6857142857142857,1.0,1.0,1/5,3.71%,FSCN1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.501492455293104,0.8140491810126291,0.7792207792207793,1.0,1.0,3/11,29.58%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.501492455293104,0.8140491810126291,0.7792207792207793,1.0,1.0,3/11,29.58%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.5217110794531749,0.8140105315343831,0.7301587301587301,1.0,1.0,5/6,46.97%,PRNP;HSF1;DAXX;MT2A;SNCA
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.24202699053835924,-0.8139710736320758,1.0,1.0,1.0,34/189,15.42%,FLNA;KIF27;EHD4;INPP5K;FSCN1;WDR35;MKKS;WHAMM;MAP4K4;KIF3B;RAPGEF6;INPP5E;EXOC7;BBS9;P2RY12;CYFIP1;TMEM67;TCTN3;ABCC4;SRGAP2;OCRL;IFT43;GSN;PPP1R9B;STK26;OPHN1;DISC1;GALNT11;NUDCD3;CCDC66;RAB3IP;CDC14B;RAP1A;EMP2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.4160185086404921,-0.8138112937490308,0.7647058823529411,1.0,1.0,4/15,18.93%,CHUK;EGFR;AKT1;NCF1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4054693849273991,0.8137869621890091,0.7526881720430108,1.0,1.0,13/49,16.05%,TGFB2;AGT;INSR;IRS2;FN1;FGR;NTRK3;IGF1R;FLT1;NTRK2;HCLS1;PLXNB1;GAB1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.3591678842278876,-0.8137278733191524,0.68,1.0,1.0,1/15,2.26%,BTG2
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.4418422079094898,-0.8132624225720595,0.7142857142857143,1.0,1.0,2/7,7.01%,PSMC4;TP53
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.3942587152803044,0.8127341486733701,0.8172043010752689,1.0,1.0,11/88,18.70%,TOM1L1;GLA;NAPA;KIF1B;SH3GL2;ABCA1;GALC;BNIP3;SCAMP3;TMED10;SOD1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.4094012883228484,0.8126220282893811,0.7634408602150538,1.0,1.0,4/37,11.02%,TMEM161A;PTPRK;RUVBL2;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.47076501721541375,0.8122775800211577,0.7948717948717948,1.0,1.0,2/17,10.31%,HMGB2;TXN
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.46134579286343336,0.8122373257887474,0.7272727272727273,1.0,1.0,5/18,16.75%,IL1RAPL1;CAMK2B;EPHA4;CTNNA2;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5301188795902776,0.8119921238646078,0.7692307692307693,1.0,1.0,4/8,28.50%,NOD2;SASH1;GPS2;DDX3X
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.520885670906099,0.8115441929222147,0.7230769230769231,1.0,1.0,4/6,36.30%,TFIP11;DCLRE1C;RIF1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.48863268567789964,0.8110006656864285,0.7532467532467533,1.0,1.0,3/10,24.74%,FOXP1;FES;CTNNBIP1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.45752599699692786,0.8108540041330684,0.7976190476190477,1.0,1.0,2/18,7.33%,GPM6A;NLGN1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.49751631672085966,0.8102688878770163,0.7530864197530864,1.0,1.0,1/12,2.24%,DPYD
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.35206416741886964,-0.810146351662925,0.8571428571428571,1.0,1.0,13/36,15.11%,CCL5;IL1B;CD276;IGF1;CD274;NCKAP1L;HLA-DPA1;IL6ST;SYK;TMIGD2;NCK1;IL12RB1;SLC7A1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.40047889931928693,0.8100692806706288,0.8387096774193549,1.0,1.0,9/45,23.60%,MAPT;PTPRK;HIF1A;GLRX2;SOD2;SOD1;GSTP1;FOS;JUN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.401332893529502,0.8100243133086836,0.7333333333333333,1.0,1.0,8/27,23.56%,CAMK2N1;CCNB3;CDC37;CDK5R1;CCND3;CDKN1B;GTPBP4;CNPPD1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.5205436985285798,0.8097033377915268,0.7777777777777778,1.0,1.0,1/6,11.76%,C5AR1
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.47897279242162927,0.8095549531613024,0.7682926829268293,1.0,1.0,2/14,13.02%,EEF1A2;SORBS1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4330491903932008,0.809494116879777,0.8314606741573034,1.0,1.0,3/36,6.70%,CR1;ANXA1;TRAF2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4368527739157382,0.8094687693687884,0.7682926829268293,1.0,1.0,9/28,32.76%,RAB20;ATP6V0B;SLAMF8;ATP6V1D;ATP6V0E2;ATP6V1B2;ATP6V1E2;MCOLN1;ATP6V0A1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.5261699610421516,0.8092941437248118,0.6923076923076923,1.0,1.0,2/6,11.28%,SNAP25;GLUL
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4865395314584834,0.8086160652154037,0.7037037037037037,1.0,1.0,5/11,21.95%,SH3D19;TNFRSF1B;TIMP3;ROCK1;TNF
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4936379530555244,-0.808327316507389,0.68,1.0,1.0,3/7,19.25%,NKD1;DAB2;WNT5B
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.5369579309801971,0.807785447635522,0.7727272727272727,1.0,1.0,4/6,33.79%,SMYD5;PRDM15;MLLT3;NCOA3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.45226842581986165,0.8077467021530909,0.7974683544303798,1.0,1.0,4/13,22.91%,VEGFA;THY1;ROCK1;COL16A1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.4372409616805068,0.8077142351304689,0.7906976744186046,1.0,1.0,5/22,20.36%,BOK;IFIT2;BNIP3;SOD2;HSPD1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.4846196288664561,-0.807513088795603,0.7222222222222222,1.0,1.0,2/7,9.20%,PHF8;KDM7A
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.30305831377935116,-0.8073003117803722,0.6666666666666666,1.0,1.0,13/102,6.92%,CCL5;GBP3;PSMB3;PSME3;CHUK;IL1A;IL1B;DAB2IP;IRAK4;PSMD12;PSMC4;MAPK13;SIRPA
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.5373075205438647,0.8068238937756766,0.78125,1.0,1.0,2/5,31.48%,LRRK2;MIA3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.4078483846669332,-0.8067658361636532,0.5454545454545454,1.0,1.0,2/9,11.13%,NFKBIE;NFKBIA
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.49066176772684733,0.8063162755951103,0.7236842105263158,1.0,1.0,1/8,7.33%,NLGN1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.37695070249589274,0.8058669808289504,0.898989898989899,1.0,1.0,39/198,23.71%,TOP2A;HMGB2;RPA2;TDG;MPG;GLRX2;WDHD1;ENDOV;RPS27A;DNA2;NEIL1;XRCC3;HINFP;INTS3;BRCA1;UHRF2;GTF2H3;POLQ;FANCL;FAN1;POLE2;ADPRS;RFC4;FANCA;ORC6;POLL;UBA52;UBB;DBF4;KMT5C;RFC1;NOP53;RBBP8;TIMELESS;DDB1;ORC3;RPA3;HELLS;BARD1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.422703854074469,0.8058596500821312,0.8,1.0,1.0,17/44,25.11%,CBR1;VEGFA;PAX8;ERRFI1;MFSD2A;CPT1A;PKD1;NDRG4;PPP2R3A;PGK1;STAT1;ALDH1A2;FGFR2;MTHFD1;TIMELESS;IFT122;HNRNPH3
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.35809289337062017,-0.8057530190310613,0.7391304347826086,1.0,1.0,1/14,2.09%,SLC30A5
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.5145885089528697,0.8055317777484428,0.7671232876712328,1.0,1.0,2/7,14.56%,VPS11;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.4240696860603218,-0.8055189673053026,0.7142857142857143,1.0,1.0,1/8,1.84%,CYP19A1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.5232439135958464,0.8053640031570882,0.7428571428571429,1.0,1.0,2/6,13.95%,RYR2;RYR3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.40270389323935263,0.8047619431864652,0.7558139534883721,1.0,1.0,2/44,6.28%,NFIL3;SOX4
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.4410627616407101,0.804581594350748,0.7763157894736842,1.0,1.0,5/22,21.25%,PIGU;PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.3854268162925074,0.8044372275277594,0.875,1.0,1.0,15/90,20.79%,RAP1GAP;HMGB2;MTCL1;RGS1;RAPGEF3;CALM3;PINK1;PLXNB1;RASGRF1;PICALM;THY1;GBA3;PKP4;MTMR9;EZH2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.38094105491692987,-0.8043983867321913,0.7058823529411765,1.0,1.0,3/13,3.55%,BCL2L1;IL1A;IL1B
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.38094105491692987,-0.8043983867321913,0.7058823529411765,1.0,1.0,3/13,3.55%,BCL2L1;IL1A;IL1B
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.3132550605095825,-0.8043174447744684,0.8666666666666667,1.0,1.0,7/47,11.88%,NUP42;NUP155;AGO1;RAE1;POLR2C;NUP214;NUP188
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.3132550605095825,-0.8043174447744684,0.8666666666666667,1.0,1.0,7/47,11.88%,NUP42;NUP155;AGO1;RAE1;POLR2C;NUP214;NUP188
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.3081152220498503,-0.8042843925360836,0.9166666666666666,1.0,1.0,6/25,20.00%,IGHMBP2;RPAIN;RECQL;HDAC10;FBH1;THAP9
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.4609807879675411,0.8037805314330967,0.7631578947368421,1.0,1.0,1/12,2.77%,HMGB2
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.4647834244047393,0.8037539160899314,0.782051282051282,1.0,1.0,2/15,6.70%,CD55;TRAF2
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.4095445008076176,-0.803713762200298,0.7307692307692307,1.0,1.0,3/8,17.79%,APOL2;IL6R;SIGIRR
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.4458423138632466,0.8036859458033361,0.7638888888888888,1.0,1.0,6/18,22.45%,NLGN1;NLGN3;FCHO2;SYT1;AMPH;NLGN4X
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),0.538943897332171,0.8036061476062506,0.7746478873239436,1.0,1.0,1/5,2.44%,MAL
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.4167344085374086,-0.8032939735167491,0.71875,1.0,1.0,1/9,3.48%,IL1A
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4385816478470323,-0.8030535012899965,0.6666666666666666,1.0,1.0,2/9,3.64%,ZNF703;SH2B3
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.4286684453664751,-0.8029903803397929,0.6666666666666666,1.0,1.0,4/9,13.41%,TTC39B;TREM2;NR1H3;PPARD
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4108865544916718,0.8024266217398545,0.7954545454545454,1.0,1.0,2/27,3.34%,TGFB2;GLIPR2
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.4673630299472931,-0.8024075568870557,0.7333333333333333,1.0,1.0,1/5,4.02%,LGALS9
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.45357928673148884,-0.8022557460669844,0.7419354838709677,1.0,1.0,2/7,10.86%,ITPA;ENPP1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.34084667157693493,-0.8021420032270431,0.6470588235294118,1.0,1.0,3/24,9.77%,SRRT;PUS10;AGO1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.44800601802955187,0.8019389121014794,0.7534246575342466,1.0,1.0,3/13,10.38%,IHO1;FMN2;PTN
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.34884557363341373,-0.8018596474830094,0.7,1.0,1.0,5/44,9.23%,RALB;ZFYVE1;LPL;WIPI1;CLEC16A
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.49390221695788294,-0.8017218608958725,0.7419354838709677,1.0,1.0,1/7,5.46%,TMEM106A
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.4374356492319433,0.801637838611384,0.7283950617283951,1.0,1.0,7/13,33.24%,PNPLA8;CDS2;LPCAT4;PGS1;LPCAT1;LPGAT1;ABCA3
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.3913601225226061,-0.8014016994993202,0.75,1.0,1.0,3/13,8.99%,ZNF675;LILRB4;TLR3
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.4996885479912798,0.8009742158710537,0.7638888888888888,1.0,1.0,3/9,20.62%,DNAJB2;HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.46054337505725407,0.8001193007332311,0.8,1.0,1.0,2/18,8.16%,SMC4;NCAPH2
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.4033356866967852,-0.8000652358670964,0.72,1.0,1.0,5/16,14.15%,CHUK;IRF5;TLR3;TLR7;IRF7
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.40622603084758824,-0.7998373376061972,0.6818181818181818,1.0,1.0,3/13,8.41%,TTC39B;ARV1;LAMTOR1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.5593272716593685,0.7996741415456954,0.8064516129032258,1.0,1.0,1/5,13.47%,BACE2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.38550475900536507,0.7995595550747571,0.7840909090909091,1.0,1.0,11/57,20.18%,PGAM1;NUP133;INSR;HIF1A;PFKFB4;PRKAG2;FBP1;SEH1L;APP;PPARA;PRKAA2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.27592396226332433,-0.799415457565462,1.0,1.0,1.0,9/57,11.88%,SIDT1;DHX38;NUP155;CHTOP;THOC5;DDX39A;RAE1;NUP214;NUP188
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.32713678465775475,-0.7993432328567079,0.7857142857142857,1.0,1.0,4/26,11.55%,NT5C3B;DCP1B;EDC3;LSM6
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.39729927216068595,0.7993037731902791,0.8351648351648352,1.0,1.0,15/55,32.08%,HMGB2;H2BC11;SMARCD3;ACTR6;SART3;SMARCC1;SMARCD2;NASP;H1-0;SMARCA5;ARID2;NAP1L2;SET;MACROH2A1;H2BC9
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.308813408750264,-0.7992689483818908,0.8181818181818182,1.0,1.0,2/42,2.77%,EHD4;DENND1C
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.4372308677506346,-0.7991931391554586,0.75,1.0,1.0,1/5,1.79%,PUS1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.4205729960539499,0.7990581827332824,0.8505747126436781,1.0,1.0,5/31,11.27%,PRKCE;ARF6;BAIAP2L1;SPIRE2;CARMIL1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.42635184390752606,0.7989949816084773,0.7682926829268293,1.0,1.0,14/27,28.47%,AGT;ANK2;RYR2;RYR3;FXYD7;ASPH;ATP1B3;ATP2A2;ATP1B2;ATP1A2;ATP2B2;TRPC1;ATP2B4;TMEM65
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.4542720665165502,0.798815060422382,0.8024691358024691,1.0,1.0,3/21,13.82%,NUDT16;NHP2;ZC3H12B
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5371987443567587,0.7987339409324342,0.75,1.0,1.0,3/5,44.86%,ASAH1;SLC6A6;RIPK1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.4637284089907602,0.7984542451346325,0.7407407407407407,1.0,1.0,3/17,16.82%,MMP21;CCDC39;NDRG4
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.43035978451975754,0.7982713205309729,0.7368421052631579,1.0,1.0,8/27,21.95%,MAPT;SLC11A1;CD93;C5AR1;CRTC3;APP;FOXP1;TNF
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.440868564378171,0.7981334045031576,0.7792207792207793,1.0,1.0,1/17,7.38%,RBM3
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.3223110012701212,-0.7980571161308556,0.7142857142857143,1.0,1.0,7/43,11.89%,TGFBR3;ETS1;ARAP1;DAPK3;EGFR;ABL1;PKN1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.444685312420491,0.7979524863936324,0.8372093023255814,1.0,1.0,2/18,11.02%,TMEM161A;KDM1A
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.4210377607786528,0.797916217687684,0.7558139534883721,1.0,1.0,10/24,22.40%,SNAP25;UNC13A;RIMS2;SYT1;RIMS3;SNAP29;UNC13C;CPLX1;STX2;STX19
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.37736438190738514,0.7977022852756054,0.8369565217391305,1.0,1.0,6/73,11.94%,MAPT;RPA2;IER5;NUP133;DNAJC7;CAMK2B
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.38576011803281746,0.7971840738325912,0.8865979381443299,1.0,1.0,26/119,24.13%,NR4A2;ERCC2;NR4A1;RORB;RXRB;RBPJ;POLR1C;NR2F1;NR4A3;POLR3H;GTF2H3;ESRRG;ESR1;POLR2D;TFAM;NR2C2;TBL1XR1;TAF9B;PPARA;TAF7;CDK9;POLR2G;NOTCH2;NR1D1;POLRMT;RORA
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.47535846613164834,-0.7966208297007424,0.7142857142857143,1.0,1.0,2/6,12.12%,PHB2;EIF2AK4
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.37134429750821957,0.7962139892207023,0.94,1.0,1.0,45/218,23.71%,BRIP1;ERCC2;PIAS4;RPA2;TDG;MPG;FANCB;WDHD1;ENDOV;FANCM;RPS27A;EME2;DNA2;NEIL1;FANCI;XRCC3;HINFP;NSMCE1;INTS3;BRCA1;DDX1;VCPIP1;GTF2H3;POLQ;KDM4B;FANCL;FAN1;ACTR5;POLE2;ADPRS;RFC4;FANCA;POLL;ERCC6;NEIL2;UBA52;UBB;MLH1;KMT5C;NOP53;RBBP8;TIMELESS;DDB1;RPA3;BARD1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.48579543401289355,0.7961192530242093,0.7733333333333333,1.0,1.0,4/8,32.55%,SNAPC3;ICE2;SNAPC4;ELL
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.35429419939742135,-0.7959505533975934,0.782608695652174,1.0,1.0,3/20,7.26%,TAL1;DUSP3;EIF4EBP1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.4658681287271166,-0.7958760710718735,0.7241379310344828,1.0,1.0,1/6,4.04%,SLC46A1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.5321280290049772,0.7954255222356955,0.7692307692307693,1.0,1.0,4/5,46.68%,VAMP7;SNX4;VAMP3;VAMP8
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.43799208366649917,-0.7953546987479354,0.68,1.0,1.0,1/8,1.23%,ITGAM
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.40147491330098084,0.7952415115623898,0.7901234567901234,1.0,1.0,4/25,11.27%,DOCK1;DOCK5;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.41104829757285666,0.794924066486386,0.8292682926829268,1.0,1.0,8/36,24.04%,CLIP3;NLGN1;SGIP1;CALY;RAB21;CD151;HFE;TF
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.42082353901487346,0.7948868890452585,0.7530864197530864,1.0,1.0,4/22,18.26%,GALNT8;GALNT13;B4GALT5;GCNT1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.4065689340096092,0.794702468382321,0.8260869565217391,1.0,1.0,11/46,14.16%,PRLR;RELN;IL15;AATK;INSR;EPHA3;GHR;FGR;IGF1R;FLT1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.528782100257973,0.7945528955789287,0.7846153846153846,1.0,1.0,2/5,20.73%,CTBP1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.49796481221936506,0.7943355201821216,0.8493150684931506,1.0,1.0,5/9,26.93%,ABCA1;ITGAV;ABCA5;PPARA;ABCG1
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.4496833963643364,-0.7941935921530014,0.7096774193548387,1.0,1.0,3/7,21.28%,IVD;MCCC1;BCAT2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.36683164478749797,0.7941531950129347,0.8787878787878788,1.0,1.0,16/104,23.80%,MAPT;MANF;RPA2;NUP133;DNAJC7;MCL1;CAMK2B;ADCY8;PINK1;SEH1L;HSPA1B;NPAS2;BAG3;ATF3;RPA3;NDC1
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.5054678358185298,-0.7941427996513418,0.6666666666666666,1.0,1.0,2/5,16.18%,SRC;CBL
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.4212242727719723,0.7935437254618849,0.810126582278481,1.0,1.0,12/30,23.50%,ERCC2;RPA2;RPS27A;RBX1;GTF2H3;FAN1;RFC4;UBA52;UBB;RFC1;DDB1;RPA3
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.3629797779099199,0.7933794430657434,0.98,1.0,1.0,91/599,20.79%,CENPF;KLF4;NFIL3;SAP30;TGIF1;ZBTB16;RPL23;NFIX;HMGB2;NRG1;TLE1;NR4A2;TSHZ3;MEIS2;RORB;PIAS4;PTPRK;ARID5B;VEGFA;SUV39H2;RUNX1T1;ZNF93;SFMBT1;RBFOX2;KCTD1;YEATS2;HCFC1;BMI1;ATP8B1;ZNF540;POU6F1;TRPS1;ID2;POU5F1;BHLHE40;LIMD1;MXD1;RPS27A;RBPJ;KDM1A;PDE2A;PRICKLE1;NR2F1;MXI1;PER1;IMPACT;ZNF536;ZNF550;NR4A3;DEAF1;ETS2;PPID;HINFP;DRAP1;OTUD7B;FBP1;BRCA1;DPF3;E2F7;RLIM;LANCL2;LDB2;YAF2;ZNF248;WNT5A;UXT;HIC2;SDCBP;CDK5R1;BCL6;PLCB1;ESR1;CTBP1;MTA3;NKX6-2;CDKN1B;NR2C2;TBL1XR1;ZBTB18;HAMP;ZNF684;FOXP1;TAF9B;KLF7;PPARA;UBA52;BCL11A;UBB;ZNF778;TAF7;EZH2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.42503985094619784,0.7932880407190342,0.7662337662337663,1.0,1.0,5/22,22.90%,ANLN;KANK1;ROCK1;STARD13;STAT1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.5271629964234802,0.7932737992291118,0.7352941176470589,1.0,1.0,1/5,9.02%,RUVBL2
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.3221137473356245,-0.7930265028342672,0.9285714285714286,1.0,1.0,7/37,8.69%,RAMP1;NEDD4;GTF2H2;LILRB4;GRK2;ARRB2;SCYL2
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.3923540931948423,0.7929611879936346,0.851063829787234,1.0,1.0,15/83,24.16%,SOX4;SEPTIN4;FANCI;PRICKLE1;DNAJB2;SASH1;PINK1;RIPK2;BRCA1;CAMLG;HSPA1B;GTPBP4;UBB;CHP1;LRRK2
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.37315721577120153,0.7928999679557317,0.875,1.0,1.0,30/113,24.13%,VIM;HMGB2;ADCY3;BRINP1;RORB;PDK4;ADAM15;EPHA3;PTK7;RUVBL2;NOD2;ADCY8;PDCD1LG2;GNAI1;PDE4B;TNFRSF1B;WNT5A;PYCARD;INSIG1;PDK3;ESR1;GSTP1;FES;ABCB4;NR1D1;CASP1;ATP1A2;CHMP5;PDCD4;RORA
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4081719945899981,0.7924223479901349,0.8089887640449438,1.0,1.0,1/47,0.37%,GDPD1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.4004282851951602,0.7922015902172036,0.8295454545454546,1.0,1.0,10/48,20.78%,SEMA3A;GADD45B;TRAF2;FCGR2B;NOD2;PYCARD;SDCBP;PLCB1;APP;ANKRD6
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.36329649453332863,-0.7921613424807973,0.7894736842105263,1.0,1.0,5/19,15.75%,CTC1;TP53;SRC;TERF2;EXOSC10
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.42120664804142194,-0.7920495871055124,0.7391304347826086,1.0,1.0,2/11,4.74%,PLA2G4C;ZFYVE1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.4875378941477723,0.7919878166385829,0.7564102564102564,1.0,1.0,1/9,4.47%,ATAD3A
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.47025311239198153,0.7918921499163244,0.7368421052631579,1.0,1.0,4/9,16.75%,NLGN1;NLGN3;C5AR1;WNT5A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.5172449251504001,-0.7918296754653935,0.6363636363636364,1.0,1.0,2/6,9.94%,NFATC3;ENG
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4962982447312163,0.791685703080796,0.7681159420289855,1.0,1.0,3/10,35.63%,STAT2;CNOT7;NLRC5
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.40875337085146773,-0.7913835090525501,0.6666666666666666,1.0,1.0,3/7,12.67%,NPL;GNPDA1;NAGK
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.3834042248015101,-0.7908102203489505,0.7419354838709677,1.0,1.0,3/8,13.39%,NBN;WDR18;KAT7
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.43658386547793204,0.7906477409705003,0.8518518518518519,1.0,1.0,9/23,31.13%,SLC11A1;PICALM;SLC39A14;FBXL5;HFE;TF;NEO1;HMOX1;CUTC
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.4226246304354527,-0.7904054265766403,0.6956521739130435,1.0,1.0,5/15,11.99%,DAB2IP;B4GALT7;TP53;NLRC3;SKI
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.4404723730681637,-0.790390131570334,0.7272727272727273,1.0,1.0,4/10,13.23%,DSCAM;ROBO3;BSG;DSCAML1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.3964379913222724,0.7903324952104105,0.7857142857142857,1.0,1.0,12/54,19.33%,HTR2B;SLC24A2;SLC11A1;ANK2;VAPB;RYR2;SLC24A1;SLC39A12;SLC24A3;ATP2A2;RMDN3;SLC39A14
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.3048602583414269,-0.7901691435055627,0.8235294117647058,1.0,1.0,2/28,1.11%,TGFBR3;LOXL3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.38526601071891214,0.7900764380661712,0.7894736842105263,1.0,1.0,7/53,12.57%,TBC1D8;ARF6;TBC1D13;MYO10;ATP8B1;DYNC2LI1;TBC1D15
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.5081412781861124,0.790004737136492,0.75,1.0,1.0,1/7,11.07%,FGR
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.4934714896535869,-0.7898789444591273,0.7241379310344828,1.0,1.0,3/5,19.15%,MKKS;NENF;BBS2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.4086417053827417,-0.789550585085617,0.6785714285714286,1.0,1.0,1/10,6.39%,LEO1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.4021436500213178,0.7891627022959372,0.7738095238095238,1.0,1.0,9/34,21.95%,EGR1;ALOX15B;IL7;HIF1A;WNT5A;PYCARD;APP;IL18;TNF
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.5259557146868367,0.7890355800498355,0.7681159420289855,1.0,1.0,1/6,10.69%,CAV3
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.38087146616986156,-0.7888977990709193,0.7878787878787878,1.0,1.0,4/12,15.11%,SLC7A8;SFXN2;SLC47A1;SLC7A1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.4542488787765644,0.7883377992695499,0.7671232876712328,1.0,1.0,4/16,23.32%,TRIM5;TRIM25;TRIM26;DDB1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.4920264531460804,0.7882498999407358,0.7101449275362319,1.0,1.0,2/7,20.52%,ATP1B3;ATP1B2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.36203543849772696,0.7879844083548843,0.8673469387755102,1.0,1.0,14/114,14.11%,CLEC12A;TGFB2;EGR1;CD163;TNS1;CDH2;KITLG;F13A1;BAALC;BMI1;TXNIP;CD93;THBD;FGL2
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.5248705462771789,0.7879385260826268,0.8311688311688312,1.0,1.0,1/5,4.15%,OSMR
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.41170669300262147,-0.7876085041157262,0.9,1.0,1.0,2/24,2.21%,CCL5;SERPINF2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.46838594790357063,0.7873930989078941,0.704225352112676,1.0,1.0,5/9,39.72%,WAPL;PARP9;MED25;GMNN;HMBOX1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.4678965603447255,-0.7872425814237344,0.7741935483870968,1.0,1.0,2/6,19.01%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.4678965603447255,-0.7872425814237344,0.7741935483870968,1.0,1.0,2/6,19.01%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3690127932704554,0.7871916235871171,0.8936170212765957,1.0,1.0,16/122,14.95%,DAPK2;AGT;PHLPP1;TRAF2;NDRG1;DAPK1;PAX8;SEPTIN4;BNIP3L;BEX2;SRA1;ALK;PINK1;CIDEB;BNIP3;PRELID1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.5107384790501235,0.7871100284536398,0.7808219178082192,1.0,1.0,3/7,25.17%,FN1;COL16A1;CX3CL1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.42796738278607716,0.7871047468011093,0.8192771084337349,1.0,1.0,9/27,25.08%,RNASE10;PTPRG;CELSR2;EPHA7;SPINT2;GTPBP4;FLOT2;PTPRR;MEGF10
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.47149115780116974,0.7866813147161751,0.7792207792207793,1.0,1.0,1/9,5.67%,RPA2
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.47109259716512497,0.7865519415409368,0.7777777777777778,1.0,1.0,2/10,9.71%,NFIB;POU5F1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.47228904904552554,0.7865434627905641,0.7894736842105263,1.0,1.0,1/13,12.92%,FLT1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.4560728696201352,0.7864267647652579,0.7792207792207793,1.0,1.0,2/16,12.45%,CR1;PDCD1LG2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.36848171509007277,-0.786383007600296,0.8571428571428571,1.0,1.0,6/16,15.11%,SLC38A1;SLC7A8;SLC25A18;ARL6IP5;SLC47A1;SLC7A1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.48142305519804207,0.7863590152416984,0.7763157894736842,1.0,1.0,1/8,1.60%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.5066442586574659,0.7863490522402299,0.8,1.0,1.0,2/7,16.40%,ALOX12;SERPINE2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3029074124013804,-0.7862375409696862,0.8571428571428571,1.0,1.0,7/43,17.34%,PKIB;CTC1;SRC;MAP3K4;TERF2;EXOSC10;SMG6
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3391524580835079,-0.7857886483251201,0.7727272727272727,1.0,1.0,4/15,9.62%,CORO1B;ARFIP1;CYFIP1;WASF3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4304214096864754,0.7857596857897698,0.8765432098765432,1.0,1.0,9/25,23.50%,ERCC2;RPA2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1;RPA3
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.44894854466919076,0.7854145211977246,0.7777777777777778,1.0,1.0,8/17,31.89%,DNA2;BRCA1;RNF138;RBBP8;BARD1;SLX4;BLM;SMARCAD1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3963777147671208,0.7850915827974381,0.8144329896907216,1.0,1.0,8/49,17.69%,TMEM161A;PTPRK;RUVBL2;KDM1A;IMPACT;PPID;ACTR5;COPS9
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.34701825868918584,-0.7848896078714702,0.7857142857142857,1.0,1.0,4/12,15.98%,MTLN;LPL;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4547933737456141,0.7845413006506851,0.8026315789473685,1.0,1.0,2/14,19.00%,ERRFI1;APP
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.47675371585017035,-0.784461366500405,0.625,1.0,1.0,1/5,7.96%,NUP155
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.47166329724964945,0.7842938393143828,0.8157894736842105,1.0,1.0,5/9,26.28%,DUSP10;AIDA;GSTP1;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.44503927590430864,0.7842481653216008,0.8051948051948052,1.0,1.0,4/17,19.82%,PPOX;FLVCR1;ALAD;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3723076558002144,0.7840030095711408,0.8969072164948454,1.0,1.0,29/99,23.34%,KLF4;ALOX15B;BMPR1B;NLGN1;MBOAT2;EPHA3;PPP1R13L;TRPS1;ID2;MAFB;ALK;SMYD5;NREP;CLASP2;APC2;OCIAD1;CEBPD;CDK5R1;BCL6;ST7;ROCK1;SUZ12;FES;CDK9;TNF;PRKCB;NR1D1;FGFR2;FLOT2
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3622820644968112,-0.7837748336346786,0.8333333333333334,1.0,1.0,3/15,4.10%,LY86;SCIMP;TRIB1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.49588175333553397,0.7836996218898916,0.7702702702702703,1.0,1.0,3/8,21.95%,AKAP6;SLC9A1;TNF
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.49588175333553397,0.7836996218898916,0.7702702702702703,1.0,1.0,3/8,21.95%,AKAP6;SLC9A1;TNF
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.47260767571086915,0.7836684157873969,0.775,1.0,1.0,5/11,28.11%,B4GALT5;SPTBN4;PTEN;B4GALT6;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.49440652482511915,0.7836634057701871,0.7,1.0,1.0,1/7,13.69%,NFKBIZ
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.40021794297861263,-0.7836601881130004,0.68,1.0,1.0,2/10,7.01%,PSMC4;TP53
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.42029274995800225,0.7834190940556883,0.8,1.0,1.0,7/25,16.75%,PPP2R5A;NSMF;CALM3;MAGI2;PPP1R15A;CD300A;CNEP1R1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.445627685644563,0.7824515012066461,0.8082191780821918,1.0,1.0,3/17,11.59%,NOCT;SLC11A1;TENT5A
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4388399286957578,-0.7821622165006193,0.6956521739130435,1.0,1.0,1/9,4.92%,CLTA
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4388399286957578,-0.7821622165006193,0.6956521739130435,1.0,1.0,1/9,4.92%,CLTA
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),0.4941050236961629,0.7818097090884317,0.7662337662337663,1.0,1.0,3/6,40.25%,GPR183;SLC12A2;PIK3CD
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.5329789898807534,0.781671559694722,0.8333333333333334,1.0,1.0,1/5,5.78%,PTPRG
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4451141565769613,0.7815450551458722,0.7922077922077922,1.0,1.0,2/15,16.21%,SNX10;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.28178599506434054,-0.7814348458255139,0.875,1.0,1.0,16/47,15.15%,IL1A;IL1B;LGALS9;SCIMP;TMEM106A;LPL;MAPK13;TLR3;TLR7;TYROBP;IL17RA;SYK;BCL10;TIRAP;IL6R;LILRA2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.4196958153502568,0.7811767540437254,0.8243243243243243,1.0,1.0,6/22,18.32%,HMGB2;PTPRZ1;BHLHE40;PTN;TNFRSF1B;NKX6-2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.392037862716326,0.7808297785825428,0.8241758241758241,1.0,1.0,9/41,22.36%,BOK;FAM162A;PINK1;CIDEB;BNIP3;PYCARD;DDHD1;FBXO7;HIP1R
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.47318008759752017,0.7804773403063987,0.7777777777777778,1.0,1.0,3/13,15.10%,HSPA5;PPP1R15A;DNAJB9
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.37913916913732015,0.7802763986855904,0.8111111111111111,1.0,1.0,16/61,23.92%,DTL;VPS11;SH3D19;PLK2;NSF;TNFRSF1B;APC2;WNT5A;CDKN1B;HECW2;TNF;RDX;DDB1;BARD1;HACE1;FZR1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.488470625968357,0.7802512848982108,0.8289473684210527,1.0,1.0,4/11,32.57%,RYR2;GRM5;PRNP;ADGRL1
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.4979682977341152,-0.7802123812564097,0.71875,1.0,1.0,1/5,14.41%,AKT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.40981970918450245,0.7799186879343752,0.8202247191011236,1.0,1.0,9/37,21.95%,PRKCE;CLIP3;ARF6;EPHA3;SORBS1;SPTBN1;PTPN9;ACSL3;TNF
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.5179334279067823,0.7795521185102052,0.7910447761194029,1.0,1.0,3/7,22.47%,DNA2;POLG2;TEFM
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.26072550709943165,-0.7793562022651728,0.8333333333333334,1.0,1.0,13/61,16.57%,GTF2F1;RPRD1B;PHAX;TAF13;SRRT;INTS9;RPAP2;POLR2C;RPRD1A;GTF2B;TAF8;GTF2E2;TBP
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.4038478907171639,0.7790125561009894,0.7674418604651163,1.0,1.0,6/26,16.87%,NDRG1;HINT1;ZNF385B;BOK;E2F7;PYCARD
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.4359983604417,0.7788439300421124,0.8313253012048193,1.0,1.0,7/18,30.97%,CMPK1;DCK;NMNAT2;GUK1;AK5;PNP;ME1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.49665324578499603,0.7788312831511967,0.7746478873239436,1.0,1.0,2/6,20.52%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.5272356186388835,0.7784777549402425,0.7714285714285715,1.0,1.0,2/5,28.77%,PPP1R15A;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.4338438742375978,-0.7782873245122638,0.6923076923076923,1.0,1.0,4/8,13.83%,PFN1;PLEKHM1;P2RY12;DEF8
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.4909091073577797,0.7781919995224451,0.746268656716418,1.0,1.0,2/7,17.04%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.44005983119613656,-0.7781760003765146,0.7666666666666667,1.0,1.0,1/7,9.41%,EP300
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.37095966439591044,-0.7781350108722732,0.75,1.0,1.0,1/18,0.58%,PPP1R16B
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.41897510762451523,0.7781233796545958,0.8271604938271605,1.0,1.0,2/28,7.91%,SLC38A4;SLC13A3
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.3836541166873312,-0.7778505312126347,0.72,1.0,1.0,2/8,9.69%,RHOG;NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.403334858353301,0.7776151309053322,0.8191489361702128,1.0,1.0,7/48,20.39%,HTR2B;MCL1;MFSD2A;TIMP3;ROCK1;NELL1;MTMR9
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.45381688932687,0.7774439871409237,0.7922077922077922,1.0,1.0,5/12,31.22%,SLC25A4;OPA1;TOP3A;TYMP;SLC25A36
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.40946385609447256,-0.7773245659877794,0.75,1.0,1.0,2/11,8.50%,STXBP4;PHB2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.35816250416977913,0.7773216894345808,0.95,1.0,1.0,41/310,19.00%,NFIL3;ACVR1B;SAP30;TOM1L1;RORB;PQBP1;SOX4;TCF7;APBB3;RBM3;HINT1;ARNT2;INSR;HIF1A;HCFC1;GLRX2;FOXN2;ZKSCAN5;TCF7L1;POU5F1;MAFB;BHLHE40;LIMD1;CELSR2;ZNF536;TULP3;SOX6;HINFP;ZNF143;DRAP1;RBM4B;HCLS1;YAF2;ACTR5;MLF2;ESRRG;ESR1;NKX6-2;NR2C2;CXXC1;APP
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.474633498312791,0.7772044257940176,0.7536231884057971,1.0,1.0,2/7,20.52%,STXBP2;FES
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.31037289209568836,-0.7770717913261793,0.8,1.0,1.0,8/39,11.49%,GAL3ST4;ST6GALNAC3;GANC;HPSE;B4GALT7;ST8SIA4;MAN2B1;NGLY1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.4188463092495045,0.7769002048417913,0.8125,1.0,1.0,4/20,21.32%,TFRC;GPI;DNAJB9;KMT5C
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3743698926789103,0.776879434183338,0.845360824742268,1.0,1.0,3/86,1.71%,KLF4;NLRP12;FZD6
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.45688793164626684,0.7765045368303355,0.8,1.0,1.0,1/11,5.00%,SLC1A2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.45291016213493746,0.7764706481073173,0.8048780487804879,1.0,1.0,3/14,9.78%,COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.433164518450311,-0.7763072546341676,0.7391304347826086,1.0,1.0,2/7,11.83%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.3964433253785965,-0.7757251036545967,0.7586206896551724,1.0,1.0,5/9,13.99%,CDAN1;TP53;SUPT16H;M1AP;RBBP4
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.5051707200848058,0.7756646923946197,0.8208955223880597,1.0,1.0,1/6,4.15%,OSMR
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.4739929453367391,-0.7756536713644301,0.8,1.0,1.0,3/6,20.40%,LPL;TIRAP;CD74
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.5306996655261138,0.775587964532007,0.8571428571428571,1.0,1.0,1/6,7.50%,GALNT13
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.5063590304118079,0.7755160601391141,0.8125,1.0,1.0,2/5,20.67%,TNFRSF1B;TNFRSF1A
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.3112274544322233,-0.7755155161103024,1.0,1.0,1.0,13/65,11.24%,CCL5;TICAM1;CX3CR1;IL1A;IL1B;DAB2IP;CD274;SIRPA;TGFB1;NLRP3;TRIM41;NR1H3;HCK
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.49176708790182944,0.775434471952104,0.7971014492753623,1.0,1.0,2/9,21.99%,HSPD1;CTPS1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.40313529438042484,-0.7753958256292521,0.7692307692307693,1.0,1.0,1/13,1.13%,NCOA4
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.4144433470588303,-0.7752841492716546,0.7096774193548387,1.0,1.0,3/7,16.55%,RPUSD3;RPUSD4;GAR1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3802118241852808,0.7751338012428926,0.8241758241758241,1.0,1.0,7/44,20.67%,ARAF;XPO1;PINK1;PKD1;ALAD;PSMC2;UBB
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.5345486358970435,0.7748495163074473,0.7894736842105263,1.0,1.0,1/5,13.39%,AGPS
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.5345486358970435,0.7748495163074473,0.7894736842105263,1.0,1.0,1/5,13.39%,AGPS
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.3470421491985997,-0.7747588883864341,0.85,1.0,1.0,6/19,17.49%,TADA2B;IL1B;PIH1D1;KAT7;TADA2A;PAXIP1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3705896919562728,0.774611239416269,0.8229166666666666,1.0,1.0,16/74,16.05%,TGFB2;PPP2R5B;AGT;FBXL2;INSR;IRS2;FN1;FGR;NTRK3;IGF1R;FLT1;NTRK2;PIK3IP1;HCLS1;PLXNB1;GAB1
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.4434440507571979,-0.7745981096955498,0.7777777777777778,1.0,1.0,2/8,8.39%,TPRKB;TEP1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.405138627134774,0.7744930680665096,0.8297872340425532,1.0,1.0,4/31,8.37%,GPM6A;ARF6;NLGN1;MYO10
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.3332808473404312,-0.7742111052286843,0.9090909090909091,1.0,1.0,4/16,16.78%,PSME3;APH1A;CTSH;GRN
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.45313279181393573,0.7741823722741561,0.7972972972972973,1.0,1.0,4/12,27.28%,ETFB;UQCRFS1;GPD2;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.2671876562607312,-0.774030870709766,1.0,1.0,1.0,6/61,7.84%,RALB;IDE;PYHIN1;IGF1;TRIB3;NVL
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.3961809337944433,-0.7739551132108621,0.68,1.0,1.0,1/11,1.00%,ZNF703
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.35691442794997014,0.7739455021979784,0.9292929292929293,1.0,1.0,40/209,21.95%,HTR2B;FGF1;ARAF;SHANK3;NRG1;KITLG;MAP3K8;PAQR3;IRS2;RPS27A;SPTAN1;CAMK2B;RBX1;PSMB4;SHC2;ZDHHC9;LRRC7;GRIN2B;RASGRP4;PEBP1;ITGAV;WDR83;RASGRF1;NEFL;SPTBN5;NRG4;SPTBN1;FGF13;UBA52;PSMC2;SPTBN4;UBB;DLG4;NRG2;PSMA3;DUSP6;PSMB2;NCAM1;IL18;TNF
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.4856031345148934,0.7738087130735941,0.8333333333333334,1.0,1.0,4/9,25.30%,IFNLR1;PRELID1;NOP53;TRAP1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3774001149282306,0.7737230275289158,0.8522727272727273,1.0,1.0,15/66,20.67%,HTR2B;DCC;SOX4;BNIP3L;IMPACT;CIDEB;RIPK2;BNIP3;TNFRSF1B;DUS2;CDKN1B;HSPA1B;NPAS2;SLC25A24;UBB
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.3844798047131333,0.773577882708373,0.8526315789473684,1.0,1.0,21/97,22.89%,NR4A2;ERCC2;NR4A1;RORB;RXRB;RBPJ;NR2F1;NR4A3;GTF2H3;ESRRG;ESR1;POLR2D;NR2C2;TBL1XR1;TAF9B;PPARA;TAF7;CDK9;POLR2G;NOTCH2;NR1D1
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",-0.4648680469671704,-0.7733767711760345,0.6521739130434783,1.0,1.0,1/5,6.36%,CD274
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.2250750853896733,-0.7730434504992775,1.0,1.0,1.0,49/210,18.22%,PSMB3;TADA2B;PSME3;ACTB;DDB2;BAP1;PSMD12;STAM2;PSMC4;USP28;COPS7B;TP53;OTULINL;BRCC3;USP12;ARRB2;COPS8;PSME4;OTUD3;KDM1B;EP300;NLRP3;ABRAXAS2;ADRM1;NFKBIA;BIRC2;INO80D;COPS7A;UFD1;USP9Y;SENP6;PSMA1;SENP1;COPS2;SMURF2;POLB;BECN1;PSMA7;COPS6;PSMD3;DESI2;USP14;PSMB5;ZRANB1;JOSD1;STAMBP;SNX3;ADRB2;USP10
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.4441329748815319,-0.7726216169127571,0.6666666666666666,1.0,1.0,3/6,11.61%,AZIN2;ALDH18A1;ASL
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.46731105985881993,0.7725511850012542,0.8169014084507042,1.0,1.0,3/11,23.30%,VPS11;RAB21;RDX
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.36631464610717585,-0.7724944886830353,0.7727272727272727,1.0,1.0,3/13,11.97%,FYN;CXCL12;WNK3
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.4091486406321507,0.7721158640473631,0.8214285714285714,1.0,1.0,7/25,32.12%,LIMD1;PRKRA;CNOT6;CNOT7;AGO4;CNOT8;DICER1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.3891017950544855,0.7720747674062791,0.8333333333333334,1.0,1.0,7/71,8.16%,PRKCE;CLIP3;MTCL1;ARF6;CEMIP;ANK3;EPHA3
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.2810739811274623,-0.7714616185553348,1.0,1.0,1.0,11/62,10.14%,SMDT1;MAIP1;MICU3;ATP2C1;MCOLN2;TMCO1;STOML2;PHB2;TRPV2;TRPV4;SLC35G1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.25463125732081615,-0.7710580531169944,1.0,1.0,1.0,13/62,16.57%,GTF2F1;RPRD1B;PHAX;TAF13;SRRT;INTS9;RPAP2;POLR2C;RPRD1A;GTF2B;TAF8;GTF2E2;TBP
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.36794512274269425,-0.7707249141012893,0.7037037037037037,1.0,1.0,2/13,7.93%,PGM2;AOAH
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.40228633917593654,-0.7705283583957449,0.7333333333333333,1.0,1.0,5/13,13.41%,TTC39B;LPL;TREM2;NR1H3;PPARD
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.36175260993356534,-0.7705014551392447,0.6923076923076923,1.0,1.0,10/10,63.86%,ITGA4;PDPK1;SP1;HMGB1;PLCG1;SIRT6;AKT3;FGF2;FGFR1;ADAM17
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.4194034161924583,0.7703434842192367,0.8555555555555555,1.0,1.0,1/32,0.73%,RHOB
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.4486454350255691,-0.7698031440101816,0.6944444444444444,1.0,1.0,2/5,16.22%,NLRP3;CD81
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.4486454350255691,-0.7698031440101816,0.6944444444444444,1.0,1.0,2/5,16.22%,NLRP3;CD81
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.29511915006404593,-0.7697285256910451,1.0,1.0,1.0,6/53,4.80%,MEI4;PDE12;GTF2H5;POLD3;GTF2H2;DDB2
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.4317645073698332,0.7696592056002546,0.8333333333333334,1.0,1.0,5/20,26.89%,TOMM20;GRPEL1;HSPD1;TOMM40;PEX10
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.4096558870935627,0.7696583823965714,0.8068181818181818,1.0,1.0,4/27,20.89%,NR4A2;PAX8;POLR2D;POLR2G
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.4124843223427307,0.7691857339681564,0.7692307692307693,1.0,1.0,7/24,29.42%,PQBP1;IFNLR1;AIM2;STAT1;TRAF3IP2;MICB;PARP9
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4094998619106896,0.769148595449729,0.8414634146341463,1.0,1.0,4/24,14.45%,CLIP3;ZDHHC15;GLUL;ZDHHC9
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.40069767203226914,-0.7690915258576377,0.8148148148148148,1.0,1.0,3/10,17.30%,ZKSCAN3;TERF2;SLC30A10
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.39312114916792773,-0.76900326212801,0.7777777777777778,1.0,1.0,2/7,5.70%,GCLC;PSPH
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3627265228985243,0.7688817974667906,0.8842105263157894,1.0,1.0,8/73,15.29%,RBM3;RBFOX2;SRSF12;PCBP4;KHDRBS2;NOVA1;CELF2;RBM5
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.3630562014759715,0.768675921969809,0.8969072164948454,1.0,1.0,31/124,25.17%,RAP1GAP;RGS1;SIPA1L1;EPHA3;CHN1;STMN3;NGEF;RAPGEF3;RRP1B;TBC1D15;NTRK2;EPHA4;EPHA5;PLXNB1;RASGRF1;PICALM;THY1;CPEB2;FGD6;SOD1;PLXNC1;PKP4;EZH2;TBC1D2;RDX;LRRK2;GNB5;ECT2;FGD4;ARHGAP9;CX3CL1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.35516295153131544,0.7683686882450587,0.97,1.0,1.0,61/366,20.74%,DAPK2;ACVR1B;CDK14;NEK11;TGFB2;PRKCE;RELN;RIOK2;CIT;PDK4;TTBK2;ACVR2A;BMPR1B;AATK;MASTL;EIF2AK3;CLSPN;PRRT1;RPS6KB2;DAPK1;NIM1K;INSR;EPHA3;PXK;FGR;IGF1R;ALK;CLK2;LIPE;CAMK2B;FLT1;PLK2;PAK5;NTRK2;FAM20A;PINK1;RPS6KA2;TYRO3;PRKAG2;EPHA4;NUAK2;GTF2H3;PKD1;INCENP;TXK;CDK5R1;PDK3;MAPK10;CTBP1;GRK4;GMFB;APP;ROCK1;TEC;MAP3K13;PRDX4;PIK3R4;NRBP2;PRKAA2;FES;CDK9
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.382185396146302,-0.7680931681996997,0.7586206896551724,1.0,1.0,3/12,13.22%,PXDNL;ACOX1;GPX1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4060176170962813,0.7680843584496997,0.8354430379746836,1.0,1.0,5/27,17.72%,GLA;ABCA2;CLK2;BRCA1;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.5035673488742383,0.7678577438781258,0.8059701492537313,1.0,1.0,1/7,13.47%,BACE2
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.39462412458919505,0.7678176696938892,0.9148936170212766,1.0,1.0,11/47,20.52%,PRKCE;ARF6;BAIAP2L1;CARMIL1;NTRK3;SEMA5A;DYNC1H1;HCLS1;PYCARD;GPSM2;FES
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.2992379027070813,-0.7677748074592167,0.875,1.0,1.0,5/34,11.88%,NUP42;NUP155;RAE1;NUP214;NUP188
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.4882803931691564,0.7675821798351885,0.7464788732394366,1.0,1.0,2/7,23.05%,ADCY10;DNAAF2
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.38972557301058003,-0.7672331491527072,0.75,1.0,1.0,3/10,14.26%,SMOX;HDAC10;SMS
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.4727123136518105,0.7669585991706203,0.8461538461538461,1.0,1.0,1/9,4.27%,TMEM161A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.4291931394285449,0.7669059367138665,0.881578947368421,1.0,1.0,1/17,1.04%,NLRP12
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43364083828561883,0.7665549094892573,0.7625,1.0,1.0,3/11,20.06%,CLK2;FBP1;PPARA
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.4678748796257435,0.7664211947352763,0.7313432835820896,1.0,1.0,2/7,15.05%,FCGR2B;GRIN2B
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.3706097932550653,-0.7661721991393816,0.8181818181818182,1.0,1.0,3/11,19.50%,BUB3;CTCF;ZW10
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.5040869243734519,0.7660337345159216,0.765625,1.0,1.0,2/5,39.84%,XRCC6;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.3754922202175257,0.7655909379302238,0.8387096774193549,1.0,1.0,3/53,7.07%,TGFB2;ARF6;APBB3
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.3455030218162405,0.7654834270801495,0.8556701030927835,1.0,1.0,15/100,15.69%,CLEC4E;CLEC12A;CD163;ADGRE1;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;PLTP;FGL2;CD300A;TNFRSF1B;STARD5
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.36530718129179296,0.7649853238816614,0.9081632653061225,1.0,1.0,24/90,28.22%,ZDHHC15;VPS37C;NLGN1;AKAP6;TIMM13;PARD3;TOMM20;ZDHHC9;CDC37;SDCBP;RPL11;NACA;AQP11;HACL1;FBXO7;SRPRA;MFN2;SPCS3;MAN1A1;TIMM22;TOMM40;ZDHHC18;SRP54;ZDHHC7
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3775333323175097,0.7636762871936981,0.8780487804878049,1.0,1.0,7/50,19.10%,NAPA;SEC24C;MCFD2;NSF;TMED10;GRIA1;TRAPPC6B
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3775333323175097,0.7636762871936981,0.8780487804878049,1.0,1.0,7/50,19.10%,NAPA;SEC24C;MCFD2;NSF;TMED10;GRIA1;TRAPPC6B
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3775333323175097,0.7636762871936981,0.8780487804878049,1.0,1.0,7/50,19.10%,NAPA;SEC24C;MCFD2;NSF;TMED10;GRIA1;TRAPPC6B
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.518464724911687,0.7634019129779116,0.7796610169491526,1.0,1.0,1/5,4.19%,SLC6A15
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.3521993789615955,0.763290789550838,0.9387755102040817,1.0,1.0,12/134,12.11%,CLEC4E;CR1;H2BC11;ATAD3A;ADAM15;SLC11A1;IFNLR1;TRIM5;TRIM25;IFITM3;FGR;NOD2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.5096204223775328,0.7632582229633043,0.8181818181818182,1.0,1.0,1/5,14.56%,BRCA1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.5068597793024541,0.7631968274089649,0.7794117647058824,1.0,1.0,1/5,13.10%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.5068597793024541,0.7631968274089649,0.7794117647058824,1.0,1.0,1/5,13.10%,NR4A3
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.5316524775474888,0.7630201578640659,0.8666666666666667,1.0,1.0,2/6,14.31%,CHI3L1;AMDHD2
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5087363315255474,0.7627410483196788,0.8266666666666667,1.0,1.0,1/5,14.85%,VCPIP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.48069419171777783,0.7626369035907136,0.8095238095238095,1.0,1.0,2/6,15.77%,PTPRT;DUSP10
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.2789641189822694,-0.7625792569210049,0.8888888888888888,1.0,1.0,11/84,14.54%,SCNM1;RP9;SNRNP35;KHSRP;DDX23;SMU1;IVNS1ABP;LSM6;PPP1R9B;SNRPB;SLU7
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3653957024549823,0.7623656560283384,0.875,1.0,1.0,6/71,11.02%,DTL;ERCC2;TMEM161A;PTPRK;RUVBL2;KDM1A
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.46755975557944035,0.7615118613846888,0.7916666666666666,1.0,1.0,2/8,11.98%,PCBP4;NOVA1
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.4498440392449828,-0.7614541720403407,0.7368421052631579,1.0,1.0,2/5,15.38%,PLK3;STX5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.4157166676237369,-0.7614007502240651,0.7931034482758621,1.0,1.0,3/9,13.17%,FYN;REST;STK26
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.3448908269316672,-0.761250266550808,0.9473684210526315,1.0,1.0,5/20,20.34%,NBN;TERF2;SMG6;UPF1;ERCC4
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.43887526484113937,0.7612273748160324,0.810126582278481,1.0,1.0,3/14,10.66%,TLE1;PDK4;MCL1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.3381412436547445,-0.7612089088604019,0.8947368421052632,1.0,1.0,6/20,13.46%,GCLC;HPGDS;GSTM4;GGT7;GPX1;GCLM
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.46236231751545387,-0.761163382125969,0.6944444444444444,1.0,1.0,2/5,9.45%,FYN;SRC
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.47717898882093407,0.7607362778670864,0.8333333333333334,1.0,1.0,2/10,17.72%,BRCA1;ERLIN1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.4468814785535672,0.7606535617894549,0.821917808219178,1.0,1.0,4/10,15.73%,MYRF;PARD3;TNFRSF1B;TPPP
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.4230242830306904,0.7606172637009327,0.8690476190476191,1.0,1.0,2/26,14.96%,NAPA;NSF
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.4699387229352439,-0.7605425475185491,0.7741935483870968,1.0,1.0,1/6,6.57%,SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.35428341136670843,0.7604838429409653,0.8958333333333334,1.0,1.0,11/87,13.69%,THBS1;NLRP12;IL15;AGT;POLR3F;PTN;PDE2A;GPRC5B;THBD;SASH1;NFKBIZ
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.5083765980155768,0.7601263152807841,0.8571428571428571,1.0,1.0,2/5,15.10%,HSPA5;DNAJB9
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.5147157167715739,0.7600905027872961,0.8732394366197183,1.0,1.0,3/6,29.58%,NHP2;METTL4;DKC1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.38194263606100215,-0.7600630811382165,0.8181818181818182,1.0,1.0,3/9,16.17%,SVIP;DERL2;OS9
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.4911473420889993,0.7597175784502908,0.7972972972972973,1.0,1.0,3/7,19.81%,CKAP5;DCTN1;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.3372579669544038,-0.7590497901364834,0.7333333333333333,1.0,1.0,4/21,9.45%,PPP1R16B;PPP1R7;TGFB1;SRC
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.31515017521339805,-0.7590402791073202,0.9166666666666666,1.0,1.0,2/32,4.46%,PDE12;KHSRP
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.4056588759349934,0.758838774051866,0.7951807228915663,1.0,1.0,7/34,19.12%,AGT;BMI1;FN1;CD300A;WNT5A;FTH1;GSTP1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.4234516615956903,-0.7587790776639668,0.8529411764705882,1.0,1.0,3/8,12.59%,ADK;DGUOK;AMPD3
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.3681742492315868,-0.758764028831774,0.8108108108108109,1.0,1.0,2/10,6.34%,CASP7;RYR1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.38237327117992026,0.7585579883722118,0.8571428571428571,1.0,1.0,13/47,25.61%,PRKCE;ARF6;BAIAP2L1;KANK1;CARMIL1;HCLS1;PYCARD;PAK3;HIP1R;SSH2;CTTN;TWF1;ARHGAP18
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.3931996623944387,0.7583595277353924,0.8539325842696629,1.0,1.0,5/43,8.09%,PLPP3;ENPP2;PLPPR4;ALOX15B;ABCA2
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.3926550359902244,-0.7582769660803426,0.7307692307692307,1.0,1.0,2/10,4.36%,PGM2;RPIA
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.470313502859953,0.7580610069137299,0.7432432432432432,1.0,1.0,2/6,11.21%,VEGFA;PDE2A
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.37198834978189144,-0.75805010143563,0.7037037037037037,1.0,1.0,2/15,9.39%,OSBPL6;CH25H
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.40234066168393656,0.7579729949128958,0.8924731182795699,1.0,1.0,6/38,19.82%,ZBTB16;FLVCR1;HCLS1;RASGRP4;CASP3;ATP5IF1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.40981775588051644,0.7579038115506516,0.8589743589743589,1.0,1.0,11/28,23.50%,ERCC2;RPA2;RPS27A;RBX1;GTF2H3;RFC4;UBA52;UBB;RFC1;DDB1;RPA3
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.3837137867134972,-0.7578776980923282,0.9375,1.0,1.0,3/16,14.41%,CHUK;EGFR;AKT1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.4505564317415679,0.7577960969610882,0.7702702702702703,1.0,1.0,5/9,31.92%,NAPEPLD;HNRNPU;PIM1;ZBTB7B;RREB1
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.496343352814978,0.7573258171266066,0.8309859154929577,1.0,1.0,1/6,5.97%,GRB10
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.34688755743072897,0.756601877537724,0.99,1.0,1.0,66/291,25.51%,EEF1A2;RPL23;EIF4A3;NR4A2;RPL37A;RPS6KB2;RBM3;NUP133;ADARB2;RPL38;COPS5;PAX8;RPS6;RPS27A;RPL23A;RPS25;TFIP11;RPS27;DARS1;NOVA1;CELF2;RPS11;RPS20;RPL9;RPLP2;RPS18;MRPL43;RBM5;RPL37;AGFG1;NXF1;RPL14;RPS4X;ANGPT2;SEH1L;RPL11;RPS24;MRPL27;MRPL55;HNRNPH1;POLR2D;RPS9;RPL36;HSPD1;POLR2G;RPS3A;MRPS14;MRPL3;RPL35;RPL4;EEF1A1;RPL32;MPHOSPH10;TNIP1;NDC1;HNRNPU;RPL3;RPL27A;RPL24;SRSF5;SRSF3;HNRNPH3;RPL12;RPL30;RPS16;RPL7
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.3470951720374934,-0.7565159799328648,0.8333333333333334,1.0,1.0,5/24,11.47%,NUP42;CCHCR1;TGFB1;SMURF1;NUP214
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.38497810332626337,0.7563852679427131,0.8295454545454546,1.0,1.0,5/46,15.03%,TRMT9B;FTSJ1;TRNT1;DDX1;TSEN54
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.34940223010095545,0.7562830327585912,1.0,1.0,1.0,51/346,21.33%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CD55;CHI3L1;GNS;SLC11A1;DGAT1;PGAM1;ACTR1B;SNAP25;MGAM;CKAP4;GSDMD;FGR;CD93;C5AR1;SPTAN1;ARSA;DYNC1H1;FGL2;GPI;LRRC7;NFASC;ACP3;PKM;SNAP29;CD300A;TNFRSF1B;ENPP4;ITGAV;MAGT1;ALAD;PYCARD;SDCBP;IQGAP1;LTA4H;ROCK1;FTH1;GSTP1;PRDX4;HSPA1B;STXBP2;PSMC2;AP2A2;SYNGR1;SURF4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3580224652822712,-0.75622079141274,0.6896551724137931,1.0,1.0,1/13,1.06%,TICAM1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.427503129583207,-0.7554373732775985,0.7435897435897436,1.0,1.0,1/6,2.03%,MYBL1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.38439962636389563,0.7553777622193762,0.8111111111111111,1.0,1.0,9/36,22.71%,TM7SF2;FAXDC2;ABCA1;PRKAG2;ABCA5;INSIG1;OSBPL5;CYP46A1;MSMO1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.4324542508747472,-0.7553029789456361,0.7575757575757576,1.0,1.0,3/6,14.06%,ABCG2;SLCO2B1;HMOX2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.4324542508747472,-0.7553029789456361,0.7575757575757576,1.0,1.0,3/6,14.06%,ABCG2;SLCO2B1;HMOX2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.43345327725958704,0.7549667271553235,0.8048780487804879,1.0,1.0,2/16,12.15%,ACSL1;ELOVL4
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.49330937424914595,0.7549662543373094,0.8378378378378378,1.0,1.0,3/8,26.47%,PAX8;FGFR2;TTC39C
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.44321328021563244,0.7549057370837083,0.8108108108108109,1.0,1.0,5/13,25.48%,VEGFA;PTN;THY1;TNF;JAM3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.3082499701804527,-0.7548890247974762,0.8461538461538461,1.0,1.0,9/29,17.54%,DAB2IP;EPS15L1;DUSP3;STAM2;EGFR;TGFA;PTPN12;CBL;CDC42
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.34427818269549093,0.7541431430718164,0.98989898989899,1.0,1.0,57/347,19.04%,THBS1;HTR2B;LRP2;FGF1;NLRP12;TGFB2;IFIT5;RPL23;NRG1;RELN;AGT;TFRC;KITLG;VEGFA;CHI3L1;TRAF2;NLGN1;INSR;IRS2;TRIM5;SEPTIN4;FN1;TXN;BOK;TRIM25;IQCJ-SCHIP1;FGR;NTRK3;IGF1R;SEMA5A;GPRC5B;NOD2;FLT1;PLK2;SASH1;NTRK2;RPS20;PINK1;RIPK2;DDX1;HCLS1;RPL37;ITGAV;PLXNB1;GAB1;RUNDC3A;WNT5A;SEH1L;NRG4;DHX33;ESR1;LITAF;PELI1;IQGAP1;CHD5;APP;ROCK1
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.29882830768334334,-0.7541360409843658,1.0,1.0,1.0,13/88,14.41%,RALB;GTF2F1;ACTB;IDE;BTBD1;TRIB3;NVL;SORL1;CRK;DISC1;DAB2;CTSZ;AKT1
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.3527834880009559,0.7540082495269383,0.9175257731958762,1.0,1.0,23/144,18.04%,RAP1GAP;NUDT4;PPP2R5B;TNS1;TFRC;MBOAT2;CA2;PPOX;PIGQ;ENDOD1;BNIP3L;BLVRB;NARF;MXI1;ALDH6A1;MPP1;RBM5;TMCC2;ALAD;PICALM;SDCBP;OSBP2;CCND3
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.497613778998103,0.7534290950060557,0.8235294117647058,1.0,1.0,2/6,15.23%,SEMA5A;STMN2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.37237684885290967,0.7533517598681225,0.9230769230769231,1.0,1.0,1/50,0.29%,THBS1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.42780026423001805,0.7532140456595816,0.7974683544303798,1.0,1.0,5/15,20.55%,CYP3A5;SLC5A9;FMO5;GBA3;GIPC2
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.43726569982970553,0.7530598365006647,0.8028169014084507,1.0,1.0,4/12,13.47%,MANF;OVOL2;OTOGL;BACE2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.47203512005727527,0.7529087117701233,0.8333333333333334,1.0,1.0,1/9,14.73%,BNIP3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.47539561580241135,0.7526161137760139,0.8311688311688312,1.0,1.0,3/10,23.60%,IMPACT;BAG3;JUN
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.4141208653651993,-0.7523234279007751,0.725,1.0,1.0,1/7,6.69%,DIP2A
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4692257253721336,0.7521216506069699,0.7887323943661971,1.0,1.0,1/8,16.82%,NDRG4
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.5226832378004916,0.7516380205065246,0.8450704225352113,1.0,1.0,2/7,16.60%,ARF6;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3740381579763404,0.7513002404745371,0.8947368421052632,1.0,1.0,18/62,25.63%,VEGFA;HIF1A;LIMD1;RPS27A;RBPJ;RBX1;PSMB4;HIF3A;EGLN3;UBA52;PSMC2;UBB;PSMA3;PSMB2;EPAS1;PSMD5;PSMD7;PSMA5
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.42392407047307856,0.7508328925584143,0.7710843373493976,1.0,1.0,4/13,25.57%,NPHP1;ROCK1;TNF;TJP1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.3500792802767714,0.7506100371196262,0.9263157894736842,1.0,1.0,9/92,11.85%,PIANP;TGFB2;IL15;CD22;CLEC2B;FCGR2B;FGR;SPPL2B;FCGR2C
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),0.4978884058282962,0.7505031575623057,0.8840579710144928,1.0,1.0,1/6,5.39%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.41635245609310206,0.7502360369678797,0.8051948051948052,1.0,1.0,5/17,16.09%,TFRC;PDE4B;PPM1E;FBP1;AIM2
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.3761188043797884,-0.7501799685102656,0.76,1.0,1.0,1/12,1.17%,PGM2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.4717924979078561,0.7501366727717895,0.821917808219178,1.0,1.0,1/11,7.36%,PGAM1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.46587564975074236,0.7499590819147481,0.8055555555555556,1.0,1.0,2/8,14.64%,PINK1;MCTP1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.4972644747875479,0.7496829428760431,0.8484848484848485,1.0,1.0,1/8,14.96%,NSF
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.41852177128126433,0.7496369890279988,0.8313253012048193,1.0,1.0,2/14,11.02%,TMEM161A;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.4683575831264032,0.7492981072026023,0.7792207792207793,1.0,1.0,1/7,6.84%,ANK3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.3844592980153352,-0.7490538207979772,0.8076923076923077,1.0,1.0,5/13,23.01%,ACTB;ARHGAP12;LRP6;DAG1;VCL
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.34590119966656446,0.7487804318732445,1.0,1.0,1.0,51/349,21.33%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CD55;CHI3L1;GNS;SLC11A1;DGAT1;PGAM1;ACTR1B;SNAP25;MGAM;CKAP4;GSDMD;FGR;CD93;C5AR1;SPTAN1;ARSA;DYNC1H1;FGL2;GPI;LRRC7;NFASC;ACP3;PKM;SNAP29;CD300A;TNFRSF1B;ENPP4;ITGAV;MAGT1;ALAD;PYCARD;SDCBP;IQGAP1;LTA4H;ROCK1;FTH1;GSTP1;PRDX4;HSPA1B;STXBP2;PSMC2;AP2A2;SYNGR1;SURF4
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.4272645743978951,0.7487687002258124,0.8194444444444444,1.0,1.0,4/13,14.75%,VEGFA;PTN;KDM1A;SMARCD3
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.42154094913894297,0.7487634052320826,0.8313253012048193,1.0,1.0,3/17,9.78%,COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.41593228388516407,-0.7486433452119398,0.7,1.0,1.0,4/8,18.26%,ABI3;CGAS;HMGA1;YPEL3
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.41593228388516407,-0.7486433452119398,0.7,1.0,1.0,4/8,18.26%,ABI3;CGAS;HMGA1;YPEL3
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.4759768916821743,0.7486323953643493,0.78125,1.0,1.0,2/5,38.73%,PLA2G4A;HADHA
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.3667414072204075,-0.7484497928581005,0.696969696969697,1.0,1.0,4/8,20.55%,VPS37B;CHMP2B;CHMP2A;TSG101
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.4560524151569315,0.748248431522369,0.8382352941176471,1.0,1.0,3/8,27.34%,STXBP2;FES;DNASE1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.4029791912093136,0.7480364064307582,0.7948717948717948,1.0,1.0,3/15,15.97%,ABCA2;ARG2;SPTLC2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.41789843558548967,0.7475581614821345,0.7951807228915663,1.0,1.0,2/17,18.34%,TTBK2;CC2D2A
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.444444405199557,0.7473506049146501,0.782051282051282,1.0,1.0,4/10,19.73%,TDG;NEIL1;UPP2;NEIL2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.40002974069899533,-0.7471452007674084,0.7619047619047619,1.0,1.0,4/8,28.29%,FAS;ATP6AP1;ATP6V1G1;ATG7
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3658653398890896,0.7469163034285474,0.9130434782608695,1.0,1.0,1/52,0.29%,THBS1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.4730252882508996,0.7463933269218934,0.7464788732394366,1.0,1.0,5/8,32.70%,SLC25A28;SLC39A14;SLC11A2;SLC39A8;SLC25A37
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.5062543657608877,0.7463724488789838,0.8285714285714286,1.0,1.0,3/8,21.95%,POU5F1;ESR1;TNF
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.3610663552331755,0.7462903118061175,0.9021739130434783,1.0,1.0,6/43,11.27%,ECM2;DOCK1;DOCK5;FN1;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.37700140443626273,0.7461812968437777,0.9,1.0,1.0,6/36,20.23%,TMEM161A;EYA2;NSMCE1;BRCA1;ERCC6;NPAS2
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3530709480495911,0.7458753201401735,0.8947368421052632,1.0,1.0,22/98,24.32%,HMGB2;H2BC11;ERCC2;RPA2;RPS27A;RBX1;PSMB4;CENPV;GTF2H3;ORC6;SART3;UBA52;PSMC2;UBB;PSMA3;PSMB2;TCF4;DDB1;ORC3;PSMD5;RPA3;PSMD7
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.4080020860367656,0.745515589052427,0.8266666666666667,1.0,1.0,7/21,24.36%,NLGN1;NLGN3;FCHO2;SYT1;AMPH;NLGN4X;RAB5A
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.49464051279546783,0.7454808316188858,0.8235294117647058,1.0,1.0,1/5,7.04%,SEC61B
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.43548921715253586,0.745434340004814,0.7894736842105263,1.0,1.0,2/16,10.91%,AGT;RBPJ
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.3614829774061648,0.7452717736789467,0.9166666666666666,1.0,1.0,17/88,21.44%,BRIP1;ERCC2;RPA2;COPS5;RPS27A;RBX1;GTF2H3;FAN1;RFC4;POLR2D;UVSSA;POLL;ERCC6;UBA52;UBB;POLR2G;RFC1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.4908475639920457,0.744843107934584,0.873015873015873,1.0,1.0,1/7,1.60%,TGFB2
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.3457516641125031,0.7447955124266581,0.9393939393939394,1.0,1.0,29/207,19.95%,HAUS6;TUBA4A;PRKAR2B;DZIP1;TUBB4A;LRGUK;TUBA1A;CEP152;TTBK2;RFX2;DYNC2LI1;NPHP1;ATAT1;CCDC39;RP2;IFT74;CFAP54;DYNC1H1;ABLIM3;SNX10;CKAP5;SNAP29;PKD1;TOGARAM1;TXNDC15;CC2D2A;KIF3A;DCTN1;MACIR
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.4601641873592479,0.7446527046295085,0.7916666666666666,1.0,1.0,1/8,12.57%,ERI2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.4601641873592479,0.7446527046295085,0.7916666666666666,1.0,1.0,1/8,12.57%,ERI2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.45541014556768966,0.744495187514184,0.8055555555555556,1.0,1.0,1/8,13.02%,SORBS1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.41575977737616093,-0.744369594302997,0.84,1.0,1.0,4/9,11.90%,RIPOR2;TREM2;CD53;TYROBP
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.4174923068742959,-0.7442941056371616,0.8214285714285714,1.0,1.0,1/6,9.77%,AGO1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.4156551711539623,-0.7441058669314602,0.75,1.0,1.0,2/8,7.65%,BUD23;RIOK1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3621342477841859,0.7439761767417037,0.9354838709677419,1.0,1.0,13/52,19.58%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;AIM2;WNT5A;PYCARD;HSPB1;APP;GSTP1;FOXP1
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.44657124177454055,0.7437878954094354,0.8194444444444444,1.0,1.0,3/8,29.70%,NPRL2;ATG5;MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.44657124177454055,0.7437878954094354,0.8194444444444444,1.0,1.0,3/8,29.70%,NPRL2;ATG5;MAP1LC3A
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.5041505978507241,0.7437158326429691,0.8311688311688312,1.0,1.0,4/8,27.50%,ARF6;EPB41L4B;IQSEC1;PTEN
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.34346240769497866,0.7437078127595865,1.0,1.0,1.0,51/350,21.33%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CD55;CHI3L1;GNS;SLC11A1;DGAT1;PGAM1;ACTR1B;SNAP25;MGAM;CKAP4;GSDMD;FGR;CD93;C5AR1;SPTAN1;ARSA;DYNC1H1;FGL2;GPI;LRRC7;NFASC;ACP3;PKM;SNAP29;CD300A;TNFRSF1B;ENPP4;ITGAV;MAGT1;ALAD;PYCARD;SDCBP;IQGAP1;LTA4H;ROCK1;FTH1;GSTP1;PRDX4;HSPA1B;STXBP2;PSMC2;AP2A2;SYNGR1;SURF4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.4469814070442095,0.7436842253686011,0.8115942028985508,1.0,1.0,5/12,25.33%,CEMIP;AKAP6;THY1;CX3CL1;TRPC1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.2535133013949559,-0.7430497111590486,1.0,1.0,1.0,25/75,23.33%,MRPL57;MRPS9;MRPL50;MRPL35;AURKAIP1;TUFM;MRPS11;FASTKD2;MRPS10;MRPL1;LARS2;MRPS30;CHCHD1;GADD45GIP1;MRPL4;MRPL16;MRPS35;MRPL37;MTIF3;MRPS23;GATC;MRPL18;MRPS33;MRPS18C;MRPS5
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.3380031125697203,-0.7426448085930522,0.7777777777777778,1.0,1.0,5/11,26.46%,ACO2;IDH3B;IREB2;IDH3G;IDH3A
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.45486167104174235,0.7419851257006523,0.8243243243243243,1.0,1.0,7/11,34.80%,EMC7;CAMLG;EMC10;EMC8;BAG6;EMC3;MMGT1
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.494086820204071,0.7415298874821092,0.8194444444444444,1.0,1.0,2/6,28.50%,DHX33;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.44325222247498974,0.7413765573028377,0.8243243243243243,1.0,1.0,3/11,10.66%,TLE1;PDK4;MCL1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.34095439898877933,-0.7412656467648918,0.6666666666666666,1.0,1.0,8/33,12.69%,NPC2;TTC39B;NPC1;LIMA1;LPL;LAMTOR1;NR1H3;LIPG
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.34095439898877933,-0.7412656467648918,0.6666666666666666,1.0,1.0,8/33,12.69%,NPC2;TTC39B;NPC1;LIMA1;LPL;LAMTOR1;NR1H3;LIPG
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.49139853053673505,0.7409191974511253,0.8461538461538461,1.0,1.0,4/7,33.79%,TRIM16;MACROH2A2;MACROH2A1;NCOA3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.49139853053673505,0.7409191974511253,0.8461538461538461,1.0,1.0,4/7,33.79%,TRIM16;MACROH2A2;MACROH2A1;NCOA3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.30474439547465065,-0.7406518157002356,0.8947368421052632,1.0,1.0,4/26,9.11%,FAIM;BCL2L1;ICAM1;TNFSF10
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.4399579393450818,-0.7405319364348023,0.7142857142857143,1.0,1.0,2/5,11.34%,ELAVL4;METTL16
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.41392033643972814,0.7404930135188913,0.825,1.0,1.0,8/23,36.11%,RUVBL2;ATAT1;MORF4L2;TAF6L;BAG6;MSL3;KAT2B;BRD8
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.45219747885943073,0.7404863082858362,0.7702702702702703,1.0,1.0,2/12,6.70%,CHI3L1;TRAF2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.3411451096201193,0.7402182686421042,1.0,1.0,1.0,102/564,23.74%,KLF4;NAMPT;MACC1;FGF1;ST18;TGFB2;NFIX;EGR1;PFKM;PLAC8;HMGB2;NR4A2;NR4A1;NFIB;MEIS2;RORB;ACVR2A;BMPR1B;ASXL3;VEGFA;SOX4;RXRB;IER5;SLC11A1;ARNT2;CSRNP3;COPS5;HSF2;HIF1A;HCFC1;RUVBL2;PAX8;POU5F1;SS18L1;RRP1B;FOSL2;RPS27A;RBPJ;KDM1A;PTOV1;NR2F1;PER1;CRTC3;NOD2;ATAD2;GABPB1;NR4A3;DCAF6;CSRNP2;HINFP;ZNF143;DRAP1;CCNC;RIPK2;BRCA1;SMARCD3;DPF3;E2F7;HCLS1;PKD1;LDB2;TXK;WNT5A;ESR1;AKIRIN1;LITAF;NR2C2;APP;RGCC;TBL1XR1;ZBTB18;SMAD1;KLF7;PPARA;UBA52;NPAS2;TNFRSF1A;UBB;TAF7;CDK9;BEX1;KDM6B;SLC9A1;PRDM15;PRPF6;SMAD5;PCGF5;IL18;TNF;TCF4;NR1D1;STAT1;FGFR2;TNIP1;FOS;EPAS1;ATF3;MTF1;SMARCD2;JUN;GNL3;SFPQ
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.5156449397910392,0.7401788695416853,0.8507462686567164,1.0,1.0,3/5,41.93%,PRMT1;NDUFAF5;PADI2
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3397721735103044,0.7401072452220173,0.96,1.0,1.0,37/281,18.71%,NFIL3;ACVR1B;SAP30;RORB;PQBP1;SOX4;TCF7;APBB3;HINT1;ARNT2;INSR;HIF1A;HCFC1;GLRX2;FOXN2;ZKSCAN5;TCF7L1;POU5F1;MAFB;BHLHE40;LIMD1;CELSR2;ZNF536;TULP3;SOX6;HINFP;ZNF143;DRAP1;HCLS1;YAF2;ACTR5;MLF2;ESRRG;ESR1;NKX6-2;NR2C2;CXXC1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.4635863517613352,0.739955256821376,0.8902439024390244,1.0,1.0,4/9,23.95%,SEMA5A;EPHA4;CDK5R1;RTN4
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.39346990331962206,0.7399445316071074,0.8064516129032258,1.0,1.0,7/30,23.24%,SH3D19;PINK1;TNFRSF1B;ASPH;ATP5IF1;TNF;TNIP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.5199677193642278,0.7399409227575363,0.8441558441558441,1.0,1.0,2/5,10.37%,DOCK5;CHRM3
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.4077273422027871,-0.7397718613565744,0.7931034482758621,1.0,1.0,2/8,15.37%,PHB2;BECN1
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.4850729983040662,0.7397485495705904,0.8260869565217391,1.0,1.0,4/6,43.25%,MTHFD1;GOT1;PLOD2;MTR
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.395060569272522,0.7396688354546017,0.7692307692307693,1.0,1.0,6/20,24.16%,TXN;PINK1;SOD2;HSPB1;FBXO7;LRRK2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.469365142453049,0.7396100843123284,0.8356164383561644,1.0,1.0,2/7,11.42%,INSR;IGF1R
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.4128089001196007,0.7393156114337421,0.8076923076923077,1.0,1.0,4/13,20.52%,FGR;CD300A;STXBP2;FES
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.48074079545025733,0.7390969691491811,0.8591549295774648,1.0,1.0,2/7,6.28%,RELN;SOX4
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.39977144828413835,0.7389223929364677,0.9,1.0,1.0,1/26,1.07%,SLC38A4
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.4462664841692377,0.7386775206656138,0.8656716417910447,1.0,1.0,3/9,31.57%,SORBS1;ECHDC3;ZBTB7B
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.4621671046750282,0.7386568920885128,0.8,1.0,1.0,3/6,19.73%,TDG;NEIL1;NEIL2
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.45661233024071124,0.7386122818946199,0.8266666666666667,1.0,1.0,5/9,30.97%,CMPK1;NMNAT2;AK5;PNP;ME1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.2825019587903558,-0.738590132197011,1.0,1.0,1.0,8/40,12.39%,PIDD1;BTG2;TP53;ZNF385A;EP300;CNOT6L;PLK3;PLAGL1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.3997792186055166,-0.7384187585768732,0.8148148148148148,1.0,1.0,2/11,6.49%,APPL2;TRIB3
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.47416220362021744,0.7382832355802992,0.8260869565217391,1.0,1.0,2/9,7.76%,GAS2L3;BAIAP2L1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.3817028422866212,0.7380680492006974,0.8571428571428571,1.0,1.0,5/32,13.26%,SLCO1A2;SLC4A10;CA2;SLCO3A1;SLC35A1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.351577396503683,0.7379322466636282,0.9175257731958762,1.0,1.0,27/103,31.23%,GEMIN2;RPL38;RPL23A;RPS27;CELF2;DDX1;MRPL20;RBM5;RPL11;POLR2D;SHQ1;SART3;PRPF6;NOP53;SNRPD2;RPL3;RPL24;SRSF5;EIF3A;TRAF7;SRSF9;HSP90AB1;CPSF6;PRPF19;RPL6;RPLP0;PRKDC
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.4255777253087631,0.7378925542939436,0.8414634146341463,1.0,1.0,8/16,34.50%,SPAST;DCTN1;UBXN2B;CHMP7;NSFL1C;CHMP4B;NEMP1;TARDBP
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.4384675264733138,-0.7375570567889477,0.7741935483870968,1.0,1.0,4/7,24.41%,EXOSC10;EXOSC9;EXOSC8;XRN1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.405385899493588,-0.7371109313346667,0.7777777777777778,1.0,1.0,2/12,8.58%,HPGDS;GSTM4
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.405385899493588,-0.7371109313346667,0.7777777777777778,1.0,1.0,2/12,8.58%,HPGDS;GSTM4
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.3460450672878874,-0.7370364324833586,0.9090909090909091,1.0,1.0,4/16,11.90%,CSF1R;SRC;TREM2;TYROBP
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.3672871849116477,0.7369855161117026,0.8829787234042553,1.0,1.0,8/51,19.79%,SYNE3;ZDHHC15;VPS37C;PARD3;ZDHHC9;SDCBP;NACA;AQP11
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),-0.4439468982087247,-0.7369018958476447,0.8055555555555556,1.0,1.0,1/5,4.02%,LGALS9
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.30478585829434424,-0.7365860471937064,1.0,1.0,1.0,6/18,10.00%,LLGL2;PLEK;LCP1;FMNL3;NCKAP1L;IKBKB
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.4680063471252079,0.7362900630046415,0.8285714285714286,1.0,1.0,2/7,37.58%,ZCCHC3;DHX58
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.42629887070635575,0.7362005756920822,0.8311688311688312,1.0,1.0,3/13,19.30%,THBD;TXK;TEC
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.34904838548368833,-0.7356765529251241,0.8064516129032258,1.0,1.0,4/10,15.98%,MTLN;LPL;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.42967582044255964,0.7348400834049508,0.8513513513513513,1.0,1.0,3/9,30.99%,CDK9;BARD1;CTR9
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.37252325391717983,0.7347643888557774,0.8690476190476191,1.0,1.0,8/36,25.47%,NUP133;REEP3;SEH1L;SUN2;NDC1;CHMP5;PDCD6IP;CHMP7
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.30990307813702256,-0.7347435106331281,0.8571428571428571,1.0,1.0,5/28,10.92%,AZIN2;APH1A;SSBP1;CHTOP;ABL1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.4332529184139937,-0.7344116997165874,0.6857142857142857,1.0,1.0,2/5,24.17%,TIRAP;CYBA
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.3870191473873873,0.7337450483833012,0.8021978021978022,1.0,1.0,8/25,17.91%,HTR2B;NTRK3;C5AR1;FLT1;NTRK2;RASGRP4;TXK;ESR1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.43528898886124834,0.7336888585424942,0.8378378378378378,1.0,1.0,2/14,20.06%,SEMA5A;PPARA
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.3236823443869758,-0.7335663526145719,0.75,1.0,1.0,2/19,2.05%,TTC39B;ARV1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.3673703532880304,0.733215108668154,0.8681318681318682,1.0,1.0,6/42,12.11%,TGFB2;PHLPP1;COPS5;IGF1R;PER1;NOD2
prerank,PanglaoDB_Augmented_2021__Platelets,0.34017232917568996,0.7332100342578104,0.9791666666666666,1.0,1.0,21/143,15.16%,THBS1;SPARC;CLEC12A;PRKAR2B;SLC2A3;ITGA2;ALOX12;SRGN;VEGFA;F13A1;FHL1;CA2;SIRPB2;PALLD;FGR;CD93;NOD2;FGL2;CD300A;HCLS1;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.4630923583829438,0.7329968894022182,0.8266666666666667,1.0,1.0,1/7,10.69%,CAV3
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3636937237484859,0.7327641502360334,0.8541666666666666,1.0,1.0,20/55,31.48%,EIF2AK3;SEC61B;VAPB;VCPIP1;SERP1;REEP3;UBE2J2;APP;RTN3;REEP2;RTN4;LRRK2;BNIP1;REEP1;TMEM33;VAPA;HMOX1;PRNP;SEC31A;MIA3
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.2890028744446113,-0.7326560932737627,0.8947368421052632,1.0,1.0,5/24,11.13%,TTC39B;LAMTOR1;TREM2;NR1H3;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5061143480018935,0.7324534117370405,0.828125,1.0,1.0,1/5,7.62%,SEMA6A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.2809566885660389,-0.7323182245775182,1.0,1.0,1.0,17/76,13.32%,CD2;CX3CR1;IL1A;LGALS9;TMEM106A;IGF1;LPL;SIRPA;HLA-E;TLR3;HAVCR2;OAS2;TYROBP;NLRC3;MAPKAPK2;ILRUN;SYK
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.3506903458150423,0.7322681972448131,0.9052631578947369,1.0,1.0,19/83,28.96%,TRAF2;NUP133;WASF1;DARS1;PPID;PARD3;SEH1L;PICALM;FANCA;DLG4;KNTC1;NAPG;NDC1;HFE;REPS2;RIMS1;PPARGC1A;NDUFAF1;PTK2B
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.4122744115148316,-0.7320502548585488,0.8571428571428571,1.0,1.0,2/6,8.50%,SLC30A5;PHB2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.48715094792729446,0.7317331157558239,0.9090909090909091,1.0,1.0,1/6,9.51%,ID2
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.32457325919988084,-0.7314421444639027,0.9333333333333333,1.0,1.0,6/31,10.27%,RAB22A;PLEKHJ1;LAPTM4B;LAMTOR1;WASHC5;CHMP2B
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.4624707814215685,0.7314381709619472,0.7910447761194029,1.0,1.0,1/5,13.37%,MAGI2
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.4077366607888596,0.7313658210000632,0.8292682926829268,1.0,1.0,3/16,10.69%,GPM6B;PXK;CAV3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.36887538296553235,0.7309213968630561,0.8390804597701149,1.0,1.0,1/29,0.29%,THBS1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.410068487056719,0.7307705482685365,0.88,1.0,1.0,1/18,2.77%,HMGB2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.35087706272698016,-0.7305172504962704,0.7857142857142857,1.0,1.0,2/12,5.28%,MYBL1;APOBEC3G
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.3917939676238632,0.7304748743144918,0.813953488372093,1.0,1.0,4/25,8.33%,GULP1;DOCK1;FCGR2B;SPIRE2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.42026699668009904,0.7303976824337134,0.7837837837837838,1.0,1.0,1/13,8.62%,IFNLR1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.39016206566177514,0.7301141991715585,0.9125,1.0,1.0,11/28,27.75%,CAV3;TCHP;PINK1;BRCA1;TMEM39A;ODF2L;LRRK2;CDK10;MTM1;LIMK2;CCP110
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.4841917930752399,0.7299795624682441,0.8548387096774194,1.0,1.0,1/5,4.75%,ARF6
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3569878676753697,0.729561906947416,0.8947368421052632,1.0,1.0,18/82,24.47%,ST18;EGR1;MAP3K8;RPS27A;NOD2;RBX1;PSMB4;RIPK2;PLCB1;PELI1;UBA52;PSMC2;UBB;PSMA3;PSMB2;PSMD5;PSMD7;MAP3K3
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.2596877187882399,-0.7295486653810325,1.0,1.0,1.0,13/80,14.38%,NUP42;LOXL3;NNAT;NUP155;EP300;VCPKMT;NDUFAB1;RAE1;NUP214;NUP188;SENP6;HDAC10;SENP1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.46511314589241837,0.7292527693625541,0.84375,1.0,1.0,2/6,16.75%,PTN;WNT5A
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.4362746133370917,0.7292243090060525,0.8082191780821918,1.0,1.0,1/10,4.16%,MYRF
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.2488804393280113,-0.7291927799362127,1.0,1.0,1.0,21/97,18.18%,ZFYVE1;STAM2;MTMR14;RUBCNL;PIP4K2B;VTA1;PLEKHM1;WIPI1;SRC;VPS37B;CHMP2B;ATG12;ILRUN;HDAC10;TECPR1;BECN1;VTI1B;VDAC1;CSNK2A2;ACBD5;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.4546614363208232,0.7290892763447674,0.8055555555555556,1.0,1.0,5/7,31.92%,NAPEPLD;HNRNPU;PIM1;ZBTB7B;RREB1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.34123473128028536,-0.7282883282828125,0.8571428571428571,1.0,1.0,5/10,16.39%,COPS7B;COPS8;COPS7A;COPS2;COPS6
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.45100284692445247,0.7281850749719423,0.8356164383561644,1.0,1.0,2/8,19.90%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.45100284692445247,0.7281850749719423,0.8356164383561644,1.0,1.0,2/8,19.90%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),0.4785681655520532,0.7277005664068092,0.8524590163934426,1.0,1.0,1/5,9.71%,POU5F1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.4450314771324839,0.7276719053522488,0.7846153846153846,1.0,1.0,2/7,19.12%,MID1IP1;GSTP1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.38436584336601654,0.7275837093738603,0.825,1.0,1.0,3/23,11.59%,NOCT;SLC11A1;TENT5A
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.3640761963910401,0.727466149666206,0.9213483146067416,1.0,1.0,4/49,8.16%,THBS1;GPM6B;ADAM15;EPHA3
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.45420339224258355,0.7274516207094603,0.7733333333333333,1.0,1.0,3/9,22.36%,BOK;TMEM14A;HIP1R
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.4616372102662089,0.7273645992017886,0.8805970149253731,1.0,1.0,3/7,20.06%,IRS2;NR4A3;PPARA
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.4697860802660054,0.7270227073051713,0.8356164383561644,1.0,1.0,1/6,4.75%,ARF6
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.4697860802660054,0.7270227073051713,0.8356164383561644,1.0,1.0,1/6,4.75%,ARF6
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.3405929997374981,0.7267001041947417,0.9368421052631579,1.0,1.0,2/69,1.04%,RAB7B;NLRP12
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.40133607767432583,0.7265108605802942,0.9186046511627907,1.0,1.0,7/25,25.04%,GPM6B;ABCA2;CAV3;PICALM;TNF;HFE;MAP1A
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.4408395836332032,0.7264951329866955,0.8028169014084507,1.0,1.0,2/9,23.99%,KDM1A;HNRNPU
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.3857620270369992,0.7264664892472016,0.9090909090909091,1.0,1.0,7/35,17.58%,SPOCK1;AGT;PRELID1;SPOCK3;SERPINE2;PICALM;TIMP3
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.2949207066759881,-0.7263360881159517,1.0,1.0,1.0,2/17,9.82%,GANC;ST8SIA4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.32387087251472546,-0.7260023360056392,0.9166666666666666,1.0,1.0,7/23,15.39%,DAB2IP;TRIB3;MAP3K5;QRICH1;DNAJC10;ATP2A3;BCL2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.38978292335964915,0.7257084579593156,0.8356164383561644,1.0,1.0,2/23,5.93%,KLF4;VEGFA
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.4592077917596841,0.7256642998019313,0.8656716417910447,1.0,1.0,3/7,25.94%,KDM1A;KDM5B;KDM5C
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.3985398108156468,-0.7255586713318607,0.75,1.0,1.0,3/7,14.52%,ICAM1;RIPOR2;PLVAP
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.4437515254072801,0.7255291654468085,0.8026315789473685,1.0,1.0,2/10,25.14%,CARMIL1;TWF1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.44915729656313996,0.7252845489576686,0.8405797101449275,1.0,1.0,4/7,18.56%,B4GALT5;PLCB1;CFL1;NR2C2
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.45997078372422695,0.7251481120123828,0.8904109589041096,1.0,1.0,1/8,21.77%,CPEB4
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.27833360140900437,-0.724865094138571,0.8947368421052632,1.0,1.0,8/21,18.33%,TAF13;HELB;TTF1;GTF2B;PRIM1;TTF2;TBP;TCEA2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.4005003902596026,0.7247329356791957,0.8311688311688312,1.0,1.0,6/15,29.65%,SYT4;SYT1;SYT11;KCNB1;SCAMP5;SYT9
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.3820684017552046,-0.7243281326288846,0.8333333333333334,1.0,1.0,2/11,8.39%,TPRKB;TEP1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.3607028239910436,-0.7241331748679056,0.8181818181818182,1.0,1.0,3/14,20.02%,BRCC3;ENY2;TRRAP
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.39978341534624706,0.7240934285601993,0.8309859154929577,1.0,1.0,1/14,5.13%,ALOX12
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.36202445455491006,0.7240699016831755,0.8494623655913979,1.0,1.0,4/40,10.36%,AGT;TRAF2;SEPTIN4;BOK
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.39261351152213775,0.7238554773789517,0.8571428571428571,1.0,1.0,5/18,23.04%,PAICS;PRPS1;DCK;HPRT1;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.3653069031584172,-0.723841025924933,0.8148148148148148,1.0,1.0,2/11,9.29%,FSCN1;TGFB1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4382332957552312,0.7234945825341536,0.8918918918918919,1.0,1.0,3/11,15.10%,HSPA5;COPS5;DNAJB9
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3603837443405151,0.7233580944142388,0.8947368421052632,1.0,1.0,4/68,7.61%,THBS1;ASPN;VASN;SPRY1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.3858974353682384,0.7233284345788807,0.872093023255814,1.0,1.0,3/26,12.91%,TCF7;RBPJ;GNAI1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.35446955077817033,0.7232119729630884,0.9333333333333333,1.0,1.0,14/63,25.97%,RNF144B;HERPUD1;PRICKLE1;RNF144A;ARIH2;RBX1;DNAJB2;HSPA1B;NOP53;FZR1;LRRK2;BBS7;USP5;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.44674459911442954,0.7226416551945772,0.855072463768116,1.0,1.0,2/8,13.33%,PPP2R5A;PIK3IP1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.39030667508944555,0.7224318587325694,0.8953488372093024,1.0,1.0,6/24,20.36%,FCGR2B;NOD2;PDCD1LG2;PYCARD;TNFRSF21;HSPD1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.3644743265658588,0.7224136891933619,0.9010989010989011,1.0,1.0,8/59,19.33%,INSR;IRS2;RAB15;SORBS1;PKM;INSIG1;CPEB2;SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.39892983077392563,0.7222071136577356,0.9024390243902439,1.0,1.0,7/29,27.14%,CR1;TYRO3;SUSD4;STAT2;SLAMF8;FAM3A;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.4711034439644262,0.7213251021635985,0.8666666666666667,1.0,1.0,1/6,7.02%,FCGR2B
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.43052053556755443,0.7209022765061555,0.8674698795180723,1.0,1.0,2/14,16.40%,ALOX12;SERPINE2
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.42069115471310425,0.7208693065834049,0.8375,1.0,1.0,1/18,1.98%,SHANK3
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.3992181524910139,0.7207796201447214,0.8148148148148148,1.0,1.0,1/21,2.92%,WDR5
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.344069922009901,0.7207714416644756,0.8666666666666667,1.0,1.0,9/44,21.25%,ZDHHC15;PIGU;PIGQ;GLUL;ZDHHC9;PIGF;UGCG;PIGL;PIGG
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.4153918073216936,0.7206245298747036,0.8450704225352113,1.0,1.0,5/12,32.35%,CDK9;METTL4;HNRNPU;TLK1;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.30535628141614984,-0.7206016483610108,0.8235294117647058,1.0,1.0,6/21,19.49%,TP53;TGFB1;EGFR;DDX5;FMR1;ZFP36
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.35655428163457414,0.7205335684304207,0.9456521739130435,1.0,1.0,10/58,15.93%,LRP2;GRIN3A;SLC11A1;RYR2;CACNA1B;TUSC3;TRPC4;SLC24A1;RYR3;MAGT1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.468991893983656,-0.7204146332527843,0.7941176470588235,1.0,1.0,1/6,0.58%,CYB5A
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.43051005724773517,-0.7203215541205668,0.7878787878787878,1.0,1.0,3/7,21.96%,SERPINB9;RAB7A;RNF213
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.43159188857938774,-0.7202933659172247,0.7419354838709677,1.0,1.0,2/7,11.28%,DAGLB;PTGS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.4823177244593079,-0.7202207958197085,0.7666666666666667,1.0,1.0,2/5,9.29%,EFNB2;TGFB1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3504660606021461,0.7200500039381936,0.9340659340659341,1.0,1.0,7/53,19.04%,DOCK1;VEGFA;SHC2;FLT1;ITGAV;HSPB1;ROCK1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.33618978724735904,0.7198432406343118,0.9578947368421052,1.0,1.0,11/120,12.76%,VIM;TBRG4;RIDA;NOCT;SLC11A1;CARHSP1;PCBP4;XPO1;RPS27A;TENT5A;PSMB4
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.35374844195627597,0.7196279046826412,0.9,1.0,1.0,17/56,28.05%,RPA2;XRCC3;NSMCE1;BRCA1;POLQ;FAN1;POLL;SWI5;RNF138;RBBP8;RPA3;SFPQ;SLX4;PSMD14;RAD54B;SPIDR;REV3L
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.3706618315936197,-0.7195571723816709,0.88,1.0,1.0,2/8,8.34%,LIMA1;PLEK
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.44077965211320974,0.7192555159316691,0.9117647058823529,1.0,1.0,2/9,15.97%,ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.44077965211320974,0.7192555159316691,0.9117647058823529,1.0,1.0,2/9,15.97%,ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.3641803126447358,-0.7189588716585386,0.8,1.0,1.0,2/14,6.92%,CD300LF;SIRPA
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3553619717641334,0.7189326441229831,0.8736842105263158,1.0,1.0,9/58,15.11%,ENPP2;RELN;IL15;AGT;VEGFA;GHR;EPHA7;RIPK2;HCLS1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.38730773024100495,0.7188112509486916,0.8620689655172413,1.0,1.0,6/27,28.83%,ANXA1;CALCOCO2;SURF4;FYCO1;PPARGC1A;PFDN2
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.3488762542401509,-0.7187755577582745,0.9130434782608695,1.0,1.0,2/18,1.23%,CX3CR1;ITGAM
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.34357641573121706,-0.7186665150986824,0.8571428571428571,1.0,1.0,4/21,8.50%,PSME3;STXBP4;APPL2;PHB2
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.4016631142647933,-0.7185382290109447,0.71875,1.0,1.0,2/6,13.34%,SLC15A3;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.39818964973870424,0.7183952217738848,0.8666666666666667,1.0,1.0,1/20,3.06%,CADM1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3587031233710923,0.7182648543517443,0.8850574712643678,1.0,1.0,7/56,15.55%,THBS1;TRAF2;EYA2;FAIM2;MCL1;BRCA1;ITGAV
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.4126056737337914,0.7177069723450844,0.8378378378378378,1.0,1.0,4/14,8.59%,TOM1L1;BAIAP2L1;ADGRG6;PKP2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.3318566569100546,-0.7175348060624942,0.8,1.0,1.0,13/13,66.86%,KPNA6;IPO5;NUP35;KPNA3;RGPD8;KPNA4;KPNA2;CBLB;KPNB1;KPNA1;NUP54;RANBP2;KPNA5
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.40321868125099614,0.7173636790839788,0.8378378378378378,1.0,1.0,6/14,27.86%,B4GALT5;APP;MTCH1;CX3CL1;ADGRB3;B4GALT6
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.35496662528082684,0.7173346473690173,0.8947368421052632,1.0,1.0,18/60,23.94%,AGT;RGS2;SPRY1;SEMA6A;CAMK2N1;PAQR3;CAV3;LMO3;CD300A;PEBP1;DUSP10;TIMP3;GSTP1;PRDM15;DUSP6;UCHL1;TNIP1;PTPRR
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.482000843670359,0.7171623013392963,0.9014084507042254,1.0,1.0,2/6,8.93%,ROBO2;ALCAM
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.3374444349447264,0.7171522776188316,0.9797979797979798,1.0,1.0,36/214,19.81%,HTR2B;RAB7B;EGR1;CADM1;IL15;AGT;PQBP1;ALOX15B;ANXA1;POLR3F;CHI3L1;TRAF2;EIF2AK3;SLC11A1;IL7;HIF1A;FGR;POLR1C;SULF2;NOD2;PDE4B;RIPK2;BRCA1;POLR3H;TXK;WNT5A;PYCARD;DHX33;PLCB1;TMED10;SOD1;SPTBN1;APP;RGCC;FOXP1;HSPA1B
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3892875162906246,0.7167572123167367,0.8505747126436781,1.0,1.0,9/30,33.64%,FANCM;EME2;DONSON;CDK9;TIMELESS;ETAA1;BLM;ATR;ZRANB3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4061676041859077,0.7166812886577667,0.8378378378378378,1.0,1.0,4/18,15.56%,ERCC2;RPA2;RBX1;GTF2H3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4061676041859077,0.7166812886577667,0.8378378378378378,1.0,1.0,4/18,15.56%,ERCC2;RPA2;RBX1;GTF2H3
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.460702478582209,0.716201187386998,0.8648648648648649,1.0,1.0,1/7,2.03%,AMER2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.4068348200204823,-0.7159298114822027,0.7391304347826086,1.0,1.0,1/7,8.11%,HLA-E
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.43754421866455107,0.7154482001986144,0.8309859154929577,1.0,1.0,2/10,11.42%,INSR;IGF1R
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.4414925883067413,0.7153324628587029,0.8904109589041096,1.0,1.0,3/9,18.70%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.36883672403061896,-0.7152721387986362,0.84375,1.0,1.0,4/12,20.34%,NBN;TERF2;SMG6;ERCC4
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.3734945309403447,-0.7150793915042594,0.84375,1.0,1.0,3/10,15.05%,PMEPA1;ZMIZ1;DDX5
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.460741734990126,0.7147608816318998,0.9066666666666666,1.0,1.0,3/7,22.55%,SMAD1;SMAD5;NOTCH2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.45375397921557914,0.7147216683462232,0.8701298701298701,1.0,1.0,2/9,4.50%,NUDT16;ENTPD3
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.33650790614625575,-0.7142715529847119,0.8275862068965517,1.0,1.0,5/13,13.46%,GCLC;ALDH5A1;GOT2;ALDH18A1;GCLM
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.4473645127488147,0.7142650848786185,0.8461538461538461,1.0,1.0,5/10,27.64%,SLC11A1;TRPC4;SLC39A14;TRPC1;SLC11A2
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3658201702195513,0.7135176695926579,0.9239130434782609,1.0,1.0,6/43,15.09%,CBR1;ANXA1;VEGFA;OVOL2;CPT1A;E2F7
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.3091425984835012,-0.7134939208501868,0.8620689655172413,1.0,1.0,3/13,20.92%,ZDHHC2;CENATAC;CHEK2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.4069336530822414,-0.7126702172701568,0.7916666666666666,1.0,1.0,1/9,6.56%,RAPGEF6
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.3646182379387658,-0.7125207810979499,0.76,1.0,1.0,1/10,3.25%,BCL2L1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.4404330520217362,0.712463105946756,0.8571428571428571,1.0,1.0,2/11,14.06%,PLK2;INTS3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3469760193261736,0.7124070123450423,0.8804347826086957,1.0,1.0,15/64,25.97%,RNF144B;CAV3;PRICKLE1;RNF144A;ARIH2;RBX1;DNAJB2;RNF139;HSPA1B;NOP53;LRRK2;BBS7;MAGEF1;USP5;DDRGK1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.36900298034239537,0.712366391756174,0.8809523809523809,1.0,1.0,9/40,20.67%,ERCC2;ANXA1;RPS27A;RBX1;DDX1;GTF2H3;MCMDC2;UBA52;UBB
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.35738585464284917,0.7122430390086033,0.945054945054945,1.0,1.0,16/61,23.50%,ERCC2;RPA2;COPS5;RPS27A;RBX1;GTF2H3;RFC4;POLR2D;UVSSA;ERCC6;UBA52;UBB;POLR2G;RFC1;DDB1;RPA3
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3301772686109846,0.712169771419939,0.9479166666666666,1.0,1.0,10/96,12.76%,DKK2;GPC5;DAAM2;SOX4;PTK7;KANK1;GSKIP;SEMA5A;GPRC5B;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.31919746177267294,-0.7119527472628664,0.9375,1.0,1.0,5/16,13.41%,TTC39B;TREM2;NR1H3;NFKBIA;PPARD
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.37465956556868774,0.7118784507260953,0.8876404494382022,1.0,1.0,10/31,23.94%,SPRY1;SEMA6A;CAMK2N1;LMO3;DUSP10;TIMP3;GSTP1;DUSP6;TNIP1;PTPRR
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.4126117466410141,0.7118157778456363,0.84,1.0,1.0,2/10,15.92%,NUP133;NXF1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.35381995003811545,0.7115853796874353,0.9263157894736842,1.0,1.0,5/57,8.16%,PRKCE;CLIP3;ARF6;PPP2R5A;EPHA3
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4375326353398329,0.7109004888635827,0.8625,1.0,1.0,3/14,7.95%,VASN;SPRY1;OVOL2
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.43688583342244913,0.710611769213006,0.88,1.0,1.0,4/11,23.05%,LRGUK;CCDC39;TOGARAM1;DNAAF2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.45040934886877243,0.7105179752734544,0.8823529411764706,1.0,1.0,4/9,35.81%,TRIM16;EZH2;KLF2;DHRS3
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.33029366537508836,-0.710206737789065,0.9,1.0,1.0,5/17,19.20%,CBFB;RAPGEF1;RAP1A;MEF2C;PRKACA
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.31487267507951155,0.7100776760150983,1.0,1.0,1.0,64/300,28.65%,MKRN3;H2BC11;FBXL7;ENC1;PIAS4;FBXL2;NUP133;HIF1A;VPS11;TRIM5;RPS27A;GAN;RNF144A;ARIH2;RBX1;HIF3A;PINK1;BRCA1;VCPIP1;UHRF2;UBE2M;RLIM;SYVN1;RNF139;TRIM26;SEH1L;KLHL8;DTX3;KIAA1586;UBE2J2;KLHL2;UVSSA;HECW2;FBXL5;UBA52;BCL11A;UBB;FBXO7;TRIM14;C10ORF90;RNF138;DDB1;EPAS1;BARD1;HACE1;NDC1;TRIM24;MAGEF1;UBE2D2;UHRF1;USP5;DTX2;DDRGK1;RNF220;POM121;PEX10;SAE1;TRAF7;TNFAIP1;TRIM52;RAD18;NUP58;KCTD13;UBR2
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.3972240277103183,-0.7097953416415267,0.7941176470588235,1.0,1.0,1/5,10.46%,MAML1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.40826411749720903,0.7094878603111142,0.9078947368421053,1.0,1.0,2/12,15.97%,ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.3684803377743863,0.709396929991872,0.8850574712643678,1.0,1.0,8/34,15.98%,AGT;RGS2;SPRY1;PAQR3;CAV3;CD300A;DUSP10;AIDA
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.4665561618648352,0.709367556371862,0.821917808219178,1.0,1.0,2/6,28.74%,KDM6B;PROX1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.33951898313817686,0.7091214220551408,0.9318181818181818,1.0,1.0,16/75,23.92%,GFAP;DTL;EEF1A2;FMN2;PLK2;NSF;APC2;WNT5A;CDKN1B;HECW2;TNF;EEF1A1;DDB1;BARD1;HACE1;FZR1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.33430876304966783,-0.7079922968546649,1.0,1.0,1.0,10/10,66.60%,TERF2;TPP1;TNKS;XRCC5;ATRX;POT1;BRCA2;TNKS2;TERF2IP;ATR
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.34258465372964614,0.7079660368612261,0.8723404255319149,1.0,1.0,12/50,27.75%,TBC1D8;TBC1D13;DYNC2LI1;TCHP;TBC1D15;ODF2L;TBC1D2;ATG5;TBC1D14;CDK10;LIMK2;CCP110
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.43163284884673886,-0.707869293329606,0.75,1.0,1.0,1/5,5.75%,ATPAF2
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.34793348179135436,0.7077962715664874,0.9270833333333334,1.0,1.0,9/109,8.52%,RHOB;RACGAP1;RELN;CGNL1;TRIP10;ARHGAP23;ARHGEF4;CHN1;NGEF
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.40814610826879794,0.7076421187806848,0.8933333333333333,1.0,1.0,3/12,20.04%,ERRFI1;ROCK1;KLF7
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.36546149731622024,-0.7074233974939057,0.8636363636363636,1.0,1.0,1/7,2.33%,DHODH
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.38099208622993264,0.7073372896612412,0.8817204301075269,1.0,1.0,2/24,11.63%,NGDN;RRP36
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4197101632001172,0.7073041078879719,0.8461538461538461,1.0,1.0,4/12,20.52%,BAIAP2L1;NTRK3;HCLS1;FES
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.40789613553605714,0.707178457211858,0.8846153846153846,1.0,1.0,4/15,15.84%,MAT2A;TMEM120B;GRIN2B;PKD1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.41732331861612176,0.7069577415102535,0.8767123287671232,1.0,1.0,3/11,21.77%,PKM;CPEB2;CPEB4
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3469163696986529,0.7068992527642016,0.9368421052631579,1.0,1.0,17/74,19.00%,SEMA3A;GADD45B;PHLPP1;TRAF2;FCGR2B;COPS5;IGF1R;PER1;NOD2;PINK1;DUSP10;AIDA;PYCARD;SDCBP;PLCB1;MAPK8IP2;APP
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3267632609011647,0.7068640709857131,1.0,1.0,1.0,28/274,17.39%,TOP2A;DTL;SLF1;MASTL;CDKN2AIP;SPDYA;FMN2;WDHD1;ENDOV;BOK;MCL1;XRCC3;HINFP;CIDEB;INTS3;BRCA1;PPP1R15A;VCPIP1;BCL2L2;TNFRSF1B;GTF2H3;POLQ;FANCL;FAN1;POLE2;ADPRS;RFC4;BCL6
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.39240829586396614,-0.7065866936227531,0.8787878787878788,1.0,1.0,1/7,6.50%,LPL
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.4005198052962062,0.7062828463532871,0.8860759493670886,1.0,1.0,2/14,7.91%,SLC1A2;SLC13A3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35629606578371664,0.7061715028368923,0.8876404494382022,1.0,1.0,7/41,23.30%,DTL;ANXA1;PLCB1;CCND3;RGCC;CDC25B;RDX
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.32017887798422145,-0.7061360956370615,0.7692307692307693,1.0,1.0,2/12,18.41%,HLCS;PARP2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.38287543868393376,0.706086410458158,0.8795180722891566,1.0,1.0,6/23,19.07%,SEMA3A;SEMA3B;SEMA6A;SEMA5A;PLXNB1;ARHGDIA
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.49036743362791546,0.7059700005842756,0.8309859154929577,1.0,1.0,3/5,41.54%,TNIP1;WDR48;OTUD4
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.34640639125320494,0.7050932672537542,0.9090909090909091,1.0,1.0,11/46,23.41%,CIT;FRMD5;SORBS1;FAM171A1;EPB41L4B;PHACTR1;ROCK1;EPB41L5;CSRP1;CDC42BPA;FHOD3
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.3900173937206969,0.705060431654619,0.8974358974358975,1.0,1.0,5/17,31.90%,LIMD1;CNOT6;CNOT7;AGO4;CNOT8
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.46371870640143487,0.7049330874199163,0.8088235294117647,1.0,1.0,1/7,10.69%,CAV3
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.40566985702241976,0.704873681613699,0.8987341772151899,1.0,1.0,7/17,34.38%,ERRFI1;TRIM16;ROCK1;MACROH2A2;MACROH2A1;NCOA3;CTSK
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.45981347560126545,0.7047647816145253,0.8985507246376812,1.0,1.0,5/8,34.80%,EMC7;EMC10;EMC8;EMC3;MMGT1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.3064450179489144,-0.7046728091983098,0.9411764705882353,1.0,1.0,3/21,13.53%,BBS10;TBC1D32;DISC1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.33993835170968445,0.7043749117998648,0.9042553191489362,1.0,1.0,9/58,20.57%,ARAF;FBXL2;CHRM3;SLC35A1;SERP1;UBE2M;CPE;UBA52;ERO1A
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3316443919539636,0.7043465394061829,0.9381443298969072,1.0,1.0,23/101,23.34%,CACNB2;SCN3B;RAB3C;ANK3;ANK2;PKP2;FCHO2;RAB15;CAV3;KCNIP4;CLASP2;MAP7;ATP1B3;KCNB2;SPTBN1;FGF13;ROCK1;DPP6;SPTBN4;TNFRSF1A;TNF;RDX;FLOT2
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.41723246846436923,0.7041983399659598,0.875,1.0,1.0,6/12,37.25%,TMEM50A;CHMP5;CHMP7;CHMP4B;STAM;SNF8
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.3757459085767478,0.7041025432247203,0.8518518518518519,1.0,1.0,1/22,1.58%,KNSTRN
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.3986914136863034,-0.7040144454035651,0.7941176470588235,1.0,1.0,1/7,1.00%,ZNF703
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4350021981805531,0.7039687595652047,0.8227848101265823,1.0,1.0,1/11,5.00%,SLC1A2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3741989782561404,0.703751355035864,0.9010989010989011,1.0,1.0,8/25,27.58%,NR4A3;SOD2;CDKN1B;MFN2;JUN;PDCD4;PTEN;PRKG1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.4785043439016037,0.703738044386517,0.8923076923076924,1.0,1.0,3/6,31.82%,WAPL;CTNNB1;RAD21
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4029670320674952,0.7034898397173143,0.9125,1.0,1.0,4/14,28.96%,KANK1;ROCK1;RUFY3;PTK2B
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.39551559944575676,-0.7030645919854844,0.9523809523809523,1.0,1.0,1/10,0.86%,HUS1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.3814668540395089,-0.7029972332318267,0.7931034482758621,1.0,1.0,1/7,3.75%,LATS2
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.4515526099441969,0.702778021211641,0.875,1.0,1.0,1/7,15.11%,HCLS1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.41321146892790817,0.7026365520558115,0.85,1.0,1.0,4/15,19.12%,SPDYA;PKD1;CCND3;RGCC
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.41379601421915607,0.7015488641207794,0.7666666666666667,1.0,1.0,3/12,23.98%,CRLF1;STAT1;MX1
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.4787429827210822,0.7014288789087819,0.8787878787878788,1.0,1.0,2/6,22.72%,FOXP1;PRKCB
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.471879522356783,0.7013447827828833,0.8970588235294118,1.0,1.0,2/6,22.03%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.471879522356783,0.7013447827828833,0.8970588235294118,1.0,1.0,2/6,22.03%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.471879522356783,0.7013447827828833,0.8970588235294118,1.0,1.0,2/6,22.03%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3321030283965597,0.7011147895614025,0.9285714285714286,1.0,1.0,22/98,29.83%,HMGB2;SUV39H2;HCFC1;RUVBL2;TCF7L1;FAM50A;SMARCD3;KDM4B;ESR1;SMARCC1;EZH2;KDM6B;KDM5B;SMARCD2;BRWD1;KDM5C;SATB2;TAF6L;SMARCA5;SETDB2;ACTL6A;JARID2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3472889401459664,0.701101679115233,0.9375,1.0,1.0,20/70,25.63%,VEGFA;HIF1A;LIMD1;RPS27A;RBX1;IMPACT;PSMB4;HIF3A;EGLN3;UBA52;PSMC2;UBB;PSMA3;PSMB2;BAG3;EPAS1;ATF3;PSMD5;PSMD7;PSMA5
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.40654648956356737,-0.7010715475580607,0.7647058823529411,1.0,1.0,6/6,59.37%,MBD2;SIRT2;SIRT1;RRP8;BAZ2A;H3-3A
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.325537564132166,0.7010711252425699,0.9897959183673469,1.0,1.0,28/285,18.34%,CENPF;HAUS6;CENPE;SH3PXD2B;MAPT;ANLN;DZIP1;TMEM41B;TTBK2;RFX2;VPS37C;RCC1;LIMD1;ATAT1;RP2;IFT74;CFAP54;DYNC1H1;ABLIM3;SNX10;SNAP29;VMP1;PKD1;AUP1;GOLGA8B;ATP2A2;TXNDC15;CC2D2A
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.3177930180631288,-0.7008518866942534,0.84,1.0,1.0,1/13,0.55%,MEP1A
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.38727191136273503,0.7001118559127913,0.9146341463414634,1.0,1.0,1/22,1.42%,ADAMTS2
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.4675299699518537,0.7000628080338096,0.9027777777777778,1.0,1.0,3/6,33.89%,PCSK6;ZDHHC17;XIAP
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4475137156488833,0.6999060953985824,0.875,1.0,1.0,1/9,6.05%,CD55
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.38191242213225673,0.6998169478359114,0.896551724137931,1.0,1.0,4/22,18.86%,ANXA1;TRAF2;PDE4B;SPTBN1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3379124698063754,0.6998079610078035,0.8823529411764706,1.0,1.0,5/35,16.88%,PGAM1;NUP133;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.3804175893704524,-0.6993339826167269,0.8571428571428571,1.0,1.0,10/10,62.00%,OPTN;TRIP11;GCC2;MYO18A;VTI1A;VAMP4;STX6;GOLGA2;GOLPH3;TMED5
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.4037526711981927,0.6983193306197948,0.8933333333333333,1.0,1.0,6/18,25.16%,CDC37;SDCBP;PELI1;SLC25A4;FLOT2;PDCD6IP
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.3680249912692554,0.6983026288885045,0.8604651162790697,1.0,1.0,9/35,31.62%,RBM3;PER1;RBM4B;APP;GRM5;PARP9;FOXO3;MAPKAPK5;ATXN2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.31856420968584565,-0.6981659756825407,0.8421052631578947,1.0,1.0,5/19,16.32%,TLR3;NR1H3;TASL;TIRAP;NINJ1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.3584109603595908,0.6979947057863186,0.8876404494382022,1.0,1.0,2/26,5.68%,SH3PXD2B;ADAM15
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.39670423043092484,0.6975506285176745,0.8311688311688312,1.0,1.0,1/18,4.08%,AGT
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3355818547181282,0.6975337757679281,0.8958333333333334,1.0,1.0,6/66,13.10%,PRKCE;DOCK1;FCGR2B;MYO10;FGR;NR4A3
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.42865895032422824,0.6970439266686629,0.8888888888888888,1.0,1.0,1/9,12.57%,ERI2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.450609247845985,0.6968976263159032,0.8888888888888888,1.0,1.0,1/8,10.45%,ADGRB2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.450609247845985,0.6968976263159032,0.8888888888888888,1.0,1.0,1/8,10.45%,ADGRB2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.42514834497034926,0.6963994940335952,0.8026315789473685,1.0,1.0,1/10,11.83%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.3353927892858836,0.6961072007826894,0.9186046511627907,1.0,1.0,5/36,16.88%,PGAM1;NUP133;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.4085146757487196,0.6960662847080558,0.8271604938271605,1.0,1.0,2/14,11.94%,ANK2;CAMK2B
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.37379113550411325,0.6959314672047795,0.8536585365853658,1.0,1.0,2/24,5.39%,TGFB2;ANXA1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.3518815911836657,0.6951524571883134,0.8735632183908046,1.0,1.0,9/42,22.97%,SLC1A2;SLC13A4;SLC13A3;SLC35A1;SLC25A21;SFXN3;SLC25A4;SLC3A2;SLC5A6
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.326027789267725,0.6951088096885033,0.9696969696969697,1.0,1.0,17/146,13.31%,HTR2B;FGF1;TGFB2;GLIPR2;DIRAS2;VEGFA;CHI3L1;GPNMB;INSR;TRIM5;ROBO1;NTRK3;IGF1R;C5AR1;NOD2;FLT1;NTRK2
prerank,PanglaoDB_Augmented_2021__Monocytes,0.3156585776293429,0.6947582370885943,0.9484536082474226,1.0,1.0,17/127,15.16%,CLEC12A;CD163;VCAN;ADGRE1;RGS2;FCGR2B;RGS1;SIRPB2;FN1;IFITM3;FGR;C5AR1;FCGR2C;NFKBIZ;FGL2;CD300A;TNFRSF1B
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.36169783865688343,0.694553550419774,0.9418604651162791,1.0,1.0,10/40,32.29%,TMEM41B;VMP1;ATP2A2;UBXN2B;ATG5;ATG13;MAP1LC3A;NSFL1C;TP53INP1;ATG2B
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.3967729350313283,0.6944393873322352,0.8918918918918919,1.0,1.0,2/14,11.38%,BHLHE40;CELSR2
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.42992024731139866,0.6943568948500212,0.8987341772151899,1.0,1.0,3/10,18.92%,ERMN;MFSD2A;NTNG1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3226935540934601,-0.6943176724397343,0.95,1.0,1.0,1/13,1.34%,BTN3A2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.31513770125591734,0.6942698092590154,0.9456521739130435,1.0,1.0,12/81,14.98%,CLEC12A;CD163;ADGRE1;SLC11A1;FCGR2B;SIRPB2;CASP5;FGR;C5AR1;FCGR2C;FGL2;CD300A
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.43676471826497093,0.6941434626631487,0.863013698630137,1.0,1.0,3/9,15.33%,IHO1;FMN2;ZCWPW1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.31195893933456775,-0.6940918841696204,1.0,1.0,1.0,7/30,14.37%,INPP5K;IL1B;PIP4K2B;SORL1;ENPP1;PTPRE;NCK1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.37045792367124875,0.693890964082191,0.875,1.0,1.0,6/23,25.08%,CDH2;ID2;CTNNA2;CDK9;FGFR2;MEGF10
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.422151036425059,0.6934594527410867,0.8441558441558441,1.0,1.0,3/11,18.44%,ABCA2;ST6GALNAC5;ST8SIA3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.30760719025910843,-0.6933099724162455,0.9230769230769231,1.0,1.0,4/18,11.96%,MEP1A;LGR4;TNFSF10;CFD
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.3874286692082788,0.693052828694708,0.8518518518518519,1.0,1.0,3/20,13.55%,ARHGEF4;CARMIL1;ABLIM3
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.45825671773030247,0.6928993167323608,0.9047619047619048,1.0,1.0,4/6,32.51%,ITGAV;PPARA;LRP1;NR1H2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.32419073811785315,-0.6928309953176027,0.96,1.0,1.0,4/14,20.11%,CYTH3;OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.34014190594387,-0.6927935204212854,0.875,1.0,1.0,2/12,6.10%,SYN1;MCTP2
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.43954781826088707,0.6927595060283427,0.8461538461538461,1.0,1.0,4/8,35.63%,SIRT3;SIRT4;HDAC9;HDAC4
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.34108738105578373,-0.6926984789131223,0.8709677419354839,1.0,1.0,4/10,15.39%,BCL2L1;BID;FIS1;BCL2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.30510797847332316,-0.6920675954133888,0.8333333333333334,1.0,1.0,7/24,14.85%,RHOG;PLEK;P2RY12;CYFIP1;NCKAP1L;GSN;CAPG
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4645554911887454,0.6920628271321713,0.9090909090909091,1.0,1.0,3/8,21.95%,ALK;TYSND1;TNF
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.36494721409264497,-0.6918236768851717,0.7916666666666666,1.0,1.0,1/9,1.34%,BTN3A2
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.4027941988494921,0.6916652706880977,0.8607594936708861,1.0,1.0,2/11,19.82%,PXK;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.3362886669088727,0.6916273919825083,0.9058823529411765,1.0,1.0,8/43,19.82%,PGAM1;NUP133;HIF1A;COX7A2;PINK1;PRKAG2;SEH1L;ATP5IF1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.381924425129532,0.6916131405881817,0.896551724137931,1.0,1.0,5/20,29.58%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.3558638389499583,0.6903684717830406,0.8902439024390244,1.0,1.0,7/30,22.96%,ACOT13;RYR3;HCN1;SOD2;HPRT1;ACACB;ALDH1A2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3405792662773579,0.690329562371147,0.945054945054945,1.0,1.0,7/56,10.69%,PKIA;PRKAR2B;AGT;RGS2;SPRY1;PAQR3;CAV3
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.3430221490969534,-0.6903007707359504,0.8571428571428571,1.0,1.0,1/16,2.09%,SLC30A5
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.31953815408261166,-0.6900138109447831,0.8947368421052632,1.0,1.0,2/16,5.71%,PFN1;SSH3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.33367396020700646,0.6892644223376705,0.9166666666666666,1.0,1.0,5/64,11.07%,PRKCE;DOCK1;FCGR2B;MYO10;FGR
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.3061045623704848,-0.688995498129768,0.9583333333333334,1.0,1.0,5/19,19.43%,WDR91;BECN1;EMP2;STX8;RAB7A
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.35568029093208947,-0.6887015280949478,0.7083333333333334,1.0,1.0,5/5,64.45%,TRIP11;TBC1D23;WDR11;FAM91A1;C17ORF75
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.41803766012986976,0.6882044262547844,0.8846153846153846,1.0,1.0,1/8,2.16%,AMY2B
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.3188127670277956,0.6879759906580818,0.9587628865979382,1.0,1.0,31/113,25.17%,KLF4;NLRP12;IL15;AGT;ANXA1;CASP5;PDE2A;GPRC5B;NOD2;NFKBIZ;TYRO3;TNFRSF1B;WNT5A;BCL6;LRFN5;NAPEPLD;APP;FOXP1;MACIR;PPARA;TNFRSF1A;IL18;TNF;NR1D1;CASP1;TNIP1;PDCD4;RORA;TRADD;GPS2;CX3CL1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.3960523024241914,0.6876749869855822,0.8481012658227848,1.0,1.0,3/15,19.16%,TENT4B;PRKRA;SND1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.3967346093830293,0.687462580261214,0.8767123287671232,1.0,1.0,7/15,32.01%,RUVBL2;ESR1;CHMP7;MACROH2A2;WAPL;RAD21;MACROH2A1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.36185024768820917,-0.6871674599561968,0.88,1.0,1.0,3/7,15.82%,PDE3A;RNF157;PDE4D
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.3328118623836202,0.687138398485303,0.9270833333333334,1.0,1.0,5/65,11.07%,PRKCE;DOCK1;FCGR2B;MYO10;FGR
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.366533162772389,-0.6869040485879155,0.9230769230769231,1.0,1.0,6/20,14.37%,INPP5K;IL1B;PIP4K2B;ENPP1;PTPRE;NCK1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.38910704078539704,0.6868285000682434,0.8717948717948718,1.0,1.0,5/15,29.65%,SYT4;SYT1;SYT11;KCNB1;SYT9
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.355298970307876,-0.6868184441067701,0.7777777777777778,1.0,1.0,2/7,14.15%,UBASH3B;IRF7
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.3569126058085545,0.6867596326437567,0.9156626506024096,1.0,1.0,3/25,17.94%,ENPP2;CARMIL1;AKIRIN1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.48143557215301214,0.6866601705160819,0.9154929577464789,1.0,1.0,2/6,21.95%,ESR1;TNF
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.45133823265176565,0.6863185900002036,0.8970588235294118,1.0,1.0,1/8,10.54%,TRIM25
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.4414726139779291,0.6859376008806577,0.8933333333333333,1.0,1.0,1/7,7.01%,SLC11A1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.3819969803809773,0.6857230071377955,0.8863636363636364,1.0,1.0,5/19,29.58%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.46037222851718956,0.6854765657317039,0.8260869565217391,1.0,1.0,1/5,18.64%,SLC25A4
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.44729135189657615,0.6854720622371397,0.8947368421052632,1.0,1.0,1/7,5.93%,VEGFA
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4243141498351377,-0.6854437050853087,0.8125,1.0,1.0,1/5,18.00%,ADRB2
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.425990381465724,0.6852383609803226,0.9166666666666666,1.0,1.0,1/7,12.11%,NOD2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.26486361706252715,-0.6849652584383141,1.0,1.0,1.0,6/42,8.72%,HPS4;GZMB;BAP1;TP53;PPP1R13B;BID
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.33961161720035155,0.6847764593935431,0.9175257731958762,1.0,1.0,7/56,12.94%,TTBK2;ADAM15;MAP2;KDM1A;IFIT2;TFIP11;DNAJB2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.36934913359482263,-0.6844950213499349,0.8333333333333334,1.0,1.0,1/9,2.76%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.2546617238236009,-0.6842306998470612,1.0,1.0,1.0,9/56,11.88%,NUP42;NUP155;TGFB1;AGO1;RAE1;ELAVL1;POLR2C;NUP214;NUP188
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.46641994004174764,0.6841575545232427,0.8289473684210527,1.0,1.0,3/6,34.04%,PLK2;PRCC;ZWILCH
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.40852110553299237,0.6840509897131789,0.8860759493670886,1.0,1.0,4/12,23.89%,CEMIP;SLC9A1;CEMIP2;CHP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.42456064905261737,0.6839035867843122,0.835820895522388,1.0,1.0,2/8,14.98%,FCGR2B;CD300A
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.3844086021505376,-0.683880024331983,0.6551724137931034,1.0,1.0,6/6,61.59%,RAB32;AP3D1;AP1M1;AP1G1;RAB38;CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.3844086021505376,-0.683880024331983,0.6551724137931034,1.0,1.0,6/6,61.59%,RAB32;AP3D1;AP1M1;AP1G1;RAB38;CD63
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3193211258442216,0.6837059382217417,0.9693877551020408,1.0,1.0,22/98,24.16%,DAPK1;INSR;HIF1A;VPS11;IRS2;TRIM5;SH3D19;PFKFB4;PLK2;BNIP3;TNFRSF1B;NPRL2;APP;ROCK1;PPARA;PRKAA2;ZC3HAV1;TRIM65;TNF;TRIM14;RDX;LRRK2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.3263377373610423,-0.6834812264482347,0.75,1.0,1.0,3/11,18.33%,TREM2;SCFD1;CEP290
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.31401888447691173,0.6833784908885766,1.0,1.0,1.0,105/739,21.02%,KLF4;NFIL3;NAMPT;MACC1;FGF1;ST18;ZBTB16;NFIX;EGR1;PFKM;PLAC8;HMGB2;CREB5;NR4A2;AGT;NR4A1;MYRF;NFIB;MEIS2;RORB;ACVR2A;BMPR1B;ASXL3;VEGFA;SOX4;RXRB;IER5;EIF2AK3;SLC11A1;ARNT2;CSRNP3;COPS5;HSF2;HIF1A;KDM3A;HCFC1;RUVBL2;PAX8;ID2;POU5F1;SS18L1;MAFB;RRP1B;FOSL2;RPS27A;RBPJ;KDM1A;PTOV1;NR2F1;PER1;CRTC3;NOD2;ATAD2;GABPB1;NR4A3;DEAF1;ETS2;DCAF6;CSRNP2;HINFP;ZNF143;DRAP1;ING1;CCNC;RIPK2;BRCA1;SMARCD3;DPF3;E2F7;HCLS1;TRIM16;PKD1;LDB2;TXK;YAF2;WNT5A;PICALM;ESRRG;PCBD2;DHX33;PLCB1;ESR1;AKIRIN1;LITAF;TFAM;NR2C2;CXXC1;APP;RGCC;TBL1XR1;ZBTB18;ERCC6;SMAD1;KLF7;PPARA;UBA52;NPAS2;TNFRSF1A;UBB;TAF7;CDK9;SMARCC1;BEX1;KDM6B;SLC9A1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3720332660970687,0.6827989809905649,0.8902439024390244,1.0,1.0,6/28,20.67%,MAPT;PINK1;PRELID1;SOD1;ATP5IF1;UBB
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.36571686696123706,-0.6821246956301519,0.8125,1.0,1.0,1/9,4.65%,MKKS
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.31831750053277047,0.6821049221869213,1.0,1.0,1.0,48/240,27.52%,SH3PXD2B;TBC1D8;NAPA;ZDHHC15;PIGU;ARF6;DMD;PTPRK;TBC1D13;PRRT1;ANK2;RAB20;SEPTIN4;NPHP1;SEPTIN8;CNTNAP2;TBC1D15;GRID2;NSF;ITSN1;WNT5A;TMED10;CPE;SNX17;STXBP2;SCG5;CEP68;RAB21;STX2;STX19;CNTN2;MFN2;TBC1D2;CNTNAP1;NAPG;LRRK2;CTTN;RAB5A;SEPTIN11;TBC1D14;ATG13;JAM3;VPS26B;ARMCX3;AMOT;TLK1;AP3B1;REEP1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3185107529909756,0.6820469209558021,1.0,1.0,1.0,16/98,25.52%,ATP8B1;CLASP2;VCPIP1;VMP1;GOLGA8B;SPTBN5;TMED10;FAM174B;UBXN2B;VPS51;SURF4;RAB30;HACE1;LRRK2;DYNC2H1;VRK1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.40139282762278283,-0.6819663843109512,0.8275862068965517,1.0,1.0,2/6,7.46%,NPR2;PDE9A
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.32698853894857105,0.6813630768224581,0.946236559139785,1.0,1.0,9/82,11.03%,DDIT4;IFIT5;ATAD3A;PQBP1;IFNLR1;TRIM5;BNIP3L;IFITM3;IFIT2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.4299619486078534,0.6807058063369534,0.8591549295774648,1.0,1.0,3/5,32.93%,HIP1R;LRP1;HIP1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.39500316255534473,-0.6805403869832599,0.8285714285714286,1.0,1.0,6/6,60.53%,WWP2;PPIF;CTTNBP2NL;NDFIP2;SNCA;NDFIP1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.35323730980883206,0.6805211099697319,0.8901098901098901,1.0,1.0,6/39,14.16%,RELN;INSR;EPHA3;FGR;FLT1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.35531395976514774,-0.6804140546704729,0.8260869565217391,1.0,1.0,1/11,0.88%,CST7
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.32518745747778105,0.6801255424895568,0.968421052631579,1.0,1.0,23/103,23.34%,CACNB2;SCN3B;RAB3C;ANK3;ANK2;PKP2;FCHO2;RAB15;CAV3;KCNIP4;CLASP2;MAP7;ATP1B3;KCNB2;SPTBN1;FGF13;ROCK1;DPP6;SPTBN4;TNFRSF1A;TNF;RDX;FLOT2
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.4115268262672486,0.680113905464291,0.8783783783783784,1.0,1.0,4/12,33.95%,LRRK2;IMPDH1;OPA1;GTPBP1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.31591116597444174,0.6793699142128784,0.9896907216494846,1.0,1.0,18/90,28.35%,TBRG4;TFRC;XPO1;STT3B;INCENP;IMMT;TIMELESS;DDB1;NDC1;EIF3A;GANAB;CCT8;DHX37;SLC11A2;EIF3D;MCM3;UBE2O;PPRC1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.45210772316686104,0.6792667675034574,0.8904109589041096,1.0,1.0,1/6,13.66%,PMP22
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.4336713789468002,-0.6792528904301639,0.9032258064516129,1.0,1.0,2/5,11.69%,DHODH;ENTPD4
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.29166720939693913,-0.6792312835697729,0.9523809523809523,1.0,1.0,3/13,13.73%,SCYL2;UBQLN2;DAB2
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.3994265479422453,0.6792304441524629,0.9487179487179487,1.0,1.0,1/15,1.49%,SH2D4A
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.3648277613490368,0.6791028390746358,0.8505747126436781,1.0,1.0,1/19,0.32%,HTR2B
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.4603391385855663,0.6787102122119654,0.9027777777777778,1.0,1.0,2/6,21.69%,UNC80;TRPM7
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.32711515115341105,0.6786267161689418,0.9666666666666667,1.0,1.0,4/44,11.02%,MAP2;TRIM5;TRIM25;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.44806544327769027,0.6785623996466703,0.9571428571428572,1.0,1.0,4/8,29.26%,TMEM39A;TNF;IRAK3;UBQLN4
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.4353378761664012,0.6785608166168843,0.9242424242424242,1.0,1.0,5/7,35.58%,RBPJ;PROX1;MYLK;LRP1;BMPR1A
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.3680190307886162,0.678412589562884,0.9176470588235294,1.0,1.0,4/20,14.87%,ID2;BHLHE40;PER1;RBM4B
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.4042946776606344,0.6780505826951443,0.8888888888888888,1.0,1.0,2/8,23.86%,RYR3;HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3274631278820216,-0.6778850219474638,0.8260869565217391,1.0,1.0,9/17,23.40%,CD226;BCL10;CARD11;CD81;RAB29;SLC39A10;IKBKG;RELA;PRKD2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.3372439049838789,0.6778774400969698,0.9354838709677419,1.0,1.0,10/76,12.89%,HTR2B;SLC24A2;ANK2;VAPB;RYR2;HERPUD1;CAV3;TRPC4;ADCY8;SLC24A1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3801354225850771,0.6778218818929779,0.9102564102564102,1.0,1.0,7/19,23.32%,ERCC2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.44607779675299863,0.6776987891957637,0.9473684210526315,1.0,1.0,4/7,41.05%,ATG13;ATG2B;ATG2A;ULK1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.44607779675299863,0.6776987891957637,0.9473684210526315,1.0,1.0,4/7,41.05%,ATG13;ATG2B;ATG2A;ULK1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.343314374010232,0.677210302171425,0.9340659340659341,1.0,1.0,4/45,8.16%,THBS1;GPM6B;VEGFA;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.32608428629874053,0.6766686604625349,0.9176470588235294,1.0,1.0,4/60,5.93%,NRG1;TFRC;SLF1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.42449201116255514,0.6764963395359024,0.8529411764705882,1.0,1.0,4/7,39.72%,PARP9;MED25;GMNN;HMBOX1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.31610327351449913,0.675948089627623,0.9893617021276596,1.0,1.0,11/109,12.76%,DKK2;GPC5;DAAM2;SOX4;PTK7;KANK1;GSKIP;SEMA5A;GPRC5B;SULF2;PSMB4
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.48131706501797555,0.6757818663178902,0.8904109589041096,1.0,1.0,2/5,20.17%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.48131706501797555,0.6757818663178902,0.8904109589041096,1.0,1.0,2/5,20.17%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.3028236225883477,0.6756392860064252,1.0,1.0,1.0,70/390,26.15%,DTL;MKRN3;H2BC11;FBXL7;ENC1;UBE2QL1;RNF144B;FBXL2;TRAF2;HIF1A;VPS11;TRIM5;TRIM25;RPS27A;GAN;RNF144A;ARIH2;RBX1;PSMB4;SASH1;HIF3A;PINK1;RNF126;BLMH;BRCA1;VCPIP1;FBXO27;UHRF2;RLIM;SYVN1;FANCL;RNF139;TRIM26;KLHL8;DTX3;PELI1;NEURL1;UBE2J2;KLHL2;UVSSA;HECW2;FBXL5;FBXL13;RNF13;UBA52;PSMC2;UBB;FBXO7;LONRF1;ZNRF1;PSMA3;PSMB2;TRIM14;C10ORF90;RNF138;DDB1;EPAS1;PSMD5;BARD1;HACE1;TRIM24;PSMD7;MAGEF1;UBE2D2;UHRF1;USP5;RNFT1;PSMA5;DTX2;RNF220
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.33913145773897074,0.6756370047582598,0.9411764705882353,1.0,1.0,12/46,23.92%,DTL;PLK2;NSF;APC2;WNT5A;CDKN1B;HECW2;TNF;DDB1;BARD1;HACE1;FZR1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.34476140684402345,0.6755848525418074,0.9425287356321839,1.0,1.0,9/58,16.06%,ZDHHC15;NUP133;RYR2;PRICKLE1;FAM53C;HEATR3;PINK1;TNPO2;RANBP17
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.33452056185336476,0.6755659259513248,0.9550561797752809,1.0,1.0,7/48,18.44%,ALG10B;BMPR1B;MGAT1;B4GALT5;SERP1;GCNT1;ST8SIA3
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.4159817923572772,0.6755647457892345,0.8985507246376812,1.0,1.0,4/7,26.26%,CNEP1R1;PRKCB;VRK1;NEK9
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3733058717370312,0.6752189253695677,0.9302325581395349,1.0,1.0,8/24,27.90%,CLVS1;ABCA1;ACP3;HOOK3;LRRK2;TMEM106B;GAA;CLVS2
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.34254166574638045,0.6752188502197894,0.9090909090909091,1.0,1.0,1/38,0.88%,MDH1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.444749977078569,0.6750556344838228,0.8918918918918919,1.0,1.0,1/6,13.75%,PINK1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.361707030711205,-0.6749986235513599,0.875,1.0,1.0,4/9,21.93%,VTA1;CHMP2B;CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.361707030711205,-0.6749986235513599,0.875,1.0,1.0,4/9,21.93%,VTA1;CHMP2B;CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.4433567793419111,0.6747963760751967,0.921875,1.0,1.0,1/5,19.58%,FOXP1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.35126643875973956,0.674512510767333,0.9186046511627907,1.0,1.0,12/39,36.59%,PER1;MTA3;MORF4L2;TBL1XR1;SFPQ;SUDS3;MSL3;SMARCAD1;HDAC9;TRERF1;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.41100455569259786,0.6744326578009161,0.9315068493150684,1.0,1.0,2/9,26.16%,RTN4;MFSD1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.32552739461326263,0.6738968508959099,0.9583333333333334,1.0,1.0,12/75,22.82%,EEF1A2;MRPL33;EEF1B2;MRPL43;MRPL20;MRPL14;MRPL27;MRPL55;MRPL19;MRPS14;MRPL3;EEF1A1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.34058200221413887,-0.6737843873618778,0.84,1.0,1.0,8/8,65.97%,BUB3;ZW10;MIS12;IK;KNL1;CHAMP1;MTBP;ZWILCH
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.3549333230118526,-0.6734922909580615,0.75,1.0,1.0,3/7,13.22%,ITPA;NT5C;GPX1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.4375238601385871,0.6733810204912306,0.9125,1.0,1.0,2/9,20.91%,SLC25A4;FBXO7
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.3125091889283222,0.6730219717423402,0.9896907216494846,1.0,1.0,20/138,24.16%,PRKCE;TTBK2;MASTL;EIF2AK3;CLSPN;RPS6KB2;GALNT13;PLK2;PINK1;RPS6KA2;PKD1;CDK5R1;PDK3;ROCK1;MAP3K13;VRK2;PRKCB;UHMK1;MAST4;LRRK2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.4087169781618832,0.6730181363156192,0.935064935064935,1.0,1.0,3/11,24.80%,PAICS;PFAS;IMPDH1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.4257541664150627,0.6725486163992415,0.8666666666666667,1.0,1.0,1/8,4.50%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.4094468541023933,-0.672510177198315,0.8,1.0,1.0,2/5,18.40%,TGFB1;MEF2C
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.3490404439033362,0.6722884143290485,0.9555555555555556,1.0,1.0,14/38,29.23%,TIMM13;ATP5ME;ATP5F1D;ATP5F1A;CHCHD3;ATP5MC1;IMMT;ATP5PB;ATP5F1E;TIMM22;GHITM;HSPA9;OPA1;AGK
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.38422271777983863,0.6720544839390256,0.863013698630137,1.0,1.0,1/12,8.02%,ACAT1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.3825583146303838,0.6719667406232891,0.8235294117647058,1.0,1.0,4/15,21.52%,PPM1E;DUSP10;DUSP16;DUSP6
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.3600983016968953,0.6712715509097411,0.9204545454545454,1.0,1.0,9/28,27.90%,CLVS1;ABCA1;ACP3;HOOK3;ATP10B;LRRK2;TMEM106B;GAA;CLVS2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.42776041271842247,0.6712379137450677,0.8769230769230769,1.0,1.0,2/7,26.96%,SOD1;TOX
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.3117346975991462,-0.6712226305211908,0.9230769230769231,1.0,1.0,3/11,15.87%,SSBP1;RECQL;HMGA1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.3499896948995105,0.6707859309250459,0.9885057471264368,1.0,1.0,11/42,32.29%,TMEM41B;VMP1;ATP2A2;UBXN2B;MFN2;ATG5;ATG13;MAP1LC3A;NSFL1C;TP53INP1;ATG2B
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.34721937669764336,0.670665704900907,0.9318181818181818,1.0,1.0,2/27,5.68%,SH3PXD2B;ADAM15
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.39363511315876343,0.6706235613140402,0.9210526315789473,1.0,1.0,1/14,3.06%,CADM1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.3623200021301402,0.6703843038025687,0.9186046511627907,1.0,1.0,3/33,11.51%,H2BC11;ROBO1;CCDC3
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.36255246574184,0.6703339304902528,0.9230769230769231,1.0,1.0,3/24,12.60%,DALRD3;FTSJ1;METTL2A
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.30574306018748004,-0.6703269146926101,0.9565217391304348,1.0,1.0,2/19,9.40%,RHOG;CYFIP1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.31077929677313587,0.6700897958351435,0.9895833333333334,1.0,1.0,19/133,24.16%,PRKCE;TTBK2;MASTL;EIF2AK3;CLSPN;RPS6KB2;PLK2;PINK1;RPS6KA2;PKD1;CDK5R1;PDK3;ROCK1;MAP3K13;VRK2;PRKCB;UHMK1;MAST4;LRRK2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.3551646655327781,0.6698496140292622,0.9195402298850575,1.0,1.0,7/25,18.92%,SEMA3A;NSMF;SEMA6A;CAMK2B;CTNNA2;PHACTR1;NTNG1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.3260723323615321,0.6698010866675711,0.967741935483871,1.0,1.0,22/69,25.33%,CACNB2;GRIN3A;SLC24A2;ANK2;RYR2;CACNA1B;TRPC4;SLC24A1;NALCN;RYR3;ITGAV;PKD1;SLC24A3;ATP2A2;CACNG8;TRPM7;SLC3A2;SLC24A4;CACNA1C;ATP2B2;CACNA1A;TRPC1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.332958476055664,-0.6697348750072712,0.8333333333333334,1.0,1.0,2/12,3.55%,ZDHHC21;IL1B
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.3937035592581355,0.6697329480738652,0.8169014084507042,1.0,1.0,3/9,32.59%,L2HGDH;GPT2;GOT1
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.36316913101921405,-0.6697004207418776,0.9666666666666667,1.0,1.0,7/7,63.71%,TERF2;TERF1;ATRX;POT1;H3-3A;DAXX;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.36316913101921405,-0.6697004207418776,0.9666666666666667,1.0,1.0,7/7,63.71%,TERF2;TERF1;ATRX;POT1;H3-3A;DAXX;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3301052234992805,0.6696539650176249,0.9333333333333333,1.0,1.0,10/43,22.81%,TOM1L1;BMI1;BRCA1;E2F7;YAF2;UXT;SUZ12;EZH2;CBX5;RBBP8
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.30240123188970963,-0.6695537203829972,0.9473684210526315,1.0,1.0,3/15,12.23%,CLEC16A;TELO2;PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.3691435829069376,0.6694325304841823,0.8831168831168831,1.0,1.0,9/23,35.19%,PINK1;TMEM39A;NRBP2;LRRK2;MTM1;UBQLN4;CHMP4B;FEZ1;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.35391472549499847,-0.6691244210118884,1.0,1.0,1.0,5/11,16.22%,LGALS9;HLA-E;RASAL3;SYK;CD81
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.34741839225123394,0.6690972442517683,0.8666666666666667,1.0,1.0,3/17,17.26%,PTPRK;SORBS1;THY1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.312010259616154,0.669022396557221,0.98989898989899,1.0,1.0,39/203,20.40%,KLF4;ST18;OGN;TGFB2;ALOX15B;BMPR1B;PTPRK;GPNMB;SOX4;CAMK2N1;IFNLR1;DNAJB2;MAGI2;RPS6KA2;SOD2;CD300A;CLMN;E2F7;RBM5;DUSP10;RNF139;PLXNB1;WNT5A;NDRG4;THAP12;CTBP1;NEURL1;CDKN1B;PRKRA;CHD5;APP;FTH1;RGCC;GSTP1;AQP11;HSPA1B;GTPBP4;NELL1;IGFBP7
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.35685704110126826,0.6688707331976251,0.9080459770114943,1.0,1.0,7/39,23.89%,SOX4;CAMLG;COPS9;RPL11;HSPA1B;GTPBP4;CHP1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.42893587076886214,0.6685528160375607,0.8611111111111112,1.0,1.0,1/7,11.21%,PDE2A
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.354064624088992,0.6684337788630492,0.9156626506024096,1.0,1.0,3/30,11.02%,HMGB2;TXN;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.3817294018106118,0.6683603605707139,0.8941176470588236,1.0,1.0,6/12,32.51%,MID1IP1;NR4A3;PPARA;PPARGC1A;LPGAT1;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.41122481296503194,0.6679576594903326,0.9,1.0,1.0,3/11,23.64%,CAV3;HAMP;ATP1A2
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.4106677249917933,0.6678338817972095,0.8666666666666667,1.0,1.0,3/11,28.51%,HERPUD1;RNFT1;BAG6
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3283443488042828,0.6678193000453736,0.9893617021276596,1.0,1.0,13/69,16.66%,IDI1;TM7SF2;MVD;IRS2;ID2;MID1IP1;CCDC3;FASN;PRKAG2;SCD;SMARCD3;FDFT1;HMGCS1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.3878447095008855,0.66638007801684,0.8734177215189873,1.0,1.0,5/12,24.41%,CCDC39;DNAH17;DNAH7;DNAAF2;DNAAF5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.39416006431801154,0.6663716925027031,0.8875,1.0,1.0,3/10,19.64%,FCGR2B;PDCD1LG2;TNFRSF21
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.40348216139414605,0.6662221037357337,0.8888888888888888,1.0,1.0,4/11,38.62%,PARP9;TIPARP;PARP11;PARP10
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.34534603599699715,0.6661109346571652,0.9157894736842105,1.0,1.0,3/33,11.63%,RIOK2;NGDN;RRP36
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.3127657492281133,0.6654288747266116,0.9560439560439561,1.0,1.0,18/62,25.17%,NLRP12;IL15;AGT;POLR3F;PDE2A;GPRC5B;NFKBIZ;WNT5A;NAPEPLD;APP;NPAS2;TNFRSF1A;IL18;TNF;TNIP1;PDCD4;TRADD;CX3CL1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.24434827429173556,-0.6653604705852462,1.0,1.0,1.0,11/61,15.76%,MRPL57;MRPS9;MRPL50;MRPL35;AURKAIP1;TUFM;MRPS11;MRPS10;MRPL1;MRPS30;CHCHD1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.31113843826744947,0.6650328491756446,0.9550561797752809,1.0,1.0,18/65,32.03%,PQBP1;KHDRBS2;RRP1B;CLK2;FAM50A;AHNAK;HNRNPH1;METTL4;MBNL2;SRSF3;HNRNPH3;C9ORF78;CLK1;AKAP17A;PTBP3;POLR2A;HNRNPF;SNRNP70
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.37516665705438634,-0.6645171610130003,0.8636363636363636,1.0,1.0,2/7,12.92%,EIF5A;PTTG1IP
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.42063288210496574,0.6644799400840505,0.8529411764705882,1.0,1.0,1/6,19.04%,ROCK1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.3926740103896648,0.6641773852536541,0.8918918918918919,1.0,1.0,3/9,14.75%,VEGFA;KDM1A;SMARCD3
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.315439995101688,0.6639286037274146,0.9292929292929293,1.0,1.0,15/71,23.60%,TGFB2;PTPRK;OVOL2;RPS27A;PDE2A;SOX6;PARD3;WNT5A;SMAD1;UBA52;UBB;SMAD5;APPL1;FOS;JUN
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.37646546822894567,0.6637889530635549,0.8987341772151899,1.0,1.0,6/20,25.94%,KDM3A;KDM1A;KDM4B;KDM6B;KDM5B;KDM5C
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.35948438659699944,0.6636984118523647,0.9302325581395349,1.0,1.0,4/21,14.87%,ID2;BHLHE40;PER1;RBM4B
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.35453719917520765,0.6636622958716757,0.8735632183908046,1.0,1.0,9/27,28.51%,CAMLG;SDCBP;RPL11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.4531227182174395,0.663586174225913,0.9154929577464789,1.0,1.0,2/5,25.14%,TMSB10;TWF1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.24245104335149353,-0.663506279249016,1.0,1.0,1.0,18/57,22.67%,GZMB;IDE;RSPRY1;SOCS6;NGLY1;CAPN2;HM13;CTSH;CTSZ;CHFR;CASP8;ZRANB1;CTSC;ATE1;UBC;VPS4B;PRKN;STUB1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),0.4573772464907824,0.6633537876835555,0.9090909090909091,1.0,1.0,2/5,38.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),0.4573772464907824,0.6633537876835555,0.9090909090909091,1.0,1.0,2/5,38.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),0.4573772464907824,0.6633537876835555,0.9090909090909091,1.0,1.0,2/5,38.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.37223266106227176,0.6633292998432833,0.9069767441860465,1.0,1.0,1/19,9.51%,ID2
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.3775115112704587,0.6631290671068639,0.9176470588235294,1.0,1.0,2/17,20.91%,PINK1;FBXO7
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.22975713488938182,-0.6630546682475441,1.0,1.0,1.0,10/62,15.76%,MRPL57;MRPS9;MRPL50;MRPL35;AURKAIP1;MRPS11;MRPS10;MRPL1;MRPS30;CHCHD1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.3693242998057966,0.6630534084789207,0.9404761904761905,1.0,1.0,8/15,35.73%,PRPS1;NMNAT2;HPRT1;MTHFD1;PNP;ME1;PPAT;GART
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.3654106322397113,0.662885074595858,0.8987341772151899,1.0,1.0,7/23,23.32%,ERCC2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.3414376219040896,-0.6626286169693928,0.8181818181818182,1.0,1.0,2/9,4.69%,IDE;UQCC2
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.3253320467981777,-0.6625565021622551,0.9,1.0,1.0,4/11,17.80%,EIF4EBP1;EIF2AK4;RBM4;FMR1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.42012573687073096,0.6625030553798705,0.9014084507042254,1.0,1.0,2/7,15.16%,NMD3;TNFRSF1B
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.3213853828596239,0.6624829254594489,0.9456521739130435,1.0,1.0,4/49,12.60%,TRMT9B;FTSJ1;PUS7;METTL2A
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.4056816942434291,0.6624542882171636,0.8904109589041096,1.0,1.0,4/9,32.69%,SDCBP;DLG4;ATXN2;LRPAP1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3319964676739625,0.6620635366034359,0.9333333333333333,1.0,1.0,11/51,19.33%,RGS20;KCTD8;RGS2;SYP;TULP3;RGS11;RASGRP4;PLCB1;GRK4;ROCK1;SLC39A14
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.39602802815620514,0.6619603878348609,0.8918918918918919,1.0,1.0,1/11,10.45%,ADGRB2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.297402518641123,-0.6617376234562513,1.0,1.0,1.0,1/17,7.01%,TP53
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.3510412232201519,-0.6614984607581306,0.9090909090909091,1.0,1.0,1/14,2.09%,SLC30A5
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4031142568361253,0.6611244020615296,0.92,1.0,1.0,2/13,17.75%,MVD;DHDDS
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.3567607818369351,0.6601828498808702,0.8846153846153846,1.0,1.0,8/17,43.27%,CDK9;CPSF6;CTR9;HSF1;ZC3H3;NCBP1;ZC3H14;CPEB3
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.30229778017336295,-0.6600047407166172,1.0,1.0,1.0,4/17,10.93%,PLA2G4C;PLA2G12A;PLB1;NR1H3
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.4325783785521564,0.6599399166926296,0.8857142857142857,1.0,1.0,1/7,6.05%,CD55
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.39226212153698425,-0.659847023462943,0.8787878787878788,1.0,1.0,2/6,10.27%,SERPINB9;MILR1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.30903587097990975,0.6598330413370463,0.9797979797979798,1.0,1.0,25/117,23.34%,RAB7B;AGT;TFRC;TRAF2;SLCO3A1;TRIM5;TRIM25;RPS27A;ALK;NOD2;RIPK2;AIM2;WNT5A;PYCARD;DHX33;APP;MAP3K13;HSPA1B;UBA52;UBB;IL18;TNF;TRIM14;PRKCB;FLOT2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.3921694557328741,0.6589566458241521,0.8939393939393939,1.0,1.0,4/9,42.32%,ZC3HAV1;PARP9;PARP10;TNKS2
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3532552725015563,0.6588541743723944,0.9024390243902439,1.0,1.0,2/21,5.93%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.4279364130480078,0.6587677294234981,0.9027777777777778,1.0,1.0,1/8,9.73%,WASF1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.31529041555988707,-0.658171712599544,0.8888888888888888,1.0,1.0,6/18,14.15%,APPL2;LGR4;TLR3;TREM2;BIRC2;IRF7
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.39908970307272157,0.6581546628824839,0.9324324324324325,1.0,1.0,5/14,17.04%,FCHO2;SGIP1;NSG2;CALY;PICALM
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3885874755354859,0.6573075532959471,0.9230769230769231,1.0,1.0,4/16,19.12%,SPDYA;PKD1;CCND3;RGCC
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.4112779793056927,0.6565402190652999,0.8987341772151899,1.0,1.0,1/8,7.01%,SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.4093476534832502,0.6560477784358462,0.9,1.0,1.0,1/9,19.58%,FOXP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3691000489151486,0.6559819259314464,0.8536585365853658,1.0,1.0,2/17,17.49%,HERPUD1;ATP2A2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.30657557351451104,0.6555839144041877,0.99,1.0,1.0,26/162,25.02%,DTL;FBXL7;RNF144B;HERPUD1;TRIM25;RPS27A;RNF144A;ARIH2;RBX1;PINK1;RNF126;RLIM;SYVN1;KLHL8;RNF13;UBA52;PSMC2;UBB;RNF149;FBXO7;DDB1;HACE1;FZR1;UBE2D2;UHRF1;FEM1C
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.2792114998266353,-0.6552195141615347,1.0,1.0,1.0,3/16,11.97%,SERPINB6;TRPV4;WNK3
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.29569951341355255,0.6550395903882797,1.0,1.0,1.0,43/254,25.90%,DTL;MKRN3;FBXL7;UBE2QL1;RNF144B;TRAF2;TRIM5;RPS27A;RNF144A;ARIH2;RBX1;PSMB4;SASH1;RNF126;BLMH;BRCA1;FBXO27;RLIM;SYVN1;PELI1;UBE2J2;HECW2;FBXL5;FBXL13;UBA52;PSMC2;UBB;FBXO7;LONRF1;ZNRF1;PSMA3;PSMB2;TRIM14;C10ORF90;PSMD5;BARD1;HACE1;FZR1;PSMD7;UBE2D2;TRAF3IP2;PSMA5;TRIM56
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.357870963770436,0.6545669873129738,0.9294117647058824,1.0,1.0,5/23,28.10%,SRSF12;CELF2;PRPF39;SRSF5;SRSF9
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.3109536351201306,0.6541487872328574,0.9540229885057471,1.0,1.0,9/46,17.77%,ANXA1;SIPA1L1;PTK7;GPR65;MICALL2;THSD7A;THSD7B;GAB1;PHACTR1
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.36714850713068803,0.653885085413852,0.961038961038961,1.0,1.0,4/16,13.35%,INSR;IRS2;SORBS1;PPP1R3B
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.4024872165060705,0.6538173297252152,0.9178082191780822,1.0,1.0,2/7,18.64%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.4024872165060705,0.6538173297252152,0.9178082191780822,1.0,1.0,2/7,18.64%,PELI1;SLC25A4
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.3914478495230342,0.6536801423229665,0.9146341463414634,1.0,1.0,4/12,21.95%,NOD2;TNFRSF1B;WNT5A;TNF
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.33412212411574094,0.6533035745281279,0.9404761904761905,1.0,1.0,5/33,17.98%,TRAF2;TRIM5;ARIH2;RNF126;PELI1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.3691191547729405,0.6530307375892791,0.891566265060241,1.0,1.0,10/18,30.54%,CAMK2N1;EPHA4;SERPINE2;TIMP3;ROCK1;LRRK2;CSTB;BAG6;SNX12;PRNP
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.4380802724641675,-0.6529247958981058,0.8636363636363636,1.0,1.0,2/5,13.43%,HAVCR1;CD226
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.3534115809692381,-0.652912638900668,0.85,1.0,1.0,3/8,16.57%,DR1;GTF2B;TBP
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.3671626062553891,0.6528012486244823,0.8780487804878049,1.0,1.0,7/18,31.05%,RYR2;CCDC39;NDRG4;BBS7;SETDB2;MEGF8;MICAL2
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.31218771630807995,-0.6527928803401131,0.9259259259259259,1.0,1.0,3/11,11.93%,WDR35;TTC21B;IFT43
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.36085113714375033,0.652619508651399,0.9404761904761905,1.0,1.0,7/22,25.07%,COPS5;RPS27A;RBX1;UBA52;UBB;DDB1;GPS1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4500348736046288,0.651730916147656,0.8970588235294118,1.0,1.0,1/6,7.62%,SEMA6A
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.3850587434275783,0.6514936833523587,0.8840579710144928,1.0,1.0,1/10,8.02%,ACAT1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3850587434275783,0.6514936833523587,0.8840579710144928,1.0,1.0,1/10,8.02%,ACAT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3850587434275783,0.6514936833523587,0.8840579710144928,1.0,1.0,1/10,8.02%,ACAT1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3857562764143343,0.6512735727547349,0.9382716049382716,1.0,1.0,3/12,23.99%,NELFB;HEXIM1;HNRNPU
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.3345835142069964,0.6511643329963381,0.9438202247191011,1.0,1.0,5/36,19.16%,RNASEH2C;STT3B;OGA;FBXO27;SND1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.3604313148097216,0.6511221638191665,0.8961038961038961,1.0,1.0,5/13,28.50%,SORBS1;FAM171A1;PHACTR1;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.3604313148097216,0.6511221638191665,0.8961038961038961,1.0,1.0,5/13,28.50%,SORBS1;FAM171A1;PHACTR1;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.4203021359794794,0.6509570314465012,0.927536231884058,1.0,1.0,2/6,20.91%,PINK1;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.38218331484832857,0.6504862758768009,0.9487179487179487,1.0,1.0,4/19,16.75%,NOD2;GPI;DNAJB9;WNT5A
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.2993731401708529,0.6502639314389747,1.0,1.0,1.0,26/277,11.21%,SOCS3;NLRP12;PRLR;VIM;EGR1;IL1RAPL1;OSMR;ANXA1;LIFR;VEGFA;GRB10;F13A1;CHI3L1;TCF7;PTPRZ1;IL7;DAPK1;AKAP6;HIF1A;PTPRT;IFNLR1;FN1;GHR;MCL1;RPS27A;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.42741819497462175,0.6501643288388045,0.9393939393939394,1.0,1.0,2/8,22.89%,THBD;NR1D1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.3798114220168894,0.6499632634206428,0.9102564102564102,1.0,1.0,5/16,25.16%,CDC37;SDCBP;PELI1;FLOT2;PDCD6IP
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.28833888758509113,-0.6498113701285468,0.95,1.0,1.0,3/21,9.78%,ACSM5;MLYCD;ACSF2
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.26179646684908076,-0.6494297075138199,1.0,1.0,1.0,5/23,15.05%,EP300;PKN1;DAB2;KDM5D;DDX5
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.29858890415238154,0.649159707486118,1.0,1.0,1.0,37/316,18.71%,KLF4;NFIL3;ZBTB16;EGR1;HMGB2;CREB5;AGT;MYRF;NFIB;RORB;SOX4;RXRB;ARNT2;HIF1A;KDM3A;HCFC1;PAX8;ID2;SS18L1;MAFB;ATAD2;DEAF1;ETS2;HINFP;ING1;BRCA1;SMARCD3;TRIM16;YAF2;WNT5A;PICALM;ESRRG;PCBD2;PLCB1;ESR1;TFAM;CXXC1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3142496316291168,-0.6490656048831933,0.8636363636363636,1.0,1.0,4/14,15.75%,CTC1;SRC;TERF2;EXOSC10
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.3261600708811309,0.6490650528553614,0.9555555555555556,1.0,1.0,11/43,26.82%,TIMM13;FLVCR1;TOMM20;BNIP3;TMEM14A;SLC25A4;SLC25A24;FBXO7;MFN2;TIMM22;TOMM40
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3589286522634112,0.64901006511498,0.9390243902439024,1.0,1.0,2/23,6.18%,WDR5;SUV39H2
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.3807137916947061,-0.6487988087494166,0.8846153846153846,1.0,1.0,3/5,23.24%,TRPV4;CAB39;STK39
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3596879031044748,0.6486268346923225,0.9523809523809523,1.0,1.0,4/23,18.49%,MAPT;IRS2;NPRL2;CDKN1B
prerank,PanglaoDB_Augmented_2021__Basophils,0.2952646051293657,0.6483434184218849,0.9893617021276596,1.0,1.0,21/109,22.70%,NFIL3;CLEC12A;INF2;F13A1;FCGR2B;SIRPB2;FGR;CD93;FCGR2C;TULP3;FGL2;CD300A;ST6GALNAC5;PDK3;LRRC25;TEC;IGFBP7;GPR183;OSBPL5;MS4A6A;GABBR1
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.36278756174681404,-0.6482423967678679,0.8076923076923077,1.0,1.0,1/7,4.88%,PHAX
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.3846484823037807,0.6481854433466295,0.9240506329113924,1.0,1.0,4/13,19.64%,FCGR2B;ID2;CD300A;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3507409807854739,0.6476563408074874,0.9111111111111111,1.0,1.0,3/23,17.91%,VPS11;BRCA1;ESR1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.326490970300397,0.6474427288308618,0.9195402298850575,1.0,1.0,6/43,12.45%,IL15;TFRC;ANXA1;IL7;IRS2;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.36539770243060143,-0.6472937883645685,0.8,1.0,1.0,3/8,11.91%,DAB2IP;TREM2;NLRC3
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.3238293091254042,-0.6468568408752678,0.9523809523809523,1.0,1.0,1/12,1.70%,NPC2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.2963211633444855,0.6461963537156038,1.0,1.0,1.0,89/368,25.74%,SOCS3;PRLR;ST18;VIM;IFIT5;EGR1;TALDO1;IL15;OSMR;ANXA1;LIFR;MAP3K8;VEGFA;GRB10;F13A1;TRAF2;PTPRZ1;IL7;TNFRSF11B;HIF1A;IFNLR1;IRS2;TRIM5;FN1;GHR;TRIM25;MCL1;IFITM3;RPS27A;IFIT2;CAMK2B;NOD2;RBX1;PSMB4;CRLF1;LMNB1;RIPK2;SOD2;TNFRSF1B;IL11RA;AIM2;TRIM26;PYCARD;CASP3;CEBPD;BCL6;PLCB1;UGCG;CFL1;PELI1;GBP2;TCP1;CDKN1B;SOD1;TEC;UBA52;PSMC2;TNFRSF1A;UBB;PSMA3;PSMB2;STAT2;NCAM1;IL18;TNF;P4HB;APPL1;STAT1;CASP1;FOS;PSMD5;LEPR;BRWD1;RHOU;HSP90B1;MX1;PDCD4;RORA;PSMD7;MAP3K3;IL21R;TRADD;FPR1;STAT6;CX3CL1;TRAF3IP2;PSMA5;PIM1;IL7R
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.41568644130739335,0.6453682608354611,0.9411764705882353,1.0,1.0,1/9,7.02%,FCGR2B
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.22517976872474083,-0.6450915555905664,0.8333333333333334,1.0,1.0,10/66,15.76%,MRPL57;MRPS9;MRPL50;MRPL35;AURKAIP1;MRPS11;MRPS10;MRPL1;MRPS30;CHCHD1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.32865268312437557,-0.6449497210309858,0.84,1.0,1.0,3/8,19.20%,GRK2;PDE4D;SRI
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.32767652590569096,-0.6448533131324875,0.9285714285714286,1.0,1.0,2/10,9.82%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.3781716721893557,0.6444171557730015,0.9315068493150684,1.0,1.0,1/9,8.02%,ACAT1
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.3316531254017704,-0.6442411954162102,0.8181818181818182,1.0,1.0,1/11,4.65%,MKKS
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.3316531254017704,-0.6442411954162102,0.8181818181818182,1.0,1.0,1/11,4.65%,MKKS
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.3316531254017704,-0.6442411954162102,0.8181818181818182,1.0,1.0,1/11,4.65%,MKKS
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.3316531254017704,-0.6442411954162102,0.8181818181818182,1.0,1.0,1/11,4.65%,MKKS
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.3320386353447651,0.6439584879538878,0.9285714285714286,1.0,1.0,3/32,9.78%,PLPP3;MEGF11;FN1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.38180746215887335,0.6439441928126147,0.8591549295774648,1.0,1.0,3/9,26.33%,NOD2;IL18;RSAD2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.3002323270816643,0.6435934262059249,1.0,1.0,1.0,37/238,22.89%,NFE2L3;NFIX;NR4A2;ERCC2;NR4A1;RORB;NOCT;RXRB;INTS12;RBPJ;NR2F1;C5AR1;NR4A3;DEAF1;ZNF143;DRAP1;INTS3;GTF2H3;CEBPD;ESRRG;NELFB;ESR1;KLF13;POLR2D;NR2C2;TBL1XR1;ERCC6;TAF9B;PPARA;INTS8;TAF7;CDK9;POLR2G;INTS6;EAF1;NOTCH2;NR1D1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.3494527298717919,0.6424291215162612,0.9655172413793104,1.0,1.0,5/29,23.64%,GEMIN2;SRSF12;SART3;PRPF6;SNRPD2
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.35439169416563043,0.6423906163601297,0.9090909090909091,1.0,1.0,4/24,15.31%,BRINP1;GPRC5B;IMPACT;VWC2
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3162962481935494,0.642236159818152,0.989010989010989,1.0,1.0,21/61,27.08%,TACR1;CD55;RYR2;CAV3;TRPC4;C5AR1;ADCY8;WNT5A;ESR1;ACKR4;TMEM178A;DLG4;CACNA1C;FPR3;ATP1A2;FPR1;ATP2B2;CACNA1A;TRPC1;PTGER4;ATP2B4
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.36752318756195157,0.6421086076970806,0.8918918918918919,1.0,1.0,1/12,7.95%,OVOL2
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.35152878424967365,0.6421053309599009,0.948051948051948,1.0,1.0,4/19,25.37%,PQBP1;AIM2;STAT1;TRAF3IP2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.34956176287869595,0.6420288812314916,0.9662921348314607,1.0,1.0,11/28,35.06%,ITPKC;GK;PIP5K1A;GK5;LPCAT1;TPK1;TKT;AGPAT3;GNPAT;IP6K1;GPHN
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.41826536316966245,0.6417173269460172,0.9333333333333333,1.0,1.0,3/7,24.05%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.3111462866170799,-0.6416142026331992,0.96,1.0,1.0,4/14,10.76%,IL1B;APPL2;SORL1;REST
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.37541294727412416,0.641454793435244,0.8717948717948718,1.0,1.0,5/9,26.26%,CNEP1R1;DCTN1;PRKCB;VRK1;NEK9
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.39908688775989415,0.6411068656030718,0.9512195121951219,1.0,1.0,1/13,9.90%,RETREG1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.42855259222668746,0.6410893642299316,0.9076923076923077,1.0,1.0,4/5,36.45%,HPRT1;PRTFDC1;PNP;NT5C2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.42143719389754597,0.6410435345849129,0.8955223880597015,1.0,1.0,2/5,30.99%,CDK9;CTR9
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4057410973059248,0.6408189960545123,0.8961038961038961,1.0,1.0,3/8,21.95%,SH3D19;TNFRSF1B;TNF
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.40278820015092087,0.6407123564216759,0.8985507246376812,1.0,1.0,1/8,17.91%,ESR1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.354018787376175,0.6406475378534544,0.9620253164556962,1.0,1.0,4/17,29.07%,VPS11;RAB21;RDX;SNX12
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.31751742962167506,0.6405994772183212,0.9791666666666666,1.0,1.0,7/55,18.41%,HAUS6;RCC1;MAP9;CLASP2;GOLGA8B;TOGARAM1;KIF11
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.32658388040813097,-0.6405249767153257,0.9047619047619048,1.0,1.0,11/11,67.38%,PARP2;PARP8;TNKS;PARP16;PARP6;PARP1;PARP12;TNKS2;PARP10;PARP11;TIPARP
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.27108566521182975,-0.640159234754233,0.95,1.0,1.0,8/17,25.25%,APH1A;TGFB1;HM13;ADAM10;PSEN1;RELA;NFKB1;TRAF6
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.3147256807693832,-0.6401520573529503,0.875,1.0,1.0,5/11,18.00%,ZDHHC21;DAPK3;CHRM2;SETD3;ADRB2
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.3244377152890226,0.639860255326228,0.9659090909090909,1.0,1.0,17/65,31.23%,PQBP1;POLR3F;POLR1C;RIPK2;POLR3H;DHX33;HSPD1;STAT1;STAT6;TRIM56;POLR3E;DDX3X;TLR2;IRF1;RIOK3;CTNNB1;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.25946071282872774,-0.6396493309771936,1.0,1.0,1.0,7/24,15.10%,CCND1;STXBP4;LSM11;PHB2;EGFR;AKT1;UBE2E2
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.43515526104671476,0.639647967360368,0.9117647058823529,1.0,1.0,2/5,19.33%,ACP3;SLC39A14
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.36245749980232467,-0.6393256935642072,0.8928571428571429,1.0,1.0,7/7,63.78%,AKT1;GCH1;HSP90AA1;CALM1;PTS;DHFR;QDPR
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.4276167349134788,0.639045338160369,0.927536231884058,1.0,1.0,1/6,10.95%,MID1IP1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.4234974719018343,0.6389222305573727,0.8688524590163934,1.0,1.0,2/5,33.34%,PTPRN2;PTPRN
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.41147028128891205,-0.6381440660852725,0.8333333333333334,1.0,1.0,1/5,17.67%,SETD3
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.3816292651568821,0.6378570632415363,0.9305555555555556,1.0,1.0,1/11,9.95%,XPO1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.35733137503214,-0.6376303433345376,0.8918918918918919,1.0,1.0,3/7,13.70%,NCKAP1L;IKBKB;NUAK1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.2992967544132373,0.6375256143693868,0.978494623655914,1.0,1.0,14/84,19.58%,VIM;HMGB2;NOCT;SLC11A1;NOD2;PDCD1LG2;PDE4B;HNRNPA0;TNFRSF1B;WNT5A;PYCARD;PELI1;GSTP1;FOXP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3015229115441526,0.6371631634492428,0.9894736842105263,1.0,1.0,26/121,26.11%,CKS2;NEK11;BRINP1;ERCC2;MEIS2;RCC1;SRA1;PSMB4;SDCBP;IQGAP1;CDKN1B;APP;PSMC2;CDK9;PSMA3;PSMB2;CDC25B;DDB1;PSMD5;FZR1;HNRNPU;PSMD7;PSMA5;CDK10;PIM3;BORA
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.37757069739444643,0.6369582555213419,0.9193548387096774,1.0,1.0,6/11,36.30%,RAPGEF3;PRKAA2;DDX3X;TAOK1;DIP2B;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.4109689890882996,0.6368753515903164,0.9571428571428572,1.0,1.0,4/8,27.23%,KLF7;KCNB1;PIM3;SIRT4
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.29873602539387134,0.6360408905665038,1.0,1.0,1.0,18/90,23.80%,THBS1;PGAM1;NUP133;HIF1A;FN1;PRKAG2;LDB2;SEH1L;SDCBP;HSPB1;CDKN1B;APP;ROCK1;STAT2;NOP53;SLAMF8;BARD1;NDC1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.31642092917054065,-0.6360399864840348,0.8421052631578947,1.0,1.0,2/11,7.55%,PLA2G4C;PLA2G12A
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3156535885781877,-0.6359272022768906,1.0,1.0,1.0,4/18,18.90%,LEO1;RNF8;RNF20;UBE2A
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.4079950550665318,0.6355294058447309,0.8888888888888888,1.0,1.0,3/7,23.89%,IMPACT;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.307270311720597,0.635381870464379,0.9655172413793104,1.0,1.0,5/37,16.88%,PGAM1;NUP133;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.3088915762709939,-0.635331405691114,0.9333333333333333,1.0,1.0,5/13,17.34%,PPP1R3F;BAG5;FEM1A;EMP2;SMG6
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.38865276794602743,0.6349572464230581,0.9102564102564102,1.0,1.0,5/11,24.59%,UCKL1;DCK;UPP2;UCK2;CAD
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3096889198007506,0.6346506883188227,0.9560439560439561,1.0,1.0,14/60,24.05%,VIM;HMGB2;FCGR2B;NOD2;PDCD1LG2;PDE4B;TNFRSF1B;WNT5A;PYCARD;GSTP1;NR1D1;CASP1;CHMP5;PDCD4
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.36129502355483867,0.6345191816395278,0.891566265060241,1.0,1.0,2/19,6.09%,RPA2;TDG
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.40548659973120404,-0.6345143032201253,0.8571428571428571,1.0,1.0,5/5,59.48%,TMEM167A;RAB11B;TRAPPC11;TMEM167B;RAB3A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.38437039105126625,0.6343624527626558,0.9012345679012346,1.0,1.0,2/12,10.33%,PRLR;GHR
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.31901937524713325,-0.6339828690654934,0.8928571428571429,1.0,1.0,9/9,68.13%,REST;HDAC2;SIRT2;RCOR1;HDAC1;HDAC3;HDAC4;HDAC9;SMARCAD1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.3758948299443797,0.633599994089726,0.9253731343283582,1.0,1.0,2/9,25.52%,VCPIP1;VRK1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3010728301948147,0.6333728186942591,1.0,1.0,1.0,25/135,25.17%,RAP1GAP;TBC1D8;TBC1D13;RGS1;SIPA1L1;NGEF;GPR65;RAPGEF3;NTRK3;TBC1D15;APC2;PLXNB1;RASGRF1;PICALM;THY1;PKP4;EZH2;ARHGAP42;TBC1D2;CCDC125;GNB5;ECT2;GARNL3;TBC1D14;CX3CL1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.25358453667156466,-0.632995078078745,1.0,1.0,1.0,3/16,13.22%,ITPA;NT5C;GPX1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.3311260365273803,0.6320581294855393,0.9222222222222223,1.0,1.0,5/36,11.63%,RIOK2;RPS6;RPS25;RPS27;RRP36
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3044922492881999,-0.6316784303076717,1.0,1.0,1.0,10/10,69.58%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC5;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3044922492881999,-0.6316784303076717,1.0,1.0,1.0,10/10,69.58%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC5;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3044922492881999,-0.6316784303076717,1.0,1.0,1.0,10/10,69.58%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC5;ANAPC7
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.4070462569890536,0.6310877556248995,0.9538461538461539,1.0,1.0,1/6,8.56%,RYR2
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.33891093925197807,-0.6306995529089782,0.8888888888888888,1.0,1.0,2/6,12.16%,CSF1R;CHCHD10
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3114981708481098,0.6306969041793121,0.9666666666666667,1.0,1.0,7/58,16.06%,RPL23;NUP133;PRICKLE1;FAM53C;HEATR3;TNPO2;RANBP17
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.34780319420117006,-0.6306507062639737,0.9354838709677419,1.0,1.0,2/8,12.33%,MKKS;TASOR
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.32081544347890084,0.6303741234704918,0.9534883720930233,1.0,1.0,4/41,11.03%,IFIT5;EGR1;IFITM3;IFIT2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.32081544347890084,0.6303741234704918,0.9534883720930233,1.0,1.0,4/41,11.03%,IFIT5;EGR1;IFITM3;IFIT2
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.36695555296717997,0.6303298774853126,0.9102564102564102,1.0,1.0,3/9,22.13%,E2F7;DBF4;WIZ
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.3905928095105458,0.630264967592982,0.9420289855072463,1.0,1.0,3/8,31.48%,PLCB1;SLAMF8;MIA3
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.32210534366291405,0.630181529225604,0.978021978021978,1.0,1.0,1/38,1.04%,NLRP12
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3086858312428912,0.6300246989173927,0.9574468085106383,1.0,1.0,3/56,7.33%,GPM6A;ANLN;NLGN1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2872023410817968,0.6297523403340386,1.0,1.0,1.0,210/1260,23.74%,BRIP1;KLF4;NFIL3;NAMPT;ZNF382;MACC1;FGF1;SAP30;ST18;ZNF793;TGIF1;NFE2L3;ZBTB16;RPL23;NFIX;EGR1;PFKM;PLAC8;HMGB2;CREB5;NR4A2;ZNF483;NR4A1;TSHZ3;NFIB;MEIS2;RORB;ZNF41;PIAS4;ACVR2A;BMPR1B;RFX2;ASXL3;ARID5B;VEGFA;SUV39H2;SOX4;ZNF93;RXRB;IER5;ZNF654;TCF7;SLC11A1;ZNF814;ARNT2;HDGFL3;CSRNP3;OVOL2;COPS5;ABCA2;PPP1R13L;KCTD1;OLIG1;HSF2;HIF1A;YEATS2;KDM3A;HCFC1;BMI1;ZKSCAN5;ZNF540;RUVBL2;POU6F1;TRPS1;PAX8;TCF7L1;ZNF235;ID2;POU5F1;SS18L1;MAFB;BHLHE40;MXD1;RRP1B;FOSL2;RPS27A;RBPJ;ZNF518A;KDM1A;PDE2A;PTOV1;SRA1;NR2F1;MXI1;PER1;CRTC3;ZNF850;NOD2;ATAD2;ZNF34;IMPACT;ZNF536;ZNF549;GABPB1;ZNF550;NR4A3;DEAF1;ETS2;DCAF6;PPID;CSRNP2;HIF3A;SOX6;HINFP;ZNF143;DRAP1;OTUD7B;CCNC;TSHZ2;RIPK2;ZNF606;FBP1;BRCA1;SMARCD3;SOD2;DPF3;E2F7;HCLS1;GTF2H3;PKD1;LDB2;TXK;ZNF248;HIVEP2;WNT5A;UXT;TBX19;HIC2;SDCBP;CEBPD;ZNF292;ESRRG;KLF9;BCL6;ZBTB47;ZNF789;ESR1;AKIRIN1;LITAF;CTBP1;MTA3;KLF13;NKX6-2;ZNF665;NR2C2;ZNF260;CHD5;APP;RGCC;TBL1XR1;ZBTB18;HAMP;ZNF684;FOXP1;SMAD1;TAF9B;KLF7;PPARA;ZNF717;UBA52;NPAS2;HSPD1;ZNF213;BCL11A;TNFRSF1A;UBB;ZNF778;TAF7;CDK9;SMARCC1;BEX1;EZH2;KDM6B;SLC9A1;PRDM15;PRPF6;STAT2;SMAD5;ZNF197;CTDSP1;PCGF5;ENO1;IL18;TNF;NOP53;WIZ;POU6F2;TCF4;ZNF142;CBX5;HEXIM1;PRKCB;RBBP8;KDM5B;NR1D1;STAT1;FGFR2;SP140L;TNIP1;TFAP2E;FOS;EPAS1;ATF3;MTF1;SMARCD2;BRWD1;JUN;MYT1L;CGGBP1;SFPQ
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.35207353460951213,-0.6295551264748688,0.9090909090909091,1.0,1.0,4/10,13.39%,CTC1;BCAR3;EGFR;KAT7
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.4078870210267367,0.6294772652986796,0.8714285714285714,1.0,1.0,2/5,29.68%,MTMR9;MTMR4
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.39089066189628247,-0.6292488819807968,0.8,1.0,1.0,2/5,15.32%,ENG;PTCH1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.33742021610852707,0.6288808489168486,0.9404761904761905,1.0,1.0,5/27,19.00%,FCGR2B;GRIN2A;IGF1R;EPHA4;APP
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.36166679845022537,-0.6286588967219134,0.8928571428571429,1.0,1.0,7/7,63.86%,MR1;ZFP36L1;ZFP36L2;PTPRC;RABL3;LIG4;ADAM17
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3280459077000304,0.6271247779797886,0.9753086419753086,1.0,1.0,4/27,13.86%,NOCT;SLC11A1;TENT5A;HNRNPA0
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.4190368045197368,0.6270219660228143,0.8571428571428571,1.0,1.0,1/5,9.78%,FN1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.27919868291681493,-0.6269820191841065,0.95,1.0,1.0,3/20,8.06%,FYN;ACTB;ZDHHC2
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.32562934127289883,0.6269544396812787,0.9770114942528736,1.0,1.0,9/30,26.68%,RAB15;CADPS;CLASP2;SDCBP;RAB2B;RAB5A;PDCD6IP;CFTR;RAB27B
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.38745341271933903,0.6261516949405103,0.8840579710144928,1.0,1.0,2/8,24.29%,OLFM1;CTTN
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.3410814146132693,0.6256958401002307,0.9659090909090909,1.0,1.0,5/25,17.58%,SPOCK1;AGT;SPOCK3;SERPINE2;TIMP3
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.3727367292396485,0.6256184484977959,0.9583333333333334,1.0,1.0,1/11,2.95%,MAPT
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.2840069235279961,0.6256175014419992,0.9797979797979798,1.0,1.0,19/97,21.59%,PHLPP1;INSR;TRIM5;FN1;CAV3;NTRK3;IGF1R;EPHA7;FLT1;PAK5;NTRK2;PEBP1;DHX33;IQGAP1;ROCK1;GSTP1;PRDM15;PAK3;VRK2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.34996954982460116,0.6251932729246317,0.9506172839506173,1.0,1.0,2/17,16.21%,SNX10;HOOK3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.29363290818534177,-0.624900464710306,0.9285714285714286,1.0,1.0,8/14,31.38%,TERF2;SMG6;ERCC4;TERF1;SMG5;NAF1;DHX36;TNKS
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3026693406014832,0.6237468906855478,0.9895833333333334,1.0,1.0,20/77,25.16%,SLC1A2;ACOT13;GSDMD;ADCY8;RYR3;HCN1;SPAST;SOD2;POLQ;ALAD;DISP1;PYCARD;HPRT1;AQP11;ACACB;ALDH1A2;KCNC2;ECT2;NACC2;PDCD6IP
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.2807833817463589,0.6237381399143974,0.9894736842105263,1.0,1.0,13/90,15.16%,CLEC12A;GPNMB;SLC11A1;FCGR2B;SIRPB2;TRIM25;FGR;C5AR1;FCGR2C;FGL2;MPP1;CD300A;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.3895147289616902,0.6235562396601673,0.8636363636363636,1.0,1.0,4/7,41.93%,SLAMF8;C5;DUSP1;PADI2
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3576096552535273,0.6234353431895743,0.9069767441860465,1.0,1.0,3/13,23.99%,NELFB;HEXIM1;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.3752931979087633,0.6233139398465681,0.9466666666666667,1.0,1.0,1/10,2.95%,MAPT
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.293703527922797,-0.6228978747540943,0.9583333333333334,1.0,1.0,12/12,70.67%,ZFP36;DHX36;ZFP36L1;ZFP36L2;TOB1;TNRC6B;AGO2;CNOT1;PABPC1;TNRC6C;CPEB3;CNOT7
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.293703527922797,-0.6228978747540943,0.9583333333333334,1.0,1.0,12/12,70.67%,ZFP36;DHX36;ZFP36L1;ZFP36L2;TOB1;TNRC6B;AGO2;CNOT1;PABPC1;TNRC6C;CPEB3;CNOT7
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.3740690052731891,0.622494409293575,0.9166666666666666,1.0,1.0,1/11,10.91%,RBPJ
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.3307447817155056,0.6220739373256349,0.963855421686747,1.0,1.0,3/26,15.56%,ERCC2;POLR1C;GTF2H3
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.28336071210704616,0.6218576643137034,1.0,1.0,1.0,151/1271,18.71%,BRIP1;CENPF;KLF4;NFIL3;ACVR1B;ZNF382;SAP30;ST18;CDK14;ZNF793;TGIF1;NFE2L3;ZBTB16;NFIX;EGR1;HMGB2;NRG1;TLE1;CREB5;NR4A2;ZNF483;AGT;NR4A1;MYRF;TSHZ3;NFIB;MEIS2;RORB;PQBP1;ZNF41;PIAS4;RFX2;PTPRK;ARID5B;POLR3F;VEGFA;SUV39H2;RUNX1T1;SOX4;ZNF93;RXRB;ZNF654;TCF7;APBB3;ZNF814;HINT1;SFMBT1;ARNT2;HDGFL3;RBFOX2;CSRNP3;OVOL2;INSR;ABCA2;PPP1R13L;KCTD1;OLIG1;HSF2;HIF1A;YEATS2;KDM3A;HCFC1;GLRX2;FOXN2;ATP8B1;ZKSCAN5;ZNF540;RUVBL2;POU6F1;TRPS1;PAX8;TCF7L1;ZNF235;ID2;POU5F1;SS18L1;MAFB;BHLHE40;LIMD1;MXD1;FOSL2;RBPJ;ZNF518A;KDM1A;CELSR2;SRA1;PRICKLE1;NR2F1;MXI1;PER1;ZNF850;ATAD2;ZNF34;ZNF536;ZNF549;ZNF550;NR4A3;DEAF1;TULP3;ETS2;CSRNP2;HIF3A;SOX6;HINFP;ZNF143;DRAP1;ING1;CCNC;TSHZ2;ZNF606;BRCA1;SMARCD3;SOD2;DPF3;E2F7;HCLS1;TRIM16;RLIM;LANCL2;YAF2;ZNF248;HIVEP2;ACTR5;WNT5A;UXT;TBX19;PICALM;HIC2;CEBPD;MLF2;ZNF292;ESRRG;CDK5R1;PCBD2;KLF9;BCL6;ZBTB47;PLCB1;ZNF789;ESR1;LITAF;CTBP1;MTA3;KLF13;NKX6-2;TFAM;CDKN1B;ZNF665;NR2C2;ZNF260;CXXC1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.42441687198564293,0.6213124529596126,0.9154929577464789,1.0,1.0,1/6,7.25%,IL7
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.3206696158266557,-0.6203169461700854,0.9545454545454546,1.0,1.0,2/13,6.36%,LGALS9;CD274
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.33676734964607546,0.6202885153716594,0.9753086419753086,1.0,1.0,5/23,25.16%,PLK2;XRCC3;C10ORF90;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.3930745513479326,-0.6201508231721558,0.8157894736842105,1.0,1.0,5/5,60.72%,VPS4B;APEH;PEX14;ABCE1;ETF1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.3858012491106016,-0.6200579851414534,0.9230769230769231,1.0,1.0,5/5,61.44%,RPP30;POP1;RPP38;POP5;SSB
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.34478786595138583,-0.6200150066186113,0.9090909090909091,1.0,1.0,2/6,13.24%,P2RY12;OPHN1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.33915862723390794,-0.6196447230428753,0.8571428571428571,1.0,1.0,8/8,66.11%,SALL1;HDAC2;INTU;MAP3K20;CREBBP;HDAC1;WDPCP;ECE1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.3532684751736769,-0.6195426216101955,0.8620689655172413,1.0,1.0,3/10,21.64%,APH1A;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.315416065361968,0.6192531652788897,0.9540229885057471,1.0,1.0,4/31,14.07%,SPRY1;ERRFI1;SH3GL2;RNF126
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.3219795641145302,-0.619171800455961,0.9375,1.0,1.0,2/11,19.28%,DVL2;LRP6
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.33443556009491576,0.618952271104854,0.9512195121951219,1.0,1.0,6/21,25.09%,RUNX1T1;WNT5A;TNF;RORA;ANKRD26;GPS2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.3684061497577158,0.6189403802096342,0.9565217391304348,1.0,1.0,4/11,24.04%,HSPB1;SOD1;ATP1B2;TF
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.33050514842121836,0.6184012677067992,0.9647058823529412,1.0,1.0,5/26,20.73%,RUVBL2;RAPGEF3;BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.33739435430495684,0.6179261669751688,0.9506172839506173,1.0,1.0,8/25,26.28%,TRAF2;SASH1;DUSP10;AIDA;GSTP1;TNF;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.31228410824775177,0.6177566322800405,0.9885057471264368,1.0,1.0,5/46,14.07%,AGT;SPRY1;ERRFI1;SH3GL2;RNF126
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.33448055398167437,-0.6175681316832583,0.9411764705882353,1.0,1.0,1/11,1.06%,TICAM1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.3630856862501672,0.6170510384089746,0.8780487804878049,1.0,1.0,3/9,30.01%,TIMELESS;SPIDR;BLM
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3916037293451288,0.6170406427948631,0.9295774647887324,1.0,1.0,3/8,37.03%,NDRG4;LRP1;HGS
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.3486014711703205,0.6167834215297467,0.961038961038961,1.0,1.0,2/16,8.38%,ACAT1;ACOT13
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.3486014711703205,0.6167834215297467,0.961038961038961,1.0,1.0,2/16,8.38%,ACAT1;ACOT13
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.36640995527853565,0.6167437133316789,0.9305555555555556,1.0,1.0,3/13,20.50%,DDX1;TSEN54;ZBTB8OS
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3349297783102656,0.6167187197140815,0.9390243902439024,1.0,1.0,9/27,29.46%,HSPA5;HSPA1B;HSPA2;HSPA14;BAG3;HSPA9;HSPA13;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.3707219584471295,0.6164801248203624,0.9130434782608695,1.0,1.0,2/10,16.75%,MFSD2A;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.2924560390571855,0.6157809421362359,0.9595959595959596,1.0,1.0,11/72,19.58%,ANXA1;CD55;FCGR2B;TRIM5;CASP5;FGR;NOD2;WNT5A;BCL6;GRK4;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.33016826082946416,0.6156955743995249,0.9523809523809523,1.0,1.0,1/25,7.38%,RBM3
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.3626873811122277,-0.6149654390012541,0.8461538461538461,1.0,1.0,3/5,24.91%,EXOSC9;EXOSC8;EXOSC2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.3626873811122277,-0.6149654390012541,0.8461538461538461,1.0,1.0,3/5,24.91%,EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.34445410704403506,-0.6147097203716807,0.868421052631579,1.0,1.0,5/5,65.58%,PGGT1B;RABGGTB;PTAR1;FNTA;CHM
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.3639483049438747,-0.6142907826223152,0.9655172413793104,1.0,1.0,3/6,17.41%,SVIP;SGTA;USP14
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.33952514402744194,0.6142301184566327,0.9411764705882353,1.0,1.0,5/20,20.67%,PINK1;EPHA4;PKD1;ATP5IF1;UBB
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.3937495773292083,0.6139572916856054,0.9342105263157895,1.0,1.0,2/10,28.51%,AUP1;BAG6
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.3053210506971998,0.6115424203016175,0.9787234042553191,1.0,1.0,6/71,17.44%,PQBP1;POLR3F;TRIM25;POLR1C;POLR3H;DHX33
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.30525739151430076,0.6113434393195218,0.9777777777777777,1.0,1.0,2/49,8.02%,FAAH;ACAT1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.3285829455433582,-0.6100118408672645,0.8214285714285714,1.0,1.0,2/6,14.26%,SMOX;SMS
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.359856512256957,0.6095921366703824,0.9594594594594594,1.0,1.0,4/11,29.26%,CALCOCO2;TMEM39A;FYCO1;UBQLN4
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.35464149853837146,0.6095825614926837,0.9358974358974359,1.0,1.0,4/14,14.56%,EIF2AK3;HIF1A;SULF2;BRCA1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.34732056242361736,-0.6089168791107032,0.90625,1.0,1.0,1/8,3.27%,ZDHHC3
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.4062270242400633,0.6088291297157327,0.9154929577464789,1.0,1.0,1/6,14.56%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.4051442987334734,0.6087432978645221,0.9090909090909091,1.0,1.0,3/5,39.06%,CPSF6;DHX9;KHDRBS1
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.4051442987334734,0.6087432978645221,0.9090909090909091,1.0,1.0,3/5,39.06%,CPSF6;DHX9;KHDRBS1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.3629559583504025,0.6087051779536464,0.961038961038961,1.0,1.0,4/12,21.25%,PIGQ;PIGF;PIGL;PIGG
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.277765432044606,0.6082766409795091,1.0,1.0,1.0,22/168,20.89%,NFE2L3;NFIX;NR4A2;ERCC2;NOCT;MTERF1;PAX8;POLR1C;DEAF1;DRAP1;POLR3H;GTF2H3;CEBPD;NELFB;KLF13;POLR2D;TFAM;ERCC6;TAF9B;TAF7;CDK9;POLR2G
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.35180914289150633,0.6078183370991128,0.9444444444444444,1.0,1.0,5/17,25.63%,ENC1;PSMB4;PSMA3;PSMB2;PSMA5
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.437219342913705,0.6076914276193717,0.9402985074626866,1.0,1.0,3/5,36.61%,CPEB2;DPH7;DPH6
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.3401509980327496,0.6076879434056429,0.9358974358974359,1.0,1.0,1/16,5.00%,SLC1A2
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.3986160436124481,0.6076662015027462,0.9545454545454546,1.0,1.0,1/6,20.18%,PRKAA2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3666302641392047,0.6072836792181387,0.9166666666666666,1.0,1.0,3/12,20.50%,DDX1;TSEN54;ZBTB8OS
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.4031554489381862,0.6072086968948774,0.9090909090909091,1.0,1.0,1/6,20.84%,HACL1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.4031554489381862,0.6072086968948774,0.9090909090909091,1.0,1.0,1/6,20.84%,HACL1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.38384136269157065,-0.6071937559221279,0.9444444444444444,1.0,1.0,2/5,23.93%,IL12RB1;SMAD7
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.23653886796791374,-0.6067213961585921,1.0,1.0,1.0,9/37,19.80%,ACTB;GATAD2B;RNF8;CECR2;RBBP4;ZNHIT1;CHD4;ACTR8;INO80
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.31888191513354713,0.6066042085095672,0.9642857142857143,1.0,1.0,5/30,14.16%,FCGR2B;GRIN2A;CACNA1B;IGF1R;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3088048376185501,0.6064997393439253,0.9318181818181818,1.0,1.0,12/50,27.26%,FBXL7;FHL1;RBX1;PSMB4;INTS3;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMA5;PSMD14
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.365584664882001,-0.6063314870269539,0.8823529411764706,1.0,1.0,2/5,22.45%,EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.310794980106322,0.6062419921737903,1.0,1.0,1.0,6/43,13.10%,ROBO2;NSMF;PAX8;GHR;SRA1;NR4A3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.3214012243324422,0.60623712447114,0.946236559139785,1.0,1.0,5/33,16.75%,PPP2R5A;NSMF;CALM3;PPP1R15A;CNEP1R1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.27468597318831756,0.6060217957325394,1.0,1.0,1.0,40/288,25.02%,TOM1L1;DTL;KCTD2;FBXL7;RNF144B;VPS37C;HERPUD1;TRIM25;TRIM9;RNF144A;ARIH2;RBX1;PSMB4;PINK1;OTUD7B;RNF126;RLIM;SYVN1;KLHL8;PELI1;HECW2;TBL1XR1;RNF13;UBXN2B;PSMC2;RNF149;FBXO7;ZNRF1;PSMA3;PSMB2;UCHL1;SPSB3;DDB1;PSMD5;HACE1;FZR1;PSMD7;UBE2D2;UHRF1;FEM1C
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.4125634941871387,0.6059436826460745,0.9253731343283582,1.0,1.0,3/6,31.74%,SRM;AMD1;SAT2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.2993080141602356,0.6055754516841091,0.967741935483871,1.0,1.0,11/64,23.73%,PLPP3;ABCA2;ACOT13;CPM;NIT1;CPE;NAPEPLD;GPAT4;SLC5A6;MTHFD1;BTD
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.38638519924098674,-0.6050761740539127,0.8285714285714286,1.0,1.0,6/6,61.39%,DENND4C;DENND1A;DENND4A;DENND3;DENND4B;MADD
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3667438020674344,0.6045110932623993,0.935064935064935,1.0,1.0,2/12,19.90%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.289625766304803,-0.6044354555838541,1.0,1.0,1.0,4/19,13.73%,GAL3ST4;B3GNT5;ALG2;RRM2B
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.3487232192268163,-0.6043512884434028,0.9130434782608695,1.0,1.0,5/5,65.15%,STX4;TAPBP;CALR;SEC22B;TAP1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.3243527888440946,0.6035337063391903,0.922077922077922,1.0,1.0,5/13,33.10%,EPHA4;RTN4RL1;PTPRS;GIT1;AJAP1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.33298123480348857,0.6034598492254136,0.9506172839506173,1.0,1.0,3/25,17.49%,SNAP29;VMP1;ATP2A2
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.37842014786927564,-0.6033272367255856,0.8636363636363636,1.0,1.0,2/5,10.49%,RDH10;DHRS9
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.36266476382144813,0.6031030211642392,0.9285714285714286,1.0,1.0,3/9,31.26%,RYR3;HSP90B1;DGKQ
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.32750608464791986,0.6028320920706266,0.9512195121951219,1.0,1.0,6/26,23.11%,IL7;HIF1A;TXK;WNT5A;HSPA1B;CASP1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.264274330975153,-0.6026930782702251,0.9523809523809523,1.0,1.0,3/15,14.81%,STOML2;MIGA1;FIS1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.3285763201644176,0.6022182831044672,0.9625,1.0,1.0,6/28,16.87%,FAM162A;PINK1;CIDEB;BNIP3;PRELID1;PYCARD
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.34817262479573724,0.6018269159463838,0.9625,1.0,1.0,4/14,28.96%,KANK1;ROCK1;RUFY3;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.2986898081996154,0.6016584947088128,0.9438202247191011,1.0,1.0,3/48,6.76%,MAPT;TFRC;EIF2AK3
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.36071617137980017,-0.6008955129058561,0.8421052631578947,1.0,1.0,1/5,15.33%,POLB
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.3169714814868071,0.6003803241514076,0.9404761904761905,1.0,1.0,3/24,15.56%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.2325822828679625,-0.6003795718262145,1.0,1.0,1.0,5/35,13.39%,CTC1;CDAN1;BCAR3;EGFR;KAT7
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.2231671261066178,-0.5999868151259248,1.0,1.0,1.0,7/45,16.57%,ACTB;SMARCD1;EP300;ZMIZ1;HMGA1;POLR1F;TBP
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.3814775927472282,0.5999247241988218,0.9444444444444444,1.0,1.0,1/8,9.28%,HERPUD1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.2934017134472067,0.5994752405903081,0.9888888888888889,1.0,1.0,10/46,26.59%,NUP133;RCC1;SPAST;REEP3;SEH1L;UBXN2B;NDC1;CHMP7;VRK1;POM121
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.31532969039419045,-0.5993512936279243,0.8823529411764706,1.0,1.0,2/7,16.78%,TASL;GRN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.369460666527091,-0.5991515834786167,0.90625,1.0,1.0,2/6,23.44%,FIS1;MCU
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.3754516771606399,0.5989798962522158,0.9714285714285714,1.0,1.0,1/8,13.03%,OGA
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.3583602301160235,0.5986693669753315,0.9166666666666666,1.0,1.0,2/10,22.29%,SLC25A21;PIPOX
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.3583602301160235,0.5986693669753315,0.9166666666666666,1.0,1.0,2/10,22.29%,SLC25A21;PIPOX
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.305367837234677,-0.5984480050908032,1.0,1.0,1.0,1/16,1.19%,CALCR
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.3223437319702838,0.5983315612817669,0.9324324324324325,1.0,1.0,7/22,25.03%,NRG1;CDC37;GAB1;NRG4;NRG2;PTPRR;CPNE3
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.3016136037759811,0.5979096511406344,0.9775280898876404,1.0,1.0,8/36,29.93%,CELF2;DDX1;RBM5;PRPF6;SNRPD2;SRSF5;SRSF9;PRPF19
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.35024469063908836,-0.5977525038477071,0.8947368421052632,1.0,1.0,1/5,12.15%,SLC25A33
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.28303714342418024,-0.5975498601567132,0.9583333333333334,1.0,1.0,2/17,9.28%,BAHD1;POLE3
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),-0.37906812350304064,-0.5971349762797431,0.8421052631578947,1.0,1.0,2/5,14.37%,SRC;NCK1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.28405187044955305,0.5965819413753837,1.0,1.0,1.0,23/99,24.32%,RPA2;WDHD1;RPS27A;DNA2;GINS1;PSMB4;POLG2;MCMDC2;POLE2;RFC4;ORC6;UBA52;PSMC2;UBB;DBF4;PSMA3;RFC1;PSMB2;TEFM;ORC3;PSMD5;RPA3;PSMD7
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.29175934919511176,0.5949814471866073,0.9655172413793104,1.0,1.0,10/44,21.04%,IL15;TFRC;ANXA1;IL7;NOD2;PDCD1LG2;PYCARD;THY1;HSPD1;RHOH
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.30095957682048297,0.5948263757258133,0.9615384615384616,1.0,1.0,8/22,33.56%,PINK1;ICA1L;FES;LEPR;LRRK2;RAB11A;MBTPS1;REEP5
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.3816583633556065,0.5948191129281015,0.9333333333333333,1.0,1.0,2/8,20.73%,CTBP1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.36511699497223105,-0.5943889636270401,0.8717948717948718,1.0,1.0,1/5,3.77%,CORO1B
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.31810332239479827,-0.5941152107414868,0.96875,1.0,1.0,2/7,20.91%,AKT1;STK10
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.28311431769074014,0.5938990550071266,0.9883720930232558,1.0,1.0,11/47,31.14%,PIAS4;NUP133;SEH1L;KIAA1586;BCL11A;NDC1;POM121;SAE1;NUP58;NUP153;TRIM28
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.31034105369962683,-0.5930269784509989,0.9354838709677419,1.0,1.0,1/7,9.77%,AGO1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.33997379352592344,0.5928633213977149,0.9333333333333333,1.0,1.0,2/11,16.75%,MFSD2A;CNEP1R1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.30690320308102903,0.5924281738570228,0.9880952380952381,1.0,1.0,3/28,15.56%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.2975750789529915,-0.592416105533384,1.0,1.0,1.0,4/10,16.69%,TP53;DDX5;MED1;TFCP2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.3911996505561909,0.5916201430430899,0.927536231884058,1.0,1.0,1/5,16.71%,SFXN3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3485193086378907,0.5916138400871941,0.9629629629629629,1.0,1.0,1/16,11.02%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.3467161114517763,0.5911180060963422,0.9473684210526315,1.0,1.0,2/9,23.99%,NELFB;HNRNPU
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.3240382243863396,0.5901622837375777,0.9294117647058824,1.0,1.0,2/19,13.70%,POLR3F;ZNF143
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.36811972324529013,0.5900866659052294,0.958904109589041,1.0,1.0,2/10,23.30%,KLF9;RDX
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.36170057101621983,-0.5899523329757669,0.9166666666666666,1.0,1.0,1/6,3.77%,CORO1B
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.2883127078338835,0.5898307440331255,0.9775280898876404,1.0,1.0,14/69,25.97%,RNF144B;PRICKLE1;RNF144A;ARIH2;RBX1;DNAJB2;HSPA1B;PSMC2;NOP53;LRRK2;BBS7;USP5;RNFT1;DDRGK1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.26581617590263174,0.5897781109227193,1.0,1.0,1.0,58/258,30.56%,KCTD2;FBXL7;HSPA5;FBXL2;SEC61B;HERPUD1;TRIM25;RPS27A;TRIM9;RNF175;STT3B;RBX1;PSMB4;DNAJB2;RNF126;FBXO27;DNAJB9;SYVN1;AUP1;ERLIN1;PELI1;UBE2J2;HECW2;TBL1XR1;FBXL5;FBXL13;UBA52;UBXN2B;PSMC2;UBB;ZNRF1;PSMA3;PSMB2;UCHL1;SPSB3;DDB1;PSMD5;HACE1;HSP90B1;FZR1;PSMD7;FAM8A1;FEM1C;PSMA5;MAN1A1;RHBDD2;PSMD14;TNFAIP1;KCTD13;BAG6;UBR2;UBE2D1;FEM1B;FBXL14;CTNNB1;NSFL1C;ANAPC7;ANAPC5
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.285416822996914,0.5891398745271538,1.0,1.0,1.0,13/47,32.52%,ARIH2;RBX1;RNF126;SYVN1;PELI1;ZNRF1;HACE1;UBE2D2;UBR5;UBE2D1;KBTBD6;RNF6;UBE2R2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.24143538934905462,-0.5890149397305147,1.0,1.0,1.0,5/51,8.46%,PSMB3;PSME3;PSMD12;PSMC4;PSME4
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.2882626821540065,0.5888031230568826,1.0,1.0,1.0,15/70,27.26%,NEK11;ERCC2;PSMB4;CDKN1B;PSMC2;DBF4;PSMA3;PSMB2;DDB1;PSMD5;FZR1;PSMD7;PSMA5;ATP2B4;PSMD14
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.33581572732859244,0.5887970028993542,0.9487179487179487,1.0,1.0,6/18,23.11%,TXN;TXNIP;PYCARD;APP;IL18;CASP1
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.2818678938369728,0.5877532012595822,1.0,1.0,1.0,19/82,22.31%,FRMD5;VEGFA;CELSR2;SEMA5A;EPHA7;EPHA4;ITGAV;PLXNB1;EPB41L4B;TGFBI;PLXNC1;ROCK1;ARHGDIA;PKP4;FES;ADAM22;IL18;TNF;P4HB
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.38955609269291935,0.5873584428449626,0.9428571428571428,1.0,1.0,4/6,33.54%,GFPT1;CSGALNACT1;GNE;EXTL2
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.3469718338237657,-0.5865960069713549,0.9642857142857143,1.0,1.0,1/7,9.77%,AGO1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.3374968976333052,-0.5858681100696231,0.8947368421052632,1.0,1.0,1/6,10.58%,SORL1
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.3374968976333052,-0.5858681100696231,0.8947368421052632,1.0,1.0,1/6,10.58%,SORL1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.3374968976333052,-0.5858681100696231,0.8947368421052632,1.0,1.0,1/6,10.58%,SORL1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.30569394578850584,-0.5858425240745715,0.9230769230769231,1.0,1.0,2/10,10.93%,LPL;NR1H3
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.3396209925615634,0.5856015793366575,0.9333333333333333,1.0,1.0,6/15,37.48%,POLR2D;POLR2G;POLR2A;TERF2IP;POLR2H;DAXX
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.3396209925615634,0.5856015793366575,0.9333333333333333,1.0,1.0,6/15,37.48%,POLR2D;POLR2G;POLR2A;TERF2IP;POLR2H;DAXX
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3063528105227527,0.5854925004253504,0.9882352941176471,1.0,1.0,2/27,9.95%,GEMIN2;XPO1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.27546784008986785,0.5854921077208822,1.0,1.0,1.0,21/115,24.92%,PDK4;HSPA5;EIF2AK3;NIM1K;MFSD2A;IMPACT;PRKAG2;NUAK2;SEH1L;NPRL2;PIK3R4;PPARA;SESN1;PRKAA2;CPEB4;ATP6V0B;ATP6V1D;ATG5;LRRK2;ATP6V0E2;ATP6V1B2
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3112431038409936,0.5851502181273714,0.9891304347826086,1.0,1.0,8/26,29.09%,RPS27A;UBA52;HSPD1;UBB;TNIP1;TLR5;IRAK3;TLR2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.27372864795289964,0.5849236453900009,1.0,1.0,1.0,14/111,19.16%,TBRG4;RNASEH2C;WDR74;RBM3;ADARB2;RBFOX2;TFIP11;NOVA1;CELF2;HNRNPA0;RBM5;HNRNPH1;POLR2D;SND1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.33146769203342646,0.584550256931467,0.9425287356321839,1.0,1.0,1/23,0.89%,RAB7B
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.3963365898322838,0.5839200288955159,0.8840579710144928,1.0,1.0,1/5,23.34%,FLOT2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3297806992213496,0.583438829924674,0.9634146341463414,1.0,1.0,4/18,20.18%,SOX4;RUVBL2;BRCA1;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.3911636979058594,0.5830293018359552,0.9305555555555556,1.0,1.0,3/5,32.62%,IMPACT;DDX3X;EIF4G1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.30760585514903493,-0.5828040076752865,0.92,1.0,1.0,3/8,18.20%,HLCS;PCCB;MCCC1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.3530644671331775,0.5824028652505843,0.9125,1.0,1.0,3/10,18.97%,ASPH;PLOD1;EGLN3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.34370760710204346,0.5823839055599057,0.9868421052631579,1.0,1.0,4/15,14.56%,EIF2AK3;HIF1A;SULF2;BRCA1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2898293830208913,0.5823439392016517,1.0,1.0,1.0,11/52,21.95%,AZI2;TRAF2;RPS27A;RIPK2;NKIRAS1;ROCK1;PRDX4;UBA52;TNFRSF1A;UBB;TNF
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.33558944249891276,0.5821473781572856,0.9864864864864865,1.0,1.0,1/16,4.19%,SLC6A15
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.36937961421325344,0.5816285546527932,0.9130434782608695,1.0,1.0,1/7,19.57%,ERCC6
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.343219813887355,-0.5809841109378892,0.8918918918918919,1.0,1.0,2/5,22.38%,TIRAP;CD36
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.24335466998533475,-0.5809339529188761,1.0,1.0,1.0,7/31,17.30%,TGFB1;SRC;EGFR;TGFA;AKT1;CBL;SLC30A10
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.2850600761875075,0.5807748093866888,0.9777777777777777,1.0,1.0,9/43,26.59%,NUP133;RCC1;SPAST;REEP3;SEH1L;NDC1;CHMP7;VRK1;POM121
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.2850600761875075,0.5807748093866888,0.9777777777777777,1.0,1.0,9/43,26.59%,NUP133;RCC1;SPAST;REEP3;SEH1L;NDC1;CHMP7;VRK1;POM121
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.2818741544078614,-0.5797455944854442,0.9565217391304348,1.0,1.0,2/10,10.62%,TMEM119;BHLHE41
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.289551423660449,0.5795059421565727,1.0,1.0,1.0,14/39,37.48%,FANCB;POLQ;POLR2D;POLR2G;MAGEF1;H1-0;UBQLN4;BLM;POLR2A;RIF1;ZRANB3;TERF2IP;POLR2H;DAXX
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.36211648748054404,0.5794805829835965,0.9508196721311475,1.0,1.0,1/7,15.77%,DUSP10
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.2849596254393232,0.579424214154345,0.978021978021978,1.0,1.0,10/54,19.43%,HMGB2;H2BC11;SLC11A1;GSDMD;FGR;NOD2;PYCARD;GBP2;HAMP;COLEC12
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.32596529749044517,0.578974348239424,0.9864864864864865,1.0,1.0,1/14,8.33%,SPIRE2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.32780650215428486,0.5788661169519719,0.9642857142857143,1.0,1.0,7/20,26.32%,PRKAG2;PHKG1;GYS1;PGM2L1;NR1D1;PGM1;GAA
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.29808366786880286,0.5786518497155542,0.9891304347826086,1.0,1.0,10/36,26.34%,RPS27A;NOD2;RIPK2;MAPK10;MAP3K13;UBA52;UBB;GPS1;GPS2;PTGER4
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.28452776459420975,-0.578514585088152,1.0,1.0,1.0,12/12,71.58%,AKAP8L;NRDE2;SUPT6H;NSUN2;TPR;NCBP2;SETD2;IWS1;KHDRBS1;DHX9;NUP153;CPSF6
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.34098746070243385,0.5784659735712108,0.935064935064935,1.0,1.0,2/13,19.91%,NSF;AP1AR
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.338305759600045,0.5783397945666975,0.9324324324324325,1.0,1.0,4/11,32.69%,ROCK1;TNF;LRP1;LRPAP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.3501096409426722,-0.5779538194845527,0.925,1.0,1.0,1/6,4.33%,CD200R1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.29396015611815546,0.5779084056702075,0.9883720930232558,1.0,1.0,12/47,27.26%,PDK4;SIRT5;PSMB4;PRKAG2;PPARA;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMA5;PSMD14
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.30900608840041116,-0.5776040554918755,1.0,1.0,1.0,7/7,69.12%,CDC42;ARHGAP21;YWHAZ;PDCD10;STK25;COPG1;RIPOR1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.39261169010049857,0.5774221499397153,0.9571428571428572,1.0,1.0,1/6,12.98%,ABCA1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.3142095069576802,-0.576672967084469,1.0,1.0,1.0,1/14,1.75%,ETS1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3140709290013134,0.5763452243864936,0.9772727272727273,1.0,1.0,7/20,28.50%,ANXA1;PLCB1;CCND3;RGCC;RDX;CDK10;DDX3X
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.3336582724774529,0.5755346861545414,0.972972972972973,1.0,1.0,3/16,10.75%,ANKUB1;ATP5MK;CCDC39
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.3160895469211901,0.5752707170697821,0.9625,1.0,1.0,2/21,10.03%,HMGB2;BHLHE40
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.3234685934785757,0.5749649379247883,0.9620253164556962,1.0,1.0,2/19,17.44%,EIF2AK3;DHX33
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.31618512454828446,0.5746686908409523,0.9746835443037974,1.0,1.0,2/17,13.16%,ACAT1;ALDH6A1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.31618512454828446,0.5746686908409523,0.9746835443037974,1.0,1.0,2/17,13.16%,ACAT1;ALDH6A1
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),0.37586609764095275,0.5740319590619173,0.9577464788732394,1.0,1.0,2/6,19.30%,TXK;TEC
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.3521940726300939,0.5732058273546056,0.935064935064935,1.0,1.0,4/9,35.85%,CFL1;TWF1;MICAL2;DSTN
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.3572786652807881,0.5731171240607436,0.9342105263157895,1.0,1.0,2/7,24.76%,PNKD;SYT11
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.38780410315750136,0.573110062208967,0.9605263157894737,1.0,1.0,1/5,9.56%,ROBO1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.33059271012966934,-0.5730006337909751,0.9629629629629629,1.0,1.0,1/7,7.21%,AKNA
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3514492627298005,0.5725814209023031,0.953125,1.0,1.0,1/9,14.98%,CD300A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.28532190278948033,-0.5725346681202246,0.9285714285714286,1.0,1.0,5/25,10.53%,DAB2IP;PYHIN1;TREM2;TMTC3;SMURF1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.30737651294509366,0.572349091715349,0.975609756097561,1.0,1.0,9/31,27.52%,RYR2;DNAJB2;VMP1;ATP1B3;ATP1B2;HNRNPU;UHRF1;DNAJC9;DYNLL1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.3062958742752111,-0.5719996039987355,0.9310344827586207,1.0,1.0,2/9,11.99%,IGF1;SKI
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.31172307123535836,0.5717742075363221,0.9647058823529412,1.0,1.0,1/27,2.95%,MAPT
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.3637197107531541,0.571111903150367,0.9615384615384616,1.0,1.0,3/9,21.95%,ALK;MFSD2A;TNF
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.3622423797666736,0.5708411130249125,0.9365079365079365,1.0,1.0,1/5,26.52%,SLX4
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.3218533525340826,-0.5708373819710932,0.9583333333333334,1.0,1.0,3/8,14.95%,IGF1;TMIGD2;IL12RB1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.29429594794182135,0.5706930257764609,0.974025974025974,1.0,1.0,7/24,29.46%,STXBP5L;DISP1;TNF;CHP1;PTPN1;SNX12;HSPA8
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.32143926103071896,0.5705846198306023,0.9487179487179487,1.0,1.0,1/13,11.30%,TENT4B
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.2877164573079391,0.5698845950730772,0.9615384615384616,1.0,1.0,7/32,27.43%,RBPJ;SORBS2;DTX3;NOTCH2;STAT1;DTX2;TRAF7
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.2988841151496318,0.5697506570400775,1.0,1.0,1.0,9/34,26.34%,CASP5;PDE2A;BNIP3;PIEZO2;TNFRSF1A;SLC9A1;CASP1;TLR5;PTGER4
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.34739577287394174,0.5693808071885409,0.948051948051948,1.0,1.0,2/12,22.90%,RBPJ;STAT1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.2764053973284462,0.5688218311303475,0.9894736842105263,1.0,1.0,1/79,0.55%,CLEC4E
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2764053973284462,0.5688218311303475,0.9894736842105263,1.0,1.0,1/79,0.55%,CLEC4E
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.38353350835892003,0.5683615573919778,0.9705882352941176,1.0,1.0,3/5,38.62%,GPS2;PLAA;PARP10
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3157032412761981,0.5681503605288569,0.971830985915493,1.0,1.0,2/14,15.61%,FANCB;POLQ
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.3067054812333371,-0.5678989709372154,1.0,1.0,1.0,1/9,8.91%,AKAP8L
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.2749237920867405,0.5676861697323751,1.0,1.0,1.0,10/60,22.79%,ZDHHC15;VPS37C;PARD3;ZDHHC9;SDCBP;PEX3;NACA;AQP11;SRPRA;SRP19
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.3212622646478996,0.5669223658089593,0.9634146341463414,1.0,1.0,5/12,36.74%,MFN2;LRRK2;MTM1;MARK1;ATCAY
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.33858644510403074,0.5662686531042834,0.9733333333333334,1.0,1.0,1/9,11.75%,GSKIP
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.31808614494273,-0.565481004443608,0.8846153846153846,1.0,1.0,4/9,22.22%,NCKAP1L;DOCK10;MEF2C;PPP2R3C
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.3547410478296442,0.5651522340978686,0.92,1.0,1.0,2/8,18.89%,PLXNB1;PLXNC1
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.39062262165225,0.5647595632132864,0.9242424242424242,1.0,1.0,2/5,30.10%,HSPA1B;HSBP1L1
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.39062262165225,0.5647595632132864,0.9242424242424242,1.0,1.0,2/5,30.10%,HSPA1B;HSBP1L1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),0.3634594550709207,0.5646599255278597,0.9710144927536232,1.0,1.0,2/9,28.77%,H1-0;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.3256048840648909,0.5646451750328663,0.975,1.0,1.0,1/14,7.25%,IL7
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.312657674626115,0.5646403369671615,0.9642857142857143,1.0,1.0,6/23,28.05%,SFXN3;ASIC2;TRPM7;SLC3A2;ATP1A2;ABCC8
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.283368269623121,0.5641360148949099,1.0,1.0,1.0,11/47,27.26%,FBXL7;FHL1;RBX1;PSMB4;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMA5;PSMD14
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.27388056360990676,0.563018405489572,0.9894736842105263,1.0,1.0,1/80,0.55%,CLEC4E
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.28500154270283423,0.5625249370491511,1.0,1.0,1.0,8/57,20.89%,WDR74;RBFOX2;DNA2;HNRNPA0;DDX1;HNRNPH1;POLR2D;POLR2G
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.3796645629814786,-0.562397933718226,0.9428571428571428,1.0,1.0,1/5,14.98%,BNIP2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.31150924864686746,0.5615045525841219,1.0,1.0,1.0,6/17,37.40%,EIF3A;EIF4A2;EIF3D;EIF4G1;EIF3I;DHX29
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2614827157878333,0.5613780454436264,1.0,1.0,1.0,29/165,23.96%,GPM6B;LRGUK;TRAF2;ANK3;NLGN1;BAIAP2L1;NLGN3;BSN;PKP2;WASF1;DARS1;PPID;PARD3;VCPIP1;VMP1;WNT5A;PICALM;TOGARAM1;FANCA;SPTBN1;RHOH;DLG4;RTN3;KNTC1;NLGN4X;NAPG;RHOU;RTN4;HFE
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.3675657672119107,0.5606411744665021,0.95,1.0,1.0,3/6,19.83%,SGCZ;SOD1;SGCD
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.31448742217292225,0.5602460205238086,0.935064935064935,1.0,1.0,5/15,34.15%,PTN;ZNF706;TAF6L;NCOA3;LOXL2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.34219227951230935,0.5591492895822899,0.9873417721518988,1.0,1.0,2/12,10.69%,ANK2;CAV3
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.2662976926918664,-0.5588679577047498,1.0,1.0,1.0,2/13,12.91%,WIPI1;ATG12
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.243377585329494,-0.5587438034647529,0.9444444444444444,1.0,1.0,4/19,17.04%,HSCB;ABCB7;MMS19;CIAO2B
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.2441219080186455,-0.5583910780147974,0.95,1.0,1.0,4/18,17.04%,HSCB;ABCB7;MMS19;CIAO2B
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.34107228991049887,0.5581331516833724,0.972972972972973,1.0,1.0,3/12,26.34%,ROCK1;SLC9A1;PTGER4
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.3171060408442962,0.5573521399755875,0.9873417721518988,1.0,1.0,4/21,23.71%,RAPGEF3;BAG3;UHMK1;BARD1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.26791400457517217,-0.5568849903054305,1.0,1.0,1.0,1/9,10.47%,ADRM1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.33911071188709696,0.5568349089693863,0.9552238805970149,1.0,1.0,2/10,13.44%,PUS7;NHP2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.27076912387701496,0.5565388980493963,0.9895833333333334,1.0,1.0,15/65,27.83%,FZD6;CELSR2;PRICKLE1;PSMB4;MAGI2;WNT5A;PSMC2;AP2A2;PSMA3;PSMB2;PSMD5;PSMD7;PSMA5;PSMD14;AP2S1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.33700321472711486,0.555720009364142,0.9452054794520548,1.0,1.0,2/8,30.99%,CDK9;CTR9
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3319331857511126,0.5557146379833992,0.9753086419753086,1.0,1.0,4/12,28.20%,HERPUD1;SYVN1;LRRK2;OPA1
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.29076907874127456,-0.5549647647718037,0.967741935483871,1.0,1.0,2/8,11.91%,SIRPA;NLRC3
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.2818607448875209,0.5546908875382744,1.0,1.0,1.0,4/54,14.70%,NLRP12;NOD2;SASH1;UACA
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.28994677492180176,0.5545977395233659,0.9885057471264368,1.0,1.0,12/31,34.32%,DGKB;DGKG;DDHD1;GPAT4;PLD1;LPCAT4;DGKE;DGKZ;LPCAT1;DGKQ;AGPAT3;GNPAT
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.33093010327421285,0.5543332437275326,0.9871794871794872,1.0,1.0,1/12,6.89%,GRM3
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.27067186754764627,0.5541344174441024,0.9764705882352941,1.0,1.0,12/34,29.07%,VBP1;FMN2;ITGAV;PFDN4;ROCK1;FLOT2;BANP;IRAK3;LILRB2;HSP90AB1;PFDN2;SNX12
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.2884780485045871,0.553359334804402,1.0,1.0,1.0,12/32,34.32%,DGKB;DGKG;DDHD1;GPAT4;PLD1;LPCAT4;DGKE;DGKZ;LPCAT1;DGKQ;AGPAT3;GNPAT
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.23951242678486623,-0.5529568766177785,0.9473684210526315,1.0,1.0,20/20,76.09%,ANAPC4;UBE2E2;UBE2A;UBE2E3;CDC26;PRKN;UBE2D4;ANAPC11;CDC16;UBE2H;ANAPC1;CDC27;CDC23;RNF4;UBE2B;UBE2D3;UBE2L3;ANAPC5;ANAPC7;FZR1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.3238444850379223,0.5524305970088689,0.9583333333333334,1.0,1.0,2/10,14.76%,CLASP2;SPAST
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.333164117060946,0.5523751723326799,0.9615384615384616,1.0,1.0,3/11,17.34%,GINS1;MCMDC2;RFC4
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.3643848654956273,0.5522812349139352,1.0,1.0,1.0,1/6,12.68%,ARG2
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.3643848654956273,0.5522812349139352,1.0,1.0,1.0,1/6,12.68%,ARG2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.21943153685654607,-0.5514532073838463,1.0,1.0,1.0,5/53,10.22%,RNF187;BFAR;DDB2;RNF19B;RNF8
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.36779686666340206,0.5511807802282149,0.9577464788732394,1.0,1.0,1/7,12.52%,IMPACT
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.380326845010119,0.5507092546796024,0.9714285714285714,1.0,1.0,1/5,17.47%,PDK3
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.3425110286022852,-0.5498102214935123,0.96875,1.0,1.0,2/6,20.49%,ANK1;LIN7B
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.3425110286022852,-0.5498102214935123,0.96875,1.0,1.0,2/6,20.49%,ANK1;LIN7B
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.287759870280005,0.5495887725917358,0.9882352941176471,1.0,1.0,7/27,21.12%,SEC61B;EMC7;SERP1;CAMLG;UBE2J2;APP;EMC10
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.35319720576265784,0.5493364858130695,0.9714285714285714,1.0,1.0,4/8,36.18%,FZR1;PTEN;RAB1A;GORASP1
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.35183197988766596,0.5488037908537963,0.9868421052631579,1.0,1.0,2/6,21.95%,ITGAV;TNF
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.30902272413034715,0.5480239559869126,0.9466666666666667,1.0,1.0,2/20,11.28%,GLYATL1;GLUL
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.34092612283810175,0.547340702038178,0.972972972972973,1.0,1.0,3/10,18.44%,B4GALT5;ST6GALNAC5;ST8SIA3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2609983097061737,0.5471734338672929,1.0,1.0,1.0,13/69,25.63%,FBXL7;FBXL2;RBX1;PSMB4;FBXO27;FBXL5;FBXL13;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMA5
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.23405865795967237,-0.5470794696744028,1.0,1.0,1.0,4/18,16.75%,PEX16;FIS1;ABCD3;PEX2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.34628542233238085,-0.5467856738050371,0.8823529411764706,1.0,1.0,1/5,4.12%,APPL2
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.3330961416824795,-0.5463450503058782,0.9642857142857143,1.0,1.0,6/6,66.71%,AKT1;RHEB;GSK3B;RFX3;CLOCK;FOXO1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.30717475535134386,0.5459741522007582,1.0,1.0,1.0,4/13,28.50%,KANK1;CCDC125;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.33896598707115067,0.5459728790756492,0.95,1.0,1.0,3/10,39.84%,RAD21;PDS5B;NIPBL
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.2593949734572193,0.5452792584455319,1.0,1.0,1.0,18/79,29.83%,SUV39H2;HCFC1;RUVBL2;SMARCD3;KDM4B;ACTR5;ESR1;ERCC6;SMARCC1;KDM6B;KDM5B;SMARCD2;KDM5C;SATB2;TAF6L;SMARCA5;ACTL6A;JARID2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.2875497425776754,-0.5442942280104959,1.0,1.0,1.0,7/26,11.24%,BAIAP2L2;CSF1R;ARHGDIB;ABI3;DAPK3;ABL1;HCK
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.30892871316018644,0.5436608428457887,0.9733333333333334,1.0,1.0,3/17,22.90%,IFITM3;AIM2;STAT1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.32184362400189737,-0.5435730039189977,0.9411764705882353,1.0,1.0,5/5,67.84%,UFD1;NPLOC4;DHX58;SEC14L1;C1QBP
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.29984520289972694,0.5435144402995953,0.972972972972973,1.0,1.0,5/16,33.65%,XRCC3;CHMP5;PDCD6IP;ATF5;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.33293881350358057,0.5432080371999803,0.9852941176470589,1.0,1.0,3/10,28.77%,BOK;TMEM33;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.31206112170684513,0.5431594731756445,0.9743589743589743,1.0,1.0,2/16,13.19%,TRAF2;SASH1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.331056489419469,0.5430093051100666,0.971830985915493,1.0,1.0,1/13,12.70%,PPP2R2B
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.23573109134515682,-0.5425126917530031,1.0,1.0,1.0,1/21,1.64%,INPP5K
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.3597693476108898,0.5422800899307423,0.9841269841269841,1.0,1.0,3/6,36.45%,HPRT1;PNP;NT5C2
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.3203802508401048,0.5422403303111389,0.972972972972973,1.0,1.0,2/14,22.40%,REEP3;SUN2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.27870035726904563,-0.5420689945720576,1.0,1.0,1.0,2/11,12.02%,KMT5B;SHLD1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.283041098854769,-0.5409374003539066,1.0,1.0,1.0,4/9,22.38%,TREM2;NLRC3;MYD88;CD36
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.309449110135562,0.5404617100189922,0.9879518072289156,1.0,1.0,5/15,31.05%,CCDC39;NDRG4;BBS7;SETDB2;MICAL2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.26722452321026285,0.5403989913879169,1.0,1.0,1.0,13/65,22.19%,DAPK1;TRIM5;BNIP3L;PLK2;PINK1;BNIP3;NPRL2;ROCK1;SESN1;PRKAA2;TRIM65;FBXO7;TRIM14
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.3575547860377585,0.5400872498359994,0.9571428571428572,1.0,1.0,1/8,14.56%,BRCA1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3370899914847298,0.5397399678337838,0.971830985915493,1.0,1.0,3/10,33.95%,LRRK2;OPA1;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.2934489592938601,0.5396113476501166,0.9879518072289156,1.0,1.0,6/26,20.74%,RUVBL2;KDM1A;BRCA1;CTBP1;SART3;CDK9
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.3264720517405978,-0.5395753770721802,0.8888888888888888,1.0,1.0,1/6,10.14%,SLC35G1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.23987965417137153,-0.538897061735832,0.9666666666666667,1.0,1.0,2/11,13.55%,SLC37A1;SLC37A4
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.23987965417137153,-0.538897061735832,0.9666666666666667,1.0,1.0,2/11,13.55%,SLC37A1;SLC37A4
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.24510613743878354,-0.5387037843080081,1.0,1.0,1.0,3/11,15.45%,CTC1;NBN;TERF2
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2532226176158191,0.5386325678642154,1.0,1.0,1.0,16/104,24.32%,VIM;CARHSP1;PCBP4;XPO1;RPS27A;PSMB4;HSPB1;UBA52;PSMC2;UBB;ZC3HAV1;PSMA3;PSMB2;SAMD4A;PSMD5;PSMD7
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.26715091075969954,0.5386061728451507,1.0,1.0,1.0,18/67,28.43%,MAT2A;BOK;GSDMD;ADCY8;SPAST;TMEM120B;POLQ;ALAD;PYCARD;AQP11;SLC9A1;KCNC2;ECT2;NACC2;PDCD6IP;OPA1;PRMT1;CPSF6
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.312220086186217,0.5374024471201603,0.9879518072289156,1.0,1.0,2/18,16.10%,RNF126;AUP1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.2419231292895087,-0.5371144758963349,1.0,1.0,1.0,4/17,15.32%,TREM2;NR1H3;NFKBIA;PTCH1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.2995857163300676,-0.5370843732269504,0.9285714285714286,1.0,1.0,2/7,9.19%,ALDH7A1;SMOX
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.28640686104924395,-0.536553777224032,0.9714285714285714,1.0,1.0,3/10,16.57%,DR1;GTF2B;TBP
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.29927983915684747,-0.5363912960764039,1.0,1.0,1.0,1/6,9.50%,ALOX5
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.2619749881028433,0.5351863205974471,1.0,1.0,1.0,10/52,23.11%,ANXA1;FCGR2B;CASP5;FGR;NOD2;WNT5A;BCL6;FOXP1;APPL1;CASP1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.2901651895605299,-0.5341611932164463,1.0,1.0,1.0,2/9,17.16%,AP4M1;LAPTM5
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.3206273505613503,-0.5339762380604938,0.90625,1.0,1.0,1/6,7.99%,ARFIP1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.33666834087145303,0.5338988230779199,0.9620253164556962,1.0,1.0,2/10,22.63%,LIPE;STS
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.3150335144475609,-0.5333481406324757,0.9230769230769231,1.0,1.0,2/5,14.52%,ICAM1;PLVAP
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.293414013694954,-0.5326619555659646,0.9642857142857143,1.0,1.0,2/6,15.32%,ENG;PTCH1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.36008445587790777,-0.5322216262486359,0.9565217391304348,1.0,1.0,1/5,9.36%,NFATC3
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.32219700745883795,0.5317690184308816,0.9583333333333334,1.0,1.0,2/9,18.70%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.32880657307840316,-0.5315455294039035,1.0,1.0,1.0,1/5,9.29%,TGFB1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.3048611327439167,-0.5314404748498452,0.9583333333333334,1.0,1.0,1/7,6.82%,NMNAT3
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.22400788681577877,-0.5314223410707521,1.0,1.0,1.0,5/28,15.05%,CBFB;EP300;PKN1;KDM5D;DDX5
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.24626240641493322,0.5302143874441994,1.0,1.0,1.0,19/248,16.20%,TBRG4;EIF4A3;ERCC2;PQBP1;WBP11;GEMIN2;DBR1;SRSF12;WBP4;BCAS2;TFIP11;ZMAT2;NOVA1;HNRNPA0;RBM4B;RBM5;GTF2H3;WDR83;MFAP1
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.3115533112464397,-0.5282565858895903,0.9428571428571428,1.0,1.0,1/5,7.23%,JMJD6
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.34726894908568406,0.5279408041465027,0.9722222222222222,1.0,1.0,2/6,23.96%,CD300A;HFE
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.32319465849478646,0.5278378725817447,0.972972972972973,1.0,1.0,4/9,33.24%,MFSD2A;MTMR9;MTMR4;ABCA3
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.2230421069340502,-0.5273253475056882,0.9523809523809523,1.0,1.0,4/25,10.27%,STAM2;VTA1;VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.22645739970253015,-0.5272475123143507,0.9545454545454546,1.0,1.0,4/24,10.27%,STAM2;VTA1;VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.3051213467336439,0.5270377139642465,0.9523809523809523,1.0,1.0,3/13,17.34%,GINS1;MCMDC2;RFC4
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.2630627843274849,-0.5254759591534306,1.0,1.0,1.0,4/15,13.34%,CEP97;CHMP2B;CCSAP;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.34574173596744023,-0.5253282727715244,0.9166666666666666,1.0,1.0,1/6,9.36%,NFATC3
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.24995188999230136,0.5252129759158263,1.0,1.0,1.0,11/89,21.54%,FZD6;GNAO1;CELSR2;PRICKLE1;PSMB4;WNT5A;PLCB1;PSMC2;AP2A2;PSMA3;PSMB2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.25233398378710453,-0.5251142740013304,0.9545454545454546,1.0,1.0,4/19,15.75%,CTC1;SRC;TERF2;EXOSC10
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.3035028978356607,-0.5245131977306902,0.9722222222222222,1.0,1.0,1/6,7.55%,PLA2G12A
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.24406313934386753,0.5245012784380059,1.0,1.0,1.0,40/208,30.05%,EIF4A3;PQBP1;WBP11;DBR1;SRSF12;WBP4;BCAS2;TFIP11;ZMAT2;NOVA1;HNRNPA0;RBM4B;RBM5;WDR83;MFAP1;HNRNPH1;POLR2D;SART3;POLR2G;PRPF6;SNRPD2;PHF5A;SFPQ;HNRNPU;SRSF5;SRSF3;HNRNPH3;HNRNPR;PRCC;BUD13;LSM5;SRSF9;SYNCRIP;ELAVL2;LSM3;HSPA8;SNU13;PRPF40B;PRPF19;POLR2A
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.3536202159975887,0.5244312161449343,0.9857142857142858,1.0,1.0,1/5,7.01%,SLC11A1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.2654779238958961,0.5236404352659408,0.989247311827957,1.0,1.0,7/32,22.66%,IFITM3;NELFB;POLR2D;CDK9;POLR2G;TRIM14;HEXIM1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.3341787326646617,0.5227081707797604,0.9743589743589743,1.0,1.0,2/6,30.01%,SLX4;BLM
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.32292418144802626,0.5224767370704461,0.9873417721518988,1.0,1.0,4/9,39.09%,SLC44A1;SLC25A26;SEC14L1;SLC25A19
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.2748189976400166,0.5222054122291028,1.0,1.0,1.0,5/40,23.89%,SOX4;CAMLG;HSPA1B;GTPBP4;CHP1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.36265449145654427,0.5213391433011617,1.0,1.0,1.0,1/5,23.34%,FLOT2
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.36046891571749784,0.5208999438702591,0.9487179487179487,1.0,1.0,3/6,42.52%,TRMT10C;SSB;POP5
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.2526072919780568,0.520821468571523,0.9895833333333334,1.0,1.0,14/63,27.83%,FZD6;CELSR2;PRICKLE1;PSMB4;WNT5A;PSMC2;AP2A2;PSMA3;PSMB2;PSMD5;PSMD7;PSMA5;PSMD14;AP2S1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.3015874715331704,0.5201081117955596,0.987012987012987,1.0,1.0,5/12,37.48%,CPEB2;ATF3;DDX3X;HSF1;DAXX
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.29374542928990194,0.5184346579026199,0.9878048780487805,1.0,1.0,3/14,22.25%,NREP;SOD1;RTN4RL1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.2770859357499597,0.5182344667788837,1.0,1.0,1.0,6/33,22.81%,ABCA2;IRS2;ABCA1;PNPLA8;PRKAA2;ABCB4
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.2385328832354495,-0.5177463196475243,1.0,1.0,1.0,5/59,8.46%,PSMB3;PSME3;PSMD12;PSMC4;PSME4
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.3344773947411807,0.5174762637386082,0.9696969696969697,1.0,1.0,1/6,10.37%,CHRM3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.31354814895884325,0.5174341669642675,0.987012987012987,1.0,1.0,3/10,34.79%,RASGRF1;PRNP;PJA2
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.324192537814768,0.5174336990671116,1.0,1.0,1.0,2/8,24.16%,RNF139;LRRK2
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.32068553557095403,-0.5172323843430865,1.0,1.0,1.0,3/5,24.77%,LAPTM5;MTMR2;ITCH
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.24105536276166833,0.5156570075361029,1.0,1.0,1.0,33/171,28.65%,VBP1;COPS5;RUVBL2;XPO1;RPS6;NHP2;EEF1B2;RPL14;RFC4;TCP1;PRDX4;HPRT1;HSPD1;SMARCC1;CYC1;PSMB2;PGK1;CTPS1;SNRPD2;GNL3;HNRNPU;PSMD7;CAD;SRSF3;ILF2;AP3S1;SRM;HNRNPR;PSMD14;EIF3D;HSP90AB1;SYNCRIP;SLC25A3
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),0.332466150915926,0.5152648004685744,0.9863013698630136,1.0,1.0,1/5,22.49%,PDHB
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.30447202400723017,0.5151236323043633,1.0,1.0,1.0,1/10,17.01%,INSIG1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.25106143406650905,-0.5150541359480538,1.0,1.0,1.0,5/19,18.18%,LAPTM4B;VTA1;CHMP2B;LYST;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),-0.3377442535478622,-0.5142354394070087,1.0,1.0,1.0,2/5,10.00%,NCKAP1L;IKBKB
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.3249069253226224,0.5140955454559586,0.972972972972973,1.0,1.0,4/7,32.65%,MTHFD1;HAAO;GOT1;KYNU
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.33097443151903494,0.5138143640002658,0.9857142857142858,1.0,1.0,1/6,25.18%,ADGRB3
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.2896110056925996,-0.513408483678482,0.9459459459459459,1.0,1.0,6/6,71.06%,SYK;JAK1;STAT5A;STAT5B;JAK3;PTK2B
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.2896110056925996,-0.513408483678482,0.9459459459459459,1.0,1.0,6/6,71.06%,SYK;JAK1;STAT5A;STAT5B;JAK3;PTK2B
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.36466647582857326,0.513152702360527,0.9848484848484849,1.0,1.0,2/6,31.43%,MEAF6;ING4
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.2521683588601813,0.51261374530582,1.0,1.0,1.0,4/38,20.89%,RIDA;ROCK1;ZC3HAV1;POLR2G
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.3440205284666183,0.5115171779039551,0.9848484848484849,1.0,1.0,2/5,32.46%,DDRGK1;LRP1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.28196388946258766,-0.5111996418583046,1.0,1.0,1.0,4/8,20.58%,AKAP8L;SAP30BP;SPHK2;AKAP8
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.27361119924593147,0.5109599901348713,1.0,1.0,1.0,5/19,31.90%,SAMD4A;CNOT6;PAN2;CNOT7;CNOT8
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.2922156614335035,0.5104874214875095,0.9866666666666667,1.0,1.0,6/20,25.16%,DYNC1H1;HSPA1B;GPSM2;HNRNPU;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.2678801559982384,0.5098687825327975,0.9873417721518988,1.0,1.0,8/30,27.52%,DYNC2LI1;IFT74;KIF3A;IFT122;SSX2IP;DYNC2H1;IFT81;DYNLL1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.27958155264399154,-0.5097849940181304,0.9615384615384616,1.0,1.0,2/9,15.49%,SRC;MED1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.2494654230085145,0.5093314538714521,1.0,1.0,1.0,17/92,25.70%,BNIP3L;PINK1;PRKAG2;BNIP3;CASP3;CDK5R1;NRBP2;SESN1;PRKAA2;UCHL1;ATP6V0B;ATP6V1D;LRRK2;ATP6V0E2;ATP6V1B2;ATG13;VPS26B
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.2832445244289213,0.5091940026469343,0.9866666666666667,1.0,1.0,3/16,21.97%,RUVBL2;MORF4L2;MEAF6
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.28686761482070117,-0.5089390464852902,1.0,1.0,1.0,3/8,19.84%,HM13;SPCS1;SEC11C
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.2888118056666464,-0.507449813128126,0.9142857142857143,1.0,1.0,2/5,22.28%,CHCHD10;KCNK1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.3192500074514706,0.5074243052578802,0.9861111111111112,1.0,1.0,3/9,34.23%,PMPCA;PMPCB;IMMP2L
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.2840199256740729,-0.5069986385391373,1.0,1.0,1.0,7/7,71.62%,SORL1;INPP5F;RAB11B;ARHGAP1;EIPR1;ACTN2;ATP9A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.3070473518083181,0.5069865597221513,0.9880952380952381,1.0,1.0,2/9,23.11%,HSPA1B;CASP1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.2812481727408171,0.5057586780550641,1.0,1.0,1.0,1/17,11.02%,KDM1A
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.29093208949324056,-0.5056619211951904,0.9743589743589743,1.0,1.0,5/5,70.93%,TIRAP;RELA;CD14;MAPK14;TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.29093208949324056,-0.5056619211951904,0.9743589743589743,1.0,1.0,5/5,70.93%,TIRAP;RELA;CD14;MAPK14;TLR2
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.2936483496397303,0.5044470882788857,0.9743589743589743,1.0,1.0,1/13,11.02%,KDM1A
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.34275640199818275,0.5042736956081212,1.0,1.0,1.0,3/5,29.87%,KIF3A;FYCO1;KIF13A
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.274940651550431,0.5037042783104424,1.0,1.0,1.0,4/25,26.93%,ABCA1;ABCA5;OSBPL5;ABCG1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.23720884755269822,0.5033028770518804,1.0,1.0,1.0,43/257,25.95%,CLIP3;TBC1D8;NAPA;ARF6;TBC1D13;NLGN1;NUP133;RAB20;AKAP6;XPO1;RANBP3L;PRICKLE1;TBC1D15;FAM53C;HEATR3;NSF;TNPO2;PKD1;CDC37;RANBP17;TMED10;RPL11;SNX17;STXBP2;SCG5;RAB21;SURF4;SRPRA;TECPR2;STX2;STX19;BAG3;APPL1;TBC1D2;NAPG;CHP1;IPO7;CTTN;RAB5A;TBC1D14;CSE1L;VPS26B;NUTF2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.28399998508724084,-0.5029951248906314,0.96875,1.0,1.0,2/8,11.42%,C3;SCARF1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.29587028068487947,0.5024619071777273,1.0,1.0,1.0,4/13,28.22%,ABCA2;SPTBN1;APPL1;ZDHHC7
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.2463659955683098,-0.5014275453238631,1.0,1.0,1.0,2/14,12.23%,IPPK;PIH1D1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.34494945576933417,0.5007270285997348,0.9743589743589743,1.0,1.0,3/5,41.05%,ATG2B;ATG2A;ULK1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.2507373606737611,0.49834359854970506,1.0,1.0,1.0,9/37,29.40%,HSPA5;TFIP11;IMPACT;AIDA;NOP53;JAM3;PTGER4;DDX3X;RIOK3
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.3259807568019075,0.4976729799982671,1.0,1.0,1.0,2/5,25.52%,PRKCB;VRK1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.32862702216589507,0.4973492226546852,0.972972972972973,1.0,1.0,2/5,29.26%,TMEM39A;UBQLN4
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.3201043560755791,-0.4969238987658815,0.9705882352941176,1.0,1.0,5/5,68.01%,SUPT6H;PHF1;OGT;MTF2;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.2602558228632613,-0.4968756203657837,0.9333333333333333,1.0,1.0,4/10,24.93%,SRC;DNAJC13;MAP2K2;DENND10
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.3395158318478139,0.4968730289451975,0.9636363636363636,1.0,1.0,1/5,25.09%,GPS2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.2808158539116916,0.49606515015846486,1.0,1.0,1.0,1/16,7.79%,SVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.2808158539116916,0.49606515015846486,1.0,1.0,1.0,1/16,7.79%,SVIL
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.30264405833441255,0.49466745346034413,0.9523809523809523,1.0,1.0,2/8,22.55%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.27326652695744635,0.49326743585941973,0.9878048780487805,1.0,1.0,7/31,29.40%,POLR3F;RIPK2;TRIM56;DDX3X;TLR2;IRF1;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2695091481800308,0.4927939043726264,1.0,1.0,1.0,8/28,26.81%,SEPTIN4;BOK;SOD1;UBB;SFPQ;NACC2;GSDME;BCLAF1
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.31112887712062265,0.4918711048445123,0.9733333333333334,1.0,1.0,1/7,23.99%,HNRNPU
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.3238691777837745,0.4911451852031644,1.0,1.0,1.0,2/6,28.16%,SRM;AMD1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.2966153633720501,0.49054118319667356,0.958904109589041,1.0,1.0,2/6,28.45%,BCLAF1;RPS6KA3
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.26538210084497815,0.49029228487174564,1.0,1.0,1.0,6/22,28.80%,HERPUD1;SYVN1;AQP11;LRRK2;OPA1;USP25
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.2812341219480175,0.490036895930486,0.9880952380952381,1.0,1.0,3/15,32.12%,PRKRA;AGO4;DICER1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3061589411193335,0.4892173106415402,0.9487179487179487,1.0,1.0,2/8,25.12%,MFN2;ATG13
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.25906913913591195,0.48831976310955194,1.0,1.0,1.0,4/29,23.63%,PINK1;BNIP3;FBXO7;ATG5
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.22494045603266727,0.48743831946759797,1.0,1.0,1.0,39/200,27.75%,TRAF2;CLSPN;MINDY1;COPS5;HIF1A;HCFC1;USP35;RPS27A;PSMB4;OTUD7B;TOMM20;BRCA1;VCPIP1;ACTR5;ESR1;USP38;SMAD1;TAF9B;UBA52;PSMC2;UBB;PSMA3;PSMB2;OTUD1;UCHL1;TNIP1;PSMD5;BARD1;PSMD7;USP5;USP48;PSMA5;CFTR;SUDS3;USP11;ATXN7L3;PSMD14;PTEN;CCP110
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.28273222013567634,0.4852350115968063,1.0,1.0,1.0,4/13,24.16%,RRP1B;CPEB2;RDX;LRRK2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),0.3216744254291892,0.4837075078520298,1.0,1.0,1.0,2/5,28.50%,RSAD2;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),0.3216744254291892,0.4837075078520298,1.0,1.0,1.0,2/5,28.50%,RSAD2;DDX3X
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.2976519882994703,-0.481956097139978,0.9722222222222222,1.0,1.0,5/5,70.25%,SURF1;CYBA;COX18;COX10;COA6
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.3193689833438894,0.47957866110614195,0.9861111111111112,1.0,1.0,1/5,24.16%,LRRK2
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.2985843833238422,0.4775167064693244,1.0,1.0,1.0,5/11,31.98%,SMARCD3;SMARCC1;SMARCD2;ARID2;SET
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.2985843833238422,0.4775167064693244,1.0,1.0,1.0,5/11,31.98%,SMARCD3;SMARCC1;SMARCD2;ARID2;SET
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.2551058540415142,0.47583306391584923,1.0,1.0,1.0,4/25,20.79%,BMI1;SMYD5;SUZ12;EZH2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.24092697906926167,0.47517738181893115,1.0,1.0,1.0,9/58,24.92%,EIF2AK3;IMPACT;SEH1L;NPRL2;SESN1;ATP6V0B;ATP6V1D;ATP6V0E2;ATP6V1B2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.25836716318431824,0.4744566815357271,0.9871794871794872,1.0,1.0,7/23,32.87%,POLR3H;SNAPC3;ICE2;SNAPC4;CRCP;ELL;GTF3C6
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.2408471218640153,0.47384811041428454,1.0,1.0,1.0,9/59,24.92%,EIF2AK3;IMPACT;SEH1L;NPRL2;SESN1;ATP6V0B;ATP6V1D;ATP6V0E2;ATP6V1B2
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.3051955369963776,0.47313206302483574,1.0,1.0,1.0,2/7,26.13%,MTHFD1;ADI1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.2690219589263159,-0.4720717263459161,1.0,1.0,1.0,1/11,5.05%,PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.26106899583298004,0.47168042291365697,1.0,1.0,1.0,6/15,35.58%,NR4A3;MFN2;JUN;MEF2D;GJA1;BMPR1A
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.23882515715027028,0.47163773360689215,1.0,1.0,1.0,9/47,26.44%,NRG1;CDC37;GAB1;NRG4;IQGAP1;NRG2;PTPRR;CPNE3;REPS2
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.28241619228336495,-0.4715357737365896,0.8888888888888888,1.0,1.0,6/6,71.78%,RCC2;SMC5;NUMA1;SMC6;SIRT2;RAD18
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.2583685516169124,-0.4708044663812302,1.0,1.0,1.0,2/8,15.13%,CEP72;MARK4
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.2785551760746112,0.4703382331886006,1.0,1.0,1.0,3/20,26.29%,SIRT5;SIRT3;LYPLAL1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.32517570587676403,0.4694541149221498,0.9705882352941176,1.0,1.0,1/5,19.04%,ROCK1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.2483885531305786,0.4679509760348603,1.0,1.0,1.0,10/41,29.93%,STT3B;OGA;FBXO27;NR1D1;DDB1;TRIM24;CLPX;BAG6;HSPA8;PRPF19
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.27373385626395835,0.4666045899630569,1.0,1.0,1.0,3/11,25.47%,CHMP5;PDCD6IP;CHMP7
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.30849509865036817,0.4661683157455314,0.9852941176470589,1.0,1.0,1/6,21.97%,MEAF6
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.3043390086699711,0.4655546934427861,1.0,1.0,1.0,3/7,32.50%,CPT1A;TMLHE;ACADM
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.3062087521105506,0.4650132745881686,1.0,1.0,1.0,2/6,29.34%,MAPK8IP1;IRF1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.21958669480779203,0.464375045799479,1.0,1.0,1.0,43/132,34.32%,INPP4B;MTMR7;DGKB;SELENOI;MFSD2A;SLC44A5;DGKG;PEMT;ETNPPL;DDHD1;PIK3R4;MTMR9;CHPT1;SLC44A1;GPAT4;CDS2;PLD1;PLEKHA3;RAB5A;LPCAT4;CPNE3;DGKE;MBOAT7;MTM1;DGKZ;PTEN;PIP5K1A;PGS1;PCTP;LPCAT1;AGK;MTMR4;PLEKHA8;FIG4;DGKQ;PLEKHA4;SYNJ2;SACM1L;AGPAT3;CDIPT;MTMR6;PIP5K1B;GNPAT
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.2353777446549161,-0.4634665468170779,1.0,1.0,1.0,2/12,18.16%,PJVK;ACBD5
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.24441433263621232,0.4626148779276387,1.0,1.0,1.0,3/27,22.65%,CSKMT;EZH2;EEF1AKMT1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.24539402406780647,-0.46138766216515187,1.0,1.0,1.0,1/11,6.99%,CDAN1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.24403636840002585,0.4609042817479378,1.0,1.0,1.0,3/29,25.97%,RETREG1;VRK1;DDRGK1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.24024998022308364,-0.45899990521970235,1.0,1.0,1.0,13/13,76.01%,CHMP2B;CNTROB;CHMP2A;VPS4B;MITD1;RHOA;CHMP6;CHMP1A;VPS4A;CHMP4B;CHMP7;PDCD6IP;CHMP5
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.28703645065727607,0.4588489975338576,0.9857142857142858,1.0,1.0,2/5,34.94%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.28703645065727607,0.4588489975338576,0.9857142857142858,1.0,1.0,2/5,34.94%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.28703645065727607,0.4588489975338576,0.9857142857142858,1.0,1.0,2/5,34.94%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.2878809974091139,-0.4585075101353823,0.972972972972973,1.0,1.0,1/6,13.91%,PRDM11
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.2723164990970768,0.45810728647632415,1.0,1.0,1.0,3/11,32.12%,PRKRA;AGO4;DICER1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.28893445203476037,0.4579627852647292,1.0,1.0,1.0,1/6,20.04%,KLF7
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.25228949673099726,0.457881777065133,1.0,1.0,1.0,7/22,33.24%,PLTP;ABCA5;ABCB4;GPS2;LRP1;NR1H2;ABCA3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.25409252186185216,0.4570208347278967,1.0,1.0,1.0,6/22,31.55%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1;STN1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.22504791843630131,0.4558631502841636,1.0,1.0,1.0,7/67,20.79%,TDG;BMI1;POLR1C;SMYD5;ERCC6;SUZ12;EZH2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.28803191365781305,0.45521909402884125,1.0,1.0,1.0,1/8,17.65%,UGCG
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3013591715575539,0.4551427619035408,0.9857142857142858,1.0,1.0,4/6,37.58%,RIOK3;C1QBP;SEC14L1;DHX58
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.3056589750644597,0.4546530443012079,1.0,1.0,1.0,3/6,32.69%,ROCK1;LRP1;LRPAP1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.21112904016801717,0.4526403709721645,1.0,1.0,1.0,42/226,30.05%,EIF4A3;PQBP1;WBP11;GEMIN2;DBR1;SRSF12;WBP4;BCAS2;TFIP11;ZMAT2;NOVA1;HNRNPA0;DDX1;RBM4B;RBM5;WDR83;MFAP1;HNRNPH1;POLR2D;SART3;POLR2G;PRPF6;SNRPD2;PHF5A;SFPQ;HNRNPU;SRSF5;SRSF3;HNRNPH3;HNRNPR;PRCC;BUD13;LSM5;SRSF9;SYNCRIP;ELAVL2;LSM3;HSPA8;SNU13;PRPF40B;PRPF19;POLR2A
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.25336244869210967,0.451988276650245,0.9866666666666667,1.0,1.0,1/16,9.39%,CSKMT
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.2587554338347986,0.45154288619937294,1.0,1.0,1.0,6/20,24.32%,TRIM25;SRA1;BRCA1;ESR1;GSTM3;TRIM24
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.23638232271325796,-0.4505495062055228,1.0,1.0,1.0,5/5,76.38%,PPP1R12B;SRI;TPM1;ANXA6;ATP1A2
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.21796899715279974,-0.4503425800025922,1.0,1.0,1.0,10/10,78.23%,BUB3;RCC2;ZW10;MIS12;IK;KNL1;CHAMP1;MTBP;ZWILCH;CENPT
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.23629995967646505,0.45028032718722155,1.0,1.0,1.0,9/42,29.40%,POLR3F;RIPK2;PYCARD;PTPRS;TRIM56;DDX3X;TLR2;IRF1;RIOK3
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.26952101039995524,0.4498173165290276,1.0,1.0,1.0,2/11,21.63%,HOOK3;TBCCD1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.27160565320391405,0.44970681983803973,0.9864864864864865,1.0,1.0,2/11,23.30%,KLF9;RDX
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.2736693667822824,-0.44784923703576046,1.0,1.0,1.0,1/7,10.92%,ABL1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.2736693667822824,-0.44784923703576046,1.0,1.0,1.0,1/7,10.92%,ABL1
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.2626056623837339,0.4470948000999687,1.0,1.0,1.0,4/13,35.28%,PRKRA;AGO4;DICER1;DHX9
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),-0.27890637425956416,-0.44504424633888984,1.0,1.0,1.0,4/5,27.58%,TYROBP;ATP6AP1;TRAF6;CCR1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.20052726162780748,0.44317838253999264,1.0,1.0,1.0,36/173,31.60%,KCTD2;ENC1;TRIM9;RBX1;PSMB4;RNF126;SYVN1;RNF139;PELI1;HECW2;TBL1XR1;UBXN2B;PSMC2;ZNRF1;PSMA3;PSMB2;UCHL1;SPSB3;NR1D1;DDB1;PSMD5;HACE1;PSMD7;FEM1C;PSMA5;PSMD14;TNFAIP1;KCTD13;BAG6;FEM1B;PRPF19;CTNNB1;NSFL1C;MAEA;KBTBD6;FBXL17
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.2304681466592898,0.4386507585603747,0.9876543209876543,1.0,1.0,5/32,25.12%,PINK1;BNIP3;FBXO7;ATG5;ATG13
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.2638211333118548,0.43815964579704275,1.0,1.0,1.0,2/11,20.43%,SLC25A4;SLC25A24
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.2641609353352098,0.43673522062308623,1.0,1.0,1.0,2/10,20.43%,SLC25A4;SLC25A24
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.2602067512557398,0.4361782443118094,1.0,1.0,1.0,2/11,23.68%,COQ6;COQ2
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.28479606948630865,0.43589193840814977,1.0,1.0,1.0,3/6,33.63%,MICB;C1QBP;TRAF3IP1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.24507866234484937,-0.4352536246541698,1.0,1.0,1.0,5/5,75.51%,RBBP4;ASF1A;HAT1;CHAF1A;NASP
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.24507866234484937,-0.4352536246541698,1.0,1.0,1.0,5/5,75.51%,RBBP4;ASF1A;HAT1;CHAF1A;NASP
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.2650731336223345,0.4340322940844028,1.0,1.0,1.0,2/10,23.68%,COQ6;COQ2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.2650731336223345,0.4340322940844028,1.0,1.0,1.0,2/10,23.68%,COQ6;COQ2
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.29683090552597774,0.4320645887314677,1.0,1.0,1.0,2/5,24.63%,SERINC5;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.27757134951379553,-0.4308962260767542,1.0,1.0,1.0,5/5,72.26%,CHMP2A;VPS4B;CEP295;CEP120;CCP110
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.2596184769256345,-0.4306361349287695,1.0,1.0,1.0,3/8,19.48%,RNF8;RNF168;MSH6
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.2887144835530239,-0.4295144779863808,1.0,1.0,1.0,1/5,13.91%,PRDM11
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.23219889731525384,-0.42893054437637385,1.0,0.9995417961457589,1.0,3/14,17.00%,WIPI1;KLHL20;AP4M1
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.29767857878759346,0.42644817239645105,1.0,1.0,1.0,2/5,30.31%,SETDB2;MEGF8
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.26115507698570334,0.41926538938589414,1.0,1.0,1.0,1/9,15.55%,ITGAV
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.2531449764284281,0.4182444422400101,0.9864864864864865,1.0,1.0,2/11,31.82%,GNL3;RAD21
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.23054206574485592,0.41751651123117994,1.0,1.0,1.0,8/24,36.52%,OTUD7B;OTUD1;PSMD14;USP25;UIMC1;OTUD7A;CYLD;BABAM2
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.23506003530412375,0.4109651697787977,1.0,1.0,1.0,3/11,23.64%,KCNB2;ENO1;ATP1A2
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.2428983053539605,0.4093245897730521,0.9864864864864865,1.0,1.0,5/13,37.58%,NOP53;ZCCHC3;C1QBP;SEC14L1;DHX58
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.20962629134497768,-0.4062170917640912,1.0,1.0,1.0,3/8,20.58%,AKAP8L;SAP30BP;AKAP8
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.25677938809629797,0.40194360679764596,1.0,1.0,1.0,3/7,31.79%,RDX;PRKACB;TTN
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.26669209297631374,0.3974792623423307,1.0,1.0,1.0,2/6,29.64%,NOTCH2;FBN1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.21807102564961625,0.38104122784102457,1.0,1.0,1.0,4/21,33.77%,AUP1;BAG6;FBXL17;ZER1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.2533366348672349,0.3691082989973577,1.0,1.0,1.0,2/6,29.67%,PPARA;OSBPL8
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.23570168332108424,0.359482574075002,1.0,0.9998930710008554,1.0,2/5,34.64%,ATP8A2;ATP8A1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.18929555532050488,-0.358705894139618,1.0,0.9999903631177242,1.0,4/11,21.64%,APH1A;ADAM10;APOE;PSEN1
